<SEC-DOCUMENT>0000014272-23-000104.txt : 20230427
<SEC-HEADER>0000014272-23-000104.hdr.sgml : 20230427
<ACCEPTANCE-DATETIME>20230427115652
ACCESSION NUMBER:		0000014272-23-000104
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		23853560

	BUSINESS ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmy-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed,d:4194f427d28d478983f182f54c3aa849--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:bmy="http://www.bms.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmy-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV80LTEtMS0xLTE5MzkzNw_9076198d-6239-40c8-b99a-e220089f3a0a">0000014272</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV82LTEtMS0xLTE5MzkzNw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV83LTEtMS0xLTE5MzkzNw_603c5d68-fb71-49f5-9bc2-4917002dfc3f">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV84LTEtMS0xLTE5MzkzNw_b44714a4-516d-4798-a21d-a46959e2bc26">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV85LTEtMS0xLTE5MzkzNw_13fe9ef2-7423-4ed6-88bd-ac3270ed37eb">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV8xMC0xLTEtMS0xOTM5Mzc_e665e000-74a1-4967-88db-5b1b6c229f43">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmy-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44f500456834760bfae19b9494f52e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2639f048af2d48f69a7b8f1ca961fb27_I20230420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173cd3ea7b2b49529ff5d4c934429570_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9853bb7a3895445aab6c6693e972cc56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i106b7888c0d4475ca672b2990121652e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3beba77678438b8c93338a7baf0121_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa468a5115d642289601acca9b294408_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d21276df0654c93ac72564897390491_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i935d511681b44311b77fcd048a596f5b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d681d267ed470d92055de618442973_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if16220a1074c4178b586f8672a245ab8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e55a2a221624cab9060feb297795982_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibafe51b214744a71a14666c467535d3d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc11bddafe3247ceb277ed8aa08dbd78_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669af0d6c71643c09655afe1a25c8cd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99faa9fe613448bbad022be735707c0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49988370bf5e41738d52d3a570580e68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78b757ad36634d1d80030dba29f7e6e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52b753521774addbcfdc534e4ab4c62_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09688e31f1224e86b9cbe88539af9e20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ief3c35e8db3d4577b4932518cea38278_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7480b54585f34368b4296b7c142bae61_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781c6b749cec4403995ae4192bf4a6e7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44b7e0dd88f7442eb9ada653b02796b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74867368269444eadf64059422c5acc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac4c3c432dec4175884bcb7121ad7b2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6661c44be2040ddb58e23420f3a637a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0632013d3854087980e90d795c1d8d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8864048307a4f86a8062658906f4268_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e01113e4591475099df5c4095d6e115_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae64455b039742d787ed2de5fd251442_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fc8f9965414a0b804d69bb0c52f940_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a360ac8b1d44afd9d65385129373f29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84eee663f7a54ab6981f1221be773582_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78114eba6d1431e8eb7de14cb30d209_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8ca2459264488eb91f63c4799ca142_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0873c9ac73324059911ec26977fd62b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i781c7d4e422d4246a9f62677261a6759_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f61e0b967e941f3a13b8cdae92da602_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe21eb2b773241f9975587ff0d8c4222_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice34df82dfdc4797b4a08dd853517723_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d461f0363f4426b69a52fb5f5622fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d1821f5f4446deb6d810a66e604eee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0d2ac040da41489147ca9c96170c3d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3125f46fdab84e90911ceb3d16a6f77a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af8bc7b28d042ba94f91804fafa4966_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341f444f1ff84f0393e86932e2bbcb98_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14834d88f10b45639a717a5dfcb76963_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea7520f9b6d647d5a6e43c02f239fa52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67aea7fd88984640aed0e394579193a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc622a66bb01497482da48709daace5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4430059dc6204ccb8d6012d670a5011e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib10f8c00022a496aa567f0b2b08b1734_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7361bec49a941e5b6e8ee3761986ec8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35cd3e93ee9f44a4863c125f17563e83_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48499737f5104edab86a6d804fd035ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="icf13f856670744549308e754a728bc4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f78af08373f410f81a0ec2062e53827_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fea4d1110624ccc8643189b89b7a264_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3d1009dc364c098f6d58018920196a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib010a27d7530452ba7bcd495694e0d53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8230d684b10a4394bebb9852f5a60f05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id817fc04753e4b50b4934057f0e357b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3029667aba2c41ac801aca48ee182c97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb614bb6595439091cb705f7444f43b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd1e462128ec4e4ab153cea1e6830820_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c44eb56471340c0b0549845ec48e95f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1425120cc214e32ba4675730b4b6cc8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e1112374584215b2d716c9948e2cbb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f0db91831245a98d378841a723e8a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb81acd0695b4f10a417aade9fb25bb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d797e1487542f49ef9a8d6421d410d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic568e0cfa6234853938bade8f38decad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5802b471774f467b8b4ed57b33660afa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec0fba4252a4678af79e56fbc82990b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c615915438143509820de8d42395deb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8cfb2e34204828954f511d64e793e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be2043674aa491d9adeb9750ff992df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4e61e9185bb4a9eb351c39c8c716d28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d38948aff744438294caa148a86cdd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f582f93ce4e422da958adfc85f8013b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218b6bfa5bcf40ed94120181ea6072f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i155f9dbf83674147910134de5a163ed4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e072e009b24d0fbc03953d84900001_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb244ebbca7645918a749ff83a2caf20_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87dc345b8de442ea6f8dbbd65882071_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa68541a773415fae251b23e344c1b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525174948c6543dc8a99d3c14aab9da3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd5a938b770d4b608475507fe2c5a3b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i937b0f049dac419089d03f3d635323d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>bmy:customer</xbrli:measure></xbrli:unit><xbrli:context id="i6ed144f6904d4064a626d5562e3a0cf0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2324127f89494362aa7de6e45d6fe141_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24309b9bca4c40368e5159601708371e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356526281a974299bee8ad28a8382769_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f0783a75914d6fb1fa14e52521a824_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb63487db81d44389500ff3f59b06f62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79428ebec0f445285e266d25006a85a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd254642fa845128c263c3a56052a25_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854b50008d0b47298b884695f1fe2849_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06140d1825848a3a6fb79f4c1f62258_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee21a224006b4db88a4217127cb842f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2820f2c35291457db2f7410b787ba2ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaacb967952a84c929370c1cb0330584a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3fe6d813fb473a96593961f0613f55_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ad784c18b14feaa7917cf92952a3bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4908dc165f094814bdc03777b63fb228_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i348f12df9a624cae9f58f9b3c31d39ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibda2aa440a934e82a577fb958f23e939_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4801a688a148d1bbef6616d73a97b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3941b5a9b1234e72b36561a89af511d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4792b9bd5d914473a84cba87ee6517b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8e035725b3442db86565959545c35a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie716e8002a604614bf64186acced27ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic73d338c52b542ddae2377e527c62f2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062ca60f3e7247c4b8d90925c36406d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib68d187be7b0471c86033eada0951b2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc25cac945148a18864b628022c5492_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb982410931493f88491ecf96248f25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4506a3f2ee45401d9643dde5c3b241dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b9651239b0491abf8341b486a23dc1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d753b05e49247a7998fcd56ba7831aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3207d415b9154ca9b0988b77bdf66bf8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21692a74de649678999f109fd39cfab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597908d9a603482f9546e5ee2009c406_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90e84082105e45269a4ddf3f2b924403_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c11a22415bf463a8cafb058afaacf34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>bmy:patent</xbrli:measure></xbrli:unit><xbrli:context id="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00f02f6049c84c88a97ca32784154910_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19139b5b67d7410eac12e965d900e982_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489f54c5481c45389d5768b529b57a7c_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bmy:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i9b4fe50bec2c45748e74cea112ead142_I20220330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2602abf9fb744d1b514e7cd6d92d706_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:MolinaLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bmy:claim</xbrli:measure></xbrli:unit><xbrli:context id="if83448985121404b8a86bb8584503c4f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OptOutEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45c0ee3f040490991410c1a6b57a08c_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93 id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i4194f427d28d478983f182f54c3aa849_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcy_4bf92cae-dabf-41bb-b959-b1cc95ddd7ea">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU5_2517b6be-7549-4b5a-a379-a018efc4e88f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNjc_59f7ff9a-3e3d-499e-acfa-86039a92e5a8">March&#160;31, 2023</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY1_257cd394-f6e4-4cf6-8222-f348219e500d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY2_d64d5260-63eb-4f7c-a784-5a6a9964d91c">001-01136</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcz_c1b677cc-a60f-4818-af42-04b0b48ba371">BRISTOL-MYERS SQUIBB COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTAtMS0xLTE5MzkzNw_83745724-9128-4647-9060-5328d4e11a3f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTItMS0xLTE5MzkzNw_b1cff1bc-2928-44c8-a42f-3d76580842c0">22-0790350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">I.R.S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"> Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYx_38d33cc8-f3c9-42b5-9043-1fee449cd393">430 E. 29th Street, 14FL</ix:nonNumeric>, <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYy_177c54e2-4ef8-4661-a912-e4a1071eaecf">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY4_0f7d95ff-cc49-4cde-8864-616e8143624d">NY</ix:nonNumeric> <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYz_2d55d439-18d9-4525-bd0c-9f649e74970b">10016</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcw_59714e78-2521-4f37-b5cd-d9986e776de5">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY5_3edd2725-e3c7-4f2e-b254-2ac155b30d7b">546-4200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTAtMS0xLTE5MzkzNw_819bf5a9-d5e1-4038-b9dc-93ae848dd97b">Common Stock, $0.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTEtMS0xLTE5MzkzNw_b91f5dc4-6c18-4e74-bec2-fee7924ce7e1">BMY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTItMS0xLTE5MzkzNw_94c6fb64-5473-4b81-b919-761c08cbba7b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTAtMS0xLTE5MzkzNw_443624f9-4cdc-4e6f-88c7-1e4ec8e29cc3">1.000% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTEtMS0xLTE5MzkzNw_f4403f61-aa6f-4021-a1ba-87221b4f73b8">BMY25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTItMS0xLTE5MzkzNw_b8fd4cf9-9d39-4fdb-9f95-139801aa7a79">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTAtMS0xLTE5MzkzNw_7540ad35-4d7b-4bc2-b41c-ef6304401d57">1.750% Notes due 2035</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTEtMS0xLTE5MzkzNw_5b141714-066d-4340-acbd-ce04bf42cb51">BMY35</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTItMS0xLTE5MzkzNw_8857bfb9-db62-466f-bb84-1417e8ce9c16">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTAtMS0xLTE5MzkzNw_924120e9-9b80-40e8-828f-c3b979b46201">Celgene Contingent Value Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTEtMS0xLTE5MzkzNw_2367d2b0-e664-4289-9fbe-658b1f2e6472">CELG RT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTItMS0xLTE5MzkzNw_592739fd-5401-4054-a2be-7d36fb152a03">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to the filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY0_5b8560da-7158-434f-90e9-8271214b62cd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU3_cecc917d-9760-4fb4-b4db-62feeb060695">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of &#8220;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY3_19f00b12-d202-4f4f-af5b-3eefeea0077b">large accelerated filer</ix:nonNumeric>,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Smaller&#160;reporting&#160;company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU4_52291101-e523-404b-80eb-f5e0fcc919fe">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcx_0ae9cf8e-0fa9-4fe8-95cc-23ad80b59e85">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160; No &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICABLE ONLY TO CORPORATE ISSUERS:</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">At April&#160;20, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i2639f048af2d48f69a7b8f1ca961fb27_I20230420" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yMzg1_0297e7be-bfdc-4450-8184-cd843e912479">2,100,847,138</ix:nonFraction> shares outstanding of the Registrant&#8217;s $0.10 par value common stock.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2023</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I&#8212;FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_16">Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_19">Consolidated Statements of Earnings and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_22">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_28">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_31">6</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_97">31</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_172">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_172">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_175">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_175">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#8212;OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_181">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_181">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_184">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_184">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_187">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_187">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_190">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_190">50</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_193">Summary of Abbreviated Terms</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_193">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_196">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_196">52</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_16"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. FINANCIAL STATEMENTS</span></div><div id="i4194f427d28d478983f182f54c3aa849_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions, except per share data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:74.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance and other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0xLTEtMS0xOTM5Mzc_05e6d6be-41c0-4f6a-a932-87c9dd076acf">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0zLTEtMS0xOTM5Mzc_e7b46ebd-11a8-4050-b7d4-e7b7e4ec6b97">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0xLTEtMS0xOTM5Mzc_889568c5-21f3-4418-8ef0-de35cd7f67f4">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0zLTEtMS0xOTM5Mzc_b5217066-592f-4cd4-afa8-03ed1aebabcc">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07">2,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0xLTEtMS0xOTM5Mzc_5263a531-d5ce-40b9-bfec-f87548801342">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0zLTEtMS0xOTM5Mzc_1b8bb6be-b67c-4ee2-8493-2bfb1557f738">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0xLTEtMS0xOTM5Mzc_28744651-755f-479e-ab70-b59c49a1a70f">2,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0zLTEtMS0xOTM5Mzc_31c0641f-e384-4679-8bdf-84d3ea8fc0d9">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0xLTEtMS0xOTM5Mzc_dbe2d16c-e03d-44d2-b36e-dc3fee996c38">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0zLTEtMS0xOTM5Mzc_a75d87ad-e863-4f75-a3a8-e37f25b64ff8">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMS0xLTEtMTkzOTM3_2d74bbb3-bb16-46a1-8b41-eb75ede8d4a9">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMy0xLTEtMTkzOTM3_980ac577-ea18-47bd-9448-117739821263">2,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMS0xLTEtMTkzOTM3_0551e595-4812-4b94-a483-a9908983bd3b">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMy0xLTEtMTkzOTM3_e37efe9e-c9b2-4ac0-80f9-f18ba0a6f128">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMS0xLTEtMTkzOTM3_200c0ba7-92de-47ae-b246-11a4f7e8d6a9">8,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMy0xLTEtMTkzOTM3_bd4638b6-8796-4f36-a5f6-ce3b16cb3527">9,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMS0xLTEtMTkzOTM3_a427cad0-cf42-4d34-99eb-8f21834c28a0">2,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMy0xLTEtMTkzOTM3_af7bd38a-a76b-4aa6-aec6-8acd70161669">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMS0xLTEtMTkzOTM3_2d677608-edef-48d1-9c2e-a7c3afa181dd">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMy0xLTEtMTkzOTM3_7e9ddacb-d7c4-437a-89d2-590568803cae">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMS0xLTEtMTkzOTM3_3132ec37-df8a-4233-9185-bd1d8ad9d735">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMy0xLTEtMTkzOTM3_624e344a-68e8-4733-ab3b-98467255c5f5">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMS0xLTEtMTkzOTM3_b3f5e624-0742-453c-b863-1037486f6d79">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMy0xLTEtMTkzOTM3_d88daf19-c436-4e61-970d-2a81f1c53907">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMS0xLTEtMTkzOTM3_04414f89-39de-49e3-a69c-44ec253f05f6">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMy0xLTEtMTkzOTM3_c680c448-605c-40a5-bd7d-f0c1466eaa59">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" footnoteRole="http://www.xbrl.org/2003/role/footnote">Excludes amortization of acquired intangible assets</ix:footnote>.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0xLTEtMS0xOTM5Mzc_1cc6b8e8-02ef-45b8-b3b8-4997fae7de2c">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0zLTEtMS0xOTM5Mzc_13fc241e-5cd4-4144-a5d2-796eddcdc38a">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes and reclassifications to earnings:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0xLTEtMS0xOTM5Mzc_6d2089b5-a26a-4308-9cc9-25e953dfa8b1">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0zLTEtMS0xOTM5Mzc_3e603ec5-5476-44c8-8f23-37f98de4b73f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0xLTEtMS0xOTM5Mzc_8f0f6366-94a8-439f-b7c0-4de31cbbbd85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0zLTEtMS0xOTM5Mzc_6d2004da-d1cd-4ce6-85e5-7a657ca590aa">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0xLTEtMS0xOTM5Mzc_98f61630-02d6-407b-baab-5fa78bc5b5e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0zLTEtMS0xOTM5Mzc_197c7c72-04f8-4170-b921-52240a722af9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0xLTEtMS0xOTM5Mzc_18ea3891-c906-40b4-8c39-6cd76cea894b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0zLTEtMS0xOTM5Mzc_54dcf994-2784-47c0-8028-6aebaba23cf4">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other comprehensive (loss)/income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0xLTEtMS0xOTM5Mzc_c72a1a23-c9c8-45d0-8c6e-fe211f8ea537">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0zLTEtMS0xOTM5Mzc_563a07ac-10d3-4219-bbb4-fd76a3c681de">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMS0xLTEtMTkzOTM3_5464a0ea-2a6d-4a4f-929a-7f53cd50297c">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMy0xLTEtMTkzOTM3_088b9cf8-ceea-4703-bf3c-88436427eae9">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to BMS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMS0xLTEtMTkzOTM3_e90ddbbb-36a6-4552-98fd-07ab989effc9">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMy0xLTEtMTkzOTM3_afac6346-db93-4788-a279-d3e83eeb8d81">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0xLTEtMS0xOTM5Mzc_a3d3d19b-77c6-4512-8816-64c740113f7d">8,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0zLTEtMS0xOTM5Mzc_b172f977-613f-43ba-8b99-74d34a783f59">9,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0xLTEtMS0xOTM5Mzc_993d7c68-56a7-42c1-abc9-4cc513d9c3b7">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0zLTEtMS0xOTM5Mzc_b0f96b8d-c762-4a27-bd9e-d0ac8aa092f8">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0xLTEtMS0xOTM5Mzc_7fd3d481-a9c0-4af9-979c-42b278ed7ce4">10,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0zLTEtMS0xOTM5Mzc_6e17e589-b175-4a57-9f70-21318f07dc81">9,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0xLTEtMS0xOTM5Mzc_692cf222-7014-405b-8915-bd21985982f7">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0zLTEtMS0xOTM5Mzc_ca8fb9c4-d9a2-4960-8b29-845f0dab90e1">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0xLTEtMS0xOTM5Mzc_7b6ac0f2-873d-4631-887e-647157eb867b">27,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0zLTEtMS0xOTM5Mzc_95af985e-5a8d-4e9d-9af1-7f376d33c73b">27,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0xLTEtMS0xOTM5Mzc_da12876a-d9f0-4794-996f-d681089600d6">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0zLTEtMS0xOTM5Mzc_46c6cbc1-af2b-4112-8d2d-ce3e04fc9588">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0xLTEtMS0xOTM5Mzc_019e6ea2-e278-40dc-9024-9b60ce868810">21,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0zLTEtMS0xOTM5Mzc_a637472e-bf94-43bc-82b3-7cf4ecbdcf91">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMS0xLTEtMTkzOTM3_b509253f-fec2-4d80-9db4-aa8cc3f26e51">33,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMy0xLTEtMTkzOTM3_e88b6148-f769-4e78-95f8-eb53e6627da3">35,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMS0xLTEtMTkzOTM3_d17d48b1-91bf-41bf-81f0-73f444fdb684">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMy0xLTEtMTkzOTM3_bb2d42b3-c906-49e4-a06e-867bff692691">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMS0xLTEtMTkzOTM3_eb57073d-c2b9-4720-a201-5d7afefa4591">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMy0xLTEtMTkzOTM3_a57ae653-31a0-425f-ad15-1b0532505242">4,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMS0xLTEtMTkzOTM3_be6553d1-d979-445f-94f2-4277c0e75a22">94,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMy0xLTEtMTkzOTM3_bbcdf693-1770-44a0-b96a-471a8fc4d798">96,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMS0xLTEtMTkzOTM3_88ff07ca-3da3-48c6-bbc3-f036caf7a74a">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMy0xLTEtMTkzOTM3_dcbce047-f6c9-4dd5-b62f-4d068061844c">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMS0xLTEtMTkzOTM3_084227dd-1225-46e3-9e42-66536ad0e12d">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMy0xLTEtMTkzOTM3_39b45ac7-6e96-49dd-903e-5ee049d1cf92">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMS0xLTEtMTkzOTM3_3987d116-41da-4a24-b29b-529e7d96a4b1">13,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMy0xLTEtMTkzOTM3_549a822b-9b07-41bc-96a1-76b594e00aca">14,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMS0xLTEtMTkzOTM3_32071144-af35-4215-81fb-553bef51dea3">19,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMy0xLTEtMTkzOTM3_e4cd11cd-7707-41c2-85d3-805970c1a563">21,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMS0xLTEtMTkzOTM3_b9f98955-04dd-4b3c-802e-daa1129de5dc">1,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMy0xLTEtMTkzOTM3_fc479911-071a-4653-886c-f14311f1c3b4">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMS0xLTEtMTkzOTM3_11fa5be5-68f2-4f56-bcf0-e5a513215a0a">35,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMy0xLTEtMTkzOTM3_b25fc408-3dbc-45af-9ba2-c2d43ba1796e">35,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMS0xLTEtMTkzOTM3_54b8bd5f-0e0f-4a44-8708-933a89b74e46">6,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMy0xLTEtMTkzOTM3_c9eee618-4da7-4368-b6cb-94171581585c">6,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMS0xLTEtMTkzOTM3_a40e6ccd-0f2c-4799-8126-5f88e90e6e5d">62,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMy0xLTEtMTkzOTM3_538d572f-69e2-4c45-8a63-57807e7f1b4d">65,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMS0xLTEtMTkzOTM3_912ed084-5deb-4b6f-8ce1-95ed23451dae"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMy0xLTEtMTkzOTM3_7db60af1-0a6f-4e21-a1ab-b1f412f4e724"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BMS Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMS0xLTEtMTkzOTM3_9ea0a082-58a5-434d-9f34-bb2e7d40c992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMy0xLTEtMTkzOTM3_cfd33413-8427-4a68-b1f8-be1d02899b67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMS0xLTEtMTkzOTM3_2e7db4c4-14d8-4471-a7fb-4d6d07f3598d">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMy0xLTEtMTkzOTM3_94a23a09-ecef-4bb7-a609-486d380ff50f">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value of stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMS0xLTEtMTkzOTM3_8abb0954-1d68-481e-96d5-7a793a627d87">45,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMy0xLTEtMTkzOTM3_f717a6ce-d3e0-456b-927f-0a4818c2d9ce">45,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMS0xLTEtMTkzOTM3_c1a9375b-f791-46ce-9653-fb68d7786321">1,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMy0xLTEtMTkzOTM3_a0433b61-17eb-4e0b-87c3-08fa237e2bd9">1,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMS0xLTEtMTkzOTM3_cf063c4f-4475-4980-a19a-c45d825b3e56">26,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMy0xLTEtMTkzOTM3_072399fa-7db8-4748-81db-963211abe4f6">25,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cost of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMS0xLTEtMTkzOTM3_a19d5f2b-f2dc-48a2-abd7-f0bba79e77cc">38,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMy0xLTEtMTkzOTM3_9d24fd0a-78b1-45ab-9f43-fbad50dba6a2">38,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total BMS Shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMS0xLTEtMTkzOTM3_70b4c310-609e-49d5-b0df-328e0c0afea7">31,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMy0xLTEtMTkzOTM3_d176b372-d1d4-4c8a-b981-d17e6ec035cf">31,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMS0xLTEtMTkzOTM3_fa359998-dc95-46b9-80f7-15be86969f90">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMy0xLTEtMTkzOTM3_460f71c4-39cb-46cf-bf8e-8dacd77acb13">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMS0xLTEtMTkzOTM3_224a3189-9cf1-468c-9be8-fafb25989158">31,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMy0xLTEtMTkzOTM3_19495236-0f3a-459b-9539-7a52af675b73">31,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMS0xLTEtMTkzOTM3_bdeb8c03-0f77-43bb-bee5-ec3ab21df825">94,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMy0xLTEtMTkzOTM3_901768f7-8930-490b-9a7d-f02896a70316">96,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0xLTEtMS0xOTM5Mzc_aa339976-2d05-4f64-a74c-851393c167ed">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0zLTEtMS0xOTM5Mzc_166f9707-a725-4ce8-92d2-d4db3ded6ece">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0xLTEtMS0xOTM5Mzc_624cad41-fa32-41da-bcfc-970c7628f226">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0zLTEtMS0xOTM5Mzc_cb000889-e21b-4bb3-9ced-79bcd7e5a4ef">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0xLTEtMS0xOTM5Mzc_9a9d8d55-1706-421f-add1-c46dce17f6a0">548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0zLTEtMS0xOTM5Mzc_26eac0d4-6854-4091-b196-ec0d45a76f3b">687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0xLTEtMS0xOTM5Mzc_bd759c41-9729-46d3-93c9-ca302ed31854">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0zLTEtMS0xOTM5Mzc_4ec828dc-9d33-420e-8eb3-97ddded729b7">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0xLTEtMS0xOTM5Mzc_66c7f93a-bb59-40cd-8626-dc32bf084eed">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0zLTEtMS0xOTM5Mzc_4585c8e7-04ba-4340-a09a-44f5f320dc2c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMS0xLTEtMTkzOTM3_c16ced75-6444-4fc3-9826-4d2d90bdc7dc">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMy0xLTEtMTkzOTM3_8649f58e-d843-45aa-b678-1d1cc6589d1c">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMS0xLTEtMTkzOTM3_f7b37ca1-c4d4-44fd-ba18-d21c95db49ce">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMy0xLTEtMTkzOTM3_4c86b1b8-c1a8-48fe-9321-5151e77b7949">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMS0xLTEtMTkzOTM3_9c41e2a1-7af4-402a-8a25-685c3a2febb2">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMy0xLTEtMTkzOTM3_3804737f-dd6d-4633-bd34-b7e3db4ba029">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMS0xLTEtMTkzOTM3_251f9d83-a15d-4aa2-96b4-d7318173e5bf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMy0xLTEtMTkzOTM3_460020fe-4c7f-4409-a29b-60a9080e1af4">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMS0xLTEtMTkzOTM3_b1cd6962-e679-4ecd-ab26-79678880aaeb">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMy0xLTEtMTkzOTM3_fe5ae3dd-afe2-48eb-b228-d49d57902604">786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMS0xLTEtMTkzOTM3_8d979563-8cc6-4c67-911d-504a538c027e">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMy0xLTEtMTkzOTM3_148bc2c2-6c1d-454c-836f-070ce8ec3fd7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMS0xLTEtMTkzOTM3_5d5f5cf2-ef5c-47a0-9bab-e56e8bf95148">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMy0xLTEtMTkzOTM3_8272a6f3-2022-401d-b8ac-07fb0d7f68a7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMS0xLTEtMTkzOTM3_beeb8a8e-09cf-4715-80ca-d5da3277ba3d">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMy0xLTEtMTkzOTM3_ee851414-3061-4264-89f3-088138e139da">930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMS0xLTEtMTkzOTM3_7490c3e5-3178-448c-92dd-941fe2d23d44">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMy0xLTEtMTkzOTM3_9f8a18d7-2d18-4fe4-bfcd-c565974d87c2">831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMS0xLTEtMTkzOTM3_3f271d84-7a01-481a-953e-369f6db07801">1,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMy0xLTEtMTkzOTM3_8b1ac005-9bc8-46d4-b036-f65c12422b79">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMS0xLTEtMTkzOTM3_c2f7191b-9758-43a0-bbe2-319446c6cec1">2,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMy0xLTEtMTkzOTM3_fa9266f8-974c-42a1-b935-cf4d7176071b">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale and maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMS0xLTEtMTkzOTM3_17688cf6-391e-4c56-8f75-196079938efe">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMy0xLTEtMTkzOTM3_add05a28-36bf-48b5-9beb-c3a05f0acda5">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMS0xLTEtMTkzOTM3_f7414ffd-b0ce-4dd9-a9be-d70f8503b49e">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMy0xLTEtMTkzOTM3_ee93c9d5-e01b-4b77-9dc4-b548eab9beac">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of equity investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMS0xLTEtMTkzOTM3_d60d498c-e4b0-4117-8b0c-e77e01fa750e">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMy0xLTEtMTkzOTM3_915fe0cf-7806-4291-8ab7-ee84d93987a2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMS0xLTEtMTkzOTM3_f3827c24-9b8c-40a5-bd5d-753fc316bdef">278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMy0xLTEtMTkzOTM3_600bdfd5-c36a-43e9-8898-0684e09d4131">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture and other proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMS0xLTEtMTkzOTM3_1e6fe6c9-be46-4aca-9811-92d6ab38e49d">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMy0xLTEtMTkzOTM3_d1801086-bca5-423c-a31d-4ea2373c024b">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other payments, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMS0xLTEtMTkzOTM3_f2dde5f9-50c6-48cf-8e2c-98da3af3548e">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMy0xLTEtMTkzOTM3_d459e40e-53fd-4748-88a6-c8f3ea65c15c">442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in)/provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMS0xLTEtMTkzOTM3_dabc78a6-79c5-4ce9-9904-19a1b0fcfa59">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMy0xLTEtMTkzOTM3_5cd3c1b7-7533-4feb-b95f-8f3428458d67">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMS0xLTEtMTkzOTM3_63f14b32-6b46-44ed-afc4-ec7159691f55">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMy0xLTEtMTkzOTM3_a3588f1e-882e-484b-8244-66671f8ddae9">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMS0xLTEtMTkzOTM3_b2654642-dd29-4ac0-9c34-c2613106c9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMy0xLTEtMTkzOTM3_14685cf9-842b-4354-95cd-f287c4dba147">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMS0xLTEtMTkzOTM3_e5afdf27-97e1-4bed-a8fb-bd39777c75f8">1,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMy0xLTEtMTkzOTM3_7f9c155d-a27f-48f1-985c-7418136aae5a">5,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMS0xLTEtMTkzOTM3_60ecd8ae-43b1-413e-be93-fea9da0a6d2a">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMy0xLTEtMTkzOTM3_63c14911-e40b-4cbd-a328-34da0682929e">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMS0xLTEtMTkzOTM3_2a61cc61-6270-44aa-8402-b30270b12d8d">1,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMy0xLTEtMTkzOTM3_2b257b3f-ffb3-413b-aef3-94a4fbe7cc9c">1,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option proceeds and other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMS0xLTEtMTkzOTM3_9d29df06-d1ad-4a0f-8af8-0aff78184301">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMy0xLTEtMTkzOTM3_1d794f78-c498-42de-bc07-f65eb47a4e3c">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMS0xLTEtMTkzOTM3_c36e7b9b-6123-4c39-8db2-6bf3752b9c1c">3,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMy0xLTEtMTkzOTM3_d3467725-c881-42fe-9e38-50b25b83c46d">5,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMS0xLTEtMTkzOTM3_5bb0cd89-5efe-449e-a17f-711885294258">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMy0xLTEtMTkzOTM3_1d57d46c-bba4-4ba4-9b5a-b892bc444049">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMS0xLTEtMTkzOTM3_bbf04f32-d381-4fe3-a0e9-5eb17325abad">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMy0xLTEtMTkzOTM3_5416eb85-7a91-41b7-8cbe-a107e86e6caa">1,737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMS0xLTEtMTkzOTM3_14e13534-5618-4fa8-8c4a-a9b391dc2ddc">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMy0xLTEtMTkzOTM3_44eac29c-1427-46e3-ac30-c885143aa1aa">14,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMS0xLTEtMTkzOTM3_97241554-39a2-42bf-8b9b-cd66af0b98ea">9,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMy0xLTEtMTkzOTM3_08f46d1f-5167-4480-a93c-8491a0164b13">12,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zMS9mcmFnOjYzNzQ3MTEwYjgyNDQyMzE4NGUzZmE5OGYwM2IwMWYyL3RleHRyZWdpb246NjM3NDcxMTBiODI0NDIzMTg0ZTNmYTk4ZjAzYjAxZjJfNzY_773c8e45-0455-432d-b239-a593a94c5fa2" continuedAt="i4c17ff62bad14b78bcbb7b9962eef686" escape="true">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ix:nonNumeric></span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_34"></div><ix:continuation id="i4c17ff62bad14b78bcbb7b9962eef686" continuedAt="i61e0f99bcadc482683c0fb069f7d3e50"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYyNQ_8518bb1c-15c4-478b-a3b0-376b9f40590b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzOQ_a8f1181c-1b8f-4e25-a30b-c534496c5d0d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#8212;Note 2. Revenue".</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY0Mg_9c42825b-3adf-40fe-9dd2-97e4e0c3c7c6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzNA_de405c6b-3061-4ea9-884f-90621a61a185" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY1Mg_0cfa60a9-b7d6-4b92-bce4-b44cf546d59e" continuedAt="ideafcff3bb38433fa34f355e578c8b8b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i61e0f99bcadc482683c0fb069f7d3e50"><ix:continuation id="ideafcff3bb38433fa34f355e578c8b8b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk3_a39425e4-59f7-4926-839e-e81b62db5d8e" continuedAt="i9c3665deba834aefbc9b4f1abb104c8d" escape="true">REVENUE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9c3665deba834aefbc9b4f1abb104c8d" continuedAt="i50e8534f654145f4be8c883e73694970"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwOQ_b28325f0-6c81-41b3-a4b7-3864c1dcff84" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0xLTEtMS0xOTM5Mzc_71a9a9e3-efde-4563-b26c-fd61c311b7dd">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0zLTEtMS0xOTM5Mzc_b3d4faec-4110-4123-a6a8-766027903861">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0xLTEtMS0xOTM5Mzc_d863e3d9-4ed1-4bf0-be11-ab05dc0ab600">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0zLTEtMS0xOTM5Mzc_32b0ecf5-e019-4b0c-be96-194705ef148c">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk5_97ed379e-8768-42d6-94af-585b7c84357c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0xLTEtMS0xOTM5Mzc_4f06b79a-b4fc-4cda-81ce-b580e3d35f8b">17,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0zLTEtMS0xOTM5Mzc_2d5b3ab1-d077-4f73-a2f7-4c218f3fde09">16,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0xLTEtMS0xOTM5Mzc_244c200d-3f01-43d2-a46f-406727e790b3">2,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0zLTEtMS0xOTM5Mzc_0dc18df4-71f1-4e25-a430-48369adc3b6b">1,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd3beba77678438b8c93338a7baf0121_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0xLTEtMS0xOTM5Mzc_3f3e7577-beb5-4a7b-80d7-8f2fb55c98b8">2,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa468a5115d642289601acca9b294408_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0zLTEtMS0xOTM5Mzc_d67880f0-7b9b-48a6-889d-994ce2edbacd">2,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0xLTEtMS0xOTM5Mzc_37e96d5c-2485-4025-be0c-f5d4f5bb5afd">1,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0zLTEtMS0xOTM5Mzc_b17dca1d-6065-45b1-b148-dfc4033c2d68">1,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0xLTEtMS0xOTM5Mzc_a0b90a36-40a8-4cef-91f2-95bfe76ffd4c">6,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0zLTEtMS0xOTM5Mzc_d898e331-c6c8-45ca-983f-c7d7b3122bb5">5,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0xLTEtMS0xOTM5Mzc_1d8312b7-0b32-4c9b-9a00-86908b9bf9c0">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0zLTEtMS0xOTM5Mzc_dbf3031b-8c10-4c26-97d8-a94298906009">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2Mg_dce04e51-aab6-4f54-b1b6-54fe2862fa4f">87</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2NA_912a1d31-525a-4224-b447-c758156cb945">74</ix:nonFraction>&#160;million for the three months ended March 31, 2023, and 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i50e8534f654145f4be8c883e73694970"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwNw_b7fb20ee-e198-4e07-ae0a-735ee609a5c4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0xLTEtMS0xOTM5Mzc_97df4735-abf2-4ddf-b78a-9ed696a85526">3,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21276df0654c93ac72564897390491_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0zLTEtMS0xOTM5Mzc_f91983d7-6344-492a-b5d8-84a092225296">3,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0xLTEtMS0xOTM5Mzc_5877ca97-869b-4c34-9c9c-9fd8a546d232">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935d511681b44311b77fcd048a596f5b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0zLTEtMS0xOTM5Mzc_f1d2b80d-8fd3-4724-acd1-b1b0c38cbfb9">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0xLTEtMS0xOTM5Mzc_4c8ee0bb-160a-4be0-be60-f55259ee9f3c">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0zLTEtMS0xOTM5Mzc_6f0d2fc9-c63b-47f7-b9f7-0878afb675f5">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0xLTEtMS0xOTM5Mzc_4f6da18a-ff17-4728-be99-b0ebc5573d37">764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0zLTEtMS0xOTM5Mzc_fb481ccb-d78f-4529-bd0d-79a9e093014a">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0xLTEtMS0xOTM5Mzc_bd36e4ab-f5ae-499c-8a27-f36226c91388">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0zLTEtMS0xOTM5Mzc_211a22ca-3d2e-45ce-a566-c313fbed1269">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0xLTEtMS0xOTM5Mzc_ca017902-0afa-40d6-96c7-ed57327d9d5c">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0zLTEtMS0xOTM5Mzc_ddf44fd7-e673-467a-9b93-b08be4d3814a">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMS0xLTEtMTkzOTM3_1c65e2f8-ab2d-40eb-94b7-c9d60e199393">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMy0xLTEtMTkzOTM3_64169542-4d76-4614-87af-71e7e2e855c9">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMS0xLTEtMTkzOTM3_931d44d8-2071-416d-9a11-bba3f0a22422">8,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMy0xLTEtMTkzOTM3_9a9138c2-1ccc-4ce7-b96e-7688b3c5f90f">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d681d267ed470d92055de618442973_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMS0xLTEtMTkzOTM3_b82e5c8c-45ae-452d-9e48-7ca1a10535b4">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMy0xLTEtMTkzOTM3_de2c6b95-acfe-487d-9e09-b7c79e0e05b7">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMS0xLTEtMTkzOTM3_c19b6efa-ad20-4851-8b3b-d9746927d55f">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16220a1074c4178b586f8672a245ab8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMy0xLTEtMTkzOTM3_70e7d8a0-857b-4e68-b9a5-13ef461a0978">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTk1NDk5_ad3db66a-538a-4ce5-aa8b-d687c8551f92">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTk1NDk5_5cb0fa5e-eb0d-458a-b772-86c84e7221bc">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTkzOTM3_85576caf-d6e9-43e4-9cc5-b1b914237478">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTkzOTM3_e3760017-acd9-421b-9131-b511478f50c4">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMS0xLTEtMTkzOTM3_1122ac46-a16e-4f8d-aa84-23b36877ac16">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMy0xLTEtMTkzOTM3_f477c683-7613-429d-99e3-10ce3827e444">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMS0xLTEtMTk1NTA3_c0219ebb-b8cb-4a92-9ebb-8cc4eb9c45f6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMy0xLTEtMTk1NTA3_e05ed104-7e88-441a-a644-518548760784">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMS0xLTEtMTkzOTM3_13cbccc2-a2a3-4d2d-a9e2-b83920aeb2f6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMy0xLTEtMTkzOTM3_f34cdc8b-441a-41e9-9738-9b11139402d9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMS0xLTEtMTkzOTM3_60f75565-a44d-4fcb-8f64-774b29ded686">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMy0xLTEtMTkzOTM3_f83ae871-7156-4a9c-b2e7-025ecd09e6b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e55a2a221624cab9060feb297795982_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMS0xLTEtMTkzOTM3_2059f728-4ade-4e9b-afe4-2806494f6882">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMy0xLTEtMTkzOTM3_11b42549-bf75-447a-8ea2-e9909fb0694d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMS0xLTEtMTkzOTM3_b4598269-f224-467c-a4b5-a0956ee47837">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMy0xLTEtMTkzOTM3_011b56ed-091a-4d78-bc5c-8bdf96caf610">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMS0xLTEtMTkzOTM3_bc5337fc-fd13-4dd7-97df-fc2f7791c074">9,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafe51b214744a71a14666c467535d3d_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMy0xLTEtMTkzOTM3_f53095ef-008c-45d1-9e70-eaf3bc47c28d">8,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMS0xLTEtMTkzOTM3_b7087f72-0362-4690-9502-d9a505f51920">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMy0xLTEtMTkzOTM3_8eb45ff9-39d1-498e-8924-d33b0a9a9130">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMS0xLTEtMTkzOTM3_4ab6e187-9330-4366-b994-39513104968f">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMy0xLTEtMTkzOTM3_d189e0c2-54e6-440d-8f7f-0dc085a04068">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMS0xLTEtMTkzOTM3_ff03bf3c-053b-456c-a0b0-9bf79a07dae9">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMy0xLTEtMTkzOTM3_07a8624f-4925-4e9c-9703-dc82a6ace499">3,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMS0xLTEtMTkzOTM3_5943a4bf-7a52-4466-8168-58959bde64d6">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMy0xLTEtMTkzOTM3_e74c4a40-2845-4f96-9e21-4024976b63c4">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMS0xLTEtMTkzOTM3_4af050e5-a909-4469-9764-de2d83524a85">8,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMy0xLTEtMTkzOTM3_fb229da2-2529-4138-9192-aee410673442">7,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMS0xLTEtMTkzOTM3_cef9a6b5-e248-40c1-a7e4-5ab824cf14bf">3,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMy0xLTEtMTkzOTM3_a940ab82-d10f-484f-b598-29330b98b38b">3,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMS0xLTEtMTkzOTM3_0c5c6e3e-2aaa-4530-a06e-c245321278ec">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMy0xLTEtMTkzOTM3_49786e1b-e04d-48ac-adec-e91a0705b759">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMS0xLTEtMTkzOTM3_944bee52-b9d5-42c2-99c9-f0c54623326f">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMy0xLTEtMTkzOTM3_4548b201-dde5-4950-b456-71770fa8bc8d">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzgy_fedffcb7-0f64-4c4b-a14d-9cab7a436149">166</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzg5_9ffcd926-4be7-4f3a-9d19-0698a955a47f">147</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for GTN adjustments related to prior period sales.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2MA_3dd6a12b-b1aa-4721-9eef-28c029d09b9b" continuedAt="i214698c0d84e4c6b8b2c4fc176fcd09a" escape="true">ALLIANCES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i214698c0d84e4c6b8b2c4fc176fcd09a" continuedAt="ic0fb41031f4840caa19f98b6cae76d0f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS refers to these collaborations as alliances and its partners as alliance partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2Ng_ac3e4aa9-763f-40ec-bc3d-adf523817bff" continuedAt="i0d9b0af06399425d88317c3ffb82ad19" escape="true">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic0fb41031f4840caa19f98b6cae76d0f" continuedAt="i96676c1f6ef74235a0b0a0d54d4b0259"><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i0d9b0af06399425d88317c3ffb82ad19" continuedAt="ieca4bcdac2354f758af24a5304ffeded"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0xLTEtMS0xOTM5Mzc_e299e06d-67a7-4deb-9633-7899a6c305b7">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0zLTEtMS0xOTM5Mzc_34f97b80-4ab9-441c-a019-2aeef75ce5a8">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total alliance revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0xLTEtMS0xOTM5Mzc_3f89e55f-25e9-4087-8ead-f7f0184cae62">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0zLTEtMS0xOTM5Mzc_3bb93a94-6f6f-4e40-bf7a-2c28380eebda">3,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0xLTEtMS0xOTM5Mzc_73161496-6696-4edf-a078-53146cd7599d">1,706</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0zLTEtMS0xOTM5Mzc_8422780e-4a2e-4c7f-971f-6ad642de6484">1,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0xLTEtMS0xOTM5Mzc_a451af61-31b7-4777-8d3a-ee87eca0ded5">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0zLTEtMS0xOTM5Mzc_dd8a093f-0fbc-4925-83db-567aac7f02af">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMS0xLTEtMTkzOTM3_a95a50ce-ce20-40f7-962c-6d7e5ff99fac">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMy0xLTEtMTkzOTM3_6c3d2ab3-b113-4847-9f7c-0bdcf1edb7de">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMS0xLTEtMTkzOTM3_7b227b68-1008-42c3-9137-6e61142743a9">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMy0xLTEtMTkzOTM3_f44d2b90-09da-4a9a-8990-d21bed37ecc3">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ieca4bcdac2354f758af24a5304ffeded" continuedAt="i80191361e61b4043b3fc58acd441cf15"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected alliance balance sheet information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0xLTEtMS0xOTM5Mzc_40a6ee6e-d9a3-41ca-8f82-34e216c6bfd8">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0zLTEtMS0xOTM5Mzc_573fe8af-0b4b-4141-a6a8-2a3a8f7c6d80">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0xLTEtMS0xOTM5Mzc_678df0ce-0047-4777-8612-bd04e1d62cae">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0zLTEtMS0xOTM5Mzc_dafca4bf-586c-4c42-9077-34d0b677f7e7">1,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0xLTEtMS0xOTM5Mzc_faa519f5-6666-400a-97d1-0d27edec1ffe">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0zLTEtMS0xOTM5Mzc_468b4db9-514c-40ce-b289-6e21d2bb0650">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i80191361e61b4043b3fc58acd441cf15">  Includes unamortized upfront and milestone payments.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i96676c1f6ef74235a0b0a0d54d4b0259">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2022 Form 10-K.</ix:continuation> </span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwMg_aec9b66f-c35f-4ab2-aaaf-e2a60fdbaf38" continuedAt="i56bde5ad1b5c4737b9434357a921ff21" escape="true">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i56bde5ad1b5c4737b9434357a921ff21" continuedAt="i9b83756859c245ea89c5416ee6559967"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwNQ_11838ae5-863e-49d0-a08c-bda3e4dcfabd" continuedAt="i8f741a27fffc4f0a9f93bfe9c3984902" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xLTEtMS0xOTM5Mzc_ecb3e5b1-c276-4667-9461-c4de1d26c975">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0zLTEtMS0xOTM5Mzc_6fd1901d-e066-4bb2-bcec-81551608971a">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy01LTEtMS0xOTM5Mzc_ac488c87-c507-42fb-855d-d72aaf2f6313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy03LTEtMS0xOTM5Mzc_c5153722-32c2-4e95-b920-f58f21c9c597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy05LTEtMS0xOTM5Mzc_84288481-f9a1-4384-8deb-c9c44e5a789a">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xMS0xLTEtMTkzOTM3_949b51cc-e9c0-4a18-bb61-93851740e905">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xLTEtMS0xOTM5Mzc_87f45a70-21e7-4822-8cb7-4726f53a343f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0zLTEtMS0xOTM5Mzc_27f1cdee-61bf-40cc-8923-23e679980590">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy01LTEtMS0xOTM5Mzc_2288a8b3-3a24-4100-a089-91cc3dea90c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy03LTEtMS0xOTM5Mzc_e2510f5e-e1a4-49a5-a4f0-690e3ca04008">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy05LTEtMS0xOTM5Mzc_11ff3b37-a70b-429b-92fc-38bfa1968023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xMS0xLTEtMTkzOTM3_d77ab360-e93c-495c-b4bd-acb6fd8d4779">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xLTEtMS0xOTM5Mzc_12425b83-9fd8-4754-a6b3-ee6186ffd3f8">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0zLTEtMS0xOTM5Mzc_5541271b-ba61-4080-bb7c-dd415a284dfe">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC01LTEtMS0xOTM5Mzc_37332d7e-fd74-42fc-8790-88b72a82f9d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC03LTEtMS0xOTM5Mzc_78e93e93-bdc4-42c7-8142-173ebd0f60ed">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC05LTEtMS0xOTM5Mzc_b2a4baea-7bff-435f-b328-23a2579bdda0">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xMS0xLTEtMTkzOTM3_a48fa2be-66da-4c39-8b68-66c826886f08">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i8f741a27fffc4f0a9f93bfe9c3984902">(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mature Products and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI0MQ_52945466-36a6-4211-99f7-d1a241b0480c">221</ix:nonFraction>&#160;million and a divestiture gain of $<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI3MA_02781fb5-1d60-480f-8fe5-6a5fdf065326">211</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i9b83756859c245ea89c5416ee6559967"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:LicensingAndOtherArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjA5Nw_c7365928-ca7a-48e1-b53b-46466d9829ff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0xLTEtMS0xOTM5Mzc_2b475c2b-b896-4fff-8049-d6f88f5821c5">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49988370bf5e41738d52d3a570580e68_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0zLTEtMS0xOTM5Mzc_2ea2fb17-ea20-46a7-8174-faa7e36384d6">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0xLTEtMS0xOTM5Mzc_0629391f-8980-4379-b7b8-c9e1d889d222">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0zLTEtMS0xOTM5Mzc_c19b7fe0-82a7-4cbe-b618-18b2f72e6b12">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0xLTEtMS0xOTM5Mzc_f8a4f7b2-53c3-42f2-b5ca-3e2edafea065">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0zLTEtMS0xOTM5Mzc_b0d16b76-dc2e-4572-84ab-ff3b2b34a062">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0xLTEtMS0xOTM5Mzc_8439189f-12ae-4762-8706-8d94d5fb213b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0zLTEtMS0xOTM5Mzc_9c65ed5e-8ea6-491f-bb04-632084c72ebb">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0xLTEtMS0xOTM5Mzc_c5a85cd8-ea26-4e06-840d-4212f70dda9a">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0zLTEtMS0xOTM5Mzc_493988b1-10e9-43cf-ac42-9d902c769d32">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0xLTEtMS0xOTM5Mzc_d54019ea-3771-40bf-b5b6-8d242bebc40a">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0zLTEtMS0xOTM5Mzc_2629d398-7b11-4f53-a5e4-3f01f8c3c197">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS obtained a global exclusive license to Immatics' TCR bispecific IMA401 program. which is being studied in oncology. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDI0Ng_ebd56ca7-6916-4271-a539-4b6324db9215">150</ix:nonFraction>&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $<ix:nonFraction unitRef="usd" contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331" decimals="-6" name="bmy:ContingentAndRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDQxOA_e3bf66e6-807b-4819-b019-4b45301be5cc">770</ix:nonFraction>&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, a Phase I development milestone for interleukin-12 ("IL-12") was achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="id52b753521774addbcfdc534e4ab4c62_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDU5Nw_cbb99ebd-38c1-4c39-b3cb-8497e9cd0fe2">175</ix:nonFraction>&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, BMS notified Dragonfly that it was terminating the global exclusive license that relates to Dragonfly&#8217;s IL-12. All rights to IL-12 were reverted back to Dragonfly effective April 18, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nimbus Change of Control Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS and Nimbus Therapeutics entered into a settlement resolving all legal claims and business interests pertaining to Nimbus' TYK2 inhibitor resulting in $<ix:nonFraction unitRef="usd" contextRef="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDI_501f3002-bc27-49b3-a693-9a749181a942">40</ix:nonFraction>&#160;million of income included in Other (income)/expense. The settlement also provides for BMS to receive additional amounts for contingent development, regulatory approval and sales-based milestones and <ix:nonFraction unitRef="number" contextRef="i09688e31f1224e86b9cbe88539af9e20_I20221231" decimals="3" name="bmy:SettlementContingentDevelopmentChangeInControlProceeds" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDY_64840105-97f4-43ed-88b0-5bd3e68f9a76">10</ix:nonFraction>% of any change in control proceeds received by Nimbus Therapeutics related to its TYK2 inhibitor. In February 2023, Takeda acquired <ix:nonFraction unitRef="number" contextRef="ief3c35e8db3d4577b4932518cea38278_I20230228" decimals="INF" name="bmy:AssetAcquisitionPercentageOfOwnershipAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTA_08abc4dc-1edb-4439-9c81-37e967351eb0">100</ix:nonFraction>% ownership of Nimbus Therapeutics' TYK2 inhibitor for approximately $<ix:nonFraction unitRef="usd" contextRef="i7480b54585f34368b4296b7c142bae61_I20230228" decimals="-8" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTQ_36275dad-1600-418d-914b-8a906594fc48">4.0</ix:nonFraction>&#160;billion in upfront proceeds plus contingent sales-based milestones aggregating up to $<ix:nonFraction unitRef="usd" contextRef="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228" decimals="-8" name="bmy:CollaborativeArrangementContingentPaymentsMaximumExposure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMjI_1593e7d0-afe4-481e-b133-0c0be27222a5">2.0</ix:nonFraction>&#160;billion. As a result, $<ix:nonFraction unitRef="usd" contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTg_cbb8c996-670a-4d9d-a3f0-3f008ea1845a">400</ix:nonFraction>&#160;million of income related to the change of control provision is included in Other (income)/expense during the first quarter of 2023 and is expected to be received in the second quarter of 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNDg_a2a790f6-d92d-4d88-8ea1-e0a6294c6237" continuedAt="i96999c19f23d4a8c9c69134728dc26f3" escape="true">OTHER (INCOME)/EXPENSE, NET</ix:nonNumeric></span></div><ix:continuation id="i96999c19f23d4a8c9c69134728dc26f3"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfOtherIncomeExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNTI_6e4cba0a-f264-4619-8447-d410136f4b30" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (Note 10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0xLTEtMS0xOTM5Mzc_434044ce-76ce-4587-aaf4-95c9a5d119b0">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0zLTEtMS0xOTM5Mzc_4f3d4305-91c5-4a45-be13-863cb29ab910">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:BusinessRoyaltyAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0xLTEtMS0xOTM5Mzc_d6c17d8f-6fe9-4ae4-954e-b49a0a645f9a">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:BusinessRoyaltyAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0zLTEtMS0xOTM5Mzc_cde5b39e-1c29-4157-8462-430fd425675c">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestiture (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:BusinessSaleRoyaltyIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0xLTEtMS0yMDE1NTY_5645143a-8e77-47dd-8829-1fb509106cdf">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:BusinessSaleRoyaltyIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0zLTEtMS0xOTg4ODc_5dc1b86b-c0be-4e58-8124-e36448bde18d">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY4ODA_a917a1a3-389d-44bc-bae6-f359b8c2f84b">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY4ODA_3a2cee87-80d5-40cf-922f-d3daa66c87d4">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0xLTEtMS0yMjY4ODY_3d6582d1-6642-475f-86c1-7b9b8af3b4e0">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0zLTEtMS0yMjY4ODY_b67d633c-a720-48a8-bc7a-ff5c753ed4c2">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjY4OTU_88b4ef92-5e0f-4694-94f6-829c682ca8f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjY4OTU_0094f611-01f4-4df9-9ea4-28375aa7e4c2">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0yMjY4OTU_b74c3f43-e922-4b01-b2fe-a223610fa3ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0yMjY4OTU_895baec9-d3e4-441d-ab46-9900a2e9d7b1">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY0Mjc_3eb2b0a8-5c13-498c-a432-40a32a029a18">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY0Mjc_5fd62728-048c-45ab-b439-472e8d513423">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjYzMjQ_701d112c-8e0b-4f3e-b56d-3055f472f390">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjYzMjQ_a9b3a131-4c7a-40a8-a9f0-9f4f2495ec22">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0xOTM5Mzc_b40e11b1-c0e7-49df-b038-732580ecc916">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0xOTM5Mzc_1207b304-9fe2-4b5e-a176-738f09bd2bd5">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMS0xLTEtMTkzOTM3_8f4237c4-65be-47f8-a6f2-56a27b2f9d7f">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMy0xLTEtMTkzOTM3_0e61b4fd-8990-49f1-8a10-0a5fb43d57ff">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMS0xLTEtMTkzOTM3_eae279b0-eed4-43ce-b590-9883ad6ead0a">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMy0xLTEtMTkzOTM3_a813939c-8a9b-4c3f-a547-94e8357dcd6e">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes $<ix:nonFraction unitRef="usd" contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfMjc0ODc3OTA3MzczNw_ab2889b6-b4b5-46be-a348-d58b93088861">400</ix:nonFraction>&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4Ng_731ba384-69af-4131-85ec-02c64f83e103" continuedAt="if8cc9ac9518f468292f211e89d2b668d" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if8cc9ac9518f468292f211e89d2b668d" continuedAt="i3d5681b1f68645a9830352ec337e23e8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Celgene Acquisition Plan, the Company expects to incur charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNDkz_3e846c58-5e9e-4b46-91da-704066d9bc86">3.5</ix:nonFraction>&#160;billion, including cash outlays of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="bmy:Cashoutlays" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTY0_2735029a-6d19-4375-8b4f-043946530e62">3.1</ix:nonFraction>&#160;billion. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNjA0_548e2f33-bf73-420f-b6cd-1a7644c5b95e">3.1</ix:nonFraction>&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition in 2022 and the MyoKardia acquisition in 2020. Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTMyOQ_42821fef-558d-4ef5-8158-85cf6e3e9bcc">250</ix:nonFraction>&#160;million are expected to be incurred through the end of 2023 and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTUxOQ_e7be9ec3-e616-4e9b-988d-29ae2adf44a4">180</ix:nonFraction> million have been recognized for these actions to date. In the first quarter of 2023, certain restructuring activities occurred resulting in employee termination costs of $<ix:nonFraction unitRef="usd" contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTQ5NzU1ODI3NDc0_27bb813b-681f-4364-ad9f-ec044949ff78">61</ix:nonFraction>&#160;million, which are primarily attributed to changes in our operating model to accelerate the delivery of medicines to patients.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OA_79273de4-c6b3-4f5d-ad1f-48a58b6efccd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0xLTEtMS0xOTM5Mzc_ced0eb1b-ff62-49e4-8579-990f319abe92">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0zLTEtMS0xOTM5Mzc_2c8d991f-ef2c-4dd5-905e-bf6cb0e5e689">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0xLTEtMS0xOTM5Mzc_c762b13c-9a91-4378-b06e-36f9bb9b7ac4">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74867368269444eadf64059422c5acc_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0zLTEtMS0xOTM5Mzc_e8fedee8-6aec-4147-98fd-878decf58b51">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0xLTEtMS0xOTM5Mzc_435cb982-b75b-454a-add6-88fbf1a24e09">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0zLTEtMS0xOTM5Mzc_5f83d7cc-02bb-4f37-a2be-a48a5870bcce">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0xLTEtMS0xOTM5Mzc_8d6c03fd-0f1c-4f1e-8a01-6825e694d642">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0zLTEtMS0xOTM5Mzc_bf28ec25-a592-4cdf-b74f-01ee295ea385">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0xLTEtMS0xOTM5Mzc_322b528b-6803-45a8-956b-e28fc67be728">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0zLTEtMS0xOTM5Mzc_d932b6a8-aade-43b5-8ed8-92c91b61a39a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0xLTEtMS0xOTM5Mzc_1c7083bb-e8cd-4253-add3-dfa7e5f5eed7">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0zLTEtMS0xOTM5Mzc_968625bb-7902-45a8-b4a1-575a9ba1f478">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMS0xLTEtMTkzOTM3_7314cfc9-229b-4d13-9a81-a0055d24b6c4">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMy0xLTEtMTkzOTM3_51c44af7-f82f-4368-9dac-31c75df0f2e6">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMS0xLTEtMTkzOTM3_6bbdf0b0-55bb-4259-8c7a-7ad657511091">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMy0xLTEtMTkzOTM3_4cd80990-2b88-47ab-a241-8a0c8f08692a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMS0xLTEtMTkzOTM3_50dbc602-03e9-42e6-b410-196605656b30">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMy0xLTEtMTkzOTM3_c44ff89d-3669-4a9e-aaa3-ba28f33e6a69">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMS0xLTEtMTkzOTM3_78968530-4600-4098-9a16-605ff3ff058e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMy0xLTEtMTkzOTM3_c72d9b3a-206a-4d17-ad5b-b9677d61d516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMS0xLTEtMTkzOTM3_11d28bfa-9eda-4add-a9eb-b078be269223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMy0xLTEtMTkzOTM3_9418c65f-e56e-46fb-8943-21b5bfe44f3f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMS0xLTEtMTkzOTM3_1a9872d7-8e71-4980-948c-10ce1019d38b">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMy0xLTEtMTkzOTM3_fa333cbb-c1aa-43ff-8a00-342e8d24f206">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMS0xLTEtMTkzOTM3_256bb28b-7f25-4cf8-bf7d-c109cb4dc3e8">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMy0xLTEtMTkzOTM3_3754faaf-5e5f-43a8-b4fa-9b572536e543">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i3d5681b1f68645a9830352ec337e23e8" continuedAt="iffaac3ae900f45b9b3591eca12c8fe6c"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OQ_66707be2-8774-4cc9-9866-aec432e834ba" continuedAt="i0b41a9cbf43a436e8d1f399eb2329257" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0xLTEtMS0xOTM5Mzc_2227650a-9e62-4026-968d-b3781964fc78">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0zLTEtMS0xOTM5Mzc_2cbd6e9c-a210-42e4-97e2-16ea6ffcc8b5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0xLTEtMS0xOTM5Mzc_92f09bb3-8f44-49fb-a978-ef9c9148c0f2">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0zLTEtMS0xOTM5Mzc_1e4fb051-71dc-4709-bdbe-c244ddd82124">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0xLTEtMS0xOTM5Mzc_e9bd38fb-1803-4080-a67d-2a622754e629">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0zLTEtMS0xOTM5Mzc_d93126d5-2de3-4471-9216-6f6aed71061a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0xLTEtMS0xOTM5Mzc_91b961e1-98bf-42e6-a4f0-4cc5890f2b63">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0zLTEtMS0xOTM5Mzc_0f67c8b2-73dc-4742-bafa-ad1be5263ff1">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0xLTEtMS0xOTM5Mzc_d424f44c-7c01-4877-b517-1cb7b8622fb4">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0zLTEtMS0xOTM5Mzc_79b652da-eddd-48ad-a60c-e8a9cf9b2db1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="iffaac3ae900f45b9b3591eca12c8fe6c"><ix:continuation id="i0b41a9cbf43a436e8d1f399eb2329257">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTgzOA_51a81171-ee28-4959-8fe2-da0ecb5395e8">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTA5OTUxMTYyOTg3NQ_523d657e-96cf-4fa4-a166-94536295b9bd">9</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0Nw_bdaf4d09-11f8-4b08-915d-0d9a4c78b978" continuedAt="i900b54cf83144b2ea9def8b095690732" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i900b54cf83144b2ea9def8b095690732"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0MQ_d6743b5e-8173-4536-a917-f49e04989199" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0xLTEtMS0xOTM5Mzc_a427cad0-cf42-4d34-99eb-8f21834c28a0">2,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0zLTEtMS0xOTM5Mzc_af7bd38a-a76b-4aa6-aec6-8acd70161669">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0xLTEtMS0xOTM5Mzc_2d677608-edef-48d1-9c2e-a7c3afa181dd">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0zLTEtMS0xOTM5Mzc_7e9ddacb-d7c4-437a-89d2-590568803cae">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0xLTEtMS0xOTM5Mzc_504ec3fc-f17f-452f-8393-45a88db0ba2b">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0zLTEtMS0xOTM5Mzc_4e69d025-33a0-4f4d-8d99-67b6bff44fd4">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The <ix:nonFraction unitRef="number" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAzMzU0Ng_31b4dea8-8f56-40e7-958b-e0f659ee6efe">5.7</ix:nonFraction>% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMjc0ODc3OTA4MTM0NQ_b2b485df-2337-4e46-95fc-91881ecc787f">89</ix:nonFraction> million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code. Income tax payments were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU0Ng_354c8d7d-9f9f-4592-99a6-e4315f40f45a">149</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU1Nw_efa7dcd5-1ef4-4e75-9c1c-c004abc0727b">255</ix:nonFraction>&#160;million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities that proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax issues for the 2008 to 2012 tax years. BMS disagrees with the IRS's positions and continues to work cooperatively with the IRS to resolve these issues. In the fourth quarter of 2022, BMS entered the IRS administrative appeals process to resolve these matters. Timing of the final resolution of these complex matters is uncertain and could have a material impact on BMS's consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits as of March&#160;31, 2023 could decrease in the range of approximately $<ix:nonFraction unitRef="usd" contextRef="iac4c3c432dec4175884bcb7121ad7b2e_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODIx_1fc0a86b-46a0-4be1-a052-6f1ec748beb0">40</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="id6661c44be2040ddb58e23420f3a637a_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODI3_41a6f19b-77e9-4633-8f6a-5267d6739a22">60</ix:nonFraction> million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits, however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by jurisdiction.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjI4_3002fcb6-1cfa-4064-a1c5-dcbd8b761189" continuedAt="id7888796ddb84a12ab77511acc228867" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="id7888796ddb84a12ab77511acc228867" continuedAt="i29a5e18e7c754caa91cb820e3224faf4"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjM2_d3135f4f-6282-4d11-b52f-0ae01520dba5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0xLTEtMS0xOTM5Mzc_adc5be29-3e7f-45f1-b6d3-7f6787589800">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0zLTEtMS0xOTM5Mzc_3dbdf914-7829-43b8-9767-00f9320bfc9b">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0xLTEtMS0xOTM5Mzc_2b60d731-c508-4c92-8950-63d10bca53a1">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0zLTEtMS0xOTM5Mzc_7e3f00fc-7e4c-4cd5-ab9c-154fc89b6145">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0xLTEtMS0xOTM5Mzc_2654a662-5b8b-490c-b395-7807901deaf1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0zLTEtMS0xOTM5Mzc_652341cf-2091-4a39-929d-2ec9724dcc71">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0xLTEtMS0xOTM5Mzc_3bff1eee-7225-41e6-95df-c1642d8e443c">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0zLTEtMS0xOTM5Mzc_631ca816-8ec9-4796-9381-8a90161efb6b">2,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0xLTEtMS0xOTM5Mzc_04414f89-39de-49e3-a69c-44ec253f05f6">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0zLTEtMS0xOTM5Mzc_c680c448-605c-40a5-bd7d-f0c1466eaa59">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i29a5e18e7c754caa91cb820e3224faf4">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2023 and 2022, respectively.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2NzM_ecf46179-0fbf-4f7d-a954-10540d044e1a" continuedAt="i285a0eb4fe8549a8b42c8a93ad0ccdea" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i285a0eb4fe8549a8b42c8a93ad0ccdea" continuedAt="id12e5eebdc744a75b1e7a2688206d60d"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3Mzk_9d24f17a-9f55-43f5-a281-8607a740ced7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market and other securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xLTEtMS0xOTM5Mzc_d8caa5dd-0714-40ed-ae9b-30e48deb3291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0zLTEtMS0xOTM5Mzc_c8fbcb81-6e8d-4926-b379-70294798e9e2">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi01LTEtMS0xOTM5Mzc_eae1282b-499b-41ca-8811-6c2084acf5d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi03LTEtMS0xOTM5Mzc_984a3446-4048-4d85-b703-fa7ac31e06a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi05LTEtMS0xOTM5Mzc_3e9f4dd1-773c-4d23-a325-f0b812497d17">7,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xMS0xLTEtMTkzOTM3_6f946331-02e3-4b04-be72-755d82674205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xLTEtMS0xOTM5Mzc_2fe7306d-79d5-4625-939a-b2dd66287c10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae64455b039742d787ed2de5fd251442_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0zLTEtMS0xOTM5Mzc_a6fd4972-bea8-4a19-9ad7-3e1327dbd550">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fc8f9965414a0b804d69bb0c52f940_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC01LTEtMS0xOTM5Mzc_ed0d4532-0233-4b17-9676-89f60b73573d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a360ac8b1d44afd9d65385129373f29_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC03LTEtMS0xOTM5Mzc_5512ebac-e322-44cf-9919-5e5d767d9916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84eee663f7a54ab6981f1221be773582_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC05LTEtMS0xOTM5Mzc_d46d5a42-e8ca-4456-a2f4-7c91fe2a868c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78114eba6d1431e8eb7de14cb30d209_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xMS0xLTEtMTkzOTM3_70663db2-55eb-4ee5-a962-e681f5682886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8ca2459264488eb91f63c4799ca142_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xLTEtMS0xOTM5Mzc_4115b2a6-3f44-4700-a561-65ddfb803a2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0873c9ac73324059911ec26977fd62b7_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0zLTEtMS0xOTM5Mzc_bfef367a-cc3f-4919-8acd-89ee39af2e76">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781c7d4e422d4246a9f62677261a6759_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS01LTEtMS0xOTM5Mzc_bbc3935e-e26a-43c8-b6b6-2cb420e84637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f61e0b967e941f3a13b8cdae92da602_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS03LTEtMS0xOTM5Mzc_9e0078e0-97c9-4ead-bc6d-b9e8eb9b4f61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe21eb2b773241f9975587ff0d8c4222_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS05LTEtMS0xOTM5Mzc_638dbc0b-157b-46ac-a92a-be017dc80210">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice34df82dfdc4797b4a08dd853517723_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xMS0xLTEtMTkzOTM3_883599d1-a634-4429-b230-11a6f0d54168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xLTEtMS0xOTM5Mzc_a35044b2-9a26-447d-89ea-9e47370ee717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0zLTEtMS0xOTM5Mzc_de468042-4d79-4189-88df-0c7dd6c6dff4">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy01LTEtMS0xOTM5Mzc_924ec066-4455-4801-aa12-0a754bd315b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy03LTEtMS0xOTM5Mzc_61fbf076-d781-47d7-95a4-d2fde242ae81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy05LTEtMS0xOTM5Mzc_f90819a3-df84-4a0b-bdf3-87a1aa3a2023">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xMS0xLTEtMTkzOTM3_4b9526b0-b6f5-4bf1-901e-542c7c7742ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d461f0363f4426b69a52fb5f5622fa_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xLTEtMS0xOTM5Mzc_d2927642-79cc-43e9-948c-347750fb8e79">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d1821f5f4446deb6d810a66e604eee_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0zLTEtMS0xOTM5Mzc_4018a5da-ebf9-46e9-85b9-ed4656b1d102">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa0d2ac040da41489147ca9c96170c3d_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC01LTEtMS0xOTM5Mzc_51e2264c-7eec-4bb9-a535-dd2b3bff7ba4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3125f46fdab84e90911ceb3d16a6f77a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC03LTEtMS0xOTM5Mzc_b0563ad6-73a9-4863-97d5-3020d2b6905f">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC05LTEtMS0xOTM5Mzc_983b89f1-3477-4927-bde6-8bc3de9bf6b7">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af8bc7b28d042ba94f91804fafa4966_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xMS0xLTEtMTkzOTM3_b6dc3ab0-acf6-47d5-a873-eb222de48cfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xLTEtMS0xOTM5Mzc_0df75222-1fc7-43c4-9022-ac6475f63857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0zLTEtMS0xOTM5Mzc_943dd700-f40d-44e0-a6bb-ae0663ba6982">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS01LTEtMS0xOTM5Mzc_19ef689f-11e0-49c5-9de2-8469963912dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS03LTEtMS0xOTM5Mzc_3b5474f5-7a80-481f-b674-6519c52578ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS05LTEtMS0xOTM5Mzc_d92ca86d-5620-472d-9641-1c6dcef2906d">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xMS0xLTEtMTkzOTM3_3489b1c9-23e2-454f-9654-4ca2f5fd5e96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMS0xLTEtMTkzOTM3_c15e93cd-f7ff-4fd2-a1fb-29589a0acef2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMy0xLTEtMTkzOTM3_a034deb2-9ca0-4827-82a1-b8eb7a883b7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341f444f1ff84f0393e86932e2bbcb98_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNS0xLTEtMTkzOTM3_0c567915-3985-4b47-af82-34bb64802940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14834d88f10b45639a717a5dfcb76963_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNy0xLTEtMTkzOTM3_3bf0a159-f6b9-4c53-ba9b-1c19ebe806f3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7520f9b6d647d5a6e43c02f239fa52_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtOS0xLTEtMTkzOTM3_fe561717-c9b3-4ffb-8788-de6e3d341775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aea7fd88984640aed0e394579193a2_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMTEtMS0xLTE5MzkzNw_d93c0224-f14d-4f69-b9e8-a0cd01de51aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMS0xLTEtMTkzOTM3_a61aec8a-0509-4aef-b461-84d3d5234ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMy0xLTEtMTkzOTM3_da2f9d2d-d297-4733-8850-fd01fda14e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNS0xLTEtMTkzOTM3_8b2cef73-8316-4495-8c3e-bfc9ab6b1962">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNy0xLTEtMTkzOTM3_30834dbd-05d5-4b69-aa74-00ae2009c90e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItOS0xLTEtMTkzOTM3_770cbe88-9f4e-46da-844b-959c1d803181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMTEtMS0xLTE5MzkzNw_8b0f040f-6dcf-46df-ab10-a71a118ba1c8">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in "Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements" in the Company's 2022 Form 10-K, the Company's fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2ODA_95c33714-ecf6-470c-af53-f531af728097" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xLTEtMS0xOTM5Mzc_a16df9de-41b9-4e1e-86df-9943f760a0bb">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0zLTEtMS0xOTM5Mzc_43c983ac-63ff-48b1-8bfd-dac39fdbe44b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy01LTEtMS0xOTM5Mzc_03334bac-d746-4541-9f3d-64818b2d993f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy03LTEtMS0xOTM5Mzc_b3c97bdf-bfd1-4e49-95e4-5af29b9df303">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy05LTEtMS0xOTM5Mzc_92df5114-285d-4672-8097-d7b3aafc91d8">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMS0xLTEtMTkzOTM3_2495429f-f8db-494c-b7b7-3c03dfeb01f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMy0xLTEtMTkzOTM3_f1747618-0dd3-46d8-90b8-a594b5dd8cf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xNS0xLTEtMTkzOTM3_d84f3a7b-00ce-4c26-b54f-7fd7a52ac72b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xLTEtMS0xOTM5Mzc_010b5ad4-a3cd-4861-9230-a07f3481b924">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0zLTEtMS0xOTM5Mzc_a0c9380f-db9c-448d-b6df-e64115ed788b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC01LTEtMS0xOTM5Mzc_4e12d9b2-4aaa-48b3-8133-ebbaae2a561f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC03LTEtMS0xOTM5Mzc_c6ad5733-f30f-4b70-8fa8-354fbaca9943">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC05LTEtMS0xOTM5Mzc_aba3e687-4f45-48d4-9de3-c22da60ba01d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMS0xLTEtMTkzOTM3_8bf3cf35-382c-48c5-9c67-a96091d411ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMy0xLTEtMTkzOTM3_cdf6d297-1e90-46fd-b70e-79f3c67a2382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xNS0xLTEtMTkzOTM3_fd54068e-35e1-4d61-b722-065cae170ce8">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xLTEtMS0xOTM5Mzc_a7141a28-d0a0-4dff-a705-d07e031dd244">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0zLTEtMS0xOTM5Mzc_d7661e4c-d276-4a93-ae45-5a3897212588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi01LTEtMS0xOTM5Mzc_58f948f3-1eea-4991-b57f-a239040aeb2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi03LTEtMS0xOTM5Mzc_067f4666-44ba-4044-879e-6be7e7c81682">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi05LTEtMS0xOTM5Mzc_fd44d156-c6d1-4a74-b1b1-ba8e95bc8003">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMS0xLTEtMTkzOTM3_b4bbb050-8b12-4805-87d1-9c5f59961b08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMy0xLTEtMTkzOTM3_ff49ec30-7333-43ce-98ab-a1dfaa8294bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xNS0xLTEtMTkzOTM3_2c24b918-337b-48ae-8fa2-279a22074854">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="id12e5eebdc744a75b1e7a2688206d60d" continuedAt="i2f78dbf2b30248d9950e749d6137e947"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2OTc_26f68c10-0f08-493d-aa0a-cd43ee96865b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0xLTEtMS0xOTM5Mzc_d3a97893-75e4-4ca3-8cde-c1a4e7daa14b">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0zLTEtMS0xOTM5Mzc_97436c65-f818-4ad9-a5ef-2f85b6806823">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0xLTEtMS0xOTM5Mzc_53121a6a-62a6-494b-85af-5affc230b477">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0zLTEtMS0xOTM5Mzc_1161722b-311b-4c49-911a-f31987947ec8">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0xLTEtMS0xOTM5Mzc_85ff3fd0-546d-497c-a410-fb9db08b2cb5">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0zLTEtMS0xOTM5Mzc_f77df033-ed79-4b19-b34d-4ed8bf6a7359">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0xLTEtMS0xOTM5Mzc_255283d3-46aa-4c56-821a-d30b040d8bae">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0zLTEtMS0xOTM5Mzc_606fe45d-c8af-45e1-b09b-3257771e0c99">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MzU_1367602f-ced5-47a5-8d46-5f59a8b2e9ac" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments with readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0xLTEtMS0xOTM5Mzc_ce5bd12a-b909-463a-a825-9750e71e7877">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0zLTEtMS0xOTM5Mzc_f9305eea-5f81-4452-bf9e-eecdc66a6ca2">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0xLTEtMS0xOTM5Mzc_d13ac1b8-b38d-4ade-a54f-e28ec7b08f83">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0zLTEtMS0xOTM5Mzc_5bd49d75-977d-4273-837e-e3decc313c7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0xLTEtMS0xOTM5Mzc_9dfcc700-c33b-4f6c-a725-50469f849c3c">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0zLTEtMS0xOTM5Mzc_c282b22d-e4fb-4dff-b8f5-7943f5d52d8d">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0xLTEtMS0xOTM5Mzc_97615577-95ba-4d95-9d70-eeeb9a20263c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0zLTEtMS0xOTM5Mzc_4b453abb-83cc-44e3-a590-18e057b852bc">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0xLTEtMS0xOTM5Mzc_6b054acb-3618-4a1d-81b4-a362e8d20197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0zLTEtMS0xOTM5Mzc_fb23d025-21d6-4985-b0b3-f44a49603de7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMS0xLTEtMTkzOTM3_790ff3ef-6c79-4264-87f3-943ee0cd5b5b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMy0xLTEtMTkzOTM3_8ff32c3c-65bf-4b76-aa9b-11bd36f954fc">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity investment losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMS0xLTEtMjEzMzUz_5f0b0ad4-7352-47cf-9944-a534f844e771">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMy0xLTEtMjEzMzU2_3ea54e88-9dfb-40f4-827f-ce77ca65fbad">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative upwards adjustments and cumulative impairments and downward adjustments based on observable price changes in equity investments without readily determinable fair values still held as of March&#160;31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAxOQ_c4ba4460-b1b0-4995-a667-f084c364fdd7">186</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAzMw_884d6f71-415b-49bb-b240-2bff81cd6b0b">61</ix:nonFraction>&#160;million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into foreign currency forward and purchased local currency put option contracts (foreign exchange contracts) to hedge certain forecasted intercompany inventory sales and certain other foreign currency transactions. The objective of these foreign exchange contracts is to reduce variability caused by changes in foreign exchange rates that would affect the U.S. dollar value of future cash flows derived from foreign currency denominated sales, primarily the euro and Japanese yen. The fair values of these derivative contracts are recorded as either assets (gain positions) or liabilities (loss positions) in the consolidated balance sheet. Changes in fair value for these foreign exchange contracts, which are designated as cash flow hedges, is temporarily recorded in Accumulated other comprehensive loss ("AOCL") and reclassified to net earnings when the hedged item affects earnings (typically within the next 24 months). As of March 31, 2023, assuming market rates remain constant through contract maturities, we expect to reclassify pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODc3MjI2_b100f6db-797d-424a-80e3-6c8ef36666ad">156</ix:nonFraction>&#160;million into cost of products sold for our foreign exchange contracts out of AOCL during the next 12 months. The notional amount of outstanding foreign currency exchange contracts was primarily $<ix:nonFraction unitRef="usd" contextRef="i4430059dc6204ccb8d6012d670a5011e_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTIz_8c076786-d74b-4b71-aa76-c455e9d40aae">4.9</ix:nonFraction>&#160;billion for the euro contracts and $<ix:nonFraction unitRef="usd" contextRef="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTQ3_9363de55-c3d3-4b71-8194-15abd91343b1">1.3</ix:nonFraction>&#160;billion for Japanese yen contracts as of March&#160;31, 2023. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i2f78dbf2b30248d9950e749d6137e947" continuedAt="i0df6c8c74c41402bbcff0fdc51694428"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS also enters into cross-currency swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in AOCL and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency swap contracts associated with long-term debt denominated in euros was $<ix:nonFraction unitRef="usd" contextRef="ib10f8c00022a496aa567f0b2b08b1734_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY4OTIx_7bffad9e-737e-4089-bfa7-337e787b8463">1.2</ix:nonFraction>&#160;billion as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency exchange contracts not designated as a cash flow hedge offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swap contracts of $<ix:nonFraction unitRef="usd" contextRef="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwMTky_dc2dae9a-8e73-4c77-8221-e916a4d124f4">1.3</ix:nonFraction>&#160;billion as of March&#160;31, 2023 are designated to hedge currency exposure of BMS's net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of AOCL with a related offset in derivative asset or liability on the consolidated balance sheet. The notional amount of outstanding cross-currency swap contracts was primarily attributed to the Japanese yen of $<ix:nonFraction unitRef="usd" contextRef="if7361bec49a941e5b6e8ee3761986ec8_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjM5_186ebbab-e1cb-4aca-8eb1-e8270c94fecb">509</ix:nonFraction>&#160;million and euro of $<ix:nonFraction unitRef="usd" contextRef="i35cd3e93ee9f44a4863c125f17563e83_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjU1_623638b3-14a1-4981-aa40-ead3caf7bb6a">584</ix:nonFraction>&#160;million as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of &#8364;<ix:nonFraction unitRef="eur" contextRef="i48499737f5104edab86a6d804fd035ab_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNzQ5_fe6f35c7-95c2-4f1e-b8d6-833a015ee642">375</ix:nonFraction>&#160;million. The related net investment hedge was entered into to hedge euro currency exposures of the net investment in certain foreign affiliates and was recognized in long-term debt. The effective portion of foreign exchange gain or loss on the remeasurement of debt denominated in euros was included in the foreign currency translation component of AOCL with the related offset in Long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March 31, 2023, the amortization of gains related to the portion of our net investment hedges that was excluded from the assessment of effectiveness was not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (<ix:nonFraction unitRef="number" contextRef="icf13f856670744549308e754a728bc4b_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzIw_9b90578e-c46b-4179-8db5-f3cdbe0a8f45">4.86</ix:nonFraction>% as of March&#160;31, 2023) plus an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="3" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzY4_3f25ee6c-3dbf-445d-9d1c-2d8fe570e041">4.6</ix:nonFraction>%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative cash flows, with the exception of net investment hedges, are principally classified in the operating section of the consolidated statements of cash flows, consistent with the underlying hedged item. Cash flows related to net investment hedges are classified in investing activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2Njk_93f6918c-3e8e-4857-bcf5-d38a6c8567d8" continuedAt="icd30bf43fad242feb16e3cd0f2355088" escape="true">The following table summarizes the fair value and the notional values of outstanding derivatives:</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i0df6c8c74c41402bbcff0fdc51694428"><ix:continuation id="icd30bf43fad242feb16e3cd0f2355088"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f78af08373f410f81a0ec2062e53827_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0xOTM5Mzc_e5f0b210-9c18-4b9d-a7ee-0ecdea08f8d8">5,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0xOTM5Mzc_b5368683-5d35-4044-a3d4-2a86801aff23">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3d1009dc364c098f6d58018920196a_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0xOTM5Mzc_afd53dae-b3a8-47d2-a2e4-77ce0fb920a1">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0xOTM5Mzc_15b2f72f-9a6c-41d6-84dc-a21e89d689bb">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib010a27d7530452ba7bcd495694e0d53_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0xOTM5Mzc_bc46fa67-b71b-4517-b5f8-87214275301c">5,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMTkzOTM3_761eef04-34af-476e-aced-2ea350a32c13">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8230d684b10a4394bebb9852f5a60f05_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMTkzOTM3_ecfd8cbb-df3e-4bf3-9260-87aecdedfc4f">2,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMTkzOTM3_43477b80-b6f3-44c0-80e6-733ea3b43c30">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0yMTU4Nzk_1e3b6a90-f466-4fe6-b55e-21537d1b7406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0yMTU4Nzk_552b0947-d6d3-404b-af04-cf78f17f390d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0yMTU4Nzk_2d1462c1-5f86-4a64-b4b6-3ab6a82a08a5">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0yMTU4Nzk_5bb98138-b0df-4528-836f-e94a83bc7c53">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0yMTU4Nzk_a60f7c6a-5d24-47a4-8d1a-1a27fce3fc17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMjE1ODc5_08b397fe-9630-498c-bf7f-d3f99826fbd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb614bb6595439091cb705f7444f43b_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMjE1ODc5_911f62d9-d4cd-4346-b908-2573fc2d15c3">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMjE1ODc5_2cfed332-d5b5-479f-8755-594d3be9dc32">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTgwMjA_a1391b3d-2c9e-46f4-8b1c-d9812678ae8b">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTgwMjY_7991bd24-e180-44dc-a633-a3daeb9b6ff3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c44eb56471340c0b0549845ec48e95f_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTgwMjg_6be2e05c-f7bb-42f8-a2ef-c6c208cc2537">1,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTgwMzA_d230dfca-54fa-4039-8156-a330d15559d8">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1425120cc214e32ba4675730b4b6cc8_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTY4MTA_11f89c89-95ed-4341-bc4f-9c61c8d0d9d2">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE2ODEw_53189d5e-5a27-48d4-bc84-969d93a2d06a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e1112374584215b2d716c9948e2cbb_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE2ODEw_d9d0a7b7-6bd8-4020-b120-6a60d6fddb38">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE2ODEw_f615ef82-8beb-458f-a02a-499b1ea29b53">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f0db91831245a98d378841a723e8a7_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTU3NDc_a44ddf81-59a9-4215-bf25-072fcb8f9ac2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTU3NDc_79a32970-78bb-45f8-899b-709b93f2e006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d797e1487542f49ef9a8d6421d410d_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTU3NDc_42fc173d-f963-45c1-9659-f340be6f2e41">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTU3NDc_bdf65515-1113-4146-91c4-c91153cc39c3">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic568e0cfa6234853938bade8f38decad_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTU3NDc_d6ff4b22-4850-4f31-a76e-67ed1cb58b77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE1NzQ3_b579f8af-76e5-46bd-bf7b-4f5d0334dc8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5802b471774f467b8b4ed57b33660afa_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE1NzQ3_3b6c3af2-44a2-46af-9c21-9fc9b9297389">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE1NzQ3_ee3f10b3-e19f-4b41-b89d-bd461555067b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec0fba4252a4678af79e56fbc82990b_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xLTEtMS0xOTM5Mzc_2924d88a-dcbd-4094-b6e3-6e68aa19bfc0">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c615915438143509820de8d42395deb_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0zLTEtMS0xOTM5Mzc_20cda705-546d-4e9e-98da-e6cfdde1a99d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS01LTEtMS0xOTM5Mzc_39581b66-d494-4476-9276-13c7cd611d00">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c615915438143509820de8d42395deb_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS03LTEtMS0xOTM5Mzc_ada14523-08d9-48ea-8ba8-b476f332b8fd">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8cfb2e34204828954f511d64e793e4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS05LTEtMS0xOTM5Mzc_cb6dfdd9-131c-4d76-8d89-a979deb1f083">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMS0xLTEtMTkzOTM3_384c5b0c-abce-43e0-aa0f-b4a917cddfc7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4be2043674aa491d9adeb9750ff992df_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMy0xLTEtMTkzOTM3_c4a3e5ee-b23c-4996-9e51-1ae1be402755">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xNS0xLTEtMTkzOTM3_8d3e47ae-e781-4354-bb07-8fc8f197014f">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e61e9185bb4a9eb351c39c8c716d28_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMS0xLTEtMTkzOTM3_b22977fb-6e83-4f6f-9744-06544e9bc7dc">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMy0xLTEtMTkzOTM3_ac700fda-f457-41cc-aa24-1b2c01081304">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d38948aff744438294caa148a86cdd_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNS0xLTEtMTkzOTM3_dcc868e5-045a-48f7-820d-16591841cc19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNy0xLTEtMTkzOTM3_99a76022-dbaf-464f-9b43-c5b8f34e9b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f582f93ce4e422da958adfc85f8013b_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtOS0xLTEtMTkzOTM3_a780ef9f-a7fe-4dfe-9fed-ba29120e7297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTEtMS0xLTE5MzkzNw_035bad6a-b16a-4495-bafc-7bce915daa97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155f9dbf83674147910134de5a163ed4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTMtMS0xLTE5MzkzNw_345dfd85-e6af-4161-9971-926116a2ca57">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTUtMS0xLTE5MzkzNw_28a56e57-f892-4e85-b928-4db7123ad406">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MjI_2d17a847-9957-4207-bb1e-64c3b2b6afc2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4OTE_762b1132-b858-444b-88de-316b2c9b9b5c">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4OTE_b5bafa8c-fa93-495c-9a08-64aab6ba784d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4OTE_f99c35dd-9b79-49dc-b669-05799a1ee2e0">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4OTE_84809a07-6c28-47ab-8551-2a2687c71aef">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4NjI_ed5b5ee4-023a-43f1-bf78-7ac196fc2678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4NjI_450a3478-dfb4-4e55-8a9b-9556e4af22cd">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4NjI_b131b895-3562-4b47-83c3-ddfcc8219d7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4NjI_bd9a119a-be8b-4fd8-9fdd-6b760d893734">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0xOTM5Mzc_5bd8428e-edc2-4265-ae46-46f2e5661985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0xOTM5Mzc_f3056fb5-2444-4765-a263-6864bef143c9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0xOTM5Mzc_f52a2393-0ecf-4af7-bbb0-78c08941efa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0xOTM5Mzc_7bea3298-e76a-4558-8989-44b4286ccc64">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0xLTEtMS0xOTM5Mzc_888a4fe6-6456-4bfc-9e7a-55862efde31a">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0zLTEtMS0xOTM5Mzc_4186c7d0-d2cc-461c-b571-a7126cf46521">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0xLTEtMS0xOTM5Mzc_8f834b3f-9a7f-4e02-b986-36755c92ebb3">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0zLTEtMS0xOTM5Mzc_df67d63e-4090-48c1-9ce2-44ac166fbd60">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0xLTEtMS0xOTM5Mzc_61e40858-40b2-4721-b3a3-c5c9ab2a60b5">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0zLTEtMS0xOTM5Mzc_1082e0db-b4b4-4920-b3d2-77aebc667323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0xLTEtMS0xOTM5Mzc_0cfafe7d-b1e3-4c61-adb2-b965e86c6625">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0zLTEtMS0xOTM5Mzc_7b9e2a26-2a62-4c1a-8d54-22eace023805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMS0xLTEtMTkzOTM3_8e6a33ef-8543-41c2-b444-f8ea74dc1301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMy0xLTEtMTkzOTM3_0c2ba29f-ce46-430c-a6bc-1df2265c55b3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMS0xLTEtMjAyMTYy_413c9461-e51e-4676-b6d6-89b549042e5a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMy0xLTEtMjAyMTU1_ab39b861-7ee0-4580-b5ca-4dfd22ecd0de">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. dollar borrowings gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMS0xLTEtMjAyMTY5_2a4cae0f-836c-44d9-b612-0a5cab984673">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMy0xLTEtMjAyMTY5_43fca35b-9d9e-404f-ac1a-0b8c4ecbde8f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_1545"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDAw_c20716b2-7e1c-4f8c-a82a-16ad0c0e596b" continuedAt="ie90829cc850e47f4a3f0d317de6fc1bc" escape="true">FINANCING ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie90829cc850e47f4a3f0d317de6fc1bc"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMy_38f3c522-8422-4de8-ab52-a9f9fbed6bac" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTEtMS0xLTE5NzI4Ng_9ff512fb-e6b0-4ff9-8a97-63af97338104">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTMtMS0xLTE5NzI4Ng_70905f9b-01ea-49b3-a841-636f5366965e">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTEtMS0xLTE5NzI4Ng_77ce9fb1-68a0-4746-b772-b5c3548b7de7">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTMtMS0xLTE5NzI4Ng_1a565440-54bf-4348-883a-6c65b923e9dc">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTEtMS0xLTE5NzI4Ng_be34c68b-cba2-4aa1-a5e4-8c412c8dd3b4">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTMtMS0xLTE5NzI4Ng_8258c604-4eca-40e9-acfa-9a03a3d999d9">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTEtMS0xLTIxMzQ0Mw_573b9bfd-20ad-425d-948d-a91f5ad79c64">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTMtMS0xLTIxMzQ0NQ_17c70c39-67df-4327-b155-385722b681a2">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMz_c5e446a8-54f9-4e4b-870f-6a52c439b7e2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of Long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTEtMS0xLTE5NzI4Ng_ecafce33-3fe3-4acd-8d60-565f58d1a66b">36,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTMtMS0xLTE5NzI4Ng_1b9c71bd-4e37-4436-82c1-97a3c629d69b">38,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to principal value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb244ebbca7645918a749ff83a2caf20_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTEtMS0xLTE5NzI4Ng_2ae2fe25-9d29-4a52-9878-d82d99b08da2">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id87dc345b8de442ea6f8dbbd65882071_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTMtMS0xLTE5NzI4Ng_4420da97-d0d8-4c54-9d72-0f6c1c92a4d1">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTEtMS0xLTE5NzI4Ng_168c1463-3859-4859-957d-02cf2ca46e63">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTMtMS0xLTE5NzI4Ng_955f1ebc-3c8d-4454-a289-7032560ad180">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTEtMS0xLTE5NzI4Ng_7199d3f6-2729-4984-b40f-262f90395285">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTMtMS0xLTE5NzI4Ng_ec2156f9-d178-4031-8fcd-9d152682fd9d">284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTEtMS0xLTE5NzI4Ng_c4645046-fc13-4a21-95b5-4371ed205506">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTMtMS0xLTE5NzI4Ng_c961bcf0-ad96-41ed-a04d-796f128629ec">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTEtMS0xLTIxMzQzNQ_6f96b806-ab3e-4df7-9d81-4760640a2bdd">37,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTMtMS0xLTIxMzQzNw_93be3a5a-c32d-421b-8a70-6fee90a07b1c">38,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0xLTEtMS0xOTcyODY_22f19f66-7980-48c9-96a2-77eb6d9b62f4">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0zLTEtMS0xOTcyODY_96f24540-5a46-4099-9ed0-d522646c6257">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0xLTEtMS0xOTcyODY_77c5a862-01d2-41b3-adad-2972ee98f1b4">35,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0zLTEtMS0xOTcyODY_1390673b-c49c-4c36-9cd4-7e16b43099b7">35,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0xLTEtMS0yMTM0Mzk_6c5b3591-87c4-4fb6-8b65-36674795ac2d">37,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0zLTEtMS0yMTM0NDE_550a2f4d-d1ab-4f2a-a4c1-177680b8a2b0">38,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI3OTg5_009455f6-4b86-41e2-b6b6-e718135908d4">34.5</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MDA3_a113b7d6-c2bc-45b6-98bd-b6b3eb19c808">34.9</ix:nonFraction> billion as of December&#160;31, 2022 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-8" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTIy_90de8d68-9baa-49fb-a67c-1f96bc2e1dbc">1.6</ix:nonFraction>&#160;billion of debt matured and was repaid including $<ix:nonFraction unitRef="usd" contextRef="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331" decimals="-6" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTA4_e73ecfae-e5ce-484b-aaa0-e791b1c7e08b">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="ieaa68541a773415fae251b23e344c1b9_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTM2_b18d30f8-3919-4c93-971b-54f94b26f880">2.750</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331" decimals="-6" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTQ0_68248566-b566-45f8-9a86-c13c04b26d16">890</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i525174948c6543dc8a99d3c14aab9da3_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTU4_04e979e1-3fb3-4218-b1bb-2cf018c543bd">3.250</ix:nonFraction>% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS issued an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzU3_65f6cc24-776b-4e77-89b9-f74ad82d5a56">6.0</ix:nonFraction>&#160;billion of debt, with maturity dates ranging from 2032 to 2062, with net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzkw_80bd0c52-b982-4d04-8359-cbe0fa99e078">5.9</ix:nonFraction>&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest. In addition, BMS purchased an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MzU4_386eb17a-71aa-4e77-9b1b-f30c0de60fd6">5.2</ix:nonFraction>&#160;billion of certain of its debt securities for $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NDAw_a9050302-9e98-470b-8674-7a2ce71362bc">5.8</ix:nonFraction>&#160;billion of cash in tender offers. In connection with this transaction, a $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NTAw_fdacc9a5-f6cc-4879-ac2b-d31b4f801fe5">275</ix:nonFraction>&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzYw_ac863602-d8e7-45be-a362-09dd7100f7e2">324</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzY4_7a05afa5-66d6-4e92-92b2-26da1543722a">377</ix:nonFraction>&#160;million for the three months ended March 31, 2023 and 2022, respectively, net of amounts related to interest rate swap contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, BMS had a <ix:nonNumeric contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDEz_2c9295f2-a98b-4275-bbc3-dc31fa1ea105">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMwMjQ4_f46da567-6a3e-4c3a-89a1-f0bd68ff7718">5.0</ix:nonFraction>&#160;billion revolving credit facility expiring in January 2028, which is extendable annually by <ix:nonNumeric contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" name="bmy:LongTermDebtRenewalPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDIy_74552306-2018-45a1-951c-92de2624bbcf">one year</ix:nonNumeric> with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. <ix:nonFraction unitRef="usd" contextRef="idd5a938b770d4b608475507fe2c5a3b1_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_512f90bb-f703-4eb2-9cbc-1b7fb34a6fe5"><ix:nonFraction unitRef="usd" contextRef="i937b0f049dac419089d03f3d635323d2_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_d52c9662-2d36-4226-bfee-a5b4847c7da2">No</ix:nonFraction></ix:nonFraction> borrowings were outstanding under the revolving credit facility as of March&#160;31, 2023 and December&#160;31, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg1_991da68a-9924-4c08-b3ea-45ea93f09e78" continuedAt="ifb328701e69743b9969d94d6df6292f9" escape="true">RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="ifb328701e69743b9969d94d6df6292f9"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg3_23fc7245-6282-49c3-80a4-1c5843d3af4f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0xLTEtMS0xOTM5Mzc_bb24deac-444b-4bde-9e54-12168fa8aa46">8,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0zLTEtMS0xOTM5Mzc_cc48251f-4dd4-4fa8-bbf9-807a1e9d89b5">8,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0xLTEtMS0xOTM5Mzc_05b1cd25-587f-43aa-95b5-c3bdbfe38112">609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0zLTEtMS0xOTM5Mzc_b568625b-af55-4fe5-8cf4-772152045037">675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0xLTEtMS0xOTM5Mzc_239e6297-4012-41f0-badc-d73afbef142a">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0zLTEtMS0xOTM5Mzc_5c720070-1447-4ae6-a363-a9d0514559f0">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0xLTEtMS0xOTM5Mzc_0512c351-1d8f-4c2a-957f-a49942e0cacd">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0zLTEtMS0xOTM5Mzc_377cd852-8310-4ba6-be3f-c7f326137ae3">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0xLTEtMS0xOTM5Mzc_5352bc2d-4c63-4c60-9bbe-e48b1021b22c">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0zLTEtMS0xOTM5Mzc_a2b4b758-de79-4d73-996f-2e3240ddd7d2">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0xLTEtMS0xOTM5Mzc_4ef9f5c7-6161-4226-80be-df5839dc1919">10,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0zLTEtMS0xOTM5Mzc_b8e2b6e2-34b3-4e28-935c-2120afb3ec24">9,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfODM_6abf10fc-bce2-4fd9-a3fe-e79c80bb9309">239</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfOTA_bc9ec4cb-56df-4c53-8f3c-9adf0ba29b21">423</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively. Receivables from the <ix:nonFraction unitRef="customer" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="INF" name="bmy:NumberOfLargestPharmaceuticalWholesalers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMTQ3_4d9c4e61-8d83-4dfb-8783-b4ae8aaefa35">three</ix:nonFraction> largest customers in the U.S. represented <ix:nonFraction unitRef="number" contextRef="i6ed144f6904d4064a626d5562e3a0cf0_I20230331" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjA2_c2b29729-f2ff-4514-9fb7-70896c7394d5">69</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2324127f89494362aa7de6e45d6fe141_I20221231" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjEz_1919ad96-a837-410a-aad5-c4315e37c501">66</ix:nonFraction>% of total trade receivables as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjI3_2f541914-6a6f-44d9-9d56-e4818180c6ee" continuedAt="ife30e4b54fe04f10bbb07f9034e3500d" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ife30e4b54fe04f10bbb07f9034e3500d"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjMx_9ae0a65e-9b5f-4405-a236-e4a71b8bd6a4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0xLTEtMS0xOTM5Mzc_c5efd024-c8f0-49c4-b92d-95cdd5e6869d">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0zLTEtMS0xOTM5Mzc_dad282a3-0bbd-4de6-a282-fa55739d6866">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0xLTEtMS0xOTM5Mzc_5bd0e03d-1635-4bf9-8e27-a76648990ce1">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0zLTEtMS0xOTM5Mzc_c92c8677-405f-4727-9453-c2e4a3953654">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0xLTEtMS0xOTM5Mzc_f389f7a2-ce5b-4e51-823b-6a64bbcbaa4f">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0zLTEtMS0xOTM5Mzc_a0e00d60-a77b-4851-8865-9654c721c098">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0xLTEtMS0xOTM5Mzc_75f02ea4-36f7-4e14-8590-f4f113f5842d">3,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0zLTEtMS0xOTM5Mzc_8eba4083-c75c-4feb-b341-30ccdb989fdc">2,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0xLTEtMS0xOTM5Mzc_ec87456d-afd7-42bd-92d1-0672d00cbfeb">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0zLTEtMS0xOTM5Mzc_3cc608a6-0be6-41e9-88c7-cefc15d598c2">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value adjustments related to the Celgene acquisition were $<ix:nonFraction unitRef="usd" contextRef="i24309b9bca4c40368e5159601708371e_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfOTY_4bb6899e-a3c4-4597-b936-cf89a2cbbcc0">32</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i356526281a974299bee8ad28a8382769_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMTEy_09c507d3-34ea-4fda-ae67-f0e86833185d">84</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTU2_55b40378-977b-405c-b7c3-5cca00bf64e6" continuedAt="i6eedd85ede814fea97889a2c34c7584e" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i6eedd85ede814fea97889a2c34c7584e"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTQ2_3e3d320b-85f5-4fc7-974b-5189e38a3d8a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0xLTEtMS0xOTM5Mzc_fc8b4de0-40fa-44ea-acf8-2956457f57ae">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0zLTEtMS0xOTM5Mzc_dfce43dc-a85a-4755-9459-d005f87dfbe6">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0xLTEtMS0xOTM5Mzc_41fdef9f-b203-4e47-a56e-38293e9a011e">5,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0zLTEtMS0xOTM5Mzc_bb9b8065-1615-441f-b579-f2e42a825093">5,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0xLTEtMS0xOTM5Mzc_41fb85c3-ea3c-4da7-9e27-03411ba66179">3,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0zLTEtMS0xOTM5Mzc_1fddb497-9767-407b-89a4-3ee9fb0990a3">3,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0xLTEtMS0xOTM5Mzc_899380cd-ab33-4103-a4f3-df137c0dfbc0">1,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0zLTEtMS0xOTM5Mzc_a6b70996-f341-4bd1-be35-b4616e8cb42c">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0xLTEtMS0xOTM5Mzc_1239d928-6d25-409e-ae46-2ac3701b2c6b">10,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0zLTEtMS0xOTM5Mzc_6d407b22-85ac-45cf-b27a-9aba70227c7f">10,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0xLTEtMS0xOTM5Mzc_90f96a7e-cfb2-498d-be06-d82ab688bac4">4,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0zLTEtMS0xOTM5Mzc_7b627ae7-3df2-4e29-bb5f-353750bc67d7">4,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0xLTEtMS0xOTM5Mzc_97b098d6-9321-4721-aba5-a57fda052909">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0zLTEtMS0xOTM5Mzc_9a0ccc4c-48c8-46f4-96da-0e0a3e6e690c">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfNzM_f8d3c2e8-9135-42e2-b74f-d15f03db2113">146</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTA5OTUxMTYyNzk1Nw_06078aff-0cea-48c2-91f8-1c6ee9f8b484">145</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxNg_860aeca3-d2fa-4933-bf5a-a256fa7577a6" continuedAt="i001024b871e6488fadba2b309f44b222" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i001024b871e6488fadba2b309f44b222"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxMw_de2cf382-7e84-4bf7-8e70-3fa8fed08a99" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts in Goodwill were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:87.217%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.583%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMS0zLTEtMS0xOTM5Mzc_4f4482a2-f21a-4b16-98ea-68155a508c9a">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMy0xLTEtMS0yMTM0NjM_b8bbfe65-3053-4d62-b68f-dc8fd08c0e9e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfNC0xLTEtMS0yMTM0NjM_fe6d69d2-c167-4502-87f1-a4247636ad41">21,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODc5NjA5MzAyOTExMg_24324367-e60a-4f97-80cf-5cfaa101c963" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:25.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.807%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful&#160;Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzkz_a47280a5-84ef-4957-bc8f-02242fdac0e1">5</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzk4_d9a9e199-ab6a-45f5-8523-a7402da428b3">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0zLTEtMS0yMTM0NzM_2ec59dc9-ad04-4f86-ad0a-17c6d19f8e66">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi01LTEtMS0yMTM0NzU_6feb02d9-e513-4a76-9d0b-1e298a45c0b0">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi03LTEtMS0yMTM0NzU_e5b6fcdc-ddd6-4988-8e84-f824d8b6f291">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi05LTEtMS0yMTM0NzU_21be85c2-4f68-497f-81ed-1f5a6b789546">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMS0xLTEtMjEzNDc1_7066f657-4223-4997-9e14-2631972e43a9">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMy0xLTEtMjEzNDc1_2b63a034-0325-48f8-94c7-fd26e867fabe">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzkz_bbfadbe3-be95-4193-8958-b13a92684c6f">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzk4_2e107ad1-cdb7-4c18-bd32-50b178c2d714">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0zLTEtMS0yMTM0NzM_e64fee5a-7816-445b-82a1-3526c53b8bbd">59,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy01LTEtMS0yMTM0NzU_a6d314f5-a3b3-42f6-8149-5b6c2804f40d">33,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy03LTEtMS0yMTM0NzU_6d0a7187-8b9f-40d3-ab22-69854f295f3e">26,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy05LTEtMS0yMTM0NzU_3ca8c3fb-c066-408b-80c5-027cf939e80f">60,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMS0xLTEtMjEzNDc1_6d95a518-d90d-46e1-ad0a-d39ebded7d92">31,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMy0xLTEtMjEzNDc1_9d71edca-b46a-4269-b6d2-fa2c9c93a7c0">28,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic79428ebec0f445285e266d25006a85a_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzkz_8fc925b3-6541-4ab3-b103-adefff160cc9">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ifbd254642fa845128c263c3a56052a25_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzk4_807fc8dc-cfd9-4702-b25d-3bacebcc8a62">10</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0zLTEtMS0yMTM0NzM_429787c0-b3f2-4070-9dca-a0aea23ab979">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC01LTEtMS0yMTM0NzU_bebecea9-7e99-4629-86a7-fa5c1d78da56">1,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC03LTEtMS0yMTM0NzU_ec3aa19b-3b84-48a2-b239-5557009c5ecd">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC05LTEtMS0yMTM0NzU_4519e1b3-3c16-4a07-85c2-178ab4fcbb73">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMS0xLTEtMjEzNDc1_a49312c2-21eb-41e2-a1ee-7cf2670ace43">1,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMy0xLTEtMjEzNDc1_67abeb9b-cc52-46da-93c9-1a657a698748">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee21a224006b4db88a4217127cb842f4_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0zLTEtMS0yMTM0NzM_cf03197b-074c-4f1f-ac34-4c37fb3002e2">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee21a224006b4db88a4217127cb842f4_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS03LTEtMS0yMTM0NzU_b6f9c4a0-746a-41b6-9d16-0e1ce860e8dc">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS05LTEtMS0yMTM0NzU_09ae2b08-cf50-46bb-b9c6-6537d7771430">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xMy0xLTEtMjEzNDc1_ec65d3d7-0545-4deb-8def-4dc89c400e1e">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0zLTEtMS0yMTM0NzM_65e39b0b-f37c-4bae-874c-b4988f24b70b">68,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi01LTEtMS0yMTM0NzU_1ab72604-c7cb-42d7-bcf9-65ffc0cdedac">34,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi03LTEtMS0yMTM0NzU_58de0f82-dcec-4fce-8448-ae72dd7e12a3">33,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi05LTEtMS0yMTM0NzU_c14256d4-e5df-43a5-bf17-7b62bc3faa7a">68,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMS0xLTEtMjEzNDc1_f96bf273-b776-48f7-b933-856a5503e757">33,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMy0xLTEtMjEzNDc1_3916e5d3-0207-4409-8100-7045301934c2">35,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of Other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMzY0_ee3a6463-520a-4361-8dcf-803a2bd8e84a">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMTA5OTUxMTYzMjc4MA_86c25e88-2a1a-4b1a-8054-5642c076c176">2.5</ix:nonFraction> billion for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPRD impairment charges were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfOTM0NTg0ODg0NDI2Ng_3d3939d2-83ff-4573-b995-061befce44d8">20</ix:nonFraction>&#160;million in the first quarter of 2023 and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODEyNA_c3bf63c7-db81-4bb7-b2c7-fbe43694a018">40</ix:nonFraction>&#160;million in the first quarter of 2022 and were included in Research and development expense. The charges represented full write-downs.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDg0_48e78a46-5214-4c0f-814b-a1b0662ba77c" continuedAt="i377e0b4d0af34612ad7ee8083b1352f0" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i377e0b4d0af34612ad7ee8083b1352f0" continuedAt="i930b0dcaf27c46cdb221578564fef2ea"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkz_5e9007ee-b35c-40e8-a90c-5db9486ff4df" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0xLTEtMS0xOTM5Mzc_7ec600c4-31b5-4ddc-840d-adffa39c481b">2,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0zLTEtMS0xOTM5Mzc_eeb03c26-5bf2-4986-917d-f726c62d78bd">3,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0xLTEtMS0xOTM5Mzc_671098c2-60f1-41e2-8904-d3ea1b19f9da">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0zLTEtMS0xOTM5Mzc_0fff8b21-a03c-4f81-9670-b1b40e82fa36">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0xLTEtMS0xOTM5Mzc_a651974a-6187-4933-9597-21185d23b91d">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0zLTEtMS0xOTM5Mzc_bf66a025-e548-4107-9560-0cddd2ea528e">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0xLTEtMS0xOTM5Mzc_7667c64a-fbd2-4720-89ab-e8d53e085e0e">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0zLTEtMS0xOTM5Mzc_2947a668-f96a-43d1-8071-6a407a13640e">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0xLTEtMS0xOTM5Mzc_ec791aa1-fe8b-4075-b415-b3dfd342a29c">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0zLTEtMS0xOTM5Mzc_5a5477ed-3de7-419e-832b-7aa9d57acd45">1,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0xLTEtMS0xOTM5Mzc_2064284a-43ca-415e-85e5-24d951a39fa0">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0zLTEtMS0xOTM5Mzc_8523dd87-1a6e-4f47-8c02-7017501779ba">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkx_71c7f04d-c161-4e4b-893c-93eb42c7f495" continuedAt="id70e255dc80443c4bc854cfa4e1c6c3f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0xLTEtMS0xOTM5Mzc_7fba640a-e5bf-4f5b-95d3-a3b7fea17f17">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0zLTEtMS0xOTM5Mzc_d84607e7-0fc9-4da2-b152-51e694a42bc2">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0xLTEtMS0xOTM5Mzc_c618fcf1-cee2-4e3a-9985-475bca72123e">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0zLTEtMS0xOTM5Mzc_df1a6339-01c0-421d-93cc-56278ddd7394">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0xLTEtMS0xOTM5Mzc_60309d9a-35ce-4cf6-9885-fde6378f3efb">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0zLTEtMS0xOTM5Mzc_0b2bb549-1a67-4f26-aa4f-4ae3a308c028">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0xLTEtMS0xOTM5Mzc_0fcf6f47-2662-4ce8-8a8a-27a5e7ca0a80">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0zLTEtMS0xOTM5Mzc_99f05909-3dcd-4c89-9712-2385acf59cc5">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0xLTEtMS0xOTM5Mzc_bfa335ff-f972-491b-8448-ec6e9419b96a">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0zLTEtMS0xOTM5Mzc_2d92d022-811e-4e3b-a656-e4ec5ed92c37">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0xLTEtMS0xOTM5Mzc_b8f35eb0-1fa6-4156-8d40-4cd2007209dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0zLTEtMS0xOTM5Mzc_499975d6-4c44-4229-9f9c-08a03ac3c6ab">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0xLTEtMS0xOTM5Mzc_78f9e47d-be29-4177-b781-f476dc0867de">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0zLTEtMS0xOTM5Mzc_9c6dab20-722f-4b71-acb1-40fdfd542b67">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0xLTEtMS0xOTM5Mzc_85d9079f-c809-4d83-9262-8fa1697b6674">4,868</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0zLTEtMS0xOTM5Mzc_0ad94044-a5c6-4ef3-ac3e-f76d1d565fa6">4,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="id70e255dc80443c4bc854cfa4e1c6c3f">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfMTA2Mg_aa25c858-94a5-42c4-a907-3141f9369245">210</ix:nonFraction> million.</ix:continuation> </span></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i930b0dcaf27c46cdb221578564fef2ea"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDgz_a79a2a22-020b-402d-85bb-3f134f76692e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0xLTEtMS0xOTM5Mzc_9e953b00-84af-4346-abdf-0316260a610d">5,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0zLTEtMS0xOTM5Mzc_64bb695c-3161-46c4-9b3e-8e1118d494f6">6,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0xLTEtMS0xOTM5Mzc_838f7c7e-6678-4306-a568-44c5e23e3289">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0zLTEtMS0xOTM5Mzc_8a6fc97e-b8ae-48b0-afc0-0c989d8d6388">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0xLTEtMS0xOTM5Mzc_fe398b17-c25d-4aa3-9676-2bb0319bc2f7">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0zLTEtMS0xOTM5Mzc_43b345a4-8c7d-477d-86eb-b86a93329812">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0xLTEtMS0xOTM5Mzc_d204b6f9-1f1b-4089-a713-391cbffcc3a2">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0zLTEtMS0xOTM5Mzc_9875ce3b-c47d-4a6d-9031-e84ed39285b0">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0xLTEtMS0xOTM5Mzc_f8d5202d-75da-4733-9459-b1676cf936d3">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0zLTEtMS0xOTM5Mzc_656d5f53-4364-4553-82be-8a35d4d28631">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0xLTEtMS0xOTM5Mzc_e487b575-29fc-412a-9063-c4e23bc57f42">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0zLTEtMS0xOTM5Mzc_42a10d8a-abcb-4370-8455-c5524f11cde4">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0xLTEtMS0xOTM5Mzc_1dce747d-7986-4025-baa5-7228f2301c06">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0zLTEtMS0xOTM5Mzc_2ddf9ef0-7861-4001-95d9-b2617e44d305">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0xLTEtMS0xOTM5Mzc_f0dcf9de-09c4-4d25-9618-41c2d7e6c4f5">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0zLTEtMS0xOTM5Mzc_e3689b31-dde7-4c58-bec7-1f697a2c0e36">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMS0xLTEtMTkzOTM3_6ee68764-1118-4a91-a4d8-56f6a71f3523">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMy0xLTEtMTkzOTM3_7ff9c46d-1229-4320-90c6-900c2566ec6a">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMS0xLTEtMTkzOTM3_ee5a5cc7-fa2b-4ab2-b7b4-56cf7d0bd8d2">13,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMy0xLTEtMTkzOTM3_cc0c2491-47b1-4f6c-b00d-bd841eccd538">14,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDky_37cadca9-2a2b-4b56-84ab-d6332db3b748" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0xLTEtMS0xOTM5Mzc_a63a97ba-7813-4270-9743-a81ac5863a6e">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0zLTEtMS0xOTM5Mzc_0228e5bc-b78f-4931-bd7f-db4a065b319a">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0xLTEtMS0xOTM5Mzc_760f94c4-0578-4d34-8e18-c6f8ad96589a">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0zLTEtMS0xOTM5Mzc_6e9635da-8f3a-4e34-8c9a-bb3b83d356ec">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0xLTEtMS0xOTM5Mzc_7d9f5030-0a3a-4784-9fac-00b120ea0889">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0zLTEtMS0xOTM5Mzc_20c9d53c-3a00-4edf-94a8-4facd536fce7">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0xLTEtMS0xOTM5Mzc_fa89fe61-c425-42cc-8639-3ec99fb68b7b">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0zLTEtMS0xOTM5Mzc_0401d0cd-27bb-4d32-b315-42086cc270eb">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0xLTEtMS0xOTM5Mzc_681fdfd6-d2dc-4848-ad2c-0a5082ae247b">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0zLTEtMS0xOTM5Mzc_b7686451-eeb8-4607-bda6-a742a26718aa">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0xLTEtMS0xOTM5Mzc_2ae00dbf-a91b-4d0c-8bc4-4c0ff84e8e24">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0zLTEtMS0xOTM5Mzc_e3bc276e-bf0d-4d48-b587-1b8d53ef3afc">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0xLTEtMS0xOTM5Mzc_dcff01b2-e599-42f2-9911-93ce5f23932a">6,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0zLTEtMS0xOTM5Mzc_57e5f12f-3d57-4eb4-8269-7536dfb64ea3">6,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY1MA_eed9afeb-72b3-4f69-aacf-2a927455e6f9" continuedAt="ib1902642983047be84ccf30903ef446c" escape="true">EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib1902642983047be84ccf30903ef446c" continuedAt="iaf891c5fd23842fdb165e6b57a92fc0f"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3Mw_5213d670-ff6c-4f23-aa29-411563443d13" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2023: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.520%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaacb967952a84c929370c1cb0330584a_I20221231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xLTEtMS0xOTM5Mzc_f374cdd4-25cc-401f-bf5f-cd7ef941560a">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaacb967952a84c929370c1cb0330584a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0zLTEtMS0xOTM5Mzc_805d6b35-2365-4efa-9950-67fb46d2fbae">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi01LTEtMS0xOTM5Mzc_8f610b8c-49d5-42ad-8022-f295f2176490">45,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e3fe6d813fb473a96593961f0613f55_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi03LTEtMS0xOTM5Mzc_1f8fb9fc-cfca-4737-a2e1-0166ce5e1f13">1,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ad784c18b14feaa7917cf92952a3bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi05LTEtMS0xOTM5Mzc_9e51d5d3-6b7d-4626-a848-2def8a87b8ef">25,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4908dc165f094814bdc03777b63fb228_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMS0xLTEtMTkzOTM3_3b9cd25e-dffa-4469-884b-518a1eabc826">825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4908dc165f094814bdc03777b63fb228_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMy0xLTEtMTkzOTM3_94b6fb3b-f08a-404a-9d60-f9a4edc35057">38,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i348f12df9a624cae9f58f9b3c31d39ed_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xNS0xLTEtMTkzOTM3_e54f1bc6-a2f5-4808-8425-de62d33344e0">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy05LTEtMS0xOTM5Mzc_6998f663-4daf-4af2-82c0-a803bcfb597f">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy0xNS0xLTEtMTkzOTM3_fe112449-d538-4459-a092-57a32d7932e5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNC03LTEtMS0xOTM5Mzc_5acd1a0e-3126-4583-89e5-5b0bd20f6f8b">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $<ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS0wLTEtMS0yMTYxNjYvdGV4dHJlZ2lvbjo5YmNmNDlmYmFhMjU0MGU2ODViNDAyMGNkMDIwMDI0Zl8xNjQ5MjY3NDQxNzI0_766000fe-0fc2-4783-b008-234303ef1c13">0.57</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS05LTEtMS0xOTM5Mzc_4c2406d8-3d80-48ed-bcd0-6c502b01d73d">1,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMS0xLTEtMTkzOTM3_f0872950-e296-4cb0-8872-2c7d8f827e27">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMy0xLTEtMTkzOTM3_226515cf-bda1-42e8-b79a-4eb9883a0725">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy01LTEtMS0xOTM5Mzc_2b8e402f-692f-41e1-9df7-36e7de8a8c79">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMS0xLTEtMTkzOTM3_801548f0-74ae-42d4-a924-aa2d242f2a61">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMy0xLTEtMTkzOTM3_ff78f8a1-a2ad-439c-a27e-1c90ba2f224d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xLTEtMS0xOTM5Mzc_7364dfa8-9cda-4ea1-971b-58af0c516a62">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0zLTEtMS0xOTM5Mzc_484b0012-38e8-41c7-96fd-877f4ebc3656">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS01LTEtMS0xOTM5Mzc_764da0e9-e8d9-4d89-b4cf-6a3355fc0865">45,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS03LTEtMS0xOTM5Mzc_3954f2be-4c13-45f4-baeb-2461b1667eac">1,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4801a688a148d1bbef6616d73a97b9_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS05LTEtMS0xOTM5Mzc_e24f37ff-8406-4489-b18a-ec642ec3209d">26,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMS0xLTEtMTkzOTM3_4c1b65ee-53e3-454d-a4aa-88b049932677">823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMy0xLTEtMTkzOTM3_f7ac40b6-f4ff-47d4-88c9-9fe8093a652e">38,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4792b9bd5d914473a84cba87ee6517b9_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xNS0xLTEtMTkzOTM3_0305bc56-ef03-4f9f-a7e2-88518b442c63">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:30.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xLTEtMS0xOTM5Mzc_5603db5a-75c8-4755-aa87-9b0e3d5cbd18">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0zLTEtMS0xOTM5Mzc_f5adacb8-5f87-4684-aa0d-0936e23436a1">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8e035725b3442db86565959545c35a_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi01LTEtMS0xOTM5Mzc_281b03fa-3cb5-42df-b440-3ad5a0762e40">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie716e8002a604614bf64186acced27ad_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi03LTEtMS0xOTM5Mzc_7a832b2d-8066-4544-b9cc-270c7cd5d842">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73d338c52b542ddae2377e527c62f2c_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi05LTEtMS0xOTM5Mzc_0487a997-850a-4c09-ae85-b8d166ab4f85">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMS0xLTEtMTkzOTM3_e563ddcb-82b5-4ad2-a1a2-0cb3712f1767">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMy0xLTEtMTkzOTM3_882d625b-a705-48f3-9433-a8dd3efbccfd">31,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68d187be7b0471c86033eada0951b2b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xNS0xLTEtMTkzOTM3_41569577-1e91-466b-8372-6b9a8c895df9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy05LTEtMS0xOTM5Mzc_7778ee7f-b2ea-4d55-82e3-3a6aaecba379">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy0xNS0xLTEtMTkzOTM3_94d3c107-bb29-4486-ac31-8282edaad019">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb982410931493f88491ecf96248f25_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNC03LTEtMS0xOTM5Mzc_d1f24432-941b-4550-b4ff-44c78bdf1ee2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $<ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS0wLTEtMS0yMTc2NzEvdGV4dHJlZ2lvbjoxYzgzMTRkYjVjMjU0ODg3YTlhMzE2OWRlODEwZTcyZV8xNjQ5MjY3NDQxNzI0_ba778cd7-4837-4bab-84bb-69159086acd5">0.54</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS05LTEtMS0xOTM5Mzc_3752643c-22ad-4ec1-8cf1-c618d35abba0">1,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi01LTEtMS0xOTM5Mzc_2754dc36-d41b-43a2-835c-1f26dbbf5545">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMS0xLTEtMTkzOTM3_b739392e-c49d-4bbf-8a39-4b0c883c7a86">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMy0xLTEtMTkzOTM3_29041630-bae9-4df9-befd-7ed7cc657ba6">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy01LTEtMS0xOTM5Mzc_9e435132-a0c2-4be0-8363-711f93475d90">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMS0xLTEtMTkzOTM3_50fadc78-02cc-4d4b-b6c2-3f13fc3c140a">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMy0xLTEtMTkzOTM3_77aed5ef-545a-4dc5-8217-1037c75efc67">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xLTEtMS0xOTM5Mzc_3152bfcc-fb3b-49ac-a8dc-2cb53df41e02">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0zLTEtMS0xOTM5Mzc_561f8a3b-dafe-457e-967f-7b59b9f165f9">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b9651239b0491abf8341b486a23dc1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS01LTEtMS0xOTM5Mzc_e1edd3e8-c928-48fb-9947-2a84424fc304">43,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d753b05e49247a7998fcd56ba7831aa_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS03LTEtMS0xOTM5Mzc_a55d68d6-307b-41a2-ba77-8e32671bdccd">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3207d415b9154ca9b0988b77bdf66bf8_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS05LTEtMS0xOTM5Mzc_b0e5f669-6b02-490e-8895-46f511563463">23,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic21692a74de649678999f109fd39cfab_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMS0xLTEtMTkzOTM3_beee47b4-f442-4d75-a29b-e8202648f6fc">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic21692a74de649678999f109fd39cfab_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMy0xLTEtMTkzOTM3_d5bb5e15-07eb-4fb1-b682-dba19314a1f1">35,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xNS0xLTEtMTkzOTM3_5611a8c4-f0f0-4aa1-a37e-1a761bf6670c">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased <ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE0OQ_d902cacd-074e-4b88-8572-65f5e9f6826b">3.7</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE4Mw_ad2607c9-bac1-419e-b4cc-36c12f1f0979">250</ix:nonFraction>&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the BMS share repurchase program was approximately $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNDk4OQ_9d4587e2-a7ce-427d-b168-ddf6252af3ed">6.9</ix:nonFraction>&#160;billion as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i597908d9a603482f9546e5ee2009c406_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA1Mg_fe93f996-001a-4336-b6de-7de61384a260">5.0</ix:nonFraction>&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand and <ix:nonFraction unitRef="shares" contextRef="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTE3OQ_2d0acc05-c3f9-4709-9b75-5388c50975a8">65</ix:nonFraction>&#160;million shares of common stock (85% of the $<ix:nonFraction unitRef="usd" contextRef="i597908d9a603482f9546e5ee2009c406_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTIxNw_c83e04f5-6a52-49d0-8454-e27ce17e97c5">5.0</ix:nonFraction>&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="iaf891c5fd23842fdb165e6b57a92fc0f"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY2OQ_90810fea-7f11-4ebb-8b66-e5c49197c957" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Other comprehensive income by component:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xLTEtMS0xOTM5Mzc_abdebf3f-fa3f-41e9-a561-cd030a1866b0">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0zLTEtMS0xOTM5Mzc_137035df-d4cc-4f6f-b85c-72a52f13ca5e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC01LTEtMS0xOTM5Mzc_28856ab7-3084-4573-91ac-e62a9a0a9f22">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC03LTEtMS0xOTM5Mzc_2d8479db-3990-46aa-b006-c8f1e444810d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC05LTEtMS0xOTM5Mzc_b772ac88-064c-47e0-a99d-934ca31571b9">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xMS0xLTEtMTkzOTM3_ed586a0c-7eba-4d4a-a696-51c23b9e35fe">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xLTEtMS0xOTM5Mzc_6e4323c6-4dd6-49ea-a636-89e987079654">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0zLTEtMS0xOTM5Mzc_13a14737-f25a-42e0-8895-e414cd6f541b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS01LTEtMS0xOTM5Mzc_94862b5c-da42-4f21-964f-2708ad96d17e">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS03LTEtMS0xOTM5Mzc_7992bfd1-797f-4c71-b11b-43b19bc771ce">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS05LTEtMS0xOTM5Mzc_4c3a62b2-caee-416b-ad9b-3b1e55c10df5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xMS0xLTEtMTkzOTM3_8609a6d1-7f58-499c-9b86-fdaa0ebfde53">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xLTEtMS0xOTM5Mzc_8f0d2ea4-be27-4608-af45-4ff21e181527">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0zLTEtMS0xOTM5Mzc_fd36e482-2169-458d-9e21-4e19682b3203">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi01LTEtMS0xOTM5Mzc_fab69e1d-2e5e-4521-b48d-eee57b490194">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi03LTEtMS0xOTM5Mzc_fa558e81-079f-4b3a-8649-1bebfcb662d3">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi05LTEtMS0xOTM5Mzc_84864cd7-8fdc-445e-b615-a1aa52c43513">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xMS0xLTEtMTkzOTM3_8f6cd966-1a1a-47c3-85f9-093a374d771a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xLTEtMS0xOTM5Mzc_b4ed0393-27bd-44da-ba74-f18baf0bd042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0zLTEtMS0xOTM5Mzc_91ecb6db-78fb-46ee-9387-5d2da0f02ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS01LTEtMS0xOTM5Mzc_27341f28-4cdb-428b-9ee1-6872d1d42b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS03LTEtMS0xOTM5Mzc_d7a299d2-c3d6-4021-b06e-f1ffb425d01a">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS05LTEtMS0xOTM5Mzc_69f7e3f5-a7ab-4345-9745-350bf5d4a603">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xMS0xLTEtMTkzOTM3_dd0e8972-b2b7-44cb-b156-8bb10a658884">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMS0xLTEtMTkzOTM3_9c8a92f8-64e4-4b8e-9038-b7c307e4176b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMy0xLTEtMTkzOTM3_7a05bfc6-8626-42d2-aa06-1579316f9b49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNS0xLTEtMTkzOTM3_4c1560c8-3318-4c6d-9fc6-012b943a03a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNy0xLTEtMTkzOTM3_fa4e1494-cb36-453d-8e97-ad46e9a8818d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtOS0xLTEtMTkzOTM3_6db717e2-bb18-4cc6-8392-f97d659636d7">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMTEtMS0xLTE5MzkzNw_c2af871c-b8af-4896-bb0b-81616dacd36f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMS0xLTEtMTkzOTM3_05d422e3-f856-49b5-9c65-3ffe0bf3d60e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMy0xLTEtMTkzOTM3_e48607e7-f416-4c88-b72d-a0ba76342005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNS0xLTEtMTkzOTM3_83d004bc-7b4b-4731-9d2f-5fa141d6e536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNy0xLTEtMTkzOTM3_a9d8887f-bd46-4706-8463-99d09b07e406">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtOS0xLTEtMTkzOTM3_0c9cae2d-ebce-429a-8d7a-6cf82a4e86e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMTEtMS0xLTE5MzkzNw_f6df1ae7-6c09-44ba-a1d0-3c5a07fa023d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMS0xLTEtMTkzOTM3_69b3040c-9626-41c0-86dd-ed6094df28e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMy0xLTEtMTkzOTM3_51e07a26-5250-4b81-a28d-88dca3882bac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNS0xLTEtMTkzOTM3_15769c23-c2e8-49e5-a692-5583907b7e56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNy0xLTEtMTkzOTM3_e0e471d6-cdf6-4767-b962-842ba8d7e518">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItOS0xLTEtMTkzOTM3_3c7ab37a-c3cd-4056-a810-589e9ba32bef">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMTEtMS0xLTE5MzkzNw_b106473e-01d8-4ea7-9a85-a1e47eb67449">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMS0xLTEtMTkzOTM3_d427175e-a2f2-4049-8a60-554e7d5e8276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMy0xLTEtMTkzOTM3_b3de8b8d-e59e-4c45-b520-1f824838997e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNS0xLTEtMTkzOTM3_3b27b969-448e-41cb-94bb-f73012196711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNy0xLTEtMTkzOTM3_99f6dd64-2493-4a93-81de-4ec71d11c2bc">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtOS0xLTEtMTkzOTM3_f86fcba1-3463-41a1-a3f4-6e05a983c480">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMTEtMS0xLTE5MzkzNw_d5191b08-c6f1-400e-8551-b297a42b8e22">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMS0xLTEtMTkzOTM3_98a366d6-4a78-4e4b-89cd-ff4c9db79941">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMy0xLTEtMTkzOTM3_1d1890bb-2e7f-4405-aef5-3bb6276db08e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNS0xLTEtMTkzOTM3_0bc114bb-9087-4fff-88ee-6a684fcc4a57">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNy0xLTEtMTkzOTM3_c3c6e4e5-cfa0-4fb2-89ca-a856d6313720">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctOS0xLTEtMTkzOTM3_a13b0426-bff0-444d-b6b1-6313be9f3ea5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMTEtMS0xLTE5MzkzNw_2ee5f046-7b00-4161-9b85-c4a8879dd4a6">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMS0xLTEtMTkzOTM3_9dcfd0f2-b739-4150-a190-cf3219d907a5">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMy0xLTEtMTkzOTM3_314b459d-8d60-450c-83a7-3ccf6fe142e9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNS0xLTEtMTkzOTM3_19ba9e2b-3d93-46e4-9961-255b8dceee56">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNy0xLTEtMTkzOTM3_f2500186-2a9c-43b6-a72c-f0ddef12d1b4">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktOS0xLTEtMTkzOTM3_64f7e841-8b5d-4b7b-885c-992ad2a5c3eb">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMTEtMS0xLTE5MzkzNw_152f0dab-4f3d-4ce8-9529-d24df7d5dbb9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to "&#8212;Note 9. Financial Instruments and Fair Value Measurements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3NQ_7bd2d3bb-b953-43e5-820f-e0a4c672ab69" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0xLTEtMS0xOTM5Mzc_4807a9f8-aa5a-49c6-9495-5ad0c1325229">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0zLTEtMS0xOTM5Mzc_9dc91eea-77bd-4597-b12b-a34f5fc8d890">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0xLTEtMS0xOTM5Mzc_170850c8-74bb-4b74-88bd-a21c0dda161c">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0zLTEtMS0xOTM5Mzc_a02eea21-e0ec-4ff7-95d0-86d17ec74186">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0xLTEtMS0xOTM5Mzc_2ff35837-dcd4-4440-9b05-53e89c56ae26">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0zLTEtMS0xOTM5Mzc_1dab6432-cb74-45bf-a5c1-b2a80f5f9f5a">890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0xLTEtMS0xOTM5Mzc_0f5935a3-b179-45d7-88dd-1e30eb113cd5">1,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0zLTEtMS0xOTM5Mzc_9e655e78-68af-453a-bfb9-497eda46bf36">1,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Foreign currency translation are net investment hedge gains of $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjYxMw_c6a5457d-fb11-45d9-88d2-deac8b392255">118</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjU5OQ_0be70f76-439b-4acb-bd29-b2e95dde0d55">125</ix:nonFraction>&#160;million as of March 31, 2023 and December 31, 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI0_8ceba4fb-7c40-494b-8df4-0bf264f8c69d" continuedAt="i11f6ca14f1424eebbc3da2cc5c70bd63" escape="true">EMPLOYEE STOCK BENEFIT PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i11f6ca14f1424eebbc3da2cc5c70bd63" continuedAt="i22ead6d69175440d9863ce6efe14ce2e"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI1_bb3dce3a-18d3-4bbe-bffb-5b61cd6aa6ca" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0xLTEtMS0xOTM5Mzc_07be8d1d-aa7e-4943-8efc-d73355430eea">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0zLTEtMS0xOTM5Mzc_99e55b19-ca84-40a3-9572-9b8e55f867fd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0xLTEtMS0xOTM5Mzc_05133ac6-7b5b-4764-85a9-9d15b89faec9">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0zLTEtMS0xOTM5Mzc_a710083c-9741-47c6-afd6-0dd56a68c6e8">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0xLTEtMS0xOTM5Mzc_195a60a3-e6e1-4ad0-bc05-cb1abe0755da">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0zLTEtMS0xOTM5Mzc_a138c5c0-42c0-431e-8c02-3b2f05bc68f3">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0xLTEtMS0xOTM5Mzc_b7d8f767-7a62-4f8e-b69e-e389ca7702dc">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0zLTEtMS0xOTM5Mzc_df14df22-fbf9-4c13-ba78-1bf243d0cc55">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0xLTEtMS0xOTM5Mzc_d306a7ce-8668-486b-a6ec-ae2fd397d9e4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0zLTEtMS0xOTM5Mzc_d61be646-161a-4b24-be7a-995521e28a5f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjE3_44bf8ecb-3f52-4a4d-bdc2-2c21afbb1dee">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjI0_49f68101-36e4-4ae2-83be-3264b7112a87">40</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI5_c1cab906-e002-4510-ad23-54f7ba081408" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0xLTEtMS0xOTM5Mzc_81b326f8-e3b6-4fbc-9180-40c2dd325a90">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0zLTEtMS0xOTM5Mzc_06920e24-7ee6-4eb0-aec0-21907092637c">60.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0xLTEtMS0xOTM5Mzc_9ef8641f-6284-47f0-bacd-f03ea85ae6a8">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0zLTEtMS0xOTM5Mzc_881b0ea3-d7c1-4821-905f-a8997e74db3c">58.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0xLTEtMS0xOTM5Mzc_a4a03a33-b38f-4ea8-a0f0-69e347e50d67">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0zLTEtMS0xOTM5Mzc_38f4a4f0-e009-4e44-b01d-3d90dba3b894">64.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i22ead6d69175440d9863ce6efe14ce2e"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDIz_980e3be9-3eb2-492a-b57c-99b3f4438215" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e84082105e45269a4ddf3f2b924403_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS0zLTEtMS0xOTM5Mzc_c5c9c007-345f-48f9-982c-b81012932fb6">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS01LTEtMS0xOTM5Mzc_57a1c936-ad7f-4a29-ae20-55c0bc5915cb">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c11a22415bf463a8cafb058afaacf34_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS03LTEtMS0xOTM5Mzc_e3a14fe3-5e1e-4f2e-92d4-a2a413b9cc69">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi0zLTEtMS0xOTM5Mzc_c85ac1d0-f035-4dc8-8ef8-cb499856629c">3.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi01LTEtMS0xOTM5Mzc_bf6b709d-bcd4-4fd7-90f4-d96c236be9c5">3.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi03LTEtMS0xOTM5Mzc_d71cd79f-e8ee-49bd-ba87-249846764f4e">2.2</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMzgyNTA_0dc449ba-9a0e-43ed-979f-fb555889447c" continuedAt="id4acc87bf2db40ccac876f61aa8d994b" escape="true">LEGAL PROCEEDINGS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id4acc87bf2db40ccac876f61aa8d994b" continuedAt="ia7eefa671e3d470c9c062c7403fba5d1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, partners, suppliers, service providers, licensees, licensors, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial claims and/or defenses in the matters, the outcomes of BMS's legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS's financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS's patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see " &#8212;Note 7. Income Taxes."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute ("Dana-Farber") filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to <ix:nonFraction unitRef="patent" contextRef="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTM0MQ_2ba5d02b-ac9b-4343-9081-d0d70b87cde3">six</ix:nonFraction> related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber's claims for damages before May 17, 2019&#8212;the date of the District Court's ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. On January 25, 2023, the Court held a hearing on a motion filed by BMS requesting that the Court enter summary judgment in BMS' favor. In April 2023, BMS and Dana-Farber entered into a settlement agreement and these litigations were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd (collectively, "AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024. On April 26, 2023, BMS filed an additional lawsuit against AZ in U.S. District Court for the District of Delaware alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes U.S. Patent No. 9,402,899.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ia7eefa671e3d470c9c062c7403fba5d1" continuedAt="i9869b2d753b84860a51909300c85c355"><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR-T &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research ("SKI") filed a complaint for patent infringement against Kite Pharma, Inc. ("Kite") in the U.S. District Court for the Central District of California. The complaint alleged that Kite's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the "'190 Patent") concerning CAR-T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the '190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite's defenses, finding that Kite willfully infringed the '190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $<ix:nonFraction unitRef="usd" contextRef="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231" decimals="-6" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI3MQ_3d01343a-d143-442d-bb78-a6f646287012">585</ix:nonFraction>&#160;million upfront payment and a <ix:nonFraction unitRef="number" contextRef="i00f02f6049c84c88a97ca32784154910_I20191231" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI5MQ_33a9b50b-5be0-430e-8776-07e14e890ffb">27.6</ix:nonFraction>% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the '190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite's motions in their entirety. In April 2020, the Court granted in part Juno's motion and entered a final judgment awarding to Juno and SKI approximately $<ix:nonFraction unitRef="usd" contextRef="i19139b5b67d7410eac12e965d900e982_D20200401-20200430" decimals="-8" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMyNA_b0e9313c-7f00-4c91-a28a-57755bff0634">1.2</ix:nonFraction>&#160;billion in royalties, interest and enhanced damages and a <ix:nonFraction unitRef="number" contextRef="i489f54c5481c45389d5768b529b57a7c_I20200430" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMwNA_56c8fd1f-8858-4d08-97d8-c4d1017a8c7f">27.6</ix:nonFraction>% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the '190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the '190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court, which the Court denied on November 7, 2022. On November 23, 2022, Juno and SKI filed a petition for rehearing with the Court, which the Court denied on January 9, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CTLA-4 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2023, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca AB (collectively, "AZ AB") alleging that AZ AB's marketing of the CTLA-4 antibody Imjudo infringes certain claims of U.S. Patent Nos. 9,320,811 and 9,273,135. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited ("Sandoz") and Teva Pharmaceutical Industries Ltd. ("Teva Limited"), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate ("SPC"). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgment issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. On November 2, 2022, BMS was granted permission from the Court of Appeal to appeal the judgment and a hearing took place on April 19-20, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and trials have been held in certain of those cases, including in Norway and France. In May 2022, a Dutch court issued a decision denying a request by BMS for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In April 2023, BMS again requested that a preliminary injunction be issued against Sandoz in the Netherlands. In addition, BMS requested that a preliminary injunction be issued against Stada in the Netherlands. On April 26, 2023, a combined preliminary injunction hearing was held.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a trial was held in Sweden regarding Teva's challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision was issued on November 2, 2022, confirming their validity and rejecting Teva's claims. In September 2022, BMS filed a request for a preliminary injunction against Teva in Denmark, but the request was denied in December 2022, based on the finding that there is no imminent threat of a launch by Teva in Denmark. In January 2023, the court in Finland granted BMS's request that a preliminary injunction be entered against Teva, prohibiting Teva from offering, storing or selling generic Eliquis products in Finland that have obtained price and reimbursement. On February 17, 2023, the court in Ireland also granted BMS's request that a preliminary injunction be entered against Teva in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2023 and March 4, 2023, BMS received Notice Letters from Biocon and ScieGen, respectively, notifying BMS that they had filed ANDAs containing paragraph IV certifications seeking approval of generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, in April 2023, BMS filed patent infringement actions against Biocon and ScieGen in the U.S. District Court for the District of Delaware. On April 25, 2023, BMS entered into a confidential settlement agreement with ScieGen, settling all outstanding claims in the litigation with ScieGen. The settlement with ScieGen does not affect BMS's projected exclusivity period for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i9869b2d753b84860a51909300c85c355" continuedAt="i787e0ee9b17f4e56a6cdc8a0dffdd5d0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging U.S. Patent No. 8,846,628 (the "'628 Patent"), an FDA Orange Book-listed formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024. In February 2023, Apotex Inc. filed a request for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '628 Patent. BMS's response to the request is due on May 15, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, BMS received an additional Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification challenging U.S. Patent No. 11,571,436 (the "'436 patent"), a newly-listed FDA Orange-Book formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2029. In response, BMS filed an additional patent infringement action against Accord in the U.S. District Court for the District of Delaware.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited ("GenRx") obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex ("GenRx-Apotex"). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi's Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi's injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia ("Full Court") appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to <ix:nonFraction unitRef="aud" contextRef="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTIxOA_a12b5738-49bc-488c-a527-89416ee1add1">449</ix:nonFraction>&#160;million AUD ($<ix:nonFraction unitRef="usd" contextRef="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI0NA_c533ff35-6f77-4dde-8141-2b7236ea5047">301</ix:nonFraction>&#160;million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government's claim for damages. In May 2020, the Australian government appealed the Federal Court's decision and an appeal hearing concluded in February 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray"), Nanocopoeia, LLC ("Nanocopoeia") and Handa Oncology, LLC ("Handa"), respectively, notifying BMS that each had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. In May 2022, BMS filed a patent infringement action against Nanocopoeia in the U.S. District Court for the District of Minnesota. In November 2022, BMS filed a patent infringement action against Handa in the U.S. District Court for the Northern District of California. No trial dates have been scheduled in any of these actions. Both Xspray and Nanocopoeia filed motions for a judgment based on the pleadings. On March 24, 2023, the Minnesota court denied Nanocopoeia's motion. On April 25, 2023, the New Jersey court denied Xspray's motion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC ("Actelion") filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the "'867 Patent"). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the '867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i787e0ee9b17f4e56a6cdc8a0dffdd5d0" continuedAt="ic81f91274a3d4b4289f4f936b1bedba2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in a consumer protection action brought by the attorney general of Hawaii relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. In February 2021, a Hawaii state court judge issued a decision against Sanofi and BMS, imposing penalties in the total amount of $<ix:nonFraction unitRef="usd" contextRef="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE2NQ_af845f08-bb79-4c4b-aad2-92d37c9ede3d">834</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE5Mg_697125d6-a3fb-4292-96f3-a2ba2c4278f6">417</ix:nonFraction>&#160;million attributed to BMS. Sanofi and BMS appealed the decision. On March 15, 2023, the Hawaii Supreme Court issued its decision, reversing in part and affirming in part the trial court decision, vacating the penalty award and remanding the case for a new trial and penalty determination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, the vast majority of cases have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA5OA_01d75a3c-d0d0-404f-bea2-ba90ec5ba988">eleven</ix:nonFraction> cases pending in Canada (<ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzMA_f834e7e5-b994-47fd-920a-4bcb4863ee92">four</ix:nonFraction> class actions, <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzNw_8fa94b0d-5a52-4a94-93bb-5f5265ccce6d">seven</ix:nonFraction> individual injury claims). Out of the <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE0NQ_a1a7e47f-20b1-49d1-a35b-eb5a05804fb7">eleven</ix:nonFraction> cases, only <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberActive" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE1MA_aa5a6b25-c01b-4229-9337-78010d76c3fd">two</ix:nonFraction> are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco ("JCCP"). On September 24, 2021, the JCCP court granted defendants' motion to exclude plaintiffs' only general causation expert and on January 5, 2022, the MDL court likewise granted defendants' motion to exclude plaintiffs' expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the <ix:nonFraction unitRef="lawsuit" contextRef="i9b4fe50bec2c45748e74cea112ead142_I20220330" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA4OA_36048054-5ea3-4ac1-9110-c04e31f509ef">18</ix:nonFraction> claims previously pending in California state court. Plaintiffs have filed an appeal, on which a California Court of Appeal heard arguments on March 28, 2023. On April 19, 2023, the Court denied plaintiffs' appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL then moved to alter or amend the MDL court's order, and defendants opposed. On November 3, 2022, the MDL court denied plaintiffs motion to alter or amend its summary judgment order. Plaintiffs filed their Notice of Appeal on December 2, 2022. As part of BMS's global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Litigations</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the "Celgene Securities Class Action"). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene's 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff''s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In March 2023, the Court granted the defendants leave to file a motion for summary judgment in the Celgene Securities Class Action, with briefing expected to be completed in or around July 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic81f91274a3d4b4289f4f936b1bedba2" continuedAt="id8df3954f91a466aa14ece834128e66f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the "Schwab Action"). In July 2020, the defendants filed a motion to dismiss the plaintiffs' complaint in full. In March 2021, the Court granted in part and denied in part defendants' motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees' Retirement System in April 2021 (the "CalPERS Action"); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the "DFA Action" and the "American Century Action"), and GIC Private Limited in September 2021 (the "GIC Action"), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The Court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement ("CVR Agreement") entered into in connection with the closing of BMS's acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use "diligent efforts" to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $<ix:nonFraction unitRef="usd" contextRef="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630" decimals="-8" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA3MQ_809d0511-0097-45ae-a008-d6fee85e04a5">6.4</ix:nonFraction>&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys' fees. BMS disputes the successor trustee's allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the Court denied BMS's motion to dismiss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 (the "Securities Act") and sections 10(b), 14(a) and 20(2) of the Exchange Act. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants moved to dismiss the complaint. On March 1, 2023, the Court entered an opinion and order granting defendants' motion and dismissed the complaint in its entirety. The claims under Sections 11, 12(a)(2), and 15 of the Securities Act and Section 14(a) of the Exchange Act were dismissed with prejudice. The claims under Sections 10(a) and 20(a) of the Exchange Act were dismissed with leave to file a further amended complaint which plaintiffs filed on April 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 19, 2022. Defendants have moved to stay the action pending resolution of the federal action or, in the alternative, to dismiss the complaint.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="id8df3954f91a466aa14ece834128e66f" continuedAt="i625b107d88504e8790c301863e48ed3a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene's former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 22, 2022. Defendants moved to stay the action pending resolution of the federal action and, in the alternative, to dismiss the complaint. On February 17, 2023, the Court granted defendants' motion to stay and declined to reach the merits of defendants' motion to dismiss. The Court deemed the action stayed pending resolution of the federal action, subject to plaintiff's right to seek to vacate the stay should changed circumstances warrant such relief, and filed a written order staying the case for 200 days.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for ANDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement, and who have since filed new suits advancing related theories. As described below, those suits, together with a suit by certain specialty pharmacies and a new putative class action suit, are pending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana Inc. ("Humana"), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana's complaint makes largely the same claims and allegations as were made in the now settled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. In May 2019, Celgene filed a motion to dismiss Humana's complaint. In April 2022, the Court issued an order denying Celgene's motion to dismiss. That order addressed only Celgene's argument that certain of Humana's claims were barred by the statute of limitations. The Court's order did not address Celgene's other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have filed a motion to dismiss Humana's amended complaint, which was fully briefed in November 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United HealthCare Services, Inc. ("UHS"), Blue Cross Blue Shield Association ("BCBSA"), BCBSM Inc., Health Care Service Corporation ("HCSC"), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation ("Cigna"), Molina Healthcare, Inc. ("Molina") and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, "MSP")) filed lawsuits making largely the same claims and allegations as were made in the now settled class action litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> opt-out action. Certain of the matters have made additional claims related to copay assistance for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These cases are now pending in the U.S. District Court for the District of New Jersey. Celgene and BMS's motion to dismiss the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended complaint applies to these other opt&#8209;out actions as well, and these other opt&#8209;out actions will proceed as described above with respect to that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opt-out action. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina's complaint makes largely the same claims and allegations as were made in the now settled class action litigation. In June 2022, the San Francisco Superior Court dismissed <ix:nonFraction unitRef="claim" contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA0NA_770803c0-2d9c-420a-9590-8620c3337276">63</ix:nonFraction> of Molina&#8217;s claims, which Molina later reasserted in the District of New Jersey as described above, and stayed the remaining <ix:nonFraction unitRef="claim" contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberDismissed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1MA_eedccef6-a63b-4a1a-a332-c22cae67ba6a">4</ix:nonFraction> claims. No activity is expected in this case until disposition of the New Jersey actions.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i625b107d88504e8790c301863e48ed3a" continuedAt="i918d0e17a34742ec8446a86fcfa38364"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other entities that opted out of the now&#8209;settled class action have also filed summonses related to <ix:nonFraction unitRef="lawsuit" contextRef="if83448985121404b8a86bb8584503c4f_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1Ng_13fe3b9b-4c9b-4e26-b028-2662a145d60d">two</ix:nonFraction> actions in the Philadelphia County Court of Common Pleas in connection with the allegations made by Humana and other opt&#8209;out entities. Those actions have been placed in deferred status pending further developments in the above opt&#8209;out cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, certain specialty pharmacies filed an action as direct purchasers against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The action makes largely the same claims and allegations against Celgene and BMS as were made with respect to Revlimid in the now settled class action litigation, and seek injunctive relief and damages under the Sherman Antitrust Act. Also in November 2022, a putative class of end-payor plaintiffs filed an action against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The class complaint brings claims based on Celgene's allegedly anticompetitive settlements of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation, seeking damages under state antitrust and consumer protection laws and injunctive relief under federal antitrust law. In March 2023, Celgene, BMS, and the generic defendants served consolidated motions to dismiss these two actions. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana's complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey's Racketeer Influenced and Corrupt Organizations Act ("NJ RICO"). The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. Humana subsequently dismissed its claims for breach of contract voluntarily. A trial for this matter began on January 31, 2023. On January 25, 2023, the Court granted Celgene's summary judgment motion on Humana's claims for violations of NJ RICO and dismissed those claims. On March 2, 2023, following a multi-week trial, the jury returned a full defense verdict in Celgene's favor on Humana's claims of fraud and negligent misrepresentation. The parties are awaiting the judge's decision on the remaining equitable claim of unjust enrichment, which is to be decided by the judge pursuant to Kentucky law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. ("HPI"), a Humana subsidiary, in Delaware Superior Court. Celgene's complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI's breach as well as a declaratory judgment. On February 14, 2023, the Court granted summary judgment in favor of Celgene on its breach of contract claims. A trial limited to damages has been scheduled for July 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017, Celgene Logistics S&#224;rl ("Celgene Logistics") and BeiGene, Ltd. (together with its assignees, "BeiGene"), entered into a License and Supply Agreement (the "LSA") pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing and closing arguments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, "Plaintiffs") filed a complaint against BMS, Celgene and Juno (collectively, "Defendants"). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least <ix:nonFraction unitRef="number" contextRef="ie45c0ee3f040490991410c1a6b57a08c_I20220401" decimals="INF" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAzNQ_1babb46b-344c-4629-8a10-e8b1027aa920">1.5</ix:nonFraction>% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims, and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i918d0e17a34742ec8446a86fcfa38364"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS's current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA and Other Remediation Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other "potentially responsible parties," and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAxNw_488c8934-ba3e-4341-9132-c9d9e4d5c288">89</ix:nonFraction>&#160;million as of March&#160;31, 2023, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of results of operations and financial condition is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related footnotes included elsewhere in this Quarterly Report on Form 10-Q to enhance the understanding of our results of operations, financial condition and cash flows.</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal strategy is to combine the resources, scale and capability of a large pharmaceutical company with the speed, agility and focus on innovation typically found in the biotech industry. Our priorities are to continue to renew and diversify our portfolio through launching new medicines, advancing our early, mid and late-stage pipeline, and executing disciplined business development. Our focus is on discovering, developing and delivering transformational medicines for patients facing serious diseases in the following core therapeutic areas: (i) oncology with a priority in certain tumor types; (ii) hematology with opportunities to broaden our franchise and sustain a leadership position in multiple myeloma; (iii) immunology with priorities in relapsing multiple sclerosis, psoriasis, psoriatic arthritis, lupus, RA and inflammatory bowel disease; (iv) cardiovascular disease (v) fibrotic disease with priorities in lung and liver, and (vi) neuroscience with a focus on neurodegenerative disease. We remain committed to maintaining a strong investment grade credit rating and returning capital to shareholders. For further information on our strategy, see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations&#8212;Executive Summary&#8212;Strategy" in our 2022 Form 10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we received approvals in the EU and Japan for three products, which further expanded our geographical reach in immunology and hematology, including (i) approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC (Japan); (ii) EC approval for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for moderate-to-severe plaque psoriasis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval for an additional indication for anemia associated with non-transfusion-dependent beta thalassemia for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues decreased by 3% during the first quarter of 2023 due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion and 2% foreign exchange impact, partially offset by In-Line Products (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and New Product Portfolio (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The $0.48 increase in GAAP EPS primarily resulted from specified items, including lower equity investment losses in the first quarter of 2023, higher litigation and other settlements income in the first quarter of 2023 and debt redemption charge in the first quarter of 2022. After adjusting for specified items, non-GAAP EPS increased $0.09 as a result of lower Acquired IPRD charges, lower weighted-average common shares outstanding, higher royalties and interest income partially offset by lower revenues.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, including non-GAAP earnings and related EPS information, are adjusted to exclude specified items that represent certain costs, expenses, gains and losses and other items impacting the comparability of financial results. For further information and reconciliations relating to our non-GAAP financial measures refer to "&#8212;Non-GAAP Financial Measures."</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic and Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Actions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products continue to be subject to increasing pressures across the portfolio from pharmaceutical market access and pricing controls and discounting, changes to tax and importation laws and other restrictions in the U.S., the EU and other regions around the world that result in lower prices, lower reimbursement rates and smaller populations for whom payers will reimburse, which can negatively impact our results of operations (including intangible asset impairment charges), operating cash flow, liquidity and financial flexibility. For example, some of the provisions of the IRA signed into law in August 2022, were as follows: (i) the government is to negotiate prices for certain high-cost Medicare Part D and Part B drugs, (ii) manufacturers are to pay an inflation-based rebate for Medicare Part B and Part D drugs, and (iii) Medicare Part D redesign. In addition, there were changes made to U.S. tax laws, including (i) a 15% minimum tax that generally applies to U.S. corporations, and a (ii) a non-deductible 1% excise tax provision on net stock repurchases, to be applied to repurchases beginning in 2023. Implementation of this legislation is expected to be carried out through upcoming actions by regulatory authorities, the outcome of which is uncertain. We continue to evaluate the impact of the IRA legislation on our results of operations and it is possible that these changes may result in a material impact on our business and results of operations. Furthermore, countries are expected to make changes to their tax laws and updates to international tax treaties to implement the agreement by the Organization for Economic Co-operation and Development to establish a global minimum tax. See risk factors on these items included under "Part I&#8212;Item 1A. Risk Factors&#8212;Product, Industry and Operational Risks&#8212;Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins" and "&#8212;Changes to tax regulations could negatively impact our earnings" in our 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Product and Pipeline Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the significant approvals received in 2023 as of April&#160;27, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approval</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment in adult patients of anemia associated with non-transfusion-dependent beta thalassemia. </span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to "&#8212;Product and Pipeline Developments" for the developments in our marketed products and late-stage pipeline since the start of the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures, Licensing and Other Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Item 1. Financial Statements&#8212;Note 3. Alliances" and "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for information on significant divestitures, licensing and other arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regional Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the changes in revenues was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:57.314%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.804%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 4% during the first quarter of 2023 primarily due to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis, Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and our New Product Portfolio partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Average U.S. net selling prices increased 1% compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 16% during the first quarter of 2023 primarily due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion, foreign exchange and lower average net selling prices partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and New Product Portfolio demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single country outside the U.S. contributed more than 10% of total revenues during the first quarter of 2023 and 2022. Our business is typically not seasonal.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GTN Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of gross product sales to net product sales by each significant category of GTN adjustments was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:70.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.852%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments percentage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to provisions for product sales made in prior periods resulting from changes in estimates were $87&#160;million and $74&#160;million during the three months ended March&#160;31, 2023 and 2022, respectively. GTN adjustments are primarily a function of product sales volume, regional and payer channel mix, contractual or legislative discounts and rebates. U.S. GTN adjustments percentage increased primarily due to product mix and higher government channel rebates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:61.789%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.799%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:61.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:61.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Change in excess of 100%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from a prior reporting period as a result of a loss of exclusivity.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-Line Products</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (apixaban)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; an oral Factor Xa inhibitor, indicated for the reduction in risk of stroke/systemic embolism in NVAF and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased 19% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU1OA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand and to a lesser extent higher average net selling prices.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 18% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU2MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion in Canada and the UK, foreign exchange impacts of 5% and lower average net selling prices. Excluding foreign exchange impacts, revenues decreased by 13%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Following the May 2021 expiration of regulatory exclusivity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe, and court decisions in (i) the United Kingdom finding the UK apixaban composition of matter patent and related SPC invalid and (ii) the Netherlands denying a BMS request for a preliminary injunction that would have prevented an at-risk generic launch, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which has led to additional infringement and invalidity actions involving our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. We believe in the innovative science behind </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the strength of our intellectual property, which we will defend against infringement. Refer to "Item 1. Financial Statements&#8212;Note 18. Legal Proceedings and Contingencies&#8212;Intellectual Property" for further information.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab)&#160;&#8212;&#160;a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells that has been approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and various gastric and esophageal cancers. There are several ongoing potentially registrational studies for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> across other tumor types and disease areas, in monotherapy and in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and various anti-cancer agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 17% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand across multiple indications and to a lesser extent higher average net selling prices partially offset by declining second-line eligibility across tumor indications. The higher demand was related to the following indications: the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combinations for NSCLC, various gastric, esophageal and bladder cancers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 11% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUxNg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand as a result of additional indication launches and core indications partially offset by foreign exchange impacts of 7%. Excluding foreign exchange impacts, revenues increased 18%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pomalidomide) &#8212; a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 2% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUyNA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower demand partially offset by higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 7% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzMg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand partially offset by lower average net selling prices and foreign exchange impacts of 5%. Excluding foreign exchange impacts, revenues increased by 12%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(abatacept) &#8212; a fusion protein indicated for adult patients with moderate to severe active RA and PsA and is also indicated for reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular JIA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 5% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to lower average net selling prices.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 1% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU0Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand partially offset by foreign exchange impacts of 9%. Excluding foreign exchange impacts, revenues increased by 10%.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BMS is not aware of any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> biosimilars on the market in the U.S., EU and Japan. Formulation and additional patents expire in 2026 and beyond. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dasatinib)&#160;&#8212;&#160;an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromosome-positive CML in chronic phase and the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(imatinib mesylate) and the treatment of children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome-positive CML.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 3% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ3NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 25% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMTY3MTI_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower demand as a result of generic erosion and foreign exchange impacts of 6%. Excluding foreign exchange impacts, revenues decreased by 19%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">In the U.S., BMS entered into settlement agreements with certain third parties to sell generic dasatinib products beginning in September 2024, or earlier in certain circumstances. In the EU, generic dasatinib products have entered the market. In Japan, the composition of matter patent has been extended to 2024 for the treatment of non-imatinib-resistant CML, but generics have been approved for other indications.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ipilimumab)&#160;&#8212;&#160;a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and esophageal cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 1% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ4NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric>.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 5% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to foreign exchange impacts of 8% partially offset by higher demand as a result of additional indication launches and core indications. Excluding foreign exchange impacts, revenues increased by 3%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mature and other products &#8212; includes all other products, including those which have lost exclusivity in major markets, OTC products, royalty revenue and mature products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 20% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to continued generic erosion and foreign exchange impacts of 4%. Excluding foreign exchange impacts, revenues decreased by 16%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">New Product Portfolio</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(luspatercept-aamt) &#8212; an erythroid maturation agent indicated for the treatment of anemia in adult patients with transfusion dependent and non-transfusion dependent beta thalassemia who require regular red blood cell transfusions and for the treatment of anemia failing an ESA in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 18% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwMw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (idecabtagene vicleucel) &#8212; is a B-cell maturation antigen-directed genetically modified autologous CAR&#8211;T cell therapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in May 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 111% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMjU2ODU_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand enabled by additional manufacturing capacity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab and relatlimab-rmbw) &#8212; a combination of nivolumab, a PD-1 blocking antibody, and relatlimab, a LAG-3 blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in March 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ozanimod) &#8212; </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and to treat moderately to severely active UC in adults. </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (lisocabtagene maraleucel) &#8212; is a CD19-directed genetically modified autologous CAR-T cell therapy indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after one or more lines of systemic therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (azacitidine) &#8212; an oral hypomethylating agent that incorporates into DNA and RNA, indicated for continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (fedratinib) &#8212; an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in August 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mavacamten) &#8212; a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive HCM to improve functional capacity and symptoms. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (deucravacitinib) &#8212; an oral, selective, allosteric tyrosine kinase 2 inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recent LOE Products </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(lenalidomide)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as a single agent is also indicated as a maintenance therapy in patients with multiple myeloma following autologous hematopoietic stem cell transplant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 24% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion and to a lesser extent lower average net selling prices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 72% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTc_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion across several European countries and to a lesser extent lower average net selling prices and foreign exchange impacts of 1%. Excluding foreign exchange impacts, revenues decreased by 71%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S., certain third parties have been granted volume-limited licenses to sell generic lenalidomide beginning in March 2022 or thereafter. Pursuant to these licenses, several generics have entered or are expected to enter the U.S. market with volume-limited quantities of generic lenalidomide. In the EU, generic lenalidomide products have entered the market. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline to approximately $6.5 billion in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(paclitaxel albumin-bound particles for injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a solvent-free protein-bound chemotherapy product that combines paclitaxel with albumin using our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform, and is used to treat breast cancer, NSCLC and pancreatic cancer, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 6% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcxMDM_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to the impact from authorized generic sales in 2023 and lower demand partially offset by manufacturing delays in the first quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_130"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated End-User Demand</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SEC Consent Order described under "&#8212; SEC Consent Order" in our 2022 Form 10-K, we monitor inventory levels on hand in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel. We are obligated to disclose products with levels of inventory in excess of one month on hand or expected demand, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception. There were no products in the U.S. wholesaler distribution channel with estimated levels of inventory in excess of one month as of March 31, 2023. Estimated levels of inventory outside of the U.S. in the direct distribution channel in excess of one month on hand were not material to our results of operations as of December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we generally determine our months on hand estimates using inventory levels of product on hand and the amount of out-movement provided by our three largest wholesalers, which accounted for approximately 82% of total gross sales of U.S. products during the three months ended March 31, 2023. Factors that may influence our estimates include generic competition, seasonality of products, wholesaler purchases in light of increases in wholesaler list prices, new product launches, new warehouse openings by wholesalers and new customer stockings by wholesalers. In addition, these estimates are calculated using third-party data, which may be impacted by their recordkeeping processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed in the U.S. primarily through contracted pharmacies under the Lenalidomide&#160;REMS (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> REMS&#160;programs, respectively. These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for the products' safe and appropriate distribution and use. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is only available through a restricted program called the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> REMS Program. Product distribution is limited to REMS certified pharmacies, and enrolled pharmacies must only dispense to patients who are authorized to receive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-U.S. businesses have significantly more direct customers. Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely. We limit our direct customer sales channel inventory reporting to where we can influence demand. When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and third-party market research data related to prescription trends and end-user demand. Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary. Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations. As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.S. business during the three months ended March&#160;31, 2023 is not available prior to the filing of this Quarterly Report on Form 10-Q. We will disclose any product with levels of inventory in excess of one month on hand or expected demand for the current quarter, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception, in our next quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:70.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;In excess of +/- 100%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Excludes amortization of acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold increased by $95 million during the first quarter of 2023 primarily due to higher profit sharing and royalties ($182 million) driven by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue growth and product mix partially offset by the elimination of the Puerto Rico excise tax and foreign exchange, including related hedging settlements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing, Selling and Administrative</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, selling and administrative expense decreased $69 million during the first quarter of 2023 primarily due to the timing of charitable giving ($150 million) and foreign currency impacts partially offset by higher costs to support new product launches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $61 million during the first quarter of 2023 primarily due to the purchase of a priority review voucher ($95 million) expected to be used with an on-going development program and higher costs to support the overall portfolio partially offset by an inventory purchase price adjustment in 2022 ($87 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired IPRD</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPRD charges resulting from upfront or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dragonfly milestone</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Immatics upfront license fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evotec designation fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of acquired intangible assets decreased by $161 million during the first quarter of 2023 primarily due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> marketed product right being fully amortized in the fourth quarter of 2022.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income)/expense, net changed by $1.1 billion during the first quarter of 2023 primarily due to equity investments, litigation and other settlements and other items discussed below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:74.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased in the first quarter of 2023 compared to the first quarter of 2022 due to additional debt maturities. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 10. Financing Arrangements" for further information. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties increased in the first quarter of 2023 primarily due to higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* and diabetes business divestiture royalties. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments generated lower losses in the first quarter of 2023 compared to the first quarter of 2022 primarily driven by fair value adjustments for investments that have readily determinable fair value. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements" for more information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integration expenses decreased in the first quarter of 2023 primarily due to lower consulting fees to implement Celgene integration initiatives related to processes and systems. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss on debt redemption during the first quarter of 2022 resulted from the early redemption of long-term debt of $5.2 billion.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Divestiture gains during the first quarter 2022 resulted from the divestiture of product rights for several mature products.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation and other settlements include $400 million of income related to the Nimbus' TYK2 program change of control provision and additional settlement costs related to commercial disputes regarding intellectual property matters in the first quarter of 2023 and $40 million of income resulting from a settlement resolving all legal claims and business interests relating to Nimbus' TYK2 inhibitor in the first quarter of 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment income increased during the first quarter of 2023 primarily due to higher interest rates.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision for restructuring includes exit and other costs primarily related to certain restructuring activities discussed further at "Item 8. Financial Statements and Supplementary Data&#8212;Note 6. Restructuring".</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate excluding specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 5.7% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $89 million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 0.4% decrease in Non-GAAP tax rate was due to the aforementioned tax reserve releases, partially offset by changes to our Puerto Rico tax decree.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, such as non-GAAP earnings and related EPS information, are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. These items are excluded from non-GAAP earnings and related EPS information because the Company believes they neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business performance. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods, including (i) amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, (ii) unwind of inventory purchase price adjustments, (iii) acquisition and integration expenses, (iv) restructuring costs, (v) accelerated depreciation and impairment of property, plant and equipment and intangible assets, (vi) costs of acquiring a priority review voucher, (vii) divestiture gains or losses, (viii) stock compensation resulting from acquisition-related equity awards, (ix) pension, legal and other contractual settlement charges, (x) equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments), (xi) income resulting from the change in control of the Nimbus Therapeutics TYK2 Program and (xii) amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. We also provide international revenues for our priority products excluding the impact of foreign exchange. We calculate foreign exchange impacts by converting our current-period local currency financial results using the prior period average currency rates and comparing these adjusted amounts to our current-period results. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are included in Exhibit 99.1 to our Form 8-K filed on April&#160;27, 2023 and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP information is intended to portray the results of our baseline performance, supplement or enhance management, analysts and investors' overall understanding of our underlying financial performance and facilitate comparisons among current, past and future periods. This information is not intended to be considered in isolation or as a substitute for the related financial measures prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our consolidated financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specified items were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Priority review voucher</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to pretax income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on items above</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to net earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes amortization of purchase price adjustments to Celgene debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations from GAAP to Non-GAAP were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS used for diluted EPS calculation &#8211; GAAP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS used for diluted EPS calculation &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to BMS &#8211; GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS attributable to specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS attributable to BMS &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net debt position was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,561)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,067)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents and marketable debt securities, together with our ability to generate cash from operations and our access to short-term and long-term borrowings, are sufficient to satisfy our existing and anticipated cash needs, including dividends, capital expenditures, milestone payments, working capital, income taxes, restructuring initiatives, business development, business combinations, asset acquisitions, repurchase of common stock, debt maturities, as well as any debt repurchases through redemptions or tender offers. During the first quarter of 2023, our net debt position decreased by $1.5&#160;billion primarily driven by $3.0 billion of cash provided by operations partially offset by $1.4&#160;billion of dividends and common stock repurchases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, $1.6&#160;billion of debt matured and was repaid including $750&#160;million 2.750% Notes and $890&#160;million 3.250% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our share repurchase program, we repurchased 3.7&#160;million shares of common stock for $250&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the share repurchase program was $6.9&#160;billion as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we paid dividends of $1.2 billion and declared dividend of $0.57 per common share. The decision to authorize dividends is made on a quarterly basis by our Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual capital expenditures are expected to be approximately $1.2 billion and 1.4 billion in 2023 and 2024, respectively. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities, research and development and other facility-related activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no borrowings outstanding under our $5.0 billion revolving credit facility as of March 31, 2023 and December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our commercial paper program, we may issue a maximum of $5.0 billion unsecured notes that have maturities of not more than 366 days from the date of issuance. There were no commercial paper borrowings outstanding as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of cash flow activities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow provided by/(used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $842 million decrease in cash provided by operating activities compared to the first quarter of 2022 was due to changes in working capital requirements reflecting the timing of cash collections and payments in the ordinary course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $305 million change in cash used in investing activities compared to 2022 was primarily due to changes in the amount of marketable debt securities held ($529&#160;million), lower divestitures proceeds ($175 million) partially offset by lower Acquired IPRD payments ($316 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.6 billion decrease in cash used in financing activities compared to 2022 was primarily due to lower repurchases of common stock ($4.8 billion) partially offset by changes in net debt borrowings ($1.7 billion) and lower proceeds from stock option exercises ($425 million).</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Pipeline Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D programs are managed on a portfolio basis from early discovery through late-stage development and include a balance of early-stage and late-stage programs to support future growth. Our late-stage R&amp;D programs in Phase III development include both investigational compounds for initial indications and additional indications or formulations for marketed products. The following are the developments in our marketed products and our late-stage pipeline since the start of the first quarter of 2023:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:54pt"><td colspan="3" rowspan="5" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that the FDA has accepted the sBLA and the EMA has validated the Type II variation MAA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as monotherapy in the adjuvant setting for the treatment of patients with completely resected stage IIB or IIC melanoma. The submissions were based on results from the Phase III CheckMate -76K trial. In the U.S., the FDA has assigned a PDUFA goal date of October 13, 2023. </span></div></td></tr><tr style="height:44pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ono, our alliance partner for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in Japan, announced the Japan's Ministry of Health, Labour and Welfare's supplemental approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> plus chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC. The approval is based on results from the Phase III CheckMate -816 trial.</span></div></td></tr><tr style="height:65pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -816 trial, demonstrating sustained clinical benefits with three cycles of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in combination with platinum-based chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC. While overall survival (OS) remained immature at this analysis, there was a continued encouraging trend in OS favoring neoadjuvant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> with chemotherapy over chemotherapy alone, long-term improvement in event-free survival (EFS) and time to distant metastasis. </span></div></td></tr><tr style="height:54pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -9ER demonstrating sustained overall survival and objective response rate benefits the treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(cabozantinib) versus sunitinib in the first-line treatment of advanced RCC. In addition, an exploratory biomarker analysis demonstrated that improvements in median progression-free survival and overall survival were sustained regardless of PD-L1 status.</span></div></td></tr><tr style="height:65pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -274 trial demonstrating significant sustained clinical benefits with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the adjuvant treatment of patients with surgically resected, high-risk muscle-invasive UC and continuous improvement in disease-free survival, non-urothelial tract recurrence-free survival, distant metastasis-free survival and second progression-free survival compared to placebo across all-randomized patients and in patients whose tumor cells express PD-L1 &#8805;1%.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beta Thalassemia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the treatment in adult patients of anemia associated with non-transfusion-dependent beta thalassemia. The approval is based on results from the Phase II BEYOND study.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multiple Myeloma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced with our alliance partner, 2seventy bio, Inc., that the FDA accepted the sBLA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed and refractory multiple myeloma who have received an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. The FDA has assigned a PDUFA goal date of December 16, 2023. The EMA has also validated our Type II variation for the extension of indication for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to treat adult patients with relapsed or refractory multiple myeloma who have received an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Validation of the application confirms the submission is complete and begins the procedure and scientific assessment. In addition, the Japan's Ministry of Health, Labour and Welfare has accepted our sNDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in patients who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody, and have experienced disease progression or relapse after the last therapy. The three regulatory applications are based on results from the Phase III KarMMa-3 study.</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:65pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lymphoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that the CHMP of the EMA has recommended approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the treatment of adult patients with diffuse large B-cell lymphoma, high grade B-cell lymphoma, primary mediastinal large B-cell lymphoma and follicular lymphoma grade 3B, who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy. The positive opinion is based on results from the Phase III TRANSFORM trial evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> compared to the standard of care.</span></div></td></tr><tr style="height:54pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced positive topline results from the Phase II portion of the TRANSCEND CLL 004, a Phase I/II, open-label, single-arm, multicenter study evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">in adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The Phase II portion of the study met the primary endpoint of complete response rate compared to historical control.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plaque Psoriasis</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy. The approval was based on Phase III POETYK PSO-1 and POETYK PSO-2 clinical trials as well as additional data from the POETYK PSO long-term extension trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Camzyos</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the CHMP of the EMA has recommended approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of symptomatic (New York Heart Association class II-III) obstructive HCM in adult patients. The positive opinion is based on results from the Phase III EXPLORER-HCM and VALOR-HCM trials.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">milvexian</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thrombosis</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced with our alliance partner Janssen Pharmaceuticals Inc., the launch of the Phase III Librexia program studying milvexian, an investigational oral factor XIa inhibitor (antithrombotic). The Librexia program will provide important data across three indication-seeking studies: Librexia STROKE, Librexia ACS and Librexia AF.<br/>&#160;<br/>The Librexia STROKE trial will evaluate milvexian in addition to standard of care antiplatelet therapy for stroke prevention in patients after an acute ischemic stroke or high-risk transient ischemic attack. The Librexia ACS trial will evaluate event reduction in acute coronary syndromes in addition to standard of care antiplatelet therapy. The Librexia AF trial will investigate milvexian compared to apixaban in the prevention of stroke in patients with atrial fibrillation.</span></td></tr></table></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses. Our critical accounting policies are those that significantly impact our financial condition and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates. For a discussion of our critical accounting policies, refer to "Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations" in our 2022 Form 10-K. There have been no material changes to our critical accounting policies during the three months ended March 31, 2023. For information regarding the impact of recently adopted accounting standards, refer to "Item 1. Financial Statements&#8212;Note 1. Basis of Presentation and Recently Issued Accounting Standards."</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_169"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (including documents incorporated by reference) and other written and oral statements we make from time to time contain certain "forward-looking" statements within the meaning of Section&#160;27A of the Securities Act, and Section&#160;21E of the Exchange Act. You can identify these forward-looking statements by the fact they use words such as "should," "could," "expect," "anticipate," "estimate," "target," "may," "project," "guidance," "intend," "plan," "believe," "will" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on our current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These statements are likely to relate to, among other things, our goals, plans and objectives regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance or results of current and anticipated products, our business development strategy and in relation to our ability to realize the projected benefits of our acquisitions of Celgene, MyoKardia, and Turning Point, the impact of the COVID-19 pandemic on our operations and the development and commercialization of our products, potential laws and regulations to lower drug prices, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about our ability to retain marketing exclusivity of certain products, and the outcome of contingencies such as legal proceedings and financial results. No forward-looking statement can be guaranteed. This Quarterly Report on Form 10-Q, our 2022 Form 10-K, particularly under the section "Item 1A. Risk Factors," and our other filings with the SEC, include additional information on the factors that we believe could cause actual results to differ materially from any forward-looking statement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we have been prudent in our plans and assumptions, no assurance can be given that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Additional risks that we may currently deem immaterial or that are not presently known to us could also cause the forward-looking events discussed in this Quarterly Report on Form 10-Q not to occur. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise after the date of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_172"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risk, refer to "Item 7A. Quantitative and Qualitative Disclosures about Market Risk" in our 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management carried out an evaluation, under the supervision and with the participation of its chief executive officer and chief financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of March&#160;31, 2023, such disclosure controls and procedures are effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company's internal control over financial reporting during the quarter ended March&#160;31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in "Item 1. Financial Statements&#8212;Note 18. Legal Proceedings and Contingencies," to the interim consolidated financial statements, and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_184"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in the Company's 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the surrenders of our equity securities during the three months ended March 31, 2023:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares&#160;Purchased&#160;as Part of Publicly Announced Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares&#160;that May Yet Be Purchased Under the Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to 28, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,292,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,749,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,749,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Includes shares repurchased as part of publicly announced programs and shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive program.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In May 2010, the Board of Directors authorized the repurchase of up to $3.0&#160;billion of our common stock. Following this authorization, the Board subsequently approved additional authorizations, including most recently, in February 2020, January 2021 and December 2021, in the amount $5.0 billion, $2.0&#160;billion and $15.0&#160;billion, respectively, to the share repurchase authorization. The remaining share repurchase capacity under the program was approximately $6.9&#160;billion as of March&#160;31, 2023. Refer to "Item 1. Financial Statements&#8212;Note 17. Equity" of the 2022 Form 10-K for information on the share repurchase program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_190"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (listed by number corresponding to the Exhibit Table of Item&#160;601 in Regulation S-K).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31a_20230331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31b_20230331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32a_20230331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32b_20230331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates, in this Quarterly Report on Form 10-Q, brand names of products, which are registered trademarks not solely owned by the Company or its subsidiaries.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Otsuka Pharmaceutical Co., Ltd.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Gilead Sciences, LLC.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Exelixis, Inc.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of AstraZeneca AB; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Novartis AG; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Merck Sharp &amp; Dohme Corp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Amgen Inc.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Sanofi; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Genentech, Inc.; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Kite Pharma, Inc. Brand names of products that are in all italicized letters, without an asterisk, are registered trademarks of BMS and/or one of its subsidiaries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_193"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF ABBREVIATED TERMS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company and its consolidated subsidiaries may be referred to as Bristol Myers Squibb, BMS, the Company, we, our or us in this Quarterly Report on Form 10-Q, unless the context otherwise indicates. Throughout this Quarterly Report on Form 10-Q we have used terms which are defined below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Form 10-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">acute myeloid leukemia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">loss of exclusivity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">marketing authorization application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">multi-district litigation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca PLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myelodysplastic syndromes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">accelerated share repurchase </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPM</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">malignant pleural mesothelioma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics License Application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAR-T</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chimeric antigen receptor T-cell</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CD38</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">cyclic ADP ribose hydrolase</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NKT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">natural killer T cells</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and integration plan implemented as a result of the acquisition of Celgene in 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NVAF</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-valvular atrial fibrillation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CERCLA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Comprehensive Environmental Response, Compensation and Liability Act</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over-the-counter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm Arzneimittel GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHMP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee for Medicinal Products for Human Use</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed cell death protein 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CML</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chronic myeloid leukemia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-L1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed death-ligand 1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">colorectal carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PsA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">psoriatic arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report of the Company on Form 10-Q for the quarterly period ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rheumatoid arthritis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Securities Exchange Act of 1934</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">red blood cell</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">renal cell carcinoma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REMS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">risk evaluation and mitigation strategy</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">generally accepted accounting principles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sBLA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental Biologics License Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gross-to-net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hepatocellular carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hypertrophic cardiomyopathy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplementary Protection Certificate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics Biotechnologies GmbH.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda Pharmaceutical Company Limited</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflation Reduction Act signed into law in August 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ulcerative colitis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JIA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">juvenile idiopathic arthritis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">value added tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LAG-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">lymphocyte activation gene-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_196"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY<br/>(REGISTRANT)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Giovanni Caforio, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David V. Elkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.A
<SEQUENCE>2
<FILENAME>bmyex31a_20230331.htm
<DESCRIPTION>EXHIBIT 31.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i53192bb607f545b2b4d6a79f0118ac1f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Giovanni Caforio, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;27, 2023 </font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.B
<SEQUENCE>3
<FILENAME>bmyex31b_20230331.htm
<DESCRIPTION>EXHIBIT 31.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i371195aeea6a4b28a2facb771347fa7b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David V. Elkins, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;27, 2023 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.A
<SEQUENCE>4
<FILENAME>bmyex32a_20230331.htm
<DESCRIPTION>EXHIBIT 32.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic852116fd4184b369831a8a4f1f2cc87_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, Giovanni Caforio, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on April&#160;27, 2023, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.520%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.B
<SEQUENCE>5
<FILENAME>bmyex32b_20230331.htm
<DESCRIPTION>EXHIBIT 32.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i859969dacce74085a73e7ce08a72eb13_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Financial Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, David V. Elkins, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on April&#160;27, 2023, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bmy-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmy="http://www.bms.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bms.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bms.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEARNINGS" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS">
        <link:definition>0000002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS">
        <link:definition>0000006 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.bms.com/role/REVENUE">
        <link:definition>0000007 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCES" roleURI="http://www.bms.com/role/ALLIANCES">
        <link:definition>0000008 - Disclosure - ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTS" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS">
        <link:definition>0000009 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENET" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET">
        <link:definition>0000010 - Disclosure - OTHER (INCOME)/EXPENSE, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.bms.com/role/RESTRUCTURING">
        <link:definition>0000011 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.bms.com/role/INCOMETAXES">
        <link:definition>0000012 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.bms.com/role/EARNINGSPERSHARE">
        <link:definition>0000013 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>0000014 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTS" roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTS">
        <link:definition>0000015 - Disclosure - FINANCING ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLES" roleURI="http://www.bms.com/role/RECEIVABLES">
        <link:definition>0000016 - Disclosure - RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.bms.com/role/INVENTORIES">
        <link:definition>0000017 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000019 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>0000020 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITY" roleURI="http://www.bms.com/role/EQUITY">
        <link:definition>0000021 - Disclosure - EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANS" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS">
        <link:definition>0000022 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIES" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES">
        <link:definition>0000023 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies">
        <link:definition>0000024 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.bms.com/role/REVENUETables">
        <link:definition>0000025 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESTables" roleURI="http://www.bms.com/role/ALLIANCESTables">
        <link:definition>0000026 - Disclosure - ALLIANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables">
        <link:definition>0000027 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETTables" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables">
        <link:definition>0000028 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.bms.com/role/RESTRUCTURINGTables">
        <link:definition>0000029 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.bms.com/role/INCOMETAXESTables">
        <link:definition>0000030 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.bms.com/role/EARNINGSPERSHARETables">
        <link:definition>0000031 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSTables" roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSTables">
        <link:definition>0000033 - Disclosure - FINANCING ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESTables" roleURI="http://www.bms.com/role/RECEIVABLESTables">
        <link:definition>0000034 - Disclosure - RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.bms.com/role/INVENTORIESTables">
        <link:definition>0000035 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>0000036 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables">
        <link:definition>0000038 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYTables" roleURI="http://www.bms.com/role/EQUITYTables">
        <link:definition>0000039 - Disclosure - EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSTables" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables">
        <link:definition>0000040 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregationofRevenueDetails" roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails">
        <link:definition>0000041 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails">
        <link:definition>0000042 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregationofRevenuebyProductandRegionDetails" roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails">
        <link:definition>0000043 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESDetails" roleURI="http://www.bms.com/role/ALLIANCESDetails">
        <link:definition>0000044 - Disclosure - ALLIANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
        <link:definition>0000045 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
        <link:definition>0000046 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
        <link:definition>0000047 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails">
        <link:definition>0000048 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGAdditionalInformationDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails">
        <link:definition>0000049 - Disclosure - RESTRUCTURING - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
        <link:definition>0000050 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>0000051 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>0000052 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>0000053 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails">
        <link:definition>0000054 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>0000055 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
        <link:definition>0000056 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails">
        <link:definition>0000057 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails">
        <link:definition>0000058 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>0000059 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
        <link:definition>0000060 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
        <link:definition>0000061 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
        <link:definition>0000062 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSShortTermDebtDetails" roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails">
        <link:definition>0000063 - Disclosure - FINANCING ARRANGEMENTS - Short-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails">
        <link:definition>0000064 - Disclosure - FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails">
        <link:definition>0000065 - Disclosure - FINANCING ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESScheduleofReceivablesDetails" roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails">
        <link:definition>0000066 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESDetails" roleURI="http://www.bms.com/role/RECEIVABLESDetails">
        <link:definition>0000067 - Disclosure - RECEIVABLES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.bms.com/role/INVENTORIESDetails">
        <link:definition>0000068 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>0000069 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails">
        <link:definition>0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails">
        <link:definition>0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
        <link:definition>0000072 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails">
        <link:definition>0000073 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails">
        <link:definition>0000074 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails">
        <link:definition>0000075 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails">
        <link:definition>0000076 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofStockholdersEquityDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails">
        <link:definition>0000077 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYAdditionalInformationDetails" roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails">
        <link:definition>0000078 - Disclosure - EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails">
        <link:definition>0000079 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000080 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
        <link:definition>0000081 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
        <link:definition>0000082 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
        <link:definition>0000083 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIESDetails" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails">
        <link:definition>0000084 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bmy_SettlementContingentDevelopmentChangeInControlProceeds" abstract="false" name="SettlementContingentDevelopmentChangeInControlProceeds" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_TecentriqRoyaltiesMember" abstract="true" name="TecentriqRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A5BillionMaximumBorrowingCapacityMember" abstract="true" name="A5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsLineItems" abstract="true" name="GrosstoNetAdjustmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AmortizationOfDeferredIncome" abstract="false" name="AmortizationOfDeferredIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AccruedRebatesAndReturns" abstract="false" name="AccruedRebatesAndReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AntiPD1AntibodyLitigationMember" abstract="true" name="AntiPD1AntibodyLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" abstract="false" name="ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_CelgeneContingentValueRightsMember" abstract="true" name="CelgeneContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustments" abstract="false" name="GrosstoNetAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Totalinventories" abstract="false" name="Totalinventories" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherRegionMember" abstract="true" name="OtherRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" abstract="false" name="CollaborativeArrangementContingentPaymentsMaximumExposure" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberDismissed" abstract="false" name="LossContingencyPendingClaimsNumberDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_OpdualagMember" abstract="true" name="OpdualagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DragonflyMember" abstract="true" name="DragonflyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CARTKiteLitigationMember" abstract="true" name="CARTKiteLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" abstract="true" name="AcquisitionsDivestituresandOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OptOutEntitiesMember" abstract="true" name="OptOutEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Divestitureandotherproceeds" abstract="false" name="Divestitureandotherproceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_InventoryPurchasePriceFairValueAdjustmentMember" abstract="true" name="InventoryPurchasePriceFairValueAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberClassAction" abstract="false" name="LossContingencyPendingClaimsNumberClassAction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_LicenseAndOtherArrangementsUpfrontPayments" abstract="false" name="LicenseAndOtherArrangementsUpfrontPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AbecmaMember" abstract="true" name="AbecmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" abstract="true" name="OtherrebatesreturnsdiscountsandadjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ResearchAndDevelopmentNonCurrent" abstract="false" name="ResearchAndDevelopmentNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" abstract="false" name="ScheduleOfProvisionForIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_AmortizationofAcquiredIntangibleAssets" abstract="false" name="AmortizationofAcquiredIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PlavixAustraliaIntellectualPropertyMember" abstract="true" name="PlavixAustraliaIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InLineProductsAndNewProductPortfolioMember" abstract="true" name="InLineProductsAndNewProductPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AllianceandotherrevenuesMember" abstract="true" name="AllianceandotherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LitigationTable" abstract="true" name="LitigationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_MatureAndOtherBrandsMember" abstract="true" name="MatureAndOtherBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BusinessSaleRoyaltyIncome" abstract="false" name="BusinessSaleRoyaltyIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Cashoutlays" abstract="false" name="Cashoutlays" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherRevenuesMember" abstract="true" name="OtherRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_YervoyMember" abstract="true" name="YervoyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" abstract="false" name="PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestonePayments" abstract="false" name="ContingentAndRegulatoryMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherOtherIncomeExpense" abstract="false" name="OtherOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsDomain" abstract="true" name="GrosstoNetAdjustmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LongTermDebtRenewalPeriod" abstract="false" name="LongTermDebtRenewalPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bmy_RevlimidMember" abstract="true" name="RevlimidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BreyanziMember" abstract="true" name="BreyanziMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LOEProductsMember" abstract="true" name="LOEProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CashDiscounts" abstract="false" name="CashDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LegalProceedingsAndContingenciesLineItems" abstract="true" name="LegalProceedingsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_CheplapharmMember" abstract="true" name="CheplapharmMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ZeposiaMember" abstract="true" name="ZeposiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" abstract="false" name="LossContingencyPendingClaimsNumberIndividualInjuryClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" abstract="false" name="RestructuringChargesExcludingAcceleratedStockbasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A3250NotesMember" abstract="true" name="A3250NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityInvestmentsNonCurrent" abstract="false" name="EquityInvestmentsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OpdivoMember" abstract="true" name="OpdivoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SprycelMember" abstract="true" name="SprycelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CamzyosMember" abstract="true" name="CamzyosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MedicaidandMedicarerebatesMember" abstract="true" name="MedicaidandMedicarerebatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InLineProductsMember" abstract="true" name="InLineProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsAxis" abstract="true" name="GrosstoNetAdjustmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_PomalystImnovidMember" abstract="true" name="PomalystImnovidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfOtherIncomeExpenseTextBlock" abstract="false" name="ScheduleOfOtherIncomeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_LicensingArrangementsTable" abstract="true" name="LicensingArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OnuregMember" abstract="true" name="OnuregMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherRoyaltiesMember" abstract="true" name="OtherRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbraxaneMember" abstract="true" name="AbraxaneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsIncome" abstract="false" name="LicensingAndOtherArrangementsIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_MyoKardiaAcquisitionPlanMember" abstract="true" name="MyoKardiaAcquisitionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SotyktuMember" abstract="true" name="SotyktuMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentValueRightsMember" abstract="true" name="ContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CommonStock0.10ParValueMember" abstract="true" name="CommonStock0.10ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NumberOfLargestPharmaceuticalWholesalers" abstract="false" name="NumberOfLargestPharmaceuticalWholesalers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_NetProductSalesMember" abstract="true" name="NetProductSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneIntegrationMember" abstract="true" name="CelgeneIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MolinaLitigationMember" abstract="true" name="MolinaLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ImmaticsMember" abstract="true" name="ImmaticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcquiredIPRD" abstract="false" name="AcquiredIPRD" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_A1.000Notesdue2025Member" abstract="true" name="A1.000Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NimbusTherapeuticsMember" abstract="true" name="NimbusTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UnamortizedBasisAdjustmentFromSwapTerminations" abstract="false" name="UnamortizedBasisAdjustmentFromSwapTerminations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OnglyzaProductLiabilityLitigationMember" abstract="true" name="OnglyzaProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MatureBrandsAndOtherMember" abstract="true" name="MatureBrandsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" abstract="false" name="PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityMember" abstract="true" name="AbilifyProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EliquisMember" abstract="true" name="EliquisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsDomain" abstract="true" name="LicensingAndOtherArrangementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfEquityInvestmentsTableTextBlock" abstract="false" name="ScheduleOfEquityInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_MarketShareUnitsMember" abstract="true" name="MarketShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AllianceRevenuesMember" abstract="true" name="AllianceRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_KeytrudaRoyaltiesMember" abstract="true" name="KeytrudaRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InrebicMember" abstract="true" name="InrebicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.750Notesdue2035Member" abstract="true" name="A1.750Notesdue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NewProductPortfolioMember" abstract="true" name="NewProductPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberActive" abstract="false" name="LossContingencyPendingClaimsNumberActive" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_EquityLineItems" abstract="true" name="EquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ContingentRegulatoryMilestoneIncome" abstract="false" name="ContingentRegulatoryMilestoneIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AssetAcquisitionPercentageOfOwnershipAcquired" abstract="false" name="AssetAcquisitionPercentageOfOwnershipAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LicensingArrangementsLineItems" abstract="true" name="LicensingArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" abstract="false" name="ResearchAndDevelopmentExpenseCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Divestituregainsandroyalties" abstract="false" name="Divestituregainsandroyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_BusinessRoyaltyAndLicensingIncome" abstract="false" name="BusinessRoyaltyAndLicensingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RoyaltyGuaranteesCommitmentsPercent" abstract="false" name="RoyaltyGuaranteesCommitmentsPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bmy_PercentageOfAggregateTotalTradeReceivablesDue" abstract="false" name="PercentageOfAggregateTotalTradeReceivablesDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsAxis" abstract="true" name="LicensingAndOtherArrangementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ALLIANCESAbstract" abstract="true" name="ALLIANCESAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A2750NotesMember" abstract="true" name="A2750NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DiabetesBusinessMember" abstract="true" name="DiabetesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2022ASRMember" abstract="true" name="A2022ASRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ReblozylMember" abstract="true" name="ReblozylMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ChargebacksandcashdiscountsMember" abstract="true" name="ChargebacksandcashdiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsTableTextBlock" abstract="false" name="LicensingAndOtherArrangementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_EquityTable" abstract="true" name="EquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_BristolMyersSquibbMember" abstract="true" name="BristolMyersSquibbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SalesRevenueGrossMember" abstract="true" name="SalesRevenueGrossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_NimbusTherapueticsTYK2InhibitorMember" abstract="true" name="NimbusTherapueticsTYK2InhibitorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ReceivablesSoldOnNonrecourseBasis" abstract="false" name="ReceivablesSoldOnNonrecourseBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquityInvestments" abstract="false" name="EquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OrenciaMember" abstract="true" name="OrenciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ResearchandDevelopment" abstract="false" name="ResearchandDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bmy-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4b80ccf9-1533-4a3a-81af-4639d1e1865f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4b80ccf9-1533-4a3a-81af-4639d1e1865f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3318ea3e-a7fe-4ce8-b04b-3cd557f4925a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3318ea3e-a7fe-4ce8-b04b-3cd557f4925a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_df6ce9df-bf21-48bc-b8cb-016c09d62171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_df6ce9df-bf21-48bc-b8cb-016c09d62171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_2a81bca0-6ae6-4685-be5e-df79435be92b" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_bmy_AcquiredIPRD_2a81bca0-6ae6-4685-be5e-df79435be92b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_0c9ac9e1-2c15-48cc-9ced-524559078072" xlink:href="bmy-20230331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_0c9ac9e1-2c15-48cc-9ced-524559078072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dbb52bf4-0d32-4c2e-9005-7ea1b6eac933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_83d9c7d4-fccd-469d-b238-426e5091b307" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dbb52bf4-0d32-4c2e-9005-7ea1b6eac933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b850f82-7988-40c4-ae5f-4cf4a40478a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bc36fc9b-05e9-45c4-8ea3-cb5fe57a8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b850f82-7988-40c4-ae5f-4cf4a40478a8" xlink:to="loc_us-gaap_Revenues_bc36fc9b-05e9-45c4-8ea3-cb5fe57a8bd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d2c38244-d745-4005-9aff-08cd8f4a944f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b850f82-7988-40c4-ae5f-4cf4a40478a8" xlink:to="loc_us-gaap_CostsAndExpenses_d2c38244-d745-4005-9aff-08cd8f4a944f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_76838054-f8e5-4235-84d3-af8ccf88fad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8bb202b7-a64c-47f7-8eaa-044151f31c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_76838054-f8e5-4235-84d3-af8ccf88fad2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8bb202b7-a64c-47f7-8eaa-044151f31c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ffbef798-ab0b-4cb8-a52c-0181fc352793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_76838054-f8e5-4235-84d3-af8ccf88fad2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ffbef798-ab0b-4cb8-a52c-0181fc352793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4d1e6f54-0244-483d-bbf5-384d3309f95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3490f7a2-ad17-4d9c-bdf9-9ac3ed9a482b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4d1e6f54-0244-483d-bbf5-384d3309f95b" xlink:to="loc_us-gaap_ProfitLoss_3490f7a2-ad17-4d9c-bdf9-9ac3ed9a482b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_975b59f6-4c3e-414d-a0fb-74b02ba2a3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4d1e6f54-0244-483d-bbf5-384d3309f95b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_975b59f6-4c3e-414d-a0fb-74b02ba2a3d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1b938a7e-a293-4bfe-91d4-17efe621f661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7f19b57-61a0-4126-95bb-c70c0f34d799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1b938a7e-a293-4bfe-91d4-17efe621f661" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7f19b57-61a0-4126-95bb-c70c0f34d799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5229610d-c974-405c-ade1-559e9daeac52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1b938a7e-a293-4bfe-91d4-17efe621f661" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5229610d-c974-405c-ade1-559e9daeac52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6093cde8-0515-475d-bd53-4b704472cf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7a55609-f006-43c2-b5eb-af5b357833de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6093cde8-0515-475d-bd53-4b704472cf0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7a55609-f006-43c2-b5eb-af5b357833de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4f0bb19c-c755-405b-8496-b650e8b32455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6093cde8-0515-475d-bd53-4b704472cf0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4f0bb19c-c755-405b-8496-b650e8b32455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_714d55ab-b492-437c-a8f4-3f460e194653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6093cde8-0515-475d-bd53-4b704472cf0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_714d55ab-b492-437c-a8f4-3f460e194653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aef60cb2-24c2-4e98-9379-588ecad6b257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6093cde8-0515-475d-bd53-4b704472cf0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aef60cb2-24c2-4e98-9379-588ecad6b257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd6f93c9-b3de-496c-84d8-8f2fd266d804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0306b217-4936-47d2-9b09-bfae85fa9d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd6f93c9-b3de-496c-84d8-8f2fd266d804" xlink:to="loc_us-gaap_ProfitLoss_0306b217-4936-47d2-9b09-bfae85fa9d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ecfd94d-8ada-4bec-90ef-07a4f34a8d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd6f93c9-b3de-496c-84d8-8f2fd266d804" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ecfd94d-8ada-4bec-90ef-07a4f34a8d5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_afdd7faf-e39e-46cd-9db1-617cd0724abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_afdd7faf-e39e-46cd-9db1-617cd0724abe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_f78e6ef1-735d-46e3-8144-c6e0c949898d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_f78e6ef1-735d-46e3-8144-c6e0c949898d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_5f33f4d2-3e0e-42fe-ae27-6ebeaabb2a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_5f33f4d2-3e0e-42fe-ae27-6ebeaabb2a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_252eed41-cd8a-453a-87fe-fa02941c8ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:to="loc_us-gaap_InventoryNet_252eed41-cd8a-453a-87fe-fa02941c8ffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_9fd7448c-7b3b-4921-a5da-515cac1215b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc5659e3-0c82-4d49-9b8f-8f7a23ee1a2f" xlink:to="loc_us-gaap_OtherAssetsCurrent_9fd7448c-7b3b-4921-a5da-515cac1215b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6b9bb57f-458a-486c-96a8-a22c7817c356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_PreferredStockValue_6b9bb57f-458a-486c-96a8-a22c7817c356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9f560526-3dea-49fd-833e-47bf11a6cce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_CommonStockValue_9f560526-3dea-49fd-833e-47bf11a6cce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_806760af-460e-4b73-9d59-4d812782a148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_806760af-460e-4b73-9d59-4d812782a148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1866ed4b-fc31-42a0-979a-2950b97faa21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1866ed4b-fc31-42a0-979a-2950b97faa21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_881eda03-7caf-4b5a-babb-24524a36437d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_881eda03-7caf-4b5a-babb-24524a36437d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_41b37c05-c520-4c79-a45a-ac48f2d4f203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_df4fe4d7-b702-4965-81a5-be1da58cf76f" xlink:to="loc_us-gaap_TreasuryStockValue_41b37c05-c520-4c79-a45a-ac48f2d4f203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0280f89a-9adf-4744-9fd1-cc2b4b89fb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_047f533c-e444-4c6e-ae71-69f884a11484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0280f89a-9adf-4744-9fd1-cc2b4b89fb07" xlink:to="loc_us-gaap_LiabilitiesCurrent_047f533c-e444-4c6e-ae71-69f884a11484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eef4190c-64b6-4238-b15d-ed5d1cf72700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0280f89a-9adf-4744-9fd1-cc2b4b89fb07" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eef4190c-64b6-4238-b15d-ed5d1cf72700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7c18be97-9fe1-41d4-ad9a-7527f2a02936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0280f89a-9adf-4744-9fd1-cc2b4b89fb07" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7c18be97-9fe1-41d4-ad9a-7527f2a02936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e90639cb-8884-4074-8210-62064f01d93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0280f89a-9adf-4744-9fd1-cc2b4b89fb07" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e90639cb-8884-4074-8210-62064f01d93f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_75422317-15a6-4ccf-822c-822d14116f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7a363c49-3351-4d65-b71e-c50c8bebb2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75422317-15a6-4ccf-822c-822d14116f5a" xlink:to="loc_us-gaap_Liabilities_7a363c49-3351-4d65-b71e-c50c8bebb2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cf68a39-10f1-492e-afed-841f45bd6df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75422317-15a6-4ccf-822c-822d14116f5a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cf68a39-10f1-492e-afed-841f45bd6df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c76beab9-c9eb-429b-887f-b446d99a2a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75422317-15a6-4ccf-822c-822d14116f5a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c76beab9-c9eb-429b-887f-b446d99a2a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e1e4a7a7-2e0e-4446-8c46-50c43891d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_efc27662-42a4-4667-bdfa-920e3eef2bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e1e4a7a7-2e0e-4446-8c46-50c43891d262" xlink:to="loc_us-gaap_DebtCurrent_efc27662-42a4-4667-bdfa-920e3eef2bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fe5c5738-41f3-4b8b-883c-30c4b73b9be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e1e4a7a7-2e0e-4446-8c46-50c43891d262" xlink:to="loc_us-gaap_AccountsPayableCurrent_fe5c5738-41f3-4b8b-883c-30c4b73b9be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_cac779aa-0373-40f4-8af7-083707e9d0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e1e4a7a7-2e0e-4446-8c46-50c43891d262" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_cac779aa-0373-40f4-8af7-083707e9d0b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_698a6596-3efd-47ce-9681-0483a5a7317d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ed25e998-ab05-4e67-a8ce-65f4a221723a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_698a6596-3efd-47ce-9681-0483a5a7317d" xlink:to="loc_us-gaap_StockholdersEquity_ed25e998-ab05-4e67-a8ce-65f4a221723a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_08190a10-cafc-4b38-9351-a73170205d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_698a6596-3efd-47ce-9681-0483a5a7317d" xlink:to="loc_us-gaap_MinorityInterest_08190a10-cafc-4b38-9351-a73170205d49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6745a967-fc31-4d4a-ab5e-f1ffa44cbec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_AssetsCurrent_6745a967-fc31-4d4a-ab5e-f1ffa44cbec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d92a0a51-814f-44b1-b63b-70e9480a8730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d92a0a51-814f-44b1-b63b-70e9480a8730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c35143f0-b94a-4ec9-9216-619d5867d554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_Goodwill_c35143f0-b94a-4ec9-9216-619d5867d554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48ff7032-ba9f-4ce7-8238-08deb9e1d6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48ff7032-ba9f-4ce7-8238-08deb9e1d6f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_a994e873-740c-4096-ac05-3647a785c5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_a994e873-740c-4096-ac05-3647a785c5f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d18bfe7a-03f1-4aa9-a34c-98962157aa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_730ea952-c9e1-4085-9081-356ecfbfb9a5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d18bfe7a-03f1-4aa9-a34c-98962157aa3e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_d1e4ea18-9b54-4593-a964-bdbd8ed8baf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_d1e4ea18-9b54-4593-a964-bdbd8ed8baf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b21f9a1a-e00f-4534-a693-adbe860b72d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b21f9a1a-e00f-4534-a693-adbe860b72d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_edf68d88-17ee-4103-bb29-709943efa87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_edf68d88-17ee-4103-bb29-709943efa87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_c5456b7c-6749-45fc-9390-782aa4faef11" xlink:href="bmy-20230331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_bmy_Divestitureandotherproceeds_c5456b7c-6749-45fc-9390-782aa4faef11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_329835cc-12ba-4aaa-95df-37eb05010a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_329835cc-12ba-4aaa-95df-37eb05010a0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_bcb51d66-0a19-47bd-ac8f-434e5ed8fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9ef70576-d4fc-4861-b53a-1bb9bcfd0f7e" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_bcb51d66-0a19-47bd-ac8f-434e5ed8fa20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_39c6185a-aadb-4e0b-bb11-16e90e22aa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_ProfitLoss_39c6185a-aadb-4e0b-bb11-16e90e22aa4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3bb4df2c-bdfc-4201-abbb-481952962809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3bb4df2c-bdfc-4201-abbb-481952962809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd978e32-11ec-4f29-b59c-26ca8b031504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd978e32-11ec-4f29-b59c-26ca8b031504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_773d1c30-caaa-4b93-9b6a-8f8cb5bb7149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_ShareBasedCompensation_773d1c30-caaa-4b93-9b6a-8f8cb5bb7149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6fc5d399-a0e2-4c08-9008-4278a1a91752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6fc5d399-a0e2-4c08-9008-4278a1a91752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_4dad9e68-b1c3-49f0-8129-8498a79727b3" xlink:href="bmy-20230331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_bmy_Divestituregainsandroyalties_4dad9e68-b1c3-49f0-8129-8498a79727b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f1777a3f-9b52-4379-8701-07b22a6686dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_GainLossOnInvestments_f1777a3f-9b52-4379-8701-07b22a6686dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a3f6be0f-e343-4ad3-9af9-3eaa959dd70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a3f6be0f-e343-4ad3-9af9-3eaa959dd70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_bb8118c0-4093-4074-89d0-f865772450a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_bb8118c0-4093-4074-89d0-f865772450a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_684d5629-4f8d-4498-9551-c000ae767fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_684d5629-4f8d-4498-9551-c000ae767fde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3c2036e5-db05-479f-b98d-924ef7a31f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3c2036e5-db05-479f-b98d-924ef7a31f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c3933c0a-db21-4704-9f90-07af0ed32e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c3933c0a-db21-4704-9f90-07af0ed32e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c8c4df7a-cfa3-497d-9d12-e37233cd0a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c8c4df7a-cfa3-497d-9d12-e37233cd0a27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_121d0ecf-6829-465d-9b7f-9c2358adf49a" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_bmy_AcquiredIPRD_121d0ecf-6829-465d-9b7f-9c2358adf49a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_8bc98c88-e7a3-4cbe-b26e-27d529be9562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e7b4fb1-9a71-4d99-993a-c68e62bc681e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_8bc98c88-e7a3-4cbe-b26e-27d529be9562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_45e19486-3cb7-4617-bced-eddddf66aa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_45e19486-3cb7-4617-bced-eddddf66aa62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c2ad3e1d-667d-443e-b038-cfbe9981f160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c2ad3e1d-667d-443e-b038-cfbe9981f160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f58ab81-5720-4125-8831-1cf0a8c2e4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f58ab81-5720-4125-8831-1cf0a8c2e4af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_6b7b48a0-aae7-4862-b08a-0f80304b09c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_us-gaap_PaymentsOfDividends_6b7b48a0-aae7-4862-b08a-0f80304b09c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_2e7c8fdd-e36c-43d0-ad7e-005ce632f585" xlink:href="bmy-20230331.xsd#bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_2e7c8fdd-e36c-43d0-ad7e-005ce632f585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_841d2821-2d24-4bfa-8023-64c3093fb2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edcbdb9d-5fa9-495d-adc7-7b6603a27fbe" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_841d2821-2d24-4bfa-8023-64c3093fb2fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c93a24b6-75cc-4b80-98d0-3a66c0e83a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f96e893f-b5de-495b-8f05-93f47d0821ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c93a24b6-75cc-4b80-98d0-3a66c0e83a07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f96e893f-b5de-495b-8f05-93f47d0821ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e659d9c6-f93a-4e67-a32f-83cba888139d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c93a24b6-75cc-4b80-98d0-3a66c0e83a07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e659d9c6-f93a-4e67-a32f-83cba888139d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c70b67ee-f5cf-4d52-b8b5-a8d493b55f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c93a24b6-75cc-4b80-98d0-3a66c0e83a07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c70b67ee-f5cf-4d52-b8b5-a8d493b55f41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d259316-a420-4845-ba2f-e07ec3c6b1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c93a24b6-75cc-4b80-98d0-3a66c0e83a07" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d259316-a420-4845-ba2f-e07ec3c6b1dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_16b0b3d0-3a85-442e-8d23-0b30d166e724" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_e1cf2a39-1239-4edf-8129-8c061757f6e3" xlink:href="bmy-20230331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_16b0b3d0-3a85-442e-8d23-0b30d166e724" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_e1cf2a39-1239-4edf-8129-8c061757f6e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_7cf08036-1dfc-4405-b6eb-8a5ddaa3f124" xlink:href="bmy-20230331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_16b0b3d0-3a85-442e-8d23-0b30d166e724" xlink:to="loc_bmy_AmortizationOfDeferredIncome_7cf08036-1dfc-4405-b6eb-8a5ddaa3f124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_85cf98b3-1ad2-4b6e-8cc6-da51bb66d4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome_16b0b3d0-3a85-442e-8d23-0b30d166e724" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_85cf98b3-1ad2-4b6e-8cc6-da51bb66d4fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_fe98f3aa-837a-4dc9-920b-36fd3fccaf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_InterestExpense_fe98f3aa-837a-4dc9-920b-36fd3fccaf7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessRoyaltyAndLicensingIncome_cabee8ec-d39d-41f2-8bd8-1b2c25b57846" xlink:href="bmy-20230331.xsd#bmy_BusinessRoyaltyAndLicensingIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_bmy_BusinessRoyaltyAndLicensingIncome_cabee8ec-d39d-41f2-8bd8-1b2c25b57846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessSaleRoyaltyIncome_18c18f46-54b1-4b1a-a637-39a8faa9be7e" xlink:href="bmy-20230331.xsd#bmy_BusinessSaleRoyaltyIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_bmy_BusinessSaleRoyaltyIncome_18c18f46-54b1-4b1a-a637-39a8faa9be7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_88957c5e-c1a4-401d-a73d-fbcfabfbdd92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_GainLossOnInvestments_88957c5e-c1a4-401d-a73d-fbcfabfbdd92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_bed8e4d0-7678-45b6-bf5b-a8553d605cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_bed8e4d0-7678-45b6-bf5b-a8553d605cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4bd06a7b-47c9-4b43-bd9b-38ad5a66cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_RestructuringCharges_4bd06a7b-47c9-4b43-bd9b-38ad5a66cb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_2a422174-eb79-4ee6-98d8-63cf35f5bca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_2a422174-eb79-4ee6-98d8-63cf35f5bca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_575abe55-ca97-4420-8407-cfa8e4c4769e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_575abe55-ca97-4420-8407-cfa8e4c4769e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9e7f845-91bb-4cb3-8cf5-1c53668ff55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9e7f845-91bb-4cb3-8cf5-1c53668ff55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_8fde795f-e5f2-471b-916d-f3abc8ba0b5f" xlink:href="bmy-20230331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_bmy_OtherOtherIncomeExpense_8fde795f-e5f2-471b-916d-f3abc8ba0b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_620b8a62-9136-4b93-a996-d87395feb0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e9ae2e23-2dca-44c9-a476-03810063de3d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_620b8a62-9136-4b93-a996-d87395feb0a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3b6b60a8-90c2-4790-9124-402dd1e98d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_eb4f4392-cf1e-4b2c-b3b0-e18094d3ff77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3b6b60a8-90c2-4790-9124-402dd1e98d76" xlink:to="loc_us-gaap_SeveranceCosts1_eb4f4392-cf1e-4b2c-b3b0-e18094d3ff77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_2e8e2dbb-4782-4bb1-be7c-8fce9b2068f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3b6b60a8-90c2-4790-9124-402dd1e98d76" xlink:to="loc_us-gaap_OtherRestructuringCosts_2e8e2dbb-4782-4bb1-be7c-8fce9b2068f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_ea6078ce-8d05-4bc6-9392-0260ecbeffa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_978897f8-1654-46cc-8302-26e6ff740cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_ea6078ce-8d05-4bc6-9392-0260ecbeffa0" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_978897f8-1654-46cc-8302-26e6ff740cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_2ddc2805-235e-412a-9133-ec2b3548ee4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_ea6078ce-8d05-4bc6-9392-0260ecbeffa0" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_2ddc2805-235e-412a-9133-ec2b3548ee4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e521229f-e7f6-48a9-a13c-84d1199df3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_ea6078ce-8d05-4bc6-9392-0260ecbeffa0" xlink:to="loc_us-gaap_RestructuringCharges_e521229f-e7f6-48a9-a13c-84d1199df3c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65b8ddd6-7bc3-41b9-b647-fe7b0b397f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aab9840b-8e43-44c4-b854-02a6a60a905c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65b8ddd6-7bc3-41b9-b647-fe7b0b397f83" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aab9840b-8e43-44c4-b854-02a6a60a905c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d8d6d17-4b80-46a4-8ad5-e1cbcbab8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65b8ddd6-7bc3-41b9-b647-fe7b0b397f83" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d8d6d17-4b80-46a4-8ad5-e1cbcbab8c33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_151ddffd-726c-4c3a-a434-550458ca6be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8b9b27c-4d3b-4e80-b944-d8d42a8644d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_151ddffd-726c-4c3a-a434-550458ca6be9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8b9b27c-4d3b-4e80-b944-d8d42a8644d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_78c71227-40d6-41e2-aa9e-88dff729565f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_151ddffd-726c-4c3a-a434-550458ca6be9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_78c71227-40d6-41e2-aa9e-88dff729565f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7af42943-b478-4fac-8f50-ef9cecd2b1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_151ddffd-726c-4c3a-a434-550458ca6be9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7af42943-b478-4fac-8f50-ef9cecd2b1a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_0c9d580e-550e-47dc-b758-df3067a21fb0" xlink:href="bmy-20230331.xsd#bmy_EquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_32eb8ed1-06d8-4883-b0fd-1cad70e9ec94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_0c9d580e-550e-47dc-b758-df3067a21fb0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_32eb8ed1-06d8-4883-b0fd-1cad70e9ec94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d2fa86de-2fb0-42b9-80f4-98d544dc71c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_0c9d580e-550e-47dc-b758-df3067a21fb0" xlink:to="loc_us-gaap_EquityMethodInvestments_d2fa86de-2fb0-42b9-80f4-98d544dc71c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f9b71a70-6816-4af9-8857-360d76d9b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_0c9d580e-550e-47dc-b758-df3067a21fb0" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f9b71a70-6816-4af9-8857-360d76d9b5ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b2b55930-7aa1-4f0b-95de-aac92c449df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_ac75aa77-c1b7-4a71-b5ad-6536fbab9e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnInvestments_b2b55930-7aa1-4f0b-95de-aac92c449df4" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_ac75aa77-c1b7-4a71-b5ad-6536fbab9e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_9214fd69-749b-4d28-a8f4-3a2dde73f08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnInvestments_b2b55930-7aa1-4f0b-95de-aac92c449df4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_9214fd69-749b-4d28-a8f4-3a2dde73f08b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_b207228d-70a9-41fd-a618-533cec4f1d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnInvestments_b2b55930-7aa1-4f0b-95de-aac92c449df4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_b207228d-70a9-41fd-a618-533cec4f1d04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fab8d7db-8a2c-4a26-a753-d64edd70a002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnInvestments_b2b55930-7aa1-4f0b-95de-aac92c449df4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fab8d7db-8a2c-4a26-a753-d64edd70a002" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSShortTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b6e4be73-0f95-49e2-a9a7-a9c7f36baf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d6c06281-6cd1-4dac-8199-90c06e48115d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b6e4be73-0f95-49e2-a9a7-a9c7f36baf78" xlink:to="loc_us-gaap_LongTermDebtCurrent_d6c06281-6cd1-4dac-8199-90c06e48115d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_7ccf35a6-49b8-4583-aebb-7e2a39bdcaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b6e4be73-0f95-49e2-a9a7-a9c7f36baf78" xlink:to="loc_us-gaap_OtherShortTermBorrowings_7ccf35a6-49b8-4583-aebb-7e2a39bdcaa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_d4d26d19-705e-4ff9-b126-9560c156b46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b6e4be73-0f95-49e2-a9a7-a9c7f36baf78" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_d4d26d19-705e-4ff9-b126-9560c156b46f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_82aa2793-4f5e-4e5b-929e-2c25b0ee7848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_82aa2793-4f5e-4e5b-929e-2c25b0ee7848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_d2083e57-6757-4893-9b80-15ef8f6b6146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_d2083e57-6757-4893-9b80-15ef8f6b6146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1f3f8d5b-01c5-4304-a1c7-d46ec49176e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:to="loc_us-gaap_DerivativeLiabilities_1f3f8d5b-01c5-4304-a1c7-d46ec49176e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d0a7cdc6-5b98-4308-af84-40a96d832c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d0a7cdc6-5b98-4308-af84-40a96d832c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6cffb9b3-58a3-4612-abd1-7c12b1703424" xlink:href="bmy-20230331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d903e21-0998-4323-afb5-8ec4521e6100" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6cffb9b3-58a3-4612-abd1-7c12b1703424" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d7457776-3ed6-4a70-b48c-c77db839ecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_550e2f77-a86a-43f8-b670-d4eb36a3b911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d7457776-3ed6-4a70-b48c-c77db839ecc3" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_550e2f77-a86a-43f8-b670-d4eb36a3b911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_0b2d0b80-e408-435b-a780-12b23bcfa0dc" xlink:href="bmy-20230331.xsd#bmy_CashDiscounts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d7457776-3ed6-4a70-b48c-c77db839ecc3" xlink:to="loc_bmy_CashDiscounts_0b2d0b80-e408-435b-a780-12b23bcfa0dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7325aa32-234d-40e6-a5da-f0ead400d271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d7457776-3ed6-4a70-b48c-c77db839ecc3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7325aa32-234d-40e6-a5da-f0ead400d271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_c01904ff-958e-4ca8-b7fa-45a7c29aba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_7e66f849-3743-40d5-9520-b6f971a5f7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_c01904ff-958e-4ca8-b7fa-45a7c29aba9d" xlink:to="loc_us-gaap_OtherReceivables_7e66f849-3743-40d5-9520-b6f971a5f7d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_55bcf131-2533-43f2-ad2f-1ac9ca1cc186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_c01904ff-958e-4ca8-b7fa-45a7c29aba9d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_55bcf131-2533-43f2-ad2f-1ac9ca1cc186" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_161b44fc-4284-4a8d-8a6c-d7ee88640796" xlink:href="bmy-20230331.xsd#bmy_Totalinventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1298d30f-b399-4094-89a4-921bdde57fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_161b44fc-4284-4a8d-8a6c-d7ee88640796" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1298d30f-b399-4094-89a4-921bdde57fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_36ddcf20-941a-44c5-a0a3-b3bbcdee13d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_161b44fc-4284-4a8d-8a6c-d7ee88640796" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_36ddcf20-941a-44c5-a0a3-b3bbcdee13d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_572c97a1-dfbf-414c-9e57-96f1106f8f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_161b44fc-4284-4a8d-8a6c-d7ee88640796" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_572c97a1-dfbf-414c-9e57-96f1106f8f63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8d7d05be-3c6b-4bbc-be04-19e317a4e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3ad91992-9dd1-4d47-bb14-8df9333f3aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8d7d05be-3c6b-4bbc-be04-19e317a4e75c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3ad91992-9dd1-4d47-bb14-8df9333f3aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_34a04e8b-aecb-48ef-9ba0-fa8b76ecf00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8d7d05be-3c6b-4bbc-be04-19e317a4e75c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_34a04e8b-aecb-48ef-9ba0-fa8b76ecf00b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afe7a199-26cb-4b1a-a1cc-8920ada2cd92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0150888d-507e-4388-a01d-1a57b7c800cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afe7a199-26cb-4b1a-a1cc-8920ada2cd92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0150888d-507e-4388-a01d-1a57b7c800cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_49e46d9d-575c-4dc0-895a-478e4da382db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afe7a199-26cb-4b1a-a1cc-8920ada2cd92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_49e46d9d-575c-4dc0-895a-478e4da382db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_a8d84d6f-21eb-4336-8749-81a06687d20b" xlink:href="bmy-20230331.xsd#bmy_ResearchandDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:to="loc_bmy_ResearchandDevelopment_a8d84d6f-21eb-4336-8749-81a06687d20b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_3f025c30-e8a0-4399-9b79-b08dfacb068d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_3f025c30-e8a0-4399-9b79-b08dfacb068d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a2b2599b-9e7c-43dc-b58a-fba3c8464133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a2b2599b-9e7c-43dc-b58a-fba3c8464133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_393311ee-a25f-4a90-a0cb-21ed57f15e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:to="loc_us-gaap_PrepaidTaxes_393311ee-a25f-4a90-a0cb-21ed57f15e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_ef61c793-06fe-4619-9a4d-0fb5eeb7cc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_f8c02a13-a971-4b80-98c0-1af4ec4059a3" xlink:to="loc_us-gaap_RestrictedCash_ef61c793-06fe-4619-9a4d-0fb5eeb7cc4e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2f74f797-f318-4767-bdac-57a543fce327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2f74f797-f318-4767-bdac-57a543fce327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_84a8ca7e-1f02-4166-976b-b8d8eb844058" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_84a8ca7e-1f02-4166-976b-b8d8eb844058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_6b8fda07-c6bb-4b97-b0e5-8e1646a2d059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_us-gaap_InventoryNoncurrent_6b8fda07-c6bb-4b97-b0e5-8e1646a2d059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b4991593-0d25-47ee-9504-58569bc33b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b4991593-0d25-47ee-9504-58569bc33b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_24522248-bbb7-4b3d-a434-1a07a021a074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_24522248-bbb7-4b3d-a434-1a07a021a074" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_e866b905-b27f-4878-8e7d-452a8e48a514" xlink:href="bmy-20230331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_e866b905-b27f-4878-8e7d-452a8e48a514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_51816908-0894-4414-bac3-587d14931ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ac129707-5ede-4a0f-af80-063f6f2e6729" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_51816908-0894-4414-bac3-587d14931ae6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bf9e5190-4396-4735-be0c-3d0ee2bec394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bf9e5190-4396-4735-be0c-3d0ee2bec394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_d562ca83-e593-4d84-b950-2efb293e7577" xlink:href="bmy-20230331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_bmy_AccruedResearchAndDevelopment_d562ca83-e593-4d84-b950-2efb293e7577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_ee69b686-8c5a-43f8-a059-e6ae1b30a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_DividendsPayableCurrent_ee69b686-8c5a-43f8-a059-e6ae1b30a6ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_c7f8d53f-7500-4b3b-a1e5-4317a62287c5" xlink:href="bmy-20230331.xsd#bmy_AccruedInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_bmy_AccruedInterest_c7f8d53f-7500-4b3b-a1e5-4317a62287c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ec9ae228-e504-46b0-96fb-bcd140ca303a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ec9ae228-e504-46b0-96fb-bcd140ca303a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_23dc773c-1f4a-4b53-be02-07a1378c0b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_23dc773c-1f4a-4b53-be02-07a1378c0b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_1e1345c1-dd08-43af-8ee1-259cc3a2baa6" xlink:href="bmy-20230331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_bmy_AccruedRebatesAndReturns_1e1345c1-dd08-43af-8ee1-259cc3a2baa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5b7628d1-edab-42f5-948f-215c01722ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5b7628d1-edab-42f5-948f-215c01722ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f639ef8d-e011-4aa2-b22d-4c60d29fe595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ad24043f-ae33-4799-b582-92c8eb640dd3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f639ef8d-e011-4aa2-b22d-4c60d29fe595" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_4267224a-6ce8-4882-8fc3-01c0ba45b241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_4267224a-6ce8-4882-8fc3-01c0ba45b241" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39fca65e-ff64-4d0d-ab56-3f594548298e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39fca65e-ff64-4d0d-ab56-3f594548298e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_16d3e105-f056-409f-a63d-bed68888c0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_16d3e105-f056-409f-a63d-bed68888c0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_3b9d6b8d-08c2-419d-93f1-cfc7a7751b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_3b9d6b8d-08c2-419d-93f1-cfc7a7751b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_00c1b211-4184-4c99-a3e9-19d7fc2804d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_00c1b211-4184-4c99-a3e9-19d7fc2804d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_7b21bfa9-af71-421e-9818-6d5dbe2d5f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f9b5994-f14f-4aa1-8992-69d435063cec" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_7b21bfa9-af71-421e-9818-6d5dbe2d5f96" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d416b362-1683-486f-988f-87207afbe918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_29b31323-e9bc-4128-b595-031ff31c140a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d416b362-1683-486f-988f-87207afbe918" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_29b31323-e9bc-4128-b595-031ff31c140a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_999768f6-a81e-4126-98d7-70f57cb36b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d416b362-1683-486f-988f-87207afbe918" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_999768f6-a81e-4126-98d7-70f57cb36b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_7e3425a8-d10c-44c9-af52-82fd8ddb3a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d416b362-1683-486f-988f-87207afbe918" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_7e3425a8-d10c-44c9-af52-82fd8ddb3a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_b894c09b-8609-43de-a258-2420e3dbc867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d416b362-1683-486f-988f-87207afbe918" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_b894c09b-8609-43de-a258-2420e3dbc867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8068961a-9107-4691-a64a-e271434144ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_ed9ca9ef-3aa2-4b0e-a774-90d1046f8b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8068961a-9107-4691-a64a-e271434144ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_ed9ca9ef-3aa2-4b0e-a774-90d1046f8b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_f8ac1b09-c1db-47ce-8ef6-8410d22402f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8068961a-9107-4691-a64a-e271434144ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_f8ac1b09-c1db-47ce-8ef6-8410d22402f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_c8cf0996-5b6c-46ea-9b44-6ed70bdbfd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8068961a-9107-4691-a64a-e271434144ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_c8cf0996-5b6c-46ea-9b44-6ed70bdbfd85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd8ebcba-7533-4e03-b5f4-18d1b964f0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fb5ca194-ca85-4e74-9035-bdb915017636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd8ebcba-7533-4e03-b5f4-18d1b964f0c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fb5ca194-ca85-4e74-9035-bdb915017636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_127d73ae-faf6-46bd-a9fd-608bff9dca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd8ebcba-7533-4e03-b5f4-18d1b964f0c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_127d73ae-faf6-46bd-a9fd-608bff9dca4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_95e9e292-557d-456d-8e8e-e1a3c62ecc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_ac7d4873-ba49-429e-9166-e636b1a31819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_95e9e292-557d-456d-8e8e-e1a3c62ecc8e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_ac7d4873-ba49-429e-9166-e636b1a31819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_afd4ca98-f901-4a50-b925-1f202e2ae3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_95e9e292-557d-456d-8e8e-e1a3c62ecc8e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_afd4ca98-f901-4a50-b925-1f202e2ae3d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_50cdb74a-5544-4e78-b9f6-f3ab8fdf76b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_293138bb-567e-4887-9c97-9addd611b752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_50cdb74a-5544-4e78-b9f6-f3ab8fdf76b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_293138bb-567e-4887-9c97-9addd611b752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2e0a8e8c-9bb7-413a-81b1-cdf8df2f5ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_50cdb74a-5544-4e78-b9f6-f3ab8fdf76b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2e0a8e8c-9bb7-413a-81b1-cdf8df2f5ccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_4824bf52-803b-4c02-b826-a393b4412121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_50cdb74a-5544-4e78-b9f6-f3ab8fdf76b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_4824bf52-803b-4c02-b826-a393b4412121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_fc611e0e-c697-4609-b6bc-0a042acccdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_50cdb74a-5544-4e78-b9f6-f3ab8fdf76b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_fc611e0e-c697-4609-b6bc-0a042acccdd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_20b0a5b1-f9d8-4ffa-8352-d5a8078edc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_54e548be-28f6-4c41-918c-c42dd73ad462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_20b0a5b1-f9d8-4ffa-8352-d5a8078edc71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_54e548be-28f6-4c41-918c-c42dd73ad462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_4adc75f2-d8bf-4178-b75a-a810637b4f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_20b0a5b1-f9d8-4ffa-8352-d5a8078edc71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_4adc75f2-d8bf-4178-b75a-a810637b4f6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1e4d6958-0564-46ca-bb44-e662d6cef260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_4ae95776-c5dc-444c-a14a-434ae4123ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1e4d6958-0564-46ca-bb44-e662d6cef260" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_4ae95776-c5dc-444c-a14a-434ae4123ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d2fcc737-8d2d-484e-94b3-5c339776a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1e4d6958-0564-46ca-bb44-e662d6cef260" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d2fcc737-8d2d-484e-94b3-5c339776a18f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_05246b4f-d084-4ec8-a551-02c400dcc6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1e4d6958-0564-46ca-bb44-e662d6cef260" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_05246b4f-d084-4ec8-a551-02c400dcc6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b16b8e0-f17e-4e80-8292-45f30ca0113a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0042b93b-e9da-4556-8889-a71ef7d8e97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b16b8e0-f17e-4e80-8292-45f30ca0113a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0042b93b-e9da-4556-8889-a71ef7d8e97a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_4aacd7f7-0edb-4a27-9341-0513f7f69160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b16b8e0-f17e-4e80-8292-45f30ca0113a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_4aacd7f7-0edb-4a27-9341-0513f7f69160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_dfb8069b-a4e3-42b8-9b04-173eca3a5823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b16b8e0-f17e-4e80-8292-45f30ca0113a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_dfb8069b-a4e3-42b8-9b04-173eca3a5823" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a8a864ff-367a-4410-94f1-ec8227351b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_7858b7a1-577c-4db4-a84e-f01d9355415c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a8a864ff-367a-4410-94f1-ec8227351b58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_7858b7a1-577c-4db4-a84e-f01d9355415c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0cc2fcfc-feef-461d-a1ef-cdd9981c9bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a8a864ff-367a-4410-94f1-ec8227351b58" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0cc2fcfc-feef-461d-a1ef-cdd9981c9bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3248e88d-2fdf-4a0a-a4d9-1121404f584b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a8a864ff-367a-4410-94f1-ec8227351b58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3248e88d-2fdf-4a0a-a4d9-1121404f584b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bmy-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bms.com/role/CoverPage" xlink:type="simple" xlink:href="bmy-20230331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CoverPage" xlink:type="extended" id="ia639523d32d0423a932ff9f84afce729_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e35f5067-73dc-4483-9343-e85e0c60833a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentType_e35f5067-73dc-4483-9343-e85e0c60833a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_daa4d840-d1c3-4a3d-bc81-bc690d32d433" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentQuarterlyReport_daa4d840-d1c3-4a3d-bc81-bc690d32d433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_21e1fa55-de21-4644-921c-f7a8fe910c35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentPeriodEndDate_21e1fa55-de21-4644-921c-f7a8fe910c35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0bdd0625-ab63-4ddb-afb2-69df14d596d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentTransitionReport_0bdd0625-ab63-4ddb-afb2-69df14d596d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5fedc41d-6746-4423-8f27-fea0d2d5e1b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityFileNumber_5fedc41d-6746-4423-8f27-fea0d2d5e1b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a83fdfd9-b3af-41af-91da-784d347182ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityRegistrantName_a83fdfd9-b3af-41af-91da-784d347182ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a84615a8-9b1e-4531-9194-1c66bd8b0801" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a84615a8-9b1e-4531-9194-1c66bd8b0801" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_912ed532-01fb-47d9-84b0-33efa2cda528" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityTaxIdentificationNumber_912ed532-01fb-47d9-84b0-33efa2cda528" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_17554b90-4dda-4538-965d-0bc9c1b79042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressAddressLine1_17554b90-4dda-4538-965d-0bc9c1b79042" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_25571cdb-72c2-4146-a494-09e89fdb999d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressCityOrTown_25571cdb-72c2-4146-a494-09e89fdb999d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f3e7e558-fe67-463e-8e1a-bee2889efd10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressStateOrProvince_f3e7e558-fe67-463e-8e1a-bee2889efd10" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5d09366a-c074-41ec-b801-b6d2c291ce57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressPostalZipCode_5d09366a-c074-41ec-b801-b6d2c291ce57" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_cb1f79fd-2879-4637-8ab4-ee0a263576c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_CityAreaCode_cb1f79fd-2879-4637-8ab4-ee0a263576c6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2793c309-2463-4317-a903-49d14e88fa08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_LocalPhoneNumber_2793c309-2463-4317-a903-49d14e88fa08" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0998e933-b8fc-4542-a472-13dd3ea7c24c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_Security12bTitle_0998e933-b8fc-4542-a472-13dd3ea7c24c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ff817c25-ed39-41ba-a2a7-ea65250c5820" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_TradingSymbol_ff817c25-ed39-41ba-a2a7-ea65250c5820" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3aec610b-d05e-4a63-9d32-eb1d642396b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_SecurityExchangeName_3aec610b-d05e-4a63-9d32-eb1d642396b1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_30483a65-822f-44ce-ac8d-9249eb0efe64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCurrentReportingStatus_30483a65-822f-44ce-ac8d-9249eb0efe64" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_af9be02b-1231-45fe-9bc5-7e0d8100de52" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityInteractiveDataCurrent_af9be02b-1231-45fe-9bc5-7e0d8100de52" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a2174c9b-5f2d-409b-9eee-307adf215110" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityFilerCategory_a2174c9b-5f2d-409b-9eee-307adf215110" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_45ce653f-8595-49a7-a4d4-ef6f9cb5533d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityEmergingGrowthCompany_45ce653f-8595-49a7-a4d4-ef6f9cb5533d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a087ac20-23fe-453b-804d-89ae908c095a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityShellCompany_a087ac20-23fe-453b-804d-89ae908c095a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15636e2e-060f-4942-8ae3-4cafc2af0b06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15636e2e-060f-4942-8ae3-4cafc2af0b06" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1813ed46-ab21-4cb7-9bec-b0ac4edb703b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCentralIndexKey_1813ed46-ab21-4cb7-9bec-b0ac4edb703b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_aea4a1b3-72e8-4f40-9ebd-88179e4e4a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentFiscalYearFocus_aea4a1b3-72e8-4f40-9ebd-88179e4e4a47" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_51edeb84-6a0f-415c-9404-30defbbe72dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentFiscalPeriodFocus_51edeb84-6a0f-415c-9404-30defbbe72dc" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c1f96fef-ee86-41a4-81b9-66005f4879d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_CurrentFiscalYearEndDate_c1f96fef-ee86-41a4-81b9-66005f4879d7" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba82c6e9-1e1c-41b5-be3b-5498a66b0247" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_AmendmentFlag_ba82c6e9-1e1c-41b5-be3b-5498a66b0247" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a1aa1c5c-cb6d-4b92-a7a6-82f20401f5d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntitySmallBusiness_a1aa1c5c-cb6d-4b92-a7a6-82f20401f5d7" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2e4feeda-6006-41c4-98a1-acf5deacb132_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:to="loc_us-gaap_ClassOfStockDomain_2e4feeda-6006-41c4-98a1-acf5deacb132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:to="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_68de4351-d8b5-4373-ba6f-21d442f8c16b" xlink:href="bmy-20230331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_CommonStock0.10ParValueMember_68de4351-d8b5-4373-ba6f-21d442f8c16b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_a8867bdd-4fba-4a79-8761-0e77a719dc11" xlink:href="bmy-20230331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_A1.000Notesdue2025Member_a8867bdd-4fba-4a79-8761-0e77a719dc11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_58b3b52c-e6fe-4008-a058-5c2986707337" xlink:href="bmy-20230331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_A1.750Notesdue2035Member_58b3b52c-e6fe-4008-a058-5c2986707337" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_16fd3dd1-4fd3-461f-8366-e81c207cbde8" xlink:href="bmy-20230331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_16fd3dd1-4fd3-461f-8366-e81c207cbde8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended" id="i5f946bbeeb2f41909964b00155a6f7cf_CONSOLIDATEDSTATEMENTSOFEARNINGS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3d3b91c9-21cb-40fc-948f-bf6fafef6134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_Revenues_3d3b91c9-21cb-40fc-948f-bf6fafef6134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_12da64e1-ded7-403b-a03e-e3c772d99100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_12da64e1-ded7-403b-a03e-e3c772d99100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1d0b615-2e48-48d9-80d9-0ce4680794c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1d0b615-2e48-48d9-80d9-0ce4680794c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1cc8596f-7f29-43b1-9b59-c9e41cbfb3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1cc8596f-7f29-43b1-9b59-c9e41cbfb3d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_7b9e24c3-887e-435e-81fa-3a71b03696ca" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_bmy_AcquiredIPRD_7b9e24c3-887e-435e-81fa-3a71b03696ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_893070e7-0b55-400b-910e-0e40e8657a8d" xlink:href="bmy-20230331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_893070e7-0b55-400b-910e-0e40e8657a8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_37278221-e094-4878-bb8e-76075d95f6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_37278221-e094-4878-bb8e-76075d95f6ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_bac7985d-1c08-4208-8948-e15880a2e645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_CostsAndExpenses_bac7985d-1c08-4208-8948-e15880a2e645" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ff881a48-f9d9-4b22-9cc1-13b6215cf550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ff881a48-f9d9-4b22-9cc1-13b6215cf550" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d7c59c8b-c008-484d-9586-b514ecba38e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d7c59c8b-c008-484d-9586-b514ecba38e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a12d8518-9478-498a-9b0a-5e2f161c3458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ProfitLoss_a12d8518-9478-498a-9b0a-5e2f161c3458" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9090e5b3-28f8-4ae8-a64c-2fe27def3f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9090e5b3-28f8-4ae8-a64c-2fe27def3f97" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f86254eb-2c37-4704-8621-3265a543196c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_NetIncomeLoss_f86254eb-2c37-4704-8621-3265a543196c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a71e97da-959c-4ccf-b35e-c5c7592295cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_EarningsPerShareBasic_a71e97da-959c-4ccf-b35e-c5c7592295cd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0f9f0d56-1dfc-4a78-a023-e28ebb11b2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0f9f0d56-1dfc-4a78-a023-e28ebb11b2a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:to="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_13680aed-b3fd-4cab-b218-7a1caf27dc39_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:to="loc_srt_ProductsAndServicesDomain_13680aed-b3fd-4cab-b218-7a1caf27dc39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:to="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_4734efcf-f169-4800-ae4a-85cfe035be4f" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:to="loc_bmy_NetProductSalesMember_4734efcf-f169-4800-ae4a-85cfe035be4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_f6ef6947-c4f6-4a29-943b-eaffdc565827" xlink:href="bmy-20230331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:to="loc_bmy_AllianceandotherrevenuesMember_f6ef6947-c4f6-4a29-943b-eaffdc565827" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGTables"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended" id="i1284c75643f847bdbc252f717bd2fa83_RESTRUCTURINGTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fdbbff3f-40b5-449d-8845-b30c0571be79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fdbbff3f-40b5-449d-8845-b30c0571be79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b248358e-b982-4970-a7c3-70f4a1a3fa98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b248358e-b982-4970-a7c3-70f4a1a3fa98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:to="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f51b685e-e042-452d-8d91-ec39d80ec3ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_f51b685e-e042-452d-8d91-ec39d80ec3ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_78ea6333-41fb-44e4-b718-c2e3814056cb" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:to="loc_bmy_CelgeneIntegrationMember_78ea6333-41fb-44e4-b718-c2e3814056cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended" id="i55de85c9a51440588cf22935875a8a34_REVENUEDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfb41eaf-9a3a-40dc-8fdc-ae674264d149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:to="loc_us-gaap_Revenues_bfb41eaf-9a3a-40dc-8fdc-ae674264d149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:to="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8364f2ff-91c2-4430-84a1-8ef831999e2b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:to="loc_srt_ProductsAndServicesDomain_8364f2ff-91c2-4430-84a1-8ef831999e2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:to="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_0e8eea78-c282-47af-8eac-44e1f63adb26" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_NetProductSalesMember_0e8eea78-c282-47af-8eac-44e1f63adb26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceRevenuesMember_f2ecfab1-bb62-422b-af3c-62847a566327" xlink:href="bmy-20230331.xsd#bmy_AllianceRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_AllianceRevenuesMember_f2ecfab1-bb62-422b-af3c-62847a566327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRevenuesMember_1615e96e-2ea4-4b08-a654-4fec82acf5d8" xlink:href="bmy-20230331.xsd#bmy_OtherRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_OtherRevenuesMember_1615e96e-2ea4-4b08-a654-4fec82acf5d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended" id="idc6ce23033f0479a841c88f528639853_REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b0cf304-70e0-47b9-9217-3900f8a88f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_us-gaap_Revenues_3b0cf304-70e0-47b9-9217-3900f8a88f40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_df110870-7ca3-4472-bb18-39438c49a8db" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_bmy_GrosstoNetAdjustments_df110870-7ca3-4472-bb18-39438c49a8db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_fd047a77-ae7c-4537-8538-a5a28cb55e5b" xlink:href="bmy-20230331.xsd#bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_fd047a77-ae7c-4537-8538-a5a28cb55e5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_52ae0aba-ba46-4ab3-be9c-0a84d60184f7_default" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_52ae0aba-ba46-4ab3-be9c-0a84d60184f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_122eeb67-87c9-469c-be8e-b186bcac3ef4" xlink:href="bmy-20230331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_122eeb67-87c9-469c-be8e-b186bcac3ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_c99245fd-4d56-41d2-b233-236498a41bf8" xlink:href="bmy-20230331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_c99245fd-4d56-41d2-b233-236498a41bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_de1488ac-ba6f-4b92-a1f7-b16490549f1f" xlink:href="bmy-20230331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_de1488ac-ba6f-4b92-a1f7-b16490549f1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:to="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:to="loc_srt_ProductsAndServicesDomain_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:to="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_55c2e65e-be0f-4d4c-80e4-1a12df20a95f" xlink:href="bmy-20230331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:to="loc_bmy_SalesRevenueGrossMember_55c2e65e-be0f-4d4c-80e4-1a12df20a95f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_12847a29-9161-42ef-b910-29d8b5de9523" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:to="loc_bmy_NetProductSalesMember_12847a29-9161-42ef-b910-29d8b5de9523" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended" id="i07b02eb835474f01b3082d231951991d_REVENUEDisaggregationofRevenuebyProductandRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4f4a1a9a-0b26-4ce2-a5e3-332085ffb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:to="loc_us-gaap_Revenues_4f4a1a9a-0b26-4ce2-a5e3-332085ffb5a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_fb22d85f-78f8-4495-853f-f8c767bc507c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_fb22d85f-78f8-4495-853f-f8c767bc507c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:to="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6da04bd1-2e01-42a6-b893-bc9d4edf8523_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:to="loc_srt_ProductsAndServicesDomain_6da04bd1-2e01-42a6-b893-bc9d4edf8523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:to="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:href="bmy-20230331.xsd#bmy_InLineProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_64bc440b-9b8b-437b-b40a-31d04521cfb3" xlink:href="bmy-20230331.xsd#bmy_EliquisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_EliquisMember_64bc440b-9b8b-437b-b40a-31d04521cfb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_41ab0fb4-a312-4b2e-8ee2-930f37e09efc" xlink:href="bmy-20230331.xsd#bmy_OpdivoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_OpdivoMember_41ab0fb4-a312-4b2e-8ee2-930f37e09efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_dee43a4e-f68f-4904-be08-61f1d4a2f314" xlink:href="bmy-20230331.xsd#bmy_PomalystImnovidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_PomalystImnovidMember_dee43a4e-f68f-4904-be08-61f1d4a2f314" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_92bbbdca-4441-4d14-99c9-aa81f6cfc058" xlink:href="bmy-20230331.xsd#bmy_OrenciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_OrenciaMember_92bbbdca-4441-4d14-99c9-aa81f6cfc058" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_a8306b89-40f0-40b3-bdaa-c63de11a0bea" xlink:href="bmy-20230331.xsd#bmy_SprycelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_SprycelMember_a8306b89-40f0-40b3-bdaa-c63de11a0bea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_a9f4d04c-3a93-4d37-a95e-1a98c1435e90" xlink:href="bmy-20230331.xsd#bmy_YervoyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_YervoyMember_a9f4d04c-3a93-4d37-a95e-1a98c1435e90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_e64fe4ac-7cba-42ca-adea-3d9a2f9030fd" xlink:href="bmy-20230331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_MatureAndOtherBrandsMember_e64fe4ac-7cba-42ca-adea-3d9a2f9030fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:href="bmy-20230331.xsd#bmy_NewProductPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_ec02a811-3c2d-44ae-8ec9-1b606f2d9c2b" xlink:href="bmy-20230331.xsd#bmy_ReblozylMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_ReblozylMember_ec02a811-3c2d-44ae-8ec9-1b606f2d9c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_43144db5-6249-4900-ae73-f9869c0cdbac" xlink:href="bmy-20230331.xsd#bmy_AbecmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_AbecmaMember_43144db5-6249-4900-ae73-f9869c0cdbac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_610b3e63-aa17-4c65-af43-812cc34fd3a1" xlink:href="bmy-20230331.xsd#bmy_OpdualagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_OpdualagMember_610b3e63-aa17-4c65-af43-812cc34fd3a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_f87e9389-5e36-4211-b284-479ec0bc6eb3" xlink:href="bmy-20230331.xsd#bmy_ZeposiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_ZeposiaMember_f87e9389-5e36-4211-b284-479ec0bc6eb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_95a41334-625f-422c-9c40-82e01c12f5f8" xlink:href="bmy-20230331.xsd#bmy_BreyanziMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_BreyanziMember_95a41334-625f-422c-9c40-82e01c12f5f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_0ee690ea-185b-4f3a-9dc7-6784f83effcb" xlink:href="bmy-20230331.xsd#bmy_OnuregMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_OnuregMember_0ee690ea-185b-4f3a-9dc7-6784f83effcb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_8c4e806c-4f2e-4a5a-9c84-41ea3da05559" xlink:href="bmy-20230331.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_InrebicMember_8c4e806c-4f2e-4a5a-9c84-41ea3da05559" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember_cf1e0efa-1fdf-4956-a316-c30f72a04a0f" xlink:href="bmy-20230331.xsd#bmy_CamzyosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_CamzyosMember_cf1e0efa-1fdf-4956-a316-c30f72a04a0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember_13cd950b-0409-4a9b-b0c1-38f9b9378696" xlink:href="bmy-20230331.xsd#bmy_SotyktuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_SotyktuMember_13cd950b-0409-4a9b-b0c1-38f9b9378696" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember_70f83e64-26ec-442d-854d-aa398ab6cc32" xlink:href="bmy-20230331.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_InLineProductsAndNewProductPortfolioMember_70f83e64-26ec-442d-854d-aa398ab6cc32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:href="bmy-20230331.xsd#bmy_LOEProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_c8e3e285-ea49-49ca-a713-9db24eb8fee9" xlink:href="bmy-20230331.xsd#bmy_RevlimidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:to="loc_bmy_RevlimidMember_c8e3e285-ea49-49ca-a713-9db24eb8fee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_0dd240bf-a58c-4b8e-8c25-ec3b0459f0d4" xlink:href="bmy-20230331.xsd#bmy_AbraxaneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:to="loc_bmy_AbraxaneMember_0dd240bf-a58c-4b8e-8c25-ec3b0459f0d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:to="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4d2195da-396f-452a-98f6-5c584763ffaf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:to="loc_srt_SegmentGeographicalDomain_4d2195da-396f-452a-98f6-5c584763ffaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:to="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_453de7b3-bd3d-4535-9fa6-1fa04d54fa83" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_country_US_453de7b3-bd3d-4535-9fa6-1fa04d54fa83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember_7faf1a5b-067d-4fb8-8d1c-518d2e7b19e9" xlink:href="bmy-20230331.xsd#bmy_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_bmy_InternationalMember_7faf1a5b-067d-4fb8-8d1c-518d2e7b19e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_eff5374d-76c1-4960-8217-7367f1347862" xlink:href="bmy-20230331.xsd#bmy_OtherRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_bmy_OtherRegionMember_eff5374d-76c1-4960-8217-7367f1347862" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#ALLIANCESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended" id="i099e40de7e8945e69ef0fc9e6674addb_ALLIANCESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b8f51376-fe13-4f52-b453-20535f0e12ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_Revenues_b8f51376-fe13-4f52-b453-20535f0e12ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6aa82c19-06cd-4ab2-94ef-14cd3612a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6aa82c19-06cd-4ab2-94ef-14cd3612a367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2cf9d145-4dc6-4c9f-953b-c00a97085d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2cf9d145-4dc6-4c9f-953b-c00a97085d74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_c8bc7a0f-9f42-4105-87c0-be3962a06977" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_c8bc7a0f-9f42-4105-87c0-be3962a06977" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ff73b705-92b0-4253-bf4c-e8ea896cd4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ff73b705-92b0-4253-bf4c-e8ea896cd4b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9f242e38-aa71-49eb-9575-c06c42a45780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9f242e38-aa71-49eb-9575-c06c42a45780" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d2c83d6f-10c4-4079-b3f6-d9393972d834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_AccountsPayableCurrent_d2c83d6f-10c4-4079-b3f6-d9393972d834" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_ea56d1e9-4090-4bba-b27a-83a524235084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_DeferredIncome_ea56d1e9-4090-4bba-b27a-83a524235084" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dfda457f-472a-419b-a12a-39e68f258cce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dfda457f-472a-419b-a12a-39e68f258cce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_a5f944f7-295b-45dd-a4cf-c1951591f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:to="loc_us-gaap_CollaborativeArrangementMember_a5f944f7-295b-45dd-a4cf-c1951591f2ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:to="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f4f2d0fd-9771-460c-b280-9e7373c4ed57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:to="loc_srt_ProductsAndServicesDomain_f4f2d0fd-9771-460c-b280-9e7373c4ed57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:to="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_2643235e-8ede-4b24-a110-a74b5e4f038e" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:to="loc_bmy_NetProductSalesMember_2643235e-8ede-4b24-a110-a74b5e4f038e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceRevenuesMember_8eb648c4-0804-4946-a21f-113e99f6f1e8" xlink:href="bmy-20230331.xsd#bmy_AllianceRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:to="loc_bmy_AllianceRevenuesMember_8eb648c4-0804-4946-a21f-113e99f6f1e8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended" id="i1aa3125259fa4f3183bb259fa0dfab35_DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_77dcbc04-cee4-4ae2-96be-26453611c91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_77dcbc04-cee4-4ae2-96be-26453611c91a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9fb2bb8a-866b-4a54-9992-80c302881585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9fb2bb8a-866b-4a54-9992-80c302881585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_a9374258-660e-4565-b291-709e7fa82555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_a9374258-660e-4565-b291-709e7fa82555" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83f48589-6e70-40c5-ba7e-43dc97fff98a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83f48589-6e70-40c5-ba7e-43dc97fff98a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesBusinessMember_3e9d608b-d2bb-47fb-aea3-7b9a46c06bb9" xlink:href="bmy-20230331.xsd#bmy_DiabetesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:to="loc_bmy_DiabetesBusinessMember_3e9d608b-d2bb-47fb-aea3-7b9a46c06bb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_25100606-1284-4c29-acda-1f00604d50e4" xlink:href="bmy-20230331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:to="loc_bmy_MatureBrandsAndOtherMember_25100606-1284-4c29-acda-1f00604d50e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended" id="i70f698d9632b4030a415ec88e2c5d7f9_DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_9a1b3aef-c3ad-4759-8f80-0102ad4c3394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_9a1b3aef-c3ad-4759-8f80-0102ad4c3394" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_df05f0b0-acfd-4371-8772-d625eaa4d65c" xlink:href="bmy-20230331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_df05f0b0-acfd-4371-8772-d625eaa4d65c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_4509db4d-7760-4650-9755-0f0695092e0a" xlink:href="bmy-20230331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_AmortizationOfDeferredIncome_4509db4d-7760-4650-9755-0f0695092e0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_10d4b97a-f7e5-49fe-adc5-1a8a5dcf215b" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_10d4b97a-f7e5-49fe-adc5-1a8a5dcf215b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_c3f6295f-c5b3-436e-8b2b-5c4fd368747d_default" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_c3f6295f-c5b3-436e-8b2b-5c4fd368747d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_31cb3763-31a4-4941-a2cd-6994e9675a13" xlink:href="bmy-20230331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_31cb3763-31a4-4941-a2cd-6994e9675a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_0970998f-d5ab-49d8-b63a-505a0b7165e6" xlink:href="bmy-20230331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_TecentriqRoyaltiesMember_0970998f-d5ab-49d8-b63a-505a0b7165e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_b9dd8086-5e7b-4e92-b33e-369f45d8d05b" xlink:href="bmy-20230331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_OtherRoyaltiesMember_b9dd8086-5e7b-4e92-b33e-369f45d8d05b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="iea01973d773b4b14a7e6a049ffd26036_DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7f580f49-ebe0-4463-9b1a-2894e5560782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7f580f49-ebe0-4463-9b1a-2894e5560782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_bd4ade12-189a-4068-a50c-d0a73f02cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_bd4ade12-189a-4068-a50c-d0a73f02cee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_e6f9af34-2467-4652-81f3-3f8eea109323" xlink:href="bmy-20230331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_e6f9af34-2467-4652-81f3-3f8eea109323" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_4a4b6946-047c-4db9-8b93-efd2d4e1b41b" xlink:href="bmy-20230331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_4a4b6946-047c-4db9-8b93-efd2d4e1b41b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_30256666-df9e-43be-b4d6-89b020cc6667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_30256666-df9e-43be-b4d6-89b020cc6667" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds_3df3b565-9e66-40d1-9bbb-8420efbb3e6d" xlink:href="bmy-20230331.xsd#bmy_SettlementContingentDevelopmentChangeInControlProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds_3df3b565-9e66-40d1-9bbb-8420efbb3e6d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_0374ef71-5de8-4d60-96a2-cfb1a74d50d0" xlink:href="bmy-20230331.xsd#bmy_AssetAcquisitionPercentageOfOwnershipAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_0374ef71-5de8-4d60-96a2-cfb1a74d50d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_f839b86a-3624-4ebb-a4f5-b3a41f4ef628" xlink:href="bmy-20230331.xsd#bmy_CollaborativeArrangementContingentPaymentsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_f839b86a-3624-4ebb-a4f5-b3a41f4ef628" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_753cb7e9-fb4e-46f7-a334-758c0c06d9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_OtherNonoperatingIncome_753cb7e9-fb4e-46f7-a334-758c0c06d9b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0621f21d-319a-44b5-a620-52a42f49252f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0621f21d-319a-44b5-a620-52a42f49252f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_5d38c4ca-09a9-428b-80d1-25a53a9f5065" xlink:href="bmy-20230331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:to="loc_bmy_MatureBrandsAndOtherMember_5d38c4ca-09a9-428b-80d1-25a53a9f5065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_babe1697-09d1-4a43-a408-0f5c73c00025_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_babe1697-09d1-4a43-a408-0f5c73c00025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_194b686d-b3c5-4962-a4ab-b5f2b7cbb925" xlink:href="bmy-20230331.xsd#bmy_CheplapharmMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_CheplapharmMember_194b686d-b3c5-4962-a4ab-b5f2b7cbb925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_ec2c23db-89e5-4697-ba59-70a67dca9cc5" xlink:href="bmy-20230331.xsd#bmy_ImmaticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_ImmaticsMember_ec2c23db-89e5-4697-ba59-70a67dca9cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_5db7e8d7-815c-4a92-8cdd-34ea022c791f" xlink:href="bmy-20230331.xsd#bmy_DragonflyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_DragonflyMember_5db7e8d7-815c-4a92-8cdd-34ea022c791f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapeuticsMember_c8b7980c-4984-4e02-9ced-aef638c7aa9f" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_NimbusTherapeuticsMember_c8b7980c-4984-4e02-9ced-aef638c7aa9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7_default" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapueticsTYK2InhibitorMember_2afda0aa-dca8-408e-85c8-c2c1e1c51f45" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapueticsTYK2InhibitorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:to="loc_bmy_NimbusTherapueticsTYK2InhibitorMember_2afda0aa-dca8-408e-85c8-c2c1e1c51f45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended" id="i58ca29e1a7474b118a78bf77bc168dd8_RESTRUCTURINGAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_829961c9-b5d9-4348-8acc-d289d2b4052b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_829961c9-b5d9-4348-8acc-d289d2b4052b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_2f925a39-d6de-4b64-99dc-bc92daf3448c" xlink:href="bmy-20230331.xsd#bmy_Cashoutlays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_bmy_Cashoutlays_2f925a39-d6de-4b64-99dc-bc92daf3448c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48807b42-7cf0-4dca-a391-cd017a9e03e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48807b42-7cf0-4dca-a391-cd017a9e03e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_a7453f1a-09b9-47b5-8477-d5a36a9ff062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_SeveranceCosts1_a7453f1a-09b9-47b5-8477-d5a36a9ff062" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:to="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:to="loc_us-gaap_RestructuringPlanDomain_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:to="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_364c4a4f-0165-4a18-9ec7-74fb21b19cea" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:to="loc_bmy_CelgeneIntegrationMember_364c4a4f-0165-4a18-9ec7-74fb21b19cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_9b166195-abbd-4ac9-b5bf-673ffd445367" xlink:href="bmy-20230331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_9b166195-abbd-4ac9-b5bf-673ffd445367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_baf57851-a6f6-4fd7-b547-25c698033890_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_baf57851-a6f6-4fd7-b547-25c698033890_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_22ecd75d-684a-46cd-98db-87a5b7193d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:to="loc_us-gaap_CostOfSalesMember_22ecd75d-684a-46cd-98db-87a5b7193d61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_30b3d9fc-3ee0-42ae-ba01-7ec809226915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_30b3d9fc-3ee0-42ae-ba01-7ec809226915" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended" id="ic22081a24bd84f96923137ddb2081721_RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_81ca6dfd-d909-41b5-bcd0-ad85655622ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_81ca6dfd-d909-41b5-bcd0-ad85655622ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f25b0816-2f9b-4c91-8307-70f064a52803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_SeveranceCosts1_f25b0816-2f9b-4c91-8307-70f064a52803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5df1461a-462a-488a-9a54-2afede370632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_OtherRestructuringCosts_5df1461a-462a-488a-9a54-2afede370632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_75fde8fb-5260-44a2-9e41-e571b97b23b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringCharges_75fde8fb-5260-44a2-9e41-e571b97b23b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_940c18c1-7e0e-499e-923e-45cb68f26c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_940c18c1-7e0e-499e-923e-45cb68f26c86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_f10d8209-8a47-448e-8c37-9e7a1e0fb029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_f10d8209-8a47-448e-8c37-9e7a1e0fb029" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:to="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_879f8ca4-c7b2-4df7-8099-541e1ed5df58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:to="loc_us-gaap_RestructuringPlanDomain_879f8ca4-c7b2-4df7-8099-541e1ed5df58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:to="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_e9692d83-2b84-4fb3-b729-d487412167a1" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:to="loc_bmy_CelgeneIntegrationMember_e9692d83-2b84-4fb3-b729-d487412167a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_b0e275c6-1585-4a0a-921a-f0ea5f1133d9" xlink:href="bmy-20230331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_b0e275c6-1585-4a0a-921a-f0ea5f1133d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_28c4544a-45b1-47a0-8afb-5cfbddcea945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_CostOfSalesMember_28c4544a-45b1-47a0-8afb-5cfbddcea945" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1ea43106-9db3-4ad1-82b5-14919a2a5415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1ea43106-9db3-4ad1-82b5-14919a2a5415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_bb5fc5df-77bd-47a9-8071-aace0a8b2547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_bb5fc5df-77bd-47a9-8071-aace0a8b2547" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="i09da10cb9fa24e079ca4d0c82de3c52e_RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7ab34f26-0d0d-40ea-810d-0fd245956657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_RestructuringReserve_7ab34f26-0d0d-40ea-810d-0fd245956657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_4fc62b77-aec2-4a56-9890-9b0c89324d03" xlink:href="bmy-20230331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_4fc62b77-aec2-4a56-9890-9b0c89324d03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_c35a0aba-9c7e-43ea-a9e9-36a88526e717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_c35a0aba-9c7e-43ea-a9e9-36a88526e717" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_2a989122-24c7-453e-8cf0-c10a01669a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_PaymentsForRestructuring_2a989122-24c7-453e-8cf0-c10a01669a05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f70cafd6-4c27-41d5-a3a1-3b833341a149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_cd53f768-71c3-41c1-971c-963f14bc493b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_cd53f768-71c3-41c1-971c-963f14bc493b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:to="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:to="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a782a90f-bb41-4619-97bd-2b551a44627e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:to="loc_us-gaap_RestructuringPlanDomain_a782a90f-bb41-4619-97bd-2b551a44627e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:to="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_4c7f99e6-7d1e-4fe4-a4e1-dbc455fb0627" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:to="loc_bmy_CelgeneIntegrationMember_4c7f99e6-7d1e-4fe4-a4e1-dbc455fb0627" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended" id="iab99d1677ed34c86bd91c3ef210106af_INCOMETAXESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_993e250c-be1b-49f6-adf6-44d1ec0d974a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_993e250c-be1b-49f6-adf6-44d1ec0d974a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_82296d13-9969-4194-beaa-6c69279117ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_82296d13-9969-4194-beaa-6c69279117ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_b0f41dba-dac4-4707-b7e0-18bc6efa057f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_b0f41dba-dac4-4707-b7e0-18bc6efa057f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_02193942-17dc-43b2-9871-40820ea0e22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_02193942-17dc-43b2-9871-40820ea0e22c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:to="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e4a199a2-1f7c-4dd5-9b32-5e262753223b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:to="loc_srt_RangeMember_e4a199a2-1f7c-4dd5-9b32-5e262753223b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:to="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c80b5448-f43c-4fc6-827d-d38f0be53f22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:to="loc_srt_MinimumMember_c80b5448-f43c-4fc6-827d-d38f0be53f22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63d08c9c-b42e-4313-8e8d-3462d392dac8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:to="loc_srt_MaximumMember_63d08c9c-b42e-4313-8e8d-3462d392dac8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="i44dc124990ae496f880a44c9fe6dec70_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f3fda344-2c2e-49a5-9e38-a1429f32ce4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f3fda344-2c2e-49a5-9e38-a1429f32ce4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20d5f92f-368d-4eb6-94e3-6b0029ff2d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20d5f92f-368d-4eb6-94e3-6b0029ff2d21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4a8977ea-2437-435d-b36c-dd11c11415f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_DerivativeAssets_4a8977ea-2437-435d-b36c-dd11c11415f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1f9e4726-63aa-4eae-9acc-3d1e81820375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1f9e4726-63aa-4eae-9acc-3d1e81820375" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a619722b-79de-4340-8572-6c78ec7b09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_DerivativeLiabilities_a619722b-79de-4340-8572-6c78ec7b09f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_785468d0-e089-4b8b-8734-8cc32f243bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_785468d0-e089-4b8b-8734-8cc32f243bd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_398edec3-fc02-40f7-a099-24081889eecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_398edec3-fc02-40f7-a099-24081889eecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_69d9b735-ceae-4252-ac68-1a792a13529c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_69d9b735-ceae-4252-ac68-1a792a13529c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_49f86e7b-6fc1-449e-a86d-6ff56fcc4aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_49f86e7b-6fc1-449e-a86d-6ff56fcc4aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5af1d4c6-0286-446d-bf61-7eb16e105854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5af1d4c6-0286-446d-bf61-7eb16e105854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_706de3a3-154c-4918-8fe1-7cfbfde4a342_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_706de3a3-154c-4918-8fe1-7cfbfde4a342_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1c4fddeb-5e0e-4348-b544-f2704e879d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1c4fddeb-5e0e-4348-b544-f2704e879d50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_226a93c9-1647-4b6a-884c-34e093edda72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:to="loc_us-gaap_CommercialPaperMember_226a93c9-1647-4b6a-884c-34e093edda72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d5875fa0-4b68-45df-953b-16465251f24c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d5875fa0-4b68-45df-953b-16465251f24c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_dd7c0d00-08d3-4ab5-9178-e541a354af44" xlink:href="bmy-20230331.xsd#bmy_ContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:to="loc_bmy_ContingentValueRightsMember_dd7c0d00-08d3-4ab5-9178-e541a354af44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5dc29275-c32a-49c8-90a1-76dba212b906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5dc29275-c32a-49c8-90a1-76dba212b906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_57f70c04-f67e-484f-bc74-74ff7c02f008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:to="loc_us-gaap_OtherAssetsMember_57f70c04-f67e-484f-bc74-74ff7c02f008" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended" id="ibddfa6c1dce4424884b393eb4f037b97_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_78ea01aa-88ec-4123-b0ea-d0f6710eaa50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_78ea01aa-88ec-4123-b0ea-d0f6710eaa50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e156eed3-71b9-4deb-a461-0355cb002f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e156eed3-71b9-4deb-a461-0355cb002f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8dc0b2f-866c-4e39-b406-ed15556093e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8dc0b2f-866c-4e39-b406-ed15556093e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8273c912-0578-42cc-8d48-bd3ac35eec42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8273c912-0578-42cc-8d48-bd3ac35eec42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8285798c-3ac8-473c-9c24-b743c5632c0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8285798c-3ac8-473c-9c24-b743c5632c0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_8068295c-6acd-4b44-b7af-7cc53a11bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:to="loc_us-gaap_CertificatesOfDepositMember_8068295c-6acd-4b44-b7af-7cc53a11bf8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e58d75bd-23ac-4e39-b761-8daad8d549f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:to="loc_us-gaap_CommercialPaperMember_e58d75bd-23ac-4e39-b761-8daad8d549f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="i20a95d1c9d5c417dbe0c1e8458b42057_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_eaaa3121-ee4c-4c73-b5f0-2ecaf378315c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_eaaa3121-ee4c-4c73-b5f0-2ecaf378315c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_79375057-2f2b-4121-8dd4-dbffdb66a88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_79375057-2f2b-4121-8dd4-dbffdb66a88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fb718f36-2c26-47df-a946-57e999980176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fb718f36-2c26-47df-a946-57e999980176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85b9568b-818b-4f4f-bc66-437b388242a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85b9568b-818b-4f4f-bc66-437b388242a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_243f6b37-471d-409d-9bc7-9057d294fe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_243f6b37-471d-409d-9bc7-9057d294fe43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9ebd84ac-3051-417b-b97d-19a25e1a24e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9ebd84ac-3051-417b-b97d-19a25e1a24e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_f4ed82a0-db93-4f71-86da-f311dc677ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_f4ed82a0-db93-4f71-86da-f311dc677ab3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_51aa40fa-2f2f-4791-b850-b78cf00594dc_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:to="loc_currency_AllCurrenciesDomain_51aa40fa-2f2f-4791-b850-b78cf00594dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:to="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_23ac8333-d902-4c81-a29d-63eb9bb246c8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:to="loc_currency_EUR_23ac8333-d902-4c81-a29d-63eb9bb246c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1efb3523-64a0-4fe0-92d3-ce63ffd820a6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:to="loc_currency_JPY_1efb3523-64a0-4fe0-92d3-ce63ffd820a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_aacfa31c-3db3-4a86-b319-337d92cdbd0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:to="loc_us-gaap_HedgingDesignationDomain_aacfa31c-3db3-4a86-b319-337d92cdbd0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1178f2f6-fbab-4ae9-bd42-c04374c8fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1178f2f6-fbab-4ae9-bd42-c04374c8fe7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_14f17eac-a533-402d-808a-d6061ab85325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:to="loc_us-gaap_VariableRateDomain_14f17eac-a533-402d-808a-d6061ab85325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:to="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_279ce8b9-85a1-4f83-aca8-f9a7fbb539ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_279ce8b9-85a1-4f83-aca8-f9a7fbb539ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ca08996-5c95-4d9e-b7df-ec4b4465990e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ca08996-5c95-4d9e-b7df-ec4b4465990e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ace4a0b6-243f-4fc7-bff9-87f3c72fabb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ace4a0b6-243f-4fc7-bff9-87f3c72fabb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_cee95598-74fe-4969-a8fa-4e37c82ed12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_cee95598-74fe-4969-a8fa-4e37c82ed12b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b02ac107-b7cb-403e-9ec1-11efd07d9e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b02ac107-b7cb-403e-9ec1-11efd07d9e6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7bf59d8d-ce0c-4847-91ea-67da6ed936af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7bf59d8d-ce0c-4847-91ea-67da6ed936af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3aef604a-a8c2-49a0-9d75-32ee6e4160ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3aef604a-a8c2-49a0-9d75-32ee6e4160ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1eb593ef-9d65-4800-aaab-a4f13837b224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:to="loc_us-gaap_CashFlowHedgingMember_1eb593ef-9d65-4800-aaab-a4f13837b224" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended" id="ic82c553df9e544c29921adb5273d4c7b_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_03e0c517-ac66-4417-8401-4aa4e59dc4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeNotionalAmount_03e0c517-ac66-4417-8401-4aa4e59dc4be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_968f8dee-b0b0-4774-b667-7ca8c99597f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeAssets_968f8dee-b0b0-4774-b667-7ca8c99597f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_dc7d9db5-042b-4cba-88a2-b2a352a3e6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeLiabilities_dc7d9db5-042b-4cba-88a2-b2a352a3e6d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_df9d50b9-342f-427e-b575-085f7c48b0c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_df9d50b9-342f-427e-b575-085f7c48b0c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1e730897-130d-430c-85dd-28cd5f9e3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1e730897-130d-430c-85dd-28cd5f9e3dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b2d2e970-eb9b-41d4-ab03-ff732cf5863c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:to="loc_us-gaap_NondesignatedMember_b2d2e970-eb9b-41d4-ab03-ff732cf5863c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_053b29ef-ad05-45fb-9368-f0aaa73b80f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_053b29ef-ad05-45fb-9368-f0aaa73b80f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_349fc9d4-c10f-44f0-9fb4-c861849ebe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_InterestRateSwapMember_349fc9d4-c10f-44f0-9fb4-c861849ebe06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_36933805-8dd0-459b-8a6f-ae23f05173d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_36933805-8dd0-459b-8a6f-ae23f05173d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f8b924dc-d474-4137-af9b-869405490971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f8b924dc-d474-4137-af9b-869405490971" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_e2ea71b9-96d4-40e3-aac2-19925ffadbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_OtherContractMember_e2ea71b9-96d4-40e3-aac2-19925ffadbe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ad99027-870f-49e3-92ce-da3fd951e885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ad99027-870f-49e3-92ce-da3fd951e885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_42551949-36b5-41a8-a066-3a8cfd4bcf00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:to="loc_us-gaap_AssetsMember_42551949-36b5-41a8-a066-3a8cfd4bcf00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_d13b3ed1-1710-4e64-aa41-6e1b3d799ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:to="loc_us-gaap_LiabilityMember_d13b3ed1-1710-4e64-aa41-6e1b3d799ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fbec405e-5154-4cc5-83c0-692b5451e1ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fbec405e-5154-4cc5-83c0-692b5451e1ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2229d73c-06a3-44e7-bc14-98620bde9140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2229d73c-06a3-44e7-bc14-98620bde9140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_cf32bf6e-4193-40b1-8bcc-5429afaff162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:to="loc_us-gaap_CashFlowHedgingMember_cf32bf6e-4193-40b1-8bcc-5429afaff162" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="ic44a1a87d4e540bd9b6ed5aac5e1f5de_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d643d030-5a30-4c6e-a24e-a41190c843a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d643d030-5a30-4c6e-a24e-a41190c843a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_28bbe9da-7882-411f-b19b-8c956cfca84f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_28bbe9da-7882-411f-b19b-8c956cfca84f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c852c728-e2d1-41e2-aec8-14a18a277feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_InterestRateSwapMember_c852c728-e2d1-41e2-aec8-14a18a277feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_dddfb8e5-2f47-44ab-abe8-65d6ea451790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_dddfb8e5-2f47-44ab-abe8-65d6ea451790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6c6b2861-f58c-4a08-a622-49d80149c90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6c6b2861-f58c-4a08-a622-49d80149c90c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d115ba4c-a955-4e56-b92c-18ca52266031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:to="loc_us-gaap_CostOfSalesMember_d115ba4c-a955-4e56-b92c-18ca52266031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_617f10e4-e28e-4fd9-87f1-8f1cbc62906b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:to="loc_us-gaap_OtherIncomeMember_617f10e4-e28e-4fd9-87f1-8f1cbc62906b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended" id="i0cc70807f19b42318b4a40bb5584446b_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e1ab8d9f-3e28-429c-90ca-17ecbf85e7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e1ab8d9f-3e28-429c-90ca-17ecbf85e7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_84dfc0bd-4784-4c66-9595-8c9dd1f364db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_84dfc0bd-4784-4c66-9595-8c9dd1f364db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d4f87f0f-8353-4bf3-87f9-a8ada0e236f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d4f87f0f-8353-4bf3-87f9-a8ada0e236f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_9f2bff13-326a-494c-bc86-e4f73b19c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_9f2bff13-326a-494c-bc86-e4f73b19c2fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41bc4ccd-8d71-48c5-9780-6d4c0ba79804_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41bc4ccd-8d71-48c5-9780-6d4c0ba79804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8759dd3e-4398-4f0a-9944-34ea0bf329a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8759dd3e-4398-4f0a-9944-34ea0bf329a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c3fb597a-215d-4124-9dfb-19cd5842ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_InterestRateSwapMember_c3fb597a-215d-4124-9dfb-19cd5842ef56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_0f240fe3-99f6-498a-b8cb-91c7bb336b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_0f240fe3-99f6-498a-b8cb-91c7bb336b62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bfef74b6-0273-479f-abff-f493d846053d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bfef74b6-0273-479f-abff-f493d846053d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d7db082a-3d80-4d7d-ac5e-4dad3a554089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_CostOfSalesMember_d7db082a-3d80-4d7d-ac5e-4dad3a554089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_59459756-80bc-4a47-b895-d8aea25a377b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_59459756-80bc-4a47-b895-d8aea25a377b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_75088150-a832-4989-ae2e-b23855f26151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_OtherIncomeMember_75088150-a832-4989-ae2e-b23855f26151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:to="loc_us-gaap_HedgingDesignationDomain_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:to="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cd85f599-85a7-4bf6-87e5-68032a7b61d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cd85f599-85a7-4bf6-87e5-68032a7b61d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:to="loc_currency_AllCurrenciesDomain_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:to="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a78615f4-11b1-44e6-af2c-a8c42cf77453" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:to="loc_currency_EUR_a78615f4-11b1-44e6-af2c-a8c42cf77453" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended" id="if3a55b9f6dc74d04b9bd7fe894ebee5e_FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6204f9b6-b31e-42a1-b435-7f5f88568c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6204f9b6-b31e-42a1-b435-7f5f88568c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_4c9c6679-2237-46a6-8256-dd65668d1106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DerivativeLiabilities_4c9c6679-2237-46a6-8256-dd65668d1106" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6132a264-7cbe-4433-8cfd-8afbb8edfc73" xlink:href="bmy-20230331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6132a264-7cbe-4433-8cfd-8afbb8edfc73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_099fd2d8-fadf-4f29-bf86-e0daa567ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_099fd2d8-fadf-4f29-bf86-e0daa567ed3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_3bdea584-8bdd-4055-8494-8a31db84514b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_3bdea584-8bdd-4055-8494-8a31db84514b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_64bf204f-205f-4745-992e-fbb2e685c066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebt_64bf204f-205f-4745-992e-fbb2e685c066" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_03680856-798b-4665-a1c4-4fd335051799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebtCurrent_03680856-798b-4665-a1c4-4fd335051799" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3e92d392-7662-49b3-ba53-16f63f759d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3e92d392-7662-49b3-ba53-16f63f759d81" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92a2b600-87e2-423a-a7e0-cbbc8737793f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92a2b600-87e2-423a-a7e0-cbbc8737793f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_eb5321f7-6ca4-4f7b-a2ca-bc8d26d4469c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:to="loc_us-gaap_InterestRateSwapMember_eb5321f7-6ca4-4f7b-a2ca-bc8d26d4469c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="i384bcc5184b44ab887f5ede3d218693e_FINANCINGARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e2789610-3346-4057-a4e1-576ce8a60a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e2789610-3346-4057-a4e1-576ce8a60a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal_55e75538-3ff9-44e5-9867-9af104b0e302" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal_55e75538-3ff9-44e5-9867-9af104b0e302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c772507c-dead-4bf5-ab9d-3067563e20ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c772507c-dead-4bf5-ab9d-3067563e20ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_147ecbb8-b990-4c68-9f58-fc1cc57eb594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_147ecbb8-b990-4c68-9f58-fc1cc57eb594" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc0c7d87-6da9-4632-863f-0ab53e7634fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc0c7d87-6da9-4632-863f-0ab53e7634fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_965ea828-b75a-4aed-ad25-f235bb519be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_965ea828-b75a-4aed-ad25-f235bb519be2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e1b2c615-d33d-4262-b016-be946866327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e1b2c615-d33d-4262-b016-be946866327e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_edf16cf6-626e-4ba8-9aea-77f80e271a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_edf16cf6-626e-4ba8-9aea-77f80e271a8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0f2e528f-4bdd-4213-a555-ef4584b3cb63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_InterestPaidNet_0f2e528f-4bdd-4213-a555-ef4584b3cb63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_f0e1d8cc-9ef2-47b6-8b4b-41d00e6b5e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LongTermDebtTerm_f0e1d8cc-9ef2-47b6-8b4b-41d00e6b5e3e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f272f0dd-3155-4d10-a6b3-9a12319a93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f272f0dd-3155-4d10-a6b3-9a12319a93d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_d924c6b3-36d2-4a62-926e-053a3f2f2c9d" xlink:href="bmy-20230331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_d924c6b3-36d2-4a62-926e-053a3f2f2c9d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_dcfe5130-533d-47d3-86f4-fc6978cd0e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LineOfCredit_dcfe5130-533d-47d3-86f4-fc6978cd0e0c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5e0f00af-0162-42f5-b4cc-0c6fa0080baf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:to="loc_us-gaap_CreditFacilityDomain_5e0f00af-0162-42f5-b4cc-0c6fa0080baf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:to="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f4ae6523-80a1-485f-9668-4df7e082ada3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f4ae6523-80a1-485f-9668-4df7e082ada3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_0ebb48b2-bbb6-43de-b361-3757e7e428ae" xlink:href="bmy-20230331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_0ebb48b2-bbb6-43de-b361-3757e7e428ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b62b9720-d090-4573-95a4-b5cb41add796_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b62b9720-d090-4573-95a4-b5cb41add796_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6b2b5dcd-1193-4b91-9c64-57343b2594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:to="loc_us-gaap_LineOfCreditMember_6b2b5dcd-1193-4b91-9c64-57343b2594f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ea0944d0-19e7-4f1d-a64b-82adbe213c36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ea0944d0-19e7-4f1d-a64b-82adbe213c36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2750NotesMember_7a643b76-db60-44fd-9f8f-a9a3e7d1ab5f" xlink:href="bmy-20230331.xsd#bmy_A2750NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:to="loc_bmy_A2750NotesMember_7a643b76-db60-44fd-9f8f-a9a3e7d1ab5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250NotesMember_0bb1ffad-1871-49c0-a654-36774a3ae3ef" xlink:href="bmy-20230331.xsd#bmy_A3250NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:to="loc_bmy_A3250NotesMember_0bb1ffad-1871-49c0-a654-36774a3ae3ef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended" id="i1931bb78e1d84bb4891df7cab2322ff6_RECEIVABLESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_035bf2ba-0970-4f39-85da-acf0a9894de8" xlink:href="bmy-20230331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_035bf2ba-0970-4f39-85da-acf0a9894de8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_d39a6d5f-6c4a-4d0e-a858-67ba1b1292ac" xlink:href="bmy-20230331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_d39a6d5f-6c4a-4d0e-a858-67ba1b1292ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_e235bbcd-6c73-4d65-b6e1-b84f58723272" xlink:href="bmy-20230331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_e235bbcd-6c73-4d65-b6e1-b84f58723272" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4d535f80-6a8b-4af3-82cf-bb71ca534680_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4d535f80-6a8b-4af3-82cf-bb71ca534680_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d77f19e3-6e37-4c8e-a69c-770f356c4eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d77f19e3-6e37-4c8e-a69c-770f356c4eb9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INVENTORIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended" id="i7c9a645cc2fd428481d363be68698bb9_INVENTORIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4d5629b5-5fe0-41ff-b340-8d812dad3861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4d5629b5-5fe0-41ff-b340-8d812dad3861" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_655e233f-9da4-4bd7-835b-328c25648bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_655e233f-9da4-4bd7-835b-328c25648bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8c5b6fbc-f965-47e2-9c30-fe3a075edd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8c5b6fbc-f965-47e2-9c30-fe3a075edd0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_15ba5fc9-bad5-46dc-bc76-40e44293d273" xlink:href="bmy-20230331.xsd#bmy_Totalinventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_bmy_Totalinventories_15ba5fc9-bad5-46dc-bc76-40e44293d273" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c04bc597-038c-4460-89f7-b0e956b04f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryNet_c04bc597-038c-4460-89f7-b0e956b04f51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_50e2df4a-f9ab-4965-ab53-07a55d23a34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryNoncurrent_50e2df4a-f9ab-4965-ab53-07a55d23a34c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b75eb5c3-af4f-47b1-b2b4-fbcdac9ce0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b75eb5c3-af4f-47b1-b2b4-fbcdac9ce0db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f623395-53e3-4aeb-acdd-4308688f7503_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f623395-53e3-4aeb-acdd-4308688f7503_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_1d40c9d7-1035-484e-95f9-09ce0613ba53" xlink:href="bmy-20230331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_1d40c9d7-1035-484e-95f9-09ce0613ba53" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="extended" id="i5d75bcf8ebb542af8e083d0c3596fb4f_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7cd5dd0f-cc25-457c-9cfc-f01494cec657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7cd5dd0f-cc25-457c-9cfc-f01494cec657" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc68f86a-c567-44a4-bce8-3d7d6b613d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc68f86a-c567-44a4-bce8-3d7d6b613d6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd083deb-ef9a-4549-b46b-a10125ad6004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd083deb-ef9a-4549-b46b-a10125ad6004" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8d77d98d-01bc-4d03-98b3-b01b52a7ad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8d77d98d-01bc-4d03-98b3-b01b52a7ad7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_484cfd65-bd81-48d2-8bd9-ab3b0079cd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_484cfd65-bd81-48d2-8bd9-ab3b0079cd6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f766e4c3-a31f-43e5-8ae7-0ea6e5d219c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f766e4c3-a31f-43e5-8ae7-0ea6e5d219c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_abed006a-89fe-47de-827a-f4c284317b84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_abed006a-89fe-47de-827a-f4c284317b84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_31976f3b-b373-4e16-afec-c52ef36a57f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_LicensingAgreementsMember_31976f3b-b373-4e16-afec-c52ef36a57f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cbde6259-41f6-4a1c-8ef9-81742099afc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cbde6259-41f6-4a1c-8ef9-81742099afc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_d82f903e-287c-41b3-b27a-2c23127fe37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_d82f903e-287c-41b3-b27a-2c23127fe37a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7e08d950-01bc-4aa1-966b-b6290650f4d6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:to="loc_srt_RangeMember_7e08d950-01bc-4aa1-966b-b6290650f4d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:to="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9c827c7-c0a3-4326-8d95-3a49e8a08e53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:to="loc_srt_MinimumMember_e9c827c7-c0a3-4326-8d95-3a49e8a08e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de9a0183-5a93-4c3e-9628-32bf895db242" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:to="loc_srt_MaximumMember_de9a0183-5a93-4c3e-9628-32bf895db242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_118fc9af-ad80-4b3b-9c67-729c8fc652f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_118fc9af-ad80-4b3b-9c67-729c8fc652f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_200909b8-8153-4bcd-91ae-e86772e87e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_200909b8-8153-4bcd-91ae-e86772e87e5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended" id="ia78d9c5d261647828861439d32bb1e91_EQUITYScheduleofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:href="bmy-20230331.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_abfeb101-be8d-4328-9dab-aba862c7b087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_SharesIssued_abfeb101-be8d-4328-9dab-aba862c7b087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ac76a091-caf4-4d2b-9ba1-732ac7943ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_StockholdersEquity_ac76a091-caf4-4d2b-9ba1-732ac7943ecd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_ed889020-6910-4d42-89f5-279539733c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockCommonShares_ed889020-6910-4d42-89f5-279539733c24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9ad10dec-c000-4828-aae7-ab7fb74d9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_ProfitLoss_9ad10dec-c000-4828-aae7-ab7fb74d9770" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_53a7733e-c661-4491-939f-15e97e70ee55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_53a7733e-c661-4491-939f-15e97e70ee55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1d72eaeb-96d0-4c90-b801-fdf250400652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_DividendsCommonStockCash_1d72eaeb-96d0-4c90-b801-fdf250400652" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7b01e2f5-0baf-4237-874c-2ad413c6830e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7b01e2f5-0baf-4237-874c-2ad413c6830e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f161748d-49a8-4bc6-8b93-79fff8c023f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f161748d-49a8-4bc6-8b93-79fff8c023f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e2bf6eaf-7f82-48ee-baab-ea03024849f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e2bf6eaf-7f82-48ee-baab-ea03024849f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4f68a9c5-3d0f-4129-badd-b111807b5d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4f68a9c5-3d0f-4129-badd-b111807b5d9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a17d5ed7-371a-432d-b637-d98d59c07ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3f870105-b7f8-4254-8329-9c69a2303395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_77d2d0c4-6682-451c-b5b6-1166f0f29507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c849cee0-8ca3-4128-b78f-c8e1ef252fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c849cee0-8ca3-4128-b78f-c8e1ef252fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:href="bmy-20230331.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:to="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_26637c0f-47c8-4d88-9444-47ab32f41a37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:to="loc_us-gaap_EquityComponentDomain_26637c0f-47c8-4d88-9444-47ab32f41a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:to="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b113ce57-1e4e-4c60-89af-f58534de65fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_CommonStockMember_b113ce57-1e4e-4c60-89af-f58534de65fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d88d12a4-2f0d-482e-bb21-de70b73fdb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d88d12a4-2f0d-482e-bb21-de70b73fdb33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_20a10207-9f82-4bef-ab2f-1d5f8a038e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_20a10207-9f82-4bef-ab2f-1d5f8a038e96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a08851e7-9e4b-46db-a28e-7072ae69bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_RetainedEarningsMember_a08851e7-9e4b-46db-a28e-7072ae69bb13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_44a1d4f7-7e52-495b-9742-62b61031805e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_TreasuryStockCommonMember_44a1d4f7-7e52-495b-9742-62b61031805e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_a521ff61-9fdc-413d-ac83-9575a59e8b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_a521ff61-9fdc-413d-ac83-9575a59e8b79" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended" id="i2061f1134b724c7ebc46f3552a36b9fc_EQUITYAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:href="bmy-20230331.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ac318cf2-5bf8-4572-90f9-4bf0ae6005ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ac318cf2-5bf8-4572-90f9-4bf0ae6005ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_900e07c8-4e55-49cd-814c-106d852f25c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_900e07c8-4e55-49cd-814c-106d852f25c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5d5c3aad-ccb1-4732-aba1-51aa6cebcd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5d5c3aad-ccb1-4732-aba1-51aa6cebcd3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:href="bmy-20230331.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a334d15f-ad53-4f2d-8703-3b94ac7f3d40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a334d15f-ad53-4f2d-8703-3b94ac7f3d40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_b393876c-18e9-4385-9b7c-abad97e02e02" xlink:href="bmy-20230331.xsd#bmy_A2022ASRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:to="loc_bmy_A2022ASRMember_b393876c-18e9-4385-9b7c-abad97e02e02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended" id="i24b66f323dea46069e18ca7f01a358b0_EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_67709c1d-6acb-4a0d-ad0b-b5a17610e1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_67709c1d-6acb-4a0d-ad0b-b5a17610e1d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_60a0db20-2c41-4dd7-a04b-caf986adb53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_60a0db20-2c41-4dd7-a04b-caf986adb53a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_52529e2c-f811-44d4-a85a-4f456545ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_52529e2c-f811-44d4-a85a-4f456545ad00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fc1224e7-2b6d-471a-85a9-7069d85f5a98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fc1224e7-2b6d-471a-85a9-7069d85f5a98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6336f4f3-6e07-43cc-8fe7-3c2c90180232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_CostOfSalesMember_6336f4f3-6e07-43cc-8fe7-3c2c90180232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_91d717ba-65c3-443a-b535-b0bcfa44aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_91d717ba-65c3-443a-b535-b0bcfa44aa2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e984dff9-869c-45ae-9c7b-7e2bd85af71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e984dff9-869c-45ae-9c7b-7e2bd85af71f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended" id="ie409b153aea3439a9df2d9abab2916d2_EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_035a8004-0035-4e6f-a07c-7300debb48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_035a8004-0035-4e6f-a07c-7300debb48d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0d8510a-62da-4f04-b7ef-47aae940d697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0d8510a-62da-4f04-b7ef-47aae940d697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:to="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_514b9dfd-8db2-42f9-869f-142ab75a4b54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_514b9dfd-8db2-42f9-869f-142ab75a4b54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_69adfbf3-10c7-4b37-b84f-0db45dbf62b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_69adfbf3-10c7-4b37-b84f-0db45dbf62b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_4b7473c7-3c9e-4a64-9ff3-33fb913ffe70" xlink:href="bmy-20230331.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_bmy_MarketShareUnitsMember_4b7473c7-3c9e-4a64-9ff3-33fb913ffe70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8a279d1c-cb08-4fe9-9016-1433bc8604b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_us-gaap_PerformanceSharesMember_8a279d1c-cb08-4fe9-9016-1433bc8604b8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended" id="ida17fcc7482c4a6a9fb2b0036d8fe8c8_EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7d1500a2-7fda-402f-a18d-6c30d52f44c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7d1500a2-7fda-402f-a18d-6c30d52f44c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fe396c83-4298-42ef-85c9-088bb83c3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fe396c83-4298-42ef-85c9-088bb83c3d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:to="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6c1a0c07-18b9-448c-bf88-e2e20b121b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6c1a0c07-18b9-448c-bf88-e2e20b121b2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_bd0addce-f82c-48f6-b7c3-4ff5404ef718" xlink:href="bmy-20230331.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_bmy_MarketShareUnitsMember_bd0addce-f82c-48f6-b7c3-4ff5404ef718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bb5c47c7-4d55-455a-9489-84321bb79798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_us-gaap_PerformanceSharesMember_bb5c47c7-4d55-455a-9489-84321bb79798" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended" id="id6f7f096a6114c6f943c1e93eb6a0768_LEGALPROCEEDINGSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:href="bmy-20230331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_4ca1821f-d5d9-4f1f-bf03-528ed11b8517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_4ca1821f-d5d9-4f1f-bf03-528ed11b8517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_ce143440-c199-499c-8c39-357d7736b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_PaymentsForRoyalties_ce143440-c199-499c-8c39-357d7736b5ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_d0611388-5bdd-40ae-a931-f9432361d57a" xlink:href="bmy-20230331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_d0611388-5bdd-40ae-a931-f9432361d57a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_e1cabc22-b7e1-47dd-bc04-1446f274668c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_e1cabc22-b7e1-47dd-bc04-1446f274668c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_aba5710d-0301-4601-87a6-05447767ebb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_aba5710d-0301-4601-87a6-05447767ebb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_44be54c9-5a15-4080-85ef-d6062f35732a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_44be54c9-5a15-4080-85ef-d6062f35732a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_08d2938c-b6a2-4a37-98fe-3c60469e56c8" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_08d2938c-b6a2-4a37-98fe-3c60469e56c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_cf45adef-988c-47ee-8031-c54cb7378084" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_cf45adef-988c-47ee-8031-c54cb7378084" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_02a381ec-8167-46e7-8cda-e66bbe703350" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_02a381ec-8167-46e7-8cda-e66bbe703350" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_0fc5df4c-928c-427e-bac7-171622e2a3af" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_0fc5df4c-928c-427e-bac7-171622e2a3af" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_5711e49d-f023-4a7f-bd80-8952b6df2ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_ContractualObligation_5711e49d-f023-4a7f-bd80-8952b6df2ee9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_97b2c26a-a4de-401b-89f3-1e090d3c7743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_97b2c26a-a4de-401b-89f3-1e090d3c7743" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:href="bmy-20230331.xsd#bmy_LitigationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fdd4660a-f72f-4644-bcf2-a9d25f68632b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:to="loc_srt_LitigationCaseTypeDomain_fdd4660a-f72f-4644-bcf2-a9d25f68632b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:to="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_5472a5f4-e39e-442b-a18c-61f330846c33" xlink:href="bmy-20230331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_5472a5f4-e39e-442b-a18c-61f330846c33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_09a09f8b-1050-46e9-9c6d-528927fc4b6e" xlink:href="bmy-20230331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_CARTKiteLitigationMember_09a09f8b-1050-46e9-9c6d-528927fc4b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_1903b4a0-8011-492e-8b86-ab0071645b3a" xlink:href="bmy-20230331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_1903b4a0-8011-492e-8b86-ab0071645b3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_f0ebcd77-ec85-46a1-aaec-b52794e5b5ef" xlink:href="bmy-20230331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_AbilifyProductLiabilityMember_f0ebcd77-ec85-46a1-aaec-b52794e5b5ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3fe3840-dd74-4aec-8cc2-4ee5c34282ad" xlink:href="bmy-20230331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3fe3840-dd74-4aec-8cc2-4ee5c34282ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MolinaLitigationMember_3461b094-b635-447a-8bee-89917ee33710" xlink:href="bmy-20230331.xsd#bmy_MolinaLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_MolinaLitigationMember_3461b094-b635-447a-8bee-89917ee33710" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OptOutEntitiesMember_3e51ad38-6893-418f-b7f9-25aef3b3ac84" xlink:href="bmy-20230331.xsd#bmy_OptOutEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_OptOutEntitiesMember_3e51ad38-6893-418f-b7f9-25aef3b3ac84" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_a4e49dcb-0831-4c49-a461-f6e27f766bd1_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:to="loc_currency_AllCurrenciesDomain_a4e49dcb-0831-4c49-a461-f6e27f766bd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:to="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_30457659-ed07-4675-9c4c-bb24a74fc27d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:to="loc_currency_AUD_30457659-ed07-4675-9c4c-bb24a74fc27d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_044833db-a3a3-427b-9f85-a264404e6598" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:to="loc_currency_USD_044833db-a3a3-427b-9f85-a264404e6598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b2183c42-5569-4366-ac74-47bf13060ceb_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:to="loc_dei_EntityDomain_b2183c42-5569-4366-ac74-47bf13060ceb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:to="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_a0bfab76-82ef-4e04-a8f7-5027d40043b1" xlink:href="bmy-20230331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:to="loc_bmy_BristolMyersSquibbMember_a0bfab76-82ef-4e04-a8f7-5027d40043b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_79438464-525c-4b56-9dcb-f336668c7aca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:to="loc_srt_SegmentGeographicalDomain_79438464-525c-4b56-9dcb-f336668c7aca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:to="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_87b19339-4575-450b-9332-52ff83f2d1f7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:to="loc_country_CA_87b19339-4575-450b-9332-52ff83f2d1f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmy-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e98a3464-44f2-4653-a15b-f98a5af54664_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityLineItems_29e5d0bc-7dd1-4893-ad37-f4a748cf7501_verboseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_fda5767c-3238-4557-871a-02f08059ad66_terseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_label_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_documentation_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems" xlink:href="bmy-20230331.xsd#bmy_EquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityLineItems" xlink:to="lab_bmy_EquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_498bfc75-56a7-4ccf-b019-7d82d0daa571_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_692c9e6f-25c5-4e3f-a1b8-c73099967b2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_f486be66-25fa-4041-a399-5618853f08e3_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7aec5275-76f7-4d19-a3e9-6300c5a5708a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_88dc0fd9-ef24-4c35-987c-93d4ec803ee1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_c241f40a-443e-4089-92f2-5465906b3636_terseLabel_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total In-Line Products and New Product Portfolio</link:label>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_label_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products and new product portfolio [Member]</link:label>
    <link:label id="lab_bmy_InLineProductsAndNewProductPortfolioMember_documentation_en-US" xlink:label="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products and new product portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember" xlink:href="bmy-20230331.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InLineProductsAndNewProductPortfolioMember" xlink:to="lab_bmy_InLineProductsAndNewProductPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_2f229586-25d5-469c-bbf7-649efc98a822_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_02084e52-9cb1-4b24-9b52-1e4f6159d39f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_c05ae083-71f6-492a-adfd-3b11f7b02eac_terseLabel_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_label_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Aggregate Total Trade Receivables Due</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_documentation_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:href="bmy-20230331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:to="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4407340b-c84e-4b37-9e2b-01d2a3f9e7b2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_69e67592-de34-44e5-88fd-93c3bd7d4715_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_be98271b-21b6-463a-ae95-8fb99a2bf687_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimates</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c7559b6a-3a3b-4947-ac0f-498d0152318e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BusinessSaleRoyaltyIncome_c147f4cb-ef79-4aea-9b37-bfba2a6b3770_negatedTerseLabel_en-US" xlink:label="lab_bmy_BusinessSaleRoyaltyIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty income - divestiture (Note 4)</link:label>
    <link:label id="lab_bmy_BusinessSaleRoyaltyIncome_label_en-US" xlink:label="lab_bmy_BusinessSaleRoyaltyIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale Royalty Income</link:label>
    <link:label id="lab_bmy_BusinessSaleRoyaltyIncome_documentation_en-US" xlink:label="lab_bmy_BusinessSaleRoyaltyIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents royalty income recognized in other income during the period related to the sale of a business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessSaleRoyaltyIncome" xlink:href="bmy-20230331.xsd#bmy_BusinessSaleRoyaltyIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BusinessSaleRoyaltyIncome" xlink:to="lab_bmy_BusinessSaleRoyaltyIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_26d677eb-d5eb-447b-b679-7d5cbc439d35_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_c67398e1-52e1-4a54-9656-28ea37697820_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual injury claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentValueRightsMember_4cbed2da-7949-4a16-8a4e-ed397daeb975_terseLabel_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent value rights</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMY Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember" xlink:href="bmy-20230331.xsd#bmy_ContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentValueRightsMember" xlink:to="lab_bmy_ContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_e76a6a6c-baa2-45b4-b703-ed777a4e2812_terseLabel_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_label_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:to="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_ad29bc9e-d74e-4c72-83f4-b47a63e4dc65_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment losses</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_d7528161-aa88-48c4-a0aa-3bfff7e650d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment losses (Note 9)</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_5bb9ceaa-3c08-4a92-9565-16d0647e0a91_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity investment losses</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRoyaltiesMember_5fac147d-af73-4caf-95de-24043c0ef7a1_terseLabel_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_label_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties [Member]</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember" xlink:href="bmy-20230331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRoyaltiesMember" xlink:to="lab_bmy_OtherRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_82b6d4c7-fffd-4d99-938e-897dce883ae2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_6de6ff05-da98-4d8d-a42c-28327f11b84f_terseLabel_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_label_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_documentation_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember" xlink:href="bmy-20230331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MedicaidandMedicarerebatesMember" xlink:to="lab_bmy_MedicaidandMedicarerebatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MolinaLitigationMember_1c8f3256-a6af-40d1-9e33-24fd7a94f383_terseLabel_en-US" xlink:label="lab_bmy_MolinaLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molina Litigation</link:label>
    <link:label id="lab_bmy_MolinaLitigationMember_label_en-US" xlink:label="lab_bmy_MolinaLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molina Litigation [Member]</link:label>
    <link:label id="lab_bmy_MolinaLitigationMember_documentation_en-US" xlink:label="lab_bmy_MolinaLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molina Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MolinaLitigationMember" xlink:href="bmy-20230331.xsd#bmy_MolinaLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MolinaLitigationMember" xlink:to="lab_bmy_MolinaLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3ff62fa8-eabf-4d08-bb1b-75f52eac2b00_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6b094cc-5073-42e8-b90a-09f11898f3bb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_b507eea0-eb2c-4d1e-822b-eeaf9e233db5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_0fa76814-0a64-4915-8bc4-5dd8368a53c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquiredIPRD_710a000c-ea71-4b76-ac8f-c2012e736995_terseLabel_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_label_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_documentation_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquiredIPRD" xlink:to="lab_bmy_AcquiredIPRD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_376d630e-8efb-4472-bd9d-20d4fc4c262e_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_5652b93a-2a4e-4beb-81ad-89f9fd0f2c3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_1cadb90b-b103-4bc2-a6f3-3ba7329f9e46_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_563960c6-67db-44c4-a7ad-ebff1030279a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ee490452-6abf-44de-b1f4-8a69a952e215_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ce612969-8d3d-48e4-8d2a-27fcae3bc78c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityTable_c9b29dcc-0532-446b-be32-5fe09a16ee04_terseLabel_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_label_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_documentation_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable" xlink:href="bmy-20230331.xsd#bmy_EquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityTable" xlink:to="lab_bmy_EquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c4f5372b-7ba5-45ea-b9cb-4719698b4f1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5b4035ba-32a2-4e45-8031-7d35ade67146_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value of stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_b39b8a4e-0a41-48ba-9542-daecf7be7ec6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation satisfied in previous period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43b35db3-db0e-4b0c-933b-d1ef918f43b0_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_aecb4c00-384f-4ecd-8774-bad5bd87b703_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_55c5153b-d921-4c3a-a1fd-fbd4396548a3_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_152e2607-b335-4e80-8acd-b12c77fa95c0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9e16345a-542a-4e34-aa45-8f3e628b292a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRevenuesMember_1c67aabe-7024-43b2-ada4-e28c13e04b60_terseLabel_en-US" xlink:label="lab_bmy_OtherRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_bmy_OtherRevenuesMember_label_en-US" xlink:label="lab_bmy_OtherRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Revenues [Member]</link:label>
    <link:label id="lab_bmy_OtherRevenuesMember_documentation_en-US" xlink:label="lab_bmy_OtherRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRevenuesMember" xlink:href="bmy-20230331.xsd#bmy_OtherRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRevenuesMember" xlink:to="lab_bmy_OtherRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_cfd0e5d3-46ab-4e33-956e-d21099614b78_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_7f36192e-d4ca-4da3-ac3c-cf0ef01baf15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds_041d805f-9963-4084-8482-17f9cd6d2cf1_terseLabel_en-US" xlink:label="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in control proceeds</link:label>
    <link:label id="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds_label_en-US" xlink:label="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement, Contingent Development, Change In Control Proceeds</link:label>
    <link:label id="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds_documentation_en-US" xlink:label="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement, Contingent Development, Change In Control Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:href="bmy-20230331.xsd#bmy_SettlementContingentDevelopmentChangeInControlProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:to="lab_bmy_SettlementContingentDevelopmentChangeInControlProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_37d573f7-4c00-44ac-806b-8f4a27277a1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_880d857c-f820-4d7c-9037-c25d4919dc35_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-derivatives designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_881a8119-60e1-40a5-8134-9216bb57e9d9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_1f06a72c-9eba-42f0-adf1-639228a652c3_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings and Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_8770e83c-bb79-4141-a018-c9ac0539f1f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_db550bfe-1ece-4f50-ac45-d7237ec6f803_terseLabel_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_label_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_documentation_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:href="bmy-20230331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:to="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_80c75390-635c-400b-841f-e08b308d4b94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_5b878726-6b3e-437f-8e3e-3573287c2be6_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense</link:label>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:to="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e309c3cb-c9d9-41b1-ba80-898e3e8abf71_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_df0eca5f-4c8b-452a-86ca-bedcb54de47e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_cc3a1d71-7bba-4276-8f67-aa12a553c5bc_terseLabel_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_label_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates and returns</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_documentation_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns" xlink:href="bmy-20230331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedRebatesAndReturns" xlink:to="lab_bmy_AccruedRebatesAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_a1e8dfd3-c609-4981-9926-3d9703069df1_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_ecab5005-1612-4c44-a4fd-2eb1a8031de0_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:to="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_952c85f1-898f-4579-81bc-7311a2022922_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_d42ab2ca-47ac-453f-9169-e16e8ecd6a10_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_add20e54-3695-4eb9-adb5-6af966bb46ea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_8caab60b-ac29-4b02-8b2d-8b869edf37b7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_7da3894e-2514-43ec-8cb8-e2f8977b381e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CamzyosMember_bfc029b0-7f4c-4c91-9523-025dafa27a8e_terseLabel_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos</link:label>
    <link:label id="lab_bmy_CamzyosMember_label_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos [Member]</link:label>
    <link:label id="lab_bmy_CamzyosMember_documentation_en-US" xlink:label="lab_bmy_CamzyosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Camzyos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember" xlink:href="bmy-20230331.xsd#bmy_CamzyosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CamzyosMember" xlink:to="lab_bmy_CamzyosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_312d2573-c303-4852-84e9-5417e061199a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation(a)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bfb21929-e3a0-40b4-9669-11d2e2c1aa2c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b84d68e7-0138-4cd3-b734-a10ab2129167_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_01b96dec-fb7f-4d78-a621-6b65c5ea990a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities, fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_cc4e31fe-799a-425b-95cc-49cd0f998cc0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_d3a456da-6d15-474e-a111-74c7cc9ff22e_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_label_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Other Income Expense</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_documentation_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense" xlink:href="bmy-20230331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherOtherIncomeExpense" xlink:to="lab_bmy_OtherOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_b68560b1-386f-4648-9859-31e0c5eb754a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_9e86c28a-fce4-4b0f-ac64-41b4c497704e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_3fd8c70e-ff7f-4a08-8e76-c323f883cebd_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LOEProductsMember_d71399f3-bb98-41a0-a31b-9482477c501d_terseLabel_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent LOE Products</link:label>
    <link:label id="lab_bmy_LOEProductsMember_label_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOE products [Member]</link:label>
    <link:label id="lab_bmy_LOEProductsMember_documentation_en-US" xlink:label="lab_bmy_LOEProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOE products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember" xlink:href="bmy-20230331.xsd#bmy_LOEProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LOEProductsMember" xlink:to="lab_bmy_LOEProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a55fa0c9-2d1a-4fe3-8fff-e6e612122cfa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_a952df90-6b81-4d79-b586-42dfb5b928fe_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c8076cd8-9ab2-46c0-a801-1816f8adfebe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_488176ea-40f9-4944-965b-2cb60c1bc3fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_04353d8c-406b-4bb2-826c-6ae1f0ba545c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of taxes and reclassifications to earnings:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NimbusTherapueticsTYK2InhibitorMember_2118eb5e-7420-4725-8929-6b3138a1a221_terseLabel_en-US" xlink:label="lab_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapuetics TYK2 Inhibitor</link:label>
    <link:label id="lab_bmy_NimbusTherapueticsTYK2InhibitorMember_label_en-US" xlink:label="lab_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapuetics TYK2 Inhibitor [Member]</link:label>
    <link:label id="lab_bmy_NimbusTherapueticsTYK2InhibitorMember_documentation_en-US" xlink:label="lab_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapuetics TYK2 Inhibitor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapueticsTYK2InhibitorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:to="lab_bmy_NimbusTherapueticsTYK2InhibitorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-supplement_DebtInstrumentRepaidPrincipal_24959abd-9b96-4c19-8a18-23534e306a2f_terseLabel_en-US" xlink:label="lab_us-gaap-supplement_DebtInstrumentRepaidPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt matured and repaid</link:label>
    <link:label id="lab_us-gaap-supplement_DebtInstrumentRepaidPrincipal_label_en-US" xlink:label="lab_us-gaap-supplement_DebtInstrumentRepaidPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repaid, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal" xlink:to="lab_us-gaap-supplement_DebtInstrumentRepaidPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_1201e0a5-ba37-48ba-baf8-652195dbbc96_terseLabel_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_label_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember" xlink:href="bmy-20230331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceandotherrevenuesMember" xlink:to="lab_bmy_AllianceandotherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d6afb63c-6fcc-4553-8cf8-a7af14c8d670_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_8c8902f8-977e-4338-9113-4e7f82b29495_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_58174cb0-e8cb-4dfb-a2c4-4681cfa09fa0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d0cbccf2-93a5-43fa-88db-26629b54ad30_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2ba9be9f-a5e3-49fb-ba9d-cb9f3b950771_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_50fe742e-1b44-4696-a183-e933feddd66f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account Receivables [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_10758cdd-c35a-493d-b0c2-9b6d869b5d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_b6dcc66b-efcf-4851-8865-ece1184f6a8e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from legal settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_67a2ff25-9f6a-4915-80fc-b2246c2ef6e8_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_d8fec082-a49d-43b2-abbe-9098c722c492_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_68f9eb2a-9dfc-4c51-b79c-11ea2e1f8424_verboseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_5f2303b1-969e-4448-98e7-2caf605d97af_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_116ea503-0e09-4f32-b513-cf5ba78fbb81_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_b004d3a1-1612-4434-83b5-a92144b5e402_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsTable_05c10d11-a962-4bd8-bbb3-bdbbe98e301f_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_label_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsTable" xlink:to="lab_bmy_LicensingArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c9d0c960-2075-4d9e-918c-8636624df72e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_cd63e954-d098-4adc-a1ab-6c8bc0fb24b4_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_a4a38fc7-cda2-4dc1-8893-c63d119e6294_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a09f67cc-3d7f-441a-a242-98ebff617a3f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_7d825aed-5933-4ec7-be58-a8b160a41a1b_terseLabel_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal period (in years)</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_label_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_documentation_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod" xlink:href="bmy-20230331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LongTermDebtRenewalPeriod" xlink:to="lab_bmy_LongTermDebtRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1047c6e3-685d-4264-9393-47d3246f7377_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_15a8dd48-9c11-4a2f-bd14-b02133c2458c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_0f0a1619-b13d-475c-a8f9-a85729cb9cfb_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1be0f7bf-d45b-45c9-b282-731cca9b7245_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_569687fc-bf16-4cdd-bebf-b642fb233570_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_09e95c8f-33e5-42c3-abd8-0bad1f7e3167_terseLabel_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_label_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Largest Pharmaceutical Wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_documentation_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of the largest pharmaceutical wholesalers used by the company in the territory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:href="bmy-20230331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:to="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_cdd74d11-ef0a-42ab-957d-51d25f3704ba_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired marketed product rights</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4f264d84-213a-4ad6-9318-2f1f6003310d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4c27a350-2ffc-48e2-ba85-173dd9cdae74_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_b8dd9b1f-4b26-49db-b224-fd623878f559_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f1724555-ee8e-405b-88be-ca29c17b5219_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a94309f6-0d23-4227-b915-58096049ac87_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_4b83ad2c-48cb-4502-9f60-f1c59aa2fd82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RevlimidMember_54d85a46-d681-442a-96aa-89fbb54fc2eb_terseLabel_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid</link:label>
    <link:label id="lab_bmy_RevlimidMember_label_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:label id="lab_bmy_RevlimidMember_documentation_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember" xlink:href="bmy-20230331.xsd#bmy_RevlimidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RevlimidMember" xlink:to="lab_bmy_RevlimidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_026fe7f4-6972-4bd6-a6f9-ac47c768b9a2_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ea51dcf4-21f8-41c4-b980-995d28a5f2c8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_41be7d8b-3416-4e20-a08a-8b65b09a00f4_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustments_012a877d-fb40-45a7-96bc-5e7e4c8ad7c9_negatedTerseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total GTN adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustments" xlink:to="lab_bmy_GrosstoNetAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_da9967d6-ad13-4fb5-98a1-4c1f174dab5b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OptOutEntitiesMember_fd80469a-bac8-4163-a623-cc4e8eb69df5_terseLabel_en-US" xlink:label="lab_bmy_OptOutEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt-Out Entities</link:label>
    <link:label id="lab_bmy_OptOutEntitiesMember_label_en-US" xlink:label="lab_bmy_OptOutEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt-Out Entities [Member]</link:label>
    <link:label id="lab_bmy_OptOutEntitiesMember_documentation_en-US" xlink:label="lab_bmy_OptOutEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt-Out Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OptOutEntitiesMember" xlink:href="bmy-20230331.xsd#bmy_OptOutEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OptOutEntitiesMember" xlink:to="lab_bmy_OptOutEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_59ef452c-0439-4c97-9b7d-0e910901cc1d_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_b9ad0456-20ea-468e-9410-73fab84c4458_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_7553ef4c-0683-46a1-a710-f7870bae3895_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cf1a7f04-6fe6-4d3a-a0aa-ab5135967b9c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_470e3053-6114-4498-8c2b-73679c1e2e2d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_13244f1e-1768-4145-9304-e5682e777c32_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_ed7fd568-fcad-4c33-be59-873d039f2685_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other termination costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_2756b5ef-2aa9-4df6-85cb-6a05d05e2d11_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_49cfa49b-faa5-4385-954c-854cb6e30038_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_61067a43-1862-44ee-be04-f614b216e990_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_399b8e4e-4b5f-449c-a29b-d3dd4fcb0d59_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_738d60c0-8f06-42a4-aea9-22ab9bf13c9b_terseLabel_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_label_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_documentation_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:href="bmy-20230331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:to="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_09924e66-fc6d-48b6-bba4-7f10c16af241_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SalesRevenueGrossMember_5d9351b7-f20d-4df2-add2-2d69a4e2d2c7_terseLabel_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross product sales</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_label_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_documentation_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember" xlink:href="bmy-20230331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SalesRevenueGrossMember" xlink:to="lab_bmy_SalesRevenueGrossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BreyanziMember_159ba317-81de-48ed-a167-b2c76daee402_terseLabel_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:label id="lab_bmy_BreyanziMember_label_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi [Member]</link:label>
    <link:label id="lab_bmy_BreyanziMember_documentation_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember" xlink:href="bmy-20230331.xsd#bmy_BreyanziMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BreyanziMember" xlink:to="lab_bmy_BreyanziMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_abb81db7-09b1-4378-87e7-d10cca2fa3c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e7e3b6a-3c08-4c1f-8643-4b5bd56b16c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5aa34e51-b18a-494e-80a0-19c2b5e6da20_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f407f846-06b8-4dfc-8295-928fd13a9d9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_012afc37-ea3e-45af-8041-01c88f101856_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_475f8445-af46-4691-ae3a-a13463334d55_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized purchase price adjustments of Celgene debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_840a26ef-3312-43eb-b0a3-d92cba96e777_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_af0e4c69-5bd7-4233-97bd-4e343c34e0dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_f55277cb-39a2-482d-96dc-7af479cfd11e_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_858ebb37-e1e8-4653-9d31-95e540a69efb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_650b45d9-b6ff-4d39-b21f-0bb5d4a6746d_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_bf4e4c6c-9b06-4e1b-be38-cbce0edd8f0c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_68ee5fec-b229-43e1-b867-615d3554f833_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_9361e3dc-0221-4121-9f54-163021189820_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_af0572c9-d732-4959-920d-4f175b308e4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_9833cd4d-e5d5-41ed-80b6-e2182cab707b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a01cb088-3efe-41f9-a652-8180804ad77d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_ebffd136-c26f-442b-b785-2877898d0853_terseLabel_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and other products</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_label_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands [Member]</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_documentation_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember" xlink:href="bmy-20230331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureAndOtherBrandsMember" xlink:to="lab_bmy_MatureAndOtherBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f77183d9-050c-4702-8c3a-d4d43d72d34e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_4a3321b7-8ced-43d2-bd50-0157702a85b0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_a461d34d-aa21-4baa-8484-8b970646118a_terseLabel_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember" xlink:href="bmy-20230331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneContingentValueRightsMember" xlink:to="lab_bmy_CelgeneContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c592ed46-f526-48f6-9c63-2c50d4088267_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestituregainsandroyalties_7ebb9b4e-605f-4ea9-93b8-18b8c1b23881_negatedTerseLabel_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_label_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_documentation_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the amount of gains and royalties as a result of business divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties" xlink:href="bmy-20230331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestituregainsandroyalties" xlink:to="lab_bmy_Divestituregainsandroyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c6b833c2-3b2c-40cd-a836-706d61e0e5a0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_457a6fb4-1997-4a65-ba7e-db7d2817903c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba01ef47-16e2-45c8-851f-77688267a7a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3e44a9ad-f70c-4f19-939e-703cc2b7aed3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_db548655-0791-4448-9025-579faa905d6e_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_YervoyMember_fc5e5986-3a39-4841-ac58-a967d2c38b91_terseLabel_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy</link:label>
    <link:label id="lab_bmy_YervoyMember_label_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember" xlink:href="bmy-20230331.xsd#bmy_YervoyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_YervoyMember" xlink:to="lab_bmy_YervoyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_8a12afd6-d196-4c7f-91b2-9eea7230825d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_af643e9c-3d03-45b6-bcc6-7ed961178680_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_652f9c4b-bf97-4cb0-af20-0f974aaa427a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_cbb575a7-9471-4b6c-b0f4-51b55b4791c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d9fd44ef-66d2-456d-9a32-455bc36b0be9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives and Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_334607d1-263a-4467-bbf2-bc75852d5e92_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_a96599ff-7766-4416-bd6e-bccc0ada4265_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d699ea15-4d15-4401-8924-0b5018d3a5c2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ef7e153b-b10b-4ed2-9802-9201427008c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt redemption (Note 10)</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_389679e8-cc0c-49b6-9221-361233373918_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_6c107fff-8cb2-408a-a43e-ac6a0b2e7df8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8eadeeec-7216-40ba-af13-68657c57a859_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_12b135f9-c9a1-45b1-a640-a1ef2322f0d7_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_9d3c30d0-8723-43e8-93b3-864ac9ecad43_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:to="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchandDevelopment_73642c5b-b6cc-4c4c-9f5f-5379837c3622_terseLabel_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_label_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_documentation_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment" xlink:href="bmy-20230331.xsd#bmy_ResearchandDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchandDevelopment" xlink:to="lab_bmy_ResearchandDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SotyktuMember_750356b2-b1ca-4702-9f41-d7bdf6784a13_terseLabel_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu</link:label>
    <link:label id="lab_bmy_SotyktuMember_label_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu [Member]</link:label>
    <link:label id="lab_bmy_SotyktuMember_documentation_en-US" xlink:label="lab_bmy_SotyktuMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sotyktu</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember" xlink:href="bmy-20230331.xsd#bmy_SotyktuMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SotyktuMember" xlink:to="lab_bmy_SotyktuMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_4cd2114e-d9ba-4107-ad6b-ef4cb8f0aaa9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_85e5e71a-fd83-4c0d-a22a-6ae28a11708d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_2b03e9bc-3575-4c45-ae76-fbd5e64bfeeb_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_6b042f41-39c1-4e23-9d4a-d8cc0fc5e46c_terseLabel_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Running royalty</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_label_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_documentation_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:href="bmy-20230331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:to="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CARTKiteLitigationMember_4bbe8a2d-4f63-4c80-86f5-e6b1053c0c3c_terseLabel_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_label_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_documentation_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember" xlink:href="bmy-20230331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CARTKiteLitigationMember" xlink:to="lab_bmy_CARTKiteLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ad1b2398-ec52-47e0-a3e2-1969473aa8c8_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ecf9eb15-b3a5-4b5b-b6b7-4481ccf7d9bc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, fair value adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_a26790af-85ea-46d5-8dca-07e70a7aeede_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A3250NotesMember_3c4b3aac-f0ec-4c7e-9570-38699154c8d1_terseLabel_en-US" xlink:label="lab_bmy_A3250NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Notes</link:label>
    <link:label id="lab_bmy_A3250NotesMember_label_en-US" xlink:label="lab_bmy_A3250NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Notes [Member]</link:label>
    <link:label id="lab_bmy_A3250NotesMember_documentation_en-US" xlink:label="lab_bmy_A3250NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250NotesMember" xlink:href="bmy-20230331.xsd#bmy_A3250NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A3250NotesMember" xlink:to="lab_bmy_A3250NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_96b7f423-4c61-4b61-9dd6-716b852f6392_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_af200662-059d-4ce2-aa99-81d94ac51f23_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, term (in years)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5dfff47d-c39b-4bd3-bd93-2005f51efa6f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a2a90ae1-4ef0-41f6-a963-b86c747eef19_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ALLIANCESAbstract_bad3091a-6c75-4fdb-afd1-9f4f00991fbd_terseLabel_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_label_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_documentation_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract" xlink:href="bmy-20230331.xsd#bmy_ALLIANCESAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ALLIANCESAbstract" xlink:to="lab_bmy_ALLIANCESAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9b34e5c8-597d-4334-9c1f-b49933850e41_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NewProductPortfolioMember_ff20da44-3704-41de-a0ea-6a4bef176511_terseLabel_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Product Portfolio</link:label>
    <link:label id="lab_bmy_NewProductPortfolioMember_label_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New product portfolio [Member]</link:label>
    <link:label id="lab_bmy_NewProductPortfolioMember_documentation_en-US" xlink:label="lab_bmy_NewProductPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New product portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember" xlink:href="bmy-20230331.xsd#bmy_NewProductPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NewProductPortfolioMember" xlink:to="lab_bmy_NewProductPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_393ee323-4cb8-473f-8a86-517af4f7411c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_490a9ed1-41fe-43bd-bf77-450d21c7ea47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d19fead1-d8b2-4581-8c9e-fc7516d1c34c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e452f3c6-08c5-4187-a85b-0e7ded266739_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_76e47bbb-036f-45b5-9065-5e88f02f5667_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_0944292a-08db-45bb-8cad-24cea975488b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_fc9b607c-ef50-41ca-8353-4eb3fcfc0a8b_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent" xlink:href="bmy-20230331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsNonCurrent" xlink:to="lab_bmy_EquityInvestmentsNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8d018a42-d9c4-4b6a-83ee-06560939c83a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d53cac4b-47cc-4942-a032-3aabc50fdfed_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_4b8640a6-16b2-4caf-b5a0-b5b8460def09_terseLabel_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition Gross-To-Net Adjustments</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_label_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:href="bmy-20230331.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:to="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c581e758-5197-4acb-bce4-9702e38a8229_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_de08908b-4a9a-46d3-a3d4-f9518af2f165_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_44811f44-d8b8-4d2c-adb9-26e98a3c4330_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_f021b140-309f-4cc8-8481-dd8ab492407e_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_6ea9fa90-44b6-4680-aa4d-089d5f6826e5_terseLabel_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract" xlink:to="lab_bmy_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_eb92fce2-ef75-4aad-98b3-5fdf3066318f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_794f9352-51e9-4207-ad01-af28b58d4b65_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_a68b97ca-bd0d-4067-bd6f-16b2e64390a8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated depreciation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:to="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_7aa4f71e-4d69-483e-a72c-50e5434cf732_terseLabel_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment" xlink:href="bmy-20230331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedResearchAndDevelopment" xlink:to="lab_bmy_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_666b7811-546b-459d-8192-319f7e97d07a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0f365fcd-699a-4d09-94b1-b40b8d2c054b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15468582-14c4-485f-bf16-1af86132dfd4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c427ec79-9d19-4806-b477-c920a36d7e3a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates and Judgements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8f6a893d-473e-4030-b26c-51d354698db7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market and other securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_90dafe53-05df-4fb4-9cd7-7ca8effb3ed5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_58813be2-1f30-483e-a5ca-b10db4b2d02e_terseLabel_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share</link:label>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="bmy-20230331.xsd#bmy_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_bmy_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_dac92a13-48a5-4590-9a40-853c020b64c9_terseLabel_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_label_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_documentation_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:href="bmy-20230331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:to="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_3793244f-b051-44ba-8314-bd830778b2f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_cd17ccb6-221f-4c99-86c7-6f2b449dc3d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_eeb0f80c-8df2-45cd-bc27-0a9341c7f654_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_f863e28c-afb5-48ca-9434-753f30e40fe4_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_97d61a60-97ba-4286-976f-a9c859d3b9b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ec6c6ad7-74da-45d5-9475-24a49e348598_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_f2fabfb2-9ed9-47c7-a523-1da8b89115cb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related charges incurred to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InternationalMember_6ea1aa83-e2b2-4ede-86ec-dcad04bcc5ba_terseLabel_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_bmy_InternationalMember_label_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_bmy_InternationalMember_documentation_en-US" xlink:label="lab_bmy_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember" xlink:href="bmy-20230331.xsd#bmy_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InternationalMember" xlink:to="lab_bmy_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_07d1b9ca-f9a9-4cb8-875b-a1962fd6885a_terseLabel_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_label_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment [Member]</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_documentation_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:href="bmy-20230331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:to="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a0e8e0aa-5916-45ab-97ca-ac311aabcad7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_aa147e7b-b032-4336-9d31-686109e3a8dc_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_label_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsLineItems" xlink:to="lab_bmy_LicensingArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_9077f093-7742-457d-a511-4e9c0dfb1399_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for debt extinguishment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Cashoutlays_e8122011-e208-43f9-af2f-62f05faf52ad_terseLabel_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_label_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_documentation_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays" xlink:href="bmy-20230331.xsd#bmy_Cashoutlays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Cashoutlays" xlink:to="lab_bmy_Cashoutlays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_6f422f3d-7a42-49a1-852d-756ee21742d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_28ecbda4-1dad-4c84-817d-f15c5b01b964_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_53aae1b3-0f05-4282-ab7c-d3b909c2b155_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a2eafbd0-43f4-4ff3-ac4b-1a9bde52d737_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d59c075c-e434-4ce7-9e99-c114fec96d19_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_85e570af-732b-4386-898e-52e64579b4f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d0118f58-d928-4f34-9fb3-fb2be358298d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3cbad960-d80c-4f0b-a0ca-102c0669a100_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_756616a0-a739-46c2-9749-49c49fce667c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_52df523c-80b3-40a3-8297-41b680c239d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_7013ea26-1aa0-41fd-8df1-9e184155e84b_terseLabel_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_label_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_documentation_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:href="bmy-20230331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:to="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_d5eb68a6-42fb-4535-99aa-81fe7ddfe327_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0827b1bc-8e61-4255-a542-4f77111ad464_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedInterest_1dc1fba7-8eab-4191-9b55-f489cd00a9d6_terseLabel_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_label_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_documentation_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest" xlink:href="bmy-20230331.xsd#bmy_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedInterest" xlink:to="lab_bmy_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_0cbd9f54-8981-47d5-b64d-3cd073cf013a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_54daea4d-b857-4c06-9f0c-522b65204ee6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_d16535ab-7591-4d4c-a1de-9bd03d5e7474_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Table Text Block]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:to="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_42af62b4-40db-45e5-a60a-52c284b33ea3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_d7eeb71f-ae86-4dd3-9f80-40ef4fd1819d_terseLabel_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_label_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan [Member]</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_documentation_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:href="bmy-20230331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:to="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8de2a94d-2d08-4871-90a0-e760f5e66c0b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_e08fb513-a971-483b-a13e-6078d9813755_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13cf50df-7654-4dee-92df-3aee6c161d09_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_317ca219-f67d-4002-9504-642d62175fe1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total BMS Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a81d35c9-77a6-46ff-818a-36b71108e233_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_eff1ae08-eeb4-4aa3-bee6-3bb83084fa5f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_67b643b6-0f25-432d-a6d5-0f5298e8b259_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_77aaf1c5-dc20-4d20-9616-638dd3741f74_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a2fd50a6-eb48-41d3-a515-c839c484d20f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_fdd8b2e5-b537-4fb1-ad32-a403e5f66bf8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_e6fb7532-4de7-485c-b650-842a51dc9549_terseLabel_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_label_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties [Member]</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember" xlink:href="bmy-20230331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_TecentriqRoyaltiesMember" xlink:to="lab_bmy_TecentriqRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4488973b-228c-4962-ae2a-166faf355c9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_653ee6de-ae7b-44f9-bb2f-76be777d8d83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_03413c2b-3359-462d-85b2-1f5d76437e29_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_423486e0-2973-4cf1-b3b0-8c668e63f036_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_b8435092-3356-4ca6-b7ed-82247430bb24_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_b69a517e-d87b-4037-956d-9a34380b3bd6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_33581863-d193-40ed-9114-cdeed5b469ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and other settlements (a)</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1a928316-34a0-43e5-8e84-4b72ee5868e0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5067ba15-2438-4674-9efd-137aba577815_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0f54f22a-2b0f-443c-8517-9d87d9a15f22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_c420ec68-f23d-47a9-9b50-7e4d240bacc8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_36b22e39-b3f8-4930-8081-c099384e59c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_18f3be68-9a6e-440d-a658-2a6e93de6ac6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_df1b20ef-144f-4c85-a78e-d9824b891fad_terseLabel_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_label_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value [Member]</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_documentation_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommonStock010ParValueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember" xlink:href="bmy-20230331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CommonStock0.10ParValueMember" xlink:to="lab_bmy_CommonStock0.10ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_856c01da-80fc-4337-abc8-ef11a0e13329_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_40c9d6fd-f6bf-42fb-91be-4b8f10f30e34_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_a1b519f9-fafe-4a12-9f97-d47d26d27037_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables &#8211; from alliance partners</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_81767df0-14e1-4326-8507-4bc597d6e9a1_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9ad71432-5c1e-4b6c-a39e-eb539176ed2c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_838d51e5-be2e-43d7-8231-7429f8c0bce6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_15514773-fe9a-49ec-bbd9-1f59c1daadc6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_df93cb81-1aa3-400c-a072-83307b1929f3_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_8216b881-f17c-4cf9-a348-80aacd226639_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0bfe7c2c-05de-490d-9c0a-9bef17cbde1e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2fb8c736-45e7-421c-887b-7ba3b8849f40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain recognized on investments sold</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_c132a32b-6189-4a80-bbb7-0d09b98b3864_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_bb41de0c-97c1-48a2-aa9f-5e276e0b825d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ed308898-92b7-4180-b608-3ac0a026597b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2de7ede8-e6fb-438d-ac75-1733fb966390_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_41705f5e-7b4c-4dfd-aa74-ed7d328fe7e0_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_eec56d71-c9bc-404a-a7c2-6c8a092b5f9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_c37dfebe-12f9-4fe8-a361-5c8c2810b5d3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_12f4ee8a-b1e1-4000-bbc8-0f12bde5b841_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_14f60f30-66e5-4e59-bea8-c914632e5fad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_c56404f7-9958-4670-afa5-ebba7fd260db_terseLabel_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_label_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_documentation_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:href="bmy-20230331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:to="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0d817dec-2d98-4799-bd6d-d1e443dcf83a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_e744197e-cab2-48de-bae2-e50d3b929d6c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_7f1af5c2-c1ee-4072-85f3-4f323b0ffded_negatedTotalLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:to="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_bf759740-b4e3-4b9f-ae4e-e51493f9db1e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a64fa043-2c91-41e9-953b-ce03861541c2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_bd3f7e4b-5946-4f7e-853a-70668ae98e61_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_bf6e9d4d-71ed-44f6-bf41-cf349d935340_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:to="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ac451af4-61da-485e-bcbc-4b1a5af23337_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fe55f9a6-2415-4f10-8ba8-8e62b118c022_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying amounts</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f9a0544a-5ac9-41cc-9bf1-b20d0c9059ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f606beeb-c3a1-4ef8-a6f7-577fd9fc29c7_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7e3197ef-d03e-48ce-8917-aeddfac12ec7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_0758eb21-b326-4592-b58e-5ba25c85808b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7ee0ebca-962d-4ea4-965c-00352853b314_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1211dbe7-ccec-4a78-a700-5942d13882f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_50316598-68ee-4d1b-95d1-a4716b3c3b96_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_fec020d4-9f43-4381-ab97-d8905bdbba0a_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:to="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_f16a9405-4d8b-424e-9923-76f82ae47b8b_terseLabel_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_label_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties [Member]</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember" xlink:href="bmy-20230331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_KeytrudaRoyaltiesMember" xlink:to="lab_bmy_KeytrudaRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MarketShareUnitsMember_02ad68d6-058a-4b49-98ad-aa17d7183cb3_terseLabel_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units</link:label>
    <link:label id="lab_bmy_MarketShareUnitsMember_label_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember" xlink:href="bmy-20230331.xsd#bmy_MarketShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MarketShareUnitsMember" xlink:to="lab_bmy_MarketShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_8cc374e1-cfeb-47a7-9f83-d03e729dd783_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative impairment amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_6107b4be-23e3-4331-9c47-5436e490ef68_negatedTerseLabel_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_label_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_documentation_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome" xlink:href="bmy-20230331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationOfDeferredIncome" xlink:to="lab_bmy_AmortizationOfDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_fe3c2f28-4f57-43a6-a3c9-37e64072e5bb_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cfb37208-a20b-4168-8c93-cf704b62e7fd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_8cc7f16e-491c-4140-ac85-4452a973f152_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2ce3fd99-d4d2-4efb-b069-eb39aeaf525e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a40c3d70-27bc-4aa4-b119-16782eb2d153_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_4c6733f2-f4b9-4393-9aba-758e03140044_terseLabel_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_label_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:href="bmy-20230331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:to="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_dccab9d2-6a5c-4f08-9e7e-116f8f64b3fc_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InrebicMember_be04bd8a-7d66-481e-bf6a-a74a918bf750_terseLabel_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic</link:label>
    <link:label id="lab_bmy_InrebicMember_label_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:label id="lab_bmy_InrebicMember_documentation_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember" xlink:href="bmy-20230331.xsd#bmy_InrebicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InrebicMember" xlink:to="lab_bmy_InrebicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_4b17d3e3-23fc-47a0-a55e-20c79d68a586_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_00167e27-b6a4-4e9f-b0f4-d222a60920a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2022</link:label>
    <link:label id="lab_us-gaap_Goodwill_57bfb4ba-4209-48dc-b65d-fda7572eb8c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at March 31, 2023</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_5af48d3a-c9ce-4029-9b93-9b642022fff4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_c62113a8-d9c3-48fa-aeda-a011763571e9_terseLabel_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:href="bmy-20230331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:to="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_5fa610aa-2cfd-4910-981f-301d3ab652bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b8c6a372-5901-43e4-a9a6-67c48e0809c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31110e03-9943-434b-ac28-d1d3eb36579b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8f3d1549-8bc1-4a59-89f9-efed8b3c6c72_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_173ac870-7cac-4315-84f8-a7eb312f832d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_68fa4875-b34a-4ca7-aaef-37b659ca59d0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_54745c0e-a922-46a9-a3ab-04897b4972ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_13386d27-70c6-4ce3-aa1f-407f4ece3723_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_06d72925-236f-4bb8-9bc4-037df7ce7225_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_613695ff-544f-4c17-b4b4-f888ec6ae1e6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0b5c3068-ebda-4d78-a128-d00f9f4dc227_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;in Excess of Par Value of&#160;Stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_aafea6ca-0f5c-426b-b928-3dee5d0028d7_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_36793785-ab78-4c6e-99b8-7b410f4336e1_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_dee99546-fc3e-4b8e-a319-241cdb94fb76_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_9b15cd30-38f7-4a9b-8dff-d12c895784a6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_62da89be-938d-4c1c-850f-09cab46cdaba_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f3f17c94-8e3e-4453-8a23-17d54163dfdd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ccdb5a9-b2dd-4c14-a63a-d5b9e746706e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_258ed726-adf6-4ec9-9578-93b0a0bded9b_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_4aded4a2-3669-4a0f-869c-9313656ec41f_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_c7fc742c-3ac5-4631-8699-ae343bc1d3de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LitigationTable_af411020-071e-4e38-82d2-14039ba591ad_terseLabel_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:label id="lab_bmy_LitigationTable_label_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable" xlink:href="bmy-20230331.xsd#bmy_LitigationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LitigationTable" xlink:to="lab_bmy_LitigationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_b2cfd486-fce4-48c2-8765-c54bd59a6c18_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_885687fe-530a-4b01-aa90-300c22e0fce3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_label_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Bank Loans and Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a5ba9cea-0dda-4aa7-81f5-688b36c46516_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52480daf-983f-4442-8df6-10adb6d599b9_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_db451292-a655-4f27-afbe-399bdf3c6497_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and downward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_2596a487-a4c2-4ebf-aaea-dbf828d18c80_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance revenues</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NimbusTherapeuticsMember_1f3b991f-8b4c-45ef-84fd-6be6c499643b_terseLabel_en-US" xlink:label="lab_bmy_NimbusTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapeutics</link:label>
    <link:label id="lab_bmy_NimbusTherapeuticsMember_label_en-US" xlink:label="lab_bmy_NimbusTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapeutics [Member]</link:label>
    <link:label id="lab_bmy_NimbusTherapeuticsMember_documentation_en-US" xlink:label="lab_bmy_NimbusTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nimbus Therapeutics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapeuticsMember" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NimbusTherapeuticsMember" xlink:to="lab_bmy_NimbusTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_37d32a6d-7891-4696-8cff-8a844c73c402_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_c07a5150-0c25-4f0e-806a-617d18ecebba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax_cafbc032-5908-45ab-9711-96defc30b907_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge gains</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_39deda59-f357-4361-814e-0fc6260c2bc8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_44698752-d221-481c-95e6-d348d971a8e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration expenses (Note 6)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_31e6e0ab-431c-4a1f-8532-e2466bda5cb5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_01e61a3e-8419-4a79-aaa5-dd153a663b86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_7efa660c-7cf1-4917-8c9b-a983c6d7ade6_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:to="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_59db3032-335c-4144-b454-32e5fb1c6cf5_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Gross to Net Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:to="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_78dc6f47-2d74-45c6-a75e-3aef2dc989f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d2689147-1550-4c8a-8dca-4ba7792f769e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gains</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_3575223f-04b6-49af-a483-726966dbdd17_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reasonably possible decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f8032ef-fcb8-43e8-9d11-3ab5276bfbea_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1d0e2c2f-6c84-4601-91f4-ec169191dbd6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_bda9bb89-a013-40ff-931d-9ff5e6971047_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_740f8876-f8bb-49b3-8d83-d433089b9af4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_6a5b3841-e3f2-4dd5-9d7c-b5cff4326268_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_8a3fa730-9e0c-4006-945b-2c2a083e2f67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_346761f8-a1c1-43d0-9a7c-581161a12903_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partnerships and other equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2116a55f-e6b5-4e1b-9ca1-83b4b97c7643_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_f36c39dc-82e8-4eff-9e93-cc2330bb9c7b_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1725349b-88ea-4a0a-9b9c-48187005f17d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_b88d5aa9-ad14-498b-9019-9ac8eb61c004_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed cases</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_2c1365b1-c5cc-410d-ba01-d59b2ed9c62e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97d780aa-00be-4cd4-888e-53b342cdb979_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_b02b5c1a-adb8-4521-9f08-bb2a9dc3cc3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for CERCLA matters</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_e3a352d8-2f1a-4768-be78-d5d7799c2154_terseLabel_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized basis adjustment from swap terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_label_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Basis Adjustment From Swap Terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_documentation_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:href="bmy-20230331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:to="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_43fa1b97-ff2d-4de1-9260-125a66e0ae9c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_00bc4b06-429a-48de-8593-1af870bf3dc9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_519fb9df-2876-4be5-8cb6-0aab1b481708_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate debt, lower range of basis point spread</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa08dd52-69a8-4a07-87e8-d1c98c492d7f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_335116c5-cef5-48ee-8bee-761a972429d3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7ec5423d-4eb5-4745-847b-b3e955d38020_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b35fb25b-ff18-42be-bfdd-c1e0f227fe6b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other comprehensive (loss)/income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4326d3f1-0e29-4e19-8590-a5a45d091df9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_301b5285-838d-4cc3-958e-45a06324b0d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fe70a024-1bf9-4544-9d47-c95ccfd9b4ac_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to BMS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_d2b3c14c-562f-4fe0-9067-1f3dca5630a3_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_fb241385-018a-441d-aeb9-216922dfdf86_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7d92bc94-530b-4744-99d7-1227275c16c6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_02c46c04-78ba-4bf0-b0e8-8d96751d5196_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ed6fd3e2-43a0-444f-b1f9-40f27537c481_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3b979c86-dd8c-4d40-a470-719ec3ce8d12_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_46e6ef23-ce58-4647-98d6-c39dacc43400_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:to="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c594ad2b-ee5c-4dd5-946f-dd5efb8be4e7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_81526034-ecae-442f-aef3-68c0eeec8fdb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_6f6d431e-207b-4ca7-926e-0f4ca29dde0b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2e17d5e8-40c8-485d-933c-225b1d1b044d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_aa78ace6-b10a-4c5a-bc8b-402521f1177b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Totalinventories_277b81e2-f49d-4918-a221-75cfb98df1b3_totalLabel_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_label_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_documentation_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the total inventory, current and non-current, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories" xlink:href="bmy-20230331.xsd#bmy_Totalinventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Totalinventories" xlink:to="lab_bmy_Totalinventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_0051af73-88ed-435f-b4d8-e6e73ea5a4a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_2c26b222-a4f2-40cb-945b-e56a63798dba_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_547bc46d-ed26-417b-8537-4f540f1698d7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization, net</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_0b64f744-3027-4d17-9452-a6e650a501d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_c7f1c61b-1fcd-4c70-8a5e-224bb22a0f90_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_df7d664c-bbda-4bf7-b888-9808d72c8fad_negatedLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_09b14150-1ce9-42ec-acd0-39b21261638e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty income, nonoperating</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:to="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_c7675f97-30b7-48e2-8464-4aa98f10a67a_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_dbe706ff-34ad-4f4a-a6a3-5202cef51e4a_terseLabel_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_label_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_documentation_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:to="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PomalystImnovidMember_d9905367-1b3b-4edb-85fb-9cef9ab0bc20_terseLabel_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_label_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_documentation_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember" xlink:href="bmy-20230331.xsd#bmy_PomalystImnovidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PomalystImnovidMember" xlink:to="lab_bmy_PomalystImnovidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_dae5ecd8-7952-4800-886a-2d43e0ba7bd9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses), after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_facd9cc2-5d6e-4877-bf37-c408341e1d40_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b1c33474-1a55-4d0a-b2ff-8687285d8550_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DragonflyMember_0484bca3-22ba-45ed-9d1d-0afa13f94eed_terseLabel_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:label id="lab_bmy_DragonflyMember_label_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly [Member]</link:label>
    <link:label id="lab_bmy_DragonflyMember_documentation_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember" xlink:href="bmy-20230331.xsd#bmy_DragonflyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DragonflyMember" xlink:to="lab_bmy_DragonflyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c4423b4-7f72-4cd7-9dbe-008d7cfa7261_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_c8811fe2-15e3-4d48-ba54-c38054f57ad6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f6be048b-7a80-4d37-a80f-1b6b92ee9239_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_42b69d6e-7ae3-4e57-95f9-014d45af28f3_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_83e47688-696b-4c63-9120-45fd9b3eb339_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_5b784116-750c-4786-b7f0-c8414d44085f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:to="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_0ef9c7e0-b618-4d8c-8833-ff075ff7da2a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7db1a39f-6fed-4200-bed8-277dccb56392_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cost of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_648907e4-18d0-4a3c-80a3-ed0ed587961c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0cdcea12-1810-40df-8ef0-5df86d79398a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_092dac11-5334-4f24-9014-7d9e4c5099ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/Expense, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2022ASRMember_295fc9b2-ecde-4b59-b67d-12d117a2eb0f_terseLabel_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:label id="lab_bmy_A2022ASRMember_label_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR [Member]</link:label>
    <link:label id="lab_bmy_A2022ASRMember_documentation_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember" xlink:href="bmy-20230331.xsd#bmy_A2022ASRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2022ASRMember" xlink:to="lab_bmy_A2022ASRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b9735983-8e34-4308-96d4-4d9851e098f5_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture (Gains)/Losses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1c28a584-59df-43f1-af9c-dcd4483cfe94_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gain</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_58dd7bb3-b215-4000-bd7d-7ab9e27b3864_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains (Note 4)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e26085d8-d3c9-4db5-b507-367add8a59b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7dcee541-df5d-4545-ac13-284c7769647a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3a45e880-8fb8-4f29-a6f0-8863ccfedbc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cd0f221f-a815-43f2-8d77-322b064df8e1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_aff0abad-43f3-4cb2-9677-282f398db880_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_bc593b98-76a8-40c8-be7e-22890b43c647_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3e111576-b0be-4615-99bf-96cb3196beb0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b3e4f25a-5f4f-4292-ac62-dc064a16c8fe_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0157d16d-73b0-4549-8fff-85d395bb86af_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_39c7a769-3f66-4f14-be65-f0f6858fc33a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7e829ca0-8760-4951-80ee-23a6b2ad20c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_61471822-8668-4214-8750-4baf973c9c08_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_a580c61f-758d-4be2-9f64-24196b7d0a6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_be114dc2-5ca4-4fb3-95ef-2e3451b60afc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c1bb29a-7440-41a7-b879-56bb0d2d7a96_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneIntegrationMember_9283d6e8-4e16-45f7-a2e0-a177958f5401_terseLabel_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Acquisition Plan</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_label_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_documentation_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneIntegrationMember" xlink:to="lab_bmy_CelgeneIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7587dc9f-7fec-42e0-92bf-95b040926305_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_44e497f7-452b-4935-b9e9-11dc7413781c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash for contributions and settlements</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b7bf5e4-b1c2-450f-8171-f35693478296_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3b57b8ae-a3c6-4c3a-8c79-cc97eef267a8_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e14c1eba-a9ff-475c-90f7-6679e403c3a7_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_4f5ca417-fd40-4bcf-9dba-0d27527a0e4a_terseLabel_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_label_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035 [Member]</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_documentation_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One750NotesDue2035Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member" xlink:href="bmy-20230331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.750Notesdue2035Member" xlink:to="lab_bmy_A1.750Notesdue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e13f2406-77a6-4c8e-8a89-fb264578e76b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payments</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a784a6db-2e13-47d9-a9f6-6bf5a80d1cee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_c36e9a9b-6080-440e-8edf-1603805e7eca_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:to="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_f4eb32f0-13b5-470d-bb9d-3967ed6dc82b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_77571baf-ba8c-4e92-a76e-6076b3e5b32a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3099aae3-a73e-4633-ba4b-97bf02e5a65d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_12f28570-cbef-4822-8932-cc18672b7312_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_1669f55b-5c02-4534-8d70-96253cd8f256_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_e96829d4-4d4c-405f-9193-188981d46c0a_terseLabel_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_label_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:href="bmy-20230331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:to="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0cbcacb6-f80f-4a35-8532-7858b69c59a0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_79f1f9ec-da56-4e1e-9657-96f601396b03_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_60b3810d-23b6-4a8c-9e79-68efe7d7c02a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_bde8fe59-acdc-494a-9884-f0a60ded6923_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_77eda282-f84f-4937-8a61-c592154137c1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts gain/(loss):</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivatives [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:to="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d300ec9d-f1ae-4b5f-b3fe-1ca6bb392bd2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_63d882ac-4d1c-4e7c-bd83-7d52ae2a6feb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnuregMember_b68a9480-240e-4cd5-81cb-775a91ebbdea_terseLabel_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:label id="lab_bmy_OnuregMember_label_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg [Member]</link:label>
    <link:label id="lab_bmy_OnuregMember_documentation_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember" xlink:href="bmy-20230331.xsd#bmy_OnuregMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnuregMember" xlink:to="lab_bmy_OnuregMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_8963d7ce-9411-42c6-83a6-2311cfe991f4_terseLabel_en-US" xlink:label="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option proceeds and other, net</link:label>
    <link:label id="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_label_en-US" xlink:label="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Stock Option Exercises And Other Adjustments</link:label>
    <link:label id="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_documentation_en-US" xlink:label="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Stock Option Exercises And Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:href="bmy-20230331.xsd#bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:to="lab_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_ab5bde61-0cc1-4ac5-98b4-bfcded0791ad_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_0473b40c-16f7-44fb-aa22-63386e33214a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_e913ca08-3cf8-48b2-96cc-b2b1a02a8754_totalLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, total</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9949df2e-0653-4ba4-818d-c28b59a3560f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CashDiscounts_f1ae16cb-2b6c-43e5-a81c-cf8456cd3237_negatedTerseLabel_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_label_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_documentation_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts" xlink:href="bmy-20230331.xsd#bmy_CashDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CashDiscounts" xlink:to="lab_bmy_CashDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_06f2731a-3731-4b46-9084-e366717b82c7_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a9a7a8be-e205-4043-8c77-aecfe238487d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_923d20b9-b949-4d2a-9044-6699b008eb66_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_6e0a91a1-5a84-4d09-9334-11d6c887aef0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncome" xlink:to="lab_us-gaap_OtherNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4b2eacb9-4ad3-4201-a597-f4c4f155cd59_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_79392a16-a716-4525-a103-60414c9f7f67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance, royalties, VAT and other</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_702ef67f-a40e-4d02-a678-5e93bdfca4e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_3868b759-6f53-40ac-b10a-44a594abe70e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_c3b6cc58-f072-4dbb-879b-dad9e9ee9028_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdivoMember_f827a0ac-a179-4229-87a1-d11f4d8f9769_terseLabel_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo</link:label>
    <link:label id="lab_bmy_OpdivoMember_label_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo [Member]</link:label>
    <link:label id="lab_bmy_OpdivoMember_documentation_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember" xlink:href="bmy-20230331.xsd#bmy_OpdivoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdivoMember" xlink:to="lab_bmy_OpdivoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a48c9f4a-1fd9-4e15-9b46-8645abe92622_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_62a5a417-c0d6-4750-95f0-077a5d608432_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_df70243c-2f25-4169-b4d1-d0c6ff005c2f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c6881d9c-c7ad-4be8-97e8-1afc1794ecb8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdualagMember_aad95543-d3bb-4d2c-af14-d13dd897e353_terseLabel_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:label id="lab_bmy_OpdualagMember_label_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag [Member]</link:label>
    <link:label id="lab_bmy_OpdualagMember_documentation_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember" xlink:href="bmy-20230331.xsd#bmy_OpdualagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdualagMember" xlink:to="lab_bmy_OpdualagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1117a014-2fe8-4a6b-9bfd-195221e8b015_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9c0a690f-f9c3-4ae2-b618-6d00fb36fdbb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &#8211; to alliance partners</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_686d572e-2597-46a1-9a71-50cc4bb0555a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring (Note 6)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_266c8a0e-5830-4552-88ec-81cc1f053213_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DiabetesBusinessMember_ec0cbb10-2740-4aa4-b340-81772dbe47ea_terseLabel_en-US" xlink:label="lab_bmy_DiabetesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business</link:label>
    <link:label id="lab_bmy_DiabetesBusinessMember_label_en-US" xlink:label="lab_bmy_DiabetesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Business [Member]</link:label>
    <link:label id="lab_bmy_DiabetesBusinessMember_documentation_en-US" xlink:label="lab_bmy_DiabetesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesBusinessMember" xlink:href="bmy-20230331.xsd#bmy_DiabetesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DiabetesBusinessMember" xlink:to="lab_bmy_DiabetesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NetProductSalesMember_d2fb3b4c-905c-4b9f-9503-32a66ff4d3cc_terseLabel_en-US" xlink:label="lab_bmy_NetProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_bmy_NetProductSalesMember_label_en-US" xlink:label="lab_bmy_NetProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Product Sales [Member]</link:label>
    <link:label id="lab_bmy_NetProductSalesMember_documentation_en-US" xlink:label="lab_bmy_NetProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NetProductSalesMember" xlink:to="lab_bmy_NetProductSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_6f40b078-7ec7-45a4-a5c7-9ffbc17d46c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_20f2786f-016f-4a4e-b1ae-716e57f9a036_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized bond discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_4c5d149c-15b9-4225-a8c5-a600f5c3e622_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determined fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_2a13c130-f1bd-4b28-8a5f-1d85438f9c25_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_1696ed5a-ad05-4eb5-9ef6-675ef5311573_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestitureandotherproceeds_860f70de-da8f-42b0-b144-c7e0f26176df_terseLabel_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_label_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_documentation_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds" xlink:href="bmy-20230331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestitureandotherproceeds" xlink:to="lab_bmy_Divestitureandotherproceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_c118196c-b46e-4fe6-935c-fba50d6d91c3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_ec5ef7be-cd9a-4bc2-9fc8-c87270f4fefc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_a1fb80a7-0e06-4618-8c3e-6f8107526a50_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ed1f3282-73a3-4f51-b2c3-412cef2c0b3d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a7b96254-d6fa-4ed1-8afe-1a5f73a60d2a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_30808d76-775e-4bd6-b690-afcdc0e9f033_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b4e020fa-eb8c-419c-ad8e-85695c8309ea_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BusinessRoyaltyAndLicensingIncome_30b40092-7c74-4f7a-b255-4727cb573488_negatedTerseLabel_en-US" xlink:label="lab_bmy_BusinessRoyaltyAndLicensingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty and licensing income (Note 4)</link:label>
    <link:label id="lab_bmy_BusinessRoyaltyAndLicensingIncome_label_en-US" xlink:label="lab_bmy_BusinessRoyaltyAndLicensingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Royalty And Licensing Income</link:label>
    <link:label id="lab_bmy_BusinessRoyaltyAndLicensingIncome_documentation_en-US" xlink:label="lab_bmy_BusinessRoyaltyAndLicensingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Royalty And Licensing Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessRoyaltyAndLicensingIncome" xlink:href="bmy-20230331.xsd#bmy_BusinessRoyaltyAndLicensingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BusinessRoyaltyAndLicensingIncome" xlink:to="lab_bmy_BusinessRoyaltyAndLicensingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_700687e5-c276-4539-92ad-95209e5e7c48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c4b42241-cc0e-497a-ae19-348ebc35e204_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_dd9b5f7a-7b17-44a2-88b6-e47224d80194_terseLabel_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature products and other</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_label_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other [Member]</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_documentation_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember" xlink:href="bmy-20230331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureBrandsAndOtherMember" xlink:to="lab_bmy_MatureBrandsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SprycelMember_b673109e-77d5-455b-8a89-7f61527d5509_terseLabel_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel</link:label>
    <link:label id="lab_bmy_SprycelMember_label_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember" xlink:href="bmy-20230331.xsd#bmy_SprycelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SprycelMember" xlink:to="lab_bmy_SprycelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8d38b602-ff0b-4414-a237-212504350699_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f31caf4e-0443-4376-88fd-9b5cc0bec159_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BristolMyersSquibbMember_68c781e0-bdd8-4480-a73d-61297b3b2692_terseLabel_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_label_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb [Member]</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_documentation_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember" xlink:href="bmy-20230331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BristolMyersSquibbMember" xlink:to="lab_bmy_BristolMyersSquibbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_321cc39f-5384-4b4d-871b-dceb955ebe0f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_85224757-8aab-4eca-b924-c55fea513db2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_52c75f13-02af-45f9-96d0-a7139bf04883_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_fc130a2d-d8c1-4a4a-b2e1-4e3fddd51408_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_22e9ba71-5b6a-4942-a404-ecb10c53f53a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages paid</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_fe15868f-618a-4cd0-9897-e0e26de3d606_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_ef4ed4da-773d-4b25-9460-3778f5afac34_terseLabel_en-US" xlink:label="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior period gross to net adjustment impacted by new accounting pronouncement</link:label>
    <link:label id="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_label_en-US" xlink:label="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Period Gross to Net Adjustment Impacted by New Accounting Pronouncement</link:label>
    <link:label id="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_documentation_en-US" xlink:label="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Period Gross to Net Adjustment Impacted by New Accounting Pronouncement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:href="bmy-20230331.xsd#bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:to="lab_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_66a29ba1-5871-4284-a2a4-4511620480ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d9ecbf79-2ea2-4045-9b4b-e5c6fdb1c2a5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0b1c5c2a-5a15-4654-9a25-6d5d641eaa77_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Benefit Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_dbae9eac-b831-463b-a46b-7b5461be23da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_095278fe-d288-46e5-8db6-0441e3224abd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_34dc078d-db37-4ccd-b160-2e87b526b039_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8ddb6c2c-9dcc-4815-8d5d-8e9ec7bcebba_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_8cb6930e-c2c7-46e9-867f-1b9fa3a3b0c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_f623ce6e-2213-413d-975e-fd79d6428ed3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_65fc6cae-2057-43a1-90b0-1f00cbaf3476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_59b47e7d-a1ed-411e-9824-80b561b3484c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_683873a7-b3fe-4132-aa73-03e7101bc7dc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation to holders of the contingent value rights</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3b8579f4-2400-474f-bd56-abfef6d0553a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_304feb7e-4735-450e-8f1f-dd7422aa3646_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8e84513b-918f-4b1c-bb12-e928868775e4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw and packaging materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_0a98c1fe-52e6-4a8a-9106-80b196a551ee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9528d456-e56d-4085-a451-70c89f3db5f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_15f98f91-85ae-44e0-a2a9-62a52b89145e_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_422cb3d7-fd7d-4228-9692-b0ac32e888d8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_169975fd-3590-4976-a396-c6353bc071d2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_c514e5db-966c-469f-8847-5f5845d4e2a3_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember" xlink:href="bmy-20230331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityMember" xlink:to="lab_bmy_AbilifyProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fd1321c9-a234-4484-b207-49e12daab709_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental shares attributable to share-based compensation plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_da82eb24-13f1-42d4-9a1d-433516cbd088_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_18f203d2-6174-47ad-b1aa-5df277517e1c_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims, active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_7a60e44b-4e6a-4a8b-8bb0-ab53f967de4a_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestments_e6490c7c-2472-46fd-b067-a734f934e37f_totalLabel_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_label_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_documentation_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments" xlink:href="bmy-20230331.xsd#bmy_EquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestments" xlink:to="lab_bmy_EquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73746160-edc1-416a-ae5d-c9167ae2621b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22f56ad4-175f-41d8-9cf7-66699a69c322_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other payments, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_099f567b-3bb8-4919-9aca-fdabe31dde2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_31ac05d4-76e4-4f8f-9936-d0fdf60e6cd7_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_a4340f15-b4f0-491e-aa3f-666b95e40004_terseLabel_en-US" xlink:label="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent sales-based milestones</link:label>
    <link:label id="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_label_en-US" xlink:label="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Contingent Payments Maximum Exposure</link:label>
    <link:label id="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_documentation_en-US" xlink:label="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Contingent Payments Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:href="bmy-20230331.xsd#bmy_CollaborativeArrangementContingentPaymentsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:to="lab_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_3fde8304-16e2-409e-9d20-42edb6308fef_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_3dc32fc4-ea53-4bd1-b4b6-f09d72bc8532_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fc87963-d5cc-4a30-9500-b4f4df8ff51e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ae7e0c0-4a6c-4994-9de7-bbf5d6af9945_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c28dfe14-5566-4ae5-99d3-007438ee6715_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_91836961-7f03-4182-b75d-b7d7c5ecf709_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OrenciaMember_01a0f2d8-b6d2-4106-9eb9-07e76e536fcc_terseLabel_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia</link:label>
    <link:label id="lab_bmy_OrenciaMember_label_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember" xlink:href="bmy-20230331.xsd#bmy_OrenciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OrenciaMember" xlink:to="lab_bmy_OrenciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_37fa2f75-2cd1-4b2c-baa1-ac9bb6e5d1f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_08eb9b92-4336-453f-bc35-e2fa7c648115_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_6b3dad84-4fb9-4f68-a934-4e8b912e7751_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9434746b-47d6-4b12-a921-42e6acf4ec6f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_15679fd3-a3b8-4267-9558-2f584a1f7b4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_22b5c58b-07b4-42ab-bdd6-7b4791bbd4ae_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_bc1c156f-6078-4ea2-94c8-ea89bbcda0ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_c9c49288-a72c-4aec-a1fe-83abff7ffcdd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_d33a9301-6659-481c-9c0b-36ed89013dec_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncome_d3ca3746-f745-4d34-a538-b68bdfa27bb2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income from - alliances</link:label>
    <link:label id="lab_us-gaap_DeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncome" xlink:to="lab_us-gaap_DeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b1098163-8dd6-4fd8-8fa2-9a88ebdf3365_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceRevenuesMember_033cf6e8-a2f8-487f-b440-b3426ea5c974_terseLabel_en-US" xlink:label="lab_bmy_AllianceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance revenues</link:label>
    <link:label id="lab_bmy_AllianceRevenuesMember_label_en-US" xlink:label="lab_bmy_AllianceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceRevenuesMember_documentation_en-US" xlink:label="lab_bmy_AllianceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceRevenuesMember" xlink:href="bmy-20230331.xsd#bmy_AllianceRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceRevenuesMember" xlink:to="lab_bmy_AllianceRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_c2cf47e1-959b-4214-bbe4-2168c4660145_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_23bc05ac-1a86-452d-be9b-dc0ddae710f9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EliquisMember_9f2308ee-36c5-4c7c-9120-60596dfe6ded_terseLabel_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis</link:label>
    <link:label id="lab_bmy_EliquisMember_label_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember" xlink:href="bmy-20230331.xsd#bmy_EliquisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EliquisMember" xlink:to="lab_bmy_EliquisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_855900e6-43bd-4c1b-9378-2db8496de76f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss recognized</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3c817756-21fd-48c1-8bbe-bd00ada89fcc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_380062e9-2718-4830-8d8d-517142ebec02_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_1d364a45-b9b3-4933-9fd6-d22f5e9a92ed_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_6dd4a55b-61cd-4b73-87e9-d7e797ed3b59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss recognized on investments still held</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_79ca92da-0426-49b4-b97a-403f6ac5bd5b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_69c73d9d-fa3d-48c2-af87-f5304ccc6605_terseLabel_en-US" xlink:label="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of ownership acquired</link:label>
    <link:label id="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_label_en-US" xlink:label="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage of Ownership Acquired</link:label>
    <link:label id="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_documentation_en-US" xlink:label="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Percentage of Ownership Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:href="bmy-20230331.xsd#bmy_AssetAcquisitionPercentageOfOwnershipAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:to="lab_bmy_AssetAcquisitionPercentageOfOwnershipAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_42d1d31d-36cf-4f27-86ac-b4cb4ae573b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b0c107b2-92cb-4192-a957-75a73f7ffaf2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_427c0c19-45fc-41d5-91d0-baad79a5faad_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation and other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_24e14d28-030e-4e96-9288-0d74c02ffbe7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f0271e97-0113-46a0-8fc0-68813a671126_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (Note 10)</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_7b2f3139-dfd1-458e-9c6f-83ca362db406_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_5dbe5342-7eb8-4a58-9324-14d0ac7c479c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total return swap contracts</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_3f142bcc-647f-4a4e-bf63-dbc19fb41d7b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_dbdab442-52a3-4023-99f3-142f7bfcaeaa_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e1c16970-eceb-407c-9841-d1bbb796d876_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2750NotesMember_3118718d-2f50-4bc1-b1c7-a6142bd1eefe_terseLabel_en-US" xlink:label="lab_bmy_A2750NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes</link:label>
    <link:label id="lab_bmy_A2750NotesMember_label_en-US" xlink:label="lab_bmy_A2750NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes [Member]</link:label>
    <link:label id="lab_bmy_A2750NotesMember_documentation_en-US" xlink:label="lab_bmy_A2750NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2750NotesMember" xlink:href="bmy-20230331.xsd#bmy_A2750NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2750NotesMember" xlink:to="lab_bmy_A2750NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_d6027ec9-8fdf-400a-bde3-0d7e03a1919d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_8f52b5af-f793-46bb-9070-2cb3e9840c51_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_6dfc4b1f-8e14-4791-80d9-c29c623c11ea_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_61384681-acc7-4e60-ba27-fae2b45c9c74_terseLabel_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20230331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ccc8cba1-5202-40ab-b5be-9772742b3f71_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt and Current Portion of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_2df3edfc-6501-47c6-b575-d61281dcddfa_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReblozylMember_e90054f9-ae4f-4af8-942a-7646e16bd49a_terseLabel_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl</link:label>
    <link:label id="lab_bmy_ReblozylMember_label_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:label id="lab_bmy_ReblozylMember_documentation_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember" xlink:href="bmy-20230331.xsd#bmy_ReblozylMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReblozylMember" xlink:to="lab_bmy_ReblozylMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8eaf5a73-a20a-4b39-b8e6-193f6c649f92_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_6130a12a-3e07-44b3-a159-9485dd33d93e_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_label_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Cash Flow Hedge Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:to="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_151991b7-8987-466d-bc0d-7bf824847bfb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_e40ea8be-b0e1-411f-94c6-f7dea5ffbf23_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of equity investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_b1d3a4e3-dd96-4a2b-a840-cb9b4f4c07ef_terseLabel_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. receivables sold on a nonrecourse basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_label_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold On Nonrecourse Basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_documentation_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of receivables sold on a nonrecourse basis during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:href="bmy-20230331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:to="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_17d895f5-728d-40d9-870a-3f492868003f_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:to="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_af7f32bd-ef79-4595-b478-eef84cbf958b_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_a493d7fa-a712-40fd-974b-7433765d7860_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbraxaneMember_2c32122c-6252-4108-9f54-39cd613a06aa_terseLabel_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane</link:label>
    <link:label id="lab_bmy_AbraxaneMember_label_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:label id="lab_bmy_AbraxaneMember_documentation_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember" xlink:href="bmy-20230331.xsd#bmy_AbraxaneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbraxaneMember" xlink:to="lab_bmy_AbraxaneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a196422a-71dc-4ded-b936-c04bf080a2b9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_f3a3cf51-ef33-4255-a476-5af2a2929701_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_a5f87026-9a78-4f35-8c90-005aa372acff_terseLabel_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_label_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_documentation_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember" xlink:href="bmy-20230331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ChargebacksandcashdiscountsMember" xlink:to="lab_bmy_ChargebacksandcashdiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4ea69c16-73f5-426d-818a-aeab15bc7d4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ZeposiaMember_24997a93-c3c3-45aa-9a2a-d0a414c34d30_terseLabel_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:label id="lab_bmy_ZeposiaMember_label_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia [Member]</link:label>
    <link:label id="lab_bmy_ZeposiaMember_documentation_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember" xlink:href="bmy-20230331.xsd#bmy_ZeposiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ZeposiaMember" xlink:to="lab_bmy_ZeposiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_22562d47-1235-4339-aca3-5e35309fa3b2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c96533fe-5868-4fc5-b12e-f2cf2437c98b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_8bea916d-a096-4801-b244-ad8ee759b018_terseLabel_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_label_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025 [Member]</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_documentation_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One000NotesDue2025Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member" xlink:href="bmy-20230331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.000Notesdue2025Member" xlink:to="lab_bmy_A1.000Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_696aae90-29e7-4024-a6a4-b81c22d586e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ae36b18c-5104-48d3-bc13-9d8ebf85b679_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_bfec605c-63ee-4de4-9136-eb1c921ccd9a_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_efa7d6a6-2e91-4298-9257-ee5f28c9e9ac_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_5331a496-9ff2-4188-99e9-317b5c6239a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_7be7232c-8890-4350-8dac-0ba7b0815d2c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7c30cd96-b4ee-4f36-babe-cf75c02065f7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8489d82f-a10e-4c93-b2f8-a41caceef537_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_8762d370-cf7e-4405-b5f4-a9640aabfc83_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9910b3b6-1b0d-4027-9126-45e87c50f554_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f8feae2d-9a86-47aa-88ac-dab60d76ab6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c621c7cd-d93e-4dcd-baed-9d61b013a2fb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbecmaMember_849d0e09-21e5-40ed-937c-0977fa6c3f01_terseLabel_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:label id="lab_bmy_AbecmaMember_label_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma [Member]</link:label>
    <link:label id="lab_bmy_AbecmaMember_documentation_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember" xlink:href="bmy-20230331.xsd#bmy_AbecmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbecmaMember" xlink:to="lab_bmy_AbecmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InLineProductsMember_983f28db-632a-4016-809a-6d13ffd6eb77_terseLabel_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Line Products</link:label>
    <link:label id="lab_bmy_InLineProductsMember_label_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products [Member]</link:label>
    <link:label id="lab_bmy_InLineProductsMember_documentation_en-US" xlink:label="lab_bmy_InLineProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-line products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember" xlink:href="bmy-20230331.xsd#bmy_InLineProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InLineProductsMember" xlink:to="lab_bmy_InLineProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_9508596e-da8b-4218-aa2e-6d71459e4da2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_471e8bd9-4dd9-4859-880f-629bf4bd3e19_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fe695732-4e76-40ee-b96a-cef24436eb6a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c950c7be-a88e-48f2-9db0-456fe47b19d2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of other intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f72be7c2-a568-4cfd-b505-0665952ed701_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7d102f2e-3d8d-4f6b-aadf-763cf6c3d0db_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_e6ecb062-389f-4677-abf3-9663f3e7735e_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_ff4ca32a-27a7-4201-b47c-aa445feca90f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reserves</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_f2819c67-cd07-4dfa-87d4-55a62835a8f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CheplapharmMember_e97c4d87-68bf-4411-b9cd-773129ce9a1b_terseLabel_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:label id="lab_bmy_CheplapharmMember_label_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm [Member]</link:label>
    <link:label id="lab_bmy_CheplapharmMember_documentation_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember" xlink:href="bmy-20230331.xsd#bmy_CheplapharmMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CheplapharmMember" xlink:to="lab_bmy_CheplapharmMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8f9677c6-2c4f-4ac1-a33a-977a126a0db4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_e2d5a3ad-3812-42e8-86a5-67079b045cc5_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and regulatory milestone payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:href="bmy-20230331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:to="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e64b5c63-1aa8-4d36-b37d-cb370fb2e145_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f9995a95-d66e-4202-a2db-04be966c136e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_d495f233-565e-4557-a87c-899dea8bcb80_negatedTerseLabel_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent milestone income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_label_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_documentation_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:href="bmy-20230331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:to="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_35e37756-7d20-4c42-8ac6-54f9c006cf3b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ff930fe6-a79e-497a-8d0a-230914598d04_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2049edb0-0a7c-4533-8f71-993f899f32a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net loss of affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ImmaticsMember_0def95d9-f9ff-4b83-9d91-7605a9ee2a6e_terseLabel_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:label id="lab_bmy_ImmaticsMember_label_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics [Member]</link:label>
    <link:label id="lab_bmy_ImmaticsMember_documentation_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember" xlink:href="bmy-20230331.xsd#bmy_ImmaticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ImmaticsMember" xlink:to="lab_bmy_ImmaticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3134bfa6-2677-4610-8840-011841497426_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_7306d322-837a-407e-8787-05955a54f776_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_46c8b673-603c-473c-9dfe-3a730b22305a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRegionMember_ed036125-5c6f-4258-982d-063d2a7684fb_terseLabel_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmy_OtherRegionMember_label_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember" xlink:href="bmy-20230331.xsd#bmy_OtherRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRegionMember" xlink:to="lab_bmy_OtherRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b7fd8c8e-b988-4928-b6f9-9a31da9332ca_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_bcf772fa-2668-4447-a4c9-bf9499f28bab_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_04a66627-c9ea-4c57-9606-ae1bc509c6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses, net of cash divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_47d95932-0e8e-4100-9875-028dd568c9e3_terseLabel_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_label_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Collaborative Arrangement</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_documentation_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:to="lab_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7739ade8-eafd-41d0-ac2e-02776f137519_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d15c6af2-80d3-4122-b852-36c79dcea741_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_932f960a-24d3-4e11-90cc-e917550069d9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmy-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CoverPage" xlink:type="simple" xlink:href="bmy-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_edc27624-e250-46da-9b90-39cf3a98576b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_edc27624-e250-46da-9b90-39cf3a98576b" xlink:to="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2e4feeda-6006-41c4-98a1-acf5deacb132" xlink:to="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_68de4351-d8b5-4373-ba6f-21d442f8c16b" xlink:href="bmy-20230331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_CommonStock0.10ParValueMember_68de4351-d8b5-4373-ba6f-21d442f8c16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_a8867bdd-4fba-4a79-8761-0e77a719dc11" xlink:href="bmy-20230331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_A1.000Notesdue2025Member_a8867bdd-4fba-4a79-8761-0e77a719dc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_58b3b52c-e6fe-4008-a058-5c2986707337" xlink:href="bmy-20230331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_A1.750Notesdue2035Member_58b3b52c-e6fe-4008-a058-5c2986707337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_16fd3dd1-4fd3-461f-8366-e81c207cbde8" xlink:href="bmy-20230331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48d221f5-60dc-4d3b-95b0-f782afa3c94d" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_16fd3dd1-4fd3-461f-8366-e81c207cbde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27a4add1-1f3b-4bb2-958f-af6f1c3b1332" xlink:to="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e35f5067-73dc-4483-9343-e85e0c60833a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentType_e35f5067-73dc-4483-9343-e85e0c60833a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_daa4d840-d1c3-4a3d-bc81-bc690d32d433" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentQuarterlyReport_daa4d840-d1c3-4a3d-bc81-bc690d32d433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_21e1fa55-de21-4644-921c-f7a8fe910c35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentPeriodEndDate_21e1fa55-de21-4644-921c-f7a8fe910c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0bdd0625-ab63-4ddb-afb2-69df14d596d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentTransitionReport_0bdd0625-ab63-4ddb-afb2-69df14d596d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5fedc41d-6746-4423-8f27-fea0d2d5e1b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityFileNumber_5fedc41d-6746-4423-8f27-fea0d2d5e1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a83fdfd9-b3af-41af-91da-784d347182ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityRegistrantName_a83fdfd9-b3af-41af-91da-784d347182ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a84615a8-9b1e-4531-9194-1c66bd8b0801" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a84615a8-9b1e-4531-9194-1c66bd8b0801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_912ed532-01fb-47d9-84b0-33efa2cda528" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityTaxIdentificationNumber_912ed532-01fb-47d9-84b0-33efa2cda528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_17554b90-4dda-4538-965d-0bc9c1b79042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressAddressLine1_17554b90-4dda-4538-965d-0bc9c1b79042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_25571cdb-72c2-4146-a494-09e89fdb999d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressCityOrTown_25571cdb-72c2-4146-a494-09e89fdb999d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f3e7e558-fe67-463e-8e1a-bee2889efd10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressStateOrProvince_f3e7e558-fe67-463e-8e1a-bee2889efd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5d09366a-c074-41ec-b801-b6d2c291ce57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityAddressPostalZipCode_5d09366a-c074-41ec-b801-b6d2c291ce57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_cb1f79fd-2879-4637-8ab4-ee0a263576c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_CityAreaCode_cb1f79fd-2879-4637-8ab4-ee0a263576c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2793c309-2463-4317-a903-49d14e88fa08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_LocalPhoneNumber_2793c309-2463-4317-a903-49d14e88fa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0998e933-b8fc-4542-a472-13dd3ea7c24c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_Security12bTitle_0998e933-b8fc-4542-a472-13dd3ea7c24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ff817c25-ed39-41ba-a2a7-ea65250c5820" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_TradingSymbol_ff817c25-ed39-41ba-a2a7-ea65250c5820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3aec610b-d05e-4a63-9d32-eb1d642396b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_SecurityExchangeName_3aec610b-d05e-4a63-9d32-eb1d642396b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_30483a65-822f-44ce-ac8d-9249eb0efe64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCurrentReportingStatus_30483a65-822f-44ce-ac8d-9249eb0efe64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_af9be02b-1231-45fe-9bc5-7e0d8100de52" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityInteractiveDataCurrent_af9be02b-1231-45fe-9bc5-7e0d8100de52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a2174c9b-5f2d-409b-9eee-307adf215110" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityFilerCategory_a2174c9b-5f2d-409b-9eee-307adf215110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_45ce653f-8595-49a7-a4d4-ef6f9cb5533d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityEmergingGrowthCompany_45ce653f-8595-49a7-a4d4-ef6f9cb5533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a087ac20-23fe-453b-804d-89ae908c095a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityShellCompany_a087ac20-23fe-453b-804d-89ae908c095a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15636e2e-060f-4942-8ae3-4cafc2af0b06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15636e2e-060f-4942-8ae3-4cafc2af0b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1813ed46-ab21-4cb7-9bec-b0ac4edb703b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntityCentralIndexKey_1813ed46-ab21-4cb7-9bec-b0ac4edb703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_aea4a1b3-72e8-4f40-9ebd-88179e4e4a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentFiscalYearFocus_aea4a1b3-72e8-4f40-9ebd-88179e4e4a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_51edeb84-6a0f-415c-9404-30defbbe72dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_DocumentFiscalPeriodFocus_51edeb84-6a0f-415c-9404-30defbbe72dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c1f96fef-ee86-41a4-81b9-66005f4879d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_CurrentFiscalYearEndDate_c1f96fef-ee86-41a4-81b9-66005f4879d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba82c6e9-1e1c-41b5-be3b-5498a66b0247" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_AmendmentFlag_ba82c6e9-1e1c-41b5-be3b-5498a66b0247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a1aa1c5c-cb6d-4b92-a7a6-82f20401f5d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88718cdf-0a61-4496-b43e-79abc68e7652" xlink:to="loc_dei_EntitySmallBusiness_a1aa1c5c-cb6d-4b92-a7a6-82f20401f5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bd3c3fc9-4e7b-4219-9b8b-38c27f9a6a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3c3fc9-4e7b-4219-9b8b-38c27f9a6a01" xlink:to="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:to="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_13680aed-b3fd-4cab-b218-7a1caf27dc39" xlink:to="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_4734efcf-f169-4800-ae4a-85cfe035be4f" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:to="loc_bmy_NetProductSalesMember_4734efcf-f169-4800-ae4a-85cfe035be4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_f6ef6947-c4f6-4a29-943b-eaffdc565827" xlink:href="bmy-20230331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3d3c33ff-9ab8-4c30-968a-af312364dbf7" xlink:to="loc_bmy_AllianceandotherrevenuesMember_f6ef6947-c4f6-4a29-943b-eaffdc565827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_635845a1-955b-4c80-9bc9-35a34b0b12d0" xlink:to="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3d3b91c9-21cb-40fc-948f-bf6fafef6134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_Revenues_3d3b91c9-21cb-40fc-948f-bf6fafef6134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_12da64e1-ded7-403b-a03e-e3c772d99100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_12da64e1-ded7-403b-a03e-e3c772d99100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1d0b615-2e48-48d9-80d9-0ce4680794c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1d0b615-2e48-48d9-80d9-0ce4680794c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1cc8596f-7f29-43b1-9b59-c9e41cbfb3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1cc8596f-7f29-43b1-9b59-c9e41cbfb3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_7b9e24c3-887e-435e-81fa-3a71b03696ca" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_bmy_AcquiredIPRD_7b9e24c3-887e-435e-81fa-3a71b03696ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_893070e7-0b55-400b-910e-0e40e8657a8d" xlink:href="bmy-20230331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_893070e7-0b55-400b-910e-0e40e8657a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_37278221-e094-4878-bb8e-76075d95f6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_37278221-e094-4878-bb8e-76075d95f6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_bac7985d-1c08-4208-8948-e15880a2e645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_CostsAndExpenses_bac7985d-1c08-4208-8948-e15880a2e645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ff881a48-f9d9-4b22-9cc1-13b6215cf550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ff881a48-f9d9-4b22-9cc1-13b6215cf550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d7c59c8b-c008-484d-9586-b514ecba38e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d7c59c8b-c008-484d-9586-b514ecba38e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a12d8518-9478-498a-9b0a-5e2f161c3458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ProfitLoss_a12d8518-9478-498a-9b0a-5e2f161c3458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9090e5b3-28f8-4ae8-a64c-2fe27def3f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9090e5b3-28f8-4ae8-a64c-2fe27def3f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f86254eb-2c37-4704-8621-3265a543196c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_NetIncomeLoss_f86254eb-2c37-4704-8621-3265a543196c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a71e97da-959c-4ccf-b35e-c5c7592295cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_EarningsPerShareBasic_a71e97da-959c-4ccf-b35e-c5c7592295cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0f9f0d56-1dfc-4a78-a023-e28ebb11b2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d651eec9-a27e-4761-9667-8e2c5dcb4fde" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0f9f0d56-1dfc-4a78-a023-e28ebb11b2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_38e42281-af0b-4fea-bf89-9aa340944743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:to="loc_us-gaap_ProfitLoss_38e42281-af0b-4fea-bf89-9aa340944743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7e222957-3418-4308-ba62-2642d397eb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7e222957-3418-4308-ba62-2642d397eb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7a7fa98c-70eb-4958-88c2-bd7c459e41cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7a7fa98c-70eb-4958-88c2-bd7c459e41cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e2b3b819-b0d6-4dbd-83be-16d4ad12518b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e2b3b819-b0d6-4dbd-83be-16d4ad12518b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bf9103a2-b7d6-460d-81fe-038996d38931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bf9103a2-b7d6-460d-81fe-038996d38931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6bec361b-a9d3-4039-b9ae-02633b74625b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8887cc9f-f8ca-468e-ae29-383677bac42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6bec361b-a9d3-4039-b9ae-02633b74625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_266115c0-2936-4012-ab9d-d957a39c6c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_266115c0-2936-4012-ab9d-d957a39c6c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_536eb48f-75bc-4b7f-b582-fc8bf0bce247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_536eb48f-75bc-4b7f-b582-fc8bf0bce247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e877f43d-d051-42d9-8706-aa1d5ac168fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fe2a6130-3631-41f6-9bea-7c80dc0aaa84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e877f43d-d051-42d9-8706-aa1d5ac168fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_38dd09cf-c4ce-4e69-930e-fc0a56492378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_38dd09cf-c4ce-4e69-930e-fc0a56492378" xlink:to="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f4d4655-f23f-4b26-8d64-019a05b8d358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f4d4655-f23f-4b26-8d64-019a05b8d358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_67e8080e-352c-417e-8de7-65baa3672b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_67e8080e-352c-417e-8de7-65baa3672b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_6debd648-428b-46e2-a099-d9cfb7a7305d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_6debd648-428b-46e2-a099-d9cfb7a7305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9e311d29-e787-4dac-ba72-f6b02aa6299d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_InventoryNet_9e311d29-e787-4dac-ba72-f6b02aa6299d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e4a029a3-3043-4fe4-9f27-7642492da976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_OtherAssetsCurrent_e4a029a3-3043-4fe4-9f27-7642492da976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b3ec7a0a-6a99-4fd8-9750-85c32cd45839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7e9cf3c6-1664-4c9a-b547-aa29825d3a5e" xlink:to="loc_us-gaap_AssetsCurrent_b3ec7a0a-6a99-4fd8-9750-85c32cd45839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_751fddc2-a233-443f-89e8-a223de99eb63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_751fddc2-a233-443f-89e8-a223de99eb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d037f874-1e35-4a4d-bc0b-b29cf0cbac0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_Goodwill_d037f874-1e35-4a4d-bc0b-b29cf0cbac0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a50f4348-957b-45c9-899e-f53a44fc2dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a50f4348-957b-45c9-899e-f53a44fc2dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7549002b-4564-4c7b-94ba-30add73eec28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7549002b-4564-4c7b-94ba-30add73eec28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a5dcd240-7e52-4ea0-980b-32f31729f729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a5dcd240-7e52-4ea0-980b-32f31729f729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f02b706f-fdab-4a95-9ce1-28774fe9a641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_59f37b20-fdd6-4a70-acd5-e9e9be4154ff" xlink:to="loc_us-gaap_Assets_f02b706f-fdab-4a95-9ce1-28774fe9a641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_38dd09cf-c4ce-4e69-930e-fc0a56492378" xlink:to="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2bc077e3-84ec-474c-8c1f-a9ed8cadacc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:to="loc_us-gaap_DebtCurrent_2bc077e3-84ec-474c-8c1f-a9ed8cadacc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b9137d2d-9f6e-4dda-b2c4-6dc2b95e9f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:to="loc_us-gaap_AccountsPayableCurrent_b9137d2d-9f6e-4dda-b2c4-6dc2b95e9f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2b960066-a44c-4d50-9973-d3fed51b0e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2b960066-a44c-4d50-9973-d3fed51b0e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8373c1f1-9d2e-4603-bbc7-f93c301ac84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_af82e161-ddea-4f07-baa8-9ca89014486a" xlink:to="loc_us-gaap_LiabilitiesCurrent_8373c1f1-9d2e-4603-bbc7-f93c301ac84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9308702b-59e2-49aa-91bc-49787078fdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9308702b-59e2-49aa-91bc-49787078fdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e8399ed2-354f-405c-9955-a3346f5dcbde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e8399ed2-354f-405c-9955-a3346f5dcbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b67a9550-bfc1-4f0e-9527-d623266fcbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b67a9550-bfc1-4f0e-9527-d623266fcbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8d2b475e-6211-4d8d-9f27-ffcecf3be15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_Liabilities_8d2b475e-6211-4d8d-9f27-ffcecf3be15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7db1c46a-76a9-484b-8d1b-32d658f0f6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_444fc359-31d9-4a38-8e79-05983e476f44" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7db1c46a-76a9-484b-8d1b-32d658f0f6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_79112843-45d7-49db-bbcb-6b11c33d2e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_38dd09cf-c4ce-4e69-930e-fc0a56492378" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_79112843-45d7-49db-bbcb-6b11c33d2e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_79112843-45d7-49db-bbcb-6b11c33d2e68" xlink:to="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_76d5d7b8-ad36-497a-ac98-d9eb6b3cd7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_PreferredStockValue_76d5d7b8-ad36-497a-ac98-d9eb6b3cd7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fa43a16d-bba8-4757-9873-f7cefedce131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_CommonStockValue_fa43a16d-bba8-4757-9873-f7cefedce131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6bd35c20-acc3-4d7a-abe1-e1a7705b24fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6bd35c20-acc3-4d7a-abe1-e1a7705b24fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0f34f098-95a9-4951-ba24-fc82ee811994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0f34f098-95a9-4951-ba24-fc82ee811994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7db08589-3fef-4102-8172-8c4d6addac6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7db08589-3fef-4102-8172-8c4d6addac6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_06ca1aa9-a2a5-46c7-9e68-6f2e2afe3293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_TreasuryStockValue_06ca1aa9-a2a5-46c7-9e68-6f2e2afe3293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9b981ae7-1e78-4ed8-8aad-7b1307a91cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84a7c230-4f83-42e1-9c7e-0248064f4777" xlink:to="loc_us-gaap_StockholdersEquity_9b981ae7-1e78-4ed8-8aad-7b1307a91cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_8c9467f8-6856-4940-86d2-98450155583d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_79112843-45d7-49db-bbcb-6b11c33d2e68" xlink:to="loc_us-gaap_MinorityInterest_8c9467f8-6856-4940-86d2-98450155583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db70a4e7-264e-429e-a947-32b84c0ba87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_79112843-45d7-49db-bbcb-6b11c33d2e68" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db70a4e7-264e-429e-a947-32b84c0ba87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_539d3240-98b4-4e1a-9d19-3f6f8291da0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_38dd09cf-c4ce-4e69-930e-fc0a56492378" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_539d3240-98b4-4e1a-9d19-3f6f8291da0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmy-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e9bf1984-4836-419b-9c9c-19b98ce0a0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:to="loc_us-gaap_ProfitLoss_e9bf1984-4836-419b-9c9c-19b98ce0a0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1df5ee4d-7a6d-4dec-ad35-3276da4ebd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1df5ee4d-7a6d-4dec-ad35-3276da4ebd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07f14512-dec9-4cde-a1aa-1cb062861440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07f14512-dec9-4cde-a1aa-1cb062861440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_897d03a5-580a-4447-85ae-f6c038793d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_ShareBasedCompensation_897d03a5-580a-4447-85ae-f6c038793d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_1421a080-6822-4ac8-86c8-4302546e03df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_1421a080-6822-4ac8-86c8-4302546e03df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_2e004c06-b065-4179-8e9b-8bb996de1a72" xlink:href="bmy-20230331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_bmy_Divestituregainsandroyalties_2e004c06-b065-4179-8e9b-8bb996de1a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_b8982781-e181-49e7-8564-e4830e970de6" xlink:href="bmy-20230331.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_bmy_AcquiredIPRD_b8982781-e181-49e7-8564-e4830e970de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_af8811cb-a38c-45d7-a899-f2d2e3cab6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_GainLossOnInvestments_af8811cb-a38c-45d7-a899-f2d2e3cab6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5bace4d1-2d72-47af-a0d9-414509dcefda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5bace4d1-2d72-47af-a0d9-414509dcefda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_a2693ac8-8add-4c10-82e5-89fc61ba9806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_a2693ac8-8add-4c10-82e5-89fc61ba9806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c12d65f1-8c82-40ad-aae4-28c805564413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c12d65f1-8c82-40ad-aae4-28c805564413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9b2e0c7-3cec-48de-acb7-27e406889e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9b2e0c7-3cec-48de-acb7-27e406889e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_c88f9cff-6b16-44dd-8661-629fa3201d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_c88f9cff-6b16-44dd-8661-629fa3201d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c9af3730-3a7e-43a3-9fbc-88d370c6bd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c9af3730-3a7e-43a3-9fbc-88d370c6bd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a62cb08b-4d7f-4f4a-8003-5778f96ae3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_40753199-8bb2-426b-9174-e5f268b87e37" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a62cb08b-4d7f-4f4a-8003-5778f96ae3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59d62cea-97af-4bcc-8278-79db66a1859c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e595a51-cc6f-4f53-8da2-385e6fa34340" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59d62cea-97af-4bcc-8278-79db66a1859c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ec5739e5-1805-4be0-b84f-d1a74b32db41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ec5739e5-1805-4be0-b84f-d1a74b32db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2c5f8030-b594-4cda-bbf6-143ada4db324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2c5f8030-b594-4cda-bbf6-143ada4db324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_1d10d30e-62ad-4c03-a852-ff653a688218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_1d10d30e-62ad-4c03-a852-ff653a688218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c726e4d0-bd73-4aca-975e-dcbf76abc790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c726e4d0-bd73-4aca-975e-dcbf76abc790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_d0d913ae-e6a8-4174-b614-41319b0bfd52" xlink:href="bmy-20230331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_bmy_Divestitureandotherproceeds_d0d913ae-e6a8-4174-b614-41319b0bfd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1d70cd54-5a39-4278-8d9c-da628dd93cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1d70cd54-5a39-4278-8d9c-da628dd93cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc99d4a7-a7ea-4b37-8d18-7a860a67a58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff15044b-a0af-4950-92d3-44cf7e5fb56e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc99d4a7-a7ea-4b37-8d18-7a860a67a58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b153963-eaf1-4baf-a6b7-a407eb6188f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b1cf1093-e322-443d-9712-a43e34e857af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b1cf1093-e322-443d-9712-a43e34e857af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_4ec5f9d2-f08d-4224-8fce-60f5117b94fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_4ec5f9d2-f08d-4224-8fce-60f5117b94fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_379f4025-82f7-4623-9786-314468d2fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_379f4025-82f7-4623-9786-314468d2fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77e6deb3-76d3-4423-a32e-1b244746d6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77e6deb3-76d3-4423-a32e-1b244746d6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_0268af4c-c037-408d-a100-f0875d86b700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_PaymentsOfDividends_0268af4c-c037-408d-a100-f0875d86b700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_9bf5edc7-545e-437c-840a-d56c5956387d" xlink:href="bmy-20230331.xsd#bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments_9bf5edc7-545e-437c-840a-d56c5956387d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb4f70cc-8870-4eb0-8f13-45b702304e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23dc9e1b-f972-47d6-b5be-6dfe7e2cd34b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb4f70cc-8870-4eb0-8f13-45b702304e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c23f03d8-bafa-41fb-ba70-144083d06b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c23f03d8-bafa-41fb-ba70-144083d06b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d18f089d-9c88-4339-b752-8b4ff7dc9195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d18f089d-9c88-4339-b752-8b4ff7dc9195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e7ebdb58-b19e-4a80-b7dd-1ed9d7fb6a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e7ebdb58-b19e-4a80-b7dd-1ed9d7fb6a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74a6d6b1-d725-427f-8bdf-878f53a2ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0498b004-0b26-441d-85dc-2331eca2d486" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74a6d6b1-d725-427f-8bdf-878f53a2ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="bmy-20230331.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_74cfaee6-2ab6-4343-b6b7-68b82f1019c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_e641286c-096d-46d2-92ed-dfd03aab4e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74cfaee6-2ab6-4343-b6b7-68b82f1019c8" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_e641286c-096d-46d2-92ed-dfd03aab4e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUE" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d148c61-4592-455a-ab51-546de4883d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d7627b97-a05d-4372-8188-91edea459d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d148c61-4592-455a-ab51-546de4883d73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d7627b97-a05d-4372-8188-91edea459d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCES" xlink:type="simple" xlink:href="bmy-20230331.xsd#ALLIANCES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_d20ec1cd-0605-4083-ac0a-2bac5d069643" xlink:href="bmy-20230331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ef80e8b1-b2f0-433f-8cc3-ef66eeeefe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_d20ec1cd-0605-4083-ac0a-2bac5d069643" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ef80e8b1-b2f0-433f-8cc3-ef66eeeefe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_3de1da0b-68e7-4351-9cb0-a46a2043088e" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_29ce4ddc-776f-4dfb-a412-e8a21df0aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_3de1da0b-68e7-4351-9cb0-a46a2043088e" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_29ce4ddc-776f-4dfb-a412-e8a21df0aa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="simple" xlink:href="bmy-20230331.xsd#OTHERINCOMEEXPENSENET"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_dc7ae941-1af6-4849-986f-2b9ae33c14ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_ac458683-0c7b-4ba8-97bc-82d9e3588492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_dc7ae941-1af6-4849-986f-2b9ae33c14ad" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_ac458683-0c7b-4ba8-97bc-82d9e3588492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_f072e79a-3455-44cb-83f8-ace9eb66ad1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6baebd08-0bb3-4f11-acb1-d32b1eaa24ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_f072e79a-3455-44cb-83f8-ace9eb66ad1f" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6baebd08-0bb3-4f11-acb1-d32b1eaa24ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bmy-20230331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2d4d97e2-d54b-480a-a6bb-bd231dad3188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f5d464d7-8d95-4b4a-966a-d84b1b70ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2d4d97e2-d54b-480a-a6bb-bd231dad3188" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f5d464d7-8d95-4b4a-966a-d84b1b70ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bmy-20230331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_522f4267-4734-40b4-80c1-022165125d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_11a23efc-890a-46f8-a35c-5f8296c546b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_522f4267-4734-40b4-80c1-022165125d9b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_11a23efc-890a-46f8-a35c-5f8296c546b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a59cd6e5-3181-4519-ae2f-3a95334f6c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_1b81eb83-e9c8-4ea2-a3d3-85893a48c677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a59cd6e5-3181-4519-ae2f-3a95334f6c38" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_1b81eb83-e9c8-4ea2-a3d3-85893a48c677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTS" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed7abb66-e18c-4b11-95b5-f752ce4cd716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7553bf3a-e10d-445f-b052-5de2dff8556b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed7abb66-e18c-4b11-95b5-f752ce4cd716" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7553bf3a-e10d-445f-b052-5de2dff8556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLES" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_d7277b95-27d8-4098-b7c8-f786bbe89b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_d8b041fa-013b-40b9-9a30-705a3655c54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_d7277b95-27d8-4098-b7c8-f786bbe89b99" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_d8b041fa-013b-40b9-9a30-705a3655c54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIES" xlink:type="simple" xlink:href="bmy-20230331.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_91cafc13-196a-46d8-ad25-88e3edd731b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_1e00ab72-7ef4-4f28-9899-52a69251451e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_91cafc13-196a-46d8-ad25-88e3edd731b7" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_1e00ab72-7ef4-4f28-9899-52a69251451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="bmy-20230331.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6de5a5ab-7457-4f35-915d-ddb669898f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_4f6604d8-5382-43f8-aecc-05db8ac89571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6de5a5ab-7457-4f35-915d-ddb669898f6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_4f6604d8-5382-43f8-aecc-05db8ac89571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c29a1a4d-9ea2-4e02-b3b6-464231939d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6c6e05d5-ce65-4ebf-8875-7a4dac8974f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c29a1a4d-9ea2-4e02-b3b6-464231939d77" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6c6e05d5-ce65-4ebf-8875-7a4dac8974f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_faec0e80-071c-4b4b-8d77-abea1f66c4f3" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_530e420e-bfbb-494c-8ce8-673124b6d757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_faec0e80-071c-4b4b-8d77-abea1f66c4f3" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_530e420e-bfbb-494c-8ce8-673124b6d757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITY" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITY"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f7561fc0-77eb-4cac-bc88-fd7caaa996ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ef6891a3-5277-4c19-b638-9c5a3c7abbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f7561fc0-77eb-4cac-bc88-fd7caaa996ed" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ef6891a3-5277-4c19-b638-9c5a3c7abbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96314122-fc1f-4b0e-83a5-a08819c8de84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_60f0299a-b954-458c-a01c-2b3a36ff050e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96314122-fc1f-4b0e-83a5-a08819c8de84" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_60f0299a-b954-458c-a01c-2b3a36ff050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="simple" xlink:href="bmy-20230331.xsd#LEGALPROCEEDINGSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f0afa42a-17d9-4222-90f5-b9590f3ca1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_9a384b76-8795-4898-b09c-7b6ce7570056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f0afa42a-17d9-4222-90f5-b9590f3ca1f3" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_9a384b76-8795-4898-b09c-7b6ce7570056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="simple" xlink:href="bmy-20230331.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a6ad23d2-6cfd-4edc-a4ee-9c76d04b1617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a6ad23d2-6cfd-4edc-a4ee-9c76d04b1617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4b6d8b3c-3475-4d08-a555-4aa92814f054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4b6d8b3c-3475-4d08-a555-4aa92814f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6ff2b310-06c7-43de-9e13-835c1d58e343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:to="loc_us-gaap_UseOfEstimates_6ff2b310-06c7-43de-9e13-835c1d58e343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_b4ffb420-b802-4c66-93d5-78365796d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_b4ffb420-b802-4c66-93d5-78365796d9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e59e76fd-878c-4e5e-a747-82e5a26a5c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af889006-b707-49f2-b4fb-4b323f31f0cc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e59e76fd-878c-4e5e-a747-82e5a26a5c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUETables" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_625e25e6-c980-4101-ad12-b048baa6a772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_52388776-2b70-4fa9-a695-2c1f06b42943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_625e25e6-c980-4101-ad12-b048baa6a772" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_52388776-2b70-4fa9-a695-2c1f06b42943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_a4e489ee-bc17-4a6e-bca0-62a14737d269" xlink:href="bmy-20230331.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_625e25e6-c980-4101-ad12-b048baa6a772" xlink:to="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_a4e489ee-bc17-4a6e-bca0-62a14737d269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cfa492fd-7e31-45fe-8d4d-9e71f3efe2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_625e25e6-c980-4101-ad12-b048baa6a772" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cfa492fd-7e31-45fe-8d4d-9e71f3efe2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#ALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_9cbcffcb-8495-43b8-9674-d0bba750afcc" xlink:href="bmy-20230331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_8e85a760-1ddb-4dad-a233-ced2f5085253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_9cbcffcb-8495-43b8-9674-d0bba750afcc" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_8e85a760-1ddb-4dad-a233-ced2f5085253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_0dec5446-9978-4456-af73-3875cfe18b7a" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_dfdd02f6-05a6-4ed1-8aa8-c870892ee07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_0dec5446-9978-4456-af73-3875cfe18b7a" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_dfdd02f6-05a6-4ed1-8aa8-c870892ee07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_6b2a5531-b12f-4d30-9256-a4b1fdb55169" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_0dec5446-9978-4456-af73-3875cfe18b7a" xlink:to="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_6b2a5531-b12f-4d30-9256-a4b1fdb55169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#OTHERINCOMEEXPENSENETTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_32d3476b-6c52-452d-81eb-84a576bb2d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_7cda511e-cf1a-4d0b-b3d3-5766596c62cb" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_32d3476b-6c52-452d-81eb-84a576bb2d64" xlink:to="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_7cda511e-cf1a-4d0b-b3d3-5766596c62cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_a33bf133-ef66-4532-9b29-669e5995aec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_a33bf133-ef66-4532-9b29-669e5995aec5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:to="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_f51b685e-e042-452d-8d91-ec39d80ec3ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_78ea6333-41fb-44e4-b718-c2e3814056cb" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_b390fa64-e355-44f0-81ef-4b43dd23398b" xlink:to="loc_bmy_CelgeneIntegrationMember_78ea6333-41fb-44e4-b718-c2e3814056cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_167f704e-8f0c-4ade-b1c5-f540585c3c22" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fdbbff3f-40b5-449d-8845-b30c0571be79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fdbbff3f-40b5-449d-8845-b30c0571be79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b248358e-b982-4970-a7c3-70f4a1a3fa98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_25e7dd1c-c6ef-4ea4-ae49-292bdbfc5338" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b248358e-b982-4970-a7c3-70f4a1a3fa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_283d5d31-2f6d-4514-a12e-41489e5d70c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_a634ac13-e264-4923-9754-697c6a180633" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_283d5d31-2f6d-4514-a12e-41489e5d70c7" xlink:to="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_a634ac13-e264-4923-9754-697c6a180633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bmy-20230331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_697e29dc-ad3c-435f-9f97-06bdea5fa9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_847e8daf-e709-4d29-9d42-0757a1b7c213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_697e29dc-ad3c-435f-9f97-06bdea5fa9fe" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_847e8daf-e709-4d29-9d42-0757a1b7c213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_663a03ce-f3f5-4e5c-811d-2733a558c821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_663a03ce-f3f5-4e5c-811d-2733a558c821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_546b1cc3-a8dd-49a5-9167-e84603843aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_546b1cc3-a8dd-49a5-9167-e84603843aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_ff9daf87-b19d-4731-afab-faf206f34809" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_ff9daf87-b19d-4731-afab-faf206f34809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_1488ffb2-6710-4185-8305-d849c7ae4216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_1488ffb2-6710-4185-8305-d849c7ae4216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d05c5d09-7f54-4998-887c-47c8df29f784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d05c5d09-7f54-4998-887c-47c8df29f784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_74858f8a-9c12-4bb9-aab4-2b74ef5c09a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c852b93-9cdf-4c4b-8592-afe2dae58810" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_74858f8a-9c12-4bb9-aab4-2b74ef5c09a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_923475d5-5692-4d2b-a1f2-27b366aa12e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8239c5ef-10cc-431d-9985-a347068bfa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_923475d5-5692-4d2b-a1f2-27b366aa12e0" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8239c5ef-10cc-431d-9985-a347068bfa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8cea8417-2ed6-495a-ad24-585ef0a10c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_923475d5-5692-4d2b-a1f2-27b366aa12e0" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8cea8417-2ed6-495a-ad24-585ef0a10c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_10f4bc10-b19b-4862-a484-8f17ac7a6125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8129ea1a-cfe0-4944-ace7-fda8a0d1ab8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_10f4bc10-b19b-4862-a484-8f17ac7a6125" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8129ea1a-cfe0-4944-ace7-fda8a0d1ab8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_ab9f78a7-f87b-429e-9768-ce2ded9ff331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c672cbff-90b3-4531-b6fc-e3ebab7fb7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_ab9f78a7-f87b-429e-9768-ce2ded9ff331" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c672cbff-90b3-4531-b6fc-e3ebab7fb7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e0cb8bb-85a1-4b5c-9472-51b1062ebaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_2b458b08-0ef7-40eb-876e-eaf9a391b38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e0cb8bb-85a1-4b5c-9472-51b1062ebaa6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_2b458b08-0ef7-40eb-876e-eaf9a391b38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9fff8d4d-4031-44f6-a859-a58658e4aaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_58c45ee2-1e18-43fd-9d52-5dffe9e1565f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9fff8d4d-4031-44f6-a859-a58658e4aaa5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_58c45ee2-1e18-43fd-9d52-5dffe9e1565f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4f315092-ade8-4ad3-b7c5-e529bbb0a5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9fff8d4d-4031-44f6-a859-a58658e4aaa5" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4f315092-ade8-4ad3-b7c5-e529bbb0a5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_0451df27-d936-4d88-b1bd-88c09789bd21" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_3feac8cb-5192-466a-8fe1-db070ff1665c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_0451df27-d936-4d88-b1bd-88c09789bd21" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_3feac8cb-5192-466a-8fe1-db070ff1665c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_94dc80dc-9c6b-4202-85c1-cb016c8ff006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_0451df27-d936-4d88-b1bd-88c09789bd21" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_94dc80dc-9c6b-4202-85c1-cb016c8ff006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a77793f6-f9d0-4cb3-8e03-3ab4d1af5785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_0451df27-d936-4d88-b1bd-88c09789bd21" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a77793f6-f9d0-4cb3-8e03-3ab4d1af5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f7ee6489-9772-4f5d-b889-b4723943d93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_0451df27-d936-4d88-b1bd-88c09789bd21" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f7ee6489-9772-4f5d-b889-b4723943d93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5f9ff1be-fd18-4801-8a98-dc4421cdf8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_9e51c58a-a462-417c-bd77-d2d9f188a3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5f9ff1be-fd18-4801-8a98-dc4421cdf8cf" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_9e51c58a-a462-417c-bd77-d2d9f188a3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_a2129f61-13a9-4e29-963d-a3ae3530263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5f9ff1be-fd18-4801-8a98-dc4421cdf8cf" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_a2129f61-13a9-4e29-963d-a3ae3530263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_599e54e8-f67c-467d-9f32-7ec8c7aee1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5f9ff1be-fd18-4801-8a98-dc4421cdf8cf" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_599e54e8-f67c-467d-9f32-7ec8c7aee1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0f37e3-95a4-4f33-a8b5-c7fe3f982b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f130ea00-7ad8-4066-9536-e73e747709fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0f37e3-95a4-4f33-a8b5-c7fe3f982b59" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f130ea00-7ad8-4066-9536-e73e747709fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_4ce3ed08-194c-4f72-86e8-4b581b8190ea" xlink:href="bmy-20230331.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0f37e3-95a4-4f33-a8b5-c7fe3f982b59" xlink:to="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_4ce3ed08-194c-4f72-86e8-4b581b8190ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_ad8db913-a809-4586-ad1d-4a1c7d2c2c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0f37e3-95a4-4f33-a8b5-c7fe3f982b59" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_ad8db913-a809-4586-ad1d-4a1c7d2c2c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b23e9ec-f589-426f-9486-f95ab4e6a0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b23e9ec-f589-426f-9486-f95ab4e6a0d6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:to="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8364f2ff-91c2-4430-84a1-8ef831999e2b" xlink:to="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_0e8eea78-c282-47af-8eac-44e1f63adb26" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_NetProductSalesMember_0e8eea78-c282-47af-8eac-44e1f63adb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceRevenuesMember_f2ecfab1-bb62-422b-af3c-62847a566327" xlink:href="bmy-20230331.xsd#bmy_AllianceRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_AllianceRevenuesMember_f2ecfab1-bb62-422b-af3c-62847a566327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRevenuesMember_1615e96e-2ea4-4b08-a654-4fec82acf5d8" xlink:href="bmy-20230331.xsd#bmy_OtherRevenuesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a09313-94e9-46de-9249-82ab55f5a826" xlink:to="loc_bmy_OtherRevenuesMember_1615e96e-2ea4-4b08-a654-4fec82acf5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ea6f345-1328-490d-b094-ff84c5290ded" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfb41eaf-9a3a-40dc-8fdc-ae674264d149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e43d255b-18e8-4f4a-b34c-9952722cee4a" xlink:to="loc_us-gaap_Revenues_bfb41eaf-9a3a-40dc-8fdc-ae674264d149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_759afdf7-6238-4509-96ed-a12c66c6ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_759afdf7-6238-4509-96ed-a12c66c6ce42" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_52ae0aba-ba46-4ab3-be9c-0a84d60184f7" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_122eeb67-87c9-469c-be8e-b186bcac3ef4" xlink:href="bmy-20230331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_122eeb67-87c9-469c-be8e-b186bcac3ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_c99245fd-4d56-41d2-b233-236498a41bf8" xlink:href="bmy-20230331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_c99245fd-4d56-41d2-b233-236498a41bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_de1488ac-ba6f-4b92-a1f7-b16490549f1f" xlink:href="bmy-20230331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_c7ea1b9e-418a-46ba-b1ce-f3a83b1954fc" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_de1488ac-ba6f-4b92-a1f7-b16490549f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:to="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0a35a50f-33be-4c09-ac00-ce38e9bfc1c7" xlink:to="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_55c2e65e-be0f-4d4c-80e4-1a12df20a95f" xlink:href="bmy-20230331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:to="loc_bmy_SalesRevenueGrossMember_55c2e65e-be0f-4d4c-80e4-1a12df20a95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_12847a29-9161-42ef-b910-29d8b5de9523" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1254276e-3a12-4a89-9a7d-fec7b0b51308" xlink:to="loc_bmy_NetProductSalesMember_12847a29-9161-42ef-b910-29d8b5de9523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_92441aaa-9b1e-4528-9cf1-474b0461e88c" xlink:to="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b0cf304-70e0-47b9-9217-3900f8a88f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_us-gaap_Revenues_3b0cf304-70e0-47b9-9217-3900f8a88f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_df110870-7ca3-4472-bb18-39438c49a8db" xlink:href="bmy-20230331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_bmy_GrosstoNetAdjustments_df110870-7ca3-4472-bb18-39438c49a8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_fd047a77-ae7c-4537-8538-a5a28cb55e5b" xlink:href="bmy-20230331.xsd#bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_2781c82a-c1ec-44ab-b8b4-4360b292b57e" xlink:to="loc_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement_fd047a77-ae7c-4537-8538-a5a28cb55e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#REVENUEDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d0808ef-d328-492f-91c5-85aafea48f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d0808ef-d328-492f-91c5-85aafea48f05" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:to="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6da04bd1-2e01-42a6-b893-bc9d4edf8523" xlink:to="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:href="bmy-20230331.xsd#bmy_InLineProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_64bc440b-9b8b-437b-b40a-31d04521cfb3" xlink:href="bmy-20230331.xsd#bmy_EliquisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_EliquisMember_64bc440b-9b8b-437b-b40a-31d04521cfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_41ab0fb4-a312-4b2e-8ee2-930f37e09efc" xlink:href="bmy-20230331.xsd#bmy_OpdivoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_OpdivoMember_41ab0fb4-a312-4b2e-8ee2-930f37e09efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_dee43a4e-f68f-4904-be08-61f1d4a2f314" xlink:href="bmy-20230331.xsd#bmy_PomalystImnovidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_PomalystImnovidMember_dee43a4e-f68f-4904-be08-61f1d4a2f314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_92bbbdca-4441-4d14-99c9-aa81f6cfc058" xlink:href="bmy-20230331.xsd#bmy_OrenciaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_OrenciaMember_92bbbdca-4441-4d14-99c9-aa81f6cfc058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_a8306b89-40f0-40b3-bdaa-c63de11a0bea" xlink:href="bmy-20230331.xsd#bmy_SprycelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_SprycelMember_a8306b89-40f0-40b3-bdaa-c63de11a0bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_a9f4d04c-3a93-4d37-a95e-1a98c1435e90" xlink:href="bmy-20230331.xsd#bmy_YervoyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_YervoyMember_a9f4d04c-3a93-4d37-a95e-1a98c1435e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_e64fe4ac-7cba-42ca-adea-3d9a2f9030fd" xlink:href="bmy-20230331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_InLineProductsMember_91036920-7cce-4740-9b47-a52836b4b260" xlink:to="loc_bmy_MatureAndOtherBrandsMember_e64fe4ac-7cba-42ca-adea-3d9a2f9030fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:href="bmy-20230331.xsd#bmy_NewProductPortfolioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_ec02a811-3c2d-44ae-8ec9-1b606f2d9c2b" xlink:href="bmy-20230331.xsd#bmy_ReblozylMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_ReblozylMember_ec02a811-3c2d-44ae-8ec9-1b606f2d9c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_43144db5-6249-4900-ae73-f9869c0cdbac" xlink:href="bmy-20230331.xsd#bmy_AbecmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_AbecmaMember_43144db5-6249-4900-ae73-f9869c0cdbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_610b3e63-aa17-4c65-af43-812cc34fd3a1" xlink:href="bmy-20230331.xsd#bmy_OpdualagMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_OpdualagMember_610b3e63-aa17-4c65-af43-812cc34fd3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_f87e9389-5e36-4211-b284-479ec0bc6eb3" xlink:href="bmy-20230331.xsd#bmy_ZeposiaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_ZeposiaMember_f87e9389-5e36-4211-b284-479ec0bc6eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_95a41334-625f-422c-9c40-82e01c12f5f8" xlink:href="bmy-20230331.xsd#bmy_BreyanziMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_BreyanziMember_95a41334-625f-422c-9c40-82e01c12f5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_0ee690ea-185b-4f3a-9dc7-6784f83effcb" xlink:href="bmy-20230331.xsd#bmy_OnuregMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_OnuregMember_0ee690ea-185b-4f3a-9dc7-6784f83effcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_8c4e806c-4f2e-4a5a-9c84-41ea3da05559" xlink:href="bmy-20230331.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_InrebicMember_8c4e806c-4f2e-4a5a-9c84-41ea3da05559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CamzyosMember_cf1e0efa-1fdf-4956-a316-c30f72a04a0f" xlink:href="bmy-20230331.xsd#bmy_CamzyosMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_CamzyosMember_cf1e0efa-1fdf-4956-a316-c30f72a04a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SotyktuMember_13cd950b-0409-4a9b-b0c1-38f9b9378696" xlink:href="bmy-20230331.xsd#bmy_SotyktuMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_NewProductPortfolioMember_f776619d-c32b-441f-bbd4-97d23ab3ca6d" xlink:to="loc_bmy_SotyktuMember_13cd950b-0409-4a9b-b0c1-38f9b9378696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InLineProductsAndNewProductPortfolioMember_70f83e64-26ec-442d-854d-aa398ab6cc32" xlink:href="bmy-20230331.xsd#bmy_InLineProductsAndNewProductPortfolioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_InLineProductsAndNewProductPortfolioMember_70f83e64-26ec-442d-854d-aa398ab6cc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:href="bmy-20230331.xsd#bmy_LOEProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fa3b8e00-06d5-48b5-9341-31de0f707cb0" xlink:to="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_c8e3e285-ea49-49ca-a713-9db24eb8fee9" xlink:href="bmy-20230331.xsd#bmy_RevlimidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:to="loc_bmy_RevlimidMember_c8e3e285-ea49-49ca-a713-9db24eb8fee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_0dd240bf-a58c-4b8e-8c25-ec3b0459f0d4" xlink:href="bmy-20230331.xsd#bmy_AbraxaneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LOEProductsMember_9b1027f8-a1dd-496d-a5b4-6f03bd730bb8" xlink:to="loc_bmy_AbraxaneMember_0dd240bf-a58c-4b8e-8c25-ec3b0459f0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:to="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4d2195da-396f-452a-98f6-5c584763ffaf" xlink:to="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_453de7b3-bd3d-4535-9fa6-1fa04d54fa83" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_country_US_453de7b3-bd3d-4535-9fa6-1fa04d54fa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternationalMember_7faf1a5b-067d-4fb8-8d1c-518d2e7b19e9" xlink:href="bmy-20230331.xsd#bmy_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_bmy_InternationalMember_7faf1a5b-067d-4fb8-8d1c-518d2e7b19e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_eff5374d-76c1-4960-8217-7367f1347862" xlink:href="bmy-20230331.xsd#bmy_OtherRegionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e0e9317f-c0ea-401d-9bdb-5e4738371887" xlink:to="loc_bmy_OtherRegionMember_eff5374d-76c1-4960-8217-7367f1347862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d589c8e3-fe8c-4aea-8492-55c7c8ef27ae" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4f4a1a9a-0b26-4ce2-a5e3-332085ffb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:to="loc_us-gaap_Revenues_4f4a1a9a-0b26-4ce2-a5e3-332085ffb5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_fb22d85f-78f8-4495-853f-f8c767bc507c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_6195cf1e-1048-4769-baec-d2d0da8ba545" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_fb22d85f-78f8-4495-853f-f8c767bc507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#ALLIANCESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_6c5e99fc-3f18-4668-90ad-d3efec91a80c" xlink:href="bmy-20230331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_6c5e99fc-3f18-4668-90ad-d3efec91a80c" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_dfda457f-472a-419b-a12a-39e68f258cce" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_a5f944f7-295b-45dd-a4cf-c1951591f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4d417cea-6ae6-43c7-8a7f-9e33c0225b71" xlink:to="loc_us-gaap_CollaborativeArrangementMember_a5f944f7-295b-45dd-a4cf-c1951591f2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:to="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f4f2d0fd-9771-460c-b280-9e7373c4ed57" xlink:to="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetProductSalesMember_2643235e-8ede-4b24-a110-a74b5e4f038e" xlink:href="bmy-20230331.xsd#bmy_NetProductSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:to="loc_bmy_NetProductSalesMember_2643235e-8ede-4b24-a110-a74b5e4f038e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceRevenuesMember_8eb648c4-0804-4946-a21f-113e99f6f1e8" xlink:href="bmy-20230331.xsd#bmy_AllianceRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5b5a7883-8660-4a84-97bb-56d5cac1d291" xlink:to="loc_bmy_AllianceRevenuesMember_8eb648c4-0804-4946-a21f-113e99f6f1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_32c0d1b1-5234-4cb2-b655-d991425ce71d" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b8f51376-fe13-4f52-b453-20535f0e12ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_Revenues_b8f51376-fe13-4f52-b453-20535f0e12ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6aa82c19-06cd-4ab2-94ef-14cd3612a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6aa82c19-06cd-4ab2-94ef-14cd3612a367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2cf9d145-4dc6-4c9f-953b-c00a97085d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2cf9d145-4dc6-4c9f-953b-c00a97085d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_c8bc7a0f-9f42-4105-87c0-be3962a06977" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement_c8bc7a0f-9f42-4105-87c0-be3962a06977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ff73b705-92b0-4253-bf4c-e8ea896cd4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ff73b705-92b0-4253-bf4c-e8ea896cd4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9f242e38-aa71-49eb-9575-c06c42a45780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9f242e38-aa71-49eb-9575-c06c42a45780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d2c83d6f-10c4-4079-b3f6-d9393972d834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_AccountsPayableCurrent_d2c83d6f-10c4-4079-b3f6-d9393972d834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_ea56d1e9-4090-4bba-b27a-83a524235084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_18180313-e89c-4c7f-8d46-b1214565a704" xlink:to="loc_us-gaap_DeferredIncome_ea56d1e9-4090-4bba-b27a-83a524235084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_94075038-ee3f-4a00-9d26-ecc96a736675" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_94075038-ee3f-4a00-9d26-ecc96a736675" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_83f48589-6e70-40c5-ba7e-43dc97fff98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesBusinessMember_3e9d608b-d2bb-47fb-aea3-7b9a46c06bb9" xlink:href="bmy-20230331.xsd#bmy_DiabetesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:to="loc_bmy_DiabetesBusinessMember_3e9d608b-d2bb-47fb-aea3-7b9a46c06bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_25100606-1284-4c29-acda-1f00604d50e4" xlink:href="bmy-20230331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65306de5-2035-45b7-a69d-a955361bd03f" xlink:to="loc_bmy_MatureBrandsAndOtherMember_25100606-1284-4c29-acda-1f00604d50e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d226894-d6f6-421d-82f3-01fd59b7a80a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_77dcbc04-cee4-4ae2-96be-26453611c91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_77dcbc04-cee4-4ae2-96be-26453611c91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9fb2bb8a-866b-4a54-9992-80c302881585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9fb2bb8a-866b-4a54-9992-80c302881585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_a9374258-660e-4565-b291-709e7fa82555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_40f4618f-b972-4e38-af54-5e668562eb5d" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_a9374258-660e-4565-b291-709e7fa82555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_f0c1a4b5-7133-4394-b94d-29247f6e67e8" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_f0c1a4b5-7133-4394-b94d-29247f6e67e8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_c3f6295f-c5b3-436e-8b2b-5c4fd368747d" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_31cb3763-31a4-4941-a2cd-6994e9675a13" xlink:href="bmy-20230331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_31cb3763-31a4-4941-a2cd-6994e9675a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_0970998f-d5ab-49d8-b63a-505a0b7165e6" xlink:href="bmy-20230331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_TecentriqRoyaltiesMember_0970998f-d5ab-49d8-b63a-505a0b7165e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_b9dd8086-5e7b-4e92-b33e-369f45d8d05b" xlink:href="bmy-20230331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c1622a99-53a6-4502-9967-1b760a824cb3" xlink:to="loc_bmy_OtherRoyaltiesMember_b9dd8086-5e7b-4e92-b33e-369f45d8d05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8b76d75a-7c76-4ab6-b3e9-a4b87d2fb29b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_9a1b3aef-c3ad-4759-8f80-0102ad4c3394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_9a1b3aef-c3ad-4759-8f80-0102ad4c3394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_df05f0b0-acfd-4371-8772-d625eaa4d65c" xlink:href="bmy-20230331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_df05f0b0-acfd-4371-8772-d625eaa4d65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_4509db4d-7760-4650-9755-0f0695092e0a" xlink:href="bmy-20230331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_AmortizationOfDeferredIncome_4509db4d-7760-4650-9755-0f0695092e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_10d4b97a-f7e5-49fe-adc5-1a8a5dcf215b" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_fd8c1310-20a9-4637-acf0-d28174ee8376" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_10d4b97a-f7e5-49fe-adc5-1a8a5dcf215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ebb95458-30a0-4427-9ff6-07755e67ef6a" xlink:href="bmy-20230331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ebb95458-30a0-4427-9ff6-07755e67ef6a" xlink:to="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0621f21d-319a-44b5-a620-52a42f49252f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_5d38c4ca-09a9-428b-80d1-25a53a9f5065" xlink:href="bmy-20230331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ed0428b-c4ac-4470-9b18-a67d83e4a821" xlink:to="loc_bmy_MatureBrandsAndOtherMember_5d38c4ca-09a9-428b-80d1-25a53a9f5065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_babe1697-09d1-4a43-a408-0f5c73c00025" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_194b686d-b3c5-4962-a4ab-b5f2b7cbb925" xlink:href="bmy-20230331.xsd#bmy_CheplapharmMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_CheplapharmMember_194b686d-b3c5-4962-a4ab-b5f2b7cbb925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_ec2c23db-89e5-4697-ba59-70a67dca9cc5" xlink:href="bmy-20230331.xsd#bmy_ImmaticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_ImmaticsMember_ec2c23db-89e5-4697-ba59-70a67dca9cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_5db7e8d7-815c-4a92-8cdd-34ea022c791f" xlink:href="bmy-20230331.xsd#bmy_DragonflyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_DragonflyMember_5db7e8d7-815c-4a92-8cdd-34ea022c791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapeuticsMember_c8b7980c-4984-4e02-9ced-aef638c7aa9f" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapeuticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f2b47ec-3b21-4fff-b556-05e451505091" xlink:to="loc_bmy_NimbusTherapeuticsMember_c8b7980c-4984-4e02-9ced-aef638c7aa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:href="bmy-20230331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_4a86aa83-2ccd-4554-8876-b7cdc1f7f2f7" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NimbusTherapueticsTYK2InhibitorMember_2afda0aa-dca8-408e-85c8-c2c1e1c51f45" xlink:href="bmy-20230331.xsd#bmy_NimbusTherapueticsTYK2InhibitorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_c7e83f08-e639-4867-ab53-824c197760c0" xlink:to="loc_bmy_NimbusTherapueticsTYK2InhibitorMember_2afda0aa-dca8-408e-85c8-c2c1e1c51f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:href="bmy-20230331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_b4ccf3ae-8312-497e-bfd7-ee2f0f5c8f97" xlink:to="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7f580f49-ebe0-4463-9b1a-2894e5560782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7f580f49-ebe0-4463-9b1a-2894e5560782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_bd4ade12-189a-4068-a50c-d0a73f02cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_bd4ade12-189a-4068-a50c-d0a73f02cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_e6f9af34-2467-4652-81f3-3f8eea109323" xlink:href="bmy-20230331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_e6f9af34-2467-4652-81f3-3f8eea109323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_4a4b6946-047c-4db9-8b93-efd2d4e1b41b" xlink:href="bmy-20230331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_4a4b6946-047c-4db9-8b93-efd2d4e1b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_30256666-df9e-43be-b4d6-89b020cc6667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_30256666-df9e-43be-b4d6-89b020cc6667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds_3df3b565-9e66-40d1-9bbb-8420efbb3e6d" xlink:href="bmy-20230331.xsd#bmy_SettlementContingentDevelopmentChangeInControlProceeds"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_SettlementContingentDevelopmentChangeInControlProceeds_3df3b565-9e66-40d1-9bbb-8420efbb3e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_0374ef71-5de8-4d60-96a2-cfb1a74d50d0" xlink:href="bmy-20230331.xsd#bmy_AssetAcquisitionPercentageOfOwnershipAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_AssetAcquisitionPercentageOfOwnershipAcquired_0374ef71-5de8-4d60-96a2-cfb1a74d50d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_f839b86a-3624-4ebb-a4f5-b3a41f4ef628" xlink:href="bmy-20230331.xsd#bmy_CollaborativeArrangementContingentPaymentsMaximumExposure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure_f839b86a-3624-4ebb-a4f5-b3a41f4ef628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_753cb7e9-fb4e-46f7-a334-758c0c06d9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_fd174587-698b-4bcc-a476-d6067b9793a4" xlink:to="loc_us-gaap_OtherNonoperatingIncome_753cb7e9-fb4e-46f7-a334-758c0c06d9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_272d44c3-d1c8-4cdd-9d8a-a349f7ec4d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_InterestExpense_272d44c3-d1c8-4cdd-9d8a-a349f7ec4d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessRoyaltyAndLicensingIncome_8dcb92e3-79bf-4e25-88bd-b19941903461" xlink:href="bmy-20230331.xsd#bmy_BusinessRoyaltyAndLicensingIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_bmy_BusinessRoyaltyAndLicensingIncome_8dcb92e3-79bf-4e25-88bd-b19941903461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BusinessSaleRoyaltyIncome_ca31a127-6ca1-48ba-b30b-f44fb2cb11f9" xlink:href="bmy-20230331.xsd#bmy_BusinessSaleRoyaltyIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_bmy_BusinessSaleRoyaltyIncome_ca31a127-6ca1-48ba-b30b-f44fb2cb11f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_735052fa-f428-4a81-a65d-9618c4d86fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_GainLossOnInvestments_735052fa-f428-4a81-a65d-9618c4d86fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_15a250c8-1ace-4311-b0d5-b8928e5da150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_15a250c8-1ace-4311-b0d5-b8928e5da150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bbd1be80-47a6-40c4-8bbb-5bd69d8f7ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bbd1be80-47a6-40c4-8bbb-5bd69d8f7ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_117c55a2-7003-489a-9ab4-86bcac29a7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_117c55a2-7003-489a-9ab4-86bcac29a7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9bc8f57d-1c02-4fd3-88fe-a8fa3770603e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9bc8f57d-1c02-4fd3-88fe-a8fa3770603e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_31771140-64e1-41f2-bf75-3fe2a9147724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_InvestmentIncomeInterest_31771140-64e1-41f2-bf75-3fe2a9147724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ac566111-b59b-4507-afb8-66bcbf5c8876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_RestructuringCharges_ac566111-b59b-4507-afb8-66bcbf5c8876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_d2de009c-046a-4804-8815-57b9a3f8aab0" xlink:href="bmy-20230331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_bmy_OtherOtherIncomeExpense_d2de009c-046a-4804-8815-57b9a3f8aab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f6fa4cda-109b-4c43-96c6-d21495ee9b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f6fa4cda-109b-4c43-96c6-d21495ee9b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_7ee31e0d-6f16-492c-b88e-0d654fd3af91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b17a1676-c214-4638-9966-318af5d78804" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_7ee31e0d-6f16-492c-b88e-0d654fd3af91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_2bee7a80-df5c-4409-a7f7-4116efcb9deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_2bee7a80-df5c-4409-a7f7-4116efcb9deb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:to="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_3e7d2c33-7c44-47f5-b795-0c37cbe2ae4d" xlink:to="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_364c4a4f-0165-4a18-9ec7-74fb21b19cea" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:to="loc_bmy_CelgeneIntegrationMember_364c4a4f-0165-4a18-9ec7-74fb21b19cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_9b166195-abbd-4ac9-b5bf-673ffd445367" xlink:href="bmy-20230331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_281f17c3-5202-44c2-8602-2b433392a485" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_9b166195-abbd-4ac9-b5bf-673ffd445367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_baf57851-a6f6-4fd7-b547-25c698033890" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_22ecd75d-684a-46cd-98db-87a5b7193d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:to="loc_us-gaap_CostOfSalesMember_22ecd75d-684a-46cd-98db-87a5b7193d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_30b3d9fc-3ee0-42ae-ba01-7ec809226915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f09dff2-2e6a-4201-be66-34521e1722ee" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_30b3d9fc-3ee0-42ae-ba01-7ec809226915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4b380027-1587-428d-a52e-e28b0c4860ca" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_829961c9-b5d9-4348-8acc-d289d2b4052b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_829961c9-b5d9-4348-8acc-d289d2b4052b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_2f925a39-d6de-4b64-99dc-bc92daf3448c" xlink:href="bmy-20230331.xsd#bmy_Cashoutlays"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_bmy_Cashoutlays_2f925a39-d6de-4b64-99dc-bc92daf3448c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48807b42-7cf0-4dca-a391-cd017a9e03e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48807b42-7cf0-4dca-a391-cd017a9e03e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_a7453f1a-09b9-47b5-8477-d5a36a9ff062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dcc9f8a1-4d36-4ff8-bbb7-b6a8bd499429" xlink:to="loc_us-gaap_SeveranceCosts1_a7453f1a-09b9-47b5-8477-d5a36a9ff062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_9be13925-46d3-459a-bd51-d47c817fd013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_9be13925-46d3-459a-bd51-d47c817fd013" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:to="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_879f8ca4-c7b2-4df7-8099-541e1ed5df58" xlink:to="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_e9692d83-2b84-4fb3-b729-d487412167a1" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:to="loc_bmy_CelgeneIntegrationMember_e9692d83-2b84-4fb3-b729-d487412167a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_b0e275c6-1585-4a0a-921a-f0ea5f1133d9" xlink:href="bmy-20230331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_61c488a9-61fc-4fb3-892e-d3b802219263" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_b0e275c6-1585-4a0a-921a-f0ea5f1133d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dbcad3de-88aa-451c-b75c-3f7cfcf34d2a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_28c4544a-45b1-47a0-8afb-5cfbddcea945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_CostOfSalesMember_28c4544a-45b1-47a0-8afb-5cfbddcea945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1ea43106-9db3-4ad1-82b5-14919a2a5415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1ea43106-9db3-4ad1-82b5-14919a2a5415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_bb5fc5df-77bd-47a9-8071-aace0a8b2547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ffa76a17-9e1e-4986-91c8-6df264752cd6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_bb5fc5df-77bd-47a9-8071-aace0a8b2547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30c6e1b6-b316-460d-8332-a51427cf2201" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_81ca6dfd-d909-41b5-bcd0-ad85655622ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_81ca6dfd-d909-41b5-bcd0-ad85655622ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f25b0816-2f9b-4c91-8307-70f064a52803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_SeveranceCosts1_f25b0816-2f9b-4c91-8307-70f064a52803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5df1461a-462a-488a-9a54-2afede370632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_OtherRestructuringCosts_5df1461a-462a-488a-9a54-2afede370632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_75fde8fb-5260-44a2-9e41-e571b97b23b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringCharges_75fde8fb-5260-44a2-9e41-e571b97b23b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_940c18c1-7e0e-499e-923e-45cb68f26c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_940c18c1-7e0e-499e-923e-45cb68f26c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_f10d8209-8a47-448e-8c37-9e7a1e0fb029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e717245-f3ea-423c-9b78-3726cc9adf1d" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_f10d8209-8a47-448e-8c37-9e7a1e0fb029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_80e3d585-191e-482b-a0a0-d86e421d5bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_80e3d585-191e-482b-a0a0-d86e421d5bdf" xlink:to="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:to="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_a782a90f-bb41-4619-97bd-2b551a44627e" xlink:to="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_4c7f99e6-7d1e-4fe4-a4e1-dbc455fb0627" xlink:href="bmy-20230331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0983f79a-583b-4d90-8098-6821896bbcdd" xlink:to="loc_bmy_CelgeneIntegrationMember_4c7f99e6-7d1e-4fe4-a4e1-dbc455fb0627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8d05caf8-e666-4f9e-b6b7-a79898da08b1" xlink:to="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7ab34f26-0d0d-40ea-810d-0fd245956657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_RestructuringReserve_7ab34f26-0d0d-40ea-810d-0fd245956657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_4fc62b77-aec2-4a56-9890-9b0c89324d03" xlink:href="bmy-20230331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_4fc62b77-aec2-4a56-9890-9b0c89324d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_c35a0aba-9c7e-43ea-a9e9-36a88526e717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_c35a0aba-9c7e-43ea-a9e9-36a88526e717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_2a989122-24c7-453e-8cf0-c10a01669a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_PaymentsForRestructuring_2a989122-24c7-453e-8cf0-c10a01669a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f70cafd6-4c27-41d5-a3a1-3b833341a149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_84741964-46a1-4588-b6d4-991d6c49f34c" xlink:to="loc_us-gaap_RestructuringReserve_f70cafd6-4c27-41d5-a3a1-3b833341a149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_cd53f768-71c3-41c1-971c-963f14bc493b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_28890289-1b5d-4cfa-a8f0-8a7e39c6c89f" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_cd53f768-71c3-41c1-971c-963f14bc493b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3b59c135-e961-41f4-bf9f-cdab1ebae5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0960df4-0403-42bd-9b25-ae57fc4536c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b59c135-e961-41f4-bf9f-cdab1ebae5b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0960df4-0403-42bd-9b25-ae57fc4536c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0c84571a-65e6-4afc-b31d-496e1ebac955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b59c135-e961-41f4-bf9f-cdab1ebae5b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0c84571a-65e6-4afc-b31d-496e1ebac955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d3eec70-6f46-4544-8fd1-61c1d36fbbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3b59c135-e961-41f4-bf9f-cdab1ebae5b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d3eec70-6f46-4544-8fd1-61c1d36fbbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_37ec07c6-a4cb-4764-8b38-d80ecf115793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_37ec07c6-a4cb-4764-8b38-d80ecf115793" xlink:to="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:to="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e4a199a2-1f7c-4dd5-9b32-5e262753223b" xlink:to="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c80b5448-f43c-4fc6-827d-d38f0be53f22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:to="loc_srt_MinimumMember_c80b5448-f43c-4fc6-827d-d38f0be53f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63d08c9c-b42e-4313-8e8d-3462d392dac8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b8e824ab-6725-4e6e-9173-9e6feec5b20b" xlink:to="loc_srt_MaximumMember_63d08c9c-b42e-4313-8e8d-3462d392dac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c96a9ebc-f834-4f4f-93c1-4e6159c6cc9d" xlink:to="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_993e250c-be1b-49f6-adf6-44d1ec0d974a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_993e250c-be1b-49f6-adf6-44d1ec0d974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_82296d13-9969-4194-beaa-6c69279117ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_82296d13-9969-4194-beaa-6c69279117ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_b0f41dba-dac4-4707-b7e0-18bc6efa057f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_b0f41dba-dac4-4707-b7e0-18bc6efa057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_02193942-17dc-43b2-9871-40820ea0e22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a457e9f1-57d6-4e32-b07b-9a40cae2e4f7" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_02193942-17dc-43b2-9871-40820ea0e22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea0cd4c9-3e3c-45eb-86e6-4a3189a2b603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:to="loc_us-gaap_NetIncomeLoss_ea0cd4c9-3e3c-45eb-86e6-4a3189a2b603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9fbd4c25-c480-4fd5-882c-34efc93dd3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9fbd4c25-c480-4fd5-882c-34efc93dd3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_281cbb70-f245-4390-ae0f-fd0a8624a9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_281cbb70-f245-4390-ae0f-fd0a8624a9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_135663a6-7281-4101-a2a6-72d0236f9035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_135663a6-7281-4101-a2a6-72d0236f9035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_ce4ef546-1db0-40b9-a05e-f74f06030b96" xlink:href="bmy-20230331.xsd#bmy_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4d5353fa-2efd-45d4-9344-e5aa82b28077" xlink:to="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_ce4ef546-1db0-40b9-a05e-f74f06030b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b7320095-9c2d-4470-ba5c-f5187642f821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_ce4ef546-1db0-40b9-a05e-f74f06030b96" xlink:to="loc_us-gaap_EarningsPerShareBasic_b7320095-9c2d-4470-ba5c-f5187642f821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1ac15c56-7176-40cf-8ece-bf384ae2daab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EarningsPerShareBasicAndDilutedEPSAbstract_ce4ef546-1db0-40b9-a05e-f74f06030b96" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1ac15c56-7176-40cf-8ece-bf384ae2daab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46a5199b-36ac-4c98-8c2d-791108dc58bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46a5199b-36ac-4c98-8c2d-791108dc58bd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_398edec3-fc02-40f7-a099-24081889eecc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_69d9b735-ceae-4252-ac68-1a792a13529c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_69d9b735-ceae-4252-ac68-1a792a13529c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_49f86e7b-6fc1-449e-a86d-6ff56fcc4aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_49f86e7b-6fc1-449e-a86d-6ff56fcc4aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5af1d4c6-0286-446d-bf61-7eb16e105854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2d02ac49-7a18-4125-a410-c04a6ff21017" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5af1d4c6-0286-446d-bf61-7eb16e105854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_706de3a3-154c-4918-8fe1-7cfbfde4a342" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1c4fddeb-5e0e-4348-b544-f2704e879d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1c4fddeb-5e0e-4348-b544-f2704e879d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_226a93c9-1647-4b6a-884c-34e093edda72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a631e68f-777e-463b-ab06-1657861e0e54" xlink:to="loc_us-gaap_CommercialPaperMember_226a93c9-1647-4b6a-884c-34e093edda72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d5875fa0-4b68-45df-953b-16465251f24c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_dd7c0d00-08d3-4ab5-9178-e541a354af44" xlink:href="bmy-20230331.xsd#bmy_ContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9a5f6b32-e991-469f-ab09-ad7a2e24d33d" xlink:to="loc_bmy_ContingentValueRightsMember_dd7c0d00-08d3-4ab5-9178-e541a354af44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dc29275-c32a-49c8-90a1-76dba212b906" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_57f70c04-f67e-484f-bc74-74ff7c02f008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2bf0b69f-9262-4a4d-88ef-51dcbc9ee744" xlink:to="loc_us-gaap_OtherAssetsMember_57f70c04-f67e-484f-bc74-74ff7c02f008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e11cbb3-688e-4cde-b37c-13a46b4ff1c6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f3fda344-2c2e-49a5-9e38-a1429f32ce4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f3fda344-2c2e-49a5-9e38-a1429f32ce4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20d5f92f-368d-4eb6-94e3-6b0029ff2d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20d5f92f-368d-4eb6-94e3-6b0029ff2d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4a8977ea-2437-435d-b36c-dd11c11415f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_DerivativeAssets_4a8977ea-2437-435d-b36c-dd11c11415f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1f9e4726-63aa-4eae-9acc-3d1e81820375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1f9e4726-63aa-4eae-9acc-3d1e81820375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a619722b-79de-4340-8572-6c78ec7b09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_DerivativeLiabilities_a619722b-79de-4340-8572-6c78ec7b09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_785468d0-e089-4b8b-8734-8cc32f243bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f35bc77b-f448-465e-b4a8-e7da3913519c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_785468d0-e089-4b8b-8734-8cc32f243bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_63c9c9b9-cb62-44b8-9ca9-68cf2509840e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_63c9c9b9-cb62-44b8-9ca9-68cf2509840e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8285798c-3ac8-473c-9c24-b743c5632c0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_8068295c-6acd-4b44-b7af-7cc53a11bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:to="loc_us-gaap_CertificatesOfDepositMember_8068295c-6acd-4b44-b7af-7cc53a11bf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e58d75bd-23ac-4e39-b761-8daad8d549f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95a248bf-6c35-4c2b-920d-59fe62a92db7" xlink:to="loc_us-gaap_CommercialPaperMember_e58d75bd-23ac-4e39-b761-8daad8d549f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4796bef-d633-43a7-a06d-51745e86db8f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_78ea01aa-88ec-4123-b0ea-d0f6710eaa50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_78ea01aa-88ec-4123-b0ea-d0f6710eaa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e156eed3-71b9-4deb-a461-0355cb002f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e156eed3-71b9-4deb-a461-0355cb002f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8dc0b2f-866c-4e39-b406-ed15556093e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8dc0b2f-866c-4e39-b406-ed15556093e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8273c912-0578-42cc-8d48-bd3ac35eec42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a0ebac90-a36e-4729-806a-583c92cccadf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8273c912-0578-42cc-8d48-bd3ac35eec42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3f11824d-ba6d-412e-a34b-83675540f292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_826015ad-1141-4143-bd03-6dedda7c64cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f11824d-ba6d-412e-a34b-83675540f292" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_826015ad-1141-4143-bd03-6dedda7c64cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a0150aa-f475-43d0-a195-e088aa2c4fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f11824d-ba6d-412e-a34b-83675540f292" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4a0150aa-f475-43d0-a195-e088aa2c4fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5b8402dc-12c4-4b28-b166-ef7b8529bdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f11824d-ba6d-412e-a34b-83675540f292" xlink:to="loc_us-gaap_EquityMethodInvestments_5b8402dc-12c4-4b28-b166-ef7b8529bdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_bb43522f-9ad4-443a-a7f8-aec5446603ff" xlink:href="bmy-20230331.xsd#bmy_EquityInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f11824d-ba6d-412e-a34b-83675540f292" xlink:to="loc_bmy_EquityInvestments_bb43522f-9ad4-443a-a7f8-aec5446603ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b9f6bcff-fe8a-4552-a074-7367b4afa373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract_20f79db6-dbb3-49db-9303-448cab144858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9f6bcff-fe8a-4552-a074-7367b4afa373" xlink:to="loc_us-gaap_EquitySecuritiesFVNIAbstract_20f79db6-dbb3-49db-9303-448cab144858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_ccf51f94-2734-4561-9133-dd173562b960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_20f79db6-dbb3-49db-9303-448cab144858" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_ccf51f94-2734-4561-9133-dd173562b960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_a15d9a7b-b976-4439-99b1-faadeda83c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_20f79db6-dbb3-49db-9303-448cab144858" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_a15d9a7b-b976-4439-99b1-faadeda83c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_d0d112c0-a58a-4c64-8685-c9a97832b321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_20f79db6-dbb3-49db-9303-448cab144858" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_d0d112c0-a58a-4c64-8685-c9a97832b321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_98918cde-e47a-48fc-9b6a-9f47c180bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9f6bcff-fe8a-4552-a074-7367b4afa373" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_98918cde-e47a-48fc-9b6a-9f47c180bf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_f05efb78-d7c3-4dab-b9ca-9b2c9bde1638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_98918cde-e47a-48fc-9b6a-9f47c180bf56" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_f05efb78-d7c3-4dab-b9ca-9b2c9bde1638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_2ce82f77-dcfd-4c2f-80e0-17ed0df1fd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_98918cde-e47a-48fc-9b6a-9f47c180bf56" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_2ce82f77-dcfd-4c2f-80e0-17ed0df1fd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7aa78757-1177-416f-856d-73e3598c95c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9f6bcff-fe8a-4552-a074-7367b4afa373" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7aa78757-1177-416f-856d-73e3598c95c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_ebdcbcc5-a024-44ab-8e1f-658ed6d78095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9f6bcff-fe8a-4552-a074-7367b4afa373" xlink:to="loc_us-gaap_GainLossOnInvestments_ebdcbcc5-a024-44ab-8e1f-658ed6d78095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_535b4786-1ba6-4e0e-bb66-2446aa575e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_535b4786-1ba6-4e0e-bb66-2446aa575e68" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_51aa40fa-2f2f-4791-b850-b78cf00594dc" xlink:to="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_23ac8333-d902-4c81-a29d-63eb9bb246c8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:to="loc_currency_EUR_23ac8333-d902-4c81-a29d-63eb9bb246c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1efb3523-64a0-4fe0-92d3-ce63ffd820a6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ec948483-3990-4ef4-9604-85fd4818627e" xlink:to="loc_currency_JPY_1efb3523-64a0-4fe0-92d3-ce63ffd820a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_aacfa31c-3db3-4a86-b319-337d92cdbd0e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1178f2f6-fbab-4ae9-bd42-c04374c8fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d7c1bb60-918b-4a6f-8625-b43671e5323d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1178f2f6-fbab-4ae9-bd42-c04374c8fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_14f17eac-a533-402d-808a-d6061ab85325" xlink:to="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_279ce8b9-85a1-4f83-aca8-f9a7fbb539ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7d375e68-9a62-4792-bec5-6469e7ee1294" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_279ce8b9-85a1-4f83-aca8-f9a7fbb539ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ca08996-5c95-4d9e-b7df-ec4b4465990e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ace4a0b6-243f-4fc7-bff9-87f3c72fabb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ace4a0b6-243f-4fc7-bff9-87f3c72fabb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_cee95598-74fe-4969-a8fa-4e37c82ed12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_cee95598-74fe-4969-a8fa-4e37c82ed12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b02ac107-b7cb-403e-9ec1-11efd07d9e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_da479834-ad99-414c-b977-a0ae717a8650" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b02ac107-b7cb-403e-9ec1-11efd07d9e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bf59d8d-ce0c-4847-91ea-67da6ed936af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3aef604a-a8c2-49a0-9d75-32ee6e4160ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3aef604a-a8c2-49a0-9d75-32ee6e4160ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1eb593ef-9d65-4800-aaab-a4f13837b224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_735c5a4b-ec58-448e-9898-78fa67af0b0c" xlink:to="loc_us-gaap_CashFlowHedgingMember_1eb593ef-9d65-4800-aaab-a4f13837b224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1abd78f-8a15-4d57-9e44-b67d8e5c0f86" xlink:to="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_eaaa3121-ee4c-4c73-b5f0-2ecaf378315c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_eaaa3121-ee4c-4c73-b5f0-2ecaf378315c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_79375057-2f2b-4121-8dd4-dbffdb66a88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_79375057-2f2b-4121-8dd4-dbffdb66a88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fb718f36-2c26-47df-a946-57e999980176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fb718f36-2c26-47df-a946-57e999980176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85b9568b-818b-4f4f-bc66-437b388242a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85b9568b-818b-4f4f-bc66-437b388242a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_243f6b37-471d-409d-9bc7-9057d294fe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_243f6b37-471d-409d-9bc7-9057d294fe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9ebd84ac-3051-417b-b97d-19a25e1a24e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9ebd84ac-3051-417b-b97d-19a25e1a24e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_f4ed82a0-db93-4f71-86da-f311dc677ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a19ebc5-7675-4d27-9bbb-a74efd36eff4" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_f4ed82a0-db93-4f71-86da-f311dc677ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4b8ac26-c7c7-461e-9eb8-a9ae94c90350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4b8ac26-c7c7-461e-9eb8-a9ae94c90350" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_df9d50b9-342f-427e-b575-085f7c48b0c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1e730897-130d-430c-85dd-28cd5f9e3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1e730897-130d-430c-85dd-28cd5f9e3dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b2d2e970-eb9b-41d4-ab03-ff732cf5863c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2183b698-81a6-4b09-8297-13dbb057df28" xlink:to="loc_us-gaap_NondesignatedMember_b2d2e970-eb9b-41d4-ab03-ff732cf5863c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_053b29ef-ad05-45fb-9368-f0aaa73b80f9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_349fc9d4-c10f-44f0-9fb4-c861849ebe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_InterestRateSwapMember_349fc9d4-c10f-44f0-9fb4-c861849ebe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_36933805-8dd0-459b-8a6f-ae23f05173d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_36933805-8dd0-459b-8a6f-ae23f05173d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f8b924dc-d474-4137-af9b-869405490971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f8b924dc-d474-4137-af9b-869405490971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_e2ea71b9-96d4-40e3-aac2-19925ffadbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391c9132-2c24-4951-b4a9-d5a408e15563" xlink:to="loc_us-gaap_OtherContractMember_e2ea71b9-96d4-40e3-aac2-19925ffadbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ad99027-870f-49e3-92ce-da3fd951e885" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_42551949-36b5-41a8-a066-3a8cfd4bcf00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:to="loc_us-gaap_AssetsMember_42551949-36b5-41a8-a066-3a8cfd4bcf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_d13b3ed1-1710-4e64-aa41-6e1b3d799ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b08ac9f3-7b2d-4349-907a-b4157dbcb8b5" xlink:to="loc_us-gaap_LiabilityMember_d13b3ed1-1710-4e64-aa41-6e1b3d799ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fbec405e-5154-4cc5-83c0-692b5451e1ef" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2229d73c-06a3-44e7-bc14-98620bde9140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2229d73c-06a3-44e7-bc14-98620bde9140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_cf32bf6e-4193-40b1-8bcc-5429afaff162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aedfae60-a3f0-4959-97a8-f8dfd15db490" xlink:to="loc_us-gaap_CashFlowHedgingMember_cf32bf6e-4193-40b1-8bcc-5429afaff162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_75fd24fd-1ac0-4e72-8c9d-dfb2411f10f8" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_03e0c517-ac66-4417-8401-4aa4e59dc4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeNotionalAmount_03e0c517-ac66-4417-8401-4aa4e59dc4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_968f8dee-b0b0-4774-b667-7ca8c99597f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeAssets_968f8dee-b0b0-4774-b667-7ca8c99597f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_dc7d9db5-042b-4cba-88a2-b2a352a3e6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2ff93d1c-f385-4bf2-8a39-7711a8032d04" xlink:to="loc_us-gaap_DerivativeLiabilities_dc7d9db5-042b-4cba-88a2-b2a352a3e6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6366bfc-2b49-4738-89af-693ad006b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6366bfc-2b49-4738-89af-693ad006b69a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_28bbe9da-7882-411f-b19b-8c956cfca84f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c852c728-e2d1-41e2-aec8-14a18a277feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_InterestRateSwapMember_c852c728-e2d1-41e2-aec8-14a18a277feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_dddfb8e5-2f47-44ab-abe8-65d6ea451790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_dddfb8e5-2f47-44ab-abe8-65d6ea451790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6c6b2861-f58c-4a08-a622-49d80149c90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60f21675-28e0-431a-b126-a9bb6a0aa9f2" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6c6b2861-f58c-4a08-a622-49d80149c90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8dfc4b3-b04b-4a63-9f73-62e1561ad0e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d115ba4c-a955-4e56-b92c-18ca52266031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:to="loc_us-gaap_CostOfSalesMember_d115ba4c-a955-4e56-b92c-18ca52266031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_617f10e4-e28e-4fd9-87f1-8f1cbc62906b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0c44c79b-a0e5-4ba6-82b9-74d445be0315" xlink:to="loc_us-gaap_OtherIncomeMember_617f10e4-e28e-4fd9-87f1-8f1cbc62906b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_facebb61-7956-4f4c-8f07-3367144840e2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d643d030-5a30-4c6e-a24e-a41190c843a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7549750d-f6aa-43f5-9a12-5af18efcbb4b" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d643d030-5a30-4c6e-a24e-a41190c843a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dadce585-f478-4671-b846-1000487e801e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dadce585-f478-4671-b846-1000487e801e" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bc4ccd-8d71-48c5-9780-6d4c0ba79804" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8759dd3e-4398-4f0a-9944-34ea0bf329a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8759dd3e-4398-4f0a-9944-34ea0bf329a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c3fb597a-215d-4124-9dfb-19cd5842ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_InterestRateSwapMember_c3fb597a-215d-4124-9dfb-19cd5842ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_0f240fe3-99f6-498a-b8cb-91c7bb336b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2f11aaaa-ab29-4922-b3df-fe669f32ad10" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_0f240fe3-99f6-498a-b8cb-91c7bb336b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bfef74b6-0273-479f-abff-f493d846053d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d7db082a-3d80-4d7d-ac5e-4dad3a554089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_CostOfSalesMember_d7db082a-3d80-4d7d-ac5e-4dad3a554089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_59459756-80bc-4a47-b895-d8aea25a377b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_59459756-80bc-4a47-b895-d8aea25a377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_75088150-a832-4989-ae2e-b23855f26151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3c7bba10-a665-4f8f-ae07-9a5726a46603" xlink:to="loc_us-gaap_OtherIncomeMember_75088150-a832-4989-ae2e-b23855f26151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_821d2ac8-c3cf-41e0-ab4d-192d0e27a0c7" xlink:to="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cd85f599-85a7-4bf6-87e5-68032a7b61d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1d5d1056-9ed7-4ea3-bc1d-fbafb7d89384" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cd85f599-85a7-4bf6-87e5-68032a7b61d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_bf9c8c22-3d13-47ac-a4d6-9ff4833fd264" xlink:to="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a78615f4-11b1-44e6-af2c-a8c42cf77453" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_bb6fe6a0-1127-4af4-ac69-f23cabbb3bd3" xlink:to="loc_currency_EUR_a78615f4-11b1-44e6-af2c-a8c42cf77453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_e7448a80-c5cd-4cf1-8231-2f5758af862c" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_5a187737-809e-4981-8d55-61ded2393a78" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e1ab8d9f-3e28-429c-90ca-17ecbf85e7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e1ab8d9f-3e28-429c-90ca-17ecbf85e7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_84dfc0bd-4784-4c66-9595-8c9dd1f364db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_ae326041-a70c-4244-9de7-a2a407492663" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_84dfc0bd-4784-4c66-9595-8c9dd1f364db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0995cfa9-9530-43e4-b715-91ae919a5351" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d4f87f0f-8353-4bf3-87f9-a8ada0e236f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_aa00da7d-a31a-4a27-afc7-90483a1b7729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d4f87f0f-8353-4bf3-87f9-a8ada0e236f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_84d9b1b8-4a21-4a7f-89b4-33fa418bd0fc" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_535e5598-09dc-4573-b1b1-b8b28ad0807c" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_9f2bff13-326a-494c-bc86-e4f73b19c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_6be34ef6-976d-4aa2-a34f-d523c3a01973" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_9f2bff13-326a-494c-bc86-e4f73b19c2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSShortTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f1f8c7b4-2b82-4ff0-afc8-16cfd808c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_14c3357d-125b-45d1-88bc-c0d1586d586a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f8c7b4-2b82-4ff0-afc8-16cfd808c33f" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_14c3357d-125b-45d1-88bc-c0d1586d586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4eb643f5-fd2c-421e-904b-2c7f4d3704b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f8c7b4-2b82-4ff0-afc8-16cfd808c33f" xlink:to="loc_us-gaap_LongTermDebtCurrent_4eb643f5-fd2c-421e-904b-2c7f4d3704b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_8efd9a13-c5d0-4067-9ef4-9b92c4409e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f8c7b4-2b82-4ff0-afc8-16cfd808c33f" xlink:to="loc_us-gaap_OtherShortTermBorrowings_8efd9a13-c5d0-4067-9ef4-9b92c4409e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3b698312-064e-41d4-9a4c-7a717ccb219a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f8c7b4-2b82-4ff0-afc8-16cfd808c33f" xlink:to="loc_us-gaap_ShortTermBorrowings_3b698312-064e-41d4-9a4c-7a717ccb219a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9eb3d23b-1718-4774-b310-413cfd0c8237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9eb3d23b-1718-4774-b310-413cfd0c8237" xlink:to="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92a2b600-87e2-423a-a7e0-cbbc8737793f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_eb5321f7-6ca4-4f7b-a2ca-bc8d26d4469c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ac6cd9a-e46d-495b-8fa5-e98d6ad7515c" xlink:to="loc_us-gaap_InterestRateSwapMember_eb5321f7-6ca4-4f7b-a2ca-bc8d26d4469c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4d932961-151c-4ab2-be20-b07c1fb4063c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6204f9b6-b31e-42a1-b435-7f5f88568c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6204f9b6-b31e-42a1-b435-7f5f88568c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_4c9c6679-2237-46a6-8256-dd65668d1106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DerivativeLiabilities_4c9c6679-2237-46a6-8256-dd65668d1106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6132a264-7cbe-4433-8cfd-8afbb8edfc73" xlink:href="bmy-20230331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6132a264-7cbe-4433-8cfd-8afbb8edfc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_099fd2d8-fadf-4f29-bf86-e0daa567ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_099fd2d8-fadf-4f29-bf86-e0daa567ed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_3bdea584-8bdd-4055-8494-8a31db84514b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_3bdea584-8bdd-4055-8494-8a31db84514b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_64bf204f-205f-4745-992e-fbb2e685c066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebt_64bf204f-205f-4745-992e-fbb2e685c066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_03680856-798b-4665-a1c4-4fd335051799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebtCurrent_03680856-798b-4665-a1c4-4fd335051799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3e92d392-7662-49b3-ba53-16f63f759d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e276fbb-4938-4f9b-8ca9-2f8fb68d2ac7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3e92d392-7662-49b3-ba53-16f63f759d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#FINANCINGARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dd0960da-4497-4d8c-ae3b-77c21ea299a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dd0960da-4497-4d8c-ae3b-77c21ea299a7" xlink:to="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5e0f00af-0162-42f5-b4cc-0c6fa0080baf" xlink:to="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f4ae6523-80a1-485f-9668-4df7e082ada3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f4ae6523-80a1-485f-9668-4df7e082ada3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_0ebb48b2-bbb6-43de-b361-3757e7e428ae" xlink:href="bmy-20230331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f574766e-e5de-4279-9082-c8337e10d9e8" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_0ebb48b2-bbb6-43de-b361-3757e7e428ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b62b9720-d090-4573-95a4-b5cb41add796" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_6b2b5dcd-1193-4b91-9c64-57343b2594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9db93c3b-cd45-486d-b479-6a432b17b6ef" xlink:to="loc_us-gaap_LineOfCreditMember_6b2b5dcd-1193-4b91-9c64-57343b2594f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea0944d0-19e7-4f1d-a64b-82adbe213c36" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2750NotesMember_7a643b76-db60-44fd-9f8f-a9a3e7d1ab5f" xlink:href="bmy-20230331.xsd#bmy_A2750NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:to="loc_bmy_A2750NotesMember_7a643b76-db60-44fd-9f8f-a9a3e7d1ab5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A3250NotesMember_0bb1ffad-1871-49c0-a654-36774a3ae3ef" xlink:href="bmy-20230331.xsd#bmy_A3250NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_840c8e5c-e325-4629-86c4-710e46ba0245" xlink:to="loc_bmy_A3250NotesMember_0bb1ffad-1871-49c0-a654-36774a3ae3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca86c1c0-a6e3-46ce-a8a6-ec1f8b44cd29" xlink:to="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e2789610-3346-4057-a4e1-576ce8a60a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e2789610-3346-4057-a4e1-576ce8a60a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal_55e75538-3ff9-44e5-9867-9af104b0e302" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap-supplement_DebtInstrumentRepaidPrincipal_55e75538-3ff9-44e5-9867-9af104b0e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c772507c-dead-4bf5-ab9d-3067563e20ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c772507c-dead-4bf5-ab9d-3067563e20ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_147ecbb8-b990-4c68-9f58-fc1cc57eb594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_147ecbb8-b990-4c68-9f58-fc1cc57eb594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc0c7d87-6da9-4632-863f-0ab53e7634fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc0c7d87-6da9-4632-863f-0ab53e7634fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_965ea828-b75a-4aed-ad25-f235bb519be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_965ea828-b75a-4aed-ad25-f235bb519be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e1b2c615-d33d-4262-b016-be946866327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_e1b2c615-d33d-4262-b016-be946866327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_edf16cf6-626e-4ba8-9aea-77f80e271a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_edf16cf6-626e-4ba8-9aea-77f80e271a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0f2e528f-4bdd-4213-a555-ef4584b3cb63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_InterestPaidNet_0f2e528f-4bdd-4213-a555-ef4584b3cb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_f0e1d8cc-9ef2-47b6-8b4b-41d00e6b5e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LongTermDebtTerm_f0e1d8cc-9ef2-47b6-8b4b-41d00e6b5e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f272f0dd-3155-4d10-a6b3-9a12319a93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f272f0dd-3155-4d10-a6b3-9a12319a93d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_d924c6b3-36d2-4a62-926e-053a3f2f2c9d" xlink:href="bmy-20230331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_d924c6b3-36d2-4a62-926e-053a3f2f2c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_dcfe5130-533d-47d3-86f4-fc6978cd0e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_007f22b5-9ed8-4b85-aa33-11563d5e1fff" xlink:to="loc_us-gaap_LineOfCredit_dcfe5130-533d-47d3-86f4-fc6978cd0e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_978e6711-b47a-47aa-a314-9e3efe363938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_978e6711-b47a-47aa-a314-9e3efe363938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_30452fc9-d7e6-4884-935d-ef81e60f56c3" xlink:href="bmy-20230331.xsd#bmy_CashDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_bmy_CashDiscounts_30452fc9-d7e6-4884-935d-ef81e60f56c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_abd1c63f-0431-47de-be62-ba7b4e5ea6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_abd1c63f-0431-47de-be62-ba7b4e5ea6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_519da3ed-4386-4800-9f8f-77769c0e1e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_519da3ed-4386-4800-9f8f-77769c0e1e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_9cb3e6e1-154e-460f-9ad6-c43b3c02285f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_us-gaap_OtherReceivables_9cb3e6e1-154e-460f-9ad6-c43b3c02285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_97abfbc0-4de6-4d45-ad84-2b7e7f9bb06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_dda44518-05aa-4e68-8e2c-831fcff92862" xlink:to="loc_us-gaap_ReceivablesNetCurrent_97abfbc0-4de6-4d45-ad84-2b7e7f9bb06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#RECEIVABLESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_b1cb1f55-5fe2-4789-b9f1-560d56663e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_b1cb1f55-5fe2-4789-b9f1-560d56663e93" xlink:to="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4d535f80-6a8b-4af3-82cf-bb71ca534680" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d77f19e3-6e37-4c8e-a69c-770f356c4eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0c65b1c-90b1-41ef-9953-49cf9b949868" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d77f19e3-6e37-4c8e-a69c-770f356c4eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a5ee363a-25b9-407e-8ada-1d41ad13ad13" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_035bf2ba-0970-4f39-85da-acf0a9894de8" xlink:href="bmy-20230331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_035bf2ba-0970-4f39-85da-acf0a9894de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_d39a6d5f-6c4a-4d0e-a858-67ba1b1292ac" xlink:href="bmy-20230331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_d39a6d5f-6c4a-4d0e-a858-67ba1b1292ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_e235bbcd-6c73-4d65-b6e1-b84f58723272" xlink:href="bmy-20230331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_57c8d367-60e2-47bf-b804-e27322aa5cd2" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_e235bbcd-6c73-4d65-b6e1-b84f58723272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_5292ba63-e57d-49fe-bca7-fe73037acbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5292ba63-e57d-49fe-bca7-fe73037acbab" xlink:to="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8f623395-53e3-4aeb-acdd-4308688f7503" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_1d40c9d7-1035-484e-95f9-09ce0613ba53" xlink:href="bmy-20230331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4007a6fe-16c6-4a30-b910-8fe6375669c6" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_1d40c9d7-1035-484e-95f9-09ce0613ba53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d0f77577-8d6c-4dd7-8532-253d1f51af4f" xlink:to="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4d5629b5-5fe0-41ff-b340-8d812dad3861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4d5629b5-5fe0-41ff-b340-8d812dad3861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_655e233f-9da4-4bd7-835b-328c25648bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_655e233f-9da4-4bd7-835b-328c25648bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8c5b6fbc-f965-47e2-9c30-fe3a075edd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8c5b6fbc-f965-47e2-9c30-fe3a075edd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_15ba5fc9-bad5-46dc-bc76-40e44293d273" xlink:href="bmy-20230331.xsd#bmy_Totalinventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_bmy_Totalinventories_15ba5fc9-bad5-46dc-bc76-40e44293d273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c04bc597-038c-4460-89f7-b0e956b04f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryNet_c04bc597-038c-4460-89f7-b0e956b04f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_50e2df4a-f9ab-4965-ab53-07a55d23a34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_InventoryNoncurrent_50e2df4a-f9ab-4965-ab53-07a55d23a34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b75eb5c3-af4f-47b1-b2b4-fbcdac9ce0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2840018d-7da0-4f60-a5ed-5f161f846a99" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b75eb5c3-af4f-47b1-b2b4-fbcdac9ce0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d919ec14-c3c7-465e-8b95-44c7d04a0c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_Land_d919ec14-c3c7-465e-8b95-44c7d04a0c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_c698c445-c1a4-45e8-aa35-8d4df99e43ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_c698c445-c1a4-45e8-aa35-8d4df99e43ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_d103ecee-46ac-4615-aedf-34fe1f26042c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_d103ecee-46ac-4615-aedf-34fe1f26042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_d5372cf8-fdad-4118-a6a2-ed6b490daca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_ConstructionInProgressGross_d5372cf8-fdad-4118-a6a2-ed6b490daca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_537f07c1-0e9f-4eef-aa40-e158a9a9de60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_537f07c1-0e9f-4eef-aa40-e158a9a9de60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77098da7-01e7-44d8-accc-0ee8e1ee395f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77098da7-01e7-44d8-accc-0ee8e1ee395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f6b0def8-8945-4c18-b92b-d65c9cbaafeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f6b0def8-8945-4c18-b92b-d65c9cbaafeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6e59d357-b310-4392-bb90-ba3b57669203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_882be814-2c46-4a4c-b4b6-59b67c1d7910" xlink:to="loc_us-gaap_Depreciation_6e59d357-b310-4392-bb90-ba3b57669203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_804f3d5b-5372-4df8-a0ad-707c5ce68bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_823bf02a-4c9d-418c-a6a9-df275f231d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_804f3d5b-5372-4df8-a0ad-707c5ce68bbc" xlink:to="loc_us-gaap_GoodwillRollForward_823bf02a-4c9d-418c-a6a9-df275f231d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa12368d-e76f-4b3b-83e1-74838d841378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_823bf02a-4c9d-418c-a6a9-df275f231d53" xlink:to="loc_us-gaap_Goodwill_aa12368d-e76f-4b3b-83e1-74838d841378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_0c7520f1-09e9-4f6d-888a-b9d0d73d3751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_823bf02a-4c9d-418c-a6a9-df275f231d53" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_0c7520f1-09e9-4f6d-888a-b9d0d73d3751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_678750e5-d682-4bde-af4c-d8b23f76ab09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_823bf02a-4c9d-418c-a6a9-df275f231d53" xlink:to="loc_us-gaap_Goodwill_678750e5-d682-4bde-af4c-d8b23f76ab09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a44f7008-c38c-425c-8b3d-a64c0d05d689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a44f7008-c38c-425c-8b3d-a64c0d05d689" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_abed006a-89fe-47de-827a-f4c284317b84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_31976f3b-b373-4e16-afec-c52ef36a57f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_LicensingAgreementsMember_31976f3b-b373-4e16-afec-c52ef36a57f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cbde6259-41f6-4a1c-8ef9-81742099afc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cbde6259-41f6-4a1c-8ef9-81742099afc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_d82f903e-287c-41b3-b27a-2c23127fe37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f57e536-a9f6-42c6-aad8-f10b59c12487" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_d82f903e-287c-41b3-b27a-2c23127fe37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7e08d950-01bc-4aa1-966b-b6290650f4d6" xlink:to="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9c827c7-c0a3-4326-8d95-3a49e8a08e53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:to="loc_srt_MinimumMember_e9c827c7-c0a3-4326-8d95-3a49e8a08e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de9a0183-5a93-4c3e-9628-32bf895db242" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e0c55e4-d2ac-4b30-930c-42dd7c320b80" xlink:to="loc_srt_MaximumMember_de9a0183-5a93-4c3e-9628-32bf895db242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_118fc9af-ad80-4b3b-9c67-729c8fc652f8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_200909b8-8153-4bcd-91ae-e86772e87e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e54bf1c3-30b6-4be2-b5f7-1600183c93e9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_200909b8-8153-4bcd-91ae-e86772e87e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_090c7948-2cea-4366-87db-8764146c10c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7cd5dd0f-cc25-457c-9cfc-f01494cec657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7cd5dd0f-cc25-457c-9cfc-f01494cec657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc68f86a-c567-44a4-bce8-3d7d6b613d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc68f86a-c567-44a4-bce8-3d7d6b613d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd083deb-ef9a-4549-b46b-a10125ad6004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd083deb-ef9a-4549-b46b-a10125ad6004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8d77d98d-01bc-4d03-98b3-b01b52a7ad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8d77d98d-01bc-4d03-98b3-b01b52a7ad7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_484cfd65-bd81-48d2-8bd9-ab3b0079cd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_484cfd65-bd81-48d2-8bd9-ab3b0079cd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f766e4c3-a31f-43e5-8ae7-0ea6e5d219c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_43b2400a-c34e-4358-ac5a-761ee6cef0fc" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f766e4c3-a31f-43e5-8ae7-0ea6e5d219c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eda4cc7a-c136-4513-8666-811e1fda5871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_79b04ca0-9cdf-41c5-85a7-b70f328d37fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eda4cc7a-c136-4513-8666-811e1fda5871" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_79b04ca0-9cdf-41c5-85a7-b70f328d37fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb5e6b77-a375-4919-95f0-63aaa2a96d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eda4cc7a-c136-4513-8666-811e1fda5871" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb5e6b77-a375-4919-95f0-63aaa2a96d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_5bb25f6f-3d13-429a-90d3-77823eae83e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_us-gaap_PrepaidTaxes_5bb25f6f-3d13-429a-90d3-77823eae83e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_1b9b2968-2779-40c7-bddf-c69df9be7811" xlink:href="bmy-20230331.xsd#bmy_ResearchandDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_bmy_ResearchandDevelopment_1b9b2968-2779-40c7-bddf-c69df9be7811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_27c153f8-4c33-4cdc-b6d1-7dae77480f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_27c153f8-4c33-4cdc-b6d1-7dae77480f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_36e0b20b-0d11-4a67-b44b-5637508da57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_us-gaap_RestrictedCash_36e0b20b-0d11-4a67-b44b-5637508da57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_4d1aeb35-8c90-4f81-a471-30822311e7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_4d1aeb35-8c90-4f81-a471-30822311e7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_58509ce7-496d-4cef-a886-6a31082e7316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_6d87cd8f-5536-4c5b-918f-41dce4a69b83" xlink:to="loc_us-gaap_OtherAssetsCurrent_58509ce7-496d-4cef-a886-6a31082e7316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_f5e5369a-4f70-4fe2-b81d-844bdedc8448" xlink:href="bmy-20230331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_f5e5369a-4f70-4fe2-b81d-844bdedc8448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_116f974c-c07b-4a14-bfc3-3b7dfc0a6c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_InventoryNoncurrent_116f974c-c07b-4a14-bfc3-3b7dfc0a6c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b21e7040-6fea-495f-addb-fb05ca0cfaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b21e7040-6fea-495f-addb-fb05ca0cfaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_08e43fc9-de71-40ac-85fc-597bc4022484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_08e43fc9-de71-40ac-85fc-597bc4022484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_2c415eb9-c1b6-4d04-9b29-4a8f11ec0166" xlink:href="bmy-20230331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_2c415eb9-c1b6-4d04-9b29-4a8f11ec0166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e63b1e03-cb79-484f-9e34-7f24796e0c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e63b1e03-cb79-484f-9e34-7f24796e0c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_496cfd4b-a908-466a-8cce-fffdddb01d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_496cfd4b-a908-466a-8cce-fffdddb01d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1d752d1b-0821-4071-9614-6c64b988ecfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1d752d1b-0821-4071-9614-6c64b988ecfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_4e9e3176-f4b7-40eb-a352-6be27c07f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_a4213386-0187-42d1-9841-51574912fda1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_4e9e3176-f4b7-40eb-a352-6be27c07f0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_43564150-f904-46c4-9830-3f33cbb84fb3" xlink:href="bmy-20230331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_bmy_AccruedRebatesAndReturns_43564150-f904-46c4-9830-3f33cbb84fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_01df74f7-e02d-44c4-ba9e-dc9ea7dcc49b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_01df74f7-e02d-44c4-ba9e-dc9ea7dcc49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fac9efe5-7075-44b7-9b74-0fec420636c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fac9efe5-7075-44b7-9b74-0fec420636c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_1f2ce2bb-67c3-49c8-8ab3-5d51fad2aec5" xlink:href="bmy-20230331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_bmy_AccruedResearchAndDevelopment_1f2ce2bb-67c3-49c8-8ab3-5d51fad2aec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_ecf89bbd-4459-46fc-8e8a-5f61c04bd2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_DividendsPayableCurrent_ecf89bbd-4459-46fc-8e8a-5f61c04bd2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_7b0acb75-bea5-4553-8cf4-85f31972845a" xlink:href="bmy-20230331.xsd#bmy_AccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_bmy_AccruedInterest_7b0acb75-bea5-4553-8cf4-85f31972845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_25561d57-a154-4649-a087-93c1f724cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_25561d57-a154-4649-a087-93c1f724cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c87cfabc-5c2b-480d-82c1-dcf6c17de8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c87cfabc-5c2b-480d-82c1-dcf6c17de8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_03608b7e-b4b3-48c1-92f1-53bf232a02d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_03608b7e-b4b3-48c1-92f1-53bf232a02d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7890a894-b9c5-47a6-adf1-5bcdf045db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e7f86598-326f-40b4-838c-27e060dc1704" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7890a894-b9c5-47a6-adf1-5bcdf045db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:href="bmy-20230331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_89a0ef28-afbe-4c11-988c-81648dfbad1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_89a0ef28-afbe-4c11-988c-81648dfbad1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cea7447b-42ce-46a4-bc4d-04d59c605431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cea7447b-42ce-46a4-bc4d-04d59c605431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_116186b7-0cd3-4532-979f-e4d4630ef980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_116186b7-0cd3-4532-979f-e4d4630ef980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_9b0879f5-2986-4285-906a-59854f9cb9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_9b0879f5-2986-4285-906a-59854f9cb9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_61a23b3f-e0bf-4603-bfbb-247091eae7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_61a23b3f-e0bf-4603-bfbb-247091eae7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_fd2ba48c-79a7-4661-89c6-9703a3935267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_fd2ba48c-79a7-4661-89c6-9703a3935267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_940d5840-5cfd-43f6-a034-a5b2e928121d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_1910055e-ebc5-4af9-97d0-9a70efb115da" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_940d5840-5cfd-43f6-a034-a5b2e928121d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_be8bef05-5020-4dec-b30c-2079b9eb5ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:href="bmy-20230331.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_be8bef05-5020-4dec-b30c-2079b9eb5ecd" xlink:to="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26637c0f-47c8-4d88-9444-47ab32f41a37" xlink:to="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b113ce57-1e4e-4c60-89af-f58534de65fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_CommonStockMember_b113ce57-1e4e-4c60-89af-f58534de65fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d88d12a4-2f0d-482e-bb21-de70b73fdb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d88d12a4-2f0d-482e-bb21-de70b73fdb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_20a10207-9f82-4bef-ab2f-1d5f8a038e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_20a10207-9f82-4bef-ab2f-1d5f8a038e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a08851e7-9e4b-46db-a28e-7072ae69bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_RetainedEarningsMember_a08851e7-9e4b-46db-a28e-7072ae69bb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_44a1d4f7-7e52-495b-9742-62b61031805e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_TreasuryStockCommonMember_44a1d4f7-7e52-495b-9742-62b61031805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_a521ff61-9fdc-413d-ac83-9575a59e8b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_146ce90e-9cdd-4cc3-8637-6c2baf0c10f2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_a521ff61-9fdc-413d-ac83-9575a59e8b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:href="bmy-20230331.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_0fc03f23-c5ff-4dad-94b3-8731d5e2e536" xlink:to="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_abfeb101-be8d-4328-9dab-aba862c7b087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_SharesIssued_abfeb101-be8d-4328-9dab-aba862c7b087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ac76a091-caf4-4d2b-9ba1-732ac7943ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_StockholdersEquity_ac76a091-caf4-4d2b-9ba1-732ac7943ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_ed889020-6910-4d42-89f5-279539733c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockCommonShares_ed889020-6910-4d42-89f5-279539733c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9ad10dec-c000-4828-aae7-ab7fb74d9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_ProfitLoss_9ad10dec-c000-4828-aae7-ab7fb74d9770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_53a7733e-c661-4491-939f-15e97e70ee55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_53a7733e-c661-4491-939f-15e97e70ee55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1d72eaeb-96d0-4c90-b801-fdf250400652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_DividendsCommonStockCash_1d72eaeb-96d0-4c90-b801-fdf250400652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7b01e2f5-0baf-4237-874c-2ad413c6830e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7b01e2f5-0baf-4237-874c-2ad413c6830e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f161748d-49a8-4bc6-8b93-79fff8c023f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f161748d-49a8-4bc6-8b93-79fff8c023f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e2bf6eaf-7f82-48ee-baab-ea03024849f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e2bf6eaf-7f82-48ee-baab-ea03024849f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4f68a9c5-3d0f-4129-badd-b111807b5d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4f68a9c5-3d0f-4129-badd-b111807b5d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a17d5ed7-371a-432d-b637-d98d59c07ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_SharesIssued_a17d5ed7-371a-432d-b637-d98d59c07ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3f870105-b7f8-4254-8329-9c69a2303395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_StockholdersEquity_3f870105-b7f8-4254-8329-9c69a2303395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_77d2d0c4-6682-451c-b5b6-1166f0f29507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f37c30ac-ea14-40ef-a80b-9abc4b1e6a31" xlink:to="loc_us-gaap_TreasuryStockCommonShares_77d2d0c4-6682-451c-b5b6-1166f0f29507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c849cee0-8ca3-4128-b78f-c8e1ef252fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3e8ded6f-7d73-49f4-ac3d-57423ceed01b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c849cee0-8ca3-4128-b78f-c8e1ef252fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f28a8a11-b01e-4404-a580-d6530dea9afa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:href="bmy-20230331.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f28a8a11-b01e-4404-a580-d6530dea9afa" xlink:to="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a334d15f-ad53-4f2d-8703-3b94ac7f3d40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_b393876c-18e9-4385-9b7c-abad97e02e02" xlink:href="bmy-20230331.xsd#bmy_A2022ASRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_0c058cd8-c0ca-4cb6-8e48-9e1aa166dd85" xlink:to="loc_bmy_A2022ASRMember_b393876c-18e9-4385-9b7c-abad97e02e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:href="bmy-20230331.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_e32d6da0-7672-4aec-a943-c97b12314334" xlink:to="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ac318cf2-5bf8-4572-90f9-4bf0ae6005ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ac318cf2-5bf8-4572-90f9-4bf0ae6005ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_900e07c8-4e55-49cd-814c-106d852f25c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_900e07c8-4e55-49cd-814c-106d852f25c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5d5c3aad-ccb1-4732-aba1-51aa6cebcd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_c13ecfcc-1dff-4624-8507-ea21f78d5866" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5d5c3aad-ccb1-4732-aba1-51aa6cebcd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e8bf36a0-f7a7-4394-8b38-fe050b6d0c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e8bf36a0-f7a7-4394-8b38-fe050b6d0c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_34c76a87-2c24-4a72-bf9e-1f75e00a66c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_34c76a87-2c24-4a72-bf9e-1f75e00a66c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_47fefaf5-9c25-427d-ab9d-c38f6a886d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_47fefaf5-9c25-427d-ab9d-c38f6a886d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c72b4f92-335b-46d2-8972-8f4a16e33817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c72b4f92-335b-46d2-8972-8f4a16e33817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_ff887ef0-d3a7-4993-8a35-364b08dc32ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_ff887ef0-d3a7-4993-8a35-364b08dc32ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fd850dc1-18db-4723-88d9-d68ee58e6ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fd850dc1-18db-4723-88d9-d68ee58e6ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_f4233517-66cc-4fdb-81b1-2f1e646fdbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_f4233517-66cc-4fdb-81b1-2f1e646fdbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_94fc07a6-c77b-49ea-8fb8-0545f352ac94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_94fc07a6-c77b-49ea-8fb8-0545f352ac94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b9d9506a-bee6-40ae-9cb8-6db7af79b8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b9d9506a-bee6-40ae-9cb8-6db7af79b8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_8ac93b98-e389-4825-9883-4edb48633257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_8ac93b98-e389-4825-9883-4edb48633257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_de15419f-4124-4bfc-a970-c4fc292f94f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_de15419f-4124-4bfc-a970-c4fc292f94f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_8a44599f-09ec-4a60-8109-b0b0dd459428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_8a44599f-09ec-4a60-8109-b0b0dd459428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_2c88e89b-b6e3-46ca-9474-46990baee7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_2c88e89b-b6e3-46ca-9474-46990baee7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_da782ccd-0b30-4fbe-976c-1cb46e909718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_da782ccd-0b30-4fbe-976c-1cb46e909718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_76a467ed-7da3-4900-a03b-48edd81cf9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_76a467ed-7da3-4900-a03b-48edd81cf9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_988fd771-b052-4258-822d-b1b275c68162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_988fd771-b052-4258-822d-b1b275c68162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_6d21c717-49d9-428d-81d4-50da692356c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_6d21c717-49d9-428d-81d4-50da692356c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_e9845cd8-da98-4f9a-9017-c2aa16bec746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_e9845cd8-da98-4f9a-9017-c2aa16bec746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1300c0a9-4ab9-4da7-b285-41393d6b159b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1300c0a9-4ab9-4da7-b285-41393d6b159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_07881178-e1fb-430f-98e5-fdc71bfe103e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_07881178-e1fb-430f-98e5-fdc71bfe103e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7827d287-68a7-41bc-90df-a30b75076f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7827d287-68a7-41bc-90df-a30b75076f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_e6283bba-a7cd-41fb-9f67-3f75ee56e19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_e6283bba-a7cd-41fb-9f67-3f75ee56e19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_5dbb6db7-7a4f-455f-b40e-e8d2faad4604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_5dbb6db7-7a4f-455f-b40e-e8d2faad4604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bce8c7e3-51ba-4685-a259-53c6ad658e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bce8c7e3-51ba-4685-a259-53c6ad658e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_222f271a-c839-4f00-8396-0ba31c7af4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_222f271a-c839-4f00-8396-0ba31c7af4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_cc65dfb3-4504-483f-9bc1-e9a73b2222a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_cc65dfb3-4504-483f-9bc1-e9a73b2222a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bcb6109a-4929-47dc-a20e-5dd8868d18f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bcb6109a-4929-47dc-a20e-5dd8868d18f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ed6de0f4-fa19-4a97-8499-79a9538c891b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ed6de0f4-fa19-4a97-8499-79a9538c891b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_01e4bfaf-ff00-4dfd-98b7-6a122dbaa1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_01e4bfaf-ff00-4dfd-98b7-6a122dbaa1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2650a0bf-59bb-40fd-b121-c7faa4566ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_15730b40-6245-42de-8d98-ce09f9a76359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2650a0bf-59bb-40fd-b121-c7faa4566ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_de302e24-72e4-442b-baee-d310d23c301b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_de302e24-72e4-442b-baee-d310d23c301b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_473a6e79-bc1a-4fc0-bb4a-d1a83241ad19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_473a6e79-bc1a-4fc0-bb4a-d1a83241ad19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2bdd3bd4-3504-47d4-8635-2b33330c8b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2bdd3bd4-3504-47d4-8635-2b33330c8b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_78e98167-f2f3-487c-aea4-95787ca5c17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_78e98167-f2f3-487c-aea4-95787ca5c17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax_322960e3-288c-426c-8208-9dc731f77f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8ac3240-3834-4e0a-b92f-9f7a2627147f" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax_322960e3-288c-426c-8208-9dc731f77f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ba2a61-fec4-46d4-9acf-65d510ce9793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ba2a61-fec4-46d4-9acf-65d510ce9793" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fc1224e7-2b6d-471a-85a9-7069d85f5a98" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6336f4f3-6e07-43cc-8fe7-3c2c90180232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_CostOfSalesMember_6336f4f3-6e07-43cc-8fe7-3c2c90180232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_91d717ba-65c3-443a-b535-b0bcfa44aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_91d717ba-65c3-443a-b535-b0bcfa44aa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e984dff9-869c-45ae-9c7b-7e2bd85af71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2e1daaec-b149-45dc-ac10-87f2a6e23918" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e984dff9-869c-45ae-9c7b-7e2bd85af71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d3af6eb5-b8ae-4603-a5e3-b6e37797fbb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_67709c1d-6acb-4a0d-ad0b-b5a17610e1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_67709c1d-6acb-4a0d-ad0b-b5a17610e1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_60a0db20-2c41-4dd7-a04b-caf986adb53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_60a0db20-2c41-4dd7-a04b-caf986adb53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_52529e2c-f811-44d4-a85a-4f456545ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9bc2ca9-497d-4a8b-a82e-741311d4a686" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_52529e2c-f811-44d4-a85a-4f456545ad00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c46e28d-785f-4ccf-9dfd-864cb73695a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c46e28d-785f-4ccf-9dfd-864cb73695a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:to="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_514b9dfd-8db2-42f9-869f-142ab75a4b54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_69adfbf3-10c7-4b37-b84f-0db45dbf62b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_69adfbf3-10c7-4b37-b84f-0db45dbf62b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_4b7473c7-3c9e-4a64-9ff3-33fb913ffe70" xlink:href="bmy-20230331.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_bmy_MarketShareUnitsMember_4b7473c7-3c9e-4a64-9ff3-33fb913ffe70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8a279d1c-cb08-4fe9-9016-1433bc8604b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6983e28-ab2e-43f8-9f25-04ac44646ab0" xlink:to="loc_us-gaap_PerformanceSharesMember_8a279d1c-cb08-4fe9-9016-1433bc8604b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de4bbf55-99b6-4e44-8fc5-d41153ca5019" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_035a8004-0035-4e6f-a07c-7300debb48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_035a8004-0035-4e6f-a07c-7300debb48d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0d8510a-62da-4f04-b7ef-47aae940d697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a72d9df6-934d-479c-9111-173781d72043" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0d8510a-62da-4f04-b7ef-47aae940d697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f694ed83-dee7-4722-93a5-226d88fa1e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f694ed83-dee7-4722-93a5-226d88fa1e37" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:to="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_70bf0f98-23b0-4f50-b23f-df3ebb0f26bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6c1a0c07-18b9-448c-bf88-e2e20b121b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6c1a0c07-18b9-448c-bf88-e2e20b121b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_bd0addce-f82c-48f6-b7c3-4ff5404ef718" xlink:href="bmy-20230331.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_bmy_MarketShareUnitsMember_bd0addce-f82c-48f6-b7c3-4ff5404ef718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bb5c47c7-4d55-455a-9489-84321bb79798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa5ccb5d-5071-443b-8708-51a918e46f39" xlink:to="loc_us-gaap_PerformanceSharesMember_bb5c47c7-4d55-455a-9489-84321bb79798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4722daf1-fac3-4b14-aab7-265440215310" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7d1500a2-7fda-402f-a18d-6c30d52f44c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7d1500a2-7fda-402f-a18d-6c30d52f44c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fe396c83-4298-42ef-85c9-088bb83c3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f347dff-13cb-4655-b3a9-9f23eb6ae184" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fe396c83-4298-42ef-85c9-088bb83c3d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20230331.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9c950ac4-9905-4882-a8c9-9c95d4ed1f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:href="bmy-20230331.xsd#bmy_LitigationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9c950ac4-9905-4882-a8c9-9c95d4ed1f91" xlink:to="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_fdd4660a-f72f-4644-bcf2-a9d25f68632b" xlink:to="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_5472a5f4-e39e-442b-a18c-61f330846c33" xlink:href="bmy-20230331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_5472a5f4-e39e-442b-a18c-61f330846c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_09a09f8b-1050-46e9-9c6d-528927fc4b6e" xlink:href="bmy-20230331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_CARTKiteLitigationMember_09a09f8b-1050-46e9-9c6d-528927fc4b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_1903b4a0-8011-492e-8b86-ab0071645b3a" xlink:href="bmy-20230331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_1903b4a0-8011-492e-8b86-ab0071645b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_f0ebcd77-ec85-46a1-aaec-b52794e5b5ef" xlink:href="bmy-20230331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_AbilifyProductLiabilityMember_f0ebcd77-ec85-46a1-aaec-b52794e5b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3fe3840-dd74-4aec-8cc2-4ee5c34282ad" xlink:href="bmy-20230331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3fe3840-dd74-4aec-8cc2-4ee5c34282ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MolinaLitigationMember_3461b094-b635-447a-8bee-89917ee33710" xlink:href="bmy-20230331.xsd#bmy_MolinaLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_MolinaLitigationMember_3461b094-b635-447a-8bee-89917ee33710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OptOutEntitiesMember_3e51ad38-6893-418f-b7f9-25aef3b3ac84" xlink:href="bmy-20230331.xsd#bmy_OptOutEntitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0b414bd0-4a6e-44ea-97f8-0d4b94ac7889" xlink:to="loc_bmy_OptOutEntitiesMember_3e51ad38-6893-418f-b7f9-25aef3b3ac84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_a4e49dcb-0831-4c49-a461-f6e27f766bd1" xlink:to="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_30457659-ed07-4675-9c4c-bb24a74fc27d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:to="loc_currency_AUD_30457659-ed07-4675-9c4c-bb24a74fc27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_044833db-a3a3-427b-9f85-a264404e6598" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_51c76273-5242-45be-9639-bf71d9fb94a4" xlink:to="loc_currency_USD_044833db-a3a3-427b-9f85-a264404e6598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b2183c42-5569-4366-ac74-47bf13060ceb" xlink:to="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_a0bfab76-82ef-4e04-a8f7-5027d40043b1" xlink:href="bmy-20230331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_36c36251-6b50-409a-a9b3-0ff00e1775f1" xlink:to="loc_bmy_BristolMyersSquibbMember_a0bfab76-82ef-4e04-a8f7-5027d40043b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_79438464-525c-4b56-9dcb-f336668c7aca" xlink:to="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_87b19339-4575-450b-9332-52ff83f2d1f7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_78f31b66-2f32-4ae1-bd09-c7ecda3acc08" xlink:to="loc_country_CA_87b19339-4575-450b-9332-52ff83f2d1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:href="bmy-20230331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_b440ed4c-94ab-472d-8891-1ed869f1a769" xlink:to="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_4ca1821f-d5d9-4f1f-bf03-528ed11b8517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_4ca1821f-d5d9-4f1f-bf03-528ed11b8517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_ce143440-c199-499c-8c39-357d7736b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_PaymentsForRoyalties_ce143440-c199-499c-8c39-357d7736b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_d0611388-5bdd-40ae-a931-f9432361d57a" xlink:href="bmy-20230331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_d0611388-5bdd-40ae-a931-f9432361d57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_e1cabc22-b7e1-47dd-bc04-1446f274668c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_e1cabc22-b7e1-47dd-bc04-1446f274668c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_aba5710d-0301-4601-87a6-05447767ebb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_aba5710d-0301-4601-87a6-05447767ebb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_44be54c9-5a15-4080-85ef-d6062f35732a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_44be54c9-5a15-4080-85ef-d6062f35732a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_08d2938c-b6a2-4a37-98fe-3c60469e56c8" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_08d2938c-b6a2-4a37-98fe-3c60469e56c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_cf45adef-988c-47ee-8031-c54cb7378084" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_cf45adef-988c-47ee-8031-c54cb7378084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_02a381ec-8167-46e7-8cda-e66bbe703350" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_02a381ec-8167-46e7-8cda-e66bbe703350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_0fc5df4c-928c-427e-bac7-171622e2a3af" xlink:href="bmy-20230331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_0fc5df4c-928c-427e-bac7-171622e2a3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_5711e49d-f023-4a7f-bd80-8952b6df2ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_ContractualObligation_5711e49d-f023-4a7f-bd80-8952b6df2ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_97b2c26a-a4de-401b-89f3-1e090d3c7743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_bddf9dd6-cf64-4eca-82ba-a2044c2b2e68" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_97b2c26a-a4de-401b-89f3-1e090d3c7743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941555408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRISTOL-MYERS SQUIBB COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0790350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">430 E. 29th Street, 14FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">546-4200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,847,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000014272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember', window );">Common Stock $0.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member', window );">1.000% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member', window );">1.750% Notes due 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.750% Notes due 2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember', window );">Celgene Contingent Value Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Celgene Contingent Value Rights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CELG RT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941279008">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,337<span></span>
</td>
<td class="nump">$ 11,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,566<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,762<span></span>
</td>
<td class="nump">1,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,321<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AmortizationofAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,256<span></span>
</td>
<td class="nump">2,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(413)<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,567<span></span>
</td>
<td class="nump">9,961<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,770<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">503<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,267<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to BMS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="nump">$ 1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share attributable to BMS, basic (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.08<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share attributable to BMS, diluted (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,048<span></span>
</td>
<td class="nump">$ 11,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AllianceandotherrevenuesMember', window );">Alliance and other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 289<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationofAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationofAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NetProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AllianceandotherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AllianceandotherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941522016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,267<span></span>
</td>
<td class="nump">$ 1,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of taxes and reclassifications to earnings:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="num">(124)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total Other comprehensive (loss)/income</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,180<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interest</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to BMS</a></td>
<td class="nump">$ 2,175<span></span>
</td>
<td class="nump">$ 1,317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941601120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,995<span></span>
</td>
<td class="nump">$ 9,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable debt securities</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">10,054<span></span>
</td>
<td class="nump">9,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,605<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">5,795<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current assets</a></td>
<td class="nump">27,086<span></span>
</td>
<td class="nump">27,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,279<span></span>
</td>
<td class="nump">6,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">21,162<span></span>
</td>
<td class="nump">21,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">33,569<span></span>
</td>
<td class="nump">35,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,868<span></span>
</td>
<td class="nump">4,940<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">94,281<span></span>
</td>
<td class="nump">96,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt obligations</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">4,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">13,139<span></span>
</td>
<td class="nump">14,586<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current liabilities</a></td>
<td class="nump">19,085<span></span>
</td>
<td class="nump">21,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">1,568<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">35,078<span></span>
</td>
<td class="nump">35,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">6,664<span></span>
</td>
<td class="nump">6,590<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">62,395<span></span>
</td>
<td class="nump">65,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>BMS Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value of stock</a></td>
<td class="nump">45,140<span></span>
</td>
<td class="nump">45,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,368)<span></span>
</td>
<td class="num">(1,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">26,568<span></span>
</td>
<td class="nump">25,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less cost of treasury stock</a></td>
<td class="num">(38,808)<span></span>
</td>
<td class="num">(38,618)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total BMS Shareholders&#8217; equity</a></td>
<td class="nump">31,824<span></span>
</td>
<td class="nump">31,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">31,886<span></span>
</td>
<td class="nump">31,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 94,281<span></span>
</td>
<td class="nump">$ 96,820<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940976128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,267<span></span>
</td>
<td class="nump">$ 1,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization, net</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">2,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment charges</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Divestituregainsandroyalties', window );">Divestiture gains and royalties</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(282)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Rebates and discounts</a></td>
<td class="num">(910)<span></span>
</td>
<td class="num">(930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">884<span></span>
</td>
<td class="nump">831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(1,064)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,970<span></span>
</td>
<td class="nump">3,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sale and maturities of marketable debt securities</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable debt securities</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(1,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi', window );">Proceeds from sales of equity investment securities</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(278)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Divestitureandotherproceeds', window );">Divestiture and other proceeds</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition and other payments, net of cash acquired</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in)/provided by investing activities</a></td>
<td class="num">(210)<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Short-term debt obligations, net</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(1,640)<span></span>
</td>
<td class="num">(5,769)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends</a></td>
<td class="num">(1,196)<span></span>
</td>
<td class="num">(1,185)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments', window );">Stock option proceeds and other, net</a></td>
<td class="num">(92)<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3,050)<span></span>
</td>
<td class="num">(5,653)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash, cash equivalents and restricted cash</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(1,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">9,325<span></span>
</td>
<td class="nump">14,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 9,048<span></span>
</td>
<td class="nump">$ 12,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestitureandotherproceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestitureandotherproceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestituregainsandroyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of gains and royalties as a result of business divestitures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestituregainsandroyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Stock Option Exercises And Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939432272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Recently Issued Accounting Standards</a></td>
<td class="text">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#8212;Note 2. Revenue".</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939429744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $87&#160;million and $74&#160;million for the three months ended March 31, 2023, and 2022, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $166 million and $147 million for the three months ended March&#160;31, 2023 and 2022, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for GTN adjustments related to prior period sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140262022931232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Alliances</a></td>
<td class="text">ALLIANCES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS refers to these collaborations as alliances and its partners as alliance partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total alliance revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected alliance balance sheet information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Includes unamortized upfront and milestone payments. </span></div>The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2022 Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939411808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</a></td>
<td class="text">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mature Products and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $221&#160;million and a divestiture gain of $211&#160;million.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS obtained a global exclusive license to Immatics' TCR bispecific IMA401 program. which is being studied in oncology. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $150&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, a Phase I development milestone for interleukin-12 ("IL-12") was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, BMS notified Dragonfly that it was terminating the global exclusive license that relates to Dragonfly&#8217;s IL-12. All rights to IL-12 were reverted back to Dragonfly effective April 18, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nimbus Change of Control Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS and Nimbus Therapeutics entered into a settlement resolving all legal claims and business interests pertaining to Nimbus' TYK2 inhibitor resulting in $40&#160;million of income included in Other (income)/expense. The settlement also provides for BMS to receive additional amounts for contingent development, regulatory approval and sales-based milestones and 10% of any change in control proceeds received by Nimbus Therapeutics related to its TYK2 inhibitor. In February 2023, Takeda acquired 100% ownership of Nimbus Therapeutics' TYK2 inhibitor for approximately $4.0&#160;billion in upfront proceeds plus contingent sales-based milestones aggregating up to $2.0&#160;billion. As a result, $400&#160;million of income related to the change of control provision is included in Other (income)/expense during the first quarter of 2023 and is expected to be received in the second quarter of 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939476080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other (Income)/Expense, Net</a></td>
<td class="text">OTHER (INCOME)/EXPENSE, NET<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (Note 10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestiture (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes $400&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI https://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI https://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939465488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">RESTRUCTURING<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Celgene Acquisition Plan, the Company expects to incur charges of approximately $3.5&#160;billion, including cash outlays of approximately $3.1&#160;billion. Cumulative charges of approximately $3.1&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition in 2022 and the MyoKardia acquisition in 2020. Charges of approximately $250&#160;million are expected to be incurred through the end of 2023 and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $180 million have been recognized for these actions to date. In the first quarter of 2023, certain restructuring activities occurred resulting in employee termination costs of $61&#160;million, which are primarily attributed to changes in our operating model to accelerate the delivery of medicines to patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $3 million and $9 million for the three months ended March 31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939443696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The 5.7% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $89 million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code. Income tax payments were $149&#160;million and $255&#160;million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities that proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax issues for the 2008 to 2012 tax years. BMS disagrees with the IRS's positions and continues to work cooperatively with the IRS to resolve these issues. In the fourth quarter of 2022, BMS entered the IRS administrative appeals process to resolve these matters. Timing of the final resolution of these complex matters is uncertain and could have a material impact on BMS's consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits as of March&#160;31, 2023 could decrease in the range of approximately $40 million to $60 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits, however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by jurisdiction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939476080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939415392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market and other securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in "Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements" in the Company's 2022 Form 10-K, the Company's fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments with readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity investment losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative upwards adjustments and cumulative impairments and downward adjustments based on observable price changes in equity investments without readily determinable fair values still held as of March&#160;31, 2023 were $186&#160;million and $61&#160;million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into foreign currency forward and purchased local currency put option contracts (foreign exchange contracts) to hedge certain forecasted intercompany inventory sales and certain other foreign currency transactions. The objective of these foreign exchange contracts is to reduce variability caused by changes in foreign exchange rates that would affect the U.S. dollar value of future cash flows derived from foreign currency denominated sales, primarily the euro and Japanese yen. The fair values of these derivative contracts are recorded as either assets (gain positions) or liabilities (loss positions) in the consolidated balance sheet. Changes in fair value for these foreign exchange contracts, which are designated as cash flow hedges, is temporarily recorded in Accumulated other comprehensive loss ("AOCL") and reclassified to net earnings when the hedged item affects earnings (typically within the next 24 months). As of March 31, 2023, assuming market rates remain constant through contract maturities, we expect to reclassify pre-tax gains of $156&#160;million into cost of products sold for our foreign exchange contracts out of AOCL during the next 12 months. The notional amount of outstanding foreign currency exchange contracts was primarily $4.9&#160;billion for the euro contracts and $1.3&#160;billion for Japanese yen contracts as of March&#160;31, 2023. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS also enters into cross-currency swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in AOCL and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency swap contracts associated with long-term debt denominated in euros was $1.2&#160;billion as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency exchange contracts not designated as a cash flow hedge offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swap contracts of $1.3&#160;billion as of March&#160;31, 2023 are designated to hedge currency exposure of BMS's net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of AOCL with a related offset in derivative asset or liability on the consolidated balance sheet. The notional amount of outstanding cross-currency swap contracts was primarily attributed to the Japanese yen of $509&#160;million and euro of $584&#160;million as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of &#8364;375&#160;million. The related net investment hedge was entered into to hedge euro currency exposures of the net investment in certain foreign affiliates and was recognized in long-term debt. The effective portion of foreign exchange gain or loss on the remeasurement of debt denominated in euros was included in the foreign currency translation component of AOCL with the related offset in Long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March 31, 2023, the amortization of gains related to the portion of our net investment hedges that was excluded from the assessment of effectiveness was not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (4.86% as of March&#160;31, 2023) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative cash flows, with the exception of net investment hedges, are principally classified in the operating section of the consolidated statements of cash flows, consistent with the underlying hedged item. Cash flows related to net investment hedges are classified in investing activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value and the notional values of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. dollar borrowings gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939370496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">FINANCING ARRANGEMENTS</a></td>
<td class="text">FINANCING ARRANGEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of Long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to principal value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Long-term debt was $34.5 billion as of March&#160;31, 2023 and $34.9 billion as of December&#160;31, 2022 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, $1.6&#160;billion of debt matured and was repaid including $750&#160;million 2.750% Notes and $890&#160;million 3.250% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS issued an aggregate principal amount of $6.0&#160;billion of debt, with maturity dates ranging from 2032 to 2062, with net proceeds of $5.9&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest. In addition, BMS purchased an aggregate principal amount of $5.2&#160;billion of certain of its debt securities for $5.8&#160;billion of cash in tender offers. In connection with this transaction, a $275&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $324 million and $377&#160;million for the three months ended March 31, 2023 and 2022, respectively, net of amounts related to interest rate swap contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, BMS had a five-year $5.0&#160;billion revolving credit facility expiring in January 2028, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. No borrowings were outstanding under the revolving credit facility as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939355408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Receivables</a></td>
<td class="text">RECEIVABLES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $239 million and $423 million for the three months ended March 31, 2023 and 2022, respectively. Receivables from the three largest customers in the U.S. represented 69% and 66% of total trade receivables as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939503536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value adjustments related to the Celgene acquisition were $32 million and $84 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939503536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $146 million and $145 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939411808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts in Goodwill were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:87.217%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:25.120%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.807%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful&#160;Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,530)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of Other intangible assets was $2.3 billion and $2.5 billion for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPRD impairment charges were $20&#160;million in the first quarter of 2023 and $40&#160;million in the first quarter of 2022 and were included in Research and development expense. The charges represented full write-downs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939355408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,795&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,940&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $210 million. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935179344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2023: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.520%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $0.57 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,808)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:30.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.618%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $0.54 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased 3.7&#160;million shares of its common stock for $250&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the BMS share repurchase program was approximately $6.9&#160;billion as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $5.0&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand and 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Other comprehensive income by component:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to "&#8212;Note 9. Financial Instruments and Fair Value Measurements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Foreign currency translation are net investment hedge gains of $118&#160;million and $125&#160;million as of March 31, 2023 and December 31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939490576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Employee Stock Benefit Plans</a></td>
<td class="text">EMPLOYEE STOCK BENEFIT PLANS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $18 million and $40 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939419984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings and Contingencies</a></td>
<td class="text">LEGAL PROCEEDINGS AND CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, partners, suppliers, service providers, licensees, licensors, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial claims and/or defenses in the matters, the outcomes of BMS's legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS's financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS's patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see " &#8212;Note 7. Income Taxes."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute ("Dana-Farber") filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber's claims for damages before May 17, 2019&#8212;the date of the District Court's ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. On January 25, 2023, the Court held a hearing on a motion filed by BMS requesting that the Court enter summary judgment in BMS' favor. In April 2023, BMS and Dana-Farber entered into a settlement agreement and these litigations were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd (collectively, "AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024. On April 26, 2023, BMS filed an additional lawsuit against AZ in U.S. District Court for the District of Delaware alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes U.S. Patent No. 9,402,899.</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR-T &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research ("SKI") filed a complaint for patent infringement against Kite Pharma, Inc. ("Kite") in the U.S. District Court for the Central District of California. The complaint alleged that Kite's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the "'190 Patent") concerning CAR-T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the '190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite's defenses, finding that Kite willfully infringed the '190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585&#160;million upfront payment and a 27.6% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the '190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite's motions in their entirety. In April 2020, the Court granted in part Juno's motion and entered a final judgment awarding to Juno and SKI approximately $1.2&#160;billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the '190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the '190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court, which the Court denied on November 7, 2022. On November 23, 2022, Juno and SKI filed a petition for rehearing with the Court, which the Court denied on January 9, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CTLA-4 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2023, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca AB (collectively, "AZ AB") alleging that AZ AB's marketing of the CTLA-4 antibody Imjudo infringes certain claims of U.S. Patent Nos. 9,320,811 and 9,273,135. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited ("Sandoz") and Teva Pharmaceutical Industries Ltd. ("Teva Limited"), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate ("SPC"). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgment issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. On November 2, 2022, BMS was granted permission from the Court of Appeal to appeal the judgment and a hearing took place on April 19-20, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and trials have been held in certain of those cases, including in Norway and France. In May 2022, a Dutch court issued a decision denying a request by BMS for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In April 2023, BMS again requested that a preliminary injunction be issued against Sandoz in the Netherlands. In addition, BMS requested that a preliminary injunction be issued against Stada in the Netherlands. On April 26, 2023, a combined preliminary injunction hearing was held.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a trial was held in Sweden regarding Teva's challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision was issued on November 2, 2022, confirming their validity and rejecting Teva's claims. In September 2022, BMS filed a request for a preliminary injunction against Teva in Denmark, but the request was denied in December 2022, based on the finding that there is no imminent threat of a launch by Teva in Denmark. In January 2023, the court in Finland granted BMS's request that a preliminary injunction be entered against Teva, prohibiting Teva from offering, storing or selling generic Eliquis products in Finland that have obtained price and reimbursement. On February 17, 2023, the court in Ireland also granted BMS's request that a preliminary injunction be entered against Teva in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2023 and March 4, 2023, BMS received Notice Letters from Biocon and ScieGen, respectively, notifying BMS that they had filed ANDAs containing paragraph IV certifications seeking approval of generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, in April 2023, BMS filed patent infringement actions against Biocon and ScieGen in the U.S. District Court for the District of Delaware. On April 25, 2023, BMS entered into a confidential settlement agreement with ScieGen, settling all outstanding claims in the litigation with ScieGen. The settlement with ScieGen does not affect BMS's projected exclusivity period for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging U.S. Patent No. 8,846,628 (the "'628 Patent"), an FDA Orange Book-listed formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024. In February 2023, Apotex Inc. filed a request for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '628 Patent. BMS's response to the request is due on May 15, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, BMS received an additional Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification challenging U.S. Patent No. 11,571,436 (the "'436 patent"), a newly-listed FDA Orange-Book formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2029. In response, BMS filed an additional patent infringement action against Accord in the U.S. District Court for the District of Delaware.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited ("GenRx") obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex ("GenRx-Apotex"). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi's Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi's injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia ("Full Court") appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449&#160;million AUD ($301&#160;million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government's claim for damages. In May 2020, the Australian government appealed the Federal Court's decision and an appeal hearing concluded in February 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray"), Nanocopoeia, LLC ("Nanocopoeia") and Handa Oncology, LLC ("Handa"), respectively, notifying BMS that each had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. In May 2022, BMS filed a patent infringement action against Nanocopoeia in the U.S. District Court for the District of Minnesota. In November 2022, BMS filed a patent infringement action against Handa in the U.S. District Court for the Northern District of California. No trial dates have been scheduled in any of these actions. Both Xspray and Nanocopoeia filed motions for a judgment based on the pleadings. On March 24, 2023, the Minnesota court denied Nanocopoeia's motion. On April 25, 2023, the New Jersey court denied Xspray's motion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC ("Actelion") filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the "'867 Patent"). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the '867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in a consumer protection action brought by the attorney general of Hawaii relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. In February 2021, a Hawaii state court judge issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS appealed the decision. On March 15, 2023, the Hawaii Supreme Court issued its decision, reversing in part and affirming in part the trial court decision, vacating the penalty award and remanding the case for a new trial and penalty determination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, the vast majority of cases have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco ("JCCP"). On September 24, 2021, the JCCP court granted defendants' motion to exclude plaintiffs' only general causation expert and on January 5, 2022, the MDL court likewise granted defendants' motion to exclude plaintiffs' expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. Plaintiffs have filed an appeal, on which a California Court of Appeal heard arguments on March 28, 2023. On April 19, 2023, the Court denied plaintiffs' appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL then moved to alter or amend the MDL court's order, and defendants opposed. On November 3, 2022, the MDL court denied plaintiffs motion to alter or amend its summary judgment order. Plaintiffs filed their Notice of Appeal on December 2, 2022. As part of BMS's global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Litigations</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the "Celgene Securities Class Action"). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene's 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff''s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In March 2023, the Court granted the defendants leave to file a motion for summary judgment in the Celgene Securities Class Action, with briefing expected to be completed in or around July 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the "Schwab Action"). In July 2020, the defendants filed a motion to dismiss the plaintiffs' complaint in full. In March 2021, the Court granted in part and denied in part defendants' motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees' Retirement System in April 2021 (the "CalPERS Action"); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the "DFA Action" and the "American Century Action"), and GIC Private Limited in September 2021 (the "GIC Action"), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The Court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement ("CVR Agreement") entered into in connection with the closing of BMS's acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use "diligent efforts" to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys' fees. BMS disputes the successor trustee's allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the Court denied BMS's motion to dismiss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 (the "Securities Act") and sections 10(b), 14(a) and 20(2) of the Exchange Act. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants moved to dismiss the complaint. On March 1, 2023, the Court entered an opinion and order granting defendants' motion and dismissed the complaint in its entirety. The claims under Sections 11, 12(a)(2), and 15 of the Securities Act and Section 14(a) of the Exchange Act were dismissed with prejudice. The claims under Sections 10(a) and 20(a) of the Exchange Act were dismissed with leave to file a further amended complaint which plaintiffs filed on April 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 19, 2022. Defendants have moved to stay the action pending resolution of the federal action or, in the alternative, to dismiss the complaint.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene's former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 22, 2022. Defendants moved to stay the action pending resolution of the federal action and, in the alternative, to dismiss the complaint. On February 17, 2023, the Court granted defendants' motion to stay and declined to reach the merits of defendants' motion to dismiss. The Court deemed the action stayed pending resolution of the federal action, subject to plaintiff's right to seek to vacate the stay should changed circumstances warrant such relief, and filed a written order staying the case for 200 days.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for ANDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement, and who have since filed new suits advancing related theories. As described below, those suits, together with a suit by certain specialty pharmacies and a new putative class action suit, are pending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana Inc. ("Humana"), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana's complaint makes largely the same claims and allegations as were made in the now settled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. In May 2019, Celgene filed a motion to dismiss Humana's complaint. In April 2022, the Court issued an order denying Celgene's motion to dismiss. That order addressed only Celgene's argument that certain of Humana's claims were barred by the statute of limitations. The Court's order did not address Celgene's other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have filed a motion to dismiss Humana's amended complaint, which was fully briefed in November 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United HealthCare Services, Inc. ("UHS"), Blue Cross Blue Shield Association ("BCBSA"), BCBSM Inc., Health Care Service Corporation ("HCSC"), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation ("Cigna"), Molina Healthcare, Inc. ("Molina") and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, "MSP")) filed lawsuits making largely the same claims and allegations as were made in the now settled class action litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> opt-out action. Certain of the matters have made additional claims related to copay assistance for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These cases are now pending in the U.S. District Court for the District of New Jersey. Celgene and BMS's motion to dismiss the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended complaint applies to these other opt&#8209;out actions as well, and these other opt&#8209;out actions will proceed as described above with respect to that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opt-out action. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina's complaint makes largely the same claims and allegations as were made in the now settled class action litigation. In June 2022, the San Francisco Superior Court dismissed 63 of Molina&#8217;s claims, which Molina later reasserted in the District of New Jersey as described above, and stayed the remaining 4 claims. No activity is expected in this case until disposition of the New Jersey actions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other entities that opted out of the now&#8209;settled class action have also filed summonses related to two actions in the Philadelphia County Court of Common Pleas in connection with the allegations made by Humana and other opt&#8209;out entities. Those actions have been placed in deferred status pending further developments in the above opt&#8209;out cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, certain specialty pharmacies filed an action as direct purchasers against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The action makes largely the same claims and allegations against Celgene and BMS as were made with respect to Revlimid in the now settled class action litigation, and seek injunctive relief and damages under the Sherman Antitrust Act. Also in November 2022, a putative class of end-payor plaintiffs filed an action against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The class complaint brings claims based on Celgene's allegedly anticompetitive settlements of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation, seeking damages under state antitrust and consumer protection laws and injunctive relief under federal antitrust law. In March 2023, Celgene, BMS, and the generic defendants served consolidated motions to dismiss these two actions. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana's complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey's Racketeer Influenced and Corrupt Organizations Act ("NJ RICO"). The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. Humana subsequently dismissed its claims for breach of contract voluntarily. A trial for this matter began on January 31, 2023. On January 25, 2023, the Court granted Celgene's summary judgment motion on Humana's claims for violations of NJ RICO and dismissed those claims. On March 2, 2023, following a multi-week trial, the jury returned a full defense verdict in Celgene's favor on Humana's claims of fraud and negligent misrepresentation. The parties are awaiting the judge's decision on the remaining equitable claim of unjust enrichment, which is to be decided by the judge pursuant to Kentucky law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. ("HPI"), a Humana subsidiary, in Delaware Superior Court. Celgene's complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI's breach as well as a declaratory judgment. On February 14, 2023, the Court granted summary judgment in favor of Celgene on its breach of contract claims. A trial limited to damages has been scheduled for July 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017, Celgene Logistics S&#224;rl ("Celgene Logistics") and BeiGene, Ltd. (together with its assignees, "BeiGene"), entered into a License and Supply Agreement (the "LSA") pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing and closing arguments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, "Plaintiffs") filed a complaint against BMS, Celgene and Juno (collectively, "Defendants"). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims, and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS's current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA and Other Remediation Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other "potentially responsible parties," and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $89&#160;million as of March&#160;31, 2023, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941435376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Business Segment Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#8212;Note 2. Revenue".</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates and Judgements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943487200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock', window );">Revenue Recognition Gross-To-Net Adjustments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $87&#160;million and $74&#160;million for the three months ended March 31, 2023, and 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939410576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Collaborative Arrangement and Arrangement Other than Collaborative</a></td>
<td class="text">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total alliance revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected alliance balance sheet information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span>  Includes unamortized upfront and milestone payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941334816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Divestitures</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsTableTextBlock', window );">Licensing and Other Arrangements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941281488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock', window );">Schedule Of Other Income Expense</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (Note 10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestiture (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes $400&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfOtherIncomeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939313440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $3 million and $9 million for the three months ended March 31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939602192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940390512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941245024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market and other securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock', window );">Schedule of Equity Investments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Debt Securities, Trading, and Equity Securities, FV-NI</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments with readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity investment losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivatives and Fair Value</a></td>
<td class="text">The following table summarizes the fair value and the notional values of outstanding derivatives:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. dollar borrowings gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfEquityInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941328112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt and Current Portion of Long-term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of Long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to principal value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939607392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Receivables</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935229248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939617408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943479872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts in Goodwill were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:87.217%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.583%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Other Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:25.120%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.807%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful&#160;Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,530)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940991264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,795&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,940&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $210 million.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,590&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939424128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stock by Class</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2023: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.520%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $0.57 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,808)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:30.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.618%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $0.54 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Other comprehensive income by component:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to "&#8212;Note 9. Financial Instruments and Fair Value Measurements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Foreign currency translation are net investment hedge gains of $118&#160;million and $125&#160;million as of March 31, 2023 and December 31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261939608832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Payment Arrangement, Cost by Plan</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $18 million and $40 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock', window );">Schedule Of Share Based Compensation Additional Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Share-based Payment Arrangement, Nonvested Award, Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261934486208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 11,337<span></span>
</td>
<td class="nump">$ 11,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,048<span></span>
</td>
<td class="nump">11,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember', window );">Alliance revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OtherRevenuesMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NetProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OtherRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OtherRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938704720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 11,337<span></span>
</td>
<td class="nump">$ 11,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Total GTN adjustments</a></td>
<td class="num">(6,240)<span></span>
</td>
<td class="num">(5,342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement', window );">Prior period gross to net adjustment impacted by new accounting pronouncement</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SalesRevenueGrossMember', window );">Gross product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">17,288<span></span>
</td>
<td class="nump">16,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,048<span></span>
</td>
<td class="nump">11,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember', window );">Charge-backs and cash discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Total GTN adjustments</a></td>
<td class="num">(2,091)<span></span>
</td>
<td class="num">(1,763)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember', window );">Medicaid and Medicare rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Total GTN adjustments</a></td>
<td class="num">(2,482)<span></span>
</td>
<td class="num">(2,084)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember', window );">Other rebates, returns, discounts and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Total GTN adjustments</a></td>
<td class="num">$ (1,667)<span></span>
</td>
<td class="num">$ (1,495)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross to Net Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Gross to Net Adjustments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior Period Gross to Net Adjustment Impacted by New Accounting Pronouncement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SalesRevenueGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SalesRevenueGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NetProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940780576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disaggregation of Revenue by Product and Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 11,337<span></span>
</td>
<td class="nump">$ 11,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Performance obligation satisfied in previous period</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">8,033<span></span>
</td>
<td class="nump">7,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,149<span></span>
</td>
<td class="nump">3,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InLineProductsMember', window );">In-Line Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">8,625<span></span>
</td>
<td class="nump">8,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EliquisMember', window );">Eliquis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,423<span></span>
</td>
<td class="nump">3,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdivoMember', window );">Opdivo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember', window );">Pomalyst/Imnovid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OrenciaMember', window );">Orencia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SprycelMember', window );">Sprycel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_YervoyMember', window );">Yervoy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember', window );">Mature and other products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember', window );">New Product Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ReblozylMember', window );">Reblozyl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbecmaMember', window );">Abecma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdualagMember', window );">Opdualag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember', window );">Zeposia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_BreyanziMember', window );">Breyanzi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OnuregMember', window );">Onureg</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InrebicMember', window );">Inrebic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_CamzyosMember', window );">Camzyos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SotyktuMember', window );">Sotyktu</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember', window );">Total In-Line Products and New Product Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">9,348<span></span>
</td>
<td class="nump">8,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_LOEProductsMember', window );">Recent LOE Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,989<span></span>
</td>
<td class="nump">3,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_RevlimidMember', window );">Revlimid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">2,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember', window );">Abraxane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_OtherRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InLineProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InLineProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EliquisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EliquisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdivoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdivoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_PomalystImnovidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OrenciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OrenciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SprycelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SprycelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_YervoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_YervoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NewProductPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ReblozylMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ReblozylMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbecmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbecmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdualagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdualagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ZeposiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_BreyanziMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_BreyanziMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OnuregMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OnuregMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_CamzyosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_CamzyosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SotyktuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SotyktuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InLineProductsAndNewProductPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_LOEProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_LOEProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_RevlimidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_RevlimidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbraxaneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940672320">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,337<span></span>
</td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,566<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,762)<span></span>
</td>
<td class="num">(1,831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(413)<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,048<span></span>
</td>
<td class="nump">11,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember', window );">Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,676<span></span>
</td>
<td class="nump">3,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,706<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncome', window );">Deferred income from - alliances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,532<span></span>
</td>
<td class="nump">$ 3,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_NetProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_NetProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AllianceRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935211520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net Proceeds</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesBusinessMember', window );">Diabetes business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net Proceeds</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature products and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net Proceeds</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941017984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (188)<span></span>
</td>
<td class="num">$ (171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentRegulatoryMilestoneIncome', window );">Contingent milestone income</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsIncome', window );">Total</a></td>
<td class="num">(363)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember', window );">Keytruda Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(279)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember', window );">Tecentriq royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember', window );">Other Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (11)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationOfDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationOfDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentRegulatoryMilestoneIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Regulatory Milestone Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentRegulatoryMilestoneIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940749456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_NimbusTherapueticsTYK2InhibitorMember', window );">Nimbus Therapuetics TYK2 Inhibitor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure', window );">Contingent sales-based milestones</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other (income)/expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember', window );">Immatics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestonePayments', window );">Contingent and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_DragonflyMember', window );">Dragonfly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_NimbusTherapeuticsMember', window );">Nimbus Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_NimbusTherapeuticsMember', window );">Nimbus Therapeutics | Nimbus Therapuetics TYK2 Inhibitor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SettlementContingentDevelopmentChangeInControlProceeds', window );">Change in control proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AssetAcquisitionPercentageOfOwnershipAcquired', window );">Percentage of ownership acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature products and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature products and other | Cheplapharm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AssetAcquisitionPercentageOfOwnershipAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Percentage of Ownership Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AssetAcquisitionPercentageOfOwnershipAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_CollaborativeArrangementContingentPaymentsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Contingent Payments Maximum Exposure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_CollaborativeArrangementContingentPaymentsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicenseAndOtherArrangementsUpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and Other Arrangements Upfront Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicenseAndOtherArrangementsUpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SettlementContingentDevelopmentChangeInControlProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement, Contingent Development, Change In Control Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SettlementContingentDevelopmentChangeInControlProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_NimbusTherapueticsTYK2InhibitorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_NimbusTherapueticsTYK2InhibitorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_ImmaticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_DragonflyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_DragonflyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_NimbusTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_NimbusTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_CheplapharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_CheplapharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261934448960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Note 10)</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_BusinessRoyaltyAndLicensingIncome', window );">Royalty and licensing income (Note 4)</a></td>
<td class="num">(363)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_BusinessSaleRoyaltyIncome', window );">Royalty income - divestiture (Note 4)</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses (Note 9)</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses (Note 6)</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption (Note 10)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gains (Note 4)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation and other settlements (a)</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investment income</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring (Note 6)</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_OtherOtherIncomeExpense', window );">Other</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">$ (413)<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_BusinessRoyaltyAndLicensingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Royalty And Licensing Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_BusinessRoyaltyAndLicensingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_BusinessSaleRoyaltyIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents royalty income recognized in other income during the period related to the sale of a business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_BusinessSaleRoyaltyIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940686816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Cashoutlays', window );">Cash outlays</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Cashoutlays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outlays</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Cashoutlays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940982592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other termination costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses (Note 6)</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAcceleratedDepreciation', window );">Accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940701712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning of period</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation', window );">Restructuring charges</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency translation and other</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, end of period</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Change in estimates</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Excluding Accelerated Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941420640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">$ 2,770<span></span>
</td>
<td class="nump">$ 1,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">18.20%<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935209232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements', window );">Decrease in effective tax rate</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">Income tax reserves</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax payments</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940686560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to BMS</a></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="nump">$ 1,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (in shares)</a></td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Incremental shares attributable to share-based compensation plans (in shares)</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Earnings per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share, basic (in usd per share)</a></td>
<td class="nump">$ 1.08<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share, diluted (in usd per share)</a></td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938516288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">1,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market and other securities</a></td>
<td class="nump">7,737<span></span>
</td>
<td class="nump">7,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261933955584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943497248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable fair values</a></td>
<td class="nump">$ 907<span></span>
</td>
<td class="nump">$ 1,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable fair values</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Limited partnerships and other equity method investments</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityInvestments', window );">Total equity investments</a></td>
<td class="nump">$ 2,005<span></span>
</td>
<td class="nump">$ 2,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140262024531120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFVNIAbstract', window );"><strong>Equity investments with readily determined fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Net loss recognized</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Net gain recognized on investments sold</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized loss recognized on investments still held</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract', window );"><strong>Equity investments without readily determinable fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Upward adjustments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Impairments and downward adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Total Equity investment losses</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 644<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFVNIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFVNIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261934355360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Cumulative upward adjustments</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Cumulative impairment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Pre-tax gains</a></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 36,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Variable rate debt, lower range of basis point spread</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR rate</a></td>
<td class="nump">4.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Cross-currency swap contracts | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Cross-currency swap contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261933564736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Assets | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Assets | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Liability | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap contracts | Liability | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">5,289<span></span>
</td>
<td class="nump">5,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">2,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency exchange contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">2,101<span></span>
</td>
<td class="nump">1,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency exchange contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Total return swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Total return swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Total return swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938705264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency exchange contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency exchange contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (57)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941657024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in Other comprehensive income</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Non-derivatives designated as net investment hedges</a></td>
<td class="nump">35<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Non-derivatives designated as net investment hedges</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in Other comprehensive income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency exchange contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Reclassified to Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in Other comprehensive income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionAbstract', window );"><strong>Foreign Currency Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Derivatives designated as net investment hedges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign exchange contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943522576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS - Short-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Non-U.S. short-term borrowings</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of Long-term debt</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">3,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, total</a></td>
<td class="nump">$ 2,752<span></span>
</td>
<td class="nump">$ 4,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261937981792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="nump">$ 36,622<span></span>
</td>
<td class="nump">$ 38,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations', window );">Unamortized basis adjustment from swap terminations</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized bond discounts and issuance costs</a></td>
<td class="num">(278)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized purchase price adjustments of Celgene debt</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">37,332<span></span>
</td>
<td class="nump">38,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of Long-term debt</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">3,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">35,078<span></span>
</td>
<td class="nump">35,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of interest rate swap contracts</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UnamortizedBasisAdjustmentFromSwapTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941560912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 34,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-supplement_DebtInstrumentRepaidPrincipal', window );">Debt matured and repaid</a></td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Net proceeds of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payment for debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption (Note 10)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">324,000,000<span></span>
</td>
<td class="nump">$ 377,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2750NotesMember', window );">2.750% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-supplement_DebtInstrumentRepaidPrincipal', window );">Debt matured and repaid</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A3250NotesMember', window );">3.250% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-supplement_DebtInstrumentRepaidPrincipal', window );">Debt matured and repaid</a></td>
<td class="nump">$ 890,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember', window );">$5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LongTermDebtRenewalPeriod', window );">Renewal period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LongTermDebtRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LongTermDebtRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-supplement_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-supplement_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-supplement_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2750NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2750NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A3250NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A3250NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935152528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RECEIVABLES - Schedule of Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,486<span></span>
</td>
<td class="nump">$ 8,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_CashDiscounts', window );">Less: charge-backs and cash discounts</a></td>
<td class="num">(609)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for expected credit loss</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Net trade receivables</a></td>
<td class="nump">7,854<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Alliance, royalties, VAT and other</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 10,054<span></span>
</td>
<td class="nump">$ 9,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_CashDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_CashDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140262024535328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ReceivablesSoldOnNonrecourseBasis', window );">Non-U.S. receivables sold on a nonrecourse basis | $</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_NumberOfLargestPharmaceuticalWholesalers', window );">Number of largest pharmaceutical wholesalers | customer</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue', window );">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberOfLargestPharmaceuticalWholesalers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of the largest pharmaceutical wholesalers used by the company in the territory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberOfLargestPharmaceuticalWholesalers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PercentageOfAggregateTotalTradeReceivablesDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReceivablesSoldOnNonrecourseBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables sold on a nonrecourse basis during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReceivablesSoldOnNonrecourseBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261937951616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 594<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">1,940<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw and packaging materials</a></td>
<td class="nump">594<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_Totalinventories', window );">Total inventories</a></td>
<td class="nump">3,128<span></span>
</td>
<td class="nump">2,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,605<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember', window );">Inventory Purchase Price Fair Value Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, fair value adjustment</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Totalinventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the total inventory, current and non-current, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Totalinventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261933939984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery, equipment and fixtures</a></td>
<td class="nump">3,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">1,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">10,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(4,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,164)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941012464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at December 31, 2022</a></td>
<td class="nump">$ 21,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Currency translation and other adjustments</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at March 31, 2023</a></td>
<td class="nump">$ 21,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261940903360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (34,530)<span></span>
</td>
<td class="num">$ (33,133)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">33,569<span></span>
</td>
<td class="nump">35,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total</a></td>
<td class="nump">68,099<span></span>
</td>
<td class="nump">68,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPRD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">6,540<span></span>
</td>
<td class="nump">6,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">IPRD</a></td>
<td class="nump">6,540<span></span>
</td>
<td class="nump">6,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amounts</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amounts</a></td>
<td class="nump">$ 59,576<span></span>
</td>
<td class="nump">60,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(33,297)<span></span>
</td>
<td class="num">(31,949)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">$ 26,279<span></span>
</td>
<td class="nump">28,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired marketed product rights | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired marketed product rights | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amounts</a></td>
<td class="nump">$ 1,583<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,097)<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Other intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941012464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of other intangible assets</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941361424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Income taxes</a></td>
<td class="nump">$ 2,846<span></span>
</td>
<td class="nump">$ 3,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ResearchandDevelopment', window );">Research and development</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 5,158<span></span>
</td>
<td class="nump">$ 5,795<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchandDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchandDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938117232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityInvestmentsNonCurrent', window );">Equity investments</a></td>
<td class="nump">$ 2,005<span></span>
</td>
<td class="nump">$ 2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_ResearchAndDevelopmentNonCurrent', window );">Research and development</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">$ 4,868<span></span>
</td>
<td class="nump">$ 4,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash for contributions and settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investments - non-current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchAndDevelopmentNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development - Non-Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchAndDevelopmentNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941368544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedRebatesAndReturns', window );">Rebates and discounts</a></td>
<td class="nump">$ 5,824<span></span>
</td>
<td class="nump">$ 6,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends</a></td>
<td class="nump">1,197<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_AccruedInterest', window );">Interest</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,144<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 13,139<span></span>
</td>
<td class="nump">$ 14,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedRebatesAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedRebatesAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943165872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes</a></td>
<td class="nump">$ 3,907<span></span>
</td>
<td class="nump">$ 3,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">$ 6,664<span></span>
</td>
<td class="nump">$ 6,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261934002832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Stockholders Equity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 31,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">2,267<span></span>
</td>
<td class="nump">$ 1,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 31,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in usd per share)</a></td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital&#160;in Excess of Par Value of&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">45,165<span></span>
</td>
<td class="nump">44,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">45,140<span></span>
</td>
<td class="nump">43,756<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1,281)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1,368)<span></span>
</td>
<td class="num">(1,229)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">25,503<span></span>
</td>
<td class="nump">23,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">2,262<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(1,197)<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">26,568<span></span>
</td>
<td class="nump">23,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (38,618)<span></span>
</td>
<td class="num">$ (31,259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares)</a></td>
<td class="nump">825<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share repurchase program (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="num">$ (250)<span></span>
</td>
<td class="num">$ (4,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Stock compensation (in shares)</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (38,808)<span></span>
</td>
<td class="num">$ (35,187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares)</a></td>
<td class="nump">823<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261941581376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Additional Information (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember', window );">2022 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938517872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized (losses)/gains, pretax</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized (losses)/gains, tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized (losses)/gains, after tax</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Reclassified to net earnings, tax</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassified to net earnings, after tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Derivatives qualifying as cash flow hedges, pretax</a></td>
<td class="num">(146)<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Derivatives qualifying as cash flow hedges, tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges, after tax</a></td>
<td class="num">(124)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Actuarial gains/(losses), pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Actuarial gains/(losses), tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gains/(losses), after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Amortization, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Amortization, after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlements, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax', window );">Settlements, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Settlements, after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Pension and postretirement benefits, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and postretirement benefits, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits, after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized (losses)/gains, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Unrealized (losses)/gains, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized (losses)/gains, after tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation, pretax</a></td>
<td class="nump">35<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation, after tax</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income, pre-tax</a></td>
<td class="num">(111)<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive income, tax</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, after tax</a></td>
<td class="num">$ (87)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261935265872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="num">(623)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation(a)</a></td>
<td class="num">(853)<span></span>
</td>
<td class="num">(890)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,368)<span></span>
</td>
<td class="num">(1,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax', window );">Net investment hedge gains</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cumulative translation adjustment attributable to gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261934375296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-based compensation expense</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Excess tax benefits from share-based compensation awards</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-based compensation expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-based compensation expense</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-based compensation expense</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261938454528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 60.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 58.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 64.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261943165872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 1,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140261932484608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)<br> $ in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>patent</div>
</th>
<th class="th">
<div>Mar. 31, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2010 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>claim</div>
</th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Obligation to holders of the contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities for CERCLA matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember', window );">Bristol-Myers Squibb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember', window );">Anti-PD-1 Antibody Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember', window );">CAR T Kite Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | Australia, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember', window );">Abilify Product Liability | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberClassAction', window );">Class action claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims', window );">Individual injury claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberActive', window );">Pending claims, active | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember', window );">Onglyza Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_MolinaLitigationMember', window );">Molina Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberDismissed', window );">Dismissed cases | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberClassAction', window );">Class action claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_OptOutEntitiesMember', window );">Opt-Out Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberClassAction', window );">Class action claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LegalProceedingsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LegalProceedingsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberActive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Active</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberActive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberClassAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Class Action</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberClassAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Individual Injury Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RoyaltyGuaranteesCommitmentsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Guarantees Commitments, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RoyaltyGuaranteesCommitmentsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=bmy_BristolMyersSquibbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_MolinaLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_MolinaLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_OptOutEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_OptOutEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>bmy-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmy="http://www.bms.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmy-20230331.xsd" xlink:type="simple"/>
    <context id="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia44f500456834760bfae19b9494f52e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2639f048af2d48f69a7b8f1ca961fb27_I20230420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2023-04-20</instant>
        </period>
    </context>
    <context id="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1bde7edbb7c14fa0b263eca4aead487e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i173cd3ea7b2b49529ff5d4c934429570_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9853bb7a3895445aab6c6693e972cc56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i106b7888c0d4475ca672b2990121652e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd3beba77678438b8c93338a7baf0121_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa468a5115d642289601acca9b294408_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8d21276df0654c93ac72564897390491_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i935d511681b44311b77fcd048a596f5b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19d681d267ed470d92055de618442973_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if16220a1074c4178b586f8672a245ab8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e55a2a221624cab9060feb297795982_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibafe51b214744a71a14666c467535d3d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icc11bddafe3247ceb277ed8aa08dbd78_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i669af0d6c71643c09655afe1a25c8cd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic99faa9fe613448bbad022be735707c0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49988370bf5e41738d52d3a570580e68_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78b757ad36634d1d80030dba29f7e6e9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id52b753521774addbcfdc534e4ab4c62_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i09688e31f1224e86b9cbe88539af9e20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief3c35e8db3d4577b4932518cea38278_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i7480b54585f34368b4296b7c142bae61_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i781c6b749cec4403995ae4192bf4a6e7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44b7e0dd88f7442eb9ada653b02796b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if74867368269444eadf64059422c5acc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac4c3c432dec4175884bcb7121ad7b2e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6661c44be2040ddb58e23420f3a637a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0632013d3854087980e90d795c1d8d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib8864048307a4f86a8062658906f4268_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e01113e4591475099df5c4095d6e115_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id21490322ff9415aaea6cdeb5ee3ee11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iae64455b039742d787ed2de5fd251442_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03fc8f9965414a0b804d69bb0c52f940_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6a360ac8b1d44afd9d65385129373f29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84eee663f7a54ab6981f1221be773582_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie78114eba6d1431e8eb7de14cb30d209_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe8ca2459264488eb91f63c4799ca142_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0873c9ac73324059911ec26977fd62b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i781c7d4e422d4246a9f62677261a6759_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f61e0b967e941f3a13b8cdae92da602_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe21eb2b773241f9975587ff0d8c4222_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice34df82dfdc4797b4a08dd853517723_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i59d461f0363f4426b69a52fb5f5622fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i39d1821f5f4446deb6d810a66e604eee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa0d2ac040da41489147ca9c96170c3d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3125f46fdab84e90911ceb3d16a6f77a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6af8bc7b28d042ba94f91804fafa4966_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i341f444f1ff84f0393e86932e2bbcb98_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i14834d88f10b45639a717a5dfcb76963_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea7520f9b6d647d5a6e43c02f239fa52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67aea7fd88984640aed0e394579193a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibc622a66bb01497482da48709daace5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6c0fe73a8454867a2e1e14954eae15c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic3c2fd3c0be4401480de8de24cb596eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4430059dc6204ccb8d6012d670a5011e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib10f8c00022a496aa567f0b2b08b1734_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if7361bec49a941e5b6e8ee3761986ec8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i35cd3e93ee9f44a4863c125f17563e83_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48499737f5104edab86a6d804fd035ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf13f856670744549308e754a728bc4b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7f78af08373f410f81a0ec2062e53827_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2fea4d1110624ccc8643189b89b7a264_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f3d1009dc364c098f6d58018920196a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib010a27d7530452ba7bcd495694e0d53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8230d684b10a4394bebb9852f5a60f05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id817fc04753e4b50b4934057f0e357b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3029667aba2c41ac801aca48ee182c97_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bb614bb6595439091cb705f7444f43b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd1e462128ec4e4ab153cea1e6830820_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4c44eb56471340c0b0549845ec48e95f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if1425120cc214e32ba4675730b4b6cc8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29e1112374584215b2d716c9948e2cbb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5f0db91831245a98d378841a723e8a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb81acd0695b4f10a417aade9fb25bb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i42d797e1487542f49ef9a8d6421d410d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic568e0cfa6234853938bade8f38decad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5802b471774f467b8b4ed57b33660afa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ec0fba4252a4678af79e56fbc82990b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3c615915438143509820de8d42395deb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9c8cfb2e34204828954f511d64e793e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4be2043674aa491d9adeb9750ff992df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4e61e9185bb4a9eb351c39c8c716d28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic9d38948aff744438294caa148a86cdd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f582f93ce4e422da958adfc85f8013b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i218b6bfa5bcf40ed94120181ea6072f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i155f9dbf83674147910134de5a163ed4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i14e072e009b24d0fbc03953d84900001_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb244ebbca7645918a749ff83a2caf20_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id87dc345b8de442ea6f8dbbd65882071_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieaa68541a773415fae251b23e344c1b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i525174948c6543dc8a99d3c14aab9da3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd5a938b770d4b608475507fe2c5a3b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i937b0f049dac419089d03f3d635323d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ed144f6904d4064a626d5562e3a0cf0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2324127f89494362aa7de6e45d6fe141_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24309b9bca4c40368e5159601708371e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i356526281a974299bee8ad28a8382769_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i24f0783a75914d6fb1fa14e52521a824_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb63487db81d44389500ff3f59b06f62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic79428ebec0f445285e266d25006a85a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifbd254642fa845128c263c3a56052a25_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i854b50008d0b47298b884695f1fe2849_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib06140d1825848a3a6fb79f4c1f62258_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee21a224006b4db88a4217127cb842f4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2820f2c35291457db2f7410b787ba2ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaacb967952a84c929370c1cb0330584a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e3fe6d813fb473a96593961f0613f55_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07ad784c18b14feaa7917cf92952a3bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4908dc165f094814bdc03777b63fb228_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i348f12df9a624cae9f58f9b3c31d39ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibda2aa440a934e82a577fb958f23e939_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d4801a688a148d1bbef6616d73a97b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3941b5a9b1234e72b36561a89af511d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4792b9bd5d914473a84cba87ee6517b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd8e035725b3442db86565959545c35a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie716e8002a604614bf64186acced27ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic73d338c52b542ddae2377e527c62f2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i062ca60f3e7247c4b8d90925c36406d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib68d187be7b0471c86033eada0951b2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cc25cac945148a18864b628022c5492_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1eb982410931493f88491ecf96248f25_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4506a3f2ee45401d9643dde5c3b241dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if6b9651239b0491abf8341b486a23dc1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d753b05e49247a7998fcd56ba7831aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3207d415b9154ca9b0988b77bdf66bf8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic21692a74de649678999f109fd39cfab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i597908d9a603482f9546e5ee2009c406_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i90e84082105e45269a4ddf3f2b924403_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c11a22415bf463a8cafb058afaacf34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-01</startDate>
            <endDate>2015-09-30</endDate>
        </period>
    </context>
    <context id="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i00f02f6049c84c88a97ca32784154910_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19139b5b67d7410eac12e965d900e982_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i489f54c5481c45389d5768b529b57a7c_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-03-01</startDate>
            <endDate>2010-03-31</endDate>
        </period>
    </context>
    <context id="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-03-01</startDate>
            <endDate>2010-03-31</endDate>
        </period>
    </context>
    <context id="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b4fe50bec2c45748e74cea112ead142_I20220330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib2602abf9fb744d1b514e7cd6d92d706_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:MolinaLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if83448985121404b8a86bb8584503c4f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OptOutEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie45c0ee3f040490991410c1a6b57a08c_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="customer">
        <measure>bmy:customer</measure>
    </unit>
    <unit id="patent">
        <measure>bmy:patent</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bmy:lawsuit</measure>
    </unit>
    <unit id="claim">
        <measure>bmy:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV80LTEtMS0xLTE5MzkzNw_9076198d-6239-40c8-b99a-e220089f3a0a">0000014272</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV82LTEtMS0xLTE5MzkzNw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV83LTEtMS0xLTE5MzkzNw_603c5d68-fb71-49f5-9bc2-4917002dfc3f">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV84LTEtMS0xLTE5MzkzNw_b44714a4-516d-4798-a21d-a46959e2bc26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV85LTEtMS0xLTE5MzkzNw_13fe9ef2-7423-4ed6-88bd-ac3270ed37eb">false</dei:AmendmentFlag>
    <dei:EntitySmallBusiness
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV8xMC0xLTEtMS0xOTM5Mzc_e665e000-74a1-4967-88db-5b1b6c229f43">false</dei:EntitySmallBusiness>
    <dei:DocumentType
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcy_4bf92cae-dabf-41bb-b959-b1cc95ddd7ea">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU5_2517b6be-7549-4b5a-a379-a018efc4e88f">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNjc_59f7ff9a-3e3d-499e-acfa-86039a92e5a8">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY1_257cd394-f6e4-4cf6-8222-f348219e500d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY2_d64d5260-63eb-4f7c-a784-5a6a9964d91c">001-01136</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcz_c1b677cc-a60f-4818-af42-04b0b48ba371">BRISTOL-MYERS SQUIBB COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTAtMS0xLTE5MzkzNw_83745724-9128-4647-9060-5328d4e11a3f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTItMS0xLTE5MzkzNw_b1cff1bc-2928-44c8-a42f-3d76580842c0">22-0790350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYx_38d33cc8-f3c9-42b5-9043-1fee449cd393">430 E. 29th Street, 14FL</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYy_177c54e2-4ef8-4661-a912-e4a1071eaecf">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY4_0f7d95ff-cc49-4cde-8864-616e8143624d">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYz_2d55d439-18d9-4525-bd0c-9f649e74970b">10016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcw_59714e78-2521-4f37-b5cd-d9986e776de5">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY5_3edd2725-e3c7-4f2e-b254-2ac155b30d7b">546-4200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTAtMS0xLTE5MzkzNw_819bf5a9-d5e1-4038-b9dc-93ae848dd97b">Common Stock, $0.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTEtMS0xLTE5MzkzNw_b91f5dc4-6c18-4e74-bec2-fee7924ce7e1">BMY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTItMS0xLTE5MzkzNw_94c6fb64-5473-4b81-b919-761c08cbba7b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTAtMS0xLTE5MzkzNw_443624f9-4cdc-4e6f-88c7-1e4ec8e29cc3">1.000% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTEtMS0xLTE5MzkzNw_f4403f61-aa6f-4021-a1ba-87221b4f73b8">BMY25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTItMS0xLTE5MzkzNw_b8fd4cf9-9d39-4fdb-9f95-139801aa7a79">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTAtMS0xLTE5MzkzNw_7540ad35-4d7b-4bc2-b41c-ef6304401d57">1.750% Notes due 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTEtMS0xLTE5MzkzNw_5b141714-066d-4340-acbd-ce04bf42cb51">BMY35</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTItMS0xLTE5MzkzNw_8857bfb9-db62-466f-bb84-1417e8ce9c16">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTAtMS0xLTE5MzkzNw_924120e9-9b80-40e8-828f-c3b979b46201">Celgene Contingent Value Rights</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTEtMS0xLTE5MzkzNw_2367d2b0-e664-4289-9fbe-658b1f2e6472">CELG RT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTItMS0xLTE5MzkzNw_592739fd-5401-4054-a2be-7d36fb152a03">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY0_5b8560da-7158-434f-90e9-8271214b62cd">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU3_cecc917d-9760-4fb4-b4db-62feeb060695">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY3_19f00b12-d202-4f4f-af5b-3eefeea0077b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU4_52291101-e523-404b-80eb-f5e0fcc919fe">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcx_0ae9cf8e-0fa9-4fe8-95cc-23ad80b59e85">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2639f048af2d48f69a7b8f1ca961fb27_I20230420"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yMzg1_0297e7be-bfdc-4450-8184-cd843e912479"
      unitRef="shares">2100847138</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb"
      unitRef="usd">11048000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0xLTEtMS0xOTM5Mzc_05e6d6be-41c0-4f6a-a932-87c9dd076acf"
      unitRef="usd">289000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0zLTEtMS0xOTM5Mzc_e7b46ebd-11a8-4050-b7d4-e7b7e4ec6b97"
      unitRef="usd">340000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0xLTEtMS0xOTM5Mzc_889568c5-21f3-4418-8ef0-de35cd7f67f4"
      unitRef="usd">11337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0zLTEtMS0xOTM5Mzc_b5217066-592f-4cd4-afa8-03ed1aebabcc"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07"
      unitRef="usd">2566000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93"
      unitRef="usd">2471000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0xLTEtMS0xOTM5Mzc_5263a531-d5ce-40b9-bfec-f87548801342"
      unitRef="usd">1762000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0zLTEtMS0xOTM5Mzc_1b8bb6be-b67c-4ee2-8493-2bfb1557f738"
      unitRef="usd">1831000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0xLTEtMS0xOTM5Mzc_28744651-755f-479e-ab70-b59c49a1a70f"
      unitRef="usd">2321000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0zLTEtMS0xOTM5Mzc_31c0641f-e384-4679-8bdf-84d3ea8fc0d9"
      unitRef="usd">2260000000</us-gaap:ResearchAndDevelopmentExpense>
    <bmy:AcquiredIPRD
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0xLTEtMS0xOTM5Mzc_dbe2d16c-e03d-44d2-b36e-dc3fee996c38"
      unitRef="usd">75000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0zLTEtMS0xOTM5Mzc_a75d87ad-e863-4f75-a3a8-e37f25b64ff8"
      unitRef="usd">333000000</bmy:AcquiredIPRD>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMS0xLTEtMTkzOTM3_2d74bbb3-bb16-46a1-8b41-eb75ede8d4a9"
      unitRef="usd">2256000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMy0xLTEtMTkzOTM3_980ac577-ea18-47bd-9448-117739821263"
      unitRef="usd">2417000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMS0xLTEtMTkzOTM3_0551e595-4812-4b94-a483-a9908983bd3b"
      unitRef="usd">413000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMy0xLTEtMTkzOTM3_e37efe9e-c9b2-4ac0-80f9-f18ba0a6f128"
      unitRef="usd">-649000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMS0xLTEtMTkzOTM3_200c0ba7-92de-47ae-b246-11a4f7e8d6a9"
      unitRef="usd">8567000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMy0xLTEtMTkzOTM3_bd4638b6-8796-4f36-a5f6-ce3b16cb3527"
      unitRef="usd">9961000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMS0xLTEtMTkzOTM3_a427cad0-cf42-4d34-99eb-8f21834c28a0"
      unitRef="usd">2770000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMy0xLTEtMTkzOTM3_af7bd38a-a76b-4aa6-aec6-8acd70161669"
      unitRef="usd">1687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMS0xLTEtMTkzOTM3_2d677608-edef-48d1-9c2e-a7c3afa181dd"
      unitRef="usd">503000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMy0xLTEtMTkzOTM3_7e9ddacb-d7c4-437a-89d2-590568803cae"
      unitRef="usd">404000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMS0xLTEtMTkzOTM3_3132ec37-df8a-4233-9185-bd1d8ad9d735"
      unitRef="usd">2267000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMy0xLTEtMTkzOTM3_624e344a-68e8-4733-ab3b-98467255c5f5"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMS0xLTEtMTkzOTM3_b3f5e624-0742-453c-b863-1037486f6d79"
      unitRef="usd">2262000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMy0xLTEtMTkzOTM3_d88daf19-c436-4e61-970d-2a81f1c53907"
      unitRef="usd">1278000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMS0xLTEtMTkzOTM3_04414f89-39de-49e3-a69c-44ec253f05f6"
      unitRef="usdPerShare">1.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMy0xLTEtMTkzOTM3_c680c448-605c-40a5-bd7d-f0c1466eaa59"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0xLTEtMS0xOTM5Mzc_1cc6b8e8-02ef-45b8-b3b8-4997fae7de2c"
      unitRef="usd">2267000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0zLTEtMS0xOTM5Mzc_13fc241e-5cd4-4144-a5d2-796eddcdc38a"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0xLTEtMS0xOTM5Mzc_6d2089b5-a26a-4308-9cc9-25e953dfa8b1"
      unitRef="usd">-124000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0zLTEtMS0xOTM5Mzc_3e603ec5-5476-44c8-8f23-37f98de4b73f"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0xLTEtMS0xOTM5Mzc_8f0f6366-94a8-439f-b7c0-4de31cbbbd85"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0zLTEtMS0xOTM5Mzc_6d2004da-d1cd-4ce6-85e5-7a657ca590aa"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0xLTEtMS0xOTM5Mzc_98f61630-02d6-407b-baab-5fa78bc5b5e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0zLTEtMS0xOTM5Mzc_197c7c72-04f8-4170-b921-52240a722af9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0xLTEtMS0xOTM5Mzc_18ea3891-c906-40b4-8c39-6cd76cea894b"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0zLTEtMS0xOTM5Mzc_54dcf994-2784-47c0-8028-6aebaba23cf4"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0xLTEtMS0xOTM5Mzc_c72a1a23-c9c8-45d0-8c6e-fe211f8ea537"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0zLTEtMS0xOTM5Mzc_563a07ac-10d3-4219-bbb4-fd76a3c681de"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMS0xLTEtMTkzOTM3_5464a0ea-2a6d-4a4f-929a-7f53cd50297c"
      unitRef="usd">2180000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMy0xLTEtMTkzOTM3_088b9cf8-ceea-4703-bf3c-88436427eae9"
      unitRef="usd">1322000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMS0xLTEtMTkzOTM3_e90ddbbb-36a6-4552-98fd-07ab989effc9"
      unitRef="usd">2175000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMy0xLTEtMTkzOTM3_afac6346-db93-4788-a279-d3e83eeb8d81"
      unitRef="usd">1317000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0xLTEtMS0xOTM5Mzc_a3d3d19b-77c6-4512-8816-64c740113f7d"
      unitRef="usd">8995000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0zLTEtMS0xOTM5Mzc_b172f977-613f-43ba-8b99-74d34a783f59"
      unitRef="usd">9123000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0xLTEtMS0xOTM5Mzc_993d7c68-56a7-42c1-abc9-4cc513d9c3b7"
      unitRef="usd">274000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0zLTEtMS0xOTM5Mzc_b0f96b8d-c762-4a27-bd9e-d0ac8aa092f8"
      unitRef="usd">130000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0xLTEtMS0xOTM5Mzc_7fd3d481-a9c0-4af9-979c-42b278ed7ce4"
      unitRef="usd">10054000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0zLTEtMS0xOTM5Mzc_6e17e589-b175-4a57-9f70-21318f07dc81"
      unitRef="usd">9886000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895"
      unitRef="usd">2605000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc"
      unitRef="usd">2339000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0xLTEtMS0xOTM5Mzc_692cf222-7014-405b-8915-bd21985982f7"
      unitRef="usd">5158000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0zLTEtMS0xOTM5Mzc_ca8fb9c4-d9a2-4960-8b29-845f0dab90e1"
      unitRef="usd">5795000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0xLTEtMS0xOTM5Mzc_7b6ac0f2-873d-4631-887e-647157eb867b"
      unitRef="usd">27086000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0zLTEtMS0xOTM5Mzc_95af985e-5a8d-4e9d-9af1-7f376d33c73b"
      unitRef="usd">27273000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0xLTEtMS0xOTM5Mzc_da12876a-d9f0-4794-996f-d681089600d6"
      unitRef="usd">6279000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0zLTEtMS0xOTM5Mzc_46c6cbc1-af2b-4112-8d2d-ce3e04fc9588"
      unitRef="usd">6255000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0xLTEtMS0xOTM5Mzc_019e6ea2-e278-40dc-9024-9b60ce868810"
      unitRef="usd">21162000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0zLTEtMS0xOTM5Mzc_a637472e-bf94-43bc-82b3-7cf4ecbdcf91"
      unitRef="usd">21149000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMS0xLTEtMTkzOTM3_b509253f-fec2-4d80-9db4-aa8cc3f26e51"
      unitRef="usd">33569000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMy0xLTEtMTkzOTM3_e88b6148-f769-4e78-95f8-eb53e6627da3"
      unitRef="usd">35859000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMS0xLTEtMTkzOTM3_d17d48b1-91bf-41bf-81f0-73f444fdb684"
      unitRef="usd">1317000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMy0xLTEtMTkzOTM3_bb2d42b3-c906-49e4-a06e-867bff692691"
      unitRef="usd">1344000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMS0xLTEtMTkzOTM3_eb57073d-c2b9-4720-a201-5d7afefa4591"
      unitRef="usd">4868000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMy0xLTEtMTkzOTM3_a57ae653-31a0-425f-ad15-1b0532505242"
      unitRef="usd">4940000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMS0xLTEtMTkzOTM3_be6553d1-d979-445f-94f2-4277c0e75a22"
      unitRef="usd">94281000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMy0xLTEtMTkzOTM3_bbcdf693-1770-44a0-b96a-471a8fc4d798"
      unitRef="usd">96820000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMS0xLTEtMTkzOTM3_88ff07ca-3da3-48c6-bbc3-f036caf7a74a"
      unitRef="usd">2752000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMy0xLTEtMTkzOTM3_dcbce047-f6c9-4dd5-b62f-4d068061844c"
      unitRef="usd">4264000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMS0xLTEtMTkzOTM3_084227dd-1225-46e3-9e42-66536ad0e12d"
      unitRef="usd">3194000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMy0xLTEtMTkzOTM3_39b45ac7-6e96-49dd-903e-5ee049d1cf92"
      unitRef="usd">3040000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMS0xLTEtMTkzOTM3_3987d116-41da-4a24-b29b-529e7d96a4b1"
      unitRef="usd">13139000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMy0xLTEtMTkzOTM3_549a822b-9b07-41bc-96a1-76b594e00aca"
      unitRef="usd">14586000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMS0xLTEtMTkzOTM3_32071144-af35-4215-81fb-553bef51dea3"
      unitRef="usd">19085000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMy0xLTEtMTkzOTM3_e4cd11cd-7707-41c2-85d3-805970c1a563"
      unitRef="usd">21890000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMS0xLTEtMTkzOTM3_b9f98955-04dd-4b3c-802e-daa1129de5dc"
      unitRef="usd">1568000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMy0xLTEtMTkzOTM3_fc479911-071a-4653-886c-f14311f1c3b4"
      unitRef="usd">2166000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMS0xLTEtMTkzOTM3_11fa5be5-68f2-4f56-bcf0-e5a513215a0a"
      unitRef="usd">35078000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMy0xLTEtMTkzOTM3_b25fc408-3dbc-45af-9ba2-c2d43ba1796e"
      unitRef="usd">35056000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMS0xLTEtMTkzOTM3_54b8bd5f-0e0f-4a44-8708-933a89b74e46"
      unitRef="usd">6664000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMy0xLTEtMTkzOTM3_c9eee618-4da7-4368-b6cb-94171581585c"
      unitRef="usd">6590000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMS0xLTEtMTkzOTM3_a40e6ccd-0f2c-4799-8126-5f88e90e6e5d"
      unitRef="usd">62395000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMy0xLTEtMTkzOTM3_538d572f-69e2-4c45-8a63-57807e7f1b4d"
      unitRef="usd">65702000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMS0xLTEtMTkzOTM3_912ed084-5deb-4b6f-8ce1-95ed23451dae"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMy0xLTEtMTkzOTM3_7db60af1-0a6f-4e21-a1ab-b1f412f4e724"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMS0xLTEtMTkzOTM3_9ea0a082-58a5-434d-9f34-bb2e7d40c992"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMy0xLTEtMTkzOTM3_cfd33413-8427-4a68-b1f8-be1d02899b67"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMS0xLTEtMTkzOTM3_2e7db4c4-14d8-4471-a7fb-4d6d07f3598d"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMy0xLTEtMTkzOTM3_94a23a09-ecef-4bb7-a609-486d380ff50f"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMS0xLTEtMTkzOTM3_8abb0954-1d68-481e-96d5-7a793a627d87"
      unitRef="usd">45140000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMy0xLTEtMTkzOTM3_f717a6ce-d3e0-456b-927f-0a4818c2d9ce"
      unitRef="usd">45165000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMS0xLTEtMTkzOTM3_c1a9375b-f791-46ce-9653-fb68d7786321"
      unitRef="usd">-1368000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMy0xLTEtMTkzOTM3_a0433b61-17eb-4e0b-87c3-08fa237e2bd9"
      unitRef="usd">-1281000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMS0xLTEtMTkzOTM3_cf063c4f-4475-4980-a19a-c45d825b3e56"
      unitRef="usd">26568000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMy0xLTEtMTkzOTM3_072399fa-7db8-4748-81db-963211abe4f6"
      unitRef="usd">25503000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMS0xLTEtMTkzOTM3_a19d5f2b-f2dc-48a2-abd7-f0bba79e77cc"
      unitRef="usd">38808000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMy0xLTEtMTkzOTM3_9d24fd0a-78b1-45ab-9f43-fbad50dba6a2"
      unitRef="usd">38618000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMS0xLTEtMTkzOTM3_70b4c310-609e-49d5-b0df-328e0c0afea7"
      unitRef="usd">31824000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMy0xLTEtMTkzOTM3_d176b372-d1d4-4c8a-b981-d17e6ec035cf"
      unitRef="usd">31061000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMS0xLTEtMTkzOTM3_fa359998-dc95-46b9-80f7-15be86969f90"
      unitRef="usd">62000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMy0xLTEtMTkzOTM3_460f71c4-39cb-46cf-bf8e-8dacd77acb13"
      unitRef="usd">57000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMS0xLTEtMTkzOTM3_224a3189-9cf1-468c-9be8-fafb25989158"
      unitRef="usd">31886000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMy0xLTEtMTkzOTM3_19495236-0f3a-459b-9539-7a52af675b73"
      unitRef="usd">31118000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMS0xLTEtMTkzOTM3_bdeb8c03-0f77-43bb-bee5-ec3ab21df825"
      unitRef="usd">94281000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMy0xLTEtMTkzOTM3_901768f7-8930-490b-9a7d-f02896a70316"
      unitRef="usd">96820000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0xLTEtMS0xOTM5Mzc_aa339976-2d05-4f64-a74c-851393c167ed"
      unitRef="usd">2267000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0zLTEtMS0xOTM5Mzc_166f9707-a725-4ce8-92d2-d4db3ded6ece"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0xLTEtMS0xOTM5Mzc_624cad41-fa32-41da-bcfc-970c7628f226"
      unitRef="usd">2429000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0zLTEtMS0xOTM5Mzc_cb000889-e21b-4bb3-9ced-79bcd7e5a4ef"
      unitRef="usd">2584000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0xLTEtMS0xOTM5Mzc_9a9d8d55-1706-421f-add1-c46dce17f6a0"
      unitRef="usd">-548000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0zLTEtMS0xOTM5Mzc_26eac0d4-6854-4091-b196-ec0d45a76f3b"
      unitRef="usd">-687000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0xLTEtMS0xOTM5Mzc_bd759c41-9729-46d3-93c9-ca302ed31854"
      unitRef="usd">122000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0zLTEtMS0xOTM5Mzc_4ec828dc-9d33-420e-8eb3-97ddded729b7"
      unitRef="usd">107000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0xLTEtMS0xOTM5Mzc_66c7f93a-bb59-40cd-8626-dc32bf084eed"
      unitRef="usd">20000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0zLTEtMS0xOTM5Mzc_4585c8e7-04ba-4340-a09a-44f5f320dc2c"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <bmy:Divestituregainsandroyalties
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMS0xLTEtMTkzOTM3_c16ced75-6444-4fc3-9826-4d2d90bdc7dc"
      unitRef="usd">194000000</bmy:Divestituregainsandroyalties>
    <bmy:Divestituregainsandroyalties
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMy0xLTEtMTkzOTM3_8649f58e-d843-45aa-b678-1d1cc6589d1c"
      unitRef="usd">387000000</bmy:Divestituregainsandroyalties>
    <bmy:AcquiredIPRD
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMS0xLTEtMTkzOTM3_f7b37ca1-c4d4-44fd-ba18-d21c95db49ce"
      unitRef="usd">75000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMy0xLTEtMTkzOTM3_4c86b1b8-c1a8-48fe-9321-5151e77b7949"
      unitRef="usd">333000000</bmy:AcquiredIPRD>
    <us-gaap:GainLossOnInvestments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMS0xLTEtMTkzOTM3_9c41e2a1-7af4-402a-8a25-685c3a2febb2"
      unitRef="usd">-155000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMy0xLTEtMTkzOTM3_3804737f-dd6d-4633-bd34-b7e3db4ba029"
      unitRef="usd">-644000000</us-gaap:GainLossOnInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMS0xLTEtMTkzOTM3_251f9d83-a15d-4aa2-96b4-d7318173e5bf"
      unitRef="usd">-4000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMy0xLTEtMTkzOTM3_460020fe-4c7f-4409-a29b-60a9080e1af4"
      unitRef="usd">-256000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMS0xLTEtMTkzOTM3_b1cd6962-e679-4ecd-ab26-79678880aaeb"
      unitRef="usd">175000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMy0xLTEtMTkzOTM3_fe5ae3dd-afe2-48eb-b228-d49d57902604"
      unitRef="usd">-786000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMS0xLTEtMTkzOTM3_8d979563-8cc6-4c67-911d-504a538c027e"
      unitRef="usd">282000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMy0xLTEtMTkzOTM3_148bc2c2-6c1d-454c-836f-070ce8ec3fd7"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMS0xLTEtMTkzOTM3_5d5f5cf2-ef5c-47a0-9bab-e56e8bf95148"
      unitRef="usd">187000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMy0xLTEtMTkzOTM3_8272a6f3-2022-401d-b8ac-07fb0d7f68a7"
      unitRef="usd">23000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMS0xLTEtMTkzOTM3_beeb8a8e-09cf-4715-80ca-d5da3277ba3d"
      unitRef="usd">-910000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMy0xLTEtMTkzOTM3_ee851414-3061-4264-89f3-088138e139da"
      unitRef="usd">-930000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMS0xLTEtMTkzOTM3_7490c3e5-3178-448c-92dd-941fe2d23d44"
      unitRef="usd">884000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMy0xLTEtMTkzOTM3_9f8a18d7-2d18-4fe4-bfcd-c565974d87c2"
      unitRef="usd">831000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMS0xLTEtMTkzOTM3_3f271d84-7a01-481a-953e-369f6db07801"
      unitRef="usd">1064000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMy0xLTEtMTkzOTM3_8b1ac005-9bc8-46d4-b036-f65c12422b79"
      unitRef="usd">1073000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMS0xLTEtMTkzOTM3_c2f7191b-9758-43a0-bbe2-319446c6cec1"
      unitRef="usd">2970000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMy0xLTEtMTkzOTM3_fa9266f8-974c-42a1-b935-cf4d7176071b"
      unitRef="usd">3812000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMS0xLTEtMTkzOTM3_17688cf6-391e-4c56-8f75-196079938efe"
      unitRef="usd">57000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMy0xLTEtMTkzOTM3_add05a28-36bf-48b5-9beb-c3a05f0acda5"
      unitRef="usd">2100000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMS0xLTEtMTkzOTM3_f7414ffd-b0ce-4dd9-a9be-d70f8503b49e"
      unitRef="usd">200000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMy0xLTEtMTkzOTM3_ee93c9d5-e01b-4b77-9dc4-b548eab9beac"
      unitRef="usd">1714000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMS0xLTEtMTkzOTM3_d60d498c-e4b0-4117-8b0c-e77e01fa750e"
      unitRef="usd">62000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMy0xLTEtMTkzOTM3_915fe0cf-7806-4291-8ab7-ee84d93987a2"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMS0xLTEtMTkzOTM3_f3827c24-9b8c-40a5-bd5d-753fc316bdef"
      unitRef="usd">278000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMy0xLTEtMTkzOTM3_600bdfd5-c36a-43e9-8898-0684e09d4131"
      unitRef="usd">253000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <bmy:Divestitureandotherproceeds
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMS0xLTEtMTkzOTM3_1e6fe6c9-be46-4aca-9811-92d6ab38e49d"
      unitRef="usd">227000000</bmy:Divestitureandotherproceeds>
    <bmy:Divestitureandotherproceeds
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMy0xLTEtMTkzOTM3_d1801086-bca5-423c-a31d-4ea2373c024b"
      unitRef="usd">402000000</bmy:Divestitureandotherproceeds>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMS0xLTEtMTkzOTM3_f2dde5f9-50c6-48cf-8e2c-98da3af3548e"
      unitRef="usd">78000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMy0xLTEtMTkzOTM3_d459e40e-53fd-4748-88a6-c8f3ea65c15c"
      unitRef="usd">442000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMS0xLTEtMTkzOTM3_dabc78a6-79c5-4ce9-9904-19a1b0fcfa59"
      unitRef="usd">-210000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMy0xLTEtMTkzOTM3_5cd3c1b7-7533-4feb-b95f-8f3428458d67"
      unitRef="usd">95000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMS0xLTEtMTkzOTM3_63f14b32-6b46-44ed-afc4-ec7159691f55"
      unitRef="usd">128000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMy0xLTEtMTkzOTM3_a3588f1e-882e-484b-8244-66671f8ddae9"
      unitRef="usd">42000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMS0xLTEtMTkzOTM3_b2654642-dd29-4ac0-9c34-c2613106c9c8"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMy0xLTEtMTkzOTM3_14685cf9-842b-4354-95cd-f287c4dba147"
      unitRef="usd">5926000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMS0xLTEtMTkzOTM3_e5afdf27-97e1-4bed-a8fb-bd39777c75f8"
      unitRef="usd">1640000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMy0xLTEtMTkzOTM3_7f9c155d-a27f-48f1-985c-7418136aae5a"
      unitRef="usd">5769000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMS0xLTEtMTkzOTM3_60ecd8ae-43b1-413e-be93-fea9da0a6d2a"
      unitRef="usd">250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMy0xLTEtMTkzOTM3_63c14911-e40b-4cbd-a328-34da0682929e"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMS0xLTEtMTkzOTM3_2a61cc61-6270-44aa-8402-b30270b12d8d"
      unitRef="usd">1196000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMy0xLTEtMTkzOTM3_2b257b3f-ffb3-413b-aef3-94a4fbe7cc9c"
      unitRef="usd">1185000000</us-gaap:PaymentsOfDividends>
    <bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMS0xLTEtMTkzOTM3_9d29df06-d1ad-4a0f-8af8-0aff78184301"
      unitRef="usd">-92000000</bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments>
    <bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMy0xLTEtMTkzOTM3_1d794f78-c498-42de-bc07-f65eb47a4e3c"
      unitRef="usd">333000000</bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMS0xLTEtMTkzOTM3_c36e7b9b-6123-4c39-8db2-6bf3752b9c1c"
      unitRef="usd">-3050000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMy0xLTEtMTkzOTM3_d3467725-c881-42fe-9e38-50b25b83c46d"
      unitRef="usd">-5653000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMS0xLTEtMTkzOTM3_5bb0cd89-5efe-449e-a17f-711885294258"
      unitRef="usd">13000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMy0xLTEtMTkzOTM3_1d57d46c-bba4-4ba4-9b5a-b892bc444049"
      unitRef="usd">9000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMS0xLTEtMTkzOTM3_bbf04f32-d381-4fe3-a0e9-5eb17325abad"
      unitRef="usd">-277000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMy0xLTEtMTkzOTM3_5416eb85-7a91-41b7-8cbe-a107e86e6caa"
      unitRef="usd">-1737000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMS0xLTEtMTkzOTM3_14e13534-5618-4fa8-8c4a-a9b391dc2ddc"
      unitRef="usd">9325000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMy0xLTEtMTkzOTM3_44eac29c-1427-46e3-ac30-c885143aa1aa"
      unitRef="usd">14316000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMS0xLTEtMTkzOTM3_97241554-39a2-42bf-8b9b-cd66af0b98ea"
      unitRef="usd">9048000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMy0xLTEtMTkzOTM3_08f46d1f-5167-4480-a93c-8491a0164b13"
      unitRef="usd">12579000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zMS9mcmFnOjYzNzQ3MTEwYjgyNDQyMzE4NGUzZmE5OGYwM2IwMWYyL3RleHRyZWdpb246NjM3NDcxMTBiODI0NDIzMTg0ZTNmYTk4ZjAzYjAxZjJfNzY_773c8e45-0455-432d-b239-a593a94c5fa2">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#x2014;Note 2. Revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYyNQ_8518bb1c-15c4-478b-a3b0-376b9f40590b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzOQ_a8f1181c-1b8f-4e25-a30b-c534496c5d0d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#x2014;Note 2. Revenue".&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY0Mg_9c42825b-3adf-40fe-9dd2-97e4e0c3c7c6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzNA_de405c6b-3061-4ea9-884f-90621a61a185">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY1Mg_0cfa60a9-b7d6-4b92-bce4-b44cf546d59e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk3_a39425e4-59f7-4926-839e-e81b62db5d8e">REVENUE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $87&#160;million and $74&#160;million for the three months ended March 31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Camzyos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sotyktu&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products and New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Recent LOE Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from performance obligations satisfied in prior periods was $166 million and $147 million for the three months ended March&#160;31, 2023 and 2022, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for GTN adjustments related to prior period sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwOQ_b28325f0-6c81-41b3-a4b7-3864c1dcff84">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb"
      unitRef="usd">11048000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f"
      unitRef="usd">144000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0xLTEtMS0xOTM5Mzc_71a9a9e3-efde-4563-b26c-fd61c311b7dd"
      unitRef="usd">145000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0zLTEtMS0xOTM5Mzc_b3d4faec-4110-4123-a6a8-766027903861"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0xLTEtMS0xOTM5Mzc_d863e3d9-4ed1-4bf0-be11-ab05dc0ab600"
      unitRef="usd">11337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0zLTEtMS0xOTM5Mzc_32b0ecf5-e019-4b0c-be96-194705ef148c"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk5_97ed379e-8768-42d6-94af-585b7c84357c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $87&#160;million and $74&#160;million for the three months ended March 31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock>
    <us-gaap:Revenues
      contextRef="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0xLTEtMS0xOTM5Mzc_4f06b79a-b4fc-4cda-81ce-b580e3d35f8b"
      unitRef="usd">17288000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0zLTEtMS0xOTM5Mzc_2d5b3ab1-d077-4f73-a2f7-4c218f3fde09"
      unitRef="usd">16650000000</us-gaap:Revenues>
    <bmy:GrosstoNetAdjustments
      contextRef="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0xLTEtMS0xOTM5Mzc_244c200d-3f01-43d2-a46f-406727e790b3"
      unitRef="usd">2091000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0zLTEtMS0xOTM5Mzc_0dc18df4-71f1-4e25-a430-48369adc3b6b"
      unitRef="usd">1763000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="idd3beba77678438b8c93338a7baf0121_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0xLTEtMS0xOTM5Mzc_3f3e7577-beb5-4a7b-80d7-8f2fb55c98b8"
      unitRef="usd">2482000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ifa468a5115d642289601acca9b294408_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0zLTEtMS0xOTM5Mzc_d67880f0-7b9b-48a6-889d-994ce2edbacd"
      unitRef="usd">2084000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0xLTEtMS0xOTM5Mzc_37e96d5c-2485-4025-be0c-f5d4f5bb5afd"
      unitRef="usd">1667000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0zLTEtMS0xOTM5Mzc_b17dca1d-6065-45b1-b148-dfc4033c2d68"
      unitRef="usd">1495000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0xLTEtMS0xOTM5Mzc_a0b90a36-40a8-4cef-91f2-95bfe76ffd4c"
      unitRef="usd">6240000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0zLTEtMS0xOTM5Mzc_d898e331-c6c8-45ca-983f-c7d7b3122bb5"
      unitRef="usd">5342000000</bmy:GrosstoNetAdjustments>
    <us-gaap:Revenues
      contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0xLTEtMS0xOTM5Mzc_1d8312b7-0b32-4c9b-9a00-86908b9bf9c0"
      unitRef="usd">11048000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0zLTEtMS0xOTM5Mzc_dbf3031b-8c10-4c26-97d8-a94298906009"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2Mg_dce04e51-aab6-4f54-b1b6-54fe2862fa4f"
      unitRef="usd">87000000</bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement>
    <bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2NA_912a1d31-525a-4224-b447-c758156cb945"
      unitRef="usd">74000000</bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwNw_b7fb20ee-e198-4e07-ae0a-735ee609a5c4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Camzyos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sotyktu&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total In-Line Products and New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Recent LOE Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0xLTEtMS0xOTM5Mzc_97df4735-abf2-4ddf-b78a-9ed696a85526"
      unitRef="usd">3423000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d21276df0654c93ac72564897390491_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0zLTEtMS0xOTM5Mzc_f91983d7-6344-492a-b5d8-84a092225296"
      unitRef="usd">3211000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0xLTEtMS0xOTM5Mzc_5877ca97-869b-4c34-9c9c-9fd8a546d232"
      unitRef="usd">2202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i935d511681b44311b77fcd048a596f5b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0zLTEtMS0xOTM5Mzc_f1d2b80d-8fd3-4724-acd1-b1b0c38cbfb9"
      unitRef="usd">1923000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0xLTEtMS0xOTM5Mzc_4c8ee0bb-160a-4be0-be60-f55259ee9f3c"
      unitRef="usd">832000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0zLTEtMS0xOTM5Mzc_6f0d2fc9-c63b-47f7-b9f7-0878afb675f5"
      unitRef="usd">826000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0xLTEtMS0xOTM5Mzc_4f6da18a-ff17-4728-be99-b0ebc5573d37"
      unitRef="usd">764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0zLTEtMS0xOTM5Mzc_fb481ccb-d78f-4529-bd0d-79a9e093014a"
      unitRef="usd">792000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0xLTEtMS0xOTM5Mzc_bd36e4ab-f5ae-499c-8a27-f36226c91388"
      unitRef="usd">429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0zLTEtMS0xOTM5Mzc_211a22ca-3d2e-45ce-a566-c313fbed1269"
      unitRef="usd">483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0xLTEtMS0xOTM5Mzc_ca017902-0afa-40d6-96c7-ed57327d9d5c"
      unitRef="usd">508000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0zLTEtMS0xOTM5Mzc_ddf44fd7-e673-467a-9b93-b08be4d3814a"
      unitRef="usd">515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMS0xLTEtMTkzOTM3_1c65e2f8-ab2d-40eb-94b7-c9d60e199393"
      unitRef="usd">467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMy0xLTEtMTkzOTM3_64169542-4d76-4614-87af-71e7e2e855c9"
      unitRef="usd">537000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMS0xLTEtMTkzOTM3_931d44d8-2071-416d-9a11-bba3f0a22422"
      unitRef="usd">8625000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMy0xLTEtMTkzOTM3_9a9138c2-1ccc-4ce7-b96e-7688b3c5f90f"
      unitRef="usd">8287000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i19d681d267ed470d92055de618442973_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMS0xLTEtMTkzOTM3_b82e5c8c-45ae-452d-9e48-7ca1a10535b4"
      unitRef="usd">206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMy0xLTEtMTkzOTM3_de2c6b95-acfe-487d-9e09-b7c79e0e05b7"
      unitRef="usd">156000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMS0xLTEtMTkzOTM3_c19b6efa-ad20-4851-8b3b-d9746927d55f"
      unitRef="usd">147000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if16220a1074c4178b586f8672a245ab8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMy0xLTEtMTkzOTM3_70e7d8a0-857b-4e68-b9a5-13ef461a0978"
      unitRef="usd">67000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTk1NDk5_ad3db66a-538a-4ce5-aa8b-d687c8551f92"
      unitRef="usd">117000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTk1NDk5_5cb0fa5e-eb0d-458a-b772-86c84e7221bc"
      unitRef="usd">6000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTkzOTM3_85576caf-d6e9-43e4-9cc5-b1b914237478"
      unitRef="usd">78000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTkzOTM3_e3760017-acd9-421b-9131-b511478f50c4"
      unitRef="usd">36000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMS0xLTEtMTkzOTM3_1122ac46-a16e-4f8d-aa84-23b36877ac16"
      unitRef="usd">71000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMy0xLTEtMTkzOTM3_f477c683-7613-429d-99e3-10ce3827e444"
      unitRef="usd">44000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMS0xLTEtMTk1NTA3_c0219ebb-b8cb-4a92-9ebb-8cc4eb9c45f6"
      unitRef="usd">34000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMy0xLTEtMTk1NTA3_e05ed104-7e88-441a-a644-518548760784"
      unitRef="usd">23000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMS0xLTEtMTkzOTM3_13cbccc2-a2a3-4d2d-a9e2-b83920aeb2f6"
      unitRef="usd">25000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMy0xLTEtMTkzOTM3_f34cdc8b-441a-41e9-9738-9b11139402d9"
      unitRef="usd">18000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMS0xLTEtMTkzOTM3_60f75565-a44d-4fcb-8f64-774b29ded686"
      unitRef="usd">29000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMy0xLTEtMTkzOTM3_f83ae871-7156-4a9c-b2e7-025ecd09e6b9"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e55a2a221624cab9060feb297795982_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMS0xLTEtMTkzOTM3_2059f728-4ade-4e9b-afe4-2806494f6882"
      unitRef="usd">16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMy0xLTEtMTkzOTM3_11b42549-bf75-447a-8ea2-e9909fb0694d"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMS0xLTEtMTkzOTM3_b4598269-f224-467c-a4b5-a0956ee47837"
      unitRef="usd">723000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMy0xLTEtMTkzOTM3_011b56ed-091a-4d78-bc5c-8bdf96caf610"
      unitRef="usd">350000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMS0xLTEtMTkzOTM3_bc5337fc-fd13-4dd7-97df-fc2f7791c074"
      unitRef="usd">9348000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibafe51b214744a71a14666c467535d3d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMy0xLTEtMTkzOTM3_f53095ef-008c-45d1-9e70-eaf3bc47c28d"
      unitRef="usd">8637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMS0xLTEtMTkzOTM3_b7087f72-0362-4690-9502-d9a505f51920"
      unitRef="usd">1750000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMy0xLTEtMTkzOTM3_8eb45ff9-39d1-498e-8924-d33b0a9a9130"
      unitRef="usd">2797000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMS0xLTEtMTkzOTM3_4ab6e187-9330-4366-b994-39513104968f"
      unitRef="usd">239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMy0xLTEtMTkzOTM3_d189e0c2-54e6-440d-8f7f-0dc085a04068"
      unitRef="usd">214000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMS0xLTEtMTkzOTM3_ff03bf3c-053b-456c-a0b0-9bf79a07dae9"
      unitRef="usd">1989000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMy0xLTEtMTkzOTM3_07a8624f-4925-4e9c-9703-dc82a6ace499"
      unitRef="usd">3011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMS0xLTEtMTkzOTM3_5943a4bf-7a52-4466-8168-58959bde64d6"
      unitRef="usd">11337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMy0xLTEtMTkzOTM3_e74c4a40-2845-4f96-9e21-4024976b63c4"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMS0xLTEtMTkzOTM3_4af050e5-a909-4469-9764-de2d83524a85"
      unitRef="usd">8033000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMy0xLTEtMTkzOTM3_fb229da2-2529-4138-9192-aee410673442"
      unitRef="usd">7694000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMS0xLTEtMTkzOTM3_cef9a6b5-e248-40c1-a7e4-5ab824cf14bf"
      unitRef="usd">3149000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMy0xLTEtMTkzOTM3_a940ab82-d10f-484f-b598-29330b98b38b"
      unitRef="usd">3727000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMS0xLTEtMTkzOTM3_0c5c6e3e-2aaa-4530-a06e-c245321278ec"
      unitRef="usd">155000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMy0xLTEtMTkzOTM3_49786e1b-e04d-48ac-adec-e91a0705b759"
      unitRef="usd">227000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMS0xLTEtMTkzOTM3_944bee52-b9d5-42c2-99c9-f0c54623326f"
      unitRef="usd">11337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMy0xLTEtMTkzOTM3_4548b201-dde5-4950-b456-71770fa8bc8d"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzgy_fedffcb7-0f64-4c4b-a14d-9cab7a436149"
      unitRef="usd">166000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzg5_9ffcd926-4be7-4f3a-9d19-0698a955a47f"
      unitRef="usd">147000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2MA_3dd6a12b-b1aa-4721-9eef-28c029d09b9b">ALLIANCES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS refers to these collaborations as alliances and its partners as alliance partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected alliance balance sheet information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income &#x2013; from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;  Includes unamortized upfront and milestone payments. &lt;/span&gt;&lt;/div&gt;The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2022 Form 10-K.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2Ng_ac3e4aa9-763f-40ec-bc3d-adf523817bff">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected alliance balance sheet information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income &#x2013; from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;  Includes unamortized upfront and milestone payments.</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:Revenues
      contextRef="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0xLTEtMS0xOTM5Mzc_e299e06d-67a7-4deb-9633-7899a6c305b7"
      unitRef="usd">3532000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0zLTEtMS0xOTM5Mzc_34f97b80-4ab9-441c-a019-2aeef75ce5a8"
      unitRef="usd">3239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f"
      unitRef="usd">144000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0xLTEtMS0xOTM5Mzc_3f89e55f-25e9-4087-8ead-f7f0184cae62"
      unitRef="usd">3676000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0zLTEtMS0xOTM5Mzc_3bb93a94-6f6f-4e40-bf7a-2c28380eebda"
      unitRef="usd">3427000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0xLTEtMS0xOTM5Mzc_73161496-6696-4edf-a078-53146cd7599d"
      unitRef="usd">1706000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0zLTEtMS0xOTM5Mzc_8422780e-4a2e-4c7f-971f-6ad642de6484"
      unitRef="usd">1556000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0xLTEtMS0xOTM5Mzc_a451af61-31b7-4777-8d3a-ee87eca0ded5"
      unitRef="usd">74000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0zLTEtMS0xOTM5Mzc_dd8a093f-0fbc-4925-83db-567aac7f02af"
      unitRef="usd">54000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement
      contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMS0xLTEtMTkzOTM3_a95a50ce-ce20-40f7-962c-6d7e5ff99fac"
      unitRef="usd">44000000</bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement>
    <bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement
      contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMy0xLTEtMTkzOTM3_6c3d2ab3-b113-4847-9f7c-0bdcf1edb7de"
      unitRef="usd">22000000</bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMS0xLTEtMTkzOTM3_7b227b68-1008-42c3-9137-6e61142743a9"
      unitRef="usd">12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMy0xLTEtMTkzOTM3_f44d2b90-09da-4a9a-8990-d21bed37ecc3"
      unitRef="usd">12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ReceivablesNetCurrent
      contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0xLTEtMS0xOTM5Mzc_40a6ee6e-d9a3-41ca-8f82-34e216c6bfd8"
      unitRef="usd">274000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0zLTEtMS0xOTM5Mzc_573fe8af-0b4b-4141-a6a8-2a3a8f7c6d80"
      unitRef="usd">317000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0xLTEtMS0xOTM5Mzc_678df0ce-0047-4777-8612-bd04e1d62cae"
      unitRef="usd">1623000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0zLTEtMS0xOTM5Mzc_dafca4bf-586c-4c42-9077-34d0b677f7e7"
      unitRef="usd">1249000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncome
      contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0xLTEtMS0xOTM5Mzc_faa519f5-6666-400a-97d1-0d27edec1ffe"
      unitRef="usd">314000000</us-gaap:DeferredIncome>
    <us-gaap:DeferredIncome
      contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0zLTEtMS0xOTM5Mzc_468b4db9-514c-40ce-b289-6e21d2bb0650"
      unitRef="usd">289000000</us-gaap:DeferredIncome>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwMg_aec9b66f-c35f-4ab2-aaaf-e2a60fdbaf38">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature products and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Mature Products and Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $221&#160;million and a divestiture gain of $211&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Licensing and Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties and licensing income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Immatics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS obtained a global exclusive license to Immatics' TCR bispecific IMA401 program. which is being studied in oncology. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $150&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dragonfly&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, a Phase I development milestone for interleukin-12 ("IL-12") was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023, BMS notified Dragonfly that it was terminating the global exclusive license that relates to Dragonfly&#x2019;s IL-12. All rights to IL-12 were reverted back to Dragonfly effective April 18, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nimbus Change of Control Income&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS and Nimbus Therapeutics entered into a settlement resolving all legal claims and business interests pertaining to Nimbus' TYK2 inhibitor resulting in $40&#160;million of income included in Other (income)/expense. The settlement also provides for BMS to receive additional amounts for contingent development, regulatory approval and sales-based milestones and 10% of any change in control proceeds received by Nimbus Therapeutics related to its TYK2 inhibitor. In February 2023, Takeda acquired 100% ownership of Nimbus Therapeutics' TYK2 inhibitor for approximately $4.0&#160;billion in upfront proceeds plus contingent sales-based milestones aggregating up to $2.0&#160;billion. As a result, $400&#160;million of income related to the change of control provision is included in Other (income)/expense during the first quarter of 2023 and is expected to be received in the second quarter of 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwNQ_11838ae5-863e-49d0-a08c-bda3e4dcfabd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature products and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business.</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xLTEtMS0xOTM5Mzc_ecb3e5b1-c276-4667-9461-c4de1d26c975"
      unitRef="usd">216000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0zLTEtMS0xOTM5Mzc_6fd1901d-e066-4bb2-bcec-81551608971a"
      unitRef="usd">172000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy01LTEtMS0xOTM5Mzc_ac488c87-c507-42fb-855d-d72aaf2f6313"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy03LTEtMS0xOTM5Mzc_c5153722-32c2-4e95-b920-f58f21c9c597"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy05LTEtMS0xOTM5Mzc_84288481-f9a1-4384-8deb-c9c44e5a789a"
      unitRef="usd">188000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xMS0xLTEtMTkzOTM3_949b51cc-e9c0-4a18-bb61-93851740e905"
      unitRef="usd">170000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xLTEtMS0xOTM5Mzc_87f45a70-21e7-4822-8cb7-4726f53a343f"
      unitRef="usd">4000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0zLTEtMS0xOTM5Mzc_27f1cdee-61bf-40cc-8923-23e679980590"
      unitRef="usd">225000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy01LTEtMS0xOTM5Mzc_2288a8b3-3a24-4100-a089-91cc3dea90c1"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy03LTEtMS0xOTM5Mzc_e2510f5e-e1a4-49a5-a4f0-690e3ca04008"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy05LTEtMS0xOTM5Mzc_11ff3b37-a70b-429b-92fc-38bfa1968023"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xMS0xLTEtMTkzOTM3_d77ab360-e93c-495c-b4bd-acb6fd8d4779"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xLTEtMS0xOTM5Mzc_12425b83-9fd8-4754-a6b3-ee6186ffd3f8"
      unitRef="usd">220000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0zLTEtMS0xOTM5Mzc_5541271b-ba61-4080-bb7c-dd415a284dfe"
      unitRef="usd">397000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC01LTEtMS0xOTM5Mzc_37332d7e-fd74-42fc-8790-88b72a82f9d9"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC03LTEtMS0xOTM5Mzc_78e93e93-bdc4-42c7-8142-173ebd0f60ed"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC05LTEtMS0xOTM5Mzc_b2a4baea-7bff-435f-b328-23a2579bdda0"
      unitRef="usd">188000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xMS0xLTEtMTkzOTM3_a48fa2be-66da-4c39-8b68-66c826886f08"
      unitRef="usd">171000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI0MQ_52945466-36a6-4211-99f7-d1a241b0480c"
      unitRef="usd">221000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI3MA_02781fb5-1d60-480f-8fe5-6a5fdf065326"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <bmy:LicensingAndOtherArrangementsTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjA5Nw_c7365928-ca7a-48e1-b53b-46466d9829ff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties and licensing income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:LicensingAndOtherArrangementsTableTextBlock>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0xLTEtMS0xOTM5Mzc_2b475c2b-b896-4fff-8049-d6f88f5821c5"
      unitRef="usd">279000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i49988370bf5e41738d52d3a570580e68_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0zLTEtMS0xOTM5Mzc_2ea2fb17-ea20-46a7-8174-faa7e36384d6"
      unitRef="usd">221000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0xLTEtMS0xOTM5Mzc_0629391f-8980-4379-b7b8-c9e1d889d222"
      unitRef="usd">30000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0zLTEtMS0xOTM5Mzc_c19b7fe0-82a7-4cbe-b618-18b2f72e6b12"
      unitRef="usd">25000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0xLTEtMS0xOTM5Mzc_f8a4f7b2-53c3-42f2-b5ca-3e2edafea065"
      unitRef="usd">31000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0zLTEtMS0xOTM5Mzc_b0d16b76-dc2e-4572-84ab-ff3b2b34a062"
      unitRef="usd">41000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0xLTEtMS0xOTM5Mzc_8439189f-12ae-4762-8706-8d94d5fb213b"
      unitRef="usd">12000000</bmy:AmortizationOfDeferredIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0zLTEtMS0xOTM5Mzc_9c65ed5e-8ea6-491f-bb04-632084c72ebb"
      unitRef="usd">12000000</bmy:AmortizationOfDeferredIncome>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0xLTEtMS0xOTM5Mzc_c5a85cd8-ea26-4e06-840d-4212f70dda9a"
      unitRef="usd">11000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0zLTEtMS0xOTM5Mzc_493988b1-10e9-43cf-ac42-9d902c769d32"
      unitRef="usd">7000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0xLTEtMS0xOTM5Mzc_d54019ea-3771-40bf-b5b6-8d242bebc40a"
      unitRef="usd">363000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0zLTEtMS0xOTM5Mzc_2629d398-7b11-4f53-a5e4-3f01f8c3c197"
      unitRef="usd">306000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDI0Ng_ebd56ca7-6916-4271-a539-4b6324db9215"
      unitRef="usd">150000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:ContingentAndRegulatoryMilestonePayments
      contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDQxOA_e3bf66e6-807b-4819-b019-4b45301be5cc"
      unitRef="usd">770000000</bmy:ContingentAndRegulatoryMilestonePayments>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="id52b753521774addbcfdc534e4ab4c62_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDU5Nw_cbb99ebd-38c1-4c39-b3cb-8497e9cd0fe2"
      unitRef="usd">175000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDI_501f3002-bc27-49b3-a693-9a749181a942"
      unitRef="usd">40000000</us-gaap:ProceedsFromLegalSettlements>
    <bmy:SettlementContingentDevelopmentChangeInControlProceeds
      contextRef="i09688e31f1224e86b9cbe88539af9e20_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDY_64840105-97f4-43ed-88b0-5bd3e68f9a76"
      unitRef="number">0.10</bmy:SettlementContingentDevelopmentChangeInControlProceeds>
    <bmy:AssetAcquisitionPercentageOfOwnershipAcquired
      contextRef="ief3c35e8db3d4577b4932518cea38278_I20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTA_08abc4dc-1edb-4439-9c81-37e967351eb0"
      unitRef="number">1</bmy:AssetAcquisitionPercentageOfOwnershipAcquired>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="i7480b54585f34368b4296b7c142bae61_I20230228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTQ_36275dad-1600-418d-914b-8a906594fc48"
      unitRef="usd">4000000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:CollaborativeArrangementContingentPaymentsMaximumExposure
      contextRef="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMjI_1593e7d0-afe4-481e-b133-0c0be27222a5"
      unitRef="usd">2000000000</bmy:CollaborativeArrangementContingentPaymentsMaximumExposure>
    <us-gaap:OtherNonoperatingIncome
      contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTg_cbb8c996-670a-4d9d-a3f0-3f008ea1845a"
      unitRef="usd">400000000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNDg_a2a790f6-d92d-4d88-8ea1-e0a6294c6237">OTHER (INCOME)/EXPENSE, NET&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty and licensing income (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty income - divestiture (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses (Note 9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses (Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture gains (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring (Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes $400&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#x2014;Note 4. Divestitures, Licensing and Other Arrangements" for further information.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <bmy:ScheduleOfOtherIncomeExpenseTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNTI_6e4cba0a-f264-4619-8447-d410136f4b30">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty and licensing income (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty income - divestiture (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses (Note 9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses (Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture gains (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring (Note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes $400&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#x2014;Note 4. Divestitures, Licensing and Other Arrangements" for further information.&lt;/span&gt;&lt;/div&gt;</bmy:ScheduleOfOtherIncomeExpenseTextBlock>
    <us-gaap:InterestExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0xLTEtMS0xOTM5Mzc_434044ce-76ce-4587-aaf4-95c9a5d119b0"
      unitRef="usd">288000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0zLTEtMS0xOTM5Mzc_4f3d4305-91c5-4a45-be13-863cb29ab910"
      unitRef="usd">326000000</us-gaap:InterestExpense>
    <bmy:BusinessRoyaltyAndLicensingIncome
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0xLTEtMS0xOTM5Mzc_d6c17d8f-6fe9-4ae4-954e-b49a0a645f9a"
      unitRef="usd">363000000</bmy:BusinessRoyaltyAndLicensingIncome>
    <bmy:BusinessRoyaltyAndLicensingIncome
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0zLTEtMS0xOTM5Mzc_cde5b39e-1c29-4157-8462-430fd425675c"
      unitRef="usd">306000000</bmy:BusinessRoyaltyAndLicensingIncome>
    <bmy:BusinessSaleRoyaltyIncome
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0xLTEtMS0yMDE1NTY_5645143a-8e77-47dd-8829-1fb509106cdf"
      unitRef="usd">188000000</bmy:BusinessSaleRoyaltyIncome>
    <bmy:BusinessSaleRoyaltyIncome
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0zLTEtMS0xOTg4ODc_5dc1b86b-c0be-4e58-8124-e36448bde18d"
      unitRef="usd">171000000</bmy:BusinessSaleRoyaltyIncome>
    <us-gaap:GainLossOnInvestments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY4ODA_a917a1a3-389d-44bc-bae6-f359b8c2f84b"
      unitRef="usd">-155000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY4ODA_3a2cee87-80d5-40cf-922f-d3daa66c87d4"
      unitRef="usd">-644000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0xLTEtMS0yMjY4ODY_3d6582d1-6642-475f-86c1-7b9b8af3b4e0"
      unitRef="usd">67000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0zLTEtMS0yMjY4ODY_b67d633c-a720-48a8-bc7a-ff5c753ed4c2"
      unitRef="usd">105000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjY4OTU_88b4ef92-5e0f-4694-94f6-829c682ca8f4"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjY4OTU_0094f611-01f4-4df9-9ea4-28375aa7e4c2"
      unitRef="usd">-275000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0yMjY4OTU_b74c3f43-e922-4b01-b2fe-a223610fa3ba"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0yMjY4OTU_895baec9-d3e4-441d-ab46-9900a2e9d7b1"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY0Mjc_3eb2b0a8-5c13-498c-a432-40a32a029a18"
      unitRef="usd">325000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY0Mjc_5fd62728-048c-45ab-b439-472e8d513423"
      unitRef="usd">37000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjYzMjQ_701d112c-8e0b-4f3e-b56d-3055f472f390"
      unitRef="usd">102000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjYzMjQ_a9b3a131-4c7a-40a8-a9f0-9f4f2495ec22"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:RestructuringCharges
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0xOTM5Mzc_b40e11b1-c0e7-49df-b038-732580ecc916"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0xOTM5Mzc_1207b304-9fe2-4b5e-a176-738f09bd2bd5"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <bmy:OtherOtherIncomeExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMS0xLTEtMTkzOTM3_8f4237c4-65be-47f8-a6f2-56a27b2f9d7f"
      unitRef="usd">12000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMy0xLTEtMTkzOTM3_0e61b4fd-8990-49f1-8a10-0a5fb43d57ff"
      unitRef="usd">-11000000</bmy:OtherOtherIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMS0xLTEtMTkzOTM3_eae279b0-eed4-43ce-b590-9883ad6ead0a"
      unitRef="usd">413000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMy0xLTEtMTkzOTM3_a813939c-8a9b-4c3f-a547-94e8357dcd6e"
      unitRef="usd">-649000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfMjc0ODc3OTA3MzczNw_ab2889b6-b4b5-46be-a348-d58b93088861"
      unitRef="usd">400000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4Ng_731ba384-69af-4131-85ec-02c64f83e103">RESTRUCTURING&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Celgene Acquisition Plan, the Company expects to incur charges of approximately $3.5&#160;billion, including cash outlays of approximately $3.1&#160;billion. Cumulative charges of approximately $3.1&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition in 2022 and the MyoKardia acquisition in 2020. Charges of approximately $250&#160;million are expected to be incurred through the end of 2023 and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $180 million have been recognized for these actions to date. In the first quarter of 2023, certain restructuring activities occurred resulting in employee termination costs of $61&#160;million, which are primarily attributed to changes in our operating model to accelerate the delivery of medicines to patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $3 million and $9 million for the three months ended March 31, 2023 and 2022, respectively.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNDkz_3e846c58-5e9e-4b46-91da-704066d9bc86"
      unitRef="usd">3500000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bmy:Cashoutlays
      contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTY0_2735029a-6d19-4375-8b4f-043946530e62"
      unitRef="usd">3100000000</bmy:Cashoutlays>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNjA0_548e2f33-bf73-420f-b6cd-1a7644c5b95e"
      unitRef="usd">3100000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTMyOQ_42821fef-558d-4ef5-8158-85cf6e3e9bcc"
      unitRef="usd">250000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTUxOQ_e7be9ec3-e616-4e9b-988d-29ae2adf44a4"
      unitRef="usd">180000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:SeveranceCosts1
      contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTQ5NzU1ODI3NDc0_27bb813b-681f-4364-ad9f-ec044949ff78"
      unitRef="usd">61000000</us-gaap:SeveranceCosts1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OA_79273de4-c6b3-4f5d-ad1f-48a58b6efccd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0xLTEtMS0xOTM5Mzc_ced0eb1b-ff62-49e4-8579-990f319abe92"
      unitRef="usd">57000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0zLTEtMS0xOTM5Mzc_2c8d991f-ef2c-4dd5-905e-bf6cb0e5e689"
      unitRef="usd">127000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0xLTEtMS0xOTM5Mzc_c762b13c-9a91-4378-b06e-36f9bb9b7ac4"
      unitRef="usd">78000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="if74867368269444eadf64059422c5acc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0zLTEtMS0xOTM5Mzc_e8fedee8-6aec-4147-98fd-878decf58b51"
      unitRef="usd">3000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0xLTEtMS0xOTM5Mzc_435cb982-b75b-454a-add6-88fbf1a24e09"
      unitRef="usd">135000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0zLTEtMS0xOTM5Mzc_5f83d7cc-02bb-4f37-a2be-a48a5870bcce"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0xLTEtMS0xOTM5Mzc_8d6c03fd-0f1c-4f1e-8a01-6825e694d642"
      unitRef="usd">65000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0zLTEtMS0xOTM5Mzc_bf28ec25-a592-4cdf-b74f-01ee295ea385"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0xLTEtMS0xOTM5Mzc_322b528b-6803-45a8-956b-e28fc67be728"
      unitRef="usd">2000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0zLTEtMS0xOTM5Mzc_d932b6a8-aade-43b5-8ed8-92c91b61a39a"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0xLTEtMS0xOTM5Mzc_1c7083bb-e8cd-4253-add3-dfa7e5f5eed7"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0zLTEtMS0xOTM5Mzc_968625bb-7902-45a8-b4a1-575a9ba1f478"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMS0xLTEtMTkzOTM3_7314cfc9-229b-4d13-9a81-a0055d24b6c4"
      unitRef="usd">67000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMy0xLTEtMTkzOTM3_51c44af7-f82f-4368-9dac-31c75df0f2e6"
      unitRef="usd">105000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMS0xLTEtMTkzOTM3_6bbdf0b0-55bb-4259-8c7a-7ad657511091"
      unitRef="usd">1000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMy0xLTEtMTkzOTM3_4cd80990-2b88-47ab-a241-8a0c8f08692a"
      unitRef="usd">2000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMS0xLTEtMTkzOTM3_50dbc602-03e9-42e6-b410-196605656b30"
      unitRef="usd">135000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMy0xLTEtMTkzOTM3_c44ff89d-3669-4a9e-aaa3-ba28f33e6a69"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMS0xLTEtMTkzOTM3_78968530-4600-4098-9a16-605ff3ff058e"
      unitRef="usd">1000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMy0xLTEtMTkzOTM3_c72d9b3a-206a-4d17-ad5b-b9677d61d516"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMS0xLTEtMTkzOTM3_11d28bfa-9eda-4add-a9eb-b078be269223"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMy0xLTEtMTkzOTM3_9418c65f-e56e-46fb-8943-21b5bfe44f3f"
      unitRef="usd">2000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMS0xLTEtMTkzOTM3_1a9872d7-8e71-4980-948c-10ce1019d38b"
      unitRef="usd">134000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMy0xLTEtMTkzOTM3_fa333cbb-c1aa-43ff-8a00-342e8d24f206"
      unitRef="usd">128000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMS0xLTEtMTkzOTM3_256bb28b-7f25-4cf8-bf7d-c109cb4dc3e8"
      unitRef="usd">135000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMy0xLTEtMTkzOTM3_3754faaf-5e5f-43a8-b4fa-9b572536e543"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OQ_66707be2-8774-4cc9-9866-aec432e834ba">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $3 million and $9 million for the three months ended March 31, 2023 and 2022, respectively.</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0xLTEtMS0xOTM5Mzc_2227650a-9e62-4026-968d-b3781964fc78"
      unitRef="usd">47000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0zLTEtMS0xOTM5Mzc_2cbd6e9c-a210-42e4-97e2-16ea6ffcc8b5"
      unitRef="usd">101000000</us-gaap:RestructuringReserve>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0xLTEtMS0xOTM5Mzc_92f09bb3-8f44-49fb-a978-ef9c9148c0f2"
      unitRef="usd">67000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0zLTEtMS0xOTM5Mzc_1e4fb051-71dc-4709-bdbe-c244ddd82124"
      unitRef="usd">23000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0xLTEtMS0xOTM5Mzc_e9bd38fb-1803-4080-a67d-2a622754e629"
      unitRef="usd">2000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0zLTEtMS0xOTM5Mzc_d93126d5-2de3-4471-9216-6f6aed71061a"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0xLTEtMS0xOTM5Mzc_91b961e1-98bf-42e6-a4f0-4cc5890f2b63"
      unitRef="usd">17000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0zLTEtMS0xOTM5Mzc_0f67c8b2-73dc-4742-bafa-ad1be5263ff1"
      unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0xLTEtMS0xOTM5Mzc_d424f44c-7c01-4877-b517-1cb7b8622fb4"
      unitRef="usd">99000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0zLTEtMS0xOTM5Mzc_79b652da-eddd-48ad-a60c-e8a9cf9b2db1"
      unitRef="usd">102000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTgzOA_51a81171-ee28-4959-8fe2-da0ecb5395e8"
      unitRef="usd">3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTA5OTUxMTYyOTg3NQ_523d657e-96cf-4fa4-a166-94536295b9bd"
      unitRef="usd">9000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0Nw_bdaf4d09-11f8-4b08-915d-0d9a4c78b978">INCOME TAXES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The 5.7% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $89 million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code. Income tax payments were $149&#160;million and $255&#160;million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is currently under examination by a number of tax authorities that proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax issues for the 2008 to 2012 tax years. BMS disagrees with the IRS's positions and continues to work cooperatively with the IRS to resolve these issues. In the fourth quarter of 2022, BMS entered the IRS administrative appeals process to resolve these matters. Timing of the final resolution of these complex matters is uncertain and could have a material impact on BMS's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that the amount of unrecognized tax benefits as of March&#160;31, 2023 could decrease in the range of approximately $40 million to $60 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits, however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by jurisdiction.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0MQ_d6743b5e-8173-4536-a917-f49e04989199">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0xLTEtMS0xOTM5Mzc_a427cad0-cf42-4d34-99eb-8f21834c28a0"
      unitRef="usd">2770000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0zLTEtMS0xOTM5Mzc_af7bd38a-a76b-4aa6-aec6-8acd70161669"
      unitRef="usd">1687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0xLTEtMS0xOTM5Mzc_2d677608-edef-48d1-9c2e-a7c3afa181dd"
      unitRef="usd">503000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0zLTEtMS0xOTM5Mzc_7e9ddacb-d7c4-437a-89d2-590568803cae"
      unitRef="usd">404000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0xLTEtMS0xOTM5Mzc_504ec3fc-f17f-452f-8393-45a88db0ba2b"
      unitRef="number">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0zLTEtMS0xOTM5Mzc_4e69d025-33a0-4f4d-8d99-67b6bff44fd4"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAzMzU0Ng_31b4dea8-8f56-40e7-958b-e0f659ee6efe"
      unitRef="number">0.057</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMjc0ODc3OTA4MTM0NQ_b2b485df-2337-4e46-95fc-91881ecc787f"
      unitRef="usd">89000000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU0Ng_354c8d7d-9f9f-4592-99a6-e4315f40f45a"
      unitRef="usd">149000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU1Nw_efa7dcd5-1ef4-4e75-9c1c-c004abc0727b"
      unitRef="usd">255000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="iac4c3c432dec4175884bcb7121ad7b2e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODIx_1fc0a86b-46a0-4be1-a052-6f1ec748beb0"
      unitRef="usd">40000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="id6661c44be2040ddb58e23420f3a637a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODI3_41a6f19b-77e9-4633-8f6a-5267d6739a22"
      unitRef="usd">60000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjI4_3002fcb6-1cfa-4064-a1c5-dcbd8b761189">EARNINGS PER SHARE&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to BMS &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental shares attributable to share-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2023 and 2022, respectively.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjM2_d3135f4f-6282-4d11-b52f-0ae01520dba5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to BMS &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental shares attributable to share-based compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0xLTEtMS0xOTM5Mzc_adc5be29-3e7f-45f1-b6d3-7f6787589800"
      unitRef="usd">2262000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0zLTEtMS0xOTM5Mzc_3dbdf914-7829-43b8-9767-00f9320bfc9b"
      unitRef="usd">1278000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0xLTEtMS0xOTM5Mzc_2b60d731-c508-4c92-8950-63d10bca53a1"
      unitRef="shares">2099000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0zLTEtMS0xOTM5Mzc_7e3f00fc-7e4c-4cd5-ab9c-154fc89b6145"
      unitRef="shares">2146000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0xLTEtMS0xOTM5Mzc_2654a662-5b8b-490c-b395-7807901deaf1"
      unitRef="shares">14000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0zLTEtMS0xOTM5Mzc_652341cf-2091-4a39-929d-2ec9724dcc71"
      unitRef="shares">18000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0xLTEtMS0xOTM5Mzc_3bff1eee-7225-41e6-95df-c1642d8e443c"
      unitRef="shares">2113000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0zLTEtMS0xOTM5Mzc_631ca816-8ec9-4796-9381-8a90161efb6b"
      unitRef="shares">2164000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0xLTEtMS0xOTM5Mzc_04414f89-39de-49e3-a69c-44ec253f05f6"
      unitRef="usdPerShare">1.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0zLTEtMS0xOTM5Mzc_c680c448-605c-40a5-bd7d-f0c1466eaa59"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2NzM_ecf46179-0fbf-4f7d-a954-10540d044e1a">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As further described in "Item 8. Financial Statements and Supplementary Data&#x2014;Note 9. Financial Instruments and Fair Value Measurements" in the Company's 2022 Form 10-K, the Company's fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of March&#160;31, 2023 and December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Marketable Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limited partnerships and other equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Equity investment losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative upwards adjustments and cumulative impairments and downward adjustments based on observable price changes in equity investments without readily determinable fair values still held as of March&#160;31, 2023 were $186&#160;million and $61&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Qualifying Hedges and Non-Qualifying Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS enters into foreign currency forward and purchased local currency put option contracts (foreign exchange contracts) to hedge certain forecasted intercompany inventory sales and certain other foreign currency transactions. The objective of these foreign exchange contracts is to reduce variability caused by changes in foreign exchange rates that would affect the U.S. dollar value of future cash flows derived from foreign currency denominated sales, primarily the euro and Japanese yen. The fair values of these derivative contracts are recorded as either assets (gain positions) or liabilities (loss positions) in the consolidated balance sheet. Changes in fair value for these foreign exchange contracts, which are designated as cash flow hedges, is temporarily recorded in Accumulated other comprehensive loss ("AOCL") and reclassified to net earnings when the hedged item affects earnings (typically within the next 24 months). As of March 31, 2023, assuming market rates remain constant through contract maturities, we expect to reclassify pre-tax gains of $156&#160;million into cost of products sold for our foreign exchange contracts out of AOCL during the next 12 months. The notional amount of outstanding foreign currency exchange contracts was primarily $4.9&#160;billion for the euro contracts and $1.3&#160;billion for Japanese yen contracts as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS also enters into cross-currency swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in AOCL and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency swap contracts associated with long-term debt denominated in euros was $1.2&#160;billion as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency exchange contracts not designated as a cash flow hedge offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency swap contracts of $1.3&#160;billion as of March&#160;31, 2023 are designated to hedge currency exposure of BMS's net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of AOCL with a related offset in derivative asset or liability on the consolidated balance sheet. The notional amount of outstanding cross-currency swap contracts was primarily attributed to the Japanese yen of $509&#160;million and euro of $584&#160;million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of &#x20ac;375&#160;million. The related net investment hedge was entered into to hedge euro currency exposures of the net investment in certain foreign affiliates and was recognized in long-term debt. The effective portion of foreign exchange gain or loss on the remeasurement of debt denominated in euros was included in the foreign currency translation component of AOCL with the related offset in Long-term debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the three months ended March 31, 2023, the amortization of gains related to the portion of our net investment hedges that was excluded from the assessment of effectiveness was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (4.86% as of March&#160;31, 2023) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative cash flows, with the exception of net investment hedges, are principally classified in the operating section of the consolidated statements of cash flows, consistent with the underlying hedged item. Cash flows related to net investment hedges are classified in investing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value and the notional values of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swap contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non U.S. dollar borrowings gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3Mzk_9d24f17a-9f55-43f5-a281-8607a740ced7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xLTEtMS0xOTM5Mzc_d8caa5dd-0714-40ed-ae9b-30e48deb3291"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0zLTEtMS0xOTM5Mzc_c8fbcb81-6e8d-4926-b379-70294798e9e2"
      unitRef="usd">7737000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib8864048307a4f86a8062658906f4268_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi01LTEtMS0xOTM5Mzc_eae1282b-499b-41ca-8811-6c2084acf5d8"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2e01113e4591475099df5c4095d6e115_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi03LTEtMS0xOTM5Mzc_984a3446-4048-4d85-b703-fa7ac31e06a3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi05LTEtMS0xOTM5Mzc_3e9f4dd1-773c-4d23-a325-f0b812497d17"
      unitRef="usd">7770000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xMS0xLTEtMTkzOTM3_6f946331-02e3-4b04-be72-755d82674205"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xLTEtMS0xOTM5Mzc_2fe7306d-79d5-4625-939a-b2dd66287c10"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae64455b039742d787ed2de5fd251442_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0zLTEtMS0xOTM5Mzc_a6fd4972-bea8-4a19-9ad7-3e1327dbd550"
      unitRef="usd">201000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03fc8f9965414a0b804d69bb0c52f940_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC01LTEtMS0xOTM5Mzc_ed0d4532-0233-4b17-9676-89f60b73573d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a360ac8b1d44afd9d65385129373f29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC03LTEtMS0xOTM5Mzc_5512ebac-e322-44cf-9919-5e5d767d9916"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84eee663f7a54ab6981f1221be773582_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC05LTEtMS0xOTM5Mzc_d46d5a42-e8ca-4456-a2f4-7c91fe2a868c"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie78114eba6d1431e8eb7de14cb30d209_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xMS0xLTEtMTkzOTM3_70663db2-55eb-4ee5-a962-e681f5682886"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe8ca2459264488eb91f63c4799ca142_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xLTEtMS0xOTM5Mzc_4115b2a6-3f44-4700-a561-65ddfb803a2e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0873c9ac73324059911ec26977fd62b7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0zLTEtMS0xOTM5Mzc_bfef367a-cc3f-4919-8acd-89ee39af2e76"
      unitRef="usd">73000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i781c7d4e422d4246a9f62677261a6759_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS01LTEtMS0xOTM5Mzc_bbc3935e-e26a-43c8-b6b6-2cb420e84637"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f61e0b967e941f3a13b8cdae92da602_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS03LTEtMS0xOTM5Mzc_9e0078e0-97c9-4ead-bc6d-b9e8eb9b4f61"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe21eb2b773241f9975587ff0d8c4222_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS05LTEtMS0xOTM5Mzc_638dbc0b-157b-46ac-a92a-be017dc80210"
      unitRef="usd">98000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ice34df82dfdc4797b4a08dd853517723_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xMS0xLTEtMTkzOTM3_883599d1-a634-4429-b230-11a6f0d54168"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xLTEtMS0xOTM5Mzc_a35044b2-9a26-447d-89ea-9e47370ee717"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0zLTEtMS0xOTM5Mzc_de468042-4d79-4189-88df-0c7dd6c6dff4"
      unitRef="usd">255000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib8864048307a4f86a8062658906f4268_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy01LTEtMS0xOTM5Mzc_924ec066-4455-4801-aa12-0a754bd315b9"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2e01113e4591475099df5c4095d6e115_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy03LTEtMS0xOTM5Mzc_61fbf076-d781-47d7-95a4-d2fde242ae81"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy05LTEtMS0xOTM5Mzc_f90819a3-df84-4a0b-bdf3-87a1aa3a2023"
      unitRef="usd">305000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xMS0xLTEtMTkzOTM3_4b9526b0-b6f5-4bf1-901e-542c7c7742ef"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i59d461f0363f4426b69a52fb5f5622fa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xLTEtMS0xOTM5Mzc_d2927642-79cc-43e9-948c-347750fb8e79"
      unitRef="usd">293000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i39d1821f5f4446deb6d810a66e604eee_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0zLTEtMS0xOTM5Mzc_4018a5da-ebf9-46e9-85b9-ed4656b1d102"
      unitRef="usd">614000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iaa0d2ac040da41489147ca9c96170c3d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC01LTEtMS0xOTM5Mzc_51e2264c-7eec-4bb9-a535-dd2b3bff7ba4"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3125f46fdab84e90911ceb3d16a6f77a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC03LTEtMS0xOTM5Mzc_b0563ad6-73a9-4863-97d5-3020d2b6905f"
      unitRef="usd">424000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC05LTEtMS0xOTM5Mzc_983b89f1-3477-4927-bde6-8bc3de9bf6b7"
      unitRef="usd">680000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6af8bc7b28d042ba94f91804fafa4966_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xMS0xLTEtMTkzOTM3_b6dc3ab0-acf6-47d5-a873-eb222de48cfa"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeLiabilities
      contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xLTEtMS0xOTM5Mzc_0df75222-1fc7-43c4-9022-ac6475f63857"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0zLTEtMS0xOTM5Mzc_943dd700-f40d-44e0-a6bb-ae0663ba6982"
      unitRef="usd">207000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib8864048307a4f86a8062658906f4268_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS01LTEtMS0xOTM5Mzc_19ef689f-11e0-49c5-9de2-8469963912dd"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2e01113e4591475099df5c4095d6e115_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS03LTEtMS0xOTM5Mzc_3b5474f5-7a80-481f-b674-6519c52578ca"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS05LTEtMS0xOTM5Mzc_d92ca86d-5620-472d-9641-1c6dcef2906d"
      unitRef="usd">213000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xMS0xLTEtMTkzOTM3_3489b1c9-23e2-454f-9654-4ca2f5fd5e96"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMS0xLTEtMTkzOTM3_c15e93cd-f7ff-4fd2-a1fb-29589a0acef2"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMy0xLTEtMTkzOTM3_a034deb2-9ca0-4827-82a1-b8eb7a883b7c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i341f444f1ff84f0393e86932e2bbcb98_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNS0xLTEtMTkzOTM3_0c567915-3985-4b47-af82-34bb64802940"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i14834d88f10b45639a717a5dfcb76963_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNy0xLTEtMTkzOTM3_3bf0a159-f6b9-4c53-ba9b-1c19ebe806f3"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iea7520f9b6d647d5a6e43c02f239fa52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtOS0xLTEtMTkzOTM3_fe561717-c9b3-4ffb-8788-de6e3d341775"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i67aea7fd88984640aed0e394579193a2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMTEtMS0xLTE5MzkzNw_d93c0224-f14d-4f69-b9e8-a0cd01de51aa"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMS0xLTEtMTkzOTM3_a61aec8a-0509-4aef-b461-84d3d5234ccb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMy0xLTEtMTkzOTM3_da2f9d2d-d297-4733-8850-fd01fda14e9d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib8864048307a4f86a8062658906f4268_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNS0xLTEtMTkzOTM3_8b2cef73-8316-4495-8c3e-bfc9ab6b1962"
      unitRef="usd">18000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2e01113e4591475099df5c4095d6e115_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNy0xLTEtMTkzOTM3_30834dbd-05d5-4b69-aa74-00ae2009c90e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItOS0xLTEtMTkzOTM3_770cbe88-9f4e-46da-844b-959c1d803181"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMTEtMS0xLTE5MzkzNw_8b0f040f-6dcf-46df-ab10-a71a118ba1c8"
      unitRef="usd">24000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2ODA_95c33714-ecf6-470c-af53-f531af728097">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xLTEtMS0xOTM5Mzc_a16df9de-41b9-4e1e-86df-9943f760a0bb"
      unitRef="usd">201000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0zLTEtMS0xOTM5Mzc_43c983ac-63ff-48b1-8bfd-dac39fdbe44b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy01LTEtMS0xOTM5Mzc_03334bac-d746-4541-9f3d-64818b2d993f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy03LTEtMS0xOTM5Mzc_b3c97bdf-bfd1-4e49-95e4-5af29b9df303"
      unitRef="usd">201000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc622a66bb01497482da48709daace5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy05LTEtMS0xOTM5Mzc_92df5114-285d-4672-8097-d7b3aafc91d8"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc622a66bb01497482da48709daace5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMS0xLTEtMTkzOTM3_2495429f-f8db-494c-b7b7-3c03dfeb01f1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc622a66bb01497482da48709daace5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMy0xLTEtMTkzOTM3_f1747618-0dd3-46d8-90b8-a594b5dd8cf3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc622a66bb01497482da48709daace5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xNS0xLTEtMTkzOTM3_d84f3a7b-00ce-4c26-b54f-7fd7a52ac72b"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xLTEtMS0xOTM5Mzc_010b5ad4-a3cd-4861-9230-a07f3481b924"
      unitRef="usd">73000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0zLTEtMS0xOTM5Mzc_a0c9380f-db9c-448d-b6df-e64115ed788b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC01LTEtMS0xOTM5Mzc_4e12d9b2-4aaa-48b3-8133-ebbaae2a561f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC03LTEtMS0xOTM5Mzc_c6ad5733-f30f-4b70-8fa8-354fbaca9943"
      unitRef="usd">73000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC05LTEtMS0xOTM5Mzc_aba3e687-4f45-48d4-9de3-c22da60ba01d"
      unitRef="usd">98000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMS0xLTEtMTkzOTM3_8bf3cf35-382c-48c5-9c67-a96091d411ff"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMy0xLTEtMTkzOTM3_cdf6d297-1e90-46fd-b70e-79f3c67a2382"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xNS0xLTEtMTkzOTM3_fd54068e-35e1-4d61-b722-065cae170ce8"
      unitRef="usd">98000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xLTEtMS0xOTM5Mzc_a7141a28-d0a0-4dff-a705-d07e031dd244"
      unitRef="usd">274000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0zLTEtMS0xOTM5Mzc_d7661e4c-d276-4a93-ae45-5a3897212588"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi01LTEtMS0xOTM5Mzc_58f948f3-1eea-4991-b57f-a239040aeb2b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi03LTEtMS0xOTM5Mzc_067f4666-44ba-4044-879e-6be7e7c81682"
      unitRef="usd">274000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi05LTEtMS0xOTM5Mzc_fd44d156-c6d1-4a74-b1b1-ba8e95bc8003"
      unitRef="usd">130000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMS0xLTEtMTkzOTM3_b4bbb050-8b12-4805-87d1-9c5f59961b08"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMy0xLTEtMTkzOTM3_ff49ec30-7333-43ce-98ab-a1dfaa8294bf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xNS0xLTEtMTkzOTM3_2c24b918-337b-48ae-8fa2-279a22074854"
      unitRef="usd">130000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <bmy:ScheduleOfEquityInvestmentsTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2OTc_26f68c10-0f08-493d-aa0a-cd43ee96865b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limited partnerships and other equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfEquityInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0xLTEtMS0xOTM5Mzc_d3a97893-75e4-4ca3-8cde-c1a4e7daa14b"
      unitRef="usd">907000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0zLTEtMS0xOTM5Mzc_97436c65-f818-4ad9-a5ef-2f85b6806823"
      unitRef="usd">1104000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0xLTEtMS0xOTM5Mzc_53121a6a-62a6-494b-85af-5affc230b477"
      unitRef="usd">574000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0zLTEtMS0xOTM5Mzc_1161722b-311b-4c49-911a-f31987947ec8"
      unitRef="usd">537000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0xLTEtMS0xOTM5Mzc_85ff3fd0-546d-497c-a410-fb9db08b2cb5"
      unitRef="usd">524000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0zLTEtMS0xOTM5Mzc_f77df033-ed79-4b19-b34d-4ed8bf6a7359"
      unitRef="usd">546000000</us-gaap:EquityMethodInvestments>
    <bmy:EquityInvestments
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0xLTEtMS0xOTM5Mzc_255283d3-46aa-4c56-821a-d30b040d8bae"
      unitRef="usd">2005000000</bmy:EquityInvestments>
    <bmy:EquityInvestments
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0zLTEtMS0xOTM5Mzc_606fe45d-c8af-45e1-b09b-3257771e0c99"
      unitRef="usd">2187000000</bmy:EquityInvestments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MzU_1367602f-ced5-47a5-8d46-5f59a8b2e9ac">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Equity investment losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0xLTEtMS0xOTM5Mzc_ce5bd12a-b909-463a-a825-9750e71e7877"
      unitRef="usd">-141000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0zLTEtMS0xOTM5Mzc_f9305eea-5f81-4452-bf9e-eecdc66a6ca2"
      unitRef="usd">-598000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0xLTEtMS0xOTM5Mzc_d13ac1b8-b38d-4ade-a54f-e28ec7b08f83"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0zLTEtMS0xOTM5Mzc_5bd49d75-977d-4273-837e-e3decc313c7f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0xLTEtMS0xOTM5Mzc_9dfcc700-c33b-4f6c-a725-50469f849c3c"
      unitRef="usd">-140000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0zLTEtMS0xOTM5Mzc_c282b22d-e4fb-4dff-b8f5-7943f5d52d8d"
      unitRef="usd">-598000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0xLTEtMS0xOTM5Mzc_97615577-95ba-4d95-9d70-eeeb9a20263c"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0zLTEtMS0xOTM5Mzc_4b453abb-83cc-44e3-a590-18e057b852bc"
      unitRef="usd">6000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0xLTEtMS0xOTM5Mzc_6b054acb-3618-4a1d-81b4-a362e8d20197"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0zLTEtMS0xOTM5Mzc_fb23d025-21d6-4985-b0b3-f44a49603de7"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMS0xLTEtMTkzOTM3_790ff3ef-6c79-4264-87f3-943ee0cd5b5b"
      unitRef="usd">-20000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMy0xLTEtMTkzOTM3_8ff32c3c-65bf-4b76-aa9b-11bd36f954fc"
      unitRef="usd">-50000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMS0xLTEtMjEzMzUz_5f0b0ad4-7352-47cf-9944-a534f844e771"
      unitRef="usd">-155000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMy0xLTEtMjEzMzU2_3ea54e88-9dfb-40f4-827f-ce77ca65fbad"
      unitRef="usd">-644000000</us-gaap:GainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAxOQ_c4ba4460-b1b0-4995-a667-f084c364fdd7"
      unitRef="usd">186000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAzMw_884d6f71-415b-49bb-b240-2bff81cd6b0b"
      unitRef="usd">61000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODc3MjI2_b100f6db-797d-424a-80e3-6c8ef36666ad"
      unitRef="usd">156000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4430059dc6204ccb8d6012d670a5011e_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTIz_8c076786-d74b-4b71-aa76-c455e9d40aae"
      unitRef="usd">4900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTQ3_9363de55-c3d3-4b71-8194-15abd91343b1"
      unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib10f8c00022a496aa567f0b2b08b1734_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY4OTIx_7bffad9e-737e-4089-bfa7-337e787b8463"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwMTky_dc2dae9a-8e73-4c77-8221-e916a4d124f4"
      unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if7361bec49a941e5b6e8ee3761986ec8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjM5_186ebbab-e1cb-4aca-8eb1-e8270c94fecb"
      unitRef="usd">509000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i35cd3e93ee9f44a4863c125f17563e83_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjU1_623638b3-14a1-4981-aa40-ead3caf7bb6a"
      unitRef="usd">584000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i48499737f5104edab86a6d804fd035ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNzQ5_fe6f35c7-95c2-4f1e-b8d6-833a015ee642"
      unitRef="eur">375000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icf13f856670744549308e754a728bc4b_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzIw_9b90578e-c46b-4179-8db5-f3cdbe0a8f45"
      unitRef="number">0.0486</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzY4_3f25ee6c-3dbf-445d-9d1c-2d8fe570e041"
      unitRef="number">0.046</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2Njk_93f6918c-3e8e-4857-bcf5-d38a6c8567d8">The following table summarizes the fair value and the notional values of outstanding derivatives:&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated as fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swap contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7f78af08373f410f81a0ec2062e53827_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0xOTM5Mzc_e5f0b210-9c18-4b9d-a7ee-0ecdea08f8d8"
      unitRef="usd">5289000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0xOTM5Mzc_b5368683-5d35-4044-a3d4-2a86801aff23"
      unitRef="usd">208000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3f3d1009dc364c098f6d58018920196a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0xOTM5Mzc_afd53dae-b3a8-47d2-a2e4-77ce0fb920a1"
      unitRef="usd">2036000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0xOTM5Mzc_15b2f72f-9a6c-41d6-84dc-a21e89d689bb"
      unitRef="usd">-81000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib010a27d7530452ba7bcd495694e0d53_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0xOTM5Mzc_bc46fa67-b71b-4517-b5f8-87214275301c"
      unitRef="usd">5771000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMTkzOTM3_761eef04-34af-476e-aced-2ea350a32c13"
      unitRef="usd">271000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8230d684b10a4394bebb9852f5a60f05_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMTkzOTM3_ecfd8cbb-df3e-4bf3-9260-87aecdedfc4f"
      unitRef="usd">2281000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMTkzOTM3_43477b80-b6f3-44c0-80e6-733ea3b43c30"
      unitRef="usd">-80000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0yMTU4Nzk_1e3b6a90-f466-4fe6-b55e-21537d1b7406"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0yMTU4Nzk_552b0947-d6d3-404b-af04-cf78f17f390d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0yMTU4Nzk_2d1462c1-5f86-4a64-b4b6-3ab6a82a08a5"
      unitRef="usd">1210000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0yMTU4Nzk_5bb98138-b0df-4528-836f-e94a83bc7c53"
      unitRef="usd">-13000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0yMTU4Nzk_a60f7c6a-5d24-47a4-8d1a-1a27fce3fc17"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMjE1ODc5_08b397fe-9630-498c-bf7f-d3f99826fbd5"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1bb614bb6595439091cb705f7444f43b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMjE1ODc5_911f62d9-d4cd-4346-b908-2573fc2d15c3"
      unitRef="usd">584000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMjE1ODc5_2cfed332-d5b5-479f-8755-594d3be9dc32"
      unitRef="usd">-7000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTgwMjA_a1391b3d-2c9e-46f4-8b1c-d9812678ae8b"
      unitRef="usd">165000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTgwMjY_7991bd24-e180-44dc-a633-a3daeb9b6ff3"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c44eb56471340c0b0549845ec48e95f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTgwMjg_6be2e05c-f7bb-42f8-a2ef-c6c208cc2537"
      unitRef="usd">1182000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTgwMzA_d230dfca-54fa-4039-8156-a330d15559d8"
      unitRef="usd">-79000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if1425120cc214e32ba4675730b4b6cc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTY4MTA_11f89c89-95ed-4341-bc4f-9c61c8d0d9d2"
      unitRef="usd">72000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE2ODEw_53189d5e-5a27-48d4-bc84-969d93a2d06a"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i29e1112374584215b2d716c9948e2cbb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE2ODEw_d9d0a7b7-6bd8-4020-b120-6a60d6fddb38"
      unitRef="usd">1157000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE2ODEw_f615ef82-8beb-458f-a02a-499b1ea29b53"
      unitRef="usd">-78000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id5f0db91831245a98d378841a723e8a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTU3NDc_a44ddf81-59a9-4215-bf25-072fcb8f9ac2"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTU3NDc_79a32970-78bb-45f8-899b-709b93f2e006"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i42d797e1487542f49ef9a8d6421d410d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTU3NDc_42fc173d-f963-45c1-9659-f340be6f2e41"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTU3NDc_bdf65515-1113-4146-91c4-c91153cc39c3"
      unitRef="usd">-14000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic568e0cfa6234853938bade8f38decad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTU3NDc_d6ff4b22-4850-4f31-a76e-67ed1cb58b77"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE1NzQ3_b579f8af-76e5-46bd-bf7b-4f5d0334dc8e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5802b471774f467b8b4ed57b33660afa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE1NzQ3_3b6c3af2-44a2-46af-9c21-9fc9b9297389"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE1NzQ3_ee3f10b3-e19f-4b41-b89d-bd461555067b"
      unitRef="usd">-18000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ec0fba4252a4678af79e56fbc82990b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xLTEtMS0xOTM5Mzc_2924d88a-dcbd-4094-b6e3-6e68aa19bfc0"
      unitRef="usd">2101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i3c615915438143509820de8d42395deb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0zLTEtMS0xOTM5Mzc_20cda705-546d-4e9e-98da-e6cfdde1a99d"
      unitRef="usd">37000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS01LTEtMS0xOTM5Mzc_39581b66-d494-4476-9276-13c7cd611d00"
      unitRef="usd">1467000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i3c615915438143509820de8d42395deb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS03LTEtMS0xOTM5Mzc_ada14523-08d9-48ea-8ba8-b476f332b8fd"
      unitRef="usd">-20000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9c8cfb2e34204828954f511d64e793e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS05LTEtMS0xOTM5Mzc_cb6dfdd9-131c-4d76-8d89-a979deb1f083"
      unitRef="usd">1564000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMS0xLTEtMTkzOTM3_384c5b0c-abce-43e0-aa0f-b4a917cddfc7"
      unitRef="usd">33000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4be2043674aa491d9adeb9750ff992df_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMy0xLTEtMTkzOTM3_c4a3e5ee-b23c-4996-9e51-1ae1be402755"
      unitRef="usd">1703000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xNS0xLTEtMTkzOTM3_8d3e47ae-e781-4354-bb07-8fc8f197014f"
      unitRef="usd">-19000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id4e61e9185bb4a9eb351c39c8c716d28_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMS0xLTEtMTkzOTM3_b22977fb-6e83-4f6f-9744-06544e9bc7dc"
      unitRef="usd">360000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMy0xLTEtMTkzOTM3_ac700fda-f457-41cc-aa24-1b2c01081304"
      unitRef="usd">9000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic9d38948aff744438294caa148a86cdd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNS0xLTEtMTkzOTM3_dcc868e5-045a-48f7-820d-16591841cc19"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNy0xLTEtMTkzOTM3_99a76022-dbaf-464f-9b43-c5b8f34e9b8e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7f582f93ce4e422da958adfc85f8013b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtOS0xLTEtMTkzOTM3_a780ef9f-a7fe-4dfe-9fed-ba29120e7297"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTEtMS0xLTE5MzkzNw_035bad6a-b16a-4495-bafc-7bce915daa97"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i155f9dbf83674147910134de5a163ed4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTMtMS0xLTE5MzkzNw_345dfd85-e6af-4161-9971-926116a2ca57"
      unitRef="usd">322000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTUtMS0xLTE5MzkzNw_28a56e57-f892-4e85-b928-4db7123ad406"
      unitRef="usd">-11000000</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MjI_2d17a847-9957-4207-bb1e-64c3b2b6afc2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non U.S. dollar borrowings gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4OTE_762b1132-b858-444b-88de-316b2c9b9b5c"
      unitRef="usd">-120000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4OTE_b5bafa8c-fa93-495c-9a08-64aab6ba784d"
      unitRef="usd">-16000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4OTE_f99c35dd-9b79-49dc-b669-05799a1ee2e0"
      unitRef="usd">-82000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4OTE_84809a07-6c28-47ab-8551-2a2687c71aef"
      unitRef="usd">-57000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4NjI_ed5b5ee4-023a-43f1-bf78-7ac196fc2678"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4NjI_450a3478-dfb4-4e55-8a9b-9556e4af22cd"
      unitRef="usd">-23000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4NjI_b131b895-3562-4b47-83c3-ddfcc8219d7e"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4NjI_bd9a119a-be8b-4fd8-9fdd-6b760d893734"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0xOTM5Mzc_5bd8428e-edc2-4265-ae46-46f2e5661985"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0xOTM5Mzc_f3056fb5-2444-4765-a263-6864bef143c9"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0xOTM5Mzc_f52a2393-0ecf-4af7-bbb0-78c08941efa8"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0xOTM5Mzc_7bea3298-e76a-4558-8989-44b4286ccc64"
      unitRef="usd">-11000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0xLTEtMS0xOTM5Mzc_888a4fe6-6456-4bfc-9e7a-55862efde31a"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0zLTEtMS0xOTM5Mzc_4186c7d0-d2cc-461c-b571-a7126cf46521"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0xLTEtMS0xOTM5Mzc_8f834b3f-9a7f-4e02-b986-36755c92ebb3"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0zLTEtMS0xOTM5Mzc_df67d63e-4090-48c1-9ce2-44ac166fbd60"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0xLTEtMS0xOTM5Mzc_61e40858-40b2-4721-b3a3-c5c9ab2a60b5"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0zLTEtMS0xOTM5Mzc_1082e0db-b4b4-4920-b3d2-77aebc667323"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0xLTEtMS0xOTM5Mzc_0cfafe7d-b1e3-4c61-adb2-b965e86c6625"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0zLTEtMS0xOTM5Mzc_7b9e2a26-2a62-4c1a-8d54-22eace023805"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMS0xLTEtMTkzOTM3_8e6a33ef-8543-41c2-b444-f8ea74dc1301"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMy0xLTEtMTkzOTM3_0c2ba29f-ce46-430c-a6bc-1df2265c55b3"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMS0xLTEtMjAyMTYy_413c9461-e51e-4676-b6d6-89b549042e5a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMy0xLTEtMjAyMTU1_ab39b861-7ee0-4580-b5ca-4dfd22ecd0de"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMS0xLTEtMjAyMTY5_2a4cae0f-836c-44d9-b612-0a5cab984673"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMy0xLTEtMjAyMTY5_43fca35b-9d9e-404f-ac1a-0b8c4ecbde8f"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDAw_c20716b2-7e1c-4f8c-a82a-16ad0c0e596b">FINANCING ARRANGEMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of Long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to principal value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Long-term debt was $34.5 billion as of March&#160;31, 2023 and $34.9 billion as of December&#160;31, 2022 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023, $1.6&#160;billion of debt matured and was repaid including $750&#160;million 2.750% Notes and $890&#160;million 3.250% Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS issued an aggregate principal amount of $6.0&#160;billion of debt, with maturity dates ranging from 2032 to 2062, with net proceeds of $5.9&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest. In addition, BMS purchased an aggregate principal amount of $5.2&#160;billion of certain of its debt securities for $5.8&#160;billion of cash in tender offers. In connection with this transaction, a $275&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments were $324 million and $377&#160;million for the three months ended March 31, 2023 and 2022, respectively, net of amounts related to interest rate swap contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, BMS had a five-year $5.0&#160;billion revolving credit facility expiring in January 2028, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. No borrowings were outstanding under the revolving credit facility as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMy_38f3c522-8422-4de8-ab52-a9f9fbed6bac">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTEtMS0xLTE5NzI4Ng_9ff512fb-e6b0-4ff9-8a97-63af97338104"
      unitRef="usd">155000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTMtMS0xLTE5NzI4Ng_70905f9b-01ea-49b3-a841-636f5366965e"
      unitRef="usd">176000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTEtMS0xLTE5NzI4Ng_77ce9fb1-68a0-4746-b772-b5c3548b7de7"
      unitRef="usd">2254000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTMtMS0xLTE5NzI4Ng_1a565440-54bf-4348-883a-6c65b923e9dc"
      unitRef="usd">3897000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTEtMS0xLTE5NzI4Ng_be34c68b-cba2-4aa1-a5e4-8c412c8dd3b4"
      unitRef="usd">343000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTMtMS0xLTE5NzI4Ng_8258c604-4eca-40e9-acfa-9a03a3d999d9"
      unitRef="usd">191000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTEtMS0xLTIxMzQ0Mw_573b9bfd-20ad-425d-948d-a91f5ad79c64"
      unitRef="usd">2752000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTMtMS0xLTIxMzQ0NQ_17c70c39-67df-4327-b155-385722b681a2"
      unitRef="usd">4264000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMz_c5e446a8-54f9-4e4b-870f-6a52c439b7e2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of Long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to principal value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTEtMS0xLTE5NzI4Ng_ecafce33-3fe3-4acd-8d60-565f58d1a66b"
      unitRef="usd">36622000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTMtMS0xLTE5NzI4Ng_1b9c71bd-4e37-4436-82c1-97a3c629d69b"
      unitRef="usd">38234000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="idb244ebbca7645918a749ff83a2caf20_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTEtMS0xLTE5NzI4Ng_2ae2fe25-9d29-4a52-9878-d82d99b08da2"
      unitRef="usd">-14000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id87dc345b8de442ea6f8dbbd65882071_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTMtMS0xLTE5NzI4Ng_4420da97-d0d8-4c54-9d72-0f6c1c92a4d1"
      unitRef="usd">-18000000</us-gaap:DerivativeLiabilities>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTEtMS0xLTE5NzI4Ng_168c1463-3859-4859-957d-02cf2ca46e63"
      unitRef="usd">92000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTMtMS0xLTE5NzI4Ng_955f1ebc-3c8d-4454-a289-7032560ad180"
      unitRef="usd">97000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTEtMS0xLTE5NzI4Ng_7199d3f6-2729-4984-b40f-262f90395285"
      unitRef="usd">278000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTMtMS0xLTE5NzI4Ng_ec2156f9-d178-4031-8fcd-9d152682fd9d"
      unitRef="usd">284000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTEtMS0xLTE5NzI4Ng_c4645046-fc13-4a21-95b5-4371ed205506"
      unitRef="usd">910000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTMtMS0xLTE5NzI4Ng_c961bcf0-ad96-41ed-a04d-796f128629ec"
      unitRef="usd">924000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTEtMS0xLTIxMzQzNQ_6f96b806-ab3e-4df7-9d81-4760640a2bdd"
      unitRef="usd">37332000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTMtMS0xLTIxMzQzNw_93be3a5a-c32d-421b-8a70-6fee90a07b1c"
      unitRef="usd">38953000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0xLTEtMS0xOTcyODY_22f19f66-7980-48c9-96a2-77eb6d9b62f4"
      unitRef="usd">2254000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0zLTEtMS0xOTcyODY_96f24540-5a46-4099-9ed0-d522646c6257"
      unitRef="usd">3897000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0xLTEtMS0xOTcyODY_77c5a862-01d2-41b3-adad-2972ee98f1b4"
      unitRef="usd">35078000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0zLTEtMS0xOTcyODY_1390673b-c49c-4c36-9cd4-7e16b43099b7"
      unitRef="usd">35056000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0xLTEtMS0yMTM0Mzk_6c5b3591-87c4-4fb6-8b65-36674795ac2d"
      unitRef="usd">37332000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0zLTEtMS0yMTM0NDE_550a2f4d-d1ab-4f2a-a4c1-177680b8a2b0"
      unitRef="usd">38953000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI3OTg5_009455f6-4b86-41e2-b6b6-e718135908d4"
      unitRef="usd">34500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MDA3_a113b7d6-c2bc-45b6-98bd-b6b3eb19c808"
      unitRef="usd">34900000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap-supplement:DebtInstrumentRepaidPrincipal
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTIy_90de8d68-9baa-49fb-a67c-1f96bc2e1dbc"
      unitRef="usd">1600000000</us-gaap-supplement:DebtInstrumentRepaidPrincipal>
    <us-gaap-supplement:DebtInstrumentRepaidPrincipal
      contextRef="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTA4_e73ecfae-e5ce-484b-aaa0-e791b1c7e08b"
      unitRef="usd">750000000</us-gaap-supplement:DebtInstrumentRepaidPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ieaa68541a773415fae251b23e344c1b9_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTM2_b18d30f8-3919-4c93-971b-54f94b26f880"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap-supplement:DebtInstrumentRepaidPrincipal
      contextRef="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTQ0_68248566-b566-45f8-9a86-c13c04b26d16"
      unitRef="usd">890000000</us-gaap-supplement:DebtInstrumentRepaidPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i525174948c6543dc8a99d3c14aab9da3_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTU4_04e979e1-3fb3-4218-b1bb-2cf018c543bd"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzU3_65f6cc24-776b-4e77-89b9-f74ad82d5a56"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzkw_80bd0c52-b982-4d04-8359-cbe0fa99e078"
      unitRef="usd">5900000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MzU4_386eb17a-71aa-4e77-9b1b-f30c0de60fd6"
      unitRef="usd">5200000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NDAw_a9050302-9e98-470b-8674-7a2ce71362bc"
      unitRef="usd">5800000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NTAw_fdacc9a5-f6cc-4879-ac2b-d31b4f801fe5"
      unitRef="usd">-275000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestPaidNet
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzYw_ac863602-d8e7-45be-a362-09dd7100f7e2"
      unitRef="usd">324000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzY4_7a05afa5-66d6-4e92-92b2-26da1543722a"
      unitRef="usd">377000000</us-gaap:InterestPaidNet>
    <us-gaap:LongTermDebtTerm
      contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDEz_2c9295f2-a98b-4275-bbc3-dc31fa1ea105">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMwMjQ4_f46da567-6a3e-4c3a-89a1-f0bd68ff7718"
      unitRef="usd">5000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bmy:LongTermDebtRenewalPeriod
      contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDIy_74552306-2018-45a1-951c-92de2624bbcf">P1Y</bmy:LongTermDebtRenewalPeriod>
    <us-gaap:LineOfCredit
      contextRef="idd5a938b770d4b608475507fe2c5a3b1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_512f90bb-f703-4eb2-9cbc-1b7fb34a6fe5"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i937b0f049dac419089d03f3d635323d2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_d52c9662-2d36-4226-bfee-a5b4847c7da2"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg1_991da68a-9924-4c08-b3ea-45ea93f09e78">RECEIVABLES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. receivables sold on a nonrecourse basis were $239 million and $423 million for the three months ended March 31, 2023 and 2022, respectively. Receivables from the three largest customers in the U.S. represented 69% and 66% of total trade receivables as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg3_23fc7245-6282-49c3-80a4-1c5843d3af4f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0xLTEtMS0xOTM5Mzc_bb24deac-444b-4bde-9e54-12168fa8aa46"
      unitRef="usd">8486000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0zLTEtMS0xOTM5Mzc_cc48251f-4dd4-4fa8-bbf9-807a1e9d89b5"
      unitRef="usd">8848000000</us-gaap:AccountsReceivableGrossCurrent>
    <bmy:CashDiscounts
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0xLTEtMS0xOTM5Mzc_05b1cd25-587f-43aa-95b5-c3bdbfe38112"
      unitRef="usd">609000000</bmy:CashDiscounts>
    <bmy:CashDiscounts
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0zLTEtMS0xOTM5Mzc_b568625b-af55-4fe5-8cf4-772152045037"
      unitRef="usd">675000000</bmy:CashDiscounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0xLTEtMS0xOTM5Mzc_239e6297-4012-41f0-badc-d73afbef142a"
      unitRef="usd">23000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0zLTEtMS0xOTM5Mzc_5c720070-1447-4ae6-a363-a9d0514559f0"
      unitRef="usd">22000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0xLTEtMS0xOTM5Mzc_0512c351-1d8f-4c2a-957f-a49942e0cacd"
      unitRef="usd">7854000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0zLTEtMS0xOTM5Mzc_377cd852-8310-4ba6-be3f-c7f326137ae3"
      unitRef="usd">8151000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivables
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0xLTEtMS0xOTM5Mzc_5352bc2d-4c63-4c60-9bbe-e48b1021b22c"
      unitRef="usd">2200000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0zLTEtMS0xOTM5Mzc_a2b4b758-de79-4d73-996f-2e3240ddd7d2"
      unitRef="usd">1735000000</us-gaap:OtherReceivables>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0xLTEtMS0xOTM5Mzc_4ef9f5c7-6161-4226-80be-df5839dc1919"
      unitRef="usd">10054000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0zLTEtMS0xOTM5Mzc_b8e2b6e2-34b3-4e28-935c-2120afb3ec24"
      unitRef="usd">9886000000</us-gaap:ReceivablesNetCurrent>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfODM_6abf10fc-bce2-4fd9-a3fe-e79c80bb9309"
      unitRef="usd">239000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfOTA_bc9ec4cb-56df-4c53-8f3c-9adf0ba29b21"
      unitRef="usd">423000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:NumberOfLargestPharmaceuticalWholesalers
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMTQ3_4d9c4e61-8d83-4dfb-8783-b4ae8aaefa35"
      unitRef="customer">3</bmy:NumberOfLargestPharmaceuticalWholesalers>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i6ed144f6904d4064a626d5562e3a0cf0_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjA2_c2b29729-f2ff-4514-9fb7-70896c7394d5"
      unitRef="number">0.69</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i2324127f89494362aa7de6e45d6fe141_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjEz_1919ad96-a837-410a-aad5-c4315e37c501"
      unitRef="number">0.66</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjI3_2f541914-6a6f-44d9-9d56-e4818180c6ee">INVENTORIES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value adjustments related to the Celgene acquisition were $32 million and $84 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjMx_9ae0a65e-9b5f-4405-a236-e4a71b8bd6a4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0xLTEtMS0xOTM5Mzc_c5efd024-c8f0-49c4-b92d-95cdd5e6869d"
      unitRef="usd">594000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0zLTEtMS0xOTM5Mzc_dad282a3-0bbd-4de6-a282-fa55739d6866"
      unitRef="usd">509000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0xLTEtMS0xOTM5Mzc_5bd0e03d-1635-4bf9-8e27-a76648990ce1"
      unitRef="usd">1940000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0zLTEtMS0xOTM5Mzc_c92c8677-405f-4727-9453-c2e4a3953654"
      unitRef="usd">1850000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0xLTEtMS0xOTM5Mzc_f389f7a2-ce5b-4e51-823b-6a64bbcbaa4f"
      unitRef="usd">594000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0zLTEtMS0xOTM5Mzc_a0e00d60-a77b-4851-8865-9654c721c098"
      unitRef="usd">464000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <bmy:Totalinventories
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0xLTEtMS0xOTM5Mzc_75f02ea4-36f7-4e14-8590-f4f113f5842d"
      unitRef="usd">3128000000</bmy:Totalinventories>
    <bmy:Totalinventories
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0zLTEtMS0xOTM5Mzc_8eba4083-c75c-4feb-b341-30ccdb989fdc"
      unitRef="usd">2823000000</bmy:Totalinventories>
    <us-gaap:InventoryNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895"
      unitRef="usd">2605000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc"
      unitRef="usd">2339000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0xLTEtMS0xOTM5Mzc_ec87456d-afd7-42bd-92d1-0672d00cbfeb"
      unitRef="usd">523000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0zLTEtMS0xOTM5Mzc_3cc608a6-0be6-41e9-88c7-cefc15d598c2"
      unitRef="usd">484000000</us-gaap:InventoryNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i24309b9bca4c40368e5159601708371e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfOTY_4bb6899e-a3c4-4597-b936-cf89a2cbbcc0"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i356526281a974299bee8ad28a8382769_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMTEy_09c507d3-34ea-4fda-ae67-f0e86833185d"
      unitRef="usd">84000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTU2_55b40378-977b-405c-b7c3-5cca00bf64e6">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $146 million and $145 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTQ2_3e3d320b-85f5-4fc7-974b-5189e38a3d8a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0xLTEtMS0xOTM5Mzc_fc8b4de0-40fa-44ea-acf8-2956457f57ae"
      unitRef="usd">162000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0zLTEtMS0xOTM5Mzc_dfce43dc-a85a-4755-9459-d005f87dfbe6"
      unitRef="usd">162000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0xLTEtMS0xOTM5Mzc_41fdef9f-b203-4e47-a56e-38293e9a011e"
      unitRef="usd">5990000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0zLTEtMS0xOTM5Mzc_bb9b8065-1615-441f-b579-f2e42a825093"
      unitRef="usd">5920000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0xLTEtMS0xOTM5Mzc_41fb85c3-ea3c-4da7-9e27-03411ba66179"
      unitRef="usd">3295000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0zLTEtMS0xOTM5Mzc_1fddb497-9767-407b-89a4-3ee9fb0990a3"
      unitRef="usd">3284000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0xLTEtMS0xOTM5Mzc_899380cd-ab33-4103-a4f3-df137c0dfbc0"
      unitRef="usd">1074000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0zLTEtMS0xOTM5Mzc_a6b70996-f341-4bd1-be35-b4616e8cb42c"
      unitRef="usd">1053000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0xLTEtMS0xOTM5Mzc_1239d928-6d25-409e-ae46-2ac3701b2c6b"
      unitRef="usd">10521000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0zLTEtMS0xOTM5Mzc_6d407b22-85ac-45cf-b27a-9aba70227c7f"
      unitRef="usd">10419000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0xLTEtMS0xOTM5Mzc_90f96a7e-cfb2-498d-be06-d82ab688bac4"
      unitRef="usd">4242000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0zLTEtMS0xOTM5Mzc_7b627ae7-3df2-4e29-bb5f-353750bc67d7"
      unitRef="usd">4164000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0xLTEtMS0xOTM5Mzc_97b098d6-9321-4721-aba5-a57fda052909"
      unitRef="usd">6279000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0zLTEtMS0xOTM5Mzc_9a0ccc4c-48c8-46f4-96da-0e0a3e6e690c"
      unitRef="usd">6255000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfNzM_f8d3c2e8-9135-42e2-b74f-d15f03db2113"
      unitRef="usd">146000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTA5OTUxMTYyNzk1Nw_06078aff-0cea-48c2-91f8-1c6ee9f8b484"
      unitRef="usd">145000000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxNg_860aeca3-d2fa-4933-bf5a-a256fa7577a6">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amounts in Goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful&#160;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:33pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other intangible assets, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of Other intangible assets was $2.3 billion and $2.5 billion for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPRD impairment charges were $20&#160;million in the first quarter of 2023 and $40&#160;million in the first quarter of 2022 and were included in Research and development expense. The charges represented full write-downs.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxMw_de2cf382-7e84-4bf7-8e70-3fa8fed08a99">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amounts in Goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMS0zLTEtMS0xOTM5Mzc_4f4482a2-f21a-4b16-98ea-68155a508c9a"
      unitRef="usd">21149000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMy0xLTEtMS0yMTM0NjM_b8bbfe65-3053-4d62-b68f-dc8fd08c0e9e"
      unitRef="usd">13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfNC0xLTEtMS0yMTM0NjM_fe6d69d2-c167-4502-87f1-a4247636ad41"
      unitRef="usd">21162000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODc5NjA5MzAyOTExMg_24324367-e60a-4f97-80cf-5cfaa101c963">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful&#160;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:33pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other intangible assets, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzkz_a47280a5-84ef-4957-bc8f-02242fdac0e1">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzk4_d9a9e199-ab6a-45f5-8523-a7402da428b3">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0zLTEtMS0yMTM0NzM_2ec59dc9-ad04-4f86-ad0a-17c6d19f8e66"
      unitRef="usd">400000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi01LTEtMS0yMTM0NzU_6feb02d9-e513-4a76-9d0b-1e298a45c0b0"
      unitRef="usd">136000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi03LTEtMS0yMTM0NzU_e5b6fcdc-ddd6-4988-8e84-f824d8b6f291"
      unitRef="usd">264000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi05LTEtMS0yMTM0NzU_21be85c2-4f68-497f-81ed-1f5a6b789546"
      unitRef="usd">400000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMS0xLTEtMjEzNDc1_7066f657-4223-4997-9e14-2631972e43a9"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMy0xLTEtMjEzNDc1_2b63a034-0325-48f8-94c7-fd26e867fabe"
      unitRef="usd">272000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzkz_bbfadbe3-be95-4193-8958-b13a92684c6f">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzk4_2e107ad1-cdb7-4c18-bd32-50b178c2d714">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0zLTEtMS0yMTM0NzM_e64fee5a-7816-445b-82a1-3526c53b8bbd"
      unitRef="usd">59576000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy01LTEtMS0yMTM0NzU_a6d314f5-a3b3-42f6-8149-5b6c2804f40d"
      unitRef="usd">33297000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy03LTEtMS0yMTM0NzU_6d0a7187-8b9f-40d3-ab22-69854f295f3e"
      unitRef="usd">26279000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idb63487db81d44389500ff3f59b06f62_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy05LTEtMS0yMTM0NzU_3ca8c3fb-c066-408b-80c5-027cf939e80f"
      unitRef="usd">60477000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idb63487db81d44389500ff3f59b06f62_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMS0xLTEtMjEzNDc1_6d95a518-d90d-46e1-ad0a-d39ebded7d92"
      unitRef="usd">31949000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="idb63487db81d44389500ff3f59b06f62_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMy0xLTEtMjEzNDc1_9d71edca-b46a-4269-b6d2-fa2c9c93a7c0"
      unitRef="usd">28528000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic79428ebec0f445285e266d25006a85a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzkz_8fc925b3-6541-4ab3-b103-adefff160cc9">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifbd254642fa845128c263c3a56052a25_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzk4_807fc8dc-cfd9-4702-b25d-3bacebcc8a62">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i854b50008d0b47298b884695f1fe2849_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0zLTEtMS0yMTM0NzM_429787c0-b3f2-4070-9dca-a0aea23ab979"
      unitRef="usd">1583000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i854b50008d0b47298b884695f1fe2849_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC01LTEtMS0yMTM0NzU_bebecea9-7e99-4629-86a7-fa5c1d78da56"
      unitRef="usd">1097000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i854b50008d0b47298b884695f1fe2849_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC03LTEtMS0yMTM0NzU_ec3aa19b-3b84-48a2-b239-5557009c5ecd"
      unitRef="usd">486000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC05LTEtMS0yMTM0NzU_4519e1b3-3c16-4a07-85c2-178ab4fcbb73"
      unitRef="usd">1555000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMS0xLTEtMjEzNDc1_a49312c2-21eb-41e2-a1ee-7cf2670ace43"
      unitRef="usd">1056000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMy0xLTEtMjEzNDc1_67abeb9b-cc52-46da-93c9-1a657a698748"
      unitRef="usd">499000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iee21a224006b4db88a4217127cb842f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0zLTEtMS0yMTM0NzM_cf03197b-074c-4f1f-ac34-4c37fb3002e2"
      unitRef="usd">6540000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iee21a224006b4db88a4217127cb842f4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS03LTEtMS0yMTM0NzU_b6f9c4a0-746a-41b6-9d16-0e1ce860e8dc"
      unitRef="usd">6540000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS05LTEtMS0yMTM0NzU_09ae2b08-cf50-46bb-b9c6-6537d7771430"
      unitRef="usd">6560000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xMy0xLTEtMjEzNDc1_ec65d3d7-0545-4deb-8def-4dc89c400e1e"
      unitRef="usd">6560000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0zLTEtMS0yMTM0NzM_65e39b0b-f37c-4bae-874c-b4988f24b70b"
      unitRef="usd">68099000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi01LTEtMS0yMTM0NzU_1ab72604-c7cb-42d7-bcf9-65ffc0cdedac"
      unitRef="usd">34530000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi03LTEtMS0yMTM0NzU_58de0f82-dcec-4fce-8448-ae72dd7e12a3"
      unitRef="usd">33569000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi05LTEtMS0yMTM0NzU_c14256d4-e5df-43a5-bf17-7b62bc3faa7a"
      unitRef="usd">68992000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMS0xLTEtMjEzNDc1_f96bf273-b776-48f7-b933-856a5503e757"
      unitRef="usd">33133000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMy0xLTEtMjEzNDc1_3916e5d3-0207-4409-8100-7045301934c2"
      unitRef="usd">35859000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMzY0_ee3a6463-520a-4361-8dcf-803a2bd8e84a"
      unitRef="usd">2300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMTA5OTUxMTYzMjc4MA_86c25e88-2a1a-4b1a-8054-5642c076c176"
      unitRef="usd">2500000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfOTM0NTg0ODg0NDI2Ng_3d3939d2-83ff-4573-b995-061befce44d8"
      unitRef="usd">20000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODEyNA_c3bf63c7-db81-4bb7-b2c7-fbe43694a018"
      unitRef="usd">40000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDg0_48e78a46-5214-4c0f-814b-a1b0662ba77c">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $210 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkz_5e9007ee-b35c-40e8-a90c-5db9486ff4df">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0xLTEtMS0xOTM5Mzc_7ec600c4-31b5-4ddc-840d-adffa39c481b"
      unitRef="usd">2846000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0zLTEtMS0xOTM5Mzc_eeb03c26-5bf2-4986-917d-f726c62d78bd"
      unitRef="usd">3547000000</us-gaap:PrepaidTaxes>
    <bmy:ResearchandDevelopment
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0xLTEtMS0xOTM5Mzc_671098c2-60f1-41e2-8904-d3ea1b19f9da"
      unitRef="usd">704000000</bmy:ResearchandDevelopment>
    <bmy:ResearchandDevelopment
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0zLTEtMS0xOTM5Mzc_0fff8b21-a03c-4f81-9670-b1b40e82fa36"
      unitRef="usd">579000000</bmy:ResearchandDevelopment>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0xLTEtMS0xOTM5Mzc_a651974a-6187-4933-9597-21185d23b91d"
      unitRef="usd">505000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0zLTEtMS0xOTM5Mzc_bf66a025-e548-4107-9560-0cddd2ea528e"
      unitRef="usd">504000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:RestrictedCash
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0xLTEtMS0xOTM5Mzc_7667c64a-fbd2-4720-89ab-e8d53e085e0e"
      unitRef="usd">53000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0zLTEtMS0xOTM5Mzc_2947a668-f96a-43d1-8071-6a407a13640e"
      unitRef="usd">148000000</us-gaap:RestrictedCash>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0xLTEtMS0xOTM5Mzc_ec791aa1-fe8b-4075-b415-b3dfd342a29c"
      unitRef="usd">1050000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0zLTEtMS0xOTM5Mzc_5a5477ed-3de7-419e-832b-7aa9d57acd45"
      unitRef="usd">1017000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0xLTEtMS0xOTM5Mzc_2064284a-43ca-415e-85e5-24d951a39fa0"
      unitRef="usd">5158000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0zLTEtMS0xOTM5Mzc_8523dd87-1a6e-4f47-8c02-7017501779ba"
      unitRef="usd">5795000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkx_71c7f04d-c161-4e4b-893c-93eb42c7f495">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $210 million.</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0xLTEtMS0xOTM5Mzc_7fba640a-e5bf-4f5b-95d3-a3b7fea17f17"
      unitRef="usd">2005000000</bmy:EquityInvestmentsNonCurrent>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0zLTEtMS0xOTM5Mzc_d84607e7-0fc9-4da2-b152-51e694a42bc2"
      unitRef="usd">2187000000</bmy:EquityInvestmentsNonCurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0xLTEtMS0xOTM5Mzc_c618fcf1-cee2-4e3a-9985-475bca72123e"
      unitRef="usd">523000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0zLTEtMS0xOTM5Mzc_df1a6339-01c0-421d-93cc-56278ddd7394"
      unitRef="usd">484000000</us-gaap:InventoryNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0xLTEtMS0xOTM5Mzc_60309d9a-35ce-4cf6-9885-fde6378f3efb"
      unitRef="usd">1326000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0zLTEtMS0xOTM5Mzc_0b2bb549-1a67-4f26-aa4f-4ae3a308c028"
      unitRef="usd">1220000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0xLTEtMS0xOTM5Mzc_0fcf6f47-2662-4ce8-8a8a-27a5e7ca0a80"
      unitRef="usd">299000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0zLTEtMS0xOTM5Mzc_99f05909-3dcd-4c89-9712-2385acf59cc5"
      unitRef="usd">285000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0xLTEtMS0xOTM5Mzc_bfa335ff-f972-491b-8448-ec6e9419b96a"
      unitRef="usd">485000000</bmy:ResearchAndDevelopmentNonCurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0zLTEtMS0xOTM5Mzc_2d92d022-811e-4e3b-a656-e4ec5ed92c37"
      unitRef="usd">496000000</bmy:ResearchAndDevelopmentNonCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0xLTEtMS0xOTM5Mzc_b8f35eb0-1fa6-4156-8d40-4cd2007209dc"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0zLTEtMS0xOTM5Mzc_499975d6-4c44-4229-9f9c-08a03ac3c6ab"
      unitRef="usd">54000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0xLTEtMS0xOTM5Mzc_78f9e47d-be29-4177-b781-f476dc0867de"
      unitRef="usd">230000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0zLTEtMS0xOTM5Mzc_9c6dab20-722f-4b71-acb1-40fdfd542b67"
      unitRef="usd">214000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0xLTEtMS0xOTM5Mzc_85d9079f-c809-4d83-9262-8fa1697b6674"
      unitRef="usd">4868000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0zLTEtMS0xOTM5Mzc_0ad94044-a5c6-4ef3-ac3e-f76d1d565fa6"
      unitRef="usd">4940000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfMTA2Mg_aa25c858-94a5-42c4-a907-3141f9369245"
      unitRef="usd">210000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDgz_a79a2a22-020b-402d-85bb-3f134f76692e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <bmy:AccruedRebatesAndReturns
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0xLTEtMS0xOTM5Mzc_9e953b00-84af-4346-abdf-0316260a610d"
      unitRef="usd">5824000000</bmy:AccruedRebatesAndReturns>
    <bmy:AccruedRebatesAndReturns
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0zLTEtMS0xOTM5Mzc_64bb695c-3161-46c4-9b3e-8e1118d494f6"
      unitRef="usd">6702000000</bmy:AccruedRebatesAndReturns>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0xLTEtMS0xOTM5Mzc_838f7c7e-6678-4306-a568-44c5e23e3289"
      unitRef="usd">1209000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0zLTEtMS0xOTM5Mzc_8a6fc97e-b8ae-48b0-afc0-0c989d8d6388"
      unitRef="usd">942000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0xLTEtMS0xOTM5Mzc_fe398b17-c25d-4aa3-9676-2bb0319bc2f7"
      unitRef="usd">589000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0zLTEtMS0xOTM5Mzc_43b345a4-8c7d-477d-86eb-b86a93329812"
      unitRef="usd">1425000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0xLTEtMS0xOTM5Mzc_d204b6f9-1f1b-4089-a713-391cbffcc3a2"
      unitRef="usd">1277000000</bmy:AccruedResearchAndDevelopment>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0zLTEtMS0xOTM5Mzc_9875ce3b-c47d-4a6d-9031-e84ed39285b0"
      unitRef="usd">1359000000</bmy:AccruedResearchAndDevelopment>
    <us-gaap:DividendsPayableCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0xLTEtMS0xOTM5Mzc_f8d5202d-75da-4733-9459-b1676cf936d3"
      unitRef="usd">1197000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0zLTEtMS0xOTM5Mzc_656d5f53-4364-4553-82be-8a35d4d28631"
      unitRef="usd">1196000000</us-gaap:DividendsPayableCurrent>
    <bmy:AccruedInterest
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0xLTEtMS0xOTM5Mzc_e487b575-29fc-412a-9063-c4e23bc57f42"
      unitRef="usd">319000000</bmy:AccruedInterest>
    <bmy:AccruedInterest
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0zLTEtMS0xOTM5Mzc_42a10d8a-abcb-4370-8455-c5524f11cde4"
      unitRef="usd">321000000</bmy:AccruedInterest>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0xLTEtMS0xOTM5Mzc_1dce747d-7986-4025-baa5-7228f2301c06"
      unitRef="usd">409000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0zLTEtMS0xOTM5Mzc_2ddf9ef0-7861-4001-95d9-b2617e44d305"
      unitRef="usd">431000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0xLTEtMS0xOTM5Mzc_f0dcf9de-09c4-4d25-9618-41c2d7e6c4f5"
      unitRef="usd">171000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0zLTEtMS0xOTM5Mzc_e3689b31-dde7-4c58-bec7-1f697a2c0e36"
      unitRef="usd">136000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMS0xLTEtMTkzOTM3_6ee68764-1118-4a91-a4d8-56f6a71f3523"
      unitRef="usd">2144000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMy0xLTEtMTkzOTM3_7ff9c46d-1229-4320-90c6-900c2566ec6a"
      unitRef="usd">2074000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMS0xLTEtMTkzOTM3_ee5a5cc7-fa2b-4ab2-b7b4-56cf7d0bd8d2"
      unitRef="usd">13139000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMy0xLTEtMTkzOTM3_cc0c2491-47b1-4f6c-b00d-bd841eccd538"
      unitRef="usd">14586000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDky_37cadca9-2a2b-4b56-84ab-d6332db3b748">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0xLTEtMS0xOTM5Mzc_a63a97ba-7813-4270-9743-a81ac5863a6e"
      unitRef="usd">3907000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0zLTEtMS0xOTM5Mzc_0228e5bc-b78f-4931-bd7f-db4a065b319a"
      unitRef="usd">3992000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0xLTEtMS0xOTM5Mzc_760f94c4-0578-4d34-8e18-c6f8ad96589a"
      unitRef="usd">399000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0zLTEtMS0xOTM5Mzc_6e9635da-8f3a-4e34-8c9a-bb3b83d356ec"
      unitRef="usd">402000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0xLTEtMS0xOTM5Mzc_7d9f5030-0a3a-4784-9fac-00b120ea0889"
      unitRef="usd">1370000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0zLTEtMS0xOTM5Mzc_20c9d53c-3a00-4edf-94a8-4facd536fce7"
      unitRef="usd">1261000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0xLTEtMS0xOTM5Mzc_fa89fe61-c425-42cc-8639-3ec99fb68b7b"
      unitRef="usd">308000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0zLTEtMS0xOTM5Mzc_0401d0cd-27bb-4d32-b315-42086cc270eb"
      unitRef="usd">283000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0xLTEtMS0xOTM5Mzc_681fdfd6-d2dc-4848-ad2c-0a5082ae247b"
      unitRef="usd">387000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0zLTEtMS0xOTM5Mzc_b7686451-eeb8-4607-bda6-a742a26718aa"
      unitRef="usd">349000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0xLTEtMS0xOTM5Mzc_2ae00dbf-a91b-4d0c-8bc4-4c0ff84e8e24"
      unitRef="usd">293000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0zLTEtMS0xOTM5Mzc_e3bc276e-bf0d-4d48-b587-1b8d53ef3afc"
      unitRef="usd">303000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0xLTEtMS0xOTM5Mzc_dcff01b2-e599-42f2-9911-93ce5f23932a"
      unitRef="usd">6664000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0zLTEtMS0xOTM5Mzc_57e5f12f-3d57-4eb4-8269-7536dfb64ea3"
      unitRef="usd">6590000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY1MA_eed9afeb-72b3-4f69-aacf-2a927455e6f9">EQUITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and shares in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared $0.57 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and shares in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared $0.54 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS repurchased 3.7&#160;million shares of its common stock for $250&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the BMS share repurchase program was approximately $6.9&#160;billion as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $5.0&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand and 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in Other comprehensive income by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to "&#x2014;Note 9. Financial Instruments and Fair Value Measurements" for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Foreign currency translation are net investment hedge gains of $118&#160;million and $125&#160;million as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3Mw_5213d670-ff6c-4f23-aa29-411563443d13">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and shares in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared $0.57 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and shares in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared $0.54 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesIssued
      contextRef="iaacb967952a84c929370c1cb0330584a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xLTEtMS0xOTM5Mzc_f374cdd4-25cc-401f-bf5f-cd7ef941560a"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iaacb967952a84c929370c1cb0330584a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0zLTEtMS0xOTM5Mzc_805d6b35-2365-4efa-9950-67fb46d2fbae"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi01LTEtMS0xOTM5Mzc_8f610b8c-49d5-42ad-8022-f295f2176490"
      unitRef="usd">45165000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e3fe6d813fb473a96593961f0613f55_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi03LTEtMS0xOTM5Mzc_1f8fb9fc-cfca-4737-a2e1-0166ce5e1f13"
      unitRef="usd">-1281000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07ad784c18b14feaa7917cf92952a3bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi05LTEtMS0xOTM5Mzc_9e51d5d3-6b7d-4626-a848-2def8a87b8ef"
      unitRef="usd">25503000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4908dc165f094814bdc03777b63fb228_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMS0xLTEtMTkzOTM3_3b9cd25e-dffa-4469-884b-518a1eabc826"
      unitRef="shares">825000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i4908dc165f094814bdc03777b63fb228_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMy0xLTEtMTkzOTM3_94b6fb3b-f08a-404a-9d60-f9a4edc35057"
      unitRef="usd">-38618000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i348f12df9a624cae9f58f9b3c31d39ed_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xNS0xLTEtMTkzOTM3_e54f1bc6-a2f5-4808-8425-de62d33344e0"
      unitRef="usd">57000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy05LTEtMS0xOTM5Mzc_6998f663-4daf-4af2-82c0-a803bcfb597f"
      unitRef="usd">2262000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy0xNS0xLTEtMTkzOTM3_fe112449-d538-4459-a092-57a32d7932e5"
      unitRef="usd">5000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNC03LTEtMS0xOTM5Mzc_5acd1a0e-3126-4583-89e5-5b0bd20f6f8b"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS0wLTEtMS0yMTYxNjYvdGV4dHJlZ2lvbjo5YmNmNDlmYmFhMjU0MGU2ODViNDAyMGNkMDIwMDI0Zl8xNjQ5MjY3NDQxNzI0_766000fe-0fc2-4783-b008-234303ef1c13"
      unitRef="usdPerShare">0.57</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS05LTEtMS0xOTM5Mzc_4c2406d8-3d80-48ed-bcd0-6c502b01d73d"
      unitRef="usd">1197000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMS0xLTEtMTkzOTM3_f0872950-e296-4cb0-8872-2c7d8f827e27"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMy0xLTEtMTkzOTM3_226515cf-bda1-42e8-b79a-4eb9883a0725"
      unitRef="usd">250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy01LTEtMS0xOTM5Mzc_2b8e402f-692f-41e1-9df7-36e7de8a8c79"
      unitRef="usd">-25000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMS0xLTEtMTkzOTM3_801548f0-74ae-42d4-a924-aa2d242f2a61"
      unitRef="shares">6000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMy0xLTEtMTkzOTM3_ff78f8a1-a2ad-439c-a27e-1c90ba2f224d"
      unitRef="usd">60000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xLTEtMS0xOTM5Mzc_7364dfa8-9cda-4ea1-971b-58af0c516a62"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0zLTEtMS0xOTM5Mzc_484b0012-38e8-41c7-96fd-877f4ebc3656"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS01LTEtMS0xOTM5Mzc_764da0e9-e8d9-4d89-b4cf-6a3355fc0865"
      unitRef="usd">45140000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS03LTEtMS0xOTM5Mzc_3954f2be-4c13-45f4-baeb-2461b1667eac"
      unitRef="usd">-1368000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d4801a688a148d1bbef6616d73a97b9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS05LTEtMS0xOTM5Mzc_e24f37ff-8406-4489-b18a-ec642ec3209d"
      unitRef="usd">26568000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMS0xLTEtMTkzOTM3_4c1b65ee-53e3-454d-a4aa-88b049932677"
      unitRef="shares">823000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMy0xLTEtMTkzOTM3_f7ac40b6-f4ff-47d4-88c9-9fe8093a652e"
      unitRef="usd">-38808000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4792b9bd5d914473a84cba87ee6517b9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xNS0xLTEtMTkzOTM3_0305bc56-ef03-4f9f-a7e2-88518b442c63"
      unitRef="usd">62000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xLTEtMS0xOTM5Mzc_5603db5a-75c8-4755-aa87-9b0e3d5cbd18"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0zLTEtMS0xOTM5Mzc_f5adacb8-5f87-4684-aa0d-0936e23436a1"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icd8e035725b3442db86565959545c35a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi01LTEtMS0xOTM5Mzc_281b03fa-3cb5-42df-b440-3ad5a0762e40"
      unitRef="usd">44361000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie716e8002a604614bf64186acced27ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi03LTEtMS0xOTM5Mzc_7a832b2d-8066-4544-b9cc-270c7cd5d842"
      unitRef="usd">-1268000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic73d338c52b542ddae2377e527c62f2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi05LTEtMS0xOTM5Mzc_0487a997-850a-4c09-ae85-b8d166ab4f85"
      unitRef="usd">23820000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMS0xLTEtMTkzOTM3_e563ddcb-82b5-4ad2-a1a2-0cb3712f1767"
      unitRef="shares">747000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMy0xLTEtMTkzOTM3_882d625b-a705-48f3-9433-a8dd3efbccfd"
      unitRef="usd">-31259000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib68d187be7b0471c86033eada0951b2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xNS0xLTEtMTkzOTM3_41569577-1e91-466b-8372-6b9a8c895df9"
      unitRef="usd">60000000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy05LTEtMS0xOTM5Mzc_7778ee7f-b2ea-4d55-82e3-3a6aaecba379"
      unitRef="usd">1278000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy0xNS0xLTEtMTkzOTM3_94d3c107-bb29-4486-ac31-8282edaad019"
      unitRef="usd">5000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1eb982410931493f88491ecf96248f25_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNC03LTEtMS0xOTM5Mzc_d1f24432-941b-4550-b4ff-44c78bdf1ee2"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS0wLTEtMS0yMTc2NzEvdGV4dHJlZ2lvbjoxYzgzMTRkYjVjMjU0ODg3YTlhMzE2OWRlODEwZTcyZV8xNjQ5MjY3NDQxNzI0_ba778cd7-4837-4bab-84bb-69159086acd5"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS05LTEtMS0xOTM5Mzc_3752643c-22ad-4ec1-8cf1-c618d35abba0"
      unitRef="usd">1150000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi01LTEtMS0xOTM5Mzc_2754dc36-d41b-43a2-835c-1f26dbbf5545"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMS0xLTEtMTkzOTM3_b739392e-c49d-4bbf-8a39-4b0c883c7a86"
      unitRef="shares">65000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMy0xLTEtMTkzOTM3_29041630-bae9-4df9-befd-7ed7cc657ba6"
      unitRef="usd">4250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy01LTEtMS0xOTM5Mzc_9e435132-a0c2-4be0-8363-711f93475d90"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMS0xLTEtMTkzOTM3_50fadc78-02cc-4d4b-b6c2-3f13fc3c140a"
      unitRef="shares">18000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMy0xLTEtMTkzOTM3_77aed5ef-545a-4dc5-8217-1037c75efc67"
      unitRef="usd">322000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xLTEtMS0xOTM5Mzc_3152bfcc-fb3b-49ac-a8dc-2cb53df41e02"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0zLTEtMS0xOTM5Mzc_561f8a3b-dafe-457e-967f-7b59b9f165f9"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6b9651239b0491abf8341b486a23dc1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS01LTEtMS0xOTM5Mzc_e1edd3e8-c928-48fb-9947-2a84424fc304"
      unitRef="usd">43756000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d753b05e49247a7998fcd56ba7831aa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS03LTEtMS0xOTM5Mzc_a55d68d6-307b-41a2-ba77-8e32671bdccd"
      unitRef="usd">-1229000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3207d415b9154ca9b0988b77bdf66bf8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS05LTEtMS0xOTM5Mzc_b0e5f669-6b02-490e-8895-46f511563463"
      unitRef="usd">23948000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic21692a74de649678999f109fd39cfab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMS0xLTEtMTkzOTM3_beee47b4-f442-4d75-a29b-e8202648f6fc"
      unitRef="shares">794000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ic21692a74de649678999f109fd39cfab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMy0xLTEtMTkzOTM3_d5bb5e15-07eb-4fb1-b682-dba19314a1f1"
      unitRef="usd">-35187000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xNS0xLTEtMTkzOTM3_5611a8c4-f0f0-4aa1-a37e-1a761bf6670c"
      unitRef="usd">65000000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE0OQ_d902cacd-074e-4b88-8572-65f5e9f6826b"
      unitRef="shares">3700000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE4Mw_ad2607c9-bac1-419e-b4cc-36c12f1f0979"
      unitRef="usd">250000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNDk4OQ_9d4587e2-a7ce-427d-b168-ddf6252af3ed"
      unitRef="usd">6900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i597908d9a603482f9546e5ee2009c406_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA1Mg_fe93f996-001a-4336-b6de-7de61384a260"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTE3OQ_2d0acc05-c3f9-4709-9b75-5388c50975a8"
      unitRef="shares">65000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i597908d9a603482f9546e5ee2009c406_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTIxNw_c83e04f5-6a52-49d0-8454-e27ce17e97c5"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY2OQ_90810fea-7f11-4ebb-8b66-e5c49197c957">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in Other comprehensive income by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold and Other (income)/expense, net. Refer to "&#x2014;Note 9. Financial Instruments and Fair Value Measurements" for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xLTEtMS0xOTM5Mzc_abdebf3f-fa3f-41e9-a561-cd030a1866b0"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0zLTEtMS0xOTM5Mzc_137035df-d4cc-4f6f-b85c-72a52f13ca5e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC01LTEtMS0xOTM5Mzc_28856ab7-3084-4573-91ac-e62a9a0a9f22"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC03LTEtMS0xOTM5Mzc_2d8479db-3990-46aa-b006-c8f1e444810d"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC05LTEtMS0xOTM5Mzc_b772ac88-064c-47e0-a99d-934ca31571b9"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xMS0xLTEtMTkzOTM3_ed586a0c-7eba-4d4a-a696-51c23b9e35fe"
      unitRef="usd">104000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xLTEtMS0xOTM5Mzc_6e4323c6-4dd6-49ea-a636-89e987079654"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0zLTEtMS0xOTM5Mzc_13a14737-f25a-42e0-8895-e414cd6f541b"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS01LTEtMS0xOTM5Mzc_94862b5c-da42-4f21-964f-2708ad96d17e"
      unitRef="usd">114000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS03LTEtMS0xOTM5Mzc_7992bfd1-797f-4c71-b11b-43b19bc771ce"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS05LTEtMS0xOTM5Mzc_4c3a62b2-caee-416b-ad9b-3b1e55c10df5"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xMS0xLTEtMTkzOTM3_8609a6d1-7f58-499c-9b86-fdaa0ebfde53"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xLTEtMS0xOTM5Mzc_8f0d2ea4-be27-4608-af45-4ff21e181527"
      unitRef="usd">-146000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0zLTEtMS0xOTM5Mzc_fd36e482-2169-458d-9e21-4e19682b3203"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi01LTEtMS0xOTM5Mzc_fab69e1d-2e5e-4521-b48d-eee57b490194"
      unitRef="usd">-124000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi03LTEtMS0xOTM5Mzc_fa558e81-079f-4b3a-8649-1bebfcb662d3"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi05LTEtMS0xOTM5Mzc_84864cd7-8fdc-445e-b615-a1aa52c43513"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xMS0xLTEtMTkzOTM3_8f6cd966-1a1a-47c3-85f9-093a374d771a"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xLTEtMS0xOTM5Mzc_b4ed0393-27bd-44da-ba74-f18baf0bd042"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0zLTEtMS0xOTM5Mzc_91ecb6db-78fb-46ee-9387-5d2da0f02ebb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS01LTEtMS0xOTM5Mzc_27341f28-4cdb-428b-9ee1-6872d1d42b13"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS03LTEtMS0xOTM5Mzc_d7a299d2-c3d6-4021-b06e-f1ffb425d01a"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS05LTEtMS0xOTM5Mzc_69f7e3f5-a7ab-4345-9745-350bf5d4a603"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xMS0xLTEtMTkzOTM3_dd0e8972-b2b7-44cb-b156-8bb10a658884"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMS0xLTEtMTkzOTM3_9c8a92f8-64e4-4b8e-9038-b7c307e4176b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMy0xLTEtMTkzOTM3_7a05bfc6-8626-42d2-aa06-1579316f9b49"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNS0xLTEtMTkzOTM3_4c1560c8-3318-4c6d-9fc6-012b943a03a5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNy0xLTEtMTkzOTM3_fa4e1494-cb36-453d-8e97-ad46e9a8818d"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtOS0xLTEtMTkzOTM3_6db717e2-bb18-4cc6-8392-f97d659636d7"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMTEtMS0xLTE5MzkzNw_c2af871c-b8af-4896-bb0b-81616dacd36f"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMS0xLTEtMTkzOTM3_05d422e3-f856-49b5-9c65-3ffe0bf3d60e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMy0xLTEtMTkzOTM3_e48607e7-f416-4c88-b72d-a0ba76342005"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNS0xLTEtMTkzOTM3_83d004bc-7b4b-4731-9d2f-5fa141d6e536"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNy0xLTEtMTkzOTM3_a9d8887f-bd46-4706-8463-99d09b07e406"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtOS0xLTEtMTkzOTM3_0c9cae2d-ebce-429a-8d7a-6cf82a4e86e4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMTEtMS0xLTE5MzkzNw_f6df1ae7-6c09-44ba-a1d0-3c5a07fa023d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMS0xLTEtMTkzOTM3_69b3040c-9626-41c0-86dd-ed6094df28e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMy0xLTEtMTkzOTM3_51e07a26-5250-4b81-a28d-88dca3882bac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNS0xLTEtMTkzOTM3_15769c23-c2e8-49e5-a692-5583907b7e56"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNy0xLTEtMTkzOTM3_e0e471d6-cdf6-4767-b962-842ba8d7e518"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItOS0xLTEtMTkzOTM3_3c7ab37a-c3cd-4056-a810-589e9ba32bef"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMTEtMS0xLTE5MzkzNw_b106473e-01d8-4ea7-9a85-a1e47eb67449"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMS0xLTEtMTkzOTM3_d427175e-a2f2-4049-8a60-554e7d5e8276"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMy0xLTEtMTkzOTM3_b3de8b8d-e59e-4c45-b520-1f824838997e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNS0xLTEtMTkzOTM3_3b27b969-448e-41cb-94bb-f73012196711"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNy0xLTEtMTkzOTM3_99f6dd64-2493-4a93-81de-4ec71d11c2bc"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtOS0xLTEtMTkzOTM3_f86fcba1-3463-41a1-a3f4-6e05a983c480"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMTEtMS0xLTE5MzkzNw_d5191b08-c6f1-400e-8551-b297a42b8e22"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMS0xLTEtMTkzOTM3_98a366d6-4a78-4e4b-89cd-ff4c9db79941"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMy0xLTEtMTkzOTM3_1d1890bb-2e7f-4405-aef5-3bb6276db08e"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNS0xLTEtMTkzOTM3_0bc114bb-9087-4fff-88ee-6a684fcc4a57"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNy0xLTEtMTkzOTM3_c3c6e4e5-cfa0-4fb2-89ca-a856d6313720"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctOS0xLTEtMTkzOTM3_a13b0426-bff0-444d-b6b1-6313be9f3ea5"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMTEtMS0xLTE5MzkzNw_2ee5f046-7b00-4161-9b85-c4a8879dd4a6"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMS0xLTEtMTkzOTM3_9dcfd0f2-b739-4150-a190-cf3219d907a5"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMy0xLTEtMTkzOTM3_314b459d-8d60-450c-83a7-3ccf6fe142e9"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNS0xLTEtMTkzOTM3_19ba9e2b-3d93-46e4-9961-255b8dceee56"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNy0xLTEtMTkzOTM3_f2500186-2a9c-43b6-a72c-f0ddef12d1b4"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktOS0xLTEtMTkzOTM3_64f7e841-8b5d-4b7b-885c-992ad2a5c3eb"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMTEtMS0xLTE5MzkzNw_152f0dab-4f3d-4ce8-9529-d24df7d5dbb9"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3NQ_7bd2d3bb-b953-43e5-820f-e0a4c672ab69">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Foreign currency translation are net investment hedge gains of $118&#160;million and $125&#160;million as of March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0xLTEtMS0xOTM5Mzc_4807a9f8-aa5a-49c6-9495-5ad0c1325229"
      unitRef="usd">108000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0zLTEtMS0xOTM5Mzc_9dc91eea-77bd-4597-b12b-a34f5fc8d890"
      unitRef="usd">232000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0xLTEtMS0xOTM5Mzc_170850c8-74bb-4b74-88bd-a21c0dda161c"
      unitRef="usd">623000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0zLTEtMS0xOTM5Mzc_a02eea21-e0ec-4ff7-95d0-86d17ec74186"
      unitRef="usd">623000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0xLTEtMS0xOTM5Mzc_2ff35837-dcd4-4440-9b05-53e89c56ae26"
      unitRef="usd">-853000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0zLTEtMS0xOTM5Mzc_1dab6432-cb74-45bf-a5c1-b2a80f5f9f5a"
      unitRef="usd">-890000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0xLTEtMS0xOTM5Mzc_0f5935a3-b179-45d7-88dd-1e30eb113cd5"
      unitRef="usd">-1368000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0zLTEtMS0xOTM5Mzc_9e655e78-68af-453a-bfb9-497eda46bf36"
      unitRef="usd">-1281000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjYxMw_c6a5457d-fb11-45d9-88d2-deac8b392255"
      unitRef="usd">118000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax
      contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjU5OQ_0be70f76-439b-4acb-bd29-b2e95dde0d55"
      unitRef="usd">125000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI0_8ceba4fb-7c40-494b-8df4-0bf264f8c69d">EMPLOYEE STOCK BENEFIT PLANS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $18 million and $40 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI1_bb3dce3a-18d3-4bbe-bffb-5b61cd6aa6ca">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $18 million and $40 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0xLTEtMS0xOTM5Mzc_07be8d1d-aa7e-4943-8efc-d73355430eea"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0zLTEtMS0xOTM5Mzc_99e55b19-ca84-40a3-9572-9b8e55f867fd"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0xLTEtMS0xOTM5Mzc_05133ac6-7b5b-4764-85a9-9d15b89faec9"
      unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0zLTEtMS0xOTM5Mzc_a710083c-9741-47c6-afd6-0dd56a68c6e8"
      unitRef="usd">48000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0xLTEtMS0xOTM5Mzc_195a60a3-e6e1-4ad0-bc05-cb1abe0755da"
      unitRef="usd">60000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0zLTEtMS0xOTM5Mzc_a138c5c0-42c0-431e-8c02-3b2f05bc68f3"
      unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0xLTEtMS0xOTM5Mzc_b7d8f767-7a62-4f8e-b69e-e389ca7702dc"
      unitRef="usd">122000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0zLTEtMS0xOTM5Mzc_df14df22-fbf9-4c13-ba78-1bf243d0cc55"
      unitRef="usd">107000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0xLTEtMS0xOTM5Mzc_d306a7ce-8668-486b-a6ec-ae2fd397d9e4"
      unitRef="usd">25000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0zLTEtMS0xOTM5Mzc_d61be646-161a-4b24-be7a-995521e28a5f"
      unitRef="usd">22000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjE3_44bf8ecb-3f52-4a4d-bdc2-2c21afbb1dee"
      unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjI0_49f68101-36e4-4ae2-83be-3264b7112a87"
      unitRef="usd">40000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI5_c1cab906-e002-4510-ad23-54f7ba081408">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0xLTEtMS0xOTM5Mzc_81b326f8-e3b6-4fbc-9180-40c2dd325a90"
      unitRef="shares">8400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0zLTEtMS0xOTM5Mzc_06920e24-7ee6-4eb0-aec0-21907092637c"
      unitRef="usdPerShare">60.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0xLTEtMS0xOTM5Mzc_9ef8641f-6284-47f0-bacd-f03ea85ae6a8"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0zLTEtMS0xOTM5Mzc_881b0ea3-d7c1-4821-905f-a8997e74db3c"
      unitRef="usdPerShare">58.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0xLTEtMS0xOTM5Mzc_a4a03a33-b38f-4ea8-a0f0-69e347e50d67"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0zLTEtMS0xOTM5Mzc_38f4a4f0-e009-4e44-b01d-3d90dba3b894"
      unitRef="usdPerShare">64.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDIz_980e3be9-3eb2-492a-b57c-99b3f4438215">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i90e84082105e45269a4ddf3f2b924403_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS0zLTEtMS0xOTM5Mzc_c5c9c007-345f-48f9-982c-b81012932fb6"
      unitRef="usd">1125000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS01LTEtMS0xOTM5Mzc_57a1c936-ad7f-4a29-ae20-55c0bc5915cb"
      unitRef="usd">93000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8c11a22415bf463a8cafb058afaacf34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS03LTEtMS0xOTM5Mzc_e3a14fe3-5e1e-4f2e-92d4-a2a413b9cc69"
      unitRef="usd">165000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi0zLTEtMS0xOTM5Mzc_c85ac1d0-f035-4dc8-8ef8-cb499856629c">P3Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi01LTEtMS0xOTM5Mzc_bf6b709d-bcd4-4fd7-90f4-d96c236be9c5">P3Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi03LTEtMS0xOTM5Mzc_d71cd79f-e8ee-49bd-ba87-249846764f4e">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMzgyNTA_0dc449ba-9a0e-43ed-979f-fb555889447c">LEGAL PROCEEDINGS AND CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, partners, suppliers, service providers, licensees, licensors, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial claims and/or defenses in the matters, the outcomes of BMS's legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS's financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS's patent rights would likely result in substantial decreases in the respective product revenues from generic competition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#x2019;s tax contingencies, see " &#x2014;Note 7. Income Taxes."&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-PD-1 and Anti-PD-L1 &#x2014; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, Dana-Farber Cancer Institute ("Dana-Farber") filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber's claims for damages before May 17, 2019&#x2014;the date of the District Court's ruling that Dana-Farber was a co-inventor of the patents&#x2014;are preempted by federal patent law. On January 25, 2023, the Court held a hearing on a motion filed by BMS requesting that the Court enter summary judgment in BMS' favor. In April 2023, BMS and Dana-Farber entered into a settlement agreement and these litigations were dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd (collectively, "AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024. On April 26, 2023, BMS filed an additional lawsuit against AZ in U.S. District Court for the District of Delaware alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes U.S. Patent No. 9,402,899.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CAR-T &#x2014; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, Juno and Sloan Kettering Institute for Cancer Research ("SKI") filed a complaint for patent infringement against Kite Pharma, Inc. ("Kite") in the U.S. District Court for the Central District of California. The complaint alleged that Kite's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product infringes certain claims of U.S. Patent No. 7,446,190 (the "'190 Patent") concerning CAR-T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the '190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite's defenses, finding that Kite willfully infringed the '190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585&#160;million upfront payment and a 27.6% running royalty on Kite's sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; through the expiration of the '190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite's motions in their entirety. In April 2020, the Court granted in part Juno's motion and entered a final judgment awarding to Juno and SKI approximately $1.2&#160;billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite's sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* from December 13, 2019 through the expiration of the '190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the '190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court, which the Court denied on November 7, 2022. On November 23, 2022, Juno and SKI filed a petition for rehearing with the Court, which the Court denied on January 9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CTLA-4 &#x2014; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 23, 2023, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca AB (collectively, "AZ AB") alleging that AZ AB's marketing of the CTLA-4 antibody Imjudo infringes certain claims of U.S. Patent Nos. 9,320,811 and 9,273,135. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020 and January 2021, Sandoz Limited ("Sandoz") and Teva Pharmaceutical Industries Ltd. ("Teva Limited"), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate ("SPC"). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgment issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. On November 2, 2022, BMS was granted permission from the Court of Appeal to appeal the judgment and a hearing took place on April 19-20, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and trials have been held in certain of those cases, including in Norway and France. In May 2022, a Dutch court issued a decision denying a request by BMS for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In April 2023, BMS again requested that a preliminary injunction be issued against Sandoz in the Netherlands. In addition, BMS requested that a preliminary injunction be issued against Stada in the Netherlands. On April 26, 2023, a combined preliminary injunction hearing was held.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the UK and the Netherlands, and may seek to market generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patents being filed in various countries in Europe. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, a trial was held in Sweden regarding Teva's challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision was issued on November 2, 2022, confirming their validity and rejecting Teva's claims. In September 2022, BMS filed a request for a preliminary injunction against Teva in Denmark, but the request was denied in December 2022, based on the finding that there is no imminent threat of a launch by Teva in Denmark. In January 2023, the court in Finland granted BMS's request that a preliminary injunction be entered against Teva, prohibiting Teva from offering, storing or selling generic Eliquis products in Finland that have obtained price and reimbursement. On February 17, 2023, the court in Ireland also granted BMS's request that a preliminary injunction be entered against Teva in Ireland.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 24, 2023 and March 4, 2023, BMS received Notice Letters from Biocon and ScieGen, respectively, notifying BMS that they had filed ANDAs containing paragraph IV certifications seeking approval of generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, in April 2023, BMS filed patent infringement actions against Biocon and ScieGen in the U.S. District Court for the District of Delaware. On April 25, 2023, BMS entered into a confidential settlement agreement with ScieGen, settling all outstanding claims in the litigation with ScieGen. The settlement with ScieGen does not affect BMS's projected exclusivity period for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification seeking approval of a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and challenging U.S. Patent No. 8,846,628 (the "'628 Patent"), an FDA Orange Book-listed formulation patent covering &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expires in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024. In February 2023, Apotex Inc. filed a request for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review of the '628 Patent. BMS's response to the request is due on May 15, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, BMS received an additional Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification challenging U.S. Patent No. 11,571,436 (the "'436 patent"), a newly-listed FDA Orange-Book formulation patent covering &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expires in 2029. In response, BMS filed an additional patent infringement action against Accord in the U.S. District Court for the District of Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Australia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi was notified that, in August 2007, GenRx Proprietary Limited ("GenRx") obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex ("GenRx-Apotex"). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi's Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi's injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia ("Full Court") appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449&#160;million AUD ($301&#160;million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government's claim for damages. In May 2020, the Australian government appealed the Federal Court's decision and an appeal hearing concluded in February 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray"), Nanocopoeia, LLC ("Nanocopoeia") and Handa Oncology, LLC ("Handa"), respectively, notifying BMS that each had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. In May 2022, BMS filed a patent infringement action against Nanocopoeia in the U.S. District Court for the District of Minnesota. In November 2022, BMS filed a patent infringement action against Handa in the U.S. District Court for the Northern District of California. No trial dates have been scheduled in any of these actions. Both Xspray and Nanocopoeia filed motions for a judgment based on the pleadings. On March 24, 2023, the Minnesota court denied Nanocopoeia's motion. On April 25, 2023, the New Jersey court denied Xspray's motion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC ("Actelion") filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the "'867 Patent"). The Complaint alleges that the sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infringes certain claims of the '867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; State Attorneys General Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain Sanofi entities are defendants in a consumer protection action brought by the attorney general of Hawaii relating to the labeling, sales and/or promotion of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*. In February 2021, a Hawaii state court judge issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS appealed the decision. On March 15, 2023, the Hawaii Supreme Court issued its decision, reversing in part and affirming in part the trial court decision, vacating the penalty award and remanding the case for a new trial and penalty determination.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRODUCT LIABILITY LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and Otsuka are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs allege &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, the vast majority of cases have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and AstraZeneca are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza* &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco ("JCCP"). On September 24, 2021, the JCCP court granted defendants' motion to exclude plaintiffs' only general causation expert and on January 5, 2022, the MDL court likewise granted defendants' motion to exclude plaintiffs' expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. Plaintiffs have filed an appeal, on which a California Court of Appeal heard arguments on March 28, 2023. On April 19, 2023, the Court denied plaintiffs' appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL then moved to alter or amend the MDL court's order, and defendants opposed. On November 3, 2022, the MDL court denied plaintiffs motion to alter or amend its summary judgment order. Plaintiffs filed their Notice of Appeal on December 2, 2022. As part of BMS's global diabetes business divestiture, BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to AstraZeneca in February 2014 and any potential liability with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SECURITIES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Celgene Securities Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2018, &lt;/span&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;two&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the "Celgene Securities Class Action"). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene's 2020 outlook and projected sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Otezla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and (3) the new drug application for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff''s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In March 2023, the Court granted the defendants leave to file a motion for summary judgment in the Celgene Securities Class Action, with briefing expected to be completed in or around July 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the "Schwab Action"). In July 2020, the defendants filed a motion to dismiss the plaintiffs' complaint in full. In March 2021, the Court granted in part and denied in part defendants' motion to dismiss consistent with its decision in the Celgene Securities Class Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The California Public Employees' Retirement System in April 2021 (the "CalPERS Action"); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the "DFA Action" and the "American Century Action"), and GIC Private Limited in September 2021 (the "GIC Action"), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The Court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above Celgene Securities Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Value Rights Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement ("CVR Agreement") entered into in connection with the closing of BMS's acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use "diligent efforts" to obtain FDA approval of liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys' fees. BMS disputes the successor trustee's allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the Court denied BMS's motion to dismiss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 (the "Securities Act") and sections 10(b), 14(a) and 20(2) of the Exchange Act. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants moved to dismiss the complaint. On March 1, 2023, the Court entered an opinion and order granting defendants' motion and dismissed the complaint in its entirety. The claims under Sections 11, 12(a)(2), and 15 of the Securities Act and Section 14(a) of the Exchange Act were dismissed with prejudice. The claims under Sections 10(a) and 20(a) of the Exchange Act were dismissed with leave to file a further amended complaint which plaintiffs filed on April 14, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 19, 2022. Defendants have moved to stay the action pending resolution of the federal action or, in the alternative, to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene's former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 22, 2022. Defendants moved to stay the action pending resolution of the federal action and, in the alternative, to dismiss the complaint. On February 17, 2023, the Court granted defendants' motion to stay and declined to reach the merits of defendants' motion to dismiss. The Court deemed the action stayed pending resolution of the federal action, subject to plaintiff's right to seek to vacate the stay should changed circumstances warrant such relief, and filed a written order staying the case for 200 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above CVR Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OTHER LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for ANDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement, and who have since filed new suits advancing related theories. As described below, those suits, together with a suit by certain specialty pharmacies and a new putative class action suit, are pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, Humana Inc. ("Humana"), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana's complaint makes largely the same claims and allegations as were made in the now settled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. In May 2019, Celgene filed a motion to dismiss Humana's complaint. In April 2022, the Court issued an order denying Celgene's motion to dismiss. That order addressed only Celgene's argument that certain of Humana's claims were barred by the statute of limitations. The Court's order did not address Celgene's other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have filed a motion to dismiss Humana's amended complaint, which was fully briefed in November 2022. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United HealthCare Services, Inc. ("UHS"), Blue Cross Blue Shield Association ("BCBSA"), BCBSM Inc., Health Care Service Corporation ("HCSC"), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation ("Cigna"), Molina Healthcare, Inc. ("Molina") and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, "MSP")) filed lawsuits making largely the same claims and allegations as were made in the now settled class action litigation and in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Humana&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; opt-out action. Certain of the matters have made additional claims related to copay assistance for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These cases are now pending in the U.S. District Court for the District of New Jersey. Celgene and BMS's motion to dismiss the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Humana &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amended complaint applies to these other opt&#x2011;out actions as well, and these other opt&#x2011;out actions will proceed as described above with respect to that &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Humana &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;opt-out action. No trial dates have been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina's complaint makes largely the same claims and allegations as were made in the now settled class action litigation. In June 2022, the San Francisco Superior Court dismissed 63 of Molina&#x2019;s claims, which Molina later reasserted in the District of New Jersey as described above, and stayed the remaining 4 claims. No activity is expected in this case until disposition of the New Jersey actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain other entities that opted out of the now&#x2011;settled class action have also filed summonses related to two actions in the Philadelphia County Court of Common Pleas in connection with the allegations made by Humana and other opt&#x2011;out entities. Those actions have been placed in deferred status pending further developments in the above opt&#x2011;out cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, certain specialty pharmacies filed an action as direct purchasers against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The action makes largely the same claims and allegations against Celgene and BMS as were made with respect to Revlimid in the now settled class action litigation, and seek injunctive relief and damages under the Sherman Antitrust Act. Also in November 2022, a putative class of end-payor plaintiffs filed an action against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The class complaint brings claims based on Celgene's allegedly anticompetitive settlements of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patent litigation, seeking damages under state antitrust and consumer protection laws and injunctive relief under federal antitrust law. In March 2023, Celgene, BMS, and the generic defendants served consolidated motions to dismiss these two actions. No trial dates have been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana's complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey's Racketeer Influenced and Corrupt Organizations Act ("NJ RICO"). The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. Humana subsequently dismissed its claims for breach of contract voluntarily. A trial for this matter began on January 31, 2023. On January 25, 2023, the Court granted Celgene's summary judgment motion on Humana's claims for violations of NJ RICO and dismissed those claims. On March 2, 2023, following a multi-week trial, the jury returned a full defense verdict in Celgene's favor on Humana's claims of fraud and negligent misrepresentation. The parties are awaiting the judge's decision on the remaining equitable claim of unjust enrichment, which is to be decided by the judge pursuant to Kentucky law.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, Celgene filed suit against Humana Pharmacy, Inc. ("HPI"), a Humana subsidiary, in Delaware Superior Court. Celgene's complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI's breach as well as a declaratory judgment. On February 14, 2023, the Court granted summary judgment in favor of Celgene on its breach of contract claims. A trial limited to damages has been scheduled for July 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BeiGene Arbitration Matter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2017, Celgene Logistics S&#xe0;rl ("Celgene Logistics") and BeiGene, Ltd. (together with its assignees, "BeiGene"), entered into a License and Supply Agreement (the "LSA") pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vidaza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in China. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing and closing arguments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MSK Contract Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, "Plaintiffs") filed a complaint against BMS, Celgene and Juno (collectively, "Defendants"). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abecma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims, and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GOVERNMENT INVESTIGATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ENVIRONMENTAL PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS's current or former sites or at waste disposal or reprocessing facilities operated by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CERCLA and Other Remediation Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other "potentially responsible parties," and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $89&#160;million as of March&#160;31, 2023, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTM0MQ_2ba5d02b-ac9b-4343-9081-d0d70b87cde3"
      unitRef="patent">6</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:PaymentsForRoyalties
      contextRef="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI3MQ_3d01343a-d143-442d-bb78-a6f646287012"
      unitRef="usd">585000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i00f02f6049c84c88a97ca32784154910_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI5MQ_33a9b50b-5be0-430e-8776-07e14e890ffb"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:PaymentsForRoyalties
      contextRef="i19139b5b67d7410eac12e965d900e982_D20200401-20200430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMyNA_b0e9313c-7f00-4c91-a28a-57755bff0634"
      unitRef="usd">1200000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i489f54c5481c45389d5768b529b57a7c_I20200430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMwNA_56c8fd1f-8858-4d08-97d8-c4d1017a8c7f"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTIxOA_a12b5738-49bc-488c-a527-89416ee1add1"
      unitRef="aud">449000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI0NA_c533ff35-6f77-4dde-8141-2b7236ea5047"
      unitRef="usd">301000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE2NQ_af845f08-bb79-4c4b-aad2-92d37c9ede3d"
      unitRef="usd">834000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE5Mg_697125d6-a3fb-4292-96f3-a2ba2c4278f6"
      unitRef="usd">417000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA5OA_01d75a3c-d0d0-404f-bea2-ba90ec5ba988"
      unitRef="lawsuit">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberClassAction
      contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzMA_f834e7e5-b994-47fd-920a-4bcb4863ee92"
      unitRef="lawsuit">4</bmy:LossContingencyPendingClaimsNumberClassAction>
    <bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims
      contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzNw_8fa94b0d-5a52-4a94-93bb-5f5265ccce6d"
      unitRef="lawsuit">7</bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE0NQ_a1a7e47f-20b1-49d1-a35b-eb5a05804fb7"
      unitRef="lawsuit">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberActive
      contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE1MA_aa5a6b25-c01b-4229-9337-78010d76c3fd"
      unitRef="lawsuit">2</bmy:LossContingencyPendingClaimsNumberActive>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9b4fe50bec2c45748e74cea112ead142_I20220330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA4OA_36048054-5ea3-4ac1-9110-c04e31f509ef"
      unitRef="lawsuit">18</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:ContractualObligation
      contextRef="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA3MQ_809d0511-0097-45ae-a008-d6fee85e04a5"
      unitRef="usd">6400000000</us-gaap:ContractualObligation>
    <bmy:LossContingencyPendingClaimsNumberClassAction
      contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA0NA_770803c0-2d9c-420a-9590-8620c3337276"
      unitRef="claim">63</bmy:LossContingencyPendingClaimsNumberClassAction>
    <bmy:LossContingencyPendingClaimsNumberDismissed
      contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1MA_eedccef6-a63b-4a1a-a332-c22cae67ba6a"
      unitRef="claim">4</bmy:LossContingencyPendingClaimsNumberDismissed>
    <bmy:LossContingencyPendingClaimsNumberClassAction
      contextRef="if83448985121404b8a86bb8584503c4f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1Ng_13fe3b9b-4c9b-4e26-b028-2662a145d60d"
      unitRef="lawsuit">2</bmy:LossContingencyPendingClaimsNumberClassAction>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="ie45c0ee3f040490991410c1a6b57a08c_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAzNQ_1babb46b-344c-4629-8a10-e8b1027aa920"
      unitRef="number">0.015</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAxNw_488c8934-ba3e-4341-9132-c9d9e4d5c288"
      unitRef="usd">89000000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU1OA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU2MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUxNg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUyNA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzMg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU0Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ3NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMTY3MTI_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ4NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwMw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMjU2ODU_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTc_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcxMDM_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</dei:DocumentFiscalYearFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes amortization of acquired intangible assets</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MGJC L5P-1Y)F1#D^I;];^.=+\CB%T+;]L7D\IU99><ZPMKJ <VHX1PLWIUP
MN@4'1L,L$!QP&H<*QAM]F+_@WZK$2B?G#!FYGM?*2V'D^%"=EENGY6IYY!P^
M$Q&ENRL@JXE\N@,X#0$.Y6*)N& XKRLJ8K<# WT/M8@51D.[A]BKB3TM\2/A
M!+-@7W"&\F6)Z4%64J&"]+HC9B/8@E08(<]20_HUI*^%G 7?LHB1$-P^/"Y4
M9'ZG4]]M<75-;-M68PUKK*$>*Z%,1/_B0C/DRXQ?,:-4X'07;6(",.=$*%??
M4#%0;OLE51@YT%=CCVKLD1;[7NP) Q^C-* )^622%RG;G%R!E"AG?=1!^.Q
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M#BDKSSO*&T$/Q0G A@I!D^)R3W!(6&X@GV\I%:\W>0?UJ=/T/U!+ P04
M"  77YM62':*+N$#  !E#   &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;*U7;6_B.!#^*U9N==J5MLT;;^T!4J&L%NEX4>GN?3C=!Q,FQ&IBL[:!]M_?
M.*$I$)/=E?J%Q,[,XV=F/"]T]T(^J01 D^<LY:KG)%IO;EU710ED5%V+#7#\
M$@N948U+N7;51@)=Y4I9Z@:>UW(SRKC3[^9[<]GOBJU.&8>Y)&J;952^#" 5
M^Y[C.Z\;#VR=:+/A]KL;NH8%Z&^;N<256Z*L6 9<,<&)A+CGW/FW0S\T"KG$
M=P9[=?1.C"E+(9[,8KSJ.9YA!"E$VD!0?.Q@"&EJD)#'CP.H4YYI%(_?7]&_
MY,:C,4NJ8"C2?]A*)SVGXY 5Q'2;Z@>Q_PH'@YH&+Q*IRG_)OI!MMQP2;946
MV4$9&62,%T_Z?'#$D0+BV!6"@T)PKM"XH! >%'+/N06SW*Q[JFF_*\6>2".-
M:.8E]TVNC=8P;L*XT!*_,M33_>%LNIC]/;Z_>QS=D\4C/B:CZ>."S+Z0X6PR
M?QA]'4T7X^\C,I[B>D2NR+?%/?GXX1/Y0!@G$Y:F& W5=362,9!N=#AX4!P<
M7#@X)!/!=:+(B*]@=:KOHA&E)<&K)8.@%G!"Y34)_<\D\(+0PF?XZ^I!#9VP
M=&R8X[4OX"TTU8#W71,1DZ'(,,D2<_MW0,8\$AF0?^^62DN\Q__9O%>@AW9T
MD]RW:D,CZ#D(K$#NP.G_^8??\OZRF?Y.8">.:)2.:-2A]Z=8BX!*SOC:>DT*
M[6:N;8K.KA\$K7;7W1T;4!7R@TY8"IT0:Y;$FK41FND$)(E.0L/RT'PF'/*X
M:?H,BE"^PHH5I50I%K.(FOJCB!:E6;<VNYKO&<!W COQ4ZOT4ZLV@/<@V8Z:
M:JO(CRU-6?R"1A.J2$150F+L!"2!U1JLX2VP&T>1N_*#QEEXJT*A;P]NNR3=
MKB4]/W0:$[N-P#P#S621CTO@$#-M9=NN$/'.J%8E@@M4.R753BU5K#Q/H.DR
M!>P_2TT41%O)-+/[L_-3AE6)JPL,;TJ&-[4,L6%B.^38CZ0$'KT0+%M<I7DB
MV#C>5,-YGM!5$;P6=I:^]];+O%J>CT+3E-CR^F,JE/KD%NEM;59>E5#GG+1%
M*+RY0/JH ?NUI(>6 F1EZ%MN7N<\^!8I/PPN>39X(QG\-DE"M99LN2VN+I9#
M+G"?:REP)L "P;@&K$;::DQ0H=D\MZ1.Y-2,MY[LUW:Z7S-C,%E8*8?51N6W
M*ZRK4G[HM\^(NT<#6P9RG<^Q6$_%ENMBXBEWRUGY+I\0S_8'9H;.!\$WF&(
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M7-*>2+YJOCC<<2EYV1PN&56=50O4_7O.Y<N)_HBQ^V@U^1=02P,$%     @
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M1-2ZS][QT;3.;&M38^ZG"(WRD^']80=<(XC&N#5Z(2QKA671U)PM_Z>GDZY
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M+J!.88$DJ".Y?",-#1&/[)!'Y38'P4,>;$RHY0E8S!3))8*/E>L)F0"DZ2/
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M*X1;% G@6;;LV&F;&'#2#@O0=D'2;1^&?:"E:XN+1*HD%2?]]3N7E&5[<S/
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M![.S'F9NN"K%A3=UN)Y@\F.PA-<"MTNR+(#SE3%^NV 'W7UU_@]02P,$%
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MZ&\]27G(15UX&P!MK-_11O:Y?]??\0J0(!8II;CW0N2X)JS\2E,UF()O0@&
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M?;4%6-S*FB^4)&$!+5T*& 4N3UB8DNR?2:('K YR=%1HV$Z$!W$/#B<=T='
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MA0&@AY8<%#20J>8Q7VF0. ^(O 3%%3-EB_1H/J:NNS -'ZR%Z0H_DP\'OH@
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MEP.1]4"U9"(W&#H<S*<=^W9M\2-3>_Z?A)7*,K7CKUO4HE)3![1OE,J*'[1
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M-&[UNP'HJO-6$ZM6OMO-E:5(^&%!/RO4[@#M+Y2RVXDST/S^QG\!4$L#!!0
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M5-: OB^E-%O!!NC^;<9_ 5!+ P04    "  77YM6,_!SY$L$  "O"0  &0
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MM1%M12B.15PFKYH+-9344%/49M=+_<@Y1M3A7[D=$N2A9ACQ7/A&JFITH.2
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MM]-+7)CZ;G=7NVE*H3P<;@]>+ RU3,,'5[]] >0N%98]5/-F^&6)73Q5H&O
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MM:HX9NTITD$ JH &U4J2^F6!0";^PW -W'&B(IWS<$?[73Q*&X(BRYB^.G8
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M/%V.!=)\S/;6ZG4+N!>JH#5#^.7<1<[K]IW)QST"=AZ2AOO<3$'$Q8W:= R
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MCY:<7/&(BK%6L&6AK9UOAQXD,!A[R*<.R[HW3A54FY-0@J\-(X%Q5R#UFF^
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MW$K_++;#EJD.=.B*?YF\7NP-W@]43C/=%/6%N_D[)7O>L+S,%4'^5S=I[N9
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M0#@LP'Q7FAJVC]3ERF$*L4"N5/"-F18D<MG0[SO+V*QH4%AXP J(^:W1'GZ
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M-3J]&4^I_#SB;ZK\;WRSNLS8GX?"GB.QLYH_'\V6ZZ4FL8"HN2]Q>YK06I-
M%"T?<=#[9; YLY"SETJ[:F%).R0SDDJ!VC-A:S)^8>*W=M-9!9^7XBYO.$C1
MKW?GDU_G.';:V-7AR"I(2'!!?-V$.XI,=2";?06@HDI6!!!<43,HE+;\%_/7
MMCM8<(E:^_0JRRAN5DV5[#Z2*^V^VK6Y ^[LE1LD[<1S3EKMD]H,#^Y3JOO*
MOQH,K4(I;76UUK/UPV10W<=[\^I50^5=N7-$X))<6Y<=$J6N7@K5P*JUOYT7
MRM)=[[LY/:Y0.P/ZOU3*[@8N0/U<Z_\/4$L#!!0    ( !=?FU:S-Q!WO0,
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MR!%"@:EU"(S^'O$:A7! 1.-GC1D<0CK'X^<&_:O73EK6S."U$G_QS.:38!1
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M9T#/-TK9PXUST'[9S/X!4$L#!!0    ( !=?FU8,E #M=P(  %0%   9
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M&M(FMTSI9X#*'J#O2RE-M;$!ZM_+Z!]02P,$%     @ %U^;5@(.\Y!*"
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M-IRJ;C:$*X1URI51^%I@GCG^^-O7\^L_2/>:34JN>X<# U#[:9 U *<>@&X
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M(@!MYG4&6VA9YLY8?J6N!^\-^+WE0]ZW4;B/T)SB(V*RTRCU11I.QOOD4R'
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M( 1,!<CK"TK%9J(VJ(Y6_C]02P,$%     @ %U^;5N.5<V]&!   DQ0  !D
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M:N=("_@1L[? @6< V<A1U+,X/!TITD-]^H)$^]([;)Q&>Z?$"_9I+W7%>43
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M6D ]WS FWQ;Z!<67D.&_4$L#!!0    ( !=?FU;")?I\6 8  ",Q   9
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MXI?9]\WV5=W?B7VXAK&%A2V '\&:_/J+VW-^,SG_/QG[$(J@"$709'WRE$I
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M"HU53O$98R$*TDS \:40^J%A%JA+V^ W4$L#!!0    ( !=?FU;Z.%>DC@0
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M 64-\/U"2K.;V W*CZ#A+U!+ P04    "  77YM6;[A?+K@"   4!P  &0
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MAW<P-U62;AB"R& FQ9:ZOV6*!6YY(G*$>_*$"B['J EEZHV!/,S'<'GQ!BZ
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MC/0A@$5FH+^'G*OC()N@;(K]_P%02P,$%     @ %U^;5G%SZ()O!@  US,
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M2G-KJ99_*&)3M):]">-\&!]$*H^&LIT87T_O)G<7T\D-FMX]?+U_O+VZ^_J
M)G>7Z'HRO4??)C>/5^CV:O+P>'^U/7:"'F0NS=<11\DSNN1I^,KRH<@0B^?H
MFH4I^L:B-4=O+[E@892]DTT>'R[1VS?OT!L4QN@VC"(YA-E97\@>Y'[T9SMO
M/VV]Q0W>WK+T R+>>X0'F!B:7]B;7_)9V1SKS?LR;F7P<!D\7.B1!KUI+'C*
M,X%2)CC*-FR%9DDL4IF;QLY9U?()^S%;L1D_[\D9F?'TE??&O__F!8,_3%T%
M$M,Z3LJ.DT)]V!C(<M3?[P_Y7S?2$$T%7V9_FP) ( , )*8%P"\#X%M'7@4
M12%["J-0A-PXYEL=6NCDU]37\8GGG_5?]WMBLAF5-IJ#M'20'G P"U]BF99S
MQ#+TF<]?PO@%3>-,I&MY%1;H7]0U>ZTG[#IX0&):;((R-H&3[ T@ P DI@5@
M6 9@V#9[699Q\W!O)?R]I!Q4TM9FH?DU*OT: <VJ4>W4]5EELFF85:>E@Z<N
M9Y4\/&F,M_7,7;,+2$P+DC=03#%P,L%VLD Q@%+3@[ '5E[+9'Z/XB1G5A8A
MMDS6L3#VW3LXWZPFNI>*8#P[PAR?T3>[F?K3V"M0Y(%2TV.EH,=S0ST>*/9
MJ>E!4.#CM26?=FGMUW(64UI-;+N1[JDB(.]H!+I(DRP[F:W3E,>SGRT8R'[*
MSD/I@H(\A4&>&P[R0$$(2DT/@D(AKRT+M<OG.O1X9%"[4EO/^7_[I##*.\11
MQV6^/'['A6P@,T,4#78:QHA8?>F<#4!J>N04WWFG;J8$*+U!J>E%#85OV$I&
M[98'.PUM(E1F@=5$]TU1%6Y+58>6"+A.2R?#TZJ+)J.&10+>*PL=#56'YM\%
MRQ;H.I)GMDP]NQN="THNZ HKNL)NZ J#TA64FAX$15>X=5W),O7JN%2] 5E-
M=-\43^%#/-5ZZE'#TIM47308#1M\5$B#K;0 ,?.V*_1.MT"[4YU3T 40805$
M>.AF'@(QSRX(+@@**X+";2M1K:@0UVM-7E!=Y1B,AK@AX16PX*,K4JT3OMT]
M!Y1TH-3TIQB*=(B;0A4!+51!J>E!4$A%0 M5Y'"ARFJB>ZF8BCAGJK)2U>GB
M;O>K\U@[>6RW]]S.T8,[V"=W+B"+*,@BH"4L4F<ISQOA:LZ;K&@#T! %7<1M
M$:N2]JTN\7:7.@^VBR(7441(W!2Y""C30:GI05!,1T"+7,10Y,)>[2I?MZ(C
MOR'A%7F1HVM7UTG*I0TJ4Y[_F"U8_,+MM5O[B3N/J(M"%5'<1]P4J@@HOD&I
MZ>]@*'SS 0I5?KT*A0>CZAL8!J-A0['*5V3E0Q6K?$,=:E2MIQF-&L#*5V#E
M'PU6+2:<]=&VW8.N20>EIL=+(93O!J%\4(2"4M.#L/?Z$RA"^74XHGA4+<::
MK(:-LU AE'\T0K5+<.N3;KL3G8?7!33Y"II\-]#D@T(3E)H>! 5-/B@T^74<
MP@,25'/<8(5'33FNJ,FW4]-=(I [<K*?O/.PNB G7Y&3[X:<?%!R@E+37PY5
MY$0!R(G6H8@,*_ELLB'F;*:*FR@4-U$#$N'J0L5DY)TV.*FXB=JY"6[*6=G)
M[D7GUVY=L!-5[$3=L!,%92<H-3T(BITH*#M1P\M1WJ"Z-C!8>31H6(W3O;?(
M[>P$FN16?K([TGF(7? 35?Q$W? 3!>4G*#4]"(J?*"@_44/1R0]J]QN#U7#0
M=,=1_$1!^.EK(F0?4B[6:=QFQP0H-T&IZ2%2W$3=<!,%Y28H-7WCB.*F (";
M@CH359>Z!I.&0DZ@J"F HJ;@\",\@\F)U[!,"10S!2#,9)EF5E:RG[WS#AT7
MK!0H5@K<L%( RDI0:GH0%"L%H*P4U"F(!+74;OUN5* X*0#A)'MB6_G([D#G
M876R_VYO YZC'7BP6_!<\%&@^"@ Y:.=&K5=M.LF!%=?,>KO;1;/=^K?LE0F
M:H8B_BQ;#3X,9?-TN_E]^T4DJV+_^%,B1+(L/BXXF_,T-Y#'GY-$_/J2;TDO
M_PN"\7]02P,$%     @ %U^;5N?8"%@#!   .A4  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C$N>&ULM5A;;^HX$/XK5O9HU4IM<^/2=@&) MU%*FP%A[,/
MJWUPDX%$)[%9VT"/M#]^[21-""=$I34OQ;?Y///Y8SI,9T?9=QX "/0:1X1W
MC4"(];UI<B^ &/,;N@8B=Y:4Q5C(*5N9?,T ^XE1')F.9;7,&(?$Z'62M6?6
MZ]"-B$("SPSQ31QC]N,!(KKK&K;QMC +5X%0"V:OL\8KF(-8K)^9G)DYBA_&
M0'A("6*P[!I]^W[@6,H@.?$MA!W?&R,5R@NEW]5D['<-2WD$$7A"06#YL84!
M1)%"DG[\FX$:^9W*<'_\AOZ8!"^#><$<!C3Z*_1%T#5N#>3#$F\B,:.[/R +
MJ*GP/!KQY"_:96<M WD;+FB<&4L/XI"DG_@U(V+/0.)4&SB9@7-HT#ABX&8&
M;A)HZED2UA +W.LPND-,G99H:I!PDUC+:$*BGG$NF-P-I9WH/8ZG_>E@W']"
MX^G\ZVPQ&4V_SE%_.D2/_?$,?>L_+49H,NK/%[-1NG>-AL#"+5;THS'A@FWD
MLPI^A7Z7JD$73Y3S2W0Q!('#2(ZNT6(^1!=?+M$7)/<G813)]^,=4TCWE1.F
ME[GZD+KJ'''511-*1,#1B/C@E^U-&78>N_,6^X-3"SC![ :Y]A5R+,>M\&?P
M?G.GQATW?PHWP7./X(V)  9<((8%(+[#:^3)@)E4.D?_H0&56W2)UHSZ&[7$
M:>17L5A[BTH+]WR-/>@:\GO/@6W!Z/WZB]VR?JNB0!-8B9!&3D@C06\?(>0]
M.OO[21JAL8"8_U-%1D,G&9K 2F0T<S*:M>I(@XZ2H&7Z\W-NKA !415ZBM=,
M\%0VW_:LCKG=CZ?N1,G)5NYDZS,2_E,$P-!%2#P:PZ4)K_*?$3\>0.U=I[Z=
M)K 2+>V<EO;9A=S6288FL!(9MSD9MYJ%G.(U]F1Z[1XHN>*(;5=K^2[W\Z[6
MSP&3+EY[&\: >#\^D8]KKSGUY32!E1BQK:)8L,XNY.P*37SH0BL3LE<]V9K%
MG $V:M)R[9&RHT[AJ/,I-9^8FNMO._D1-:&5N2GJ+ML]OZJU5EVZT,J$%'67
M75O)?$35C9\3L'.8I*L.-8X(NRB+[/JZ2/Z8DS_5",JE#:]>@,D*/I:LZV\[
M^1TUH96Y*:HQNW5^86NMPG2AE0DIZC"[MK+YB+#;%96%\U/&KCAUZQR1=E$H
MV?65TOND?6KFKKWSY/?4A%9FJ"C1[+OS"UQK?:8+K=S0* HTI[;>^8# ,\!F
M2>"M WU7'6JV#_1M[G6A8F"KI#G'I58W1*1-F7PU;P#VD[;7P?J#?3](VW@%
M3-I5G&"V"@E'$2PEI'73EAZQM%&73@1=)[VN%RH$C9-A %C2H [(_26EXFVB
M+LC;I;W_ 5!+ P04    "  77YM6QSH:^B4%  !5&P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6S-66UOZC84_BM6=C6U4FF(*2_M*!*%=A>IL K*
MW8=I'UQB(+J)S;7-2Z?]^!TG(2$0O-*FT[Y XMB/SWG.R?$3N[GFXKN<4ZK0
M)O"9O+7F2BUN;%M.YC0@\I(O*(,G4RX"HN!6S&RY$)2XX:# MW&Y7+,#XC&K
MU0S;GD2KR9?*]QA]$D@N@X"(USOJ\_6MY5C;AJ$WFRO=8+>:"S*C(ZK&BR<!
M=W:"XGH!9=+C# DZO;7:SDT'U_6 L,<WCZ[ESC72KKQP_EW?]-Q;JZPMHCZ=
M* U!X&]%.]3W-1+8\2,&M9(Y]<#=ZRWZ0^@\./-").UP_W?/5?-;JV$AET[)
MTE=#OOY*8X>J&F_"?1G^HG7<MVRAR5(J'L2#P8+ 8]$_V<1$[ P G/P!.!Z
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M8L08%:O$ V=<%#BQHX0(:\7MLJCIVVI,1M>@G&[EZZ'6[$X^=,$LC*)T!?R
MGL/X$(.2 )@CT3DQ/979&S7X1M4\4VHRT\K@PX[9V6C2NL^-JGFFU&24U4(
MZA<"E^\1LLV/80)>,*),^:SF#<5N'JHD9W2M8$I-)E>M%> ;#]B+^ZF?WVDW
MQ9WV)GU_F4WS=3G-?=TTKS\Y+]_,U*J=T06#*3697[5@@/I'\2N<X!.*P![3
MD 1OC3F]EI.%*H><T86!*;4<F77V8CO&=)M](," 3PX)S]\.ET?+CQ"FV:OW
MB^,SYW:>?TI0R>1?-CP@N@T3!B*\$9)VNR_&&<T_%LAW.-EGK\_7A',29YL[
MC ),TQ/$[QLBUL+%3MI ^<G&Y']02P,$%     @ %U^;5F/2#D ' P  ?0@
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M_=[85"-9=I'E1(MMT5>MA3:5HABFIO%&:0W,_D8(?9C8 ^I6/O@)4$L#!!0
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MO^X^;#=K&+V*B<0T$Z_16W1W&Z-7+UZC%X@6:$.S#)9-3&T)22@K.VD#+IN
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M0JLO@/(IV-B\ 1L=.)A"J^M6U@?#UN?U_@PW9PE>X/4/G0]N.A_?=OM]O:G
MROI@V/IT\6BX:6M.",%!_Y"K+LX)W);! U8.",,.J$LU^1J?AON'TPC<'$?@
M@=?F*+$R+A@>2+RT\6$/!X-WW@IOX66P\C+8V.@"&YU=F$*KZU:N!L.NYKA6
M!V,2H-.]A:$ARM 0> SRFH)O]W8P>.=A\UMX'*(\#G&,S=B-SF),H=5U*[-#
M8+-S5,&_@ EY.SCU6+E[OZ3 (Y@+N@X%C<+?4G"6+L2&<J95:/:'E+?P-43Y
M&N(:JVW0(776;0BMKEO9) +;I-?[.=(<$#G>@!SX#M*T2([G>7K;091!(K!!
MZN+F2-/ZG#AVP\SIPSR_A:IR2 1V2%TJJ=]84G=P:)!U04&+XR3*O!!X:*+;
MY+!W@P$[E_U;>!BB/ P)C&UWH^,94VCU'XR5FW%A-W-4*WL!$_!N<.:Q:I5A
M<>$!2EN1M_LU&+#KPS:%5I>O?(MK[#<DU^ALQA1:7;<R,"YL8(XK<AC3L8$J
M-VI=K+TC2#'CR_)DEFS116/>GD:J[E:GO\;EF2=+A6^/CMU0O@R3#$5L(5/M
MT[YL(GQ[&FM[(=)U>:#I,14BC<N7*T;GC!<!\OU%FHKGB^(#JC-QH_\!4$L#
M!!0    ( !=?FU;H_2+7KP(  )T&   9    >&PO=V]R:W-H965T<R]S:&5E
M=#<R+GAM;*U576_:,!3]*U963:VT-2&!=NH@4OA8B]0OE79]F/9@D@NQZMB9
M;:#;K]^U$S)**>K#7HCMW'-\SL&^Z:ZD>M(Y@"'/!1>ZY^7&E&>^K],<"JJ/
M90D"W\RD*JC!J9K[NE1 ,P<JN!\&P8E?4":\N.O6;E7<E0O#F8!;1?2B**CZ
MW0<N5SVOY:T7[M@\-W;!C[LEG<,$S$-YJW#F-RP9*T!H)@51,.MY2>MLT+'U
MKN [@Y7>&!/K9"KEDYV,LYX76$' (366@>)C"0/@W!*AC%\UI]=L:8&;XS7[
M-^<=O4RIAH'DCRPS><_[XI$,9G3!S9U<74#MQPE,)=?NEZSJVL CZ4(;6=1@
M5% P43WI<YW#!@!Y=@/"&A!N ]IO *(:$#FCE3)G:T@-C;M*KHBRU<AF!RX;
MAT8W3-A_<6(4OF6(,_'YS<WP<7QY29+K(;FYOQC=D?'U?7)]/NY?CD@RF8SN
M)^0S2;*,V=@I)V-1G1W[)QP.P5#&]1&6/$R&Y/#@B!P0)L@5XQP+=-<W*-)N
MY:>UH'XE*'Q#4$2NI#"Y)B.10?82[Z.YQF&X=M@/]Q)>475,HM8G$@9AM$//
MX/WP<(^<J D\<GRG;P4N9;;"= @5&69IJ)BS*0>2: U&DR'3*9=ZH8#\2*;:
M*#SG/W>E6.T2[=[%WOTS7=(4>AY>;@UJ"5[\\4/K)/BZ*X+_1/8BD'832'L?
M>YP44AGVISI0<H:GI\F$NDQVN:\H.X[2-JIE'$9!T/67FZYV%'4VBEZH[31J
M.WO5CHN2,H5MS%BMTN2@WJ>X\UK,MM[7)>UMM?[&32] S5T#U"25"V&J*]&L
M-CTV<:UE:[V/O;=JE?]HJL:-!W[.A"8<9D@9')^B(%4UPVIB9.GZR50:[$YN
MF./W Y0MP/<S*<UZ8C=HODCQ7U!+ P04    "  77YM61;Q TNL"   T"
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M5^CS:93E?\&NE+5&P-]FC,;E8(X@#I/B/_Y:.J(V@.O1#X#E -@>X'0,0.4
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MS56(F/6T0+;EV?/Q4]T,XT3?:89;F>$:S?C @S'!J3!$N_>+T4[- @B]2<L
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M@-+BJZ7BAM%-_N'/ V6,QOGEFF!^:(0 __V14O9\(R:HOAU;_ ]02P,$%
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MYJ5@%F?PQ6:H8:QR*I+,[=X"X4HF*D<X_*2,.8+#2[2,"QH=P]WD$@X/CN
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M+GN2$,O[S'PB:*9;M045LO'3P[7LS9$I _E\2:EXF:@-RF[?_Q=02P,$%
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M;<IWE':!F5\*H?<=ZZ#Z03#Z#%!+ P04    "  77YM6,,EQ"EX#  !Z#
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MR2Q1MWSQ$0M!-8,7\43:7U@4<ST'HIE4/"V"-8.4LOR?/!0+L1$0U'8$!$5
M8'GG+[(LSXDB[:;@"Q!FMD8S#2O51FMRE)FL#)703ZF.4^W^U>#RYEN_#\//
M-[U/T.U?]S]<?(;!9>=Z"(<PG!*!AT9V# .RU.E0T!&"L F:]@%<<S9'J?3C
MSH*(^ !Z7"K8.T=%:"+WX2U0!E<T270*9--5FK)YL1L5]+HYO6 'O1"N.%-3
M"7T68_PXWM522[W!2F\WJ 2\(N((0O\  B\(X6YX#GMO]RMPPW(=0XL;[L"]
MU8L@:&060N<LNH<9HVJKX$H<LPG/9$8B;#EZETD4<W3:[][X=>]]!<OCDN6Q
M13_9P3)/9]>FL\=3O;4EL9MC(Z<P6L+FO#+M)K_P_5)#PH7"5/[8IN[X'ZBK
ME>IJE3FX8P(C/F'TEZ8=;<J+M"FWL<WQ:A;/G%_SMN\'M:8[W\*B7K*H5[+H
M/V1H?;"P)P+&AV2.0I]PD*&@/#8;8HE$2.#C/UF"XC!"6 O91KN:0%C !Y#F
M>\</("9+6;'")Z6VDTIHO7ON]4TAC3UV.[P2XX4>:)0,&Z_L\,8_4'=:JCO]
MRPX__</AI^%V?_O>^LKP7MOA3S!863PL+=YXRN+^QHWH5X(/4-AJAT7XE-.K
MD5YH!C]8,PU>V>P%@;\L<'VI^M6WZO/]7@ ^.M+K.TYT?WUM^I7WUG]Q?#6#
MX!F'NKM1#J8H)K;HE9K*C*F\,BQ'R\*ZDY>3Z^EY5:X/_ EE$A(<ZU#OZ$0O
MK,@+W;RC>&:+RQ%7NE2US:G^.$!A)NCG8\[5JF->4'YNM'\#4$L#!!0    (
M !=?FU8\J3&B@ H  )J/   9    >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM
M;+7=76_:6 +&\:]RQ(Y6,U);L,EK-XE$\+O=)DJFNQ>KO7#@)/'6V(QMDF8T
M'WYM<#"F< +:?VY:()S?L4,><6P>X.PYS;[GCU(6XL<D3O+SSF-13#]WN_GH
M44["_%,ZE4GYD_LTFX1%>35[Z.;33(;C^:!)W-5[O:/N)(R2SL79_+;K[.(L
MG15QE,CK3.2SR23,7BYEG#Z?=[3.ZPTWT<-C4=W0O3B;A@_R5A;?IM=9>:V[
M5,;11"9YE"8BD_?GG8'V.>B?5@/F]_AG))_SE<NBVI6[-/U>77''YYU>M44R
MEJ.B(L+ROR<YE'%<2>5V_%&CG>6<U<#5RZ^Z-=_Y<F?NPEP.T_A?T;AX/.^<
M=,18WH>SN+A)GQU9[]!AY8W2.)__*YX7]ST^[(C1+"_223VXW())E"S^#W_4
MOXB5 ;J^98!>#]!W'="O!_1W'7!0#SA8'Z!M&7!8#SC<=8:C>L#1K@..ZP''
M:P/ZO2T#3NH!)^LS;!MP6@\X71N@'6Q[X'JOCUQOU[W0E@_VSH^V]OIP:_/'
MN[OXPYK_51IA$5Z<9>FSR*K[EUYU8?ZG/1]?_C%&297"VR(K?QJ5XXJ+P+0'
M@;B^N1J:IN%^M6_%X*LAAE=??R^OF%^'KGDK?C5D$49Q_IOX142)^!+%<1F@
M_$/[ZEFW*+>G4KNC>N[+Q=SZEKDU\25-BL=<F,E8CMOCN^5^+'=&?]V92UT)
M6O+ND]!//@B]IVOBVZTA?OWEMPW;-50S@VGV2?1[<Z:G8 PU8\A1R6@5HYTJ
M&%/-W,KIZ]9HAV(:%C(I-BB66OD29LN-4>V3O0\S^+:-<79F]/[KUH@X?,YG
MT::=<]6<-TN6#Y@N1G$8338@W@Z/>F^Q3?J&X?XNN_2Z#=MW)=A]5[;\";>B
MT5_FO#]WC[?E7#Z$L;C.TI&4XRAYR,4@&8MAF;_RBDQ&D<S%OX-RD' +.<G_
MLRG-BQGZFV>HE@N?\VDXDN>=<CV0R^Q)=B[^_C?MJ/>/31$D,8/$3!*S2,PF
M,8?$7!+S2,PGL0#"6@D^6";X0*5?W,R2I,RJR-*7,"Y>-@54">P;4!(S2,PD
M,8O$;!)S2,PE,6^!:8OGL.HX[^FB]ZE<G9QUGU:C1\X90%@K>H?+Z!TJHV>$
MD_*(-!=Y.BN/Z38E;S'^<.47<M(_:/\ZALHY]@T4B9DD9I&836(.B;DDYI&8
M3V(!A+5B=[2,W9$R=E=W<?00SD_6%*EX3..QS'*1WHOB48K1Z]*U$$]A/),B
MJ\ZW;#P*5<ZR[],BB1DD9I*816(VB3DDYI*81V(^B05'/ST]'1WT>LOGIU8Z
MCY?I/%:F<S :93,Y%G$4WD5Q5%1'D/=I)H;FS3 8B$E8%&5<-^51Z>Z;1Q(S
M2,PD,8O$;!)SCG]>^IRV5SXN.9]'8CZ)!1#62N/),HTGRC1>9E%>I/''+R_5
M<^3M'[/H[FY3]I3*OMDC,8/$3!*S2,PF,8?$7!+S2,PGL0#"6BD]7:;T]-W/
MPIZ2"28Q@\1,$K-(S"8QA\1<$O-(S">Q ,):"=9ZS0NFO?_S9% -K"Z)#K3C
MM;-!ZEGVC1ZJF:AFH9J-:@ZJN:CFH9J/:@&EM3.X4EK0U,>>Y1/FQVOCHR:J
M2W?I^$4$Y1'HXF31QD@JO7V?-5'-0#43U2Q4LU'-0347U3Q4\U$MH+1V=O4F
MN_J[KX'K*:@XDYJ!:B:J6:AFHYJ#:BZJ>:CFHUI :>TX-[TB35EZN/@ZF]S)
MK'I59E%-R\5?VTMJEVIL[^"B)2)4,VOM8/6<>_L0P$(GM%'-0347U3Q4\U$M
MH+1V&IN.D*8N"0T'-^)WX4>%?&M!C':%4,U -1/5+%2S4<U!-1?5/%3S42V@
MM'9FFW*1=OC^"V*R]#%$-0/53%2S4,U&-0?57%3S4,U'M8#2VG%N2DN:NK5T
M';Y,YNO@J@RQ*.N6"=X86K28I/U<\M#TE9)''<:?[W5XLE;<--$-LU#-1C4'
MU5Q4\U#-1[6 TMH9:ZI'FKI[M$,77BWL':Z%ME9YUH^/UN.UV_U,=.LL5+-1
MS4$U%]4\5/-1+:"T=L*:.I&F[A-=Q^%3]$,,9GF1A7$4"C<I9%R]=WJV6*Q.
M95:\B+^:>WP01AK'X>;*GWJVO=.(%H]0S40U"]5L5'-0S44U#]5\5 LHK9WL
MIH*DO7\'24-+2*AFH)J):A:JV:CFH)J+:AZJ^:@64%K[$P^:.I*^6QUI&D;C
M35%5#]\WJJAFH)J):A:JV?J&2MC!6DW>0:=T4<U#-1_5 DIK)[ I(^GJ,M+.
M2^5O253(L;@MPD+.W\<VF,@L&JE7SNK)]\XOVEQ"-1/5+%2S4<U!-1?5/%3S
M42V@M';0F^:2_O[-)1UM+J&:@6HFJEFH9J.:@VHNJGFHYJ-:0&GM.#?-)5W=
M7'ISY8QVE5#-0#43U:Q:6UWK]GM:>ZUKHU,ZJ.:BFH=J/JH%E-9.8--6TM5M
MI4'UQO'[E^HI=3P;%2*HWTI>+9:'@Z\#8[ QEVAU"=4,5#-1S4(U&]4<5'-1
MS4,U']4"2FL'N*DNZ>]?7=+1ZA*J&:AFHIJ%:C:J.:CFHIJ':CZJ!936CG-3
M7=+?J"[)I$KQXA-4JR+_]H\QO513>\<6_5@E5#-1S4(U&]6<6EM]SX*VMG!W
MT1D]5/-1+:"T=AB;CI.N[C@-XS#/YY]2GR:[)1)M/*&:@6HFJEFH9J.:4VNK
MB3Q8#R1:B4(U']4"2FL'LJE$Z>I*E%L^.3Y%X^I%G2CY[RQ[V2V5:/,)U0Q4
M,U'-0C4;U9Q:6TWE\7HJT3H3JOFH%E!:.Y5-G4E7]BO6UJP?ZJ]U>2.3:'T)
MU0Q4,U'-0C4;U9Q:6\VDOIY)M).$:CZJ!936_JJ)II/45W>2KI*'^.7/<,-Y
M7?6;4M7LOKE$-0/53%2S4,U&-0?57%3S4,U'M8#2VA%N2DU][=W/[/;1ZA*J
M&:AFHIJ%:C:J.:CFHIJ':CZJ!936CG-37>HKNQ1[G=E54WO'%JTHH9J):A:J
MV:CFH)J+:AZJ^;76.H=]TCX0"*@9VV%<^2HV=?'H2UK>$KZU%D;;1ZAFH)J)
M:A:JV:CFH)J+:AZJ^:@64%H[KTU-J7_P_FMAM+2$:@:JF:AFH9J-:@ZJN:CF
MH9J/:@&EM>/<E);Z;WR;6Y1/HCR78S$*<UDMAK=]8^RE6MH[M6@W"=5,5+-0
MS48U!]7<6E.\0.NA$_JH%E!:.XI-X:BO+AQM[CALCR/:.4(U ]5,5+-0S48U
M!]7<_L\-IJ/^>A[1SA&J!936SF/3.>JK.T=7T^+CU:P09KFTW?:I96IB[Q"B
M-2-4,U'-0C4;U1Q4<U'-0S4?U0)*:\>U:23U3][_P!3M)Z&:@6HFJEFH9J.:
M@VHNJGFHYJ-:0&GM.#=5IKZZRK1WXU?M[9U=M,>$:B:J6:AFHYK3?[O'A$[H
MH9J/:@&E+0+9S1^E+(RP""_.)C)[D$,9Q[D8I;.DY*O74I>WBDS>5Q^E]GF@
M=[H_W7ZI?;:UZO9NPUR<3<,'^27,'J(D%[&\+\G>I^/R^'K^Q>2O5XIT>M[1
M.N(N+8IT,K_X*,.QS*H[E#^_3]/B]4HUP7.:?9]O]L7_ %!+ P04    "  7
M7YM6YPK4@50#   &%   #0   'AL+W-T>6QE<RYX;6SM6-%.VS 4_97(C FD
MB;3-2)O15MHJ(4W:)B1XV!MR&Z>UY#B9X[*6QWW/OFI?,M\X3=+BVS%>*--2
M0>Q[?,X]MF\:P[#0:\&N%XQI;Y4*68S(0NO\G>\7LP5+:7&6Y4P:),E42K7I
MJKE?Y(K1N !2*OQ>IQ/Z*>62C(=RF5ZFNO!FV5+J$>G7(<_>/L8CT@W?$L_*
M3;*8C<CMR>MORTQ?O/+L_>C-T5'G]O1B-WY2 J?$=XJ>/T+TK(/K&@R3#K>E
MR^''1L@2CS%:WT$S61HF=##RP#V=7S]^(JO4(/O7*7*Z:GE"B/V.>SIM:K6$
M?E4&XV&2R:8: F(#1IVFS+NC8D0F5/"IXL!*:,K%VH9[$)AE(E.>-F5HTG4A
M4MQ;N&M[4*&53LIEILK<-H/]/:V&[P";'ACD0M0&>\0&QL.<:LV4O#2=<G 9
M? !Y5?MFG1N'<T77W=XY:0CES2299BIFJD[3)9O0>"A8 G84GR_@KK/<!U#K
M+#6-F--Y)FGI8<.H&D9VQH2XAL?W:[*EO4I:^U;NFJR;QE#5M#*V _IM-:O=
ME@V>I.OE_"[3'Y9F.K+L0WVR*\42OBK[JZ0V@*EW<76:YV+]7O"Y3)F=_*,3
MCH=TP_,6F>+W)AN4RLP$F"+>'5.:S]J1[XKF-VRE-^6T2G#/O?^>_^!YSB13
M5+1-F]I_A..@_UR6RV=TU[#38_6&.W23YX=O\MF^!YY<G]5IX;"7M3J;'+K)
MP4LP&;T D_UG^Y[?:]*O3AFMH\S60::.>G!@')$O</P435)ONN1"<UGU%CR.
MF7QPGC'RFD[-'SE;^F9\S!*Z%/JF!D>D:7]F,5^F43WJ"A:B&M6T/\'TNF%]
M6C6YN(S9BL63JJOFT[+IF8;)6EU V$4NR\N-8!R+N1' L#R8 XQC65B>?VD^
M W0^%L.\#9S( .4,4(YEN9!)^<'RN#F1N=PSC:(@"$-L12<3IX,)MFYA"#]N
M-<P;,+ \D.GOUAK?;;Q"]M<!MJ?[*@2;*5Z)V$SQM0;$O6[ B"+W;F-Y@('M
M E8[D-^=!VK*S0D"V%7,&_8$XT@480C4HKM&PQ!9G1 ^[OW!GI(@B"(W IC;
M01!@"#R-.((Y  \8$@3E>W#G?>1OWE-^\Y^_\6]02P,$%     @ %U^;5I>*
MNQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q
M%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(
MMB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!
M;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B
M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M_YU4CY=SZ^WRU^77SLG=>\4YW%<,SW\!4$L#!!0    ( !=?FU;W,"8&)P(
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  77YM6:<C& N\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  77YM6
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( !=?FU8$@4!>PP8  -,I   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  77YM6
MJ[)A<_($  "!$@  &               @($'#P  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ %U^;5DAVBB[A P  90P  !@
M     ("!+Q0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M !=?FU8N<!/X$ 8  , :   8              " @488  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    "  77YM6A(K#K5,'  !_(   &
M            @(&,'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ %U^;5I9N*YU&"@  %QH  !@              ("!%28  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( !=?FU;5Y^^;TP4  (L-
M   8              " @9$P  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    "  77YM6#$::%\ $  "["@  &               @(&:-@
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ %U^;5J;XKJ(@
M"   910  !@              ("!D#L  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( !=?FU8'-9-4M ,  .<'   9              "
M@>9#  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ %U^;
M5NYE6@I>!0  ; T  !D              ("!T4<  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    "  77YM66R\?U)$&  #I#@  &0
M        @(%F30  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( !=?FU9I]'_QS0(  $X&   9              " @2Y4  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ %U^;5H ?"]2?#P  L#(
M !D              ("!,E<  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    "  77YM6PM2 RWP&  #\#@  &0              @($(9P
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( !=?FU8A8J'P
M/ ,   H'   9              " @;MM  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ %U^;5KJCP?#7 @  !@8  !D
M ("!+G$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  7
M7YM6C/#?:O@"  !Y!@  &0              @($\=   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( !=?FU8S\'/D2P0  *\)   9
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M970R,RYX;6Q02P$"% ,4    "  77YM6^"UQX8H*   U'   &0
M    @(&$M0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M !=?FU8[FG.!O04  ,<-   9              " @47   !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ %U^;5B)@7[T%!   X0@  !D
M             ("!.<8  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    "  77YM6YOF%?"0$  "Z"0  &0              @(%UR@  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( !=?FU:S-Q!WO0,
M -D'   9              " @=#.  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ %U^;5JW '*2U P  Y0@  !D              ("!
MQ-(  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  77YM6
M#)0 [7<"  !4!0  &0              @(&PU@  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( !=?FU;;2D_=\ (  &H&   9
M      " @5[9  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ %U^;5@(.\Y!*"   <1L  !D              ("!A=P  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  77YM6U7/IAHL#  !D"
M&0              @($&Y0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( !=?FU8).BO,S (  .T%   9              " @<CH  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ %U^;5AO#L@Z3
M @  @ 4  !D              ("!R^L  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    "  77YM6+=#MR<$"   !!@  &0
M@(&5[@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( !=?
MFU;AGUHDT0,  +T(   9              " @8WQ  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ %U^;5A4I>U(?!   (@L  !D
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M=#0R+GAM;%!+ 0(4 Q0    ( !=?FU:SL_W[<P@  !I'   9
M  " @<$, 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M%U^;5G+""I.U!0  J"$  !D              ("!:Q4! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    "  77YM6=9_?)90#  "C#@  &0
M            @(%7&P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( !=?FU9XQ/U(^P,  !41   9              " @2(? 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ %U^;5L(E^GQ8!@
M(S$  !D              ("!5",! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    "  77YM6U80KI_T#   O#0  &0              @('C
M*0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( !=?FU:[
MO[S.>0,  .8.   9              " @1<N 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ %U^;5OHX5Z2.!   [!8  !D
M     ("!QS$! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !=?FU8G>@*I6 <  -L\   9              "
M@85# 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ %U^;
M5H?Y-A_: P  VA   !D              ("!%$L! 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    "  77YM68-"2!N8"  "@!P  &0
M        @($E3P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   ( !=?FU9C$".E@ ,  " +   9              " @4)2 0!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ %U^;5G%SZ()O!@  US,
M !D              ("!^54! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    "  77YM6&=;R+U$'  ".0   &0              @(&?7 $
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( !=?FU;GV A8
M P0  #H5   9              " @2=D 0!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ %U^;5L<Z&OHE!0  51L  !D
M ("!86@! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    "  7
M7YM6I/WH(:\"  #X!@  &0              @(&];0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( !=?FU; $_K+@@,  .,+   9
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M970V."YX;6Q02P$"% ,4    "  77YM6T$(R I@#  !D#0  &0
M    @('J@P$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M !=?FU85>!%ZE@(  .(%   9              " @;F' 0!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ %U^;5L*=@'+;!0  'R<  !D
M             ("!AHH! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"
M% ,4    "  77YM6Z/TBUZ\"  "=!@  &0              @(&8D $ >&PO
M=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( !=?FU9%O$#2ZP(
M #0(   9              " @7Z3 0!X;"]W;W)K<VAE971S+W-H965T-S,N
M>&UL4$L! A0#%     @ %U^;5LH"T3&@ P  W@T  !D              ("!
MH)8! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    "  77YM6
M@7RC0W@#  ##"@  &0              @(%WF@$ >&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;%!+ 0(4 Q0    ( !=?FU;3:<Y6%0,  .H(   9
M      " @2:> 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%
M  @ %U^;5K1OKY.F!@  1R8  !D              ("!<J$! 'AL+W=O<FMS
M:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    "  77YM64@O(]08#  !4"P
M&0              @(%/J $ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+
M 0(4 Q0    ( !=?FU;<4L>K-P4  &\9   9              " @8RK 0!X
M;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ %U^;5@&"?[;V
M @  Z <  !D              ("!^K ! 'AL+W=O<FMS:&5E=',O<VAE970X
M,"YX;6Q02P$"% ,4    "  77YM6$R#XP\,#  #Y#P  &0
M@($GM $ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( !=?
MFU9=ZR?O9P,  !P,   9              " @2&X 0!X;"]W;W)K<VAE971S
M+W-H965T.#(N>&UL4$L! A0#%     @ %U^;5C#)<0I> P  >@P  !D
M         ("!O[L! 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4
M    "  77YM6/*DQHH *  ":CP  &0              @(%4OP$ >&PO=V]R
M:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( !=?FU;G"M2!5 ,   84
M   -              "  0O* 0!X;"]S='EL97,N>&UL4$L! A0#%     @
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H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !< %P .QD  .+9 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>300</ContextCount>
  <ElementCount>379</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>111</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EARNINGS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCES</Role>
      <ShortName>ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - OTHER (INCOME)/EXPENSE, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENET</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - FINANCING ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCINGARRANGEMENTS</Role>
      <ShortName>FINANCING ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLES</Role>
      <ShortName>RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITY</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/REVENUE</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - ALLIANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESTables</Role>
      <ShortName>ALLIANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENET</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RESTRUCTURING</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INCOMETAXES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - FINANCING ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCINGARRANGEMENTSTables</Role>
      <ShortName>FINANCING ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCINGARRANGEMENTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESTables</Role>
      <ShortName>RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYTables</Role>
      <ShortName>EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITY</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails</Role>
      <ShortName>REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails</Role>
      <ShortName>REVENUE - Disaggregation of Revenue by Product and Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - ALLIANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESDetails</Role>
      <ShortName>ALLIANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCESTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - RESTRUCTURING - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails</Role>
      <ShortName>RESTRUCTURING - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - FINANCING ARRANGEMENTS - Short-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS - Short-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - FINANCING ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails</Role>
      <ShortName>RECEIVABLES - Schedule of Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - RECEIVABLES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESDetails</Role>
      <ShortName>RECEIVABLES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLESTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIESTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails</Role>
      <ShortName>EQUITY - Schedule of Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYAdditionalInformationDetails</Role>
      <ShortName>EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="bmy-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</ParentRole>
      <Position>84</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. bmy-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntitySmallBusiness -  bmy-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="bmy-20230331.htm">bmy-20230331.htm</File>
    <File>bmy-20230331.xsd</File>
    <File>bmy-20230331_cal.xml</File>
    <File>bmy-20230331_def.xml</File>
    <File>bmy-20230331_lab.xml</File>
    <File>bmy-20230331_pre.xml</File>
    <File>bmyex31a_20230331.htm</File>
    <File>bmyex31b_20230331.htm</File>
    <File>bmyex32a_20230331.htm</File>
    <File>bmyex32b_20230331.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap-sup/2022q3</BaseTaxonomy>
    <BaseTaxonomy items="931">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmy-20230331.htm": {
   "axisCustom": 2,
   "axisStandard": 30,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap-sup/2022q3": 3,
    "http://fasb.org/us-gaap/2022": 931,
    "http://xbrl.sec.gov/dei/2022": 56
   },
   "contextCount": 300,
   "dts": {
    "calculationLink": {
     "local": [
      "bmy-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmy-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmy-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmy-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmy-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmy-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 640,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 6
   },
   "keyCustom": 46,
   "keyStandard": 333,
   "memberCustom": 63,
   "memberStandard": 48,
   "nsprefix": "bmy",
   "nsuri": "http://www.bms.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.bms.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - OTHER (INCOME)/EXPENSE, NET",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENET",
     "shortName": "OTHER (INCOME)/EXPENSE, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - RESTRUCTURING",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.bms.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.bms.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.bms.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - FINANCING ARRANGEMENTS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.bms.com/role/FINANCINGARRANGEMENTS",
     "shortName": "FINANCING ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - RECEIVABLES",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.bms.com/role/RECEIVABLES",
     "shortName": "RECEIVABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.bms.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
     "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - EQUITY",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.bms.com/role/EQUITY",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "menuCat": "Policies",
     "order": "24",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.bms.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - ALLIANCES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.bms.com/role/ALLIANCESTables",
     "shortName": "ALLIANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables",
     "shortName": "OTHER (INCOME)/EXPENSE, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - RESTRUCTURING (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.bms.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.bms.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.bms.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - FINANCING ARRANGEMENTS (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.bms.com/role/FINANCINGARRANGEMENTSTables",
     "shortName": "FINANCING ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - RECEIVABLES (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.bms.com/role/RECEIVABLESTables",
     "shortName": "RECEIVABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.bms.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Supplemental Financial Information (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.bms.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.bms.com/role/EQUITYTables",
     "shortName": "EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - REVENUE - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
     "shortName": "REVENUE - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails",
     "shortName": "REVENUE - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:GrosstoNetAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - REVENUE - Disaggregation of Revenue by Product and Region (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
     "shortName": "REVENUE - Disaggregation of Revenue by Product and Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - ALLIANCES (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.bms.com/role/ALLIANCESDetails",
     "shortName": "ALLIANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyIncomeNonoperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:LicensingAndOtherArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:ContingentRegulatoryMilestoneIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
     "shortName": "DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLegalSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
     "shortName": "OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - RESTRUCTURING - Additional Information (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
     "shortName": "RESTRUCTURING - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i781c6b749cec4403995ae4192bf4a6e7_I20230331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i173cd3ea7b2b49529ff5d4c934429570_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i173cd3ea7b2b49529ff5d4c934429570_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - EARNINGS PER SHARE (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.bms.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000006 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS",
     "menuCat": "Notes",
     "order": "6",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "idb244ebbca7645918a749ff83a2caf20_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "ieb81acd0695b4f10a417aade9fb25bb8_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - FINANCING ARRANGEMENTS - Short-Term Debt (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails",
     "shortName": "FINANCING ARRANGEMENTS - Short-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails",
     "shortName": "FINANCING ARRANGEMENTS - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:UnamortizedBasisAdjustmentFromSwapTerminations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - FINANCING ARRANGEMENTS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails",
     "shortName": "FINANCING ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails",
     "shortName": "RECEIVABLES - Schedule of Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - RECEIVABLES (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.bms.com/role/RECEIVABLESDetails",
     "shortName": "RECEIVABLES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - INVENTORIES (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.bms.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - REVENUE",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.bms.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i173cd3ea7b2b49529ff5d4c934429570_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i173cd3ea7b2b49529ff5d4c934429570_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails",
     "shortName": "EQUITY - Schedule of Stockholders Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - EQUITY - Additional Information (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
     "shortName": "EQUITY - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - ALLIANCES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.bms.com/role/ALLIANCES",
     "shortName": "ALLIANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i1bde7edbb7c14fa0b263eca4aead487e_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i90e84082105e45269a4ddf3f2b924403_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i90e84082105e45269a4ddf3f2b924403_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "ie45c0ee3f040490991410c1a6b57a08c_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "ie45c0ee3f040490991410c1a6b57a08c_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20230331.htm",
      "contextRef": "i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 111,
   "tag": {
    "bmy_A1.000Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One000NotesDue2025Member",
        "label": "1.000% Notes due 2025 [Member]",
        "terseLabel": "1.000% Notes due 2025"
       }
      }
     },
     "localname": "A1.000Notesdue2025Member",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.750Notesdue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One750NotesDue2035Member",
        "label": "1.750% Notes due 2035 [Member]",
        "terseLabel": "1.750% Notes due 2035"
       }
      }
     },
     "localname": "A1.750Notesdue2035Member",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2022ASRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 ASR",
        "label": "2022 ASR [Member]",
        "terseLabel": "2022 ASR"
       }
      }
     },
     "localname": "A2022ASRMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2750NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.750% Notes",
        "label": "2.750% Notes [Member]",
        "terseLabel": "2.750% Notes"
       }
      }
     },
     "localname": "A2750NotesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A3250NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.250% Notes",
        "label": "3.250% Notes [Member]",
        "terseLabel": "3.250% Notes"
       }
      }
     },
     "localname": "A3250NotesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$5 Billion Maximum Borrowing Capacity",
        "label": "$5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ALLIANCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALLIANCES [Abstract]",
        "label": "ALLIANCES [Abstract]",
        "terseLabel": "ALLIANCES [Abstract]"
       }
      }
     },
     "localname": "ALLIANCESAbstract",
     "nsuri": "http://www.bms.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bmy_AbecmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abecma",
        "label": "Abecma [Member]",
        "terseLabel": "Abecma"
       }
      }
     },
     "localname": "AbecmaMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability [Member]",
        "label": "Abilify Product Liability [Member]",
        "terseLabel": "Abilify Product Liability"
       }
      }
     },
     "localname": "AbilifyProductLiabilityMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbraxaneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abraxane [Member]",
        "label": "Abraxane [Member]",
        "terseLabel": "Abraxane"
       }
      }
     },
     "localname": "AbraxaneMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest",
        "label": "Accrued Interest",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedRebatesAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.",
        "label": "Accrued rebates and returns",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "AccruedRebatesAndReturns",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.",
        "label": "Accrued Research And Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquiredIPRD": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired IPRD",
        "label": "Acquired IPRD",
        "terseLabel": "Acquired IPRD"
       }
      }
     },
     "localname": "AcquiredIPRD",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquisitionsDivestituresandOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "label": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "terseLabel": "Acquisitions, Divestitures and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "AcquisitionsDivestituresandOtherArrangementsAbstract",
     "nsuri": "http://www.bms.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bmy_AllianceRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliance Revenues",
        "label": "Alliance Revenues [Member]",
        "terseLabel": "Alliance revenues"
       }
      }
     },
     "localname": "AllianceRevenuesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AllianceandotherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliance and other revenues [Member]",
        "label": "Alliance and other revenues [Member]",
        "terseLabel": "Alliance and other revenues"
       }
      }
     },
     "localname": "AllianceandotherrevenuesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AmortizationOfDeferredIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 2.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of deferred income",
        "label": "Amortization of deferred income",
        "negatedTerseLabel": "Amortization of deferred income"
       }
      }
     },
     "localname": "AmortizationOfDeferredIncome",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AmortizationofAcquiredIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Acquired Intangible Assets",
        "label": "Amortization of Acquired Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationofAcquiredIntangibleAssets",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AntiPD1AntibodyLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti-PD-1 Antibody Litigation [Member]",
        "label": "Anti-PD-1 Antibody Litigation [Member]",
        "terseLabel": "Anti-PD-1 Antibody Litigation"
       }
      }
     },
     "localname": "AntiPD1AntibodyLitigationMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AssetAcquisitionPercentageOfOwnershipAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Percentage of Ownership Acquired",
        "label": "Asset Acquisition, Percentage of Ownership Acquired",
        "terseLabel": "Percentage of ownership acquired"
       }
      }
     },
     "localname": "AssetAcquisitionPercentageOfOwnershipAcquired",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_BreyanziMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breyanzi",
        "label": "Breyanzi [Member]",
        "terseLabel": "Breyanzi"
       }
      }
     },
     "localname": "BreyanziMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BristolMyersSquibbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bristol-Myers Squibb",
        "label": "Bristol-Myers Squibb [Member]",
        "terseLabel": "Bristol-Myers Squibb"
       }
      }
     },
     "localname": "BristolMyersSquibbMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BusinessRoyaltyAndLicensingIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Royalty And Licensing Income",
        "label": "Business Royalty And Licensing Income",
        "negatedTerseLabel": "Royalty and licensing income (Note 4)"
       }
      }
     },
     "localname": "BusinessRoyaltyAndLicensingIncome",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_BusinessSaleRoyaltyIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents royalty income recognized in other income during the period related to the sale of a business.",
        "label": "Business Sale Royalty Income",
        "negatedTerseLabel": "Royalty income - divestiture (Note 4)"
       }
      }
     },
     "localname": "BusinessSaleRoyaltyIncome",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CARTKiteLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAR T Kite Litigation [Member]",
        "label": "CAR T Kite Litigation [Member]",
        "terseLabel": "CAR T Kite Litigation"
       }
      }
     },
     "localname": "CARTKiteLitigationMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CamzyosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Camzyos",
        "label": "Camzyos [Member]",
        "terseLabel": "Camzyos"
       }
      }
     },
     "localname": "CamzyosMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CashDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reductions to trade receivables incurred during the period attributable to cash discounts.",
        "label": "Cash Discounts",
        "negatedTerseLabel": "Less: charge-backs and cash discounts"
       }
      }
     },
     "localname": "CashDiscounts",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Cashoutlays": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outlays",
        "label": "Cash outlays",
        "terseLabel": "Cash outlays"
       }
      }
     },
     "localname": "Cashoutlays",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CelgeneContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Contingent Value Rights [Member]",
        "label": "Celgene Contingent Value Rights [Member]",
        "terseLabel": "Celgene Contingent Value Rights"
       }
      }
     },
     "localname": "CelgeneContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CelgeneIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Integration [Member]",
        "label": "Celgene Integration [Member]",
        "terseLabel": "Celgene Acquisition Plan"
       }
      }
     },
     "localname": "CelgeneIntegrationMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ChargebacksandcashdiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charge-backs and cash discounts [Member]",
        "label": "Charge-backs and cash discounts [Member]",
        "terseLabel": "Charge-backs and cash discounts"
       }
      }
     },
     "localname": "ChargebacksandcashdiscountsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CheplapharmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cheplapharm",
        "label": "Cheplapharm [Member]",
        "terseLabel": "Cheplapharm"
       }
      }
     },
     "localname": "CheplapharmMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CollaborativeArrangementContingentPaymentsMaximumExposure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement Contingent Payments Maximum Exposure",
        "label": "Collaborative Arrangement Contingent Payments Maximum Exposure",
        "terseLabel": "Contingent sales-based milestones"
       }
      }
     },
     "localname": "CollaborativeArrangementContingentPaymentsMaximumExposure",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CommonStock0.10ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CommonStock010ParValueMember",
        "label": "Common Stock $0.10 Par Value [Member]",
        "terseLabel": "Common Stock $0.10 Par Value"
       }
      }
     },
     "localname": "CommonStock0.10ParValueMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ContingentAndRegulatoryMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone Payments",
        "label": "Contingent and Regulatory Milestone Payments",
        "terseLabel": "Contingent and regulatory milestone payments"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestonePayments",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentRegulatoryMilestoneIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 1.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Regulatory Milestone Income",
        "label": "Contingent Regulatory Milestone Income",
        "negatedTerseLabel": "Contingent milestone income"
       }
      }
     },
     "localname": "ContingentRegulatoryMilestoneIncome",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BMY Contingent Value Rights [Member]",
        "label": "Contingent Value Rights [Member]",
        "terseLabel": "Contingent value rights"
       }
      }
     },
     "localname": "ContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DiabetesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes business [Member]",
        "label": "Diabetes Business [Member]",
        "terseLabel": "Diabetes business"
       }
      }
     },
     "localname": "DiabetesBusinessMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Divestitureandotherproceeds": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.",
        "label": "Divestiture and other proceeds",
        "terseLabel": "Divestiture and other proceeds"
       }
      }
     },
     "localname": "Divestitureandotherproceeds",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Divestituregainsandroyalties": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the amount of gains and royalties as a result of business divestitures.",
        "label": "Divestiture gains and royalties",
        "negatedTerseLabel": "Divestiture gains and royalties"
       }
      }
     },
     "localname": "Divestituregainsandroyalties",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_DragonflyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dragonfly",
        "label": "Dragonfly [Member]",
        "terseLabel": "Dragonfly"
       }
      }
     },
     "localname": "DragonflyMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "terseLabel": "Earnings per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_EliquisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliquis [Member]",
        "terseLabel": "Eliquis"
       }
      }
     },
     "localname": "EliquisMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments",
        "label": "Equity investments",
        "totalLabel": "Total equity investments"
       }
      }
     },
     "localname": "EquityInvestments",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - non-current",
        "label": "Equity investments - non-current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsNonCurrent",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity [Line Items]",
        "label": "Equity [Line Items]",
        "terseLabel": "Equity [Line Items]",
        "verboseLabel": "Equity [Line Items]"
       }
      }
     },
     "localname": "EquityLineItems",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_EquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity",
        "label": "Equity [Table]",
        "terseLabel": "Equity [Table]"
       }
      }
     },
     "localname": "EquityTable",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments",
        "label": "Gross to Net Adjustments",
        "negatedTerseLabel": "Total GTN adjustments"
       }
      }
     },
     "localname": "GrosstoNetAdjustments",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_GrosstoNetAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Axis]",
        "terseLabel": "Gross to Net Adjustments [Axis]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsAxis",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Domain]",
        "terseLabel": "Gross to Net Adjustments [Domain]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsDomain",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_GrosstoNetAdjustmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Gross to Net Adjustments [Table]",
        "label": "Gross to Net Adjustments [Line Items]",
        "terseLabel": "Gross to Net Adjustments [Line Items]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsLineItems",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_ImmaticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immatics",
        "label": "Immatics [Member]",
        "terseLabel": "Immatics"
       }
      }
     },
     "localname": "ImmaticsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InLineProductsAndNewProductPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-line products and new product portfolio",
        "label": "In-line products and new product portfolio [Member]",
        "terseLabel": "Total In-Line Products and New Product Portfolio"
       }
      }
     },
     "localname": "InLineProductsAndNewProductPortfolioMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InLineProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-line products",
        "label": "In-line products [Member]",
        "terseLabel": "In-Line Products"
       }
      }
     },
     "localname": "InLineProductsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InrebicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inrebic [Member]",
        "label": "Inrebic [Member]",
        "terseLabel": "Inrebic"
       }
      }
     },
     "localname": "InrebicMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InventoryPurchasePriceFairValueAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Purchase Price Fair Value Adjustment",
        "label": "Inventory Purchase Price Fair Value Adjustment [Member]",
        "terseLabel": "Inventory Purchase Price Fair Value Adjustment"
       }
      }
     },
     "localname": "InventoryPurchasePriceFairValueAdjustmentMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_KeytrudaRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Keytruda Royalties",
        "label": "Keytruda Royalties [Member]",
        "terseLabel": "Keytruda Royalties"
       }
      }
     },
     "localname": "KeytrudaRoyaltiesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LOEProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOE products",
        "label": "LOE products [Member]",
        "terseLabel": "Recent LOE Products"
       }
      }
     },
     "localname": "LOEProductsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LegalProceedingsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Proceedings And Contingencies [Line Items]",
        "terseLabel": "Legal Proceedings And Contingencies [Line Items]"
       }
      }
     },
     "localname": "LegalProceedingsAndContingenciesLineItems",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicenseAndOtherArrangementsUpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and Other Arrangements Upfront Payments",
        "label": "License and Other Arrangements Upfront Payments",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "localname": "LicenseAndOtherArrangementsUpfrontPayments",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Axis]",
        "terseLabel": "Licensing and Other Arrangements [Axis]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsAxis",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingAndOtherArrangementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Domain]",
        "terseLabel": "Licensing and Other Arrangements [Domain]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsDomain",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LicensingAndOtherArrangementsIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements Income",
        "label": "Licensing and Other Arrangements Income",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsIncome",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Table Text Block]",
        "terseLabel": "Licensing and Other Arrangements"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsTableTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_LicensingArrangementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements",
        "label": "Licensing Arrangements [Line Items]",
        "terseLabel": "Licensing Arrangements [Line Items]"
       }
      }
     },
     "localname": "LicensingArrangementsLineItems",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingArrangementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements [Table]",
        "label": "Licensing Arrangements [Table]",
        "terseLabel": "Licensing Arrangements [Table]"
       }
      }
     },
     "localname": "LicensingArrangementsTable",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LitigationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation [Table]",
        "terseLabel": "Litigation [Table]"
       }
      }
     },
     "localname": "LitigationTable",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LongTermDebtRenewalPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Renewal Period",
        "label": "Long-term Debt, Renewal Period",
        "terseLabel": "Renewal period (in years)"
       }
      }
     },
     "localname": "LongTermDebtRenewalPeriod",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberActive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Active",
        "label": "Loss Contingency, Pending Claims, Number, Active",
        "terseLabel": "Pending claims, active"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberActive",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberClassAction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Class Action",
        "label": "Loss Contingency, Pending Claims, Number, Class Action",
        "terseLabel": "Class action claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberClassAction",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Dismissed",
        "label": "Loss Contingency, Pending Claims, Number, Dismissed",
        "terseLabel": "Dismissed cases"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberDismissed",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "label": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "terseLabel": "Individual injury claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberIndividualInjuryClaims",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_MarketShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market share units [Member]",
        "terseLabel": "Market share units"
       }
      }
     },
     "localname": "MarketShareUnitsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureAndOtherBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature and Other Brands",
        "label": "Mature and Other Brands [Member]",
        "terseLabel": "Mature and other products"
       }
      }
     },
     "localname": "MatureAndOtherBrandsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureBrandsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature Brands and Other",
        "label": "Mature Brands and Other [Member]",
        "terseLabel": "Mature products and other"
       }
      }
     },
     "localname": "MatureBrandsAndOtherMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MedicaidandMedicarerebatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Medicare rebates [Member]",
        "label": "Medicaid and Medicare rebates [Member]",
        "terseLabel": "Medicaid and Medicare rebates"
       }
      }
     },
     "localname": "MedicaidandMedicarerebatesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MolinaLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molina Litigation",
        "label": "Molina Litigation [Member]",
        "terseLabel": "Molina Litigation"
       }
      }
     },
     "localname": "MolinaLitigationMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MyoKardiaAcquisitionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MyoKardia Acquisition Plan",
        "label": "MyoKardia Acquisition Plan [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "MyoKardiaAcquisitionPlanMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NetProductSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net product sales [Member]",
        "label": "Net Product Sales [Member]",
        "terseLabel": "Net product sales"
       }
      }
     },
     "localname": "NetProductSalesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NewProductPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New product portfolio",
        "label": "New product portfolio [Member]",
        "terseLabel": "New Product Portfolio"
       }
      }
     },
     "localname": "NewProductPortfolioMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NimbusTherapeuticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nimbus Therapeutics",
        "label": "Nimbus Therapeutics [Member]",
        "terseLabel": "Nimbus Therapeutics"
       }
      }
     },
     "localname": "NimbusTherapeuticsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NimbusTherapueticsTYK2InhibitorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nimbus Therapuetics TYK2 Inhibitor",
        "label": "Nimbus Therapuetics TYK2 Inhibitor [Member]",
        "terseLabel": "Nimbus Therapuetics TYK2 Inhibitor"
       }
      }
     },
     "localname": "NimbusTherapueticsTYK2InhibitorMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NumberOfLargestPharmaceuticalWholesalers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of the largest pharmaceutical wholesalers used by the company in the territory.",
        "label": "Number Of Largest Pharmaceutical Wholesalers",
        "terseLabel": "Number of largest pharmaceutical wholesalers"
       }
      }
     },
     "localname": "NumberOfLargestPharmaceuticalWholesalers",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_OnglyzaProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onglyza Product Liability Litigation",
        "label": "Onglyza Product Liability Litigation [Member]",
        "terseLabel": "Onglyza Product Liability Litigation"
       }
      }
     },
     "localname": "OnglyzaProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OnuregMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onureg",
        "label": "Onureg [Member]",
        "terseLabel": "Onureg"
       }
      }
     },
     "localname": "OnuregMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdivoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Opdivo [Member]",
        "terseLabel": "Opdivo"
       }
      }
     },
     "localname": "OpdivoMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdualagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opdualag",
        "label": "Opdualag [Member]",
        "terseLabel": "Opdualag"
       }
      }
     },
     "localname": "OpdualagMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OptOutEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opt-Out Entities",
        "label": "Opt-Out Entities [Member]",
        "terseLabel": "Opt-Out Entities"
       }
      }
     },
     "localname": "OptOutEntitiesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OrenciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Orencia [Member]",
        "terseLabel": "Orencia"
       }
      }
     },
     "localname": "OrenciaMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.",
        "label": "Other Other Income Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherOtherIncomeExpense",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Region [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRegionMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues [Member]",
        "label": "Other Revenues [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherRevenuesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Royalties",
        "label": "Other Royalties [Member]",
        "terseLabel": "Other Royalties"
       }
      }
     },
     "localname": "OtherRoyaltiesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherrebatesreturnsdiscountsandadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other rebates, returns, discounts and adjustments [Member]",
        "label": "Other rebates, returns, discounts and adjustments [Member]",
        "terseLabel": "Other rebates, returns, discounts and adjustments"
       }
      }
     },
     "localname": "OtherrebatesreturnsdiscountsandadjustmentsMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Stock Option Exercises And Other Adjustments",
        "label": "Payments For (Proceeds From) Stock Option Exercises And Other Adjustments",
        "terseLabel": "Stock option proceeds and other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_PercentageOfAggregateTotalTradeReceivablesDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.",
        "label": "Percentage Of Aggregate Total Trade Receivables Due",
        "terseLabel": "Percent of aggregate total trade receivables due from three pharmaceutical wholesalers"
       }
      }
     },
     "localname": "PercentageOfAggregateTotalTradeReceivablesDue",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_PlavixAustraliaIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Australia Intellectual Property [Member]",
        "label": "Plavix Australia Intellectual Property [Member]",
        "terseLabel": "Plavix Australia Intellectual Property"
       }
      }
     },
     "localname": "PlavixAustraliaIntellectualPropertyMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PomalystImnovidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pomalyst/Imnovid [Member]",
        "label": "Pomalyst/Imnovid [Member]",
        "terseLabel": "Pomalyst/Imnovid"
       }
      }
     },
     "localname": "PomalystImnovidMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Period Gross to Net Adjustment Impacted by New Accounting Pronouncement",
        "label": "Prior Period Gross to Net Adjustment Impacted by New Accounting Pronouncement",
        "terseLabel": "Prior period gross to net adjustment impacted by new accounting pronouncement"
       }
      }
     },
     "localname": "PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ReblozylMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reblozyl [Member]",
        "label": "Reblozyl [Member]",
        "terseLabel": "Reblozyl"
       }
      }
     },
     "localname": "ReblozylMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReceivablesSoldOnNonrecourseBasis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables sold on a nonrecourse basis during the year.",
        "label": "Receivables Sold On Nonrecourse Basis",
        "terseLabel": "Non-U.S. receivables sold on a nonrecourse basis"
       }
      }
     },
     "localname": "ReceivablesSoldOnNonrecourseBasis",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "label": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "terseLabel": "Revenue Recognition Gross-To-Net Adjustments"
       }
      }
     },
     "localname": "ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ResearchAndDevelopmentExpenseCollaborativeArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.",
        "label": "Research and Development Expense, Collaborative Arrangement",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseCollaborativeArrangement",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ResearchAndDevelopmentNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development - Non-Current",
        "label": "Research and development - Non-Current",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentNonCurrent",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ResearchandDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development",
        "label": "Research and Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchandDevelopment",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "label": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesExcludingAcceleratedStockbasedCompensation",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RevlimidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revlimid [Member]",
        "label": "Revlimid [Member]",
        "terseLabel": "Revlimid"
       }
      }
     },
     "localname": "RevlimidMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_RoyaltyGuaranteesCommitmentsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Guarantees Commitments, Percent",
        "label": "Royalty Guarantees Commitments, Percent",
        "terseLabel": "Running royalty"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercent",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bmy_SalesRevenueGrossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross [Member]",
        "label": "Sales Revenue, Gross [Member]",
        "terseLabel": "Gross product sales"
       }
      }
     },
     "localname": "SalesRevenueGrossMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ScheduleOfEquityInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Equity Investments",
        "label": "Schedule of Equity Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfEquityInvestmentsTableTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfOtherIncomeExpenseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Income Expense [Text Block]",
        "terseLabel": "Schedule Of Other Income Expense"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeExpenseTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Schedule of Provision for Income Taxes [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfProvisionForIncomeTaxesTableTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Schedule Of Share Based Compensation Additional Information [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation Additional Information"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_SettlementContingentDevelopmentChangeInControlProceeds": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement, Contingent Development, Change In Control Proceeds",
        "label": "Settlement, Contingent Development, Change In Control Proceeds",
        "terseLabel": "Change in control proceeds"
       }
      }
     },
     "localname": "SettlementContingentDevelopmentChangeInControlProceeds",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_SotyktuMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sotyktu",
        "label": "Sotyktu [Member]",
        "terseLabel": "Sotyktu"
       }
      }
     },
     "localname": "SotyktuMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SprycelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sprycel [Member]",
        "terseLabel": "Sprycel"
       }
      }
     },
     "localname": "SprycelMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SupplementalFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Financial Information [Abstract]",
        "label": "Supplemental Financial Information [Abstract]",
        "terseLabel": "Supplemental Financial Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalFinancialInformationAbstract",
     "nsuri": "http://www.bms.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bmy_TecentriqRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tecentriq royalties",
        "label": "Tecentriq royalties [Member]",
        "terseLabel": "Tecentriq royalties"
       }
      }
     },
     "localname": "TecentriqRoyaltiesMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Totalinventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the total inventory, current and non-current, as of the balance sheet date.",
        "label": "Total inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "Totalinventories",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UnamortizedBasisAdjustmentFromSwapTerminations": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.",
        "label": "Unamortized Basis Adjustment From Swap Terminations",
        "terseLabel": "Unamortized basis adjustment from swap terminations"
       }
      }
     },
     "localname": "UnamortizedBasisAdjustmentFromSwapTerminations",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_YervoyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yervoy [Member]",
        "terseLabel": "Yervoy"
       }
      }
     },
     "localname": "YervoyMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ZeposiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zeposia",
        "label": "Zeposia [Member]",
        "terseLabel": "Zeposia"
       }
      }
     },
     "localname": "ZeposiaMember",
     "nsuri": "http://www.bms.com/20230331",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "terseLabel": "Australia, Dollars"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "Currency [Domain]",
        "verboseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r427",
      "r455",
      "r691",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r496",
      "r637",
      "r658",
      "r680",
      "r681",
      "r706",
      "r719",
      "r730",
      "r796",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r496",
      "r637",
      "r658",
      "r680",
      "r681",
      "r706",
      "r719",
      "r730",
      "r796",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r361",
      "r638",
      "r707",
      "r728",
      "r791",
      "r792",
      "r798",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r361",
      "r638",
      "r707",
      "r728",
      "r791",
      "r792",
      "r798",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r488",
      "r496",
      "r523",
      "r524",
      "r525",
      "r613",
      "r637",
      "r658",
      "r680",
      "r681",
      "r706",
      "r719",
      "r730",
      "r784",
      "r796",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r488",
      "r496",
      "r523",
      "r524",
      "r525",
      "r613",
      "r637",
      "r658",
      "r680",
      "r681",
      "r706",
      "r719",
      "r730",
      "r784",
      "r796",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r427",
      "r455",
      "r692",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r362",
      "r363",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r708",
      "r729",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r362",
      "r363",
      "r665",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r708",
      "r729",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Account Receivables [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts payable \u2013 to alliance partners"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r251",
      "r365",
      "r366",
      "r685"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Net trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r202",
      "r217"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r17",
      "r202",
      "r217"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r206",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued Liabilities",
        "terseLabel": "Accrued liabilities for CERCLA matters"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r35",
      "r688"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r121",
      "r240"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r49",
      "r54",
      "r801"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r260",
      "r264",
      "r266",
      "r267",
      "r586"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation(a)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r51",
      "r53",
      "r54",
      "r253",
      "r650",
      "r663",
      "r664"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r54",
      "r171",
      "r606",
      "r659",
      "r660",
      "r746",
      "r747",
      "r748",
      "r758",
      "r759",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Supplemental Financial Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r20",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value of stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r533",
      "r534",
      "r535",
      "r758",
      "r759",
      "r760",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital\u00a0in Excess of Par Value of\u00a0Stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r254",
      "r367",
      "r378"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Less: allowance for expected credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r80",
      "r108",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r200",
      "r216",
      "r244",
      "r296",
      "r345",
      "r355",
      "r359",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r565",
      "r569",
      "r588",
      "r727",
      "r794",
      "r795",
      "r815"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r236",
      "r257",
      "r296",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r565",
      "r569",
      "r588",
      "r727",
      "r794",
      "r795",
      "r815"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r369",
      "r384"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r100",
      "r368",
      "r384",
      "r642"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable debt securities, fair value",
        "verboseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r178",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r558",
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r156",
      "r157",
      "r558",
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r162",
      "r163",
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Integration expenses (Note 6)"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r158",
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r82",
      "r238",
      "r683"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Money market and other securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r75",
      "r82",
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r75",
      "r193"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Pre-tax gains"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r296",
      "r317",
      "r321",
      "r323",
      "r325",
      "r332",
      "r333",
      "r376",
      "r415",
      "r417",
      "r418",
      "r419",
      "r422",
      "r423",
      "r453",
      "r454",
      "r457",
      "r461",
      "r468",
      "r588",
      "r682",
      "r738",
      "r753",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r560",
      "r561",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Alliances"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Alliance revenues"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Alliance Statement [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r207",
      "r225"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r758",
      "r759",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r272",
      "r274",
      "r283",
      "r646",
      "r654"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to BMS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r168",
      "r169",
      "r173",
      "r272",
      "r274",
      "r282",
      "r645",
      "r653"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest",
        "verboseLabel": "Comprehensive income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r167",
      "r173",
      "r272",
      "r274",
      "r281",
      "r644",
      "r652"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r721",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r89",
      "r90",
      "r190",
      "r191",
      "r364",
      "r667",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r87",
      "r89",
      "r90",
      "r91",
      "r190",
      "r192",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r89",
      "r90",
      "r190",
      "r191",
      "r364",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r470",
      "r471",
      "r482"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Performance obligation satisfied in previous period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Obligation to holders of the contingent value rights"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r62",
      "r638"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r799",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-currency swap contracts"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r88",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "verboseLabel": "Short-term debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r136",
      "r294",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r440",
      "r447",
      "r448",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "FINANCING ARRANGEMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r201",
      "r203",
      "r214",
      "r301",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r603",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r203",
      "r214",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r195",
      "r197",
      "r424",
      "r603",
      "r702",
      "r703"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal value",
        "verboseLabel": "Principal value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r438",
      "r587",
      "r702",
      "r703"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r37",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rates"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r301",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r603",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Repaid, Principal",
        "terseLabel": "Debt matured and repaid"
       }
      }
     },
     "localname": "DebtInstrumentRepaidPrincipal",
     "nsuri": "http://fasb.org/us-gaap-sup/2022q3",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r138",
      "r139",
      "r140",
      "r141",
      "r194",
      "r195",
      "r197",
      "r213",
      "r301",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r603",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r194",
      "r197",
      "r797"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized bond discounts and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r194",
      "r197",
      "r797"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Unamortized purchase price adjustments of Celgene debt"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Reasonably possible decrease in unrecognized tax benefits"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncome": {
     "auth_ref": [
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Income",
        "terseLabel": "Deferred income from - alliances"
       }
      }
     },
     "localname": "DeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeNoncurrent": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Income, Noncurrent",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredIncomeNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r80",
      "r154",
      "r544",
      "r549",
      "r550",
      "r756"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r199",
      "r215",
      "r485",
      "r486",
      "r487",
      "r716"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r80",
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r80",
      "r342"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization, net"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r258",
      "r259",
      "r587",
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Variable rate debt, lower range of basis point spread"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r807"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain (loss) on derivative, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r179",
      "r180",
      "r183",
      "r184",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r177",
      "r179",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r177",
      "r179",
      "r183",
      "r184",
      "r186",
      "r187",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r258",
      "r259",
      "r587",
      "r693"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Fair value of interest rate swap contracts",
        "verboseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r481",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r500",
      "r528",
      "r529",
      "r531",
      "r536",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Employee Stock Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r396",
      "r751",
      "r783"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedLabel": "Divestiture (Gains)/Losses",
        "negatedTerseLabel": "Divestiture gains (Note 4)",
        "terseLabel": "Divestiture gain"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r315",
      "r317",
      "r323",
      "r324",
      "r325",
      "r329",
      "r580",
      "r581",
      "r647",
      "r655",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per common share attributable to BMS, basic (in usd per share)",
        "verboseLabel": "Earnings per common share, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r317",
      "r323",
      "r324",
      "r325",
      "r329",
      "r580",
      "r581",
      "r647",
      "r655",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per common share attributable to BMS, diluted (in usd per share)",
        "verboseLabel": "Earnings per common share, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r592"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rates on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements": {
     "auth_ref": [
      "r802",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Percent",
        "terseLabel": "Decrease in effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r530"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Excess tax benefits from share-based compensation awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r137",
      "r233",
      "r275",
      "r276",
      "r277",
      "r302",
      "r303",
      "r304",
      "r306",
      "r312",
      "r314",
      "r331",
      "r377",
      "r469",
      "r533",
      "r534",
      "r535",
      "r545",
      "r546",
      "r579",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r606",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r103",
      "r346",
      "r741"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 2.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Limited partnerships and other equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFVNIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI [Abstract]",
        "terseLabel": "Equity investments with readily determined fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r245",
      "r585",
      "r686"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 1.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity investments",
        "verboseLabel": "Equity investments with readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r656",
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "negatedTerseLabel": "Net gain recognized on investments sold"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r656",
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Net loss recognized"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 3.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GainLossOnInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "terseLabel": "Impairments and downward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "terseLabel": "Cumulative impairment amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r375"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossOnInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "negatedTerseLabel": "Upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Cumulative upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r582",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r438",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r583",
      "r610",
      "r611",
      "r612",
      "r702",
      "r703",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r438",
      "r489",
      "r494",
      "r583",
      "r610",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r438",
      "r489",
      "r494",
      "r583",
      "r611",
      "r702",
      "r703",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r438",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r583",
      "r612",
      "r702",
      "r703",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r438",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r610",
      "r611",
      "r612",
      "r702",
      "r703",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r178",
      "r182",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r370",
      "r371",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r449",
      "r466",
      "r577",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r698",
      "r764",
      "r765",
      "r766",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r242",
      "r393"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r390",
      "r392",
      "r393",
      "r395",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r113",
      "r640"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross carrying amounts"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r109",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyDerivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Derivatives [Abstract]",
        "terseLabel": "Foreign exchange contracts gain/(loss):"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transaction [Abstract]",
        "terseLabel": "Foreign Currency Transaction [Abstract]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r693",
      "r714",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r65",
      "r99",
      "r737"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedLabel": "Equity investment losses",
        "negatedTerseLabel": "Equity investment losses (Note 9)",
        "negatedTotalLabel": "Total Equity investment losses"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r788"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation and other settlements (a)"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r80",
      "r134",
      "r135"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt redemption (Note 10)"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralCashFlowHedgeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Cash Flow Hedge Information [Abstract]",
        "terseLabel": "Derivatives designated as cash flow hedges"
       }
      }
     },
     "localname": "GeneralCashFlowHedgeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r241",
      "r389",
      "r641",
      "r700",
      "r727",
      "r770",
      "r777"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at March 31, 2023",
        "periodStartLabel": "Balance at December 31, 2022",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r155",
      "r778"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Currency translation and other adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r177",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r80",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of other intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r80",
      "r118"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r58",
      "r198",
      "r209",
      "r230",
      "r345",
      "r354",
      "r358",
      "r360",
      "r648",
      "r697"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r59",
      "r80",
      "r103",
      "r208",
      "r228",
      "r343"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_GainLossOnInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net loss of affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r123",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r397",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r297",
      "r541",
      "r542",
      "r543",
      "r547",
      "r551",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r298",
      "r313",
      "r314",
      "r344",
      "r539",
      "r548",
      "r553",
      "r657"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "auth_ref": [
      "r802"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "terseLabel": "Income tax reserves"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax payments"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r325",
      "r499"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Incremental shares attributable to share-based compensation plans (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r391",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r110",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r107",
      "r111"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r196",
      "r211",
      "r278",
      "r341",
      "r602"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense (Note 10)"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r288",
      "r292",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r105",
      "r689"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r255",
      "r684",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Other non-current assets",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r105",
      "r744"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw and packaging materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r105",
      "r690"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r64",
      "r340"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Recognized in Other comprehensive income"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings and Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r34",
      "r296",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r566",
      "r569",
      "r570",
      "r588",
      "r696",
      "r794",
      "r815",
      "r816"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r205",
      "r222",
      "r727",
      "r755",
      "r768",
      "r811"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r237",
      "r296",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r566",
      "r569",
      "r570",
      "r588",
      "r727",
      "r794",
      "r815",
      "r816"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r203",
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r203",
      "r219",
      "r437",
      "r452",
      "r702",
      "r703"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/FINANCINGARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-Term Debt, Term",
        "terseLabel": "Long-term debt, term (in years)"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Damages paid"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [
      "r789",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r789",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery, equipment and fixtures"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r11",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r44",
      "r204",
      "r221",
      "r296",
      "r376",
      "r415",
      "r417",
      "r418",
      "r419",
      "r422",
      "r423",
      "r588"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in)/provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r75",
      "r78",
      "r81"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r60",
      "r81",
      "r210",
      "r229",
      "r235",
      "r270",
      "r273",
      "r277",
      "r296",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r322",
      "r345",
      "r354",
      "r358",
      "r360",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r581",
      "r588",
      "r697",
      "r794"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to BMS",
        "verboseLabel": "Net earnings attributable to BMS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r165",
      "r469",
      "r758",
      "r759",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85",
      "r86",
      "r95",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r256",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r178",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets",
        "totalLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r48",
      "r51",
      "r495"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Actuarial gains/(losses), after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Actuarial gains/(losses), tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax": {
     "auth_ref": [
      "r52",
      "r167"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax",
        "negatedTerseLabel": "Settlements, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r47",
      "r51",
      "r589",
      "r590",
      "r593"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation",
        "verboseLabel": "Foreign currency translation, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r46",
      "r51",
      "r589",
      "r590",
      "r593"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Non-derivatives designated as net investment hedges",
        "verboseLabel": "Foreign currency translation, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r262",
      "r263",
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Unrealized (losses)/gains, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r262",
      "r263",
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Marketable debt securities",
        "verboseLabel": "Unrealized (losses)/gains, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r262",
      "r263",
      "r265"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "negatedTerseLabel": "Unrealized (losses)/gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r104",
      "r280",
      "r594",
      "r599",
      "r601",
      "r643",
      "r651",
      "r746",
      "r747"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive income, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges",
        "totalLabel": "Derivatives qualifying as cash flow hedges, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "totalLabel": "Derivatives qualifying as cash flow hedges, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTotalLabel": "Derivatives qualifying as cash flow hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized (losses)/gains, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r261",
      "r264",
      "r571",
      "r572",
      "r576"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in Other comprehensive income",
        "verboseLabel": "Unrealized (losses)/gains, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Unrealized (losses)/gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r264",
      "r268"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassified to net earnings, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r264",
      "r268",
      "r573"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Reclassified to net earnings, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Reclassified to net earnings, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r51",
      "r55",
      "r147"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Settlements, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r51",
      "r55",
      "r147"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Settlements, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r46",
      "r52",
      "r591",
      "r600"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Foreign currency translation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Derivatives designated as net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r57",
      "r137",
      "r271",
      "r274",
      "r280",
      "r594",
      "r599",
      "r601",
      "r643",
      "r651",
      "r746",
      "r747"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, after tax",
        "totalLabel": "Total Other comprehensive (loss)/income",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of taxes and reclassifications to earnings:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r49",
      "r51",
      "r716",
      "r800"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTotalLabel": "Pension and postretirement benefits, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r49",
      "r51"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits",
        "negatedTotalLabel": "Pension and postretirement benefits, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r48",
      "r51",
      "r147"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Actuarial gains/(losses), pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r49",
      "r52",
      "r167"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "totalLabel": "Pension and postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r51",
      "r55",
      "r269",
      "r495"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r51",
      "r55",
      "r269",
      "r495"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Amortization, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Amortization, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r52",
      "r275",
      "r280",
      "r539",
      "r552",
      "r554",
      "r594",
      "r597",
      "r601",
      "r643",
      "r651"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTotalLabel": "Other comprehensive income, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r693",
      "r714",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Total return swap contracts"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r146",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other (Income)/Expense, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "terseLabel": "Other (income)/expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income)/expense, net",
        "negatedTotalLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Reclassified to Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r745",
      "r769"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Alliance, royalties, VAT and other"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other termination costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-Term Borrowings",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r400",
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "terseLabel": "Payments for royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "Payment for debt extinguishment"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition and other payments, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r485",
      "r486",
      "r487",
      "r716"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r687",
      "r699",
      "r769"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from divestiture of businesses, net of cash divested",
        "verboseLabel": "Net Proceeds"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r749"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Net proceeds of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Proceeds from legal settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Short-term debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r98",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Sale and maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": {
     "auth_ref": [
      "r289",
      "r372"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Proceeds from Sale of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sales of equity investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r235",
      "r270",
      "r273",
      "r290",
      "r296",
      "r305",
      "r313",
      "r314",
      "r345",
      "r354",
      "r358",
      "r360",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r564",
      "r567",
      "r568",
      "r581",
      "r588",
      "r648",
      "r697",
      "r722",
      "r723",
      "r748",
      "r794"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r120",
      "r239"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r122",
      "r224",
      "r649",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r223",
      "r231",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables",
        "totalLabel": "Receivables",
        "verboseLabel": "Receivables \u2013 from alliance partners"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r152",
      "r232",
      "r823"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r740",
      "r752",
      "r824",
      "r825"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r82",
      "r84",
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash for contributions and settlements"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r666",
      "r743",
      "r752"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r398",
      "r400",
      "r403",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r399",
      "r402",
      "r406",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and related charges incurred to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r399",
      "r402",
      "r406",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r80",
      "r404",
      "r406",
      "r785"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Provision for restructuring (Note 6)",
        "totalLabel": "Provision for restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "totalLabel": "Total charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r400",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, end of period",
        "periodStartLabel": "Restructuring reserve, beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.",
        "label": "Restructuring and Related Cost, Accelerated Depreciation",
        "terseLabel": "Accelerated depreciation"
       }
      }
     },
     "localname": "RestructuringReserveAcceleratedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r400",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Change in estimates"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r786",
      "r787"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation and other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r21",
      "r142",
      "r220",
      "r662",
      "r664",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r233",
      "r302",
      "r303",
      "r304",
      "r306",
      "r312",
      "r314",
      "r377",
      "r533",
      "r534",
      "r535",
      "r545",
      "r546",
      "r579",
      "r659",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r480",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r279",
      "r296",
      "r338",
      "r339",
      "r353",
      "r356",
      "r357",
      "r361",
      "r362",
      "r364",
      "r376",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r588",
      "r648",
      "r794"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails",
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyIncomeNonoperating": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails": {
       "order": 3.0,
       "parentTag": "bmy_LicensingAndOtherArrangementsIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Income, Nonoperating",
        "negatedLabel": "Royalty Income",
        "negatedTerseLabel": "Royalty income, nonoperating"
       }
      }
     },
     "localname": "RoyaltyIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r54",
      "r813",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r156",
      "r157",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r38",
      "r138",
      "r139",
      "r140",
      "r141",
      "r194",
      "r195",
      "r197",
      "r213",
      "r702",
      "r704",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Long-term Debt and Current Portion of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r179",
      "r183",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives and Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r123",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Divestitures"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings/(Loss) Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r109",
      "r112",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r700",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r25",
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Gross to Net Adjustments [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/REVENUEReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r406",
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r127",
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r126",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r497",
      "r498",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Marketing, selling and administrative",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of units granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Stock compensation (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r28",
      "r227"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-Term Bank Loans and Notes Payable",
        "terseLabel": "Non-U.S. short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r13",
      "r201",
      "r218",
      "r727"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "totalLabel": "Short-term debt, total"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCINGARRANGEMENTSShortTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r296",
      "r317",
      "r321",
      "r323",
      "r325",
      "r332",
      "r333",
      "r376",
      "r415",
      "r417",
      "r418",
      "r419",
      "r422",
      "r423",
      "r453",
      "r454",
      "r457",
      "r461",
      "r468",
      "r588",
      "r682",
      "r738",
      "r753",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r42",
      "r137",
      "r233",
      "r275",
      "r276",
      "r277",
      "r302",
      "r303",
      "r304",
      "r306",
      "r312",
      "r314",
      "r331",
      "r377",
      "r469",
      "r533",
      "r534",
      "r535",
      "r545",
      "r546",
      "r579",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r601",
      "r606",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/CoverPage",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r331",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGS",
      "http://www.bms.com/role/CoverPage",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r142",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r18",
      "r19",
      "r137",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchase program (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r22",
      "r23",
      "r97",
      "r727",
      "r755",
      "r768",
      "r811"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total BMS Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "BMS Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r165",
      "r166",
      "r172",
      "r233",
      "r234",
      "r276",
      "r302",
      "r303",
      "r304",
      "r306",
      "r312",
      "r377",
      "r469",
      "r533",
      "r534",
      "r535",
      "r545",
      "r546",
      "r579",
      "r594",
      "r595",
      "r601",
      "r606",
      "r660",
      "r661",
      "r755",
      "r768",
      "r811"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r295",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r467",
      "r469",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Net Investment Hedge Activity [Abstract]",
        "terseLabel": "Summary of Net Investment Hedge Activity [Abstract]"
       }
      }
     },
     "localname": "SummaryOfNetInvestmentHedgeActivityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired marketed product rights"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r370",
      "r371",
      "r449",
      "r466",
      "r577",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r764",
      "r765",
      "r766",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTax": {
     "auth_ref": [
      "r812"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cumulative translation adjustment attributable to gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Net of Tax",
        "terseLabel": "Net investment hedge gains"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r19",
      "r137",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r143",
      "r144"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Less cost of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r137",
      "r142",
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]",
        "terseLabel": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossOnInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedTerseLabel": "Net unrealized loss recognized on investments still held"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates and Judgements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r316",
      "r325"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average common shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r315",
      "r325"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r732": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r733": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r734": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r735": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r736": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0000014272-23-000104-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000014272-23-000104-xbrl.zip
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M^5([I/X(TH][I?.UEO='8^RG]^]Z,NI<!B*?*^_]S\:3G71(/6Q_>M7QJ'V
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M[J9._YCRUE'=4YXO_6A;E-4.1AKS#8Y'G3XMYN:.*82"& I9CK[ QX@<BW&
MQC3("9>:L+GC3R :,_&Z7A-*9L.@%('V,A1OP9 )&E(AT80YVUF(QK20X;2
MX7DYPT6T'+7TI! F%E\8KY109>;<E+/"5 HTH1K03R(>LQGEPX#!R22B8<=2
M5* 8;#11ANB=P"9%8G,N'M]\CSK4]+!.LM+PB*$_W<3>QVO$#NFHBT>'..PM
MHAQ:M"67$%D0$5C,,.7L=#8LEP9M:,)ZE4E^2B?5K_V#<Z'X* KY2'S^3:?C
MX7'&[<$I=L>=Q=Q,%4*M.NY$K%5!I-,^&Y4U,F$U7I!M@N>98TAGHJ5USU1%
M7F;O#%"MY%DH,*^0K*0L.DT8C?T.2'>)3QL/._]9:#4-421%,0-RQ ""T"!S
M1"\YJ$B18A-6F,TSIK/*HH@AY*1%]I PQU2<Y,\18@H0FI!%\1V83B?B%UE'
M-=I8%PM:\AZRSUZ#5H6U-M8AH.062T=O%<_9Z*>/SCC,VEH-F=VI$*RJ=;"W
M.+(4IB/Q\PCCUX.4]5Z/(Z5T YA=&'"_K@D1)J2Q+M-4TCG 7,UD3AP'$V"$
M9%5385@=XL&@7[HWL%?.C>!@LR8C"T=^&"#6[=OK'C@2@F5M,)\M<I_'&:KO
M,&^;G5X\'NWR<3PZIJHNNWO_5NO]PT[LC =S-<IT86;K1Q("@_6>M"Q2*2!O
M8V!JZ;W1 4L@)>9WYO'6</U!E?_XX71\"S;X!R8]C_N=J5STCVM;WD/>(ZRC
M<@_.[L$?SV]P?N3\>[W#Y<.91:>Z55V..H-Q+D+=?%#Z1*B]>I^"H)1?"EHC
M!(TYM&HK?PU.IA8NBG5'45.8/5N.A51@5IT8P8ADY?R*QH("(K'DZNPUR  J
M22]2,DE(EZ)()IZ7PE3G0>H<(M,8KS]![<I1Z\< _TC2@B8'VK$Q5@ERL2'G
M$"1F581*OA%[R#0)X!GL>%'W4XL.0J($('0(!HFUN:[$0DMN_A/^MFDT'AZG
M\?&0\7W:Q?Y'$V[4/: ^U157!]/YOX:D^0%$1R)G[XL#4!0#9K1&1Z%<G=MM
M-"H;IX-_XS!W<"7]Y[@SFDSIUC,:@DW)REFE$$%-RO)AG41!*Z2NZR%L$TSB
M7($T>QMHA98BREH:*@$YBG6+-)N]LX4HG<UR-A[1VS"&L\<RN9JV;AQK)F,)
M.H"SVJ=@9$I"V":4SYA'+&<S5<WQ'JNB]<H& "!D @K"<*2ADL'4A+5G\VMI
M9S-ID@UE U*B+0#,:;)%5;"@0^%BD]/CGPS21 \_7<TP&F^5JRPL;*2Q=3X5
MC@DU9H-,4VM):6-0%B=0B12;4#AS3N&<S>(O$"EYDNA=W?57HZ% SKF 6AE'
M3>)!5X)SA[I=-L>/V9,.L3M),.UU^AVVU)/51VLG1WS;Q=1<5-D6 62BY3A&
M1HPZI)2R0@LQ-3EG>)ZAGHE6JZA+HH1"D 9!$+Q/RG"<(Y5EN)N02/1=4$_&
M]S8'_<$TY[M_,+WJ#.)%5&823(ME!JP;?%OK$)+%.G94DE1&-R%+MSD(SZ:0
M=8*D$VB5J>X';GRM"!EK=63,+BJ:W_' .O&U78?:IQ#6KQML>'O'-[ $XD:&
M^[*U5B: 2$J R#D:3TJ#$D77TIS8K*['DP9UO4SDLH@<&<H("MAS%>[[F 0:
MM%+*^>WZ<TOU"#O#O[![3'^<OO_X+[XC#M/AZ1-Z0]V+ENW]2>O]H^/Q:'*&
M; A:45C-3D9G[0T([X(7%$1VP=3R;UG]'&BIIJ#E/9,&\%HP72C>HA=66>.#
ML 64;4"AC^M 2S<$+46"[9TF,$&",R*$7 R'Z\%D2U*:^4V^:XXEO+XB('4_
MH""T4J4$D :1.,S*% W5E=RR 45:YM\27A]:9*PE4:>+ D")$"23/-)1IE#8
M,*J? ZV;M837AY;+!85*TMG*R34AJF"SI, _1%/F.!)ZW_N=/O93![OK_3HG
M5*_^9)29AO49'/G2:*NLTM%@='Z_+\*S0';X^KPFD@4P)@H='*CLO*/,$;0I
M61D)L&2DWRDZ-R&X\R(K0I?D2PC6@ 04L6Y6;$.L::R*O;AH@*PTWJXTA8U;
MU%9@\E%F "PY9&LXZ)4J:*>+"@U@#(V7E:;$ AZ(R%I='!K :(.?K*"2D9S3
MQO\D['*1?= U1B)U<V>@B$QH04OR%%TF"2EJD958VI7&^Z#KDY5(/J$"$Q1S
M7,^2$F2Q.H$+(:%L!+?]IJP,>CT:UC.>XM&/U^9JCO>Y1E;KG4X!D]-:U<S)
M("4E98-S)5L5&["ZH\E2TI2Y@+H&R&4@4"J# HNA6&6=4U:B=28LI:2Y'N<:
MI:1822+6@@YU6R"-4D>?,E)0&:UH I-ML)0T)=Z)I"1%=BV./8XL(3ACO"M%
M9)_8OBREI,$>Y_JD))&&7+S*)5?*ZB+4#2:R-]I(]CMZ*27-]3C7)R4F9+"R
M"&UU 5 VVH!&E6B*L4J5.4Z].N_]CPL8?R67<64THF_NAKQ [N;Z2(D.67HE
MBV$! 9LIVKK3)%I+5M21MZ6(--377.,L((I:*+\F;R)(\#6#)F%(P4HGDLY+
M$6FHH[E&*R(5&Q!;,D8/%$20,E'46=:2YNXLQW>NZ4AC1:0I<8UEUU(\&=0<
MQZ @KQU0"=8("X5T S+P&BLB30EJ+!8?DXO*9U$+D@4H07H!=7TS!&N7(M)0
M1W-](H*0:T6M6(S,=0PM>,/D)"7,['J*; !=O0V;?^7&/)SL[W+ ;\"?1OQZ
MTUH8?YS6308_JI;Q_K1)2[8[!X??%-]YH29&$7N:$$N1#IB.>/0Y%N$QJ>**
M+S^'Q%Q;_L!/(#&:#0L'PT66XJ$('31Y&[0B%6.*8;FR8RDQGZZS Z^AKA>6
M(H*Q.J"3#DTN*3H;;!-&8Y=>Z78SE= 9)4J(-EMPV:"ENANQ*DJ'@J8)LSQ+
MKW2[P9%#%IK"5B9XL""0LB =P+@@@\:?1&(6WRM=XTRR-0A8*Y3H!,6'&+TM
M(H.POI RL0$\9OZ25:]Q 7&J15"MC9$[+CCP*B-X)T)&3'0&SWPK]/S!<XTS
M[#:)0DZC!U.K**(B20R4 4*2)BV"]GS7#/N\Z U;,U4RDZ5( -QK7F3RF12D
M:(*EA=";6P3F^C0&0 MA0F:[)B"EZ+,54F7K!!HAFS VM\HO^V92S^P#,MN=
MT>M/>,E@2)V#_MI).JS%82I%&&+ZX23\R0X7Q\,A]=/I]('I[-O]M>?;/\YX
M_D7YH.[J3"-N_"4CT^<'**^,SL[]T L-L0T(LHX&&XPB@2J$Z-!J22E&I1HQ
M53VO(OCGT[VE"%Z)UDE1?&+18'('P2(:ZXJ(*@H?I=.P*"+X<#@8C<Z%I=;1
M'M)HO,W879<P?JTYH\?8Z3_A!OQQ>B8GV]2=[D]_V#GZI*$X.GS4';P].W%I
MIF>O(U220TV1"7;=0EMC@8Q)R)(,!1L7QDS?FH[\#$)3G+8R4H*  60MO$N>
M2#LK@[>4YGA:YJ;=ZE(8;W^.T*2L*6BB4.OP@[>ZEHHMTAFKR>OY%<8Y$YHF
MN]-;HS";-%[OO^&>KQ=>C<?,BZ* AQ"<=L5( 53S0RW:7).ZLM <I\V_HBRH
M.7N_ 2T=?[[[;&<T "7=!Q7\CNUG4Y&Z>&.M$P[ 0-#"DS. 3OF8(#:H7/I?
M..Q@[%(U>!=!?S+HYT%_8A C]E]OE<*6,=?SGJS_L;5]_;#/ODBZ*\YC$;Z6
MZ($:Y$H4E)2PBDS=5WC^-?G;V9G7FY@YM[[GFP-*_/4M#O/\6J^+Q5T+(60I
M)<LBI)2\!2U]B/Q_A\HV8,AE*2FW1-N+SE*(D).VD$3PQ6;C!0N+$C+8A5@0
M^81=5J?+;5Z:L68)9V1.A,IE9[0 HR*ZF#($8P.0R*8!681+!SM/DGF-Z\@+
M,[R0M(^J5$?KR9)-FFI^JQ:E 6NWEI)R.Y+BV7MFZR&R*:M[QT:*,7BCBD$K
MBFB I"P=[,(*)\DB5"T)::P +P.BSQS5%F/1I=B$E*XY&;2=E;^?LZG@!1\A
MO+@EAY>N) %,3@FB$1&"!F%<$:2-BPW82FK.=&<IR[,;!8""6#?5RBJ#5!@3
M95LB_Q1-U-" 1,49D)2E^BS5YSS)4FF;9<J%";XOV3LC$7)(D)(C4^:?X\^9
M+"]IU)SKSO6%(%JH4#<8CJ@22$Q>\!\$3R2]2L$M=6<IRTV191FCE<!_3#"@
M:]&O%)TPQ=7B": ;L!!G2:.6ZC.[0?5DHRH<.V.08-VDKF(D0+1%.%R<Y5(+
M2Z/F=MCV)TDMC%D26'8PGA*PXD1I="+6'.NU\*H!.\[-F0(M!7K&N;()@**Q
MX*0&D404!H('P^+M*9@&E"I;$JJE#LU6APK+M)%*I*0DD%81F5L9IT6$:-/9
M*J&Y#DKF3*"7K*H)"G1]88DHVJ8L<R3+JA-E++7 %!H;7(G*-Z ([YPIT%*@
M9RO0*I"4+*\.C <E353929M"8%*E4EP.4RUU:*E#W]"A;(K(,4BOI0*#P6?M
MO >)3FGRV("U/U<3Z(]E>.<M'BU)U/PR?8I>8LK"!A.AU'Q3Z1 S!:8I)L8Y
MK@<P'S+Y,\@(L*\/CB1X9T 5"%0"^FR9!V20H@&%1N;6]R_%\@=*&!KK2:2"
M5FGP1@?M(ULN7[3/E##//R5=NM/YD,GKG,TWE+,-I4C-%$\B>$BA(/^QVD #
MPJ2EW;KQ*6LO5 0GG8,"UD4?@;)Q46MK!9:%V.9MZ4X;)Y:*DB@101E51_L]
M%A?(V!*35R&(!:@QLSGHY_= -=6+SNT*LVM<69"L-$$:T%Z"-B)X-:E.#4H'
MDVDIB3^M9"A"8Z-/)"E"]M8ST]<ZU<+_(CELP&C%G-JH&?GK1@MC2#Z5J$B#
M$N"5#P:*D3);(!<TP?SSN#D5QI_$85[C?IY"1U#9F+I)HXT410SHT$52R+:P
M ?4"E@[SAG:38!$0H*T#1 @R!V3^%)P1I82@<@-6F<VIC?IY'.8USG\"64E!
M>A,C8*"HC4RZNE$G;59+]O8CDC'9$GM.T];FA;&!1+(IJF@S!Y-1>*G9<0HB
M(S&Q)"X%\)8$<%X$(H6L?0"/9;+>3GL5("%*_L7;E!LPL[ETCTV705>,5R7H
M1$"@5,9@/.:2O"E>R"8L %T0H]0LKWB- __21QL+FI@*.\,<0"HAO22TPJG2
M@%SE!1' >1$(:4P).19?XT8)+DBV0Y#)H+2:\G)@:^D5;WZ2/'I4! :C,1 P
MH0.O$2+J[""9W*#]#];[:="CG3'+6KWR<M%X.!B-M\H.=FE!!SYGO_6"=PZP
M6(Q96*"L8DB:1:RP\*1H<>%$:J+VTS.7(G4S(B6$"A1-S$5XL H\>5(A!$=@
MT6HS$2EU+E*J\2+U<UDI=7614M=GI4)RNL[: $:F7B(&LL(+JQ1_4V@73:1^
M+BLU$Y$*0*6H7+,-!1#)$&*6P66CF4\I"(OF^&9FI7YT)5\C?6! G8B%)E,4
M$".A$AX12RC"@%!NT:1K9@;KIY0NRA #AJA,$""M#+7"E\^^:*4)B1;-'?ZT
MMFLFGC$&:ZPC06RR0"D9O?'@C"?M$(+0BR9=/ZWMFHET88I*89U<E!F<=UB4
M302Q6!<SD%@TSS@SV_6=RSX:Z0B=!.VUS1Z,8MFA:&T*1-Y&2DXHV2!AFNU:
MGFLVE(T4)D2*6D6ILK=0I8BERIA:+<^'',Y&UQ?([_TLEFDF;LZHG! M4RB5
M($OP!!2$\3E'G9U/#1*FI66:N3#IG(NIV]RG )FIN/()E2HF94/2^H5S<S_/
M9(FU&5%&7:?A(,J"3HELBP9 8XOW"V<G?IX19LF,U"D2(D0%6928A ZLRIZ#
MZ-K_"Z>ULXYG9S/22TD$[8M% A#:1JLQ2AV\TB$0+)ZCGS7*,])E%8/6426!
M0+'4V2)O=5!)E016+YPNSY[.;3$\?*P6C:B7K)T<\;T6,O#4(J>DV/,K%X _
M!^^EPY0L.$K*+1X'^$F%:R:62Y4LZN:3P28$E4K=1TF7NI+#2Y:EV"#+-6<%
M9V9O.)!,*N!#UBF#==*#TAPY%*G84473I'G ><9V)GJ;.6A@IA$3.@LF2(\.
M0BE>HTI8%F<+FIL?#+R1!4K9NYPTF.@S\WY%R,%ZCC%;X[T23L[_<H YA.<:
M,^6UL%XD;S @,)V*WC.O@B23M!&+;9#76Z4X_H#0%)W8.[V_HIP1FX/Q-T?O
M&^G:"-%Z4\N .PW2%"1E9%2:V+\E&1NP*GD6N-V(J1,!0)2051 1$%P43#H2
M>>.+-DA-8I!?Q$2K!=8EPZK#Y %\L@9T3AY#I8P2$&/(J!NL2S>(V\VLK9<Q
MLR:Y'"E 1H<F05*%D#%1(N/\0_%P2+DS?H1ILF;O(RC,'YUNET_=P)-.[[CW
MQV X'+QEFOX0C_CD;R[OFQ>$<F;.H'UT3F2(5M34-R-<(94,ZM@ 8O=DT#]@
MTM:K2K-[>D2?+K?LTU:9HGA=XRZ7R<3YL6UZ,^B^J7)PX:2&\,B@V=T5 6PF
M$\A0,T&$+CI;;;326<V_OBZEX8=LPW&_,Q6%=#P:#WHT?(]SCW!T/*2)\3L_
M>'Z3\V/GW^M=+I_^I2P!B@T",@@+:)7-QEA%&IEF-2#*?SCH)ZH3/W7,IL:/
M?YQ^+F8/S_KGLY/G%_B+@ZA:@52N^, T2EN%Z#)9 I-M(0D-< IS#-,U%NT
M+4(,,2&D.A?KR4@3K)!.>.V:L._Y'\<CMLBCT4KZSW%GU/DP#EJM3-WBJS\>
M#$^?'@_3(8[HZ;"3Z!%VAG]A]YA6\JOCZ0Y@#=$J;:Q15GF)P8$*(1)YS,JC
MUUXY&^9?JQH US5RH: *0LDV>@6DK-<Y8@UGLD@^$#1H'.!1AQTR/>F\H;S>
MY_XXZ,0N3>L3_7&Z@:\&PX==9%@_X4JIWJ=_L'(PI,D$XP_GS8Z&X_O;-0UJ
M^J3Z=8.;QN'3(HY#%)5 2^LS9%,-="QDBI=UPRS+IELM!>A:!&@:?R^B "DH
MPGF-S@0)3+UJOJ0$,LHHB6R4YM^_WY+<S(N'Q^C!A9B%2A*"B-ZB+H5TDM80
MI#3_'KX1@%WCO!D0Q2!S*># B!)D<,G8!!SKV.";,-;_MWWJS<K$+J7#_J [
M.#C]@ZG@9Q<NHKG.B9V\,<G7H@=%8<1B#/D0/ "2:U*)C1E OO3]%U>ELP=Q
M*M:*&IJM4?**4@D1LLO"46G A' SS,;-3*I$J\&['#US?= ^&"%*T<6$*&RQ
M:D%YP"S!NSY.D%P Y2G6K?  C/*&@W^;%6-HT1ML@!F?4T[P<- [.A[3<&=0
MQF]Q2)]<N8AFO$06'+"@"GHP4OFDK$X:C15&H3(-$*890K[D!!?+ AJ(;(6$
MSR(R.>#XQ'NPP1192'E85$YPZV;C1C@!>WX)(DNOC >/&FV)+A1(D@D!_[:@
MG&"6X%T?)R!2$I4"I@!,P5GM$)1T4KD4/=OV!HS$K?<SE;\#X'K_Z7"0:#3:
MIA'A,!VNL &C-]0='#5H[DUY)8I*VJ@@P3 S5\6!%-%Y%U%1 _9 :R2 U[B]
M(:88K O,FCRDH()V(LD46><$&]0&;)C^?IW>VG^.N5W5, [Z=:ST,X/9&_1W
MQH/4E#2$J"(S$BA!%@48=90Q0\*,%%S*3=AY\HK0K.0\F?/&[E/LL 8^Q*/.
M&+L-@<F3+F2SE[HP>]08K DZ6%F8F.AB%@BFE(Y[Q]VZ>.YLUXO>T9 .Z]WJ
MXI^;J9IS(Y )A]FQN9,^2BB$Z()TJ;#U8S.H8P.VA;HB9-LTQDZ?\AH.^YW^
M05.&BB!P+%8G]XH(X"7$G(1VSD7+.J94 SC]%?'9'4XR/$\G;FGJH1H"D09?
MI,HEH%7LE"@4XTN(.FF9=:"\,!!M#OKUQ8>#;G>R6'BZCK$A*)GD #US.<U:
M5")BF(R8%2VE  A-FCJ;&XLW^_$JMH.)E<UCTAHBF\6B#%HF( JB<:5)&71S
MIH2SQS876S"BC2IS9S.NTF@3,EGP*A77I!I]\TPKYP!HFT/P-BGA.;HS)3BB
M8F1-C$5M&[4<=I[(SNR!M;:P>>9(G7L9.+Y LE8BFVG4NJ!I4LV >8O?9P]N
MS*@0 00&#>05&N=*#,Q]E:;0A%W.YVRX[/J&HDLA]I>*M&.EL\G&+',RGHI@
M+32I :MVYDW=;@2F$)*N=?5-W7PTRN*C5MDJZS 9E7Q<')AF/%QVC9!E\$)R
MA.%1@L\R1BKLTVRNHYVN"454YB9XO)D%< %D-!BB5.R4:G:C-4PY?$ FE#(W
MH##'/#'(&X&H[B\90\PF!PEUEL!#BNB9\ULC%TF%9C!<=JWK3))/21@1"N0L
M Y42L@^J")L@3V>SY0(,:MX6NY/7ESV:/0EMG#)1 Z@</=LX$_A_8)(VN##0
MS(+=71],Y*0E+X1"*\#*NA\72&\Q)<K*85X<F&;,[JY1LYS.6GMFW]&P8F4D
MI9TCHURRJJBT,)#=*KN[/GR$58FUJ6AF=N 21)^#"(JMG@5ALUD8?&Z;W5T?
M1-%R5.1=)!<%.)F\929'F%&$6FTR+@Q$,V!WUX>23(FU!E, PV$L2N\M1*N\
M4"H9"*I!9:[GQN+-OL!UTEAD=*:("( N8(Q%FB)%XM@WJ;!XJ,YD,G0VVZ50
M#%Z!%$%+"+IX#T'6]9I6@2]GJWP6"MO93X;.!&@G<PC.2_:>''A;C-I)R QV
M("JV+*!IGLV<V6RV($!GL@TN)HX)=<:0DT1KJ1A@K2Y-VMIJGICL[($%(VHA
M%D4$!@2KL&5X,W%D$MEHY[,<P 7 \_;6#ES;9*B-P1J.. )')$%B+%Z#C. M
M*LWZMS#0S&;MP/7-K#FCHS#$X0<X9J_!EY2-C>B\EHB+ ]/,UPY<VV2;$BZ#
M-#%( PE9OX*O9;YC+M:RFBT,9+>\=N#:2N,K:8-"!S5G,ECG0P@<#8:2=4@%
MX\+@<_MK!ZX+(A.R0<BHLPEU1_-@2N$@OGBHE1PU+ Q$,UD[<'THN;H,)Z 5
M&KPJP8 E0Z2$" F$;0!*ASBD;3IZ7S=W<##$WL=;Z/ +K.QL-P20X)23*A41
MI8*Z.%1&YG2L2YFTSU$T*8Z:&3*SCYIR,,I'1H\-7]WQS;ML,<CBO)0@;9,2
MOZ^T4>KER^/7%G<?7E.WS0Q.6,LLQ# _).FS! [ G$NY4>,=<P_P;(:E.3(S
M60O,BH#M,;IBHG?6".5MM$U:?[7R%H?Y\QT<&-+QL),X6INPR^?]SGBTO?-\
M$;65O!'"EQ)1)) ^!N'(144Y:52:1'/!K(YT X>O:3QQMQ,0%Q'!(!W:I+52
ML8"QQLN4G0J0@JV#7[JY")[__)2&93#L83_1!,K%A%&0!^&5K,-A1MG (6(N
MNJ@8%(!H0!;SK(WIS>3$(G>4U#D#%:"@HN0878:23$P<P.?&P7([9O%&L/!)
M3LJE2<.6SFKT"4L4QF-!3.<#)TW"XA8-W,T4'S0A60(T22;POL02:K:X(E>4
M)#=A@M*(,'$]]8,6\X9,K>WYI#/N'$R8_4..QC\*P_FN3U=E_2<.\NF'TV[6
M_TC3%N%J_F=ZJA9_S_^\WY7OB*_ICR_=DV]ZZ/P&5]Z1KW!D((15@G0!I>KV
MCU(X3+(6&')F$N7+(-54,L(\Y@9^33(>KFSO_GM2,^^61"+4-,"KB42XF#'X
M Y1$B")4L4PBDX?D/0:74"OGV0)#D)-M%9?8?=W:?@K'CR1P!JE#--&Z7(M,
M4M4F"M;D( 0%/\T2$@*F1)\_-,O:WK9.*=$6<$6:/SGU[YK9BTDC/A0#R0"'
M:6"T#]DXZZ-1C*Q#-UUNL,3NZPSF$SA^9&%B%DY7^Y8JO;<R>$FL3AHP9B]P
MDCXK^?O43XEYY)9?P^5I%]]T3E:..0+#;@?K%%RW2VE\C-VGPP'WTS<W#;[2
MXQ\>#X?43V>[%*>S;_=7GJ_>F$,4E<1>S2&*'XG1WW,D/,Z?$:3.:% +-G]X
MT>]@2%ZXR"$D<'")$#C,URACUK7VNK9"R89(WA>@?[[S9>AG+-%-D;R+PQ"A
ME&)]R2 Y]"TBFN+8=:ABI$ .@">^7XHIGZX?E+]I:?E>=RO;XHH4=GJJ\M?0
M;PZ\8;*49-THPYOH:Q:@\4H$0RI1F$&_?:^69>K<?T('V%V;M.>#*OPQ[(S&
M@^[&*0U'._\Y[L1XPX1I)@@FD.BBE#4SGCTT1LDV$EW0,9GH<(Y+!U0S]G[N
M\#'5.?ZCPT["[IFM'!SWQ\/*G6[&4J[$3K=33MDJYN,T?M+!^OTFK.-U#2V]
M=[5=?#LZ[EP^'G%V[+O=;8@UNTI$2HIY-YL%<I ()8=06$L-OD_G:13OWNH?
M=$_?X:<8WQ(-GTXI7P<-]Q:#33&#UHFA2:%(6U!'23H2G6V$(86]>72^KP?8
MS-GKZ8&HF/1A+*%$!Y!E-!+(I5HF467W/MWL%GK@.N5S8]#M]/'VQ/'O@_'>
M^*0N=GJ7FI[)D>\?"?7,\7WP1BH) MAW>1NC-QZ,8&$O\^V_OFAXCL9;Q^,)
M(^DT9KJ"P"1!I(M@((((08(4=3%6'7H1_FP?Y3J -E]61ET<J+IJ#W1.[@^I
M.P%O=-@Y:N$P#0?=BVVNE]P=# _N*8XP[YV=<:]@&K?+8##N#\9TIU6&@]XV
ME5'-WM-_G<;5P9LG:OO-GMXXSJ_6WNP_#J^V7CT[V=K=[FVNKNO]U7787WVF
MMU9?PX;:.]E:_;.WN;O]:D,].MQ:?6:>Z,WNWKN!V-A]+?9?/3O=5,].MQX_
M$YOO#LS6ZF9O8_?@=/_5<['W;O-P;_= ;/WE3[9V0B_U'O6W>G\=;NYNG&R\
M>'ZRL;O?W7CUS.RIYV;C5??51N_/[D9O_>W6ZH'<?_7H]1.]?;C7.^ENO4IO
M-]X]5_NON,6/_WJUN?L,]MYU._OU_!>/>GOO<F?_\9K>>+%W>GX-/^MX7SVW
MF^]6WFWN[O<V^1[[+S;DYNKAJZT7?_;V>L]/]E[LO]I4?[[>VTTG^Z_^+)L=
M\>[)[MIX8T=P7VR8C7?I99%>6[2N'2'D-B06Y6B2:7L,N99$-27HUK)7O]ZK
M)Y_VJHVU)+3'=G!L'@"4;R/%U)9UG:54Q17A[K38];S>_KK 3Z2]GG>G-1XT
M4\2[]*_MT_T7^2@JL/LOUN3&N[63_=VUD\W>\]/-U>ZK_=W7IULO-DZY<T_W
M7JW UNI?O8T7VZ6"]U(S%2[,C-N!F44;%$$[,!5IIVH8%8:B*-YI#8:9AO^\
M4\WBO4^LRODOH\'Q,-%H^O60.?7$S.7.FP>_\Y^SP589^&'*9>4S./:)FM5#
MU>%PC5@W&IP\X/TUH_%I!:_7Z;</J7-P.+ZO[='XM[>=/#Z\+X7XWW<NG%>-
M7AN[G8/^_6$]FX^.CK#_X/<XO,>WG7Z>WOVS9WQT;:*Z3N$K%W_CLC'&+IV?
M$"<]UTZ#;A>/1G3__,-ON3,ZZN(IVW*6/FI/+OJMA\,#?MDX&(\'O?N&W_4-
M#<<U8CQ[R.1YT\,?NN&NF';%F#M\G,^??';X[N30O7'^_%CP=X/X\F%Q5[X_
M=F]R[^'Y">=H'-4^YNOXK6H'_?..OO/)BY^]BKK++],:,1G,K?^:>$;QV]D9
MX\'1I8>/,.=._^"^:,G)8SZTX]ZDL[X#Q//CW,S!\/[Y PJ[R7;!7J=[>O__
M[#+K&;4VZ6UK>]##_O_Y=83]47O$CK5,3QQUWM%]"0S)Y.O;:0\XOL\$O[,>
MD:KVY_/-]=VUU=;.[LKNVLYWR<XL6KNS]O#Y]OKN^MI.:V5SM;7V/P__M;+Y
M>*WU<&MC8WUG9WUK<X:OH*[T"B^0+5'_8#SH_]I:O?OP;DL) V%VS;:?M!HN
M;?7++__WQ::?68BJ-*P6O\V!#$TLR*.M[8U6Y9O]07_SN,<W2:TS&LI.=;)E
M!Z6<B4)B3IQU\DDXBH:*DY'\68&+3W)46WVL!+L.?ZX.TG$-'6KFU)VS920S
M\M)/U/[IWHMD]]0SON>CSL9CICVO]@1[VM[^BS]?;;[8?[W_@J]5C]CS,D7J
MK;W)C_^"_*\_N_NJ^R:^.GJUOWKP;N_%^MO]U</.YJMG8NO%?G>OMR'W>]O=
M/;7'QS:[3)%.]_[R[,'3Z4N():B$U,X82QMDC.T83&A'F5(P.6='>.>!%.UG
M$_?[ 84'K474@A]H^LJP@]W6\WXG#3*U-G:^T/9PI;;?@L0_.\8AOV#W=)N.
M!L,QQV(U3W#,#S@9WR^=$\KM\?#XYU.*Y^:EJI6#;:2V8V/?AFBPC=J%-@KI
MJ20@[\N=!__]7\&!_>U3O3B7K2N*S0MV+Y6.C*XH+Y?[J=9W/O6*-EI<Z>'/
MGJ]L[ZYM/]EK;:\]W=K>;3U]OKWS?&5SM[6[U6(2L,N>OB5U:VN[)<TO^1^M
MK4>MW7^MS=#Y7^V]/N(O[[G+RL/=VGP9-,Q]^Q\-AJWQ(;7^<Z[IK>EX3HOZ
MF?)M>-6GD^>M3:?H+EJ8S+^T>_S,PWH9NY_3]BGAL$W]G\WBO$HO32BNE(!M
M33JW(01J8RK8KN4N P9%!OV=!QMU+>!__Y>TXC<M?VW5CO^2\?D2O3N+FCB^
M^NTCPJ=OA?!=36BWMI?.F>GHD)LW*;_S9>]<L#OZ^=SSGF3W[%+6 =K%$K0A
M%=OV2JEVJ=449" C1#YSS[!TSP]VMU<V=]8G3GCIG^>I_>?^>?Q>V<\==)T6
M:4U#E=9XT/J.V-W.D2FOI7,ZHSKCUWK4Z5*+5;#. ]Z@^9SF,=6'39_U\UE'
M]3);R$99T;::8AN*2VUT'MH&+8; !X-,=1*QKD.5VB[#^FO1"'^ET:P;%_UM
M.NC4_-7^>)./_'3BG]Z]3#):YQ(+O16E#5[Z-A:H\]Q11/"1 WEYY\$?V^L[
MNUM/VAM[:]L[K9UGS]?_^*..2S]=V=R;(XUP=?KB"I;VE[433..)-+0&I35\
M+P4M'+5&1Y1J<D!N=?JMSGC42H>3>/ ?BZCI'[E"\P57V)AI-'!WE=97FD;[
MGMNJ&[GKI+'P/7-^7YK@.Y^?4T<GK4NG(C[K],'1[3.<V['GM4S0D / R:3X
M)./WX32W]R''L1>"0GZ%5/.FQW0T'+RI]VGH2,JC3GS\W/)WR<]5FZJF*["-
M?[Q^LO'XSU?[+];YF6NPJ?[J;J[^U=M\O'%VS5_\+-/?WSUB?_ <F KIO7=K
M)WN*V_1J[>U>C]O_ZIGF=NK]%\_%YHL]L2?]VR>[*Y/\CR>[:V;CW>MWFV]?
M>NW . 7M()5O@P77#H+YE-$UN8"D1%WN/%BE+K[%(7UQ!.9,"ZY#P*<&Y;IE
M_%/*\ID1GHCX=+SI)MYJ@=5V%T_6SW+RIG6]&AR.W+8^KG^JCU&F4F1,;16J
M/D)B1@>JM'5VUGCA025QYT%-971!:".^JI'7[7MN1C6OP/LF@OS+Q"6T!L/6
MH-9^;KTZ'G9&N9,F8PF#,DDQZGSL0B:G#@^PWWDW^?Z/I;GZ_*VZ5#XC=N_?
M:<[H_U0,;F1XT5WIV>MWM^_NW,SSK_CVK;7>47=P6K/$YSA.FW;6!:?0VAS<
M_20(FXM<M*N-[MVX$UW)>4BCT=D_3[@!LI$.](?&\TY>:I^U3NSTBDZA#2H:
MIJ.@V[(0 80Z$Z+O/  M6FMW6RJ,#UL[XR'1^->6A$=//G6&O][\\.L98 _Y
MX]9P=_"VF6'(#Z%V^E(ZEPR0:@.5&D18V4:.)]H$*(63A)0XB*BJN#<8OIX=
M2A,"L35\RC$C$X6?;\1P#UZ*XG(ME-].J6;[I$SMNH%AV]8-=R5HJR S5)>,
M"]X21D\''-=W]SM'TZ#_9T/HW4N5C<F@0UOZS @99=HQB]0.Q4(@!\&)6),4
MA9RGZ8PK#]Z>P5Q';H^&K(6=(^RVZ(32\;CSI@[H,F&@T3]:O[ (M*H,S'#D
M]HKDX)<;U(WJ6%:&A#^E-J2W+TUP=0&O;RNC9!N*=G7A5V[G$+PEYVPFP_&P
M5)_JPC_.@J.;@Z:6,>\^/1ST?]KY5_-24\[*L8DBG1S#HZ@=E8&VPB2-B5ID
MQ\;*@&4N)SX;K&B"O9I-M#EY]H?YS?_^+Z^D^VW4&E.7CJK(M?H3F?NUQ2:T
M>UR#^Q:RF6C5E*]9!:B31G^_N?X;B\,:,C\W/U+\:#!DE9L8KU\G$RG\!<\\
M,?;S^4^E,V*;UJJYJ2Q9I4Z>]@\HMT:5+K>Z.!JWAI,4O2^C_.5,RU?'HW&G
MG$Y_ZO3KZ,!]-5FS-B>"<+7TMAVF*L/)<OVSJ6<:<@\='0]'QW4.>CQH\1F3
M$0^I?HG_J$2GYCVMI/']GV(B5_N[TGQY6O5O3^2*NSJX:[_MI+5J)C.Y-S-R
M_$TA9E2G;<N4S@;*[Q^S-@[K67<>[';&W4E>!6$Z;"76^5%SALU_^.6'.'&E
M.Z>]..C^,FK0C,&/OOKF63K-!'8ZF5K^%ENQMX<=_N6#J6O@#--5^N;K8[RH
M8D81"- C)!&]!6NUP.(#6I#TC5#AS&><2A4G^M7(4&$Z-[K9VQ,;K_;,YNYS
MM;G;/=Q<_>/UWCL.&R;G/3_9[*WKC=4_NYLO/IT;':A)^UZ]EIN[>W+KQ9K8
M>+S]BMMX6$.*_=TUM?=J<@^Y)[F-E^0JR!"+P=#.AC@6%-JW8\BI'322!Y]S
MJ,'&= _+UF23C%];_S];<-%ZBL/67]@];G "P\QE^,PV3DWC4H"O(,!KGTWN
M!UE,3M"V2?HVD(-V+:37+D0N*$CDJ*9K;GPV^KH4T^\VM6MG+FR:&OQI[EAU
M<(U/&[L]2?XL325 LB5::!MPN@W12S;%,K2=E4GX%"-64WP^XS,UQJUS2!8@
M9^4:Q!R@&"' V+JCHQ6Q(+%_"Q#X=T67[OZW9!0_(,:GES *F$QXE<E$6&*#
M;$O;^^3:DH"2)Q52TG<>R$DHW-H<C%DR\C'5Q:CFIS;1/R:[2R;QO8+[&9,H
M=2N[4N?9D646:@55E!';WBDE(Q2GHY\PB:6@7H.177*):Y3ESU->:SG^Q$8X
M9,V6N.38#B68MM3!"XGHT(4EE_B:F)NZ3:G1[+ 4&P8OHA06<E9"> KH+]U\
M=LDE?D",WUW")9P!@5F;-F07F1)S7!=!IC85CE[87,ML7.42SGS")?1/;:)_
M4':77.)[!?<S+F&B!.DDM(6UN0T:1!M3S.U$ F(!E:*9CDHL!?4:C.R22URC
M+'_&);PW+I88VCE:53-12SM&#^TJX>03A23MDDM\3<Q3"*EN?9XA$@3M8S8@
M5?#LW% 4X9=<XIK%6%S")8+B/A?$E#AZP>$=^;97OK23CL&%"%;5VOH/J7M
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MQ\2"\@_=\^_5 /\_]MZTJ:UD6QO\*PKZ1O>I#M*5\^"Z300VN [G+0G;R.7
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MK^S;VQG"G[Y[&L99),=Y(RNVVX#.Q+/&I/!6A-Y,*WJ].[6Y.%?WO#$N(]B
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M6)+INA2=<7& NC/'&(2QQ\XJ9&B(H#/:B!SE,F?5X4E%'60V!NEU(4OVAP(
M#Q525@!@:0!PDU&YP"733B*MC$0\,8FL2!+YR!R1WC%!U=J&63=R47Y])0M$
M3;- +*P^PU/H9&VWPTK?R&[;00_Z.FRX"*@>&V-+8V-DS^['P%?[C%TXR1Y;
M)?[J#X=O!OWCU_"L3N\4YF]W;+;H]X:OJO49?ZZ=5V?[;#2P('N=GAV<YV*
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MP?"<<C@L<B.LU2@$HA'W3B+' T96:X$Q(UR'].2+GB_U0OD9P\%#4K@"!\N
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MQ[?*J;7ZXEAVIB_?; 2D:6QGBMEJL3ZGT<[5*;R<OAOCJNR*-P<'?0:IA:<
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M-8B'X?>/LY]6=0E[<:WG+Z?_!I)VAI7K2]6K?'L5PJ"Z!^Q=W+#X\PM_%?C
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MS$H.$TR#9H)RJT4^P0$+5OJ]QH7[-14:E>G=YJG=:D3"/D2A@=3J2+0GQN!
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MMMD:''6'AT>U:/U1O@3NU8_7G]KL9SO_[V'A+77L #3N30T<Y*.+0=@>?*5
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M>RDF8ROZV';@=EV9C^NU#U?+\YP]"Q<UVB]2L)UM%?_M'\4XN%JPO:HS./6
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M$*,TB*M%Q"M$FP_1Q(P.O5IS31"L&$&<:8YTB X!EG$>A57:9-]6Z\?7#:^
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MWOF114W_J'^ZK!%D:X>MKK.M6OSA6\-^\WL<QVQC+F0ZF:[_JNV]^UAS(%&
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MM<Z6^J4?R7%L[6\PN6 (KYG6RY,8V; V<U&H5AQ^:W80H;5?UG;^@O^N_5K
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MMW_];?O_^WN[\6G[3:VQO3>5SG:S*>2,7IEW/?TIFTE^\D<Q#%O9<[P4K+%
MO5HQVMLYD)%[9\$6)RJ!F$EBD.9<H<!A)IE,W#$\=P_)JL5<U6+NQ;-OJQ9S
M58NY,K28FY'Z7FXQ>FR7N:LO_)A&<\LX<56ON;*>+-X9;Q!/\FQKOQ2.#,&+
M:X:RZD?EYG[_<I^'>XESPQ/O=B*-8P^D-''!![H@X^-O'C>^?/U6WSKDC>--
MDL?6.*[S^MX'7#_^3.OTPWD=7)#]]L[4\;?&^0?RM?WA%-P76M_ZYUMCR]/Z
M^>&/QA:,>V___.M6_73_^*BY?SR[J1MG''/N(U+2YVJK6B%K$T=&>&-%(,3D
MO2^J]2UQQ2?3@65M[E9AV:IBV<*.]E98MA LFRZDDUC@+.>)$"\0MUP@%PE#
M6C+OJ+'.$, R1J>/\BX5EJT #5["XM+C^E>S:P:.*#&?8L15X=JGJ2#SQSA[
M=;PHFYUP42JA9&41E@)+9_16"](3%71",N6B9#9F2L@C<MQ8;"47R2RJ?DR)
MZL!4^OHTA4PJ?5VPODXW6 M1.&8B(IZ"OA*AD.:2(N!#*7 J8-'\@LJ85,QF
MM0)\$V8SYC*H%IK?P2MI%B?]'L5L7D>IU2=A-I\ #:^57*T0<@Z$;%Q61#ZK
M;VT3^/Q  &DAG%FDHU*(JY!/$0!6DN0$!L]0^I#6-LB,2%>)"JU6)9%+QF@J
M/7VDGEYA,H=\=\L?B.")T]*AG.&,>!0::4(YBDQRKEV(1(=\$+[4I<M7@,DL
M88QF^]_#9D%D,G\ICAFVNOT^W'_$8LQKB\\\+XGIP_O";S>CW.]ML_,7+,-N
M9^=B7?H52LZ#DI^NL)GC?4#)S0-KB++$,L2T"8B#/4/Y !A*3!BG/4V:Y^Y"
MXK9R(>5Q^JH@S4ON2%5*^W1*>WY3:9FE0#RT0AH'@3CV"1E*$PHL6"NEURKP
MM0V@.:57VA7@-TL8J<D;QH>C:C&3;*P)MY&O+4+SDDE($^?O7;?MBEI*W<Z5
MI?DX.ECWKMNO(',^R&S>Y#G[!RQ(H6D@2$I.$5<B(2T]0<H!S;&).1XQ0.9T
M=YR';>E7D9L2ZN_"$V\J_7TJ_3V_J;].JB 9\\@JBA'75B/GE44I":\$BX'[
M7-80/]I/J4(Z*QG2R4Y(+I@;HLLUS4)LC^J3WYJ$7GF'3T9[LE/8_ZN(J.UV
MMG_DT@W#9O\H^X:Y>[0;7"_AD)H_8D#GL=>M4'0>%#V[P8+V/A]H#3PG&8I$
MQ EQ:3@R/$FDJ?%24V]U L>Q*,Q)?R^]\UA%?$H:\;E#N2LEGD>)SV\J,<99
M9PE!F.0R=B$99*+EB&JFA+4J%E2(WEKAN3P*O )4: FC/UM7TG(.L[:^UN2<
ME^1 6R!\W;YMO8>Y/('IW[JL1QYV1P6MNIW+Z/GD\HH9+0!4=]]-,R.GN&>)
M,Q0-I8@[6$A'4T264B8)3I8YNS!F5 6)7D-ZSZ-5O5+I>51ZBB=I(YR-WJ#
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MGD: 4L]LLD23$#;>"+Q*1]BK\R#/@TI5TGI/:9T/JXLF!.L="LISQ)FR2)M
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M=Z5AE^^"FO.",ZY-GB-$&?!B+GA"N:X6XM[2)%(0T:QSHO@5\8(O+M'\%JZ
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M8.J(1XWN&1;/G>LR/*/=&\)(;[/(524Z[F@('IGCP$V]6%S=N:+1R]WKQC
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M2LC9.X9GU=A7)4F,"7/$N$U@><F(K(\!T6B9P)913[(OJ$*;"FV>#=IHL*F
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MRJ*V$^Y354[Z3* <YCMK+/LMRWD(21,DC#4H1[#()2H05C1YIY.QGI:#/F\
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MN*%WF,L7SN_WS::#)S] KX>Q)[X/=H6L2SPW,2;'ERY7_ML77#_:$HHYXU)
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ME0EYG^?CTF__"+/Q#2:C>64N"CG=CYS(#6X$D1JF2[)<@P)N1/YAA H(4Y_
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MNQ<*8_R&,=9.MA07 H93@F='-+B;-FM)$P]>1XA44@[TD>86>]U8NY$PSO(
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M JER&@1"&#3W&A*88AD8\Q3Q9*1T[O6_N/D/7UG]>7@5]U)9_2+^Z;0 S>Q
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M.=-/!>8>%.;H=9C#446KHP,7759II1(,"1@0%L(%'G#$M-)U5'5=QW\5@"L
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M!_BK\FWDY6P/?_[5DQ;G07.I$WKF:!1>7OSP^\4H=OO5HU0?^CW=[.=N_R(
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M&BD)+#D%H%0(((Q0+#K'#)=I;9\[U:]8?MG1*P1_04#@^NKOJ!.!!0XN&I1
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MN#)-9IDF6^@3TU&H/"14!):F22"@J U B6!68DR,DBMKK!ZC]'V:I*Y-<),
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M1Z63?*V%?B\*- E]74#($"9[/ADAE+/238N)5US.:)G@_!$*A(MP!Q-0-U&
MA0H3S#:=9*KG=?$<DNAWB7H$\7$@BA!/=@&+-ZKU,(4EO<YX&)%FNN]7IY_Q
MP227(>D<D;-SAF5%#:SV?%WNM:#T>)W<:_Z47I=[+5@6/R,E-)M<Y]6N+O.H
M.7_H+/A1RO\SB<#^Y0A3/L8<;*!-,.QYGJ.*C-<>GA\?*LPMT#6'J/>%RA9
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M'2HE5L@+PNX^061I-CM75C5K590D;Y+P::%Q5;<>"(N3&B0KJV .(VZ^J&]
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MFZ(W[#P]4.&Y"56!8/IFV(4,WDMDUP8LOS%@92@<M_BL;6>1[[[=,OO6:Y>
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M]P<SP-E8>ENVN6#&8)($"JV[_J*W:3P9\E;9"0X?,6+W/*/72WAL#*-O+8,
MYUDPGE"'.".&X7G,\/E3Y4JRG.E X-0OCMU4VM',-.104X0GTSUO8!-A0M<I
ML(T$;U3,33WMV2'7)>%0HY91FD>X>F^IN1Z\L@3Y%NRC>I6$"#?+2YB?PPJ/
M%U\R P.ZIL/A./6UJ/Z["E*_NZ>NNBEB\".&<"JPVU_;; "O^);%=^P^W_NI
MCN(>)>WJLB^Q8B1,'MC0)O"B^2T#5%N+S[)+PQ.P[0MR>65H>^_ [#P)VKYK
M'0#-+/SYJ1#LEGG0ZS\-,?_AWSKF\^/P;]YDE]ZPC5!QUN!/V2"@]?DZ?_%.
M&H9_[=3Q,HZT'O976X(^O@N(7PJ9V5S8[8%-7P]0_VXL[!J _'=@8370_PYF
M5)XF[4_PI>JM]S3TV%6J')Z4\[NL_U5/LNEGJA'G]*'4)F?]!Y;NN%2'3CK"
MT^U0GQ*XW[;:LWFOV.S0@]-R;6<M&1C/F2*C:6ZS:,ZVUI,RJ-.REMXDG;37
M;.VC$1K- R%WVVU^6M8.IF39K4YG/748.O-EA4VRW%7YK]ZDU\Y>TYCZS99F
MC9"0#ZA%FR AORMQ>7.57Z^['O1O;9\LSWY;9G<]I2-ZDU: 9_9>N\6!EH\-
MD(]JR-.@;YXQHJ'O\>1[-(^XFJ[0;6 0YV(41K?IKA6LVRW;7+6Z1.L.KZ[@
M];<@,K7MF]3188)&R[=&R$P=)MBX<]VR^Z;V0#=]D\S^>IS0>I->KMN"#A-L
M_D@=)M@)[;>_<G<S;:"\=B3'UD&"AF_1FG(!M81L@(34@8+-OT?SB*OI*MT&
M!@HNX:;Q?3[^Z728I+=1N&.:GK<RM+E6(UY=TUL53DYOT6MK>EK1:[2,:X3<
MU,&"33O6'7?5**#V0K_V%G5T/4'#MTAW"6RN$&N$8-0Q@DT\UK:WGDI:;98L
MOT6ZVJ/I6Z2KT9LMS'2(0-^C 233"(+=U1#!1<:3(&*[5DS0TV6(C=^BOH[>
M-'R+]EU=*-I4N=8(6:G# IMVI#O=]71PTC[GY;=H9<&HM^BU!6-'AP6:*L0:
M(1AU6& 3C[4N0-^ +5JU E)OD4XHTP)2AP7T/7180(<%).>Z&F7W 8]W+2S@
MVCJIH.E;Y&E\H89OT;YEZ;A 4P5;(X2EC@MLVIFV^[I<H.%;Y)AZBQJ^1?N.
MC@LT58@U0C#JN, F'FO+T=ED3=^BGJ>WJ-E;M&^O$#779N/FC]1!@:VY1_.(
MJ^GJW 8&!7[CV6UZOVLQ@8ZI-8>F;]&:$.WU%JT0$]"Z75/%6B-$I0X);-J1
M=BS=D[CQ6[1JLIW>HH9G0^JPP.:/U&&!G=!YK;X."S1\BVQ3;U'#MVB56CIM
M.6[^2!T5V)I[-(^XFJ[--2$J\""?.F/C2<8-EH1&.K[AF3'*TG 2C/,=T^W<
MKD:(;/@6=1R]10W?HGUKA81(K=QM_L@UA 7&Z4C'!%[-Y>%I;)K&;Y'N$=WT
M+=(Q@49+L49(QN^/":Q/,NYH0,#V=)Y2P[?(6;GGCMZBUS8:;5,;C4T58SHB
MH._1 ))I!,%^KR[7Z$# EW3,8N,T:7^"GXS+W8P">*VNK56ZQF^2;N?5^$U:
M3QJ.UNLV2DP^X.>R[(:[/'8P&-!I]5P=#FC\)EE]7230\$U:4QF'%H\;)1X?
MRBMKNGC<U8A R]-XIDW?)*=E]KMZDYJ]2?L]'11HJB1;@W1LWH3U2$T >J0F
M #U2$X >J0E C]0$H$=J M C-0'HD9H ]$A- 'JD)@ ]4A. 'JD)0(_4!*!'
M:@+0(S4!Z)&: /1(30!ZI"8 /5(3@!ZI"4"/U 2@1VH"T",U >B1F@#T2$T
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M:@+0(S4!Z)&: /1(30!ZI"8 /5(3@!ZI"4"/U 2@1VH"T",U >B1F@#T2$T
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MW-%X@.UUM4G2["WR3(T$T/ MVN]JJ[&Q8DQ' _0]&D RC2#8EXX&K$]_4Z&
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M\8D>]_%)I;F0<UU\N5L=IZ-34PMJ\CG1S[800S2*":A"TMC9=AT1^]JQEZW
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M,^^#!B<# :UTQ?VJ,D_I++5<2IB1C%8V?B022(S!/;!:G+257E@<69L1)"F
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MME)".HP*,/7=4;W4J#6F?ETN5:9^-VO82KETT*@N->SL[^K-@]>9[-S#;HZ
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MCO/5RNM;HHW+I=P%2_G.#;A%9G)AS%@F"]J>*NY>!61D$W=5LU ]7#)/9R-
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MU\Y0+(K=A.CS56J\6#G8U_&VRH&I_BJD=#QVOM:_(FBFB]X#%F"8*G#RK.[
M^+\*=]#%:3HK]P@,6:"C-85NR?=CM,/W)AM8YY&J.=,1B!;.^ARDH(R:YRE&
M9DB\$EMLT:K3*&I]"49+=/ZDHS+'>-3O#/[A)R$?32_5QCOM4%%9,<9TDV.I
MOQ0[I$^D1I>#EHLLYY2+H<YLL8U;#)C!?3 HV_!=$F@9NZ&P[)Q7O[R[=[#4
M6,G!TE%CG0=+Z]'#UZV;.W9VIL]*K^Y^.[UA9Y<(V@*&X]7E&(^MQ#9I5#;$
M-JF4V/GIKZUS992<GIQ=_KK%5LE9*F[35^$O$J;NA(B6]O,[;JBBI_.?Q#>
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M@ULJJT:HM(T^(L_B2E/6VOPUS0OW;%F?,3B9*".NY$H$0TZ;G#8Y;<8KE&>
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M#:Y5#]-=4Q#UW>6$8^HQ=HW]MB?[&/LJ[R-0N6AI'R+5CCOJTJ?.?&%[O9_
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M9Q15'L.,8YC5Z3',G]NN.8 ?O<"V?OG_4$L#!!0    ( !=?FU;O2EW^(1<
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M/)JN4)UXG[0:A-R:$Y\..+/H^DF)S<80FUDJBM$ 8NS7YK#!J<[_R@,2WT'
MOWU?7)T7%NR]#]F2\LH[D>@7&*B9,U'>+Z?<V^PEBQM<082>$88YH=:"((F-
M+1H=AN7Z77Y9%\J4P'.+FXJ)C&>1K4<N0_HDC])N/,JYV<RWQ.MP8GM -A&]
M0G!928X&/B)>WB:PT,#83!4T-H=02S)9&*.>(WGCN.L7J6^V7K^N/  4Y>CA
M[.EDNC@K!;MBF4S?OH&FE(LO8]=TCS9PR -[,D/1-H<1$<4Y#K4""*(!13 /
MJR!5$*#!X.Z(8BN-L\FBI-"CC_%? \!QZCG,PW:CZA(T:+#I "C@14G0P*,?
M^4,F;HQ+@X9MXG,YK12U)$/V#*;;P>?Y2I2;PXFL(NZW<[XC(IA+=H!7L &T
M$53*.#1 Y"KT863XOBC21*7R%5+'+.'0M8C9(O[<"P.'K(J7A"T:34N5<=Y?
M93+()=7 W[Y3_N AJ],VC09&)V$=[(R20S$WW%O(L[']I5#6?H*9A?FRX!T%
MAPKEMD/%:KH[V51G9/5_)LY9>7QUQV1=&)9A+,Y6%Z#GWEPBE?T-N<+V%M+K
M.I_FUHFOY6"J=*(G8=%@B(M7Z))W#(?4I8^P$Y;Z2])?A1POD^I*^D E&GYP
MV(+9Y=/L+I4&*%QQNB+N7ZS<\%TJ#0SO]MM)=%%N>PZA!N:+S<]UDN0IW2*E
MJ#3=)'7IC"1G5V$5$4OG)DO-J(\>/JP@X)7S^*TY73ID.2=\@=1'LX0:>-W_
MT:7G,R0=O4.D@=EXW:,#GSPP<::AX_X[Y*OHNP,**44"7[FFLO7KARWPKAGU
MVT^6$]KR%6@+Z+FX2BAWM)E+264YV8/$ZKIM,B^:EV<]+T 3.1DZ#;P^\RLF
M"LGU4AX]]^[Q\65Y, :LQHXY;^@T70W[2Y@YD.SH-HT&OC9:\A6,\G*K=X@T
M,+M%%G^M/.S@\#:1!F;?@?M9A-G$M:-_<AJ7_Y#,)LJG0>.V,_]5J@0:-2(W
M>#:?6+7[,Q'#\Z32;;80+P)$P>A^F]<!--Y9^4%GX7H/6*Q:0*P!-IL":C:#
M4Z7\6LJM1]$U.O\B]F"IDR]((:>80YN:3M\-.<5.*&_1:.!V47Y?[2YD/JT&
MC3 GG#P1EV('DK:I-#!\X]<Y9\&0^ID2KZXAS-W*^Y5PFY'40>0!*$9V"@B7
M!HB.O&#U(PB1+><VD09F[W-S3?,K:Q#+@S_*V/[LW?G9@$0GAK%&E3)IT*PH
MD=.?=F4Z(QB(7!RQ**BQB//[W'.H^-%@7IPE4A?PREFAG9N?Y< 5$&L 6'S#
M4T3X,ZYR!Z607H/&W'D.<XGJ=9HB:@T:TEF(,[@6%LGM4&E@^/J0X6!X79)5
M2A-I6M\WS]^=G47Y23NDS;/F);)_*Z37 )8>6TQ"?PS;,+*4<RDV7Q72:]"8
M>[!1'FRE]A7QF;\)_N6YDD>R% 5K%EWX*UYIJHK1-?7ISIS57R1>7I*G@)4?
M>%!FUP#XZ)!A=+@P"2M4CB7F<VC0H 'HXM%QBKQ<5F>QA!91>[+JT4?3DA5I
MV-,"5B[\TY*RBH]=/8=L7>=FX:33U:[38@%V*9,&[M!VF @<RYNQ0Z2!V:6A
M?OEY*256#9JX26!FBGV5;Z"@$O1(@]X1_H,&\K[8O<NP<+N(6@/LD@L#:B>*
MBZ@U:,BO= 6Z;:*8#RTDUZ I'9?#\F!AA:HM(@W,ACW^A\O4'O\"CPD*Z#5H
M3.7K17K?)L*/%\G?2"_)6"L+>.7,4[2 H ?\,F2O?8QOG9'-.>R.5!.4>'6M
M)LAKENF:0/0:*)F)>NBC2[D_9\LD)U*<-*DF18/'3-N$N^)D*5B:7#MGEKB!
MS)P0(H_V8(0]-5%%PFL_-I%7 \8/X2)<K]RH_&OC<>&^Z-FRBI?046F:QJ"I
M5V]FL$")1P-XLM-2>2HGATG7"2RY"QG?@P3\UGZK>(NRA%/71L<FWX8$?#&@
MU!?%-Q9%;/'<6^SI*KPOLXM8@FLI))Y2BX<YFPEO#*A\0'+,B0W!CT79@S#.
MOPZ+T:TH18,EJ33?4';43(%1FR-G9K?;,7NM-KJ\YA"^]I/3S0]J9\<S=!I$
M(->,3"B8E$QZR)N*!=0:-,1LGC6;YFB(8;!-I8'A0SIQO+]6R)'J72H-#(^N
M?TR(]4-L"2SBS]>/$6%7GE!&#9I7.GLJ)E KR= CA1I%X*5'1[=(M#DK>L49
M1-;.W0JBRA%8.)E@5U6+Z#5P/GGB)D[GRDH8<OJMB%R#IJ3+\B$59?GQ]U^;
M'7?.(,[QD%JH(K,&S4QM'$>>8_?=GN=R"K,:]V4*H#B^4N#4-=[(E(74[YL=
M<C;A;[AEEA_WXS^MD<^EZS$,+JY-([=\=XBT&&I1+Q,U;(K(7]O_Y ]-^=:<
M+LC7G_X#4$L#!!0    ( !=?FU;\L9E ZS$  )SW 0 4    8FUY+3(P,C,P
M,S,Q7V-A;"YX;6SM?5ES6TF.[GO_"M^ZKS>[<E\ZIGM"9<M5BG!)OI)<-?/$
MR 5I<XHB/23E97[]19):J)T2<:@CQZV.MBV:/@?+ET@ B03^[=^_G8Q>?8'I
M;#@9__,G\7?^TRL8YTD9CC_^\Z</QV^9_^G?__6WO_W;_V+L/WXY?/?JS22?
MGL!X_NKU%.(<RJNOP_FG5W\6F/WUJDXG)Z_^G$S_&GZ)C/UK\8]>3SY_GPX_
M?IJ_DERJZW\[_8<K)189-5-!<J8SSRP(F5A-1>F2A3;6_Y^/_U F).$29P:2
M9EI*QX(ND@F>O/6U. -E\=#1</S7/]HO*<[@%3(WGBU^_.=/G^;SS__X^>>O
M7[_^_5N:COX^F7[\67*N?C[_]D]G7_]VX_M?U>+;(H3P\^)O+[XZ&][V17RL
M^/D_?G]WE#_!263#\6P>Q[F]8#;\QVSQX;M)CO.%S!^DZ]6=WV@_L?.OL?81
M$Y(I\?=OL_+3O_[VZM52'-/)" ZAOFJ_?SC<N_+*=#+[>YZ<_-S^[N?7!_M'
M!^_VWNP<[[XY.L9??]_=/SXZ>+N[<[B_M__K$3*P>.#\^V?XYT^SX<GG$9Q_
M]FD*]9\_I9/OK"F:JR45__O!1_Y\26>.HWPZ6HCE'?Y\]N!&&17)\&T.XP)+
MX9R_=C3)5[XT:JJ93,__Y2@F&"T^'9S.V,<8/P]>3V;SV<ZX['[[#.,9S 9>
ME9!=T:SF7)BVH; DE4>@6C \B*2XNRJHQL\,&5HHM,996FCU[ 6H72E_AM%\
M=OY)$ZI<"/0N&I:"W(RG@_KK9%+:4X]@^F68878T&96!3I[G7 ,31BFFHXK,
MBUB13Q6* .&MJ1UP=SLU5_E<@<S.-+^:3 M,T8S]].HK-*-S9M&6I,5IOH&E
MJ^OI[!L_STY/3A;/9,,YG)S_^V;>"'$PGW2B@*6^D9-- 7$$(_RKC[_"&*9Q
MA"3ME)/A>#B;3U$T7^",YP$N= ]1 8NN AIP\"QQG9C*Q1A7=9 F$H-C/<K6
M 8I\B4#I0#%DH#F$&>!C/B%5;^ +C":?F[-P3E*I-D,HE:4J!=,^999\3HP+
MFWDH5@HGB+%R+T'K0$2]1(C0J6%C9*!',-C)_WTZG$+9>W_X9B"C%RE'SFP$
MBWQYPQ(88*6ZH)5)$&1ZP*FX_LQU]*A?DAXW$AJ-RDXFT_GP?Q8<3^H%+6-T
M9#\.TPAV9C.8SP8\AY@#"":S, BEC.Y[1E?<2&U,X,YS)]=1YEIO6T?-YL6I
MF5[09-;\8/X)IOM(UV=H>\OXXQZ&AB<7.TQ)R<A4->-%2=QA)+# N6$.HD@6
MD%ZEB,WY_12M Q!["1#6?X1TH DR="Q)>#>9S=XB\Z\G8Z3K%$D[6-(X&<]^
M@3J9PO)[Q_$;S':_H9."BAB.X_3['HIOACQE_)<HV=&"JSE,838?B.0-KUXR
M%SQ*B&?-(ACT>'/547/M?/3$T.J0G<V]JB\P/D4(I:QLS0&W:@.!:8-B:3X>
MR\E4,"[Z5#2Y [5\=Y_BKKX@[Z;;]00]D:W'&P:GR*R\U)H5IW'/: 8AQ%H9
M][EXY"9HW47<?G=6XL$@K%N+W%?8;*0X,OB\GT[J<-ZD,W#6*\\-[E0>\/U2
M&>9U42Q6]#NJ]S4620R<R[?W>5OR*2'ER;%H=6;:5=?6=61<:V%$52('^U*W
MI><UZ4]$W_6EU!?E$SM92.B9<?@%QH""&M2: &,_SV+B":U,PC\9F3&&]Z)F
M9:0+U+[W':3TRL23PF@SJ9-!8!_FE[ >Z"+ 5F2+MPU"8U#!4JJ&J<:<XJ$&
MDX@5?X4 PFU&Z<"KBY+%(AS3&!VQ5&K O2XK*"%J?ST3U-DV\[S&[^D:O@[<
M)TJ7T <]^3R%3[AFAE_.C"PR=U!Q*>W,Y]-A.IW'-(+CR1TV-CB33*@6UY8"
MIH4N+/*:F-,)36^4417J#/&&)/?*_-$!:9N*O(:^?_OYNBC?X<^$Q]FO#WY_
M?[C[V^[^T=X?NWO[^.,NX<GV;4_OZ)#[04;(SKOO! ,&/D'YZ(!%&133J0(+
MHF@F'%2P4E1KM[AB.[1?^-/HM-7%O&\)6US?ZRR#[*H(R3AF1>2X#*1EN.@2
MRXYG7I4N+H3M2><I+/1IGZ3"X2.,7>=:[\W6:Z0,5O#"<G"X6W"3T7, P8P)
M$$J$F UUT/\C;;W/@$URM=(>'-U">7-++J1B>5"Y@&?<M",M9] ]*:;)QV%(
M[62NG+IR9!VZNN3]??L \3DNBV^]G\SF4Y@/I]".Y\^"S/>C.)[ME/\ZG<W;
MIQ?BRBX:@S)CE7-TJU26+!E(&,^:I(SS2A78HK@V8.616TJWZY8<JK<>W3TS
M'K:RL%_'V:>WH\G7WZ!\A%_C<-P^W*EHAPXAC^)L-JS#9=$K\MLXT)6G)# N
MS<ZT-+=)S.M@6;*&@T^J'6UO$=&/I;]/!6;/BN).%=\Y=-].IJBA\>O3Z13&
M^?OQ%)=;S.?4MI^66KU@;#J<X0;[YG3:O$*8#B?E0L(.XUQC8F))!XEKTN%F
MZZMFJFK+001M32<5$=VRU:<RN6<#^G/!9"NF>^=+'(Z:&XE<'L41'$%&NN=#
MN&WCB5 MSTDRJ7'/T1 \"\H%9KR''(M-TE 7NU/1WJ="P6<UV9TI?!OA[)-B
M\E)L15D&EM O8KC;Y'8<Y)FOLA9I;?&<NG2FTTS,1B<O7''46CL6" I]1U<D
M"PE=R50C>%-C*):ZO*J?)R_/B;)[SFX>HY_M!NT:<BU!%^9CB6B&(+/ H3+N
MHJY*1U_(CQ\?'[0_]V6/_F"*7*?;.*OY9>?=SO[KW:/?=G>/CS[L[WQXLX>?
M;GA$<\=#"4]FUB&;Z$!F612^]$7G@YJ--0$4X]GC_EQT0&OA*P+$1:D 1)34
M=7Y7"-AXJ\?X$9WH]MON?Y\.OZ _,I[/=N:OXW3Z'5?"'W%T"H-82W$U5@8J
MX#*PN;!0DF!6N%RXDQH?3+V!KT-8G[:SI^/B1MJ97"=D^]3O<?H7+$SFI==Z
MP;+S8*$*YI1I-?;(O!=:LVR!YZ"##[X0@^0><OJT*]%!@TK^A)<.,R!"D:"V
MIYV38JK">!H])P4<L2DKL C2,0L)8DQ)1D%M%6\EI$_9$SH0;"YSPA+)+_CN
MR?0[$C*01@(4+5@N'GT9TZY*M_NO-7(9M,B^5FK_=/7]?4HPT"G[R1*FC4VN
M,A1J<5K[S%Q2"=UB*5@TZ+\:87+,0@J3J,^K;U+1IRN)=/K>4-IT+0CFD_S7
MI\D(Q3AK7LC\^Z!474$7QY+CL@5#IK5":+=A18G&Y^HLM56_2<7FF1BH@'(M
MBT<O72F;0DK&55Q1;5EYC/*"C9Y%*;/SZ$\I0WVUX!8R^N3,;JC]F^F5S81.
MF=D\F8Q7J C56&ZD91C?(Q6XU)A7K6K2I2I$M#D#]:G1=1KZY*D2ZWTC<9,I
M?:>48>,]CM['8=D;OXZ?A_,X&GANG>6+7B[-8TI.801E AIL+Z3SZ#!IZDSL
M':3TR4\EA@"%\.F0D//I21,ME+6R<\);B_Y68C4K@3YUY"RX$)D,AJ> T7>4
MU 6VCR2Q3TXO-7(Z5!9A_#N/PS&4W3@=#\<?9RM$OX$ZS,/YP'L!)7+%7&YP
M3R:RA/$8D]I('975RE'G11ZFJD_.,S%NB%5"!I7C*<39Z?3[RG:H15(N<\.R
M671@=(%%C<3$K'V515?)J;V/FU3TJG,',18VE#F9[M\-8QJ.%NFZ 9>>5X^&
M*<2"X,/0CJ$?A#%]EDDG'VHB;UBX\GI"3L[C4ZY=-4IE!KK==<JV99Z<8#94
M[W44N)-3'^_?I*)/T=-3M7T=O1O*F@R];\ZBMXNKN2N$M;040-4B\,RL3K9=
M]_4L"5,8%%,$KD_I."<&P ,D]2FFHD(#I19HDX.KA$S&^0RJ+@N?(#CD$- ?
M:Y<N8D'6G9&NRI:Q5-19E;NIZ5.$104((MG3;7*3\<=CF)Z\@31?H04"MRKD
MQ#Q:**:YT\Q+P9F5W.K*10F*.FUX.R5]BI7(MHC-9=Z%D].ZZ-[TY)S14BKA
MF#"QW4[.%:F2N?U2A!;"5O)^M0_11.G8.8P<5-:!*65PT15T5),3@(XFS[@:
M4Y*)^L+IG8Y=;QR@S9%PCU?T*)%W>#3RI-HRW).MCRHPP:MHQSKHRE4HS&M1
MM4G%EDI]B$9#>4^=*WJD/8.B24\ZAHM:\B:893>FCS#.;=5D9Q/$%%@.D-!3
M#&V?<)4EK6T)(<IHZ5OFWTE.3UTS>CA1J:2+#?L\O@0!.KKHF%Q4D>#;F<_X
M"]I3K7P015IJH_10+/^4>#5=E,5 S=)9*UM"&#TA:UUKQ8.^EN2@,&22*5,7
MI:R\OJ>;\E.T?3,<?9J0*0]S)J>XEM['[\W\7A1?@,G&M=Z^HK;+.KZM))69
M0IZ24RDDH X[;Z>DI]LDA>X)1-]9!N*<F!RS<Z'U"%0.B>$50Z!8'>->.>X@
M%)ZHLY)WD-+3#8X""!3"[YM?;H./U@3+%-2"X7@&%JP7C&NOHHD.=W_J\[HN
M_'*2DB\HTD!8-ETT3 ,:]NA1(-94':443BKR"3,/Q.A]*XSJ'&,/1R6/4A/=
M78#A>#)=".",*>Y%X%%PEF/-:/Y5NZN*8?F"'2ZY*9HZ_W&=AC[MN3V RD8J
MHG/4EF,TG.(0@Y%L,4M#<V]80'J8,A9R336%2-URY+;9)4^E_WQKLTZ;&'"%
M+<M,BHZXZ@RP*FJ-6N<$F3I">G39\W;O/#U*LS=<R2<+E[+[^F>8SK^W;C_S
MU@L>%^OGLUOX@Q)DY!&7B!>ZHG>4!$M6)>8X!.UY],@\>6WPW?3TR< 1:)],
M]&1@:$, OPY'HT%&NZA5Y2P%1*&&'#"<%999$8KQUA5CJ..'\W?W*6 @4/*3
M1$IX1>GJ."=$UNZWLWWX@C+M:W5<299B:(,CP#'?#M"Y+Y"0XV+)<_'KT-6G
M$TL"()"KHKL*EPL"!S$$#6AJF-,<72:.GEALY6/*:@R:O<FF4E>)WTU-G\HV
M"0!!)/8NKKJM'*87X5,%UY(9[?PFQL"BTID%'ZP4QL6H.NG^>)V01Q9J]EWY
MFPM[Z\W+=XY^>_ONX$_*8=R7S^RJ4?GM1!-UPV@7D./L$_IQ7X;XM%^^?YBU
MY=QNK<[:\=9.G@^_+,_J Z!=-\ZRHEOLZ2VZ<^T&JT@II%P+KXYZ&:U/'4$,
MD0'*8O1-:^J%ONSO<=YNZ'\_J'=W_$*X@X8H, Q/1C-M@F(8_VB62BH>BD^Q
M4N=,GDAJG^+.CE!W2W32N5+IHMCX?7&T?#PY&V1Z6Z^(09*BAB@B \[;U4NE
M6;2-OI+ 6YZ<+-0W#M8BK%?]Q+<%+W*-=0>F.P/U 91J??&^=51OTT:X8BG)
M@%$Z>G **H;IU&9]?>H>&4G_F+"BT1W):.LWPP6O:$,ACLND>8"?SXSL(!MM
M;'*96:?;X$YD/*C 6;L,&G6-4(5XP,EZX!5]"J<[!@.EL+NS*K^<SH9CP!!@
M>8MST?CJ; KW0,G@E<F9"9EB"P0B"Z94IAPD;KC@D>>N[<H]]#TR$O\Q+0N5
M_BA3^5<\MH.Z/'F[W$_??MD?#E).1A1K&8\BM.8#A<7L<7=5&@PZ:#7*#I+Z
M:U#6IQ#_F9QL I51CG^\300'YY/@5T0@P25=DV ANG9R%0(+ 460K0<K$_XF
MMA3=WD(=Y>#(D*WP[;XL.J!, T_H,@C!A(7 0;;=@[HBI)_MBSO"QGU3)1\A
M>L+,^.<IY.%"(OCG$9RUW=\Y:34,_[/X?*!2TJ7*Q91+7/^2"Q930AJ]"$8&
M*SVGSF*L0U>?#DNW!!=R=75WQ')MOF\NP7E0D@D!2%3%,"29D)FT.?K$E3#D
M3>(?(*E/Q[!;@P^=DNCJ.C]%=#4C,MQ:P" Y2Q0[IXK(JM4RQ=8Z.R@6DHW,
M5X^^0DI.D)>;W4[)"P@KJ7%"H!*Z _Z3SW$X;8')06W78=]AV%N6YTK'DU_@
MS7#V>8*$'M2!K=D4A7Q&W"Z9SMRSP/$7+9V/(@;AR,<LKDU<GTYVMP2B;A1'
MG:?Z&(<([W&93K['T8)G76()8%M[A:Q:$SO.O$!+Z'7PT04G7;J60W\H477C
M';WJR=,Q'$CE35<'=C9+ZN LX%TD/@95..>BJNUD9S$]"JEPZ#YQE]#_MM;;
M0GTWX%9"UL&'^T'P0:<1VCJ15K2 ;"]=I3,_:8"4V 2\=>77B-58< >,-3 %
M,0832G&\DUJ1VXA9!R3^!P,)C68(BP]SZT &;V#Y^]YXI7G[("4OA,^\E3>I
MLRX=H7!6O37.26UXI/9@[R5H'<"$'PPP=!KJ$#3G3> ;L];K8BQN?[KZPK1N
M$^&,$2QSSB,XZRKY+.)["5HK)\=_>-0\544=HN;:+=V!RI(K"X:5Q2TQ%RI+
M 0D,4D/%/5340'TS^D&BUD+/#Y;2I=54MP":GJXD@^""P*R"4IE')% B^XZW
MEE6!M[%EE4-1$BQULNX1Y*T%JA\L\=N5]CJ$U\)7NY##66/P5ON=?=8%<<YR
MC2W@<VVTE9#HN3F)A!<>)75_FO6I6PM<SUU3U#VZ2)1'DJLYKSC8>W_X9B"D
M*!QR9=:W_=<:?'MR&!UFJ8R/I>IP[7CRUMS,ZC/74O@/DM_=2)Y=FXHS@[;:
M_\VG''SVGH%K8,L)6)(6F'3%R) @&/)V16L3MQ9N?K24;B>:Z[J>X^UP',?Y
MJA2@Y%12**R-_$4SAL"/)3OFDK5<H0VKY",OUZ>.LDSJ$#Z?E74=U*-/D^G\
MO)WH0!L007O+5$X.U[YP+&5H#87QOVIMC.2+:RW"7D 5R*:(NJ](BD9AA!,P
M+LE9[48[R#(6!:(P:UV+@A6N<*X\^@6I]2H155CJ(KN[:'D)MPNH(4.B%_+2
MW[>3*1)V.LV?<'<XJ"L#H@:JHD.1O&#&M<$,0IK6/4PPD2N//DO0D;I/],-4
MO80+!.3&AE97Y!@ZJ&^&30#C,AO8A,Z*CYS%"*Y5GDH$LX^,5\\5UXF'3#VA
MZ18R'ED!\D.AY*G:((G]5J!ZI8ZX@?3@<Q/6[C>8YN%LT<]UZ8N6_SH]/SQ$
M5S?[6G"'5#8SK0I27APPSDT&JR2B_%I+HENCQ<VH> &5'U38V;+*.KE6L#>;
MG:(PT" N=E.O19%>"B:+U$RG&IE'?#"KL^)!U20K^?6W.ZEY =<'NO2,-U -
M7=]MY+G]OUUB^!)'#;.',)M/AWD.97%!9ERN?K#RS?<P'4[*S2#ZK$?*[C?<
MBL<?X3#.8;=6R.C,860NV[P7UZ[:Z.0Y"Q[7A(K69@Y>1?)A4MOE<(M7.&JP
MX!$7+)D"#8:)^<H-PX^T*QR1!-3%/4^]PO&\06^/,7[=/'2D_JXS4K==L@)K
M0@G9LMJR<<LFG[C?,8_1?O3>"Q6V!,\'^V<\[U6+EP_/3=7_' G3['BR[1IY
M-;DR70SZ_CX9%GW1025CJJ:.Q)Z:,'W>JQPO'YZ;JI\,GDL6#^HJVP?CC00\
ML$6:H(1E4;?4AM>&I8CK#+B#K+)-@KS$MP,V^G0GY04!_KD!U55'LS=[?^P>
M'>\=?SC</7JW]WIW_VAO_]>=_3<'Q[_M'NX<'N[L_[KL%_9NF-N [?''>!Y[
M3Z=-$(O@^TV;K#R:725VK>YGM._?L%-:A\+8L*M:RX]<O'3GEI<NBWD&PB:>
MU +3WC"M)3!?,++%#WD1UH*3^@&-K/FJ39)S%Q..YH?PL2EI,OW^^W"$"V4R
M/AO@/@"1JUS,QI+XBX92S^YV9&Z%,ZY:6.<NS1JOZD, U85^5W-KU!*GJ<]9
MN7K<,C.K-TP'+E?NN;),+*XB:XRWD@6,O*(I)495Q5I(ON\=?0A-NE8\F8SI
MCH47U[>^+TG8GXPGYQ'WP*.#&'Q23,0B<7^VR&/&N*9$(U*RMO40H3X7OHN8
M/L0%76*#5AM=>2>+C7=O__7![[N[__$>]^/=_=WCH_P)RFGK![,0R)7+/$]W
M1)[\J@U]#AH6B9JVGE^2ND#!U9M2$")(0&3)DB,"+0=T79UE7'G!N54%%'4$
M=#]%!"W@%^-/SAFL$'Q5,3*O'#)8%GWH>6+*UJ)JSK$ZZAXVUTAXI#/2[8$Q
M(1QNZ?C^9,F3.!_G'<K.#"":UPM3>V96,_X#\)!94:&TR762^50\$TEF:9)Q
M7MLU/) '7]0'-Z1#C=,+FU3_K;/8E4UP('P6OK8Y=VVP"/X_LFB58RI$7V,,
M":[W+;U7[S=>T ?78DOZWDRX'5_9]SX8EPVP+-IL4BY*FW956$VYQE13*8&Z
MBO7)5_:WE9'KT.)OK@0R/)S#\_7D) W'"[FT_>CC=/''0T#QM_XU,Z0O0?&@
MT;=VUGFF3;(L59,8>MI&%<M-3M0@69^Z7K4:[1 Z'>F+L-)Y-I^>YM8 ?OSQ
M]:<X_=B:DZ3";72I3>8+:.FT8JD$]&A\+*9EG).CKW*^24>O&L9TB)&-=4"^
MVYSA\GCR;C@??ER(YPCF\]$B=A_(J-O\3<T@N99M ]L.(SRS*E=E$+(Y4O?;
M7XNP1S:0>:EPH5<273_$17NK./IU.CG]O#^9X\]YD;X]A7)6GC(97^ZFYU\?
M&&?P8<:P'(-K:2#.O.:N7;=$DYA1,H&ZX/")I#ZR_\Q+Q=@V%$EJM6:-$$!2
M=K\U29P.9Y^63=@659,I@*OMD#*(UA(T)\5\KH:);)2UOE9CNFAQ=2]1CVQ,
M\U*11*L<DOAY><W[1G9RX&L!%TQE8#"&UTXD),FB0Z]BRCY%GLRURSJW1L]W
M//ZQ/65>FL*I)$MXX_H\5EL2<SE]6O+DHY5(@[++CIXQ!,N*=PJ)A,3)_9>[
M:.E5JYA.<Z8$NNCJJ.9P]^CX\,/K8_S2_J_GYQ>3>L4MCZT:YC)8>_IAS08O
MV_"XAHI-H@.;6Z,>E6RR/+96J+D9BL 1&.VB Y>E"$ /UE&W<WHX\GP\;T?P
M!9?0.,-"BF( 25>M@D0_2 "BO+4I5XDS$)X'752MCOI&PS42^E I0J;Y&YV;
M-Q W;?_,JZPMTCH2/,C2/!OGVV%TF_@-+C-?,X0D.7HXU)"^@Y0^G=:08X!"
M_!UEU1H=;5Q!ZP)]V1_ZG&F(ECN?6^%#ZXN6LFU3JR3CTG+("6J-W2;;[B6/
M5!+X TR_P$[.,&HN!I35T0Z#X+P/& HP8=N(29M12XI+)BU87+*:YT+=@.T1
MY/77@M+AZ][,)*'VGN,X!$U(EAY%()5I<P%E;#ZG8I!E4D9[ $V=8Z(]#GD>
MT]P=N#K27;='(V"DD#)@).LJQBN^C?(6"J&NBQ AE*HR=7OCIQZ-;.L@_EF,
MT5/TT57\N+MSN-]"JO>[AT>_[1SN/CTXO.M)&T9^:Q%(%-;]N8 <E)WFDG^$
M_=.3!-/63V-TBI\N9JS,#D[GLSF&FJU6TYKD2RF6N=0&(8@46++:L0JNE8:V
M'84Z&?-($C>U(W>\[L9[?HFS81[$F(+7/#$/K:6[SIHECQLJE]'BXHF!&^I*
MXD<1V"<WJ$NL7;<^W6F1ML5DL[9Q=-;7:$'<SGP^':;3Q0SNX\GEE*.SIB6K
M5=D#77RQ1;CE%3-MHV;MO!DCYYQRBLEG19\:W93J/CE/VX3DEO7=U?;Y=F]_
M9__UWLZ[O?V6H%S<4MO9?_-V9^_PCYUW'W9_W]TY^G"XO+VV\P4WKL98G4QG
M<76F_-,W7=KW;[A5=R@,H@W^XJUO)]-6)-G.\"[??'9I9^FX-ULX&P@C2JFU
M,"=;=Z.L(HM::68,U\;G:!-0N\R/I7%3R_O ^W(^/3E=A#._3B>SV8?Q%.*H
M$=#.17]IZFN]S ?%IY"D0QD5U6:AXHI,06N&:U3+Z*W6Y/D/$L+[Y!)TBL[K
M!GC[:B?S%:Z3OFH[5ID88+3F,,+"'8+C+J4%2!9CP #.H]2<#,9>/Q0G!^5=
MM/5IWW]6W)$HKS-HK;LJ6J7(Y:IPL6H96M6C;M6P-;:4O>$,:LB0BTPB]L48
M7B&\5\U57X0U?+K>^^"1'C553+]/:FN/T>Z*7%P0>!VGT^_M^NM)FX.S'?_T
ML=1LT5O=2% $/2ANO'; <RC&<VCH!J9=R2PYXUFIBEL7I:B)/Z";6Q^\<0>@
MQ0,OE\[;+_O#@9*0/!3!N"VX+KS'%<)QH8H<VY2_ #E0V\/;Z.B#K[>Y-F^T
MR-E4XG3=GQ:4_ [S3ZU!T"5W159T!0LPB6PP+5-@GE?=:KH-.HBXS6?JQ,P=
MI/3!Z^H* 9O)G1@$EW#\<XADG<X/(9;AZ#L:2)B>#,>+K38.IW_$T2DL;>>@
MAN1$=)Q9+]#A:[- O3>.*<N+LR4D$ZD/.9],;!_.L+HW)=WHKA>>ST4)X0T)
M;LG9>9B ;?HWCQ0'43KN]KNI229C@N+,Q2C0B^:)A=8!-L8<9-8ZE$KM+:QQ
M0?CQW%V-$F[R&;,S,3K'LFC38=IP)UPFA5FC;$TQ!?J9C0^0U <'B0X;UZT;
MI3Z><[O\\/EKG);WTV&&RT;\.^/Q:1R=6>,@A:[%!N9T2$P7Z5GTN/&K*$L!
MIRKWZ?EWT@?YZ(.WUAT<GUWSSXGA-Y.OXX=X29([*7UACK<I! +#EVB%9T:I
M#%E747C742,-)[U*J_4"R-3JIRQ#F)Q DT^;7W%78%5C\L65UK%/9MPII&71
M&<6*U5 POHZ<=S#E\F'"^M32A!YG]+KI.!+9_W6U>>V5T8 ;!QEK/)LF?G@L
M$T2AP<6+?IE,IY.OP_%'!(\%G7 38[P&PW1H)T(A.OPENZILBM5YZIM(-\G8
MU,2LSOY[?3J=MH8'Q69NI1?,YM)&O+:# ]'FO'+\'+07@OR.]RUD],G]WU3_
MUXW'IE*GO6IU&W<NM^86T2)CJ;70\8I%2(DY:-V!4\DQ4I>:W$5+GQQO:B"0
MR)\,#9>$Q/%?[R9QW.K/]R=SF+V/WYO+-"CHQ-LBT*/G[?I K8$E@9M:,)9G
M86S2EKJ&X4&B^I#][ H?M!K9KH=QD<5KUF[>D:MQ[TLZ\3G69XO(^;@RGE>7
MP!5(P7@(:!>41+M0DV$>@Q C!5C!J>\XWCTJ^?&\M&?LC=OMD^8?OXWY/&7O
M98S2!84(;C &@ZZX#, 6C3\Y@/.:VINZBY8^.1Y/UOV--D04@J?K;G6%F@_C
M>%X_\WX*)\/3DT&1W"LPCEEGVJA8I"^TNFIAH/IJDQ77V^X2P^$F37UR0SJ"
MQ8:*((3'=/@%Y? %W@UC&HZ6)7BBJNH+XI.+C/NHXII%D1TKVB*G0;@;PT (
M,'$+(7WR-PB!L*G(NS<.B]9IS685'ETNV3*3%HQRCXSZUMT@!EN\DIE\K.F#
M1/5JR'?W]N%)NB#I.;9"Q*+2\C)ANQ@4_35^/EZF>)N<9@.;:TTA*69\Q$W.
M"O2^$P;8+@N9A.-*KS5"YG%O[=/0[HVQT+'0N^M%]7IW[X^=7][M'JVV:,J
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M0IMUIU7K8&9\9#5%E;VV6I#/<5B#K#[DJSL"";52R-!R!MSC^*V=N00TZ@*
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M\?=0)'Y-ZY2!,RI%AX&5J&D7M,4Q4&0F.^,33]SF$%N?DJR!<O#ZT5+4=S7
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MX8YNHB&WMYN>B>GAJN@*Z'T@O93!9J%8"+;6TPB:X (PFVR0+@CAH)]J<0\
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M670^%<Y-T+G3(< #K3ROC_GHT1V/K *3!E0T]-+3!8;!B]'H D\-U+O(Q.R
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M=A5PK][VBMA';E24 0N#S,FZ-R6RH*QGA0. 4]'SYKT0OK/0]%TLT&;4]1H
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M%Q7I@XP]IWK%@L7I:!F73C'M0B%!%)J^#BI[;;E1^?FG>NW-5VE%Q=Z3M;J
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MMJ%U)]FO.2!()Y,%QJ<LST/8-5F5E7/$*F]*72G:,P84T98*[DW0+-4V&AK
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M\,L8;OMWMSVTQ\$K*XD-*1%)E2)6.OS6"Y:"E8IUL$)P,Z8C%XU=*%\Q"/6
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MB!:U(DTP=51ZMP[/84KNVO)J(^M;$'I?0I"5D4:CY0$JE;9BXXBCEI-HA3#
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M#;LZ&=P9"P&'-R<W8YC=O0\3CP1S1F<12!!&$ D,@66()"H.66BO3 ?S.U\
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M*!DRBX((6O;7!> DJ&P(TZ5%4$0GH':P\<V(W2N!Z[<N==NPKA-I6XR3*=-
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M206/0Z_G!RFWX&A86@%G13U<XT43RQ5H(BKJ9"V>2.(5;'P0/$OF1?6LX"9
M^R[X;,7AEV;'MZ9T!UG!)4R+ IPFH#JJSEP+Z##UEQ49-^J*ZGL3B5*S#(X"
MVFIEB'6,*/S%&-61!Y]I9&C?O%]1>*4F<M^2L VQNVFC?;!"%O5RZ/_@9:@,
M85!&_L39GB5TRK.R2L@$6N7:8]I60.S?7:W G)?MNQTHVT$MT$E*,R+Z0?&4
MSX8?_??^U \>NW%M8MQ+PC--)3L)) 3.4'4:&HS(*8C:NT$V CH&$:A'\0X^
M^<\FD;Z4@'RLH/6,<FJ(F\7E0@G-!)X)FD/9>BHLN-I3&!J#.PHQZ803'=03
M796"VR&D4S\>]H<W#Y,@/+56,4!4($-9N1B(YQ:(H89[T"X$5EMUK$=R#,)0
M@<8=% NMB3T]M$U*SY+,AAA0*)).!>+0GR::!\VH8)96;W]X$<PQ\+\.I3NH
M'RK+&4?#*5('?^/F;#B%,4P>FBR\XBQGS5 QI3++0R3BHQ7$*:.\<F"#J1V_
MWH3G& 2A&KU?K :JV]3R9.R<#?-H?#O+LK3M9MGXT!IM+,U1+_6O<*I91H->
M!L-E-!"BU%DHQ;W0P>78:_#\>HTKD0F(.4:T!$K02G-)K$([ 3S*B;%)6=T\
M0'M>JW%EIL.NX/OC*J/1S=C?GMQ-OXW&9=/FR>WH;CAE/1]1>\7,B0HE5Z0,
M)XYFAP9.IGBY4:I\;9>S(;3#IA>VX>K:_'MEVG?1H/(SS)]J!1:I-D<IT%FX
M!93">R\F8IE$HE"=K.*9J_K3FE]%=32"T9;B7;6OK(CN%10RE5&&CS+\]#L/
MTJR2BL+[1&(,C$@C>.FY840Q[_$J#C&)_6B2)FB/1H:ZXE!%%W8YRP.")UV6
M QN-&D]ZB,0[*4AT)C NF!1"-KXP#Y;1W(6';2CQ9C*:14^M7FZS ;L(-S%5
M9A24=N_,47<9*H@(3OIHLDBR=AGIRV@.G<O<BK?KBJK:T[B+^V$MLH?1V@VP
M=93/W(3K0&G-2CQL)!HM&+!O(:&1*AN3)9%&CWYYT,2"M,0!WD),ZX1FSKL7
MCM<2G0>0C6WH7KF<Z:1PY.3ZZB$7)YRP1N/-:0&='6$5<<'$8HLD9X!R_*?!
M_?_S4_<?=JI'[5$54G4_0.7W+^>7_S@]O?YZ^?$_/YQ>G/YV]O7+^<G%]<PD
M7:GR/?VS? DMPE"MWM<R0E7OK,O!*QFTSH*+!%YJJE$B;/0F4^:%LH'VVKVZ
M@N9>><7)>%R&-1;K\</]TZ]\\??E1R>EAOS)+O8N1!X]2JLS">T>&X@O^54C
MF6 L2:]M[8QE>]2M$[J#V>] 6@]EP:.>-H:ZR!+1/@:D#4VHYFD@07EF-*/
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MM\]O8/;#__S/?_F7?_]_(/P_+SZ^ Z_6_/%>KBKPLI"TD@)\S:L[\%<ARS^
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M+D(B8Q$P#K4MBR#.B!8 $:5089KBC*LT#M!"F]ALW2<!)UIW>9#W^QCO>6X
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M7XQ_L7SU*!<\B*D,L@BF2"40DY!"*I2 $4-(I2P()>6VZT:GGN>F'2UXL%:
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MA"(U<?P\#6$6*?V1P2E-(HD%3[9QN':NZ9/]#-@='/E#TFZHYUN,H F>=7-
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M\)"&*?9R\_'5(D4!#8* 0TE34X,E32#EF8(\#% HTR@AQ/KTVG[#<WOQ-]B
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M=PS'NP3/W.2KJ?!7U@5"-D, M!Y#;? L=Z/XLW/XWD439^OEG6PZ1G<(-R,
M/V[&\B<S*XW5NAT/N-[-S=Z0QG0B>R'87USA16BFCCWT0=V)^$0OS0[3XVLA
MZC2"='E#<_%V]9(^Y!5=+F*&@RAF%$:A21PK<0RS($(P%5%,A4Q2Y+;)=::?
MV>EG ZLND?J-FTI69EN;MG&,YA^EJ<3F)IWG.+:31 _,C2QU.X3 0#3DM2#]
MZ58/"Y[TZ%POD^I,SU"?ZT??Y<-T8>,3_VM>W;U\U _]O2STNE*MBWNJ1_&!
M+=NSJY_T?TN52]WS32&_Y.O'LEE_+EA$6)VM/Z 809QI,2$Q#J&@DJN4R51R
M)PFY'-+<U&8//5AOX8-R@]^\20_M" 8%UWB813N1FG9N1M:S[2[=5ST:L!F.
MJ6VRFZ[=B,"G_>G:#*KU&?H30'\,>])*#X FE55_!#Y78(\M#Q/KVB&HM&!I
M*_&3++[D7-N-']2;?*7[STVEEDV,>_E9]U">_M.K]3W-5PL<L2@6+(*"!2:\
M,>"01!&# DE%4*;TWYT2!?@$-S<!WR+=.\]1@M\;L(ZQ45XGT4ZUO]?4C!UV
M,6Q6G"5Y#/H\B;-7:)/*]!BD/A?L4?KP<8;P!2WS\I,V^:CXL/H++7+C<?U(
M*XD6VFAFF <!C#*L](*<"YBE*8:,BIB)+#5E788?*CS?\=PD]]W;%Q\^@D)#
MN^1480?1=M(Y!GTCR^+1N<,:-6A@FZSF&^#@8Q>[%YX_[*=JE .)'=U^QQ.*
M_61T'UFTN-]-ELJB6GPT6PB;B->8QR@VUA\)]1J>1Q12I 143."()#'.J)7J
M/&MW;J+RR6PGEE7.M<WPJZ3F_&V3/M?)DGM.7K>27$#)R$(QF UK:3@S]JXW
M7]^R]];K?^W>^.>M3?)"GQG"YGT]]^>ANZ9"JGR55_)=_L4L'RO==*[?]69S
MX%?Z]W7Q<DG+\KV>UG8)@$P<:!*DD$51K V&+( 9U58#0R%/4T5)S)W6<0,P
MS.TUWPT!+LT8P&X0[4:<R1FDQP'J@0 SDH&KN2$S9KM%.NH\C+XMNIV"=_ZF
M8, VZ& 2O6U]NB.8>+MS,$7'6YS#FQJZK-)&D5ZOU5%(1*(DPC&%,0ZI5L((
M0TK-AJ:*9!)F+"2AT[&=_<;G)G'[V(#\]B!7I?-":8\ZV\70,$)&7_#L8/E<
MSAP/UMN29:_IB9<EQX,Z7GJ<N&9H"2;Y1:X>M[GC$4]2JJ^$:1!BB",60BHH
MAC+,.(ID@%EB9:N<:7]N+VD3!%2T&%WK#!U2U_V&>B!DY)>TK2K4PAM<?.F0
M%-?:2X/)F;3T4F%-TH 23"<IZ*W ='C7Q 683D(^KK]T^K+!2;:YE*)\H^&\
M+<O'>G]/&:?,@BL1R%A$$">4&2LC,M4D)10A"@A)$&9IYIA@^TQ7<Y.S#3H3
M'K4\2 +GG%/['+EV=H@?RD86O U(8!YIL,_=JR[&AF31[B'#7P;M<QU-G3V[
M9\ G,F?WW>%C5T>O=Z1^@BKCF#6^-2ENI'Z8]%?C5BY2%26(A%HG,->+$T$C
M2'G$(5>!5 %B5+F=Y;7O>G8RTF*M-W<<:\\Z$#YD?\<7C5/O\&PI-<"O0 ,=
M[+"/M<ECP]<HVSR='7_'C1X;0KJW>JQ:<%^-?9)5M:S=^R:**5_=ZI]>:8MI
MN:Y+"#3G2=ZNZA"G]7(CF(L (Y$%L8+:LM$63Y!AF.$LA"A5A(M$A%Q9E\P=
M!F%NZM7 -"& O %JJHW42.V7,@,GHW\).#[%8V]);0=P!79# 'MCT+]O9N#M
M"K3C #=3S8#]>G/\F9AH23K2C#BM7"\CLV-Q.[#AR=:_EPU\?XE\84O#S.-/
M_$Z*QV5M:Q?Y%_VDFG/OV\"JS:'VMZOZ0V=^MQ>!M1=9^UE^JUYH3OY81*F(
MTTBEL Z1PIARF 4)@YG"-$S#-*5(N%C1WA'.[7.U&]9^D.35?A8,-PO<_YS:
M&>K?=:9&M^=[)ZD]K0\,?%#C][A+.AJWGFQ___@F72*,1N_SE<1X'0UTCVRK
M''Q0)OF)7)6UM?)1+LW"YN6ZK,I/=]04?2WU.H<^U3 =CY)?ULF,5* &"5\8
ME*"%":Z+PGR8VQKO_H^)^R'/UQ+_,C#3+ON]$'?D"O#3ZO?-:/A":AV1'R4W
MD1ZYRCG=7$N_+;(L$%F<<JBR4!MP0O]$@BB%/(P%)H@('GV7E(9=H.=FT[U?
MKZ#8"GP)A"SU4&N7'RW!2E8@7^G?5[5JZ"_"K:N7=:(G =$,(0*30"*( QK#
M#$48DA EC,6I)()\GUR'OIZ%.20[U%Q\MTR'G=-O]W&?VY1.$B0Q2JY#4R7#
M< ">D]#<-,=4AS:3-K-<AYV0_Z],=F@S"6-E.[3J>V"]8WE+E[_2JFI.!VZ=
M8CR7Y<XU@520T#34-HJVN" .50"I4 @F$0G#C"9QR)T.XUGU.C=SHP:]\>AJ
MN$T6JP/LCA6-K;BW^T!X9W1DA6_(; $?$PE^'\7!X\22KZK%5GU.6Z[8A8:C
M.L5.-U^P!-/F/:?E72.9KYO0[D66IH',(@X92PG$""-( Y1!3B@/XH@HI)+%
M2D/4JX#/CLNG4QU:O3*D>66.NAW;0*+B[X_-\F;(PN8DOP[FZ&"ZIK0A6Y!;
MZ['%>=[9/\S*Z^+"IVEVLI_I[:FNX9XT@CIO&%!V5&O.S2MD_H>MQ=.[O&HS
MSFSBH5D<!TQ)B"27$*M8VRL<QU"D8632<*G,+GF 15]SLU(,3GCS"B*P00QV
MD!WJ=?8PW!^#X9&WD96BD[(!$?J]3Z=]^5-_'$Y5$?4R+MU*I=JQTU4]M:>%
MZ0JJV@WEH,:JY2U#4VS5!^&?/IGTGW65Z$U-5^-\_U56=VNQR *>:ILKT.O
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M=8W;RRIDOGBMUSO5T[40>MK+6A ^%-J8^))KH N>!6G"108)92'$"=?KDBQ
M$&4H41D52C*K%[>OH[F]Q U6T(*] C5<32G8 +9[GWOY[7ZW?;(V]F;;8,*L
M7WA;-DZ\_*7D/]VNO_RLFVC>>_W#[G7O;7B25]]V>!L9L+Y^V/?[#<V+NJC=
MV]6#_HR]DU_D$K5+3)QE*$VD-OX#9=+S8W-R*V8PY"P).&(\4E:542SZFILP
MU-C^^[^B)/@?R.V;WD6HW2?>$TTC*X%!N2EAV0"] C54@$;(:6+!B2=CH*NG
M26T#BR$_-Q5L;KD@;=*9$T*;$S\WLLC70O^^#GC9!+YLE[D!CN)(9*:6;L(@
M9MK0R,*$PX1*I )&8QP[J<GED.8F.DU$(C\X#]B$V-7)ENJ:.O3;MB+1)DL3
M;ROI5.MMP;8_#TC,=-GLVDG;M',VL@):) [8Y0,8Q0'BCTZ?J: N S1]KB@O
M!)Y,)N6G9?>-I_?Y/7LL/VL$].%15CDO/__M?X=O5W<YR_43U5HC(4*99+&$
M*0X#B-,PAIDYIY^P"$49130,K:HO6?<X-[UM0(-]U,# !EO<]ALT=I3W[V%Y
M)W)D$>SG<,!NEQV9]CM@WDF=:%?L@@?4::_,B9^._3.[=B;;4W,:UOX^F]N-
M@RQJ6#X^/#21J0MS)G(O\$P^T%S<%-KRRQ_H<A%B$A/*!"2,)!!S1* 6YPR&
MVIS&,@H2&BH'N]FZX[FI=7T:^)Y6CYMBD46-U\G2M6?=RIX=A<N1!;NF<0?T
M"C10K\ 6K#?[U)D>6ROT']'/>UW YE?/XE&[NIO2QG0FX9DEZ7[_@-K(RV5N
MJE_HMZH^V57(+W+U*#>A)B@,D QH#!F-4H@S1O5/*H-)'"(2"\8X2:PK)'=V
M-3?-V:"M]:8Y]+8![% *N)O=?IO0'V<C:TL'70.LP![>' HI>^-O(KOO(A[=
M:AQ;4=-5Z;B[@>GJ'5L-Y*#JL=T= ],7?:6%V-;;%0E5+(DX3)1)0A''$<RX
M%E":4H4PST22NE6IVF]]=IIIP VO7GS(G)U;<3 ?8^NA-17NZ6I.#=E73IJ#
MMJ=-/'-J6$?994Y>-.Q%/5./V+3>)CS)>$:"4+^M)$TEQ%&D?T(H@EBF*@M9
M2/3ZS$.1\EV/<WNAS];6;A[L0>EE^FFW>_.]DCFR&ES(HZ\2Y<?<C%NB?*^_
M.90H/QZ^98GR$S<.DYSWLC)1F'4 AY#BQ=-OI11O5]O*$^;<R9<FM5N<H11S
M%D"9<0:Q4 S2D&.(DPQQ10.B__^B6E=T::<]]ET[B= 6P(BN4%D!;L*)'UKL
M@#V!];:L"MT"=],AA[FP$Z1Q&![;B:_)K6.U;_;(_=$@!_GJ3WO5:Z[[:7:6
M*7?&/.F50\>3"I<[(<\5;$ +_L-".E/%;M+)FHRQNXSF+^IJK"9MM @XXUR%
MD$0TUD:7HC#+!(-ADH2$Q9B**-BFZ[+7O['P6KW+SW)^32":%MG"K[2@2EAU
MI)*>=N+M5/:[SN/WBRYQ2 [^\5EXT$&9BK;JL=<$XF-/R001*A?!G$W<B@^R
M7:)9O/0W\/.S^:"],X$S[W+*<I-&;E/ /&24,$D4I+'4ZW6BK6?]&P$Y(RIB
M) [2U"K Q:Z[N2W;=U;;TL!U-(Q[J+64:6^$C2VV6ZYJI%=@BW6$ O!VK/C2
MN^[.IE4MJX$?:8_=78.+W]35Y=^O*UEJ"7NWUD*U*S7_3G]?WU;R7J_$ R53
M'$J(&#;K;Y) BK((2A)%2@HADL0E"L.ZX[FI2HL;[*"6X'>#%M1P79W]MO1;
M[@.,0.K86P0MY"M0@];*8S#7%ON;?$57W(C2;@AV7 ^I_N)$G+\R+G;=3EV/
MQ8F,$X55W.Z_-"'A=5G*JER@((TS+K1]$\54FSN1@"S@>@G-$I$E>M4L$!N6
MA+#I8&Y2M)=$C]8 AV8;;/FSTYA+6!E92_8(J;&-D4GP<-#>LP>VS7^GC(&'
M@SN?)?#9=</>WYMBS:44Y1L-Z)V\I<O#1,J"\R1A4"JN3.%5!+,LB:%6$80R
MK!++"M$VG<WMO=Y@!6:J].)%HP7E#J[;6][)LMT;[XN[D=_^0]IJH'O9CCTZ
M[&WX\"0,G5U-*A(V@WXN&%;W#!./MZNZ\5+;%:74=]]I.^.5.>ZY?C#-MR%R
M24I#I<(8$BT8VB) ,<P"Q2$+0YSP4*I$9BXJ8M7KW.3D[<W'5VZ:84>NG7AX
MIVQD%7F[ BU@L$%<+T;V,(]PO-N))4_:8M?GI"+C1,-SM7&[V4UV-L7,3=!D
M6Y/8U/)J(G5$IB0/LA!23 3$$=,_,28A"4C&TS#DF(0V*M/5R=Q$95L)W"W\
MJ9/')%-$LI!"(K1&8ZYM/I82#A&2-)1(93C$=I4L?3$Y3=5*#1+L4/IDM%NB
M?;$TMH?(D1YK\;49?T>2G<WMC=9N_K73V<[F)Y%5FP%N5-3JVF&VFM;CJGCD
MU6-A0B]6XJ.LB^Z^7)>5*=3#VY_1(E8FN)XA2!(B(<9U]1R9PI!3E02Q("EU
M\C';=CPW<=V  \7^ -HS?TWI;'Y'BUO7/2WKB; S[<:@=V0M^7A$: L:&*17
M8,N\^:<_\\Z5*4\6GG6WDQIYKF0\M_.<[[]L9VSGN'XOJVVZ%X022>,@@H$,
M",0J"B&+402YBAE-,\58YK2UWMG;W/1I W9O7V83=J._'NNO]=$M4_2N2=I8
M1^L,3AW</0]N^V(7LSO19IAO8@?OAW42YGD3['1?WV7GJW/8Y[:[NF]R3UA:
M>\S:S(?F*!@+ BPBBB!*4*BMHPC#+&(QI"1$&+-8XL!JF7FB[;D)3..\;7-M
MNARB.\5;MT1<R,;(@N!"A%."T3-#'I13]'E;DZ41/3.(_<RAYRX94,PDYR;0
M3YL<1:&GJ/%B?S:O^R*(.0H$0OI53/2;R40&&6,19((QJ5<P48"LUBW=W<SN
M)=T@!?M0P>\U6)?2'N>)[7YU_=$U]EL\/E,.U5"\,#95691AS+D52NDEI*MB
MROF;IRN=TCN @QHJ_5</K(2P7MV:#/@F2<M[C;J-E.5$!)PD@>8NC2$61$*"
M,@ZS)$J2$ N5AFXU$4YV,SMQ-/4 *E,/0&B<CE413A-IM]2YG)ZQQ7!;*<%
M-"X7OGQL"L0U6,&O)L>5YT-VW;3XJJ-PNI-I*RIT#O2HMD+WU4.%@*Z:X+_/
M!15R<S!B+V+V55[RY;I\+.1G^:UZH?'_L> BB22),12!*0U'!8<44083GC$>
M*!9BAMUT8@"*N<G('EI7#1DR![82,S*SHRN0QK^--Z['4+N"FQ-G^X'=NW%H
MDT./!-1#\>AGN8A*;ZHU!,/$HG8!3<>:=TEC [.LR*)JCB+*\H-Z)1_69;Z)
MHZ&81IGB*>2"ZM6CX";4D420)Y%>4Q*9A,1)^#KZFIN\[4,U><)% ]8QE4H'
MMW:"YHFQD67K.5DMSA&BD2SX\)4RI:.G:9.E] _Y*$V*Q2U#:\HU9[Q,U@V3
MXR1).8>1,%71,:*0AC@T&^-,J02E-%(N&5#VVG92@PE.Z]<9 < >0-=B<CO6
M+ V985R,[BWJ)V! ];BCH7HK'K=K>>+:<4=#.BX==WS) ,_OWB+IHUS)KW39
M5"Y8I"(+8RH%C$ED$J+ICSB3<09IQE 24/VRVITXZNQE;A_M%AQXJ-&!'_,5
M>)*T*/_DX,@\RZB%Q]<'3U/X.*J=CV-#60/4!T\._EX??$WE[AW&FYN[MX^/
M+F_OV7NG<_;VP3_P]?9>/,Q ^71'"_F"EB;2YOY!KLKZN=AS*+]XVEUR0Y_,
MK^JDE>^V!YI1@%.>R @F62P@#A,,2:17/3@548@3E49IZE1=^V)(<]/9&BZL
M\8+],>UOA9@\9?O7M0,#3>+5X>?2/4RPG0DV[;2-+/L3S9A[G7!O)/NJ)GXY
MH&EKCGLC\*@RN;^6_6>PV]1*_R\I;N4O-%^97SY/K+5+789BF@EA@K8Y0A#3
M4$$F$(8L"%$4\1#'&=_FK/-3Y] -H954/,M2-XV3O\6K]:!:UZ4.-X4,Z_1T
M7K/3.4ZJG8Q//$>SJ6]8)PTU@P/UZ*Z &=_VK\\'.7WBN6'<3Y!JSA'8;)++
M#2/4)9W<P![<U+\LJD5=1]M\3WZ1Z]N"/MSIMI=UQ&2@ HH21"!#D;;-TYA#
MFBFB_Q.G(>&,<&7EUNCL96[F]CX^IYC3;BZ[]=,;0R-+H0LYU@)F-?@N+=(-
M[.F0_M=.@[K;GD1.K(:W40:[B[WF6W^[^B++PVS(N^,M3 8J90H*'#.(8ZZU
M(,Q"F$:(<TI8JHTYE]6Y.X2YR</V2U\"D\X";*'OY01WK#H]8%[LK+%QV1Y9
M:GIRL9_B?90C,,-)'#<]>Q> .:1IMR#(,EV[34L#4T]UI>QMLTKO9^[=VT?:
M"\B,$Y)DJ4DGHY I3"H$9%)K)DMPJ%@81;%;52LOJ.:FF^=3L#OFL?(R97;Z
M.?E$3+2C_'0N9?H.M<<L63Y)])5.RPNF:?-N^:3Q*$&7U\;==];?/YIHF0_J
M79W,H+JYH\6]?H0?*V/Y_O5.TU32I1:I14 DB7FF8!3)&.*01Y":8U8!HP*I
M5$8HL=HM<NET;DK:X#:17\L&.7@X@ Z^[K [E)JWG8+^G?DQB!W;V&PX_:!
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M7IWS]>.JTBI[LU[F7&NLXXFO\PW,Z#7>@00;E*,<^NHGP]?A[O,=37O@NW?
M1X? ^^\8Z'JMUOR/CW)SK$E;$[<%O;]^K.[6A8D OKXW_:*%2E.418+ ( XX
MQ&F@UR8\HE!@@2.1AB)R=+O:]3NWSW\-&Q1R[QA8#?P*T"UT0&OLCJY6RWFP
M=+/Z9W=L%VM-[ XRN-D0NT,-KKN)=7>MNM'DRZUJV>NT+E4W*H[<J8ZW#XQ(
MO']8KI^D;%VT[W+*\F6]Q-FX #&-HM!D_,ZX%% K4PB9B ,8H#C5FD6SF#EM
M'/?V.#>!V@"NZY[)5;FKI\3:^M>.@72]E-LIDE<B1]:B#598M#L[>VC'"+.S
MI<97S%UO?],&X-D._R@:S_I&=[]'>Y#[Y;JVN71;?S%!J!_SV[MJL_ZD.$':
MZA&04A.CPBB%&<XPS!A)@T3_$674UO_1W]W<=&9STGT'&=2800/:?H5OP72_
M5\0O?R/+2P]U [PD%AS:>TO\<CF1U^1B3IW<*/84=;A3+!J9S*UB/Z!]]XK#
M70.WSO.5_*!>%E+D5?L<\YB$4N $JCA,(,Y4 @E/(ACR.! XR+(P<<H+<-S%
MW)36(*QSB]08'7?)CPFT,]<NHV5D 3UD9(38O_.C][4O?MS!M-OB9P=XM"M^
M_DIWJ^I5;@[]Y,8I6Y\GU\N28OU$E_76:RH9(PQ+F 2F,+(IETDBED&4L8PC
M%D99AAP.Y_?U9_4\3W_V?@\RJ#'7:[<M:GN;H)/K?HOJ8NHF2B(T"5WVQI,O
MVB8RFS[?Y:7Q9NHVZY-XU9ULO9=&7T\0"JC^/WU'^;BL+V&/I1:(L@1B-_#R
M)S]6E@V7'?95Y^V3658V@]BWJ:RNO\#5?[=>ZCO*YB3;=M.*)\Q$)(8P8B&'
M..!Z59M%"=0+69$@&<B8.KG-SG<U-^OJQ:^?FA/K+=K__J]9B-+_ 62-^L\#
MG/BG&7;PVU_,VQ2N^A;DOX'V/.IU514Y>ZSJ8[O5&MS0.FQQC.W"?I)\.NI/
M=S2];[YSP"?=\=UW7)*RS:0@>:-A-BN_1[WX^_ @BZ:\1U-\O;GN,_TFR]??
M=,>ZCWQ%BZ>WE;POW^MAFW--ZZ7NZ79SHF2!XY0FBF&HG\ 48IK$D-%40L%2
M$68H)4'$76(@1\3JI&(3!$UNL[.R>D0@;Y*A569,0]+%C3/!C 9(*IQ"E,@0
MXIAG,(N1@FF:U.MVJN??/:??]Y_@*7,5SWJ"[3YR,YFVD;^2A\54C*B#W5#!
M;JR;&6VOKX=[!0Z'!S;C\YW$<-1)\)H$<1RDWR&)XJB4GT[".&Z7?K+1[RHT
M11)C2JB *C611@H9/Q"1>BT2<1ZRE$IA%5?<V]-L-7Z;8OVR)/2N1:^\$#7V
MUOR)-/2C5*CJ)6.D3/3?J:I4[W#[<M%?6@F*UUOV_&GQOV[^MA LQED2QS!(
M"8(8XPR2((QAG!)%*0EBD5@%&^XW.K>W_7_1![JZ G^3*[NW_("@[A=ZZ+!'
M?G<M1FS]FIX:XHDWLI3\I]OUEY\WES=OY.9?N[?QH+E)7KQ3 ]B\8R?_YK[;
M\C=9?%D_;;)W\EC&)$M@1","<881I#S.("6)7EWS*&,$V4:K[#<\M]>JP6;O
M]S\@J7];9.C01WZU&EB>HQQ.C;7#WWYP^63^]5,@]_WI)_]^:9:23W?KHMJ<
M%=ZK#TM-)2610(%( C%/%22(A9!(25/-5A;&8EAJDM,=SNW=VT^342-N#O>_
M<C[<W\NTI3?=(W]C^]2/J-OF )BH$&LW1=XSBISI[CNE$>D>_/G<(3WW#:W'
MI*0V ,3+O0CN37#KT\LE+<M<Y5*897D;@DU5@B-).(Q$$$$<LP0RSA.82D$2
MA-(LR9RV[YP1S$V)-@,XB()W+<CD.@MVHC0JMR.KU);6??#;Z/BG*[##W[@P
M?8?*#R;/6UDGU_XGKO,TD)[CPD]#&QHF>2?*'+R7U0?UF7[3_UH^BOK@8YTX
M:'^C^?/ZS$9$$H>*<,P@4V8KD;, 4A4&,-#_Q)12'*;492O1,[ZY;1\>EH%O
M]I;<U-+W!-IIZ7><EI&5]G!&#O:2M++*.O9*C_(*;,<)VH$>16*,OI4TTBQX
MDFS?Z"85])&H?2[W8W7CO[Z7AO5V6SG@OZ2XE:8DDOE+LY'U4?+VZ]26&UL)
M4TN*,Q:G,4TAP:DYJY5PR *%88Q8'#.<$L2=(@_\0YR?!5WD7S0^/1 @9)G?
MKNJ3D+0$*ZT^N^H-X,Z,T#$&8809MOM@?-]Y&_F;T:2+Z?UR[ 8)ZE$^JRK6
MAB,\'VT=!CQ9?;'+YF*"PF,# <ZF(MEE!+N4*KNPITM=M3L=VQ6R+=^NMG4I
M/Z@V81I=WJS+W"!X0_.B/LFV\S<*H@3&4L$D$29R+1&04)-^6G\]>)2P@$DR
MS+/K!=_</A[[WLS]#XG1$(.^.9LYU"?L9TI=7<B33]2$'N?=V/8*<I<F^>:N
MG*Z^;#M L!GAU=YT3N2G]CH/WMW:?M!])R^X5VK/.\W]=G-!V:47M#QT<5T7
MA7Y%:A#EBZ?=-3?TR?SN^BLM1/V?S[I7_:&ZT6_4>_V.O5K?ZV_:(HIP$J0"
MP3")*,0X22%C*H2,IW$6AR*6)'3Z2HP <FZ?BAHI,%#![PU"UQH%8\RDY<?A
M.\_/R%\(EZD95CQI).Y\%F'R#7'Z8DXCD7RR*-18?0T3^1>/^=*XKDK=\%N]
M.%E_:8#\4NC5QX*2)"9$U<=/$JW6*(%,)-+LG/* "HK#)'91Z\[>YB:[6[!N
M8MO-J)UJ>N-I9/G;XJR7+?M(KT"-U9\86E'B2=6Z^YI4GJR&_5QG[&ZZ++_@
M)UE\R=M:RD>2]GY=NS-DHUOE9[,_M_]W4SCF_;KZFZP^2KZ^79GTAS=U\<<W
MZZ+]E;D.+41"B*0HAEB8_^  P8R$& 8L#E F(AIS)WMQ6OASD[37WQXD-S[J
MK])D()("TB^RH+<2-*4WS7+V2=*B-$O9@^R(7 _9[)0Q"8KMF(>E29SHR;%3
MVOD^#V/[-LQ(83U4T%H:8,\2J6-3FD&#>M17=>TN_=M*/R$5V WT"C1#!6I=
M@+W!^D_^..T<><XD.1'X[Y*6<MJ).9?C<F(4PSZ?QK%?&L^^+#^L7G\S2>$>
M\_*N\>F8",F%5*E$<<0@0P&#6(H0DBP(305'A,,T"#*>..1XLN[82INF3_9D
M( /] 3+ES_2G1\C[A_J#]*.>+0E0X%BRN9]_N^^&'SJGD?J]O4O#Y"':QK?=
M$7WN+-?6U'A2V/[^)A5%Z^$_US'[&_W&C!A/\C+_9RV#']2-^5.]Q:@EL_W'
MC1;'0E9Y49L&QO]@',WU#2:N(,I(DA*90<[-:63"$BU6(8)1@L(HBM*(H&R
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M_?N]K>2\/3$>K91O:(>ZA40OV$T#4YU#X=XC$8!G)_]Y[6ERZ.H@D@ #=</
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M<W<=MC<.;@A6"E?FIF^W"_G&Q-GSY8,-3-[^?%"+M9K9$A%08VP3@0G ,A.
M24Y!5BA*&!(8H=13)_Q\:].;=S3&UOD$<F^NMS)X#\!N1!$-ML%G"1W$.I8F
MK:E1%<$O(Q)/#[RGK;'5P"^[?4(+W.$F/_H0R\?%9F4K@,UTFD$.<0I02C7
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M1N_>[G79W?_FL 4&,Q.P"D'JC6K^__WB5M2"!>N[)H]UADJ*,HPUX&D.K:J
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M PY#/'<RVKF']K$C'W%X[LSQ:8:#O\>?M9ZLI%[73#\JI+Z0=N9"2UE 5J2
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M%R*%DIGYE!8 (U0"Q@4!2D/(4@41\CO?] (^3(WQWU0_U'I3[T5YGIYXB1?
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M;1HYW#E:RE>;\B.%8)R:>73!<A/WZI0 JDH%("PTT07F2'N52@VV9&HTWR8
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MPI:/  R+#&#%M:T>P8#DFF1$0B*(4_4(M^:FQO*W\WE5JR*LE)D%/?JN!US
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M^C&& \QNS!$7O($99&ML8H= LC77(F@-;NH1O>G#TIM*W.&)1"D.#8Y*+>X
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M3,/R%!<P%WQ<VI-A':V!#SL!)%K*DJ2,@33E"F AL9E8$@5RQ!'.A.2T]*K
M$=6ZJ3%,L'"(O:KKYE9)Y(.OI-4P+X$;R;U8UPY,CB_2J_[I:T.@'RO?+:IM
MXR;(#0'K44;=((V$?3YNA5@]*GGB0$+=:)/#NIGQ-..Y@ PP:<_HYAD$5*<$
M<)XQ*@42 FF?[X);LU,C_-;J[E&C6DKO]=O/KS_<)M_9QEKA1]V.'>#&R?%A
M'9ALMXAV+(['D7YH1"(_QT9'934_( [IRO-N_Z7)/\P;LEQMK$Y!S6V=8IC&
ME2]_L0=[9*&M]+2>*<10GDD",FT("9>%H2%5$C.;E65)J<A@[KPZZ=?TU/BH
M8WW"ZV"#[>QO#NFLC0?)IN."^QJ;9Z]<7L<<#NN!2:H+<Q/3[4U/K.V)-3[Y
M.@;,[JN9P\$]TH+FUXYT>+)2#^;9M3K"YIOJON>;9?)@PB)1/;!Y6]-FJ9/Y
MT@3@]L6O3_>9VYOB?N9B>_NC_\#Y6YS%TK!>Z5DO]7S@:$NF88YV5TT#G^#W
M_9&JFMV:9\KZN7-V/\-(,\AI";3.),!2F5 W*U( LYP5MKZ?HL+E\W+TY*E]
M/7;&)=8Z-\8ZAJN?]Z\"8>C8T\U_Y^%]UM<3D>5:B;_=+W_\W=S3!)7FAWTL
M>?RD48;M60>VH_+\!8%KE]6BVJ@/U0\EWYO/R>+>:E'5D^(_UDH_SC]46LW2
ME O,TP+@C)IPCT@%2$X1@$R3,N4:2>&W).G0Z-2&ZMOUIOI>?\ >:QO-#-3F
M;-O:;4^*K=:>-=N<<'=<!8R,YM"+>[6YH+8WV1O<+/3=)(W-B34ZXE*=!T2Q
M5N!<FAQW8<T#A*/U,I][0]4_MR<AZE#CBPDVF?RT^ =;539C\[,9>[,<4LVI
MU""SZAF8JQP0P0N0,L8AQP26J=>9=H<VI\9#6]N2E2W/9R/K&Q-I_Z5625W.
MS ;>33C]L*S,=W5=N^2KZGFY)]RH*3*^ S/3WMJ;=I+9&&SW&':P6YMCRG,Z
M Q1-C/-RBR-+;SI#<"RTZ7YK&"E]5!N[8UP7;9)F$O1DZ,XP8', S^X+"--Z
MO2 W8RPE4N89*"@C-@VX!*14!$@H*!&89K+4LXW[R3?WIKTH:H0S;5;<ISZ]
M]LNCS=RK%K_^_:'UPI8PK;8>)&SG@A]!>?2*&T\-@_7 =&5AKM-([CK@_O)'
M"WFR,SZYO0RS-W'Y(Q:)OSP:'I7&_ $Y9+. )X1&6GRS+VKZSKQ=M]^7CXO-
M#*$<PD+D0"B=FWF>,O,\;OY3%I#1,C.S/XEF/]2*+]T#K---^0RC;H/#C::[
MYPN8OA'3&41+)7*<(0FPLJ>B2VP"5EQRP)&B>2X12;/4+V"]'L]QRG,,@:9K
MT'D]1H-'FGS3*=1]DU@KD\;,F,%E/Q#1(LHSS8P<1O8[>QP[7K@^OJ""(?A/
MVIZFYRC7/,LYT!J:4#'C"G M)1!0I3K+2JT*[A,JNC0ZM2"Q%E=H"]2+9Z?K
M?YG;@_-_;_28X@D>[-"WVG<2:0A2E5&K5$'M:F8*6,YP+E,*I:9^7[G8^(_S
MQ3N%O85^ ,A1"GF>$?/Q0\1\"X5 @.9$ 9RSM$ 9YJETJCH[V L_FLS8<[B;
M=WRK$1%5WV.'O=M',S:B W] '50Y[/1HJ<>3V3A$:00%C5V3DQ''. 3!1_?B
MZ-[ \S?'3]^-!:W*E*49!I!K0_TYQH!*7 )!<R&TI!PSX?/A[6EK:M_;UR>(
M)V&;S:KBCYMZ97.S3%[]_L7SB$X/V&[$$PG"@?G&D6ENDML#1.^8S<R+>*;G
M,ERQ3O;TM#3N^9[++A^=\G&XQ8]=UJO-[$.UJ>[K5)?7;*UN?U:V.B=' F(!
M\B+3 &N5 IH6)8!V3YSE!4J9DY[BZ<=/+8396V@7'E7RIS72\9S,&0#[2>)Z
M6 ;F!4]$G(=[O^-](]S<V1G=YK?]R#[ST%$&<[]#V_%[X:JP@.!WM;HW@^-6
M_.NQ6E=UIMKM0KZIU@_+]E?SLS SGT?S9G2$KGB&(3)SEA02!C"&$C#%*<A@
M0;-,:JE)X3-G"3-C:A3PYOT_WG[Y^O[K'Y_??KE)/KQ__?;CE_<??TMN/[Y)
M/GW]C[>?D]O/GV\__O;V][<?OWH&$X$=Y19G# __P%33.F!"C(X+]8FWKA-)
MQXODST%4KJY#,E)T$FC$J('+=4 =QC17/BW^<N:=_8?EPAA17W6W7&]6:E.M
MZFSQMM3EG7F%UW8R4$J:<4$QR%'*[4:(F7E1:0*E+"NS,A>P$$6L)4\?PZ8V
M36MMK\?UPS/#=R5Z(PO!>G7C]8M)0W7."RPX_=)X]6MB_;I)WAC3%_9\2N-$
M8KTX)__:.;XRHA)L"/8C+&-YF369I:X0,'V6PX*>'W@"^0>KYG;%XMUR]87-
ME=T;ZX@K"O'X_;$^O//;RAAFBQJSN3T38L5I7RF]7"G+#6DF<"%2#$K"3<#,
M=0IXJ@@@DA9E#F4.J5? ',6JJ<7/M:UU^?7&V.3>6.M[7CE*=[E1^>B=,,;.
M>U<5=N<@,,8"ZZ*-L'=N)4V'[1VKQ;UOS,?8^A:7NJ-B'>LL=12;QCUJ'1/&
MHY/841\>*$?[_8%5*_L9:*K)U6GYK>+M\I5JI@1*?M(S)0LMD<H 1BP%&&,-
M.+0['ZDV03<J!2;02YK6M>6IT>[>\$1\8V8BY4FY[I"[T>H@0 Y,G1T,M_4F
MFT,\K43/9FE8,=F:;JZ)J%[K"U<L)5OG=L=5M?6%XTCAUOL!_D=ZWRXVU>:I
MU:GXK![L.>+%O575?5S/D%4Q$Z0 4A(!L,0I8+A,00FI$D@H(F'F>L*WKZ&I
M\5!CZZ[V\\[:I#'7_01P+[K]'!03LX$I)Q0NKP/#+E@$G1_N??!HQXE=W.N>
M+G:Z/D#\NA)V0EM+:=43VMM5?6"MKF)5;P7B0A5*9P@(E1. "UP"2F0!;+D1
M)@1&.'7*E79J;6K$L#.X7OEK5INZ-GOMM;KAW<\2T5$<?"=V=  ]9*UC CF6
MF/4%0",I5[LBTZ=7??$9XZE4N[KS3)O:^::P^>)ORZ7\JYK/S>,/#F]WMHQN
M^;HNC#T3.<5,9APHE8NV;C@NM(G4<J4YX0HKK_J_7JU/C9:WQM=CX%"LH+O9
M:NBE=<%3-]:O<]QFEX-!/C"'1T7;>Y(9A%JDB:9?VZ-.-H-@.9QPACWDBCWK
M8ZG$&8%Y5J0( R68 AAG&C"E$2B(2)52@FCI5;GN3#M3H[#VW$$[A9H[J'QZ
MH5KH0F($E7FG2PZP8*75ZE(@U>;GC$JI4O^S3%>B.L(^_<"HNO%\!*P&9O0&
MIHZ)-]O)?.0=[_,HQ-S /M'*^/O1YUT]N;W<<_D5_-IP=T<=.5.P-!&BF;BG
MPOR'Y!)0A 3(LIQ#"7F*L5<5O).M3)-;%\L%V#(!JRT.(($C0!DKB6FU !RF
MS!!KS@ 7Q%!LFN49U!"6I3^Q7@7H:+0Z#* >G'H-3*,P:F/@3;(W,3*?GD,@
M)IL>M3$^EYYS\R23GKW8?S6T/OULA7 6IB^L3DUF1C.!*@,:4PDPA02P+(.@
MS(7FE$@-.7(9[:<>/K5!WAS][ACHOBAWA-OE1<QKT!AX+,<$PGTQ\AI QM2=
M/M";WCP#Z^EF%WS;Q8+.%^/&?#+L!K6]AS/S6*&2]3>E-HED&Q5)0_H<ACVK
ME$>WC+8H><[8[AKDV6O"8L0[]E2O7KY;KCXK*[(A-H^V<,HL37/(=(ELL63#
M<RC7@&-)@"I4B9258&#I;*'N;0K-5_=H\5Q[3N\V;=[MHU:'>[^WYOJ%-6=!
M=8MLKL)H'$+<FEB7='EF9+SPYA(,D2*<L\V,&N1<<O8PSKEX?>"9?)L,U\P^
MQ=/[A9F:F8=;>49;DM,N^>VJ9&8%S[(,,*PS.Y/D@.*< Y47K$"EB8,X\ZJ2
MZ=;NU*:5M=GM]TP\-8401&NQ)V>X(N]&(0/@.3"CU!8G6Y.3K<VUC&NRM7J(
MVIM^2,4ZL^_8ZKCG]_V@.#K+[WE[J":B"39%U11Z5P]SM6G.7MPV]2^:J#K'
M)1>XD$#)K  8EAR0')4 ZQRG&A:&G[RV1ET:G1HW=6VN0V_6,?8F6:CS*Q'A
MP+NQ4VPX!Z:FKKGV]%AK< UJU^28@H#N $43!W1H<F2A0'<0CD4#/>Z]+EGC
MZXHMUG/6-G!G7KIO5@Y!""M2:'-%=@<(U[.4%UC;([4HS0P;25C:L,E$484J
M\I3E*91>LO@!-DR-IG9?_,W>AWID+>OUTWVM*<]X*J1[W-AK8- ')K.M]3?)
MUP/ MQXD>Q<ZIU\C2E)? 6#D+ X?"UXDER, HG,9'2&/"@S1JC6[OU^I1ASF
MD_ZL?JC%H_IJ3V/-1*FA*" '4 NK,%FF@+!<@2S#W,PH6:JIG]!R3V-3X[KG
MMMJUS];:Y,_:7L^,M%Z<'2.Q2.@-'8$% ^<?>CD@$BODZFMJW%#+P>FC$,OE
MGC "^;Q\8O/-4ZL'MUPL']2*68Z:25W*HL "<"[KH^LEX(000$EJIG29()K)
M[:JT&W^<;2M@17I@^FA-;54-_;CB/*0IY1##/ 50* IPI@1@0J8 49[!K( %
M(BI@H3\FKF.L]&_!W2K]+CHFQX+:C9.O0VX<0G[^*M;I#9?1^O^Y>[?FN'%M
M3?"O(**GNZLBA+UY 0GB])-\V\<Q+MMCN_:.,_60@:O$J52F#IE26>?7#\!+
M)O/&!)@@Q>Z'<MD22:SU@?BX%K NSEQ\$0E/1'Q^G$E9^**ZAQ1\^0;WVIEO
MC3DHBT=:;%X^ZS>@2J#A.,6)(EC[K0R;?B,1S%"*(**49"H,:(JMMOO/#3 W
M0ZTK(S!".E?0/ EC__KW <[8F_2NN#C5T>Q3_HI*FB<?.UDMS3ZENM4T>Z]S
MCUOZ)DNI;[@WE>>T8;9</QK/3G-$&[@LF,1!JA2,$=5^F$(4TI3&,-'8F:Y"
MH4162]IFL+DM[U;>:MM#["2VC^JY"&__4O<-VMA?^S-X 6@^_/!2H/B E],Z
M1LHGBA/%3%V)IE/XDRT\/>%0%Q\Q67B4K3+=<"GK>]PI]NOZ@2Y?RLW'AY5I
M!-><SPM"@B0VE<59S""2PAP]*@:))E5"6<"X72.QLR/,C4Q;(?_>2&E/ Z<!
MO,R<5\,R,ET>(G(Y:L'VW;*FQ:LAFH@+W:%RHK]>&'HX[_1]DQ%=K]A==NN_
MT&\EX:9J:K>@Y6>Y^7W5A!74E=-,/<S;(C<Y\N^J>+2OLLC78MMJ1%"92"XR
MB$D2:4<R"&"6I11& L4R8!0S07STE_(A[-R(]I9OGDS#Y&5=BO+O5?LU:?J:
M>.Y*Y66F[?:ZYC)_(W\1++I@G2Y*;-1L+@&-JJ#6%=3*MI,_26EBG[,R<KEB
M+Z+.HH2Q3]!MRQI['7-H13HC2O&X+BH3Q)2UDM4>2?'R=BWD0E$N".<13$0J
M]9<$8\A4C"%'01:C4(8"6=G9EN/-[6/0%%S;D_FFJK8F-<R@D1P8T5UKU?7C
MWL_K(Z Y,C7[ ') %3LK>*XH9M?__(EKVEDI>US:SNZVH<T'E_J?U;.?Y5X9
MIY4PB:-G?ET%T5!>=?'XI"GRXT8^E L6\CA&&,&0)@E$(J"014K!+,UPE"4B
M2Q*GF!:?PLV-N&Z7R[Q*]:LFM-KW^L,("RII'2-@O,ZBG<7Z6G,S^LE.1^YN
M^;@ZRKGS[]J6W=S3%=B_R6H:!_11](^WM\:+'D6;N%.C?U"/6SN.,(;[+NV[
M@MZM5VKYTNRA!2A#C-,81I%I?I%( 8D(!0RHHF&L")+2JOS)B6?/C6JWXMGO
M.QZB=7DS]@H,1J:TK60#]E\/<;#?>;T"CXGV7"^_%DY[K&<4[ME=/;QCLGW5
M,Z)V=U3/73+,RGROE.3:'7[_D]\;@C/9<%],N\Q[\]_[_WS*G^G2<&*5PYOS
MC13F%YHA]W_0N7*1<(2BF"&(%8X@X@)K F,2!B8"DBN*H]2I5<0(,LZ-"&L5
M3=BP;)0$^KLC2[!> :Y%OZG^!'*G067U%%O]JM^[F:9C3+V=A?K*$SJVO[Z=
MRU:_.D6X;NRKI]+\"3JRWX"=6LTE9G(/?KA_A\E8S5=/9IOU2QU3M^[I_>1L
MTXXX0YY,VS$DG-3"'1'B0T-WS*&&?78ZE01WU:*S+ R5C&"8R-@T\L@@HPF"
M/,Z"!*D$4^'4].W$&'.C_4\?;]]\_/3QQ\?WCOV-3^%GQ[U7HC(R=W:D&Z4P
M<X_VGGCIU B3\DJ/BH>\T'?IP&)-A8GPWKR8 YF-Y@_#&'4\D]PL5,JD=FX9
MQ#0+] */,=1_43!D*2.1E"2*G8[6^P:;VTIO9;T!CT;:Z@,O6WD=:S?U88PB
MEA)SWH2I(5&9:-L[400&H2;4A*HH4U;%_[QC/$7#XXDPMB-:7\B-S+@[T+YN
M0=N*>@,^]Q3A<*^790&)KYI9?4--6S?+0NFCVEDV]PS(G&DJ&52I'EDL$4ZS
M#*8D-=76TQB2,-*\G"A!6"Q9;,?&AP^>&_-NRS<X)\ATT>I?\]=@,/:QB:7Z
M;GDP)W2])O^E^[CI\EY.*+&7[W+J]\/,H@_K0N9WJ_:)G1.$K?6>,)RA,$PA
M3@(.$<Y2R+ *(-<_U9]N%&2)<C&.+@\YMX7:2+RKL-:1>7!/' OD[3[G?O$<
M>=%?"Z7SE]T>'4_?=XL!)_W*VP-P^*UWN'-@K0+YV)3BK#NT_I#%@^DUO0BD
M(AS+ +(TS+0_EG&897$,E0IPHA06-*)#\NK/C&>U/EXAK;X5U^S8+DTK8DUV
M#T!HB1VSZL_A;$<P5\$V599=*^*V;;.1$KSKP\H]I_X"$+Y2ZL\-,VU&_05E
MCQ+J+UT_C"-^%)*63\7+]\V:__E/NGR2"RQ82&.B8*I,>6VM'&129##"6'#.
MDC0FD5LAD^-!!E#"V#NRLBP!7Y<5&VP:@4%I)'9C@Q.(VO' 0)0F:C/0(E))
M=P,J^?PM_?.Z>UKT)P:8=+F?5_!PH?=<Z3=KR@3)?S4_J*JN55=]U>]_(3=Y
M4<4[=6/L=R78MFDT*<I(@"6"828"B&BLK8B QE"*0(HDPR0-^0 K8B1Q9VJ$
M-!I5NV^/>^H 5NLSI&_1"+,=<,$E#2,]VZ&>[4 HF$GMIB9"9:G )";9SF9T
M["@UC]F>8J/Z\FQ[3YF[=N+M/EZO.8^OERCW2ZWDK\"H>2Y1KI[/;Y(O:5GF
M*N=UI<"=LI,FRGF:D)%SY*Z5<A;I<9Z@MLV,\S7<%59&+4@[^ON?CUH<N6O.
M^T/^W+S1R/VY"$@D* ]#F,0Q@DA%")(@1! +(A%/ D*DTZ:GT^ASV_^LF:7E
MDK\W@O<?P7F8 P=B'P/92>BZR60VW]OZ!XWL>WW C?B@DM_CQN@@W'RRJO78
MTW.E*RPG&=#Y(>X)&K<&V=OOW]K.0B11G+ (2BXD1"PAD*58P# 288AI)%E@
M15K'CYX;(QGA@);./BOA *I^;KD.@)&)H]5]0&K& 0CVF1G#P9@H,>/B"^&4
MEW%:W9ZTC(,;)LO*."UH-RGCS!6#J]-KKY N_U&LGQX_KS>&S>IP;RFVP=YM
M?8,OJ_;R!2,X3D@6:X_<6%-QD$&2"OTW0;(DE ')5.*V8SM0DOEMZ[[3YG&Y
MR3?F0_^+$;C\]>^?JN(TS@7M!TU-R*.,)AF""1%*3XT*(56$0\$%0EG,E23(
ML:? :!,S:;N!W;28DD'33$:2"8$9BR&+P@2BP)QL"/T!QY01&6$69RD:L&,Y
MW6*98D?R<&I*\(O620+TZS239.>63+ .1K8S6I% I8*I4[X!72UVZ3W[M9;6
M*]#>ZK6UQ#5P^NLZ,4B*J1M27 /5B5X55SUNF*5QNURN_S*U+CZLBW?K)[91
M3\NFWT[Y37*9/YM>&6W-6QFE@:D5 D7,B;8J6 )9$F 8IY@*H;]OA)$!O.DD
MQ$S9TAP;_QN@K295TV&I?=$Z-;.0(M\ 4PS/C3O=IL>.,?VC/0U/MC*"G9 W
MX'8/\+<USO4FO+<BQ5<!YXD1W<:>E <'P7+(?L,>,C#UL!N:A067,D$A%"H1
M$"4H@92',8PRQ#%.28I,VPC[<\RA@5M3I,=4)YN.:8;N86PS#5T;*UAMQ "U
MUPM*LPE$\QA\5NW<=IO#U'NZS5[N(J8HD5D6P$RQS!P2$4A3597EC;GVG 7C
MX=  D[.CSM3.:,Z(\N:,2+9G1,Z]DB]@SD6@HBA4D&;&18Y5!#.!M:D712Q(
MD5"9#(>&>7C%? +>G ISAX.XZR"<\N2M*^FVH' C[/F=A&'';!=1\7FN=GZP
MZ0_2+BI^\N3L\EW#Z/P-71I3[ON]E)M/ZSK,I<JAHTH%E)E>/K&*(>(L@B35
MI!)ED8I))I@F>9=-T',#S6V7LY$35(*"5E*G?,2+V-J1AP_$1J:-86 Y$\8E
M)#Q1Q=EA)B6)2\H>TL/%ZP?:><4=736M[=^N5^5ZF8OJ'V]HF9=?U%?]'K5G
MF&^>RGPER_*=+'F1/S8]H7>]H+_JFWDNRUT<"^,)B1G)($ZI-A,#GD$FL6G;
MG)& H9AK7\XIEFA,:>='45HGD_+0U:JI0L7UOY<OX&-9FNWH3NOU[QM] 2V$
M:VCRJ*^!I14UE\D=VPCKZ%D5#=MI>@-.3KK^<:,OZ"A<U]C=37VK\UA14U-,
MCR]K<%19IS4FIX#]R!:=9%#_.3.WSS1?FFW)#^OB.UW*[Y(_%74MI>/H^5B&
M89C@%+* 28A2[503PI2V?SF+0Y(RR9Q,7U^"S>T[]!LM_I0;(WR5@ O*K>S^
MLB"<)H[%$JDHH3!12$$4D0A2GD90\"!%-$QYIN3B619L/>>IZPHXWN3]OBHD
M79KF*Z#M_/3W*G1@E&06IVETV%N9>&K&-@#>?KRIMKS!3N ;L%4&JG4!C3I[
MP07M?.TTJ[[_DR6F#,%Z@DP4)[%FDWHR!$R77)-!SQ]:R:+<%$]\4_5RJJJ3
M+LTF\"W?Y,_5B"=S3/1W5X2I@#AFIKH5(C!3IO5)(F*2,):EU"G'9(@0<_O,
M[NG@6N5BP!S8T>_8R(Y,M7OB-[YSI0#8:3!^PLDU('JKK#% A(FK;@P'Z;@B
MQQ7/&ABVQ7GQ)$7-P9I69=G& ,6$8XI3 F.5IA"I$$$FTP2J0*59DBD>Q]2%
M[,Z.-#=&:XZ6-D9$QR"KLV#:L987B$:FID;&]@"NDG*,$*E+4/@*ASH[SK2A
M3Y?4/0ISNGC#,#[8-BK[HK;I<">LM6W%.RRSB' :P RGVB0B20BS0$H8Q31E
M$151P#,7EG <?V[<L>OSME:G6^ .K3[H.C%VC#,BW"/SD!>DG6EI(%Z>R,IU
M]$DI;" TA\0V]#'N)8Q_HS_SAZ>')K4R#1$.LRB"69IF$$7:W,EPHBF-445P
MS D/K(CLZ,ESHZA&./OBQ?LX]?/*5=J/S!B-7)>S<)WJ%Y_4]HH"QOO/FZR"
M\4DUNB6,3U\PT,C@]U(\+>47];[J??NO7.AEK=;%0W4T\TT^R]63_* %?/]3
M+XD57;Y]*C=ZU1?EFY>OQ5IH'\ET5OPNB^><=X]L:9(%/ T5Q$DF]-J5$20J
M13!"YF0$BX"FTLD<&4O2N;%"HPDP;P5H=0%;90![ :TZU7Y$JY"C$3/:Q%N:
M.W.8SM'WCH;-)/CC1W58-LI6TNC ^[*P1I-S6EML;+B/K+;1!QR\O?7T\%3M
MHO4=/.S.:&48(L$CF'!JJDBQ&))$*AC)&"4A2P.JN..FE\OX<_LJ=,0'ZRH(
MF^]Y6@/R$!TG).$A8Q&A$".DC?&08L@R3&"2,A:(2&!*4I>LJC$G9(($@M>?
M$.N=S+%@'G]_<XOPJ0*-;>)!<[JM-3 ;$%[/LP>"YV]'U&GTJ?=)AT!S8O=T
MT&/<"WZ]E<L[N=+/W,B[.O.^\:-)E,4BE1E$,DQ-IR0,:20#2$.,29*I! 56
MG8W[!IG;YZ21$]SR_WS*R[R*!C6U(^WK89V%LY^6?($T,O>T^'1D'% S["Q&
M]M7#?& U41VQ09@YU1:[!$9/E;&SMTY6;^R2\-W*8Q>OO7:WIXVY[:Q_;?YW
M_E5YH N<9%APHB!6DD-D6)%$)L(U80$*2)3&03)L$\=.@+G19BN_,32V$?5=
M%6Z,4]\EU=J5=SUA<ITGUST7_^B/?<;D'?@K-D[<T/.^'V(Y_"MM<[B!<W[W
MPO$Y5\0>=ENC'S1$_ZRU;^)&$)*(8&T;HB1B$)$X@8Q( L-0<(S"&&>ATWZ$
M_=!S(\&=Y(!KF:LJ/::L59&SIVJ:JLW,4FXVR^KXT-$-=I@3.]H;!^G1]XZW
M(!MQ*TBKOW0$-W7E6M$]QQHZP>4SPM!NX.GC"IT .1E-Z/:$87QV^O&WF[>T
M*%[RU5W=LBICF*E$(LA"'FD^"Q3,0AQ"%2<IB1'.(K.39T]E5J/.C<6VJZKB
M,+F3VXVM[!"W(RKO.([M))\G)KH!K=2^VXDYH>2)FNS&G)25G& X)"2WFP<>
M^)3:!-C%,+,$LXQ*2&.>0L1C"C..">2<8"E5E&*:.9T>=)\^M[.!JH!1&XD+
M:"6JXUG 'GB6._U#(1E['[^2:XS(Y%,*^]I[WWOVM#OKI]0ZVC<_>=' TO2R
MS.]657Y#^>]2W%6E@TS^@['>FQU+&2(>2D8A)4I!A!,.2:"]H33%1*(@U@O:
MJ1"'Q9ASLQAV(NLE#1JAP4YJQQ+:%J#;K7O/4([,!I=0]+AE/  @7\6N+4:<
MMK"U/01'1:P=;AW0AB?\&TX"4X2^%$\R"N*D>?>1,H$?(89*F' #QA4D0O-/
M("*<1)@&$EDE/?4-,C>&J<3\[Z 2%&A)@1'5H47-.2PO'\GY0&ADXC@)SI!&
M/N=0<FCIXP&MB0[EOJQD*^J[KJB>FOU< **O[<^Y6Z=K '1!^+U60)>N'69Y
M=9+&OM)<?)8;;6C%*D)!"C&FQE'*),QH1J!B48H2G$F<,A=#ZWB(N;'>+LL3
M/-*7 3O&)U"TLYRNPV9DONNF=0(C7G_32&>KZ+SRGHR@$P-,:O.<5_#0Q.FY
MTG^)*;/I\F&Y_LO84K)M_O%&JG4A#_L(FR@_BC-$4\%@I)E!.UZ"&!<LA2E3
M"<T"$7(I/7=B=Y/0:LE,7U2[IVZ1UXI%CM-I1TP3S\[K-=D^B.&L-I*-<I5C
M>%B_B%5*'G7;OIFNAM$P[">H8N0HV&SJ& T#U*62T< 1W#W93N+%?S[EFY>/
M*]-KK3)GJE"%7884CU-)*&$P#3+MVJ) FWA2*!BF09P%B<226[NVUJ/.S>KK
M1O34HH..[/;NG#WLE[W@4< <F57[<71));L"6GO7>12()_*E![ZR3AZU,SX]
M+K;]LR;SN9W5ZSKA[C</['5P''KV2?_@XT8^E N%)(LC%< P9HFVQP,!&2,"
MQB3%4J2"9Y&3?]XWV-PX^U3D)?C#B LJ>5W['O3A;&<H^T)O9)(>#IQ[#P0+
M1'SU0>@;:MI>"!9*'_5#L+G'C4"$S!=UUNWW![I<MB,L,$YPR*B"C&8<(FGJ
M#>-4:OL/IRR6B284*X/OS//G1A.UB*"2<1NM;4<-YQ#L9P,/N(Q, &Z06"_Z
M"XJ?6.>EY'^[6S__7=]9+W']E]W*/O>\21;S!67:]7OILJ'5UK3=<+]>ZCO*
MVKHPF_VGRI[& 2&4RE@OX=A4?8]CO:P1@P0S%40RH6DBW.JL68X\NV5>">M:
M.\T69KOO_RC@C>VQ=63^GZTC4;5A'[V.K#-<WLJEV8X[<:$T1SB.2Z2Y/F!@
M7/?ZX6&]JD9[ES_G0JY$^546W^]I(=^97:Q"BD48J2A+<  YDPJBJH(:B2/(
M>9BE.&(X#B.GL&Z+0>?&25M!@6@D-#T>P5,IP*,L0&ED/]^A<#CV=FSE&]&1
MB:H6%U3RWH"MQ#= RPPJH4T7@EILC_'=#B#Y"N^V&7+:Z&X'$(Z"NUWN]9$W
MMPC3E*@D83#A@4DHB9%I+!M DD9)S$6FHL0IH63_\7/CF(/\MVNRVP9EL,V(
M(0ZRU,9*0O.\W \>_HK)9.>6\)FKW ^E/LD[NOQ:K+F4(E_=E54)UZJKEER9
MGEJ[_39)TBPB D$D$(<H2!0D(8EAF&4D"P5*>6!]*&4]ZMR6=B4XZ$@.;DUZ
M4U?V ?N=;A-Q^9AJ%'A'9@IOR#J=IC@CU7.:8O^LR4Y3G-7KGJ:XWSS,5GC_
M\+A<OTC9%!2LS) WM)15+6FY*JM#N\_KZBQ'BMN_3._1*H&J^_NWZW*C7:O_
MD)MODJ_O5B:N9Q%PQBEG*519H!T>&B<P2[3#@[,D8RGA":%._?=&DW1N-&=B
MHUK9JK)UK?#Z'Z5C'LMXTVMG&\UBTL;>,3)*P4HK\+4.D06W1:$OJ0HL5'4
M:OU I:!I"EMNS)X2>)$;L-/I!MP^F*Z:_@RUT>'W9/.-)^>DYN/H<!]:HN,/
M..)7Y0?]^4:NI,HW=;U;6?"\E%]4Y1M_J3K-E@M,5*B(Y%#0)#4U *7V6Q.L
M_U!I$,8D94'L_2MB(]G<OAKO?W)SA&WB]%DM>UF7MJYVU2"KZ&GO:T+_<F\D
M[F]B/7X_?$_7:W\O6@U,)%,M?A5$"QHE)_X\N* [Y>? 2J[YT;\+G(/HWFD
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M4QC%8<B5)"14R):#KA-E;JQ5B0W6E=S@L=&G\L*J[LXW8-53?-/W-%UFP>G
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MX:>(<';!S7>LL]78KQ/U[ ++V?AGIX<,X[5_K-?BKWRY_*:_4A_6Q5^T$(N
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MLP@RG C]A\ \D5R96@G/LF#K">>A.]XKS,3XJ-M] 3P@.3+I;R'4(M9E!FY
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M/7W%T,9^%9&90[ZV//>_\LW]6VUIK1]DL8W3HR%)4612.4+!(1)20$;B%/(
M,15D 8T8<6OK9S7NW.BJ_5Y71]K;ZO%_:<E!*_K@Y"W;J;"SC48 >'0_SPNV
M _KX.2'EK8N?W:@3]_!S@N*X@Y_;[0.[]YQZM"EZ_UENF@3MA8IIS%420JGB
M&*(H22!%.(4)51&-2$1PX%0XS&+,N5'5=@4-:0A@@[$=#WE&;F0..DT[-Z"2
M^ 90I6<.W"Z7Z[^H7E! K0O0= LRS45OV@(!'GL%V</GJWF0Q8C3=A.RA^"H
MO9##K>Y.V]M[6MQ)1OF?)5T)DR]ACIM,8$1;X9<F*L-!E$)"<0:1BA.8<1+
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M<+S\(3\CY3>Y,\T-/VW6I@.P>//]7UM35JM)"%T]WAN;M_)V[Z,>B*((8XX
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MO940M,O!\C9%O:LAUN9DJ<C\[:%DEU :I^O2ZNZJJB]5#/K[5<P&W@5MC8Q
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M;VV TI[7/= D+Q?Q<3BZG:<X(-EF$J4"&DNA,J=+?T'&(3&3O*?4,U?;*MI
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M?@@B*A>C"ZJV.OL^55U7A]H+UBH+HP?PNBI5-6^G=RN'/%'!4>=*ZR8G0:B
MASQZ(J R2\SEQ)FM_7+L-17=AL7V!)^6S&Y;/'U/D8*!]=90ES305/J8IFC
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MVXRR*FT$EB,_Y/W<S[#NE'=!2*/0AB!!^_(T!NU\7:K?L6@3EP;Y4MONVHK
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MT#Y-Q_-T,QLPF72,-$!0A37)"7!)6&"6^>ASD+QZIX0F='6;R=')255#0CU
M74/>/;6 BM[GS',I)UQVJ465;81$_Y($(C7U2=>NA[TEB3W2;E4PLILUOI/
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MV3=7Y=:ZPM??*M_>+NH_I*]N3SV3J<A0IZSY3,=4M13$AQ# *<%R"4%FL\O
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M5(;O8$@]^Z%I9W>,B)+V;.YC!L+V3)^1GL+;(VUF$25'+L@,B,A!N;H<5[(
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MWN;;UDQ%NJY.*L#D?9T>$&LQ?AV;B-ER2[Y0\SE^3]$SK6IK)_5'X310!!W
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M0LG%JF" "2M!65^(<878I;Q,Y.8P+5-SC=5I]OQH=GHK@?2+K>THPGH?D#-
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MH#H%H!*I(V3D%EBRXW3,QH70?(O*/@0.WB-S];%/R]/3WY>KOW"59D[(4)A
MTKF^.D N5@?(0RK"ZB(D3W=+@YN=^189TT97QT/)O0TR R70@:.P/<(,ZQX
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MR21>5U=D:Y5C1;2.S.Y UC3)@:-IF=:"Z0!K=&/.5_-XGM-K7'^;29-9$"P
M2YP#L8-NBE(!=-V@RQP9B;:UD_<K!=.$]H^&H 'L[@ L&Y/PZJE]\_?WO%CG
M+>Q5XIA#7000?=V=XSB@LAPD<T)(\C#:1P<>IV::P/S10-1(#+T ZM*YV)Y
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MPO]M[\J:VTB2\[O_2]IU'R^.X.@8*U8KT:+&CGUBU)%%81<"9 #4CN;7.PL
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MK]/9HB8GKZ4T&\U'DXO;2?2;8\S1^I:1%(32^=IN2->YU1(4YJB<D5+H0P9
M]LAJS[=N#[1.AH*5 ?NFCTS [BR,*H:,7"ONES>352U@JA5WED&BDU1X4>A$
M/=22V9&5GJ\)'V!)'%+7PW=C=Y'&=9LP%Y32GD3"/)+C$^KP'<X\1!99SO25
M$H?R:5OPT_,]YX&O@:VT/N"]_]&85?[[Y7Q1S\>WI)Z3CZ_>=3Y$WTYG)*&[
M6;8J+9&<0^<C1(-T/IH4P"M+&XCQGL6 :/,AK:K]<]SSM>X#&5<#0\[P#YR]
M"FUY/@?K1$H96)0,5(GDY2WOJ*2H#'KF+3]D@'6?O'9;8L>>[AT,6OZLA]CU
MB6]-4,9B!IMK*P'/6)T 'FOKL)P=3\5CZ_L-O3+<;7T=>R)Z6+@YCA/L[6@2
MQJ,_EO+Z6&[D\V$Z6?]P5TA5.K45W[V,D7>N9&OKM?\ZADMH!T[4#E4\"JN3
M<=P<LH"N#5?=5LVQY[Y[0," SY^=I%'E8++@R?):WY(]R<'5RUM9@68Y&"^D
M-NE0M1Z[\M(-_\><(#^HMO\$!\+U08G>*5WOY>= *E*D'_",Q)1$O98?,5G5
M>D+OWIGJMAR./<-^>/T/^#38*.MT8V[>G(I<,I98H*TA1%_G%UJ(PNDZ8-++
M;"+7_I#I]UUXZ0;_8\_%'TS;QU%OTED<E7UFG>/<.D!>R">2K(!WJ*%D.B)C
M0<[D(8NT-Z&]V]6P/TT"?5-M_BQ%)C>+^L;E=\)FX2P85XO6>4QTDN4"@31D
M-;.FL$.&BG9@I1O&CSDC?DA='\?^??(]C,:UEU+M2!_&>(;I<C9:C/#1\PN-
M<#+& ,&F3/S3NO?%6)#U,BAJ@[SYC(%FQ'=#]S'GNO>KSX%;X4\SOASOEF.L
MQ8]@@RJ@M"Y PD= ET4)(2O##EFW_2RQW8!Z[.GD=OHZCK!)EX5Y?<[$A"Y9
ME* Y+4YER$4(0GO0,IF0C28SZY E%)O0W@V]QYZIW9LV!]T/A)C%T<7DU251
M-4D_/L_(2B(IK^O.ZT_CI:8[=4D10A11)Y4D)\D7+HP!?3!UCIWDR8:B\J&V
MY)9\=</_,6=2>T/!H-?&,C3ZB&3&]S+-RWOZR>A<HJ2#C2E03I+G'!,')(W(
M2"(1X9 N8T>RNR'[Z+.=>]#A\"V43=?T<]6R,47#F:>3S@M:TC8G.N[(=M,Y
M.V=<YJX<*M7?D*UNZ#_J7&=/&!C\MG[+7\XF(RL*2N UB.\M..4]6!^\EBXY
MSP^9K=DPMG'LF<?M]##PT/,RDLY1Q1(*E&K_J%PR>$?.KPE<B!Q#X/F0R?#.
M@#KV7-ZFLC^.D.[U)BR,9H'% MK'"(J56FPE."1;0E#:&$SR@+#:Z"25QYY*
MVTH+1] 4^22ERZ^7XPKGY]AOUR1YPQ>V;IJ\"[_[::*,+B0I"+'22?(\D 6(
M7I#[46P0AIQI94OC9=VVB?+)-(T>M#5XM9(R"?5.@X/5/53)! H%5B QK$2$
M>AD(LN0L"YDD:VYU;4CBH!HA;X*/^SO:/E4S@ 12Y\5\Y]+H<PGCJQNEJ[U>
M61D,6@\QU1',)3&(407(/#A2"0_YIOZI%5+WR]*@6B+OA.P!J7XX\:".4ND2
M%+LQ>&+.,F8%<AD9L_3)D14%(DKZ'TLNBN;;=7LV!M4O^0# WYN*CV?;OU7F
M@]YQ8Z&((D&Y.N@-@P*O+7T..G&;^D'P1N@\5)+U .C<2C4#B/P\NHQ6=P??
M3;[CZN>ED77-H13"&X82A'.)'%*3P GFP.=D)2_6%M;Z5O?F5 ZJ;_$N^-NS
M@H;HT/_U]/W'O[UY<_;YXZN__/+FPYNW[SZ?OC_Y<+8<_/1+'3E6%R&MP.5;
MWOQ>/^(._OQ.[]O9G6_';2-O_O5HGL;3^>4,/Y;;K_Z$RUWP%=F8\^6<MUB)
M.PT_*@+G-_$J'X,(AD/!5#MCT-'K0RI@=-:<)?36MP[J[4;QSM/CUJ&8CV7Y
MC@<J.YG1$KY86N3S7W[<_,V:CI-_AEE>30O-,A2#44-T 4ET3$+0M(YKMQ%K
MO2UDL#<673/B^XTP'!"S#\;1]:+^ 1BM*^/GC)2\9.[]=%TW4P=;E\2%4&C)
MX#:9[&_R.)T.'BPS/CM=Z'-K&^$9<GH>_]P/0*;[T=9P@;<>J"V0YU '+4>N
M/"A=,_N),W"VT!)'(7WSID//$M0O^)JIO1N<MM#!  !5CP=:G6&,\_4X=2.E
M*8H<.(.L3LA+9$(7DI1,(GG&'=F/K4N$'A Q2.!LH^!I2VD/ "YG.*:O+G[%
M"<["^&223_+7T614;8F:@UB;Z%?,>9XMMS&0,9$D*"7)^=-2U]Z,J02E0A"M
MLV$;$=AO 'U_,-N?E@8 P4^D)2+@"['U&K_C>/JM2F_-TYJEVL$@E^+!&9](
M>,L>ZS:"11%I>P_%\M; ZT!6OV'K_<&MM48& +(7S=6GK-7WUW.^@X^TA]=^
M MZ2B1%<A. $@E5<<IY5,*YUX=CN5/>[(P[#73BP[@> ]I/Q\F\P/\[Z>B6?
M&VN93SR#"2D25RQ#R"S2:1&X-9QA^U+(;I3U[.0>&"_WLS3ME3< 2+[Y^FT\
M_8%XAK/OHX2/\_8Y_+XN!J@](A_EFA&C43 027%0.5L(3$5(H7AG0B9#)[2N
MQVI"><\;<;^0[D'YQPGY-[_C+(WF]<"L*9./W^J?S,^UT,*C2% <)\955B1[
M72M?E#::C*_,6K<Q;$9\OT;R\0&_ 02.*A%Z7?Q[D].XHZJ<1_7?,'XW*=/9
MUY6/LX<$Z2YT["]QVDPZ TFH)D6^I\M@G2Z@4BK@ZRT09U2*5AJO0^N:S9\F
MH8HJQJ(U>!\-*%0*7$D:LN)<RQ0T:U[N^J^$ZJ:8W6-"=0/U#\#V65%.?[S,
MSFBNXDIF9+Z!$JNP40&N1(A6!Q5UZV* .P3\-$G334!PWZW<6B,#@-/V@KMA
M>Y)K$?F'\!77(=)HO).TLB%$,N>4+ Y\$1J8"DDIHTR(K:WJ??#1+[AW@-6F
M8;I]ZW@ ./^$=.B,4@W^5./_M\EH,?]T]MM5;M&'7&*1P%FRH**T$)TJ0$ZQ
MTCD6(YK75#U+T,##='O'R\.T22/E]8A$\IC._QIF_\#%4G9+)M8<J&B5E:GF
MLCW6R7R*9$,,25FBY[(4M.P%]^OIIP\\/G8H+#42_P"VLE.<+3W2R3KL<<6&
M"\+ZS!.DR&HS>O2U&;VA(T+*F)QA*K:N:7J"E(%'I@Z]?;50V !PUR+B9T4F
M*\: EZH6D_D$GG,.W$KK>+:"J=9EW__*]+;P<0ZL^V-&^^I:S[L)F2R72ZTL
M;X1]_A(FZXCSK_2(Q?S=9-5LZIQ)'1QC"H@)36HQ!0*S":QD+&.,RC4?-'LH
MW@9NQC;&;*LELT\ _8D6UO_BZ.(+N0PGWW$6+G#YY>NPP+=A-*N3?/ \L.PT
M9P&,R#7?0R*,%@OI.03TBF7CCW7EO<C\P+V"GV-IMH7@424?[T?];PGWPW1Y
M)157YG9-$NPCZ[@5 ?M+-^XNCV'D&8OQ"K.3D!$MP50(6H!!@Q F.U<"1]EZ
MS_Q9\HQ56#D4#B74ZO'(%800+0BCE6*";'#>/"K^KSSCAIC=7YYQ$_4/P$R[
MFWZP+!96O ,A8QV[KAE$(0OD(LG"9$68V+R7R,^89]P(!,_F&3?1R #@M)>@
M7 DZI:@S:&9KZ9:,X"QSH'GPW*$R13:OW/C)\XP;P>H0><9-=#P G+^0JDH\
ML,0L<%<G9RJ7(!;G  4*5ONIQN;7_/YL><:-\+)9GG$#Y0TSSQ@S"SDGA.)$
M N7(>XZVGD.E:,44%GO_UON?.\^X#98:B7\ 6]E3::L8=5*VIMJSUG6J60"O
MG >G)*V!:+UMWK;CSY-GW&7[:J&P >"N07#0%JEL+@6XK%>X#+$=9? U94MF
MC G(7?,>2?_*,S;P<0ZL^P&@O=-%EKLAPOER L/M[VL$Y,-T\3=<?,(TO9B,
M_L!\;C/7C 4!MM38,A,% G<93)(L:U&42JW;D^R-F8$;JHU1N<U=I[U#Y&=>
M*ZMTS=OI;/VK^G?\O*#T)CG:PP0YQ$I@ :>3!^9<C$XFF7T^E@7T*(<#-]F/
M=%7M#J8!9OK>O_GUY/WIIX^OWKQY_>[#KV<G'UZ_^OCA,WU\\^'5NS=GVZ?P
MNCYYU]S<5APT2KH19+Z.%JNLQ(0 -EF,"..3-,+Y36[C.E_AD]<L) 7>,[+7
MG1,0'$&E_CXKS+SXUH,U-R)PE\C$>UH.%^O+N=58C&028E:)/)(0:VXF@W.>
M \=<[S?P8(U_ 4"//+9?<V%_VKX=9-A%DCV>Y?/9XA;IKVC#7;49S%D9PP(4
M2T:(,DI!3(5$X;/0Q3@CNXU;H,??PCO]=(/UQ]_<#U1V5N"TF30'A84:%%E'
M0EA47,7,:D$^@E(8P-OB@&4524+)DG":(^+F_?W@HH4^GX3&EL+M.99]0MOG
MZ6M>_XG3_..&I75T2]-*";HH( ,+5\.;R(=)8'B1DCE%OHSL<(*\\)JAP&%;
M'4[W(]">L?'JY-/GOXP6^( 'Y@/SQ47@3). 3+U:D4P&+9P7MB05S4MVZ7//
M[\=QV@L:FHBP9QB<CL/WT>\GE]6B&H_"N\D"QV-,B\LP/IU-O^%L\6/-%/=,
M1A48.%:;O7B!X*(S$")CEANEX_TN5X_BHO,+^\E0[ 4H^Q%RWX=+'(U'Y0<Q
MD"_3XOTHU)^O&2D,8\K6 B9'IKD)'%:=/[6P7J&.&DN7H^6YE_0S VD_!TLS
M8?:,BH^3B_&//\)]1AYLD446E$XQR-DJDA9QXU(2H!!UDDHX$7('?'1\73_3
MBO:"E'T(N.^2BRG]-CS@0"K#(_-DK]?)<DK90'LATH;H/;>(4MK[1;^/EUP\
M^O1.B#!'@8@&XNM[T_BV^'BY>$-6]6)TG7J7J'G(TH%Q7H+BKD"TQ8/0 8ND
M<S#=3T0_OD,\\NQ.RK='H?R=1==S#.-JW.325P\*E<\I G.2K)^D/ 15IP89
M)+/9&A-SI^CM"W&+V^_LQQUI&</:6H(]:CZM::Y]A=?TUPCO:BEHGJP15I*[
MI.B\TA'!&^DA%LNS+W4Y/%>!,L?T[Q?3[_]Q]8X5$JY^ND'"<S3T%[+87IO3
MQJ+=&A[?<1:GS0#RV^MSR92V1GO 7,>7&*O)G::%$J-0P:J2A'TNF;PY('Y[
MW0\ VNGN 1@V%.,0]H;?SEZ?,Z6<E#E"D*'F?VT$7\@'"L*H6O=)[#Q7,+FQ
MZNF=_9P(^U/]IF+L4?491^?O\2*,E_;,:@^,@CN9B&VMC0<EC0&RANK,Z5BX
M9(8E?"Z[=84 >O1*^?3A1N^/O+"?L%,K@V!7"?:L_!75:]1+DZ01FH.)-8K*
M?(#@HP16"F/(K=7E.6OP9<W??EL_&_[.ZIHVD%W/SM\OL]%\,1W_]0<][>S_
M+D<QKKV8P&()T1IPM>)'(:O=Q8L%S>B@4HPI&>_I_U$'\*GG]Z?Q[34U;2RV
MGIV_ZSE1O^+T8A:^?1FE,%[=I?-*.F44G7@Z@8K:P-(0+I+6@W')AM1II,8+
MGN"3!/036F[I%K:1;=\ P8O[+*R7C75%\DA[HRA2U/ FAYB9AV0Q9;)R4F*=
M;M*\!)"G".C/0VRDV&EK*??I,DPO)XM93<B>.QNYE[).E[/UP@XC2U<2[5J4
MXF01F9?GFFQ<.PRK)Z[]A=4/M]R%Z_?U"(,V2ION),&>38>EZ70ZFR;$/)I<
M/"@9?']=[1QS+CYG ZG0^E"8 AV/D8Y:P6JA?A1HNES?[/S"?A).K<Z/_<EV
M #<AWD_G\QM.?IS2;EJK3<=CO, \_O%N4F;UJ_SA<M7A-@7N!"^0=:8U4>A3
M+*RZX@XSY]%IWKIKSV84]EB%N1^(3 ^FKP&@\:KC3KWS,/T1QC6+<YZ0*TGK
M%A+W=<23K[E;VI&EMME::1X63^Q^3?@1.GK,C1P$63O+ON?C;T7TCU\O0^V.
MASB_53U_BK-$_YYG9CB7SH$F29%[&9#<2\FAD*THI.%9VRY56QU>U6/@;*]H
MV8>D![#QW-M67X>OX0+GIV&45^T5D:<0DQ"UJ2(GNX%XBHDIX$J9(JRJ#L5^
MS[W[)/7HD_=QT.VDD<$"[&QZ>?%EL>[@&8.VG&5@DO$Z/YF#L\$ TTI9:RS&
MV+H'U8M$]6BX]PBR;;4R/)B=XJ1*[]4XC+[.KTQ"%5&KY$$'3AXM<PP<G>*0
M#3/D(VLK1>OYO"]3U4\!6G]F^XYZZ3O2\"(WKT?SKZ/Y'/,Y<UEX65M<F5#C
M+]*"=P5!)L.4\:A-ZA1KZ/[*?NK9#F-Z[4OR@P<4?9[/3U+5XGDJ=9@N+0WO
MB#ME:QDG(]LRZ>6X1^M8IUK(C5[:"53N9P75MM(?/*S>T6^^C_)EG<[[]\O9
MC]5WYTP$Z7@M$N>F%@>A);<W!T!C8D1+,-)=BJVW?7\GL/F?%6P-=#)XW-6U
M]!W/64DZEQJ.%G4M"8L00[+ +3="('$<NMP+ZOJ^;L%1]K,":PNA#\"DKSS5
M_@ZT'C[&\3J;<4Y.":_EL% (#'2XVP(Q5Y/1:Q%-+@*QM;?X*"'=('7$ ??=
MQ3\ #)VD-+NDMZ[O1Y%P5E65"Y+9A^ED51VY./<VBB0,"49E)!>$1V*HSL-$
MYEF6R=KF4]6Z4=8-94<<?-^#@O;?^VG]1?V_.B_A/__M_P%02P,$%     @
M%U^;5K&63_M2"   >R4  !4   !B;7EE>#,Q85\R,#(S,#,S,2YH=&WM6FMS
MV[82_=Y?@<K3-)G1BWKX(3N>L66ET4QBI[9RDWSJ@ 0HH08)!@ EZ_[ZNPN0
MDFQ+KC*=-*KG=J:*22P6N]B#LPL0)S]?7/5'7SX,R,0FDGSX>/YNV">56J/Q
MJ=UO-"Y&%^3MZ/T[TJDW S+2-#7""I52V6@,+BND,K$VZS4:L]FL/FO7E1XW
M1M<-5-5I2*4,KS/+*J<G^ 9^.66G/YW\7*N1"Q7E"4\MB32GEC.2&Y&.R2?&
MS2VIU0JIOLKF6HPGEK2:K3;YI/2MF%+?;H65_+34<]+PSR<--\A)J-C\](2)
M*1'L=45TV\%1*PSWFP=QM],-6V&'[=.#H[@9!(<T"N(_ C"R >*^C[%SR5]7
M$I'6)AS'[W5:]8-N9H]G@ME)+V@V?ZDXT=.36*46QM/0W__IU3Q29OF=K5$I
MQFG/N53Q7<OF2$FE>WM-]]\QMM1BF@@Y[_TZ$@DWY)+/R+5*:/IKU4 8:H9K
M$7M!(_[+P28PSSW.O,D'H$>*E)<N!"TT>O#Y[?!\."+M@-XW>-5OJL?@NE59
M[PB4KE@>P51S_8-,[P^N1\,WP_[9:'AU2<Z_D-'; >F_'0[>D,'G0?_C:/B?
M ;EZ Q*#ZXV^[8HS'SY>WWP\NQR1T16Y&?2=2^UF"^QW;MV<79^?70YN:E>?
MWPV^D+/^"%M:S69KRZA]=[<Z:]T:5LEO0DUIF@K2I['20E5)Q+45\9S8";4O
M]KJ'Q]LB+Z., 2W4)(]MK]LIL2A2!J'KU?#-#_(SJ)<^_/.CWY^6SGZ]B],P
M)!,ZY43SJ> S(-1S+8Q5LO9^SK4A-U]S$89 J$E&T_F+O<-6<'!LR.\YU; &
MY)Q<\TQI2U1*WBB=D*!9^YU ^"!FG'SU4H3#O#/RGNIH\F(OV&\>MX.J8V8(
MZM$S"&IKYX)Z3@W,. 0EF9/;5,TD9V->A: (4T8%8J=][)@"8U(%.17&HB(E
M$&F2IU;G''R!+.L2KHH))0D\:4$EB6D$KS11B;#$*B_W2"#E$3>&ZCF*)/26
M.U@L=!IXQ\ L&%*Z; UCH$ D-&1G$$NA.UC" $.SB8@FQ.3XL^P_XYH72M"!
M1!@):1PK@IFP$W#09#QR!J+>#$Q3#-R<0C=&POGZ"7DFJ&S_>U#)22Q2B#8"
M9QG=*@ 1Q*%9K[2+%.@%8 ;5)/P=R1RY!1"T-I15P*' QPR@@"A&=$NYA&F!
M$// "%@)S!6L593()0@ -A4 R ULG&41-1,22S4S)7 U'P-Y0K5K"<67W@.P
MM[J"/U,:\X3=SP2"G9V#X.A>E!;YS(.LJ#>0/E0<"WAT\1L2JKE#"D1>A)*[
M!,<!J*$49H+B*)8 =2)]XC,3)I+*Y- /254KZ2&3:15Q!J\->0D(81P@YV$P
MN(LF-!US<@9\=9U+D C:M!9T7_)7KFO09?[)/PJL05,/5=1/D-16$.QQA+9L
M/5!\;Z 8!BH3^2JN00(+AJWKL?V'"#UJ/D1H>_^'(93N#$);1_7F <X#;&5A
MEP'!<LGNKY%4Q3P<T=QLWP438LC)8B2?8E6N00&0U%081WT@Q5.G!ROP)6FN
M4K#FDCJ8%3EV"95J0<_8*(! P1:CI&!NVV[RT @FJ!;H@/"5@$L**6K*#69G
MMRJ-2^6.*)7A8!!LV%VG#"A31+FD2)O@EC-BF>6AAZ\9UA<]\"[DV 7(&#1Q
MMC7E[C:@P]T!]*&GW/MXWIJW'L%Z>\;;&MVP(J:"(6BI42E%:J<& (^%)R*9
M:E:B"G N:"BDL'/,]NN&Q37F .@0Y9?'/=&5PM5ED+O"H2S7&6#;N.HDBI1F
MS@!7PHYY"D6'!.!""\]P[: (E.<>O+#&1 8D_DS@&^T.?$L^YE,J<T=:&%P>
MQU OBBF$Q:RI^Q85Q18D[!\?EH(%/R%<H2,0J/$%9ZARN]F";=($74ASK*OC
MI_9$A15A6;&[%5C,!-CCT(8#_/L1QW8'<25A^E@^Q@3NRXOBS;6L!=XWT"0F
M=15%N<;(KV30-5H392R\QZ-/T&4B4%2>[KS<T"4&" .!/9 N#(>]$W='"GC:
MD.8+NUYYJR;4+,H-I#X'><Y<3G#S4?#UG$AQRV5QOO! OOJWI^B;8+[;6['N
MSL#\[VW%W&'E8H54EPR%A+F*TB59(<Z^H>QX5,@N3*-0S%JES2+3NQ>@,DF$
MM9P_D0Y"!;4$MC,!]CDE+P'+P+X&V1W^Q9*Z7(#\:R[ ?+?8\C1")U[]?\/U
MO1(\'@AAJ2@ 9[C%Q<UR)#@ HTC2BXW/C--;S+J^5'-YUQ69[B2T/!Q:!S?S
M!-[\+L4?,:RA-<J@I^$+5ML(SJ(XA2Z ,*@AJS[Y&\C\)D\ (#!/SITBFZP]
M4GM&B7WW=D*8OV,-I(%!YX[G #CNX+I 6-6G/Y%.E9QRS($I'1?G[[J@1IYD
M4LTYM,XFRO,AO8=?P-NW% B;L5G?[6^&%S!ICA7)&>R#I/^TU#KPGY;(-K8'
M/A];M_,KFD-8.ES7P E),\-[Y1_'D'0R2><]D3I37*?C0EFHK%5)#[_T3S%S
M0<53?"QVJ\$W%Y< .D%]?W\?[P%8#?^S<N#BBD#=71%H6/:X[>BP?M3<W-RL
M!XNVAM/M]8,')J/IZTJ[4G8HX-EK97<DN/^I_L_<8.9]Y(?*_ODP.V=?['4
MMNYWS3?B]_6+)4RW\+P(KXM^!K[@B10IG7AB6G AKY^3]9<$BFG\07/V%_/T
MQ.6&[VZWT]@3%H:+MO"D/Z$"<E-:UE;GKI#"--:?"!Z3P1V/<MP-DRM?)SZX
M3K. 1,,MV#7./[BIDRE_5:GG3S:G_-'=G264W*)O+KO0$/"4V\U=-MTBV7@1
MJ/CUUY+<!:G3_P%02P,$%     @ %U^;5MJ[ARI3"   UB8  !4   !B;7EE
M>#,Q8E\R,#(S,#,S,2YH=&WM6FUS&CD2_GZ_0DOJLDD5;P/8&.RXRL:X0E5B
M9VURV7RZTHPTH+-F-)$T$/;77[<T ]@&'[E<UFSJ4A7,C%JM;O6CIUM")[]<
M7 _&GS\,R=0FDGSX>/YN-""56J/QJ3UH-"[&%^3M^/T[TJDW S+6-#7""I52
MV6@,KRJD,K4VZS<:\_F\/F_7E9XTQC<-5-5I2*4,KS/+*J<G^ 8^.66G?SOY
MI58C%RK*$YY:$FE.+6<D-R*=D$^,FSM2JQ52 Y4MM)A,+6DU6VWR2>D[,:.^
MW0HK^6FIYZ3AGT\:;I"34+'%Z0D3,R+8FXIH=X.@=T YIX>T$[:.:"NF4=CM
M!NU.-Z;=\)\!&-D <=_'V(7D;RJ)2&M3CN/W.ZUZ]R"SQW/![+0?-)M_KSC1
MTY-8I1;&T]#??_5J'BFS_*NM42DF:=^Y5/%=R^9(2:7[+YKNWS&VU&*:"+GH
M_SH6"3?DBL_)C4IH^FO50!AJAFL1>T$C_N!@$YCG'N?>Y"[HD2+EI0M!"XT>
M_OYV=#X:DW80WC=XW6^J)^"Z55F_!TK7+(]@JKE^)M,'PYOQZ'(T.!N/KJ_(
M^6<R?CLD@[>CX26Y'%V=70U&9^_(]25(#&^V^K8OSGSX>'/[\>QJ3,;7Y'8X
M<"ZUFRVPW[EU>W9S?G8UO*U=__YN^)F<#<;8TFHV6SM&[8>[U=GHUJA*+NA,
M,/*/.AG*.Y&:*HFXMB)>$#NE]N6+@Z/C78&74<: %6J2Q[9_T"FA*%(&D>O7
M\,TSN1G42Q_^_-'O3TOGL'Z TS B4SKC1/.9X'/@TW,MC%6R]G[!M2&W7W(1
MAL"G24;3Q<L71ZV@>VS(;SG5L 3D@MSP3&E+5$HNE4Y(T*S]1F*E(6:<?/%2
MA,.\,_*>ZFCZ\D5PV#QN!U5'S!#4WD\0U-;>!?6<&IAQ"$JR('>IFDO.)KP*
M01&FC K$3OO8,07&I I2*HQ%14H@TB1/K<XY^ ))UN5;%1-*$GC2@DH"61!>
M::(288E57NZ10,HC;@S5"Q1)Z!UWL%CJ-/".@5DPI'3)&L9 @4AH2,X@ED)W
ML(0!AN93$4V)R?%CU7_.-2^4H .),!*R.!8$<V&GX*#)>.0,1+T9F*88N#F#
M;HR$B\T3\I.@LOW7024GL4@AV@B<572K $00AV:]UBY2H!> &123\#V2.7(+
M(&AC**N 0X&/&4 !48SHEG(%TP(AYH$1L!*8JU>K*)%+$ !L*@"0&]@XRR)J
MIB26:FY*X&H^ ?*$8M<2BB^]!V!O=0U_IC3F";M_$@AV]@Z"XWM16N8S#[*B
MWD#Z4'$LX-'%;T2HY@XI$'D12NX2' >@AE*8*8JC6 +4B?2)STR82"J30S\D
M5:VDATRF5<09O#;D%2"$<8"<A\'P:S2EZ823,^"KFUR"1-"FM>#@%7_MN@8'
MS#_Y1X$E:.JABOH)DMH:@CV.T):=!XKO#13#0&4B7\<U2&#!L',]=O@0H;WF
M0X2V#Y\-H71O$-KJU9M=G ?8R<(F X+EDMU_1E(5\W!$<[-[%TR((2?+D7R*
M5;D&!4!2,V$<]8$43YT>K,!7I+E.P9I+ZF!6Y-@55*H%/6.C  (%6XR2@KE=
MN\E#(YB@6J #PE<"+BFDJ"DWF)W=JC0NE3NB5(:#0;!?=YTRH$P1Y9(B;8);
MSHA5EH<>OF;87/3 NY!C%R!CT,39SI2[WX .]P?01YYR[^-Y9]YZ!.O=&6]G
M=,.*@"TG@I8:E5*D=FH \%AX(I*I9B6J .>"AD(*N\!LOVE87&,.@ Y1?GG<
M$UTK7%T&^5HXE.4Z VP;5YU$D=+,&>!*V E/H>B0 %QHX1FN'12!\MR#%]:8
MR(#$?Q+X1OL#WY*/^8S*W)$6!I?',=2+8@9A,1OJOF5%L0,)^\>'I6#!3PA7
MZ @$:GS!&:K<;K=@ES1!E](<Z^KXJ3U184585NQN!18S ?8XM.$ ?WW$L?U!
M7$F8/I:/,8'[\J)X<RT;@?<--(E)7451KC'R:QET@]9$&0OO\>03=)D(%)6G
M.Z^V=(D!PD!@#Z0+PV'OQ-V1 IXVI/G2KM?>JBDURW(#J<]!GC.7$]Q\%'R]
M(%+<<5F<+SR0KW[W%'T3S/=[*W:P-S#_OJV8.ZQ<KI#JBJ&0,-=1NB(KQ-DW
ME!V/"MFE:12*6:NT669Z]P)4)HFPEO,GTD&HH); =B; /J?D%6 9V-<@N\-?
M+*G+!<B_Y +,=XLM3R-TXO7_-UP_*L'C@1"6B@)PAEM<W"Q'@@,PBB2]W/C,
M.;W#K.M+-9=W79'I3D++PZ%-<#-/X,WO4OP1PP9:HPQZ&KYDM:W@+(I3Z ((
M@QJRZI._@<QO\@0  O/DW"FRR<8CM9\HL>_?3@CS=ZR!-##HW/$< ,<=7!<(
MJ_KT)]*9DC...3"ED^+\71?4R)-,J@6'UOE4>3ZD]_ +>/N6 F$[-NO_Q0^]
M_\H-$O<SQ?P"YM$1)3F#K9'TOS:UNO[7)K(_[O1V\L:;OXO506>;V=;M:HL>
M(= "US4P7]+,\'[YY1@2:B;IHB]29X7K=%SH#Y6U*NGC)8899F6HYHI1W("^
MN;C?T.[5#X,>7G&P&OZS<N#B]D/=W7YH6/:XK7=4[S6W-S?KP;*MX71[_>"!
MR6CZIM*NE!V*I==O95])L'%:'OFALC\?KTT?X0XL2??Y\.?O9=AW<+F(JT-"
M!D[@,1LIK7]B/I"=-D_&YHL/S[:XFWYQ;YZ@)VYJ_'"#G<:^L#!<M(,+@ZG@
M,;E<4NVUKVT?W !:1KSA%N*:B_]C/XZ^AX:VWF!:"\6#2U"9\K? ^O[4>,8?
M78M:(=J13G/5A88 Z]QN[[+M@L[6.U;%I[_QY>Z>G?X;4$L#!!0    ( !=?
MFU:%FY(FZ 0   (0   5    8FUY97@S,F%?,C R,S S,S$N:'1MS5?K;]LV
M$/^^O^+F8'T ULMV$K\:('&R-4#35UQT^S10(F5QI425I.)X?_V.I)RTM9T&
MW;(V" 19Q[O[W?LX_?GTU6S^Q^LS*$PIX/6[DQ?G,^@$4?2^/XNBT_DI/)]?
MO(!!&"<P5Z32W'!9$1%%9R\[T"F,J<=1M%PNPV4_E&H1S=]&5M0@$E)J%E)#
M.T=3^P6?C-"CGZ8_!P&<RJPI664@4XP81J'1O%K >\KT!PB"]M1,UBO%%X6!
M7MSKPWNI/O KXNF&&\&.UG*FD?\]C9R2:2KIZFA*^15P^JS#L^%^+TD.<CI(
MAH.T?S :]A,R)(,\R7M9-CS\,T&0$1[W/-JL!'O6*7D5%,SJ'P]ZX>%^;29+
M3DTQ3N+XEXX[>C3-9650GT)^_^K%; @S[-H$1/!%-78F=3SKFIQ)(=5X+W9_
M$TL)<E)RL1H_GO.2:7C)EO!6EJ1ZW-48AD SQ7-_4/._&6)">.[GTD,^1#F"
M5VQM0M*SH,]^?WY^<CZ'?H]\#OA3NXE:H.E&UN,1"OT$>8:N9NH[09\Q97C.
M,V(S$-(5F(+!K. LA[-KEC6&7S%XE>,)IN!UHW1#$*21D SA70B7(<SPR3++
M_F@O.8@G27\_[@+1.SWQHYA^3&5MJ^13JSZS9!0?@,R=1RZ)2DG%=/#J6K 5
M'&?&4GIQW/N&@/_5:/3YZL'-'FPU>R.(E^'V$)YWX3<NKTA5<9B17"HNNU P
MQ3!+,I<V-EN(Z5I)UDDIT\XMY0H^5'(I&%VP+IPHKHT4P<6**0V7'QN>IMB$
MRII4JT=[PUYR.-'PIB$*,T&LX"VKI4(Q%?PJ50E)'+P!U.T4?/2G@%44XW9!
M5%9XP/VDZ[O9$WOLT5Y_,/%RW.M3FXZ0<P0$2VX*'U%,;H5]%QU+*HK)GA6D
M6C"+K.1:VVK _^-:<>%U] Z]CB[DC4"@&9H@+/N-2,70.,5LZ]36#U_X] EY
M"FC(YU_WG]"G-TEV"^D&3IMIR:@_<%:0TAG?=:"M]QTGK]!%I:_A##. 8-0I
M?G7$UJ,YX=:_M6+: NQ:,A$"D T3B0B$KVO$AA3+E?.*5)G]C@*I&U!.)YYJ
MA+=/UDPYG>[777$.-ZID9X^_H?UG=3&Z5UGX>-RGFG%D8>D:D@JVIJ924:8"
MA"I(K=EX_3*A7->"K,:\<AH=TZ25E4IC9&G%3:YL.65$M W"]0I/;H?C( GW
M'<RI08<9NE;<CL[0D2)#-VFC83B*=Y/C,+FA14ZVEX\6:(S<LTZ_LV:H":6X
M3XQ[]34D6SO:AAVR_O^;7.RC.<"VXIY;FMA%>'J;D?>PO VO#3X:#EH*3F%M
MQ!UN$2S?C*WSR?9Q^-T&@_/95_QTQQA_<-Q.XI@;5)?=PY)9@;T.Y:X;ZXDD
MBKKNM6.S^6+-O$F)R!7LW>U@4#_\VKF]96T93O#0S73X;YKI74W_1RH'9\.\
MX#C;<1X;5J%NG)+N;H4?4V:O57FC*JX+G+/M^G./C<(.\ K8=<%3;M9\?CZ'
MWF?'H-%T%(H5B!F&X]?E\%8H[;Y![=K>;A5@=]:"6(QXM%;RBE./\*[Q[/ N
M.2X#J=UBVO4!I7Z5Z5N<@#L0QP4"[<AS:&K\8@W!W7%WK_GBPEA+?V,>*R:(
MK>.-*^1MYW8S-KYE(2FV[\;L9MEU/=EY'VV?_G;L[NE'_P!02P,$%     @
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M=N=:[V;9=>O8><ULGN[2:Z_?QW\#4$L! A0#%     @ %U^;5DC2IR.[E0(
M=N8A !               ( !     &)M>2TR,#(S,#,S,2YH=&U02P$"% ,4
M    "  77YM6[TI=_B$7  #5"P$ $               @ 'IE0( 8FUY+3(P
M,C,P,S,Q+GAS9%!+ 0(4 Q0    ( !=?FU;\L9E ZS$  )SW 0 4
M      "  3BM @!B;7DM,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0    ( !=?
MFU9NV.AZ*78  !?L!  4              "  57? @!B;7DM,C R,S S,S%?
M9&5F+GAM;%!+ 0(4 Q0    ( !=?FU8O8K&W'"@! &\;#  4
M  "  ;!5 P!B;7DM,C R,S S,S%?;&%B+GAM;%!+ 0(4 Q0    ( !=?FU99
M%;+<TKL  # N"  4              "  ?Y]! !B;7DM,C R,S S,S%?<')E
M+GAM;%!+ 0(4 Q0    ( !=?FU:QED_[4@@  'LE   5              "
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8=&U02P4&      H "@"0 @  ,U4%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
